var images_info;if (!images_info) images_info =[]; images_info["52"]={"52000":{"type":"graphic_figure","displayName":"Brugia life cycle","title":"<EM>Brugia </EM>life cycle","html":"<div class=\"graphic\"><div style=\"width: 600px\" class=\"figure\"><div class=\"ttl\"><EM>Brugia </EM>life cycle</div><div class=\"cntnt\"><img style=\"width:580px; height:467px;\" src=\"images/ID/52000_Brugia_life_cycle.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The typical vectors for <EM>Brugia malayi</EM> filariasis are mosquito species from the genera <EM>Mansonia</EM> and <EM>Aedes</EM>. During a blood meal, an infected mosquito introduces third-stage filarial larvae onto the skin of the human host, where they penetrate into the bite wound <STRONG>(1)</STRONG>. They develop into adults that commonly reside in the lymphatics <STRONG>(2)</STRONG>. The adult worms resemble those of <EM>Wuchereria bancrofti</EM> but are smaller. Female worms measure 43 to 55 mm in length by 130 to 170 mcm in width, and males measure 13 to 23 mm in length by 70 to 80 mcm in width. Adults produce microfilariae, measuring 177 to 230 mcm in length and 5 to 7 mcm in width, which are sheathed and have nocturnal periodicity. The microfilariae migrate into lymph and enter the blood stream, reaching the peripheral blood <STRONG>(3)</STRONG>. A mosquito ingests the microfilariae during a blood meal <STRONG>(4)</STRONG>. After ingestion, the microfilariae lose their sheaths and work their way through the wall of the proventriculus and cardiac portion of the midgut to reach the thoracic muscles <STRONG>(5)</STRONG>. There, the microfilariae develop into first-stage larvae <STRONG>(6)</STRONG> and subsequently into third-stage larvae <STRONG>(7)</STRONG>. The third-stage larvae migrate through the hemocoel to the mosquito's proboscis <STRONG>(8)</STRONG> and can infect another human when the mosquito takes a blood meal <STRONG>(1)</STRONG>.</div><div class=\"graphic_reference\">Reproduced from: Centers for Disease Control and Prevention. DPDx: Lymphatic filariasis. Available at: <a href=\"http://www.cdc.gov/dpdx/lymphaticFilariasis/index.html\" target=\"_blank\">http://www.cdc.gov/dpdx/lymphaticFilariasis/index.html</a>.</div><div id=\"graphicVersion\">Graphic 52000 Version 6.0</div></div></div>"},"52006":{"type":"graphic_picture","displayName":"Carotid angiograms in ICNSV","title":"Carotid angiograms in primary angiitis of the central nervous system","html":"<div class=\"graphic\"><div style=\"width: 504px\" class=\"figure\"><div class=\"ttl\">Carotid angiograms in primary angiitis of the central nervous system</div><div class=\"cntnt\"><img style=\"width:484px; height:254px;\" src=\"images/RHEUM/52006_Carotid_angiograms_in_ICNSV.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Left panel: An anteroposterior view of a right carotid angiogram in a patient with primary angiitis of the central nervous system (PACNS) reveals focal narrowing of multiple vessels in both the anterior and posterior systems. Right panel: A lateral view of a right carotid angiogram in PACNS demonstrates beading and multiple irregularities both proximally and distally.</div><div class=\"graphic_reference\">Courtesy of Leonard H Sigal, MD.</div><div id=\"graphicVersion\">Graphic 52006 Version 2.0</div></div></div>"},"52007":{"type":"graphic_figure","displayName":"Saphenous nerve block","title":"Saphenous nerve block","html":"<div class=\"graphic\"><div style=\"width: 513px\" class=\"figure\"><div class=\"ttl\">Saphenous nerve block</div><div class=\"cntnt\"><img style=\"width:493px; height:289px;\" src=\"images/SURG/52007_Saphenous_nerve_block.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Medial view of the extremity: For saphenous nerve block,&nbsp;the tibial tuberosity is first marked. A subcutaneous longitudinal wheal of local anesthestic is&nbsp;injected posterior to the medial tibial condyle (shown as a&nbsp;dashed line)&nbsp;or, alternatively, around the saphenous vein, if it is easily visualized with ultrasound. </div><div id=\"graphicVersion\">Graphic 52007 Version 5.0</div></div></div>"},"52010":{"type":"graphic_picture","displayName":"SCCA left vest skin","title":"SCCA of the left vestibule with direct extension to the skin","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">SCCA of the left vestibule with direct extension to the skin</div><div class=\"cntnt\"><img style=\"width:396px; height:313px;\" src=\"images/ONC/52010_SCCA_left_vest_skin.jpg\" alt=\"Image\"/></div><div class=\"graphic_reference\">Reproduced with permission from: Parsons JT, Stringer SP, Mancuso AA, Million RR. Nasal vestibule, nasal cavity, and paranasal sinuses. In: Million RR, Cassisi NJ (Eds). Management of Head and Neck Cancer: A Multidisciplinary Approach. Philadelphia: J.B. Lippincott Company, 1994. Copyright Â© 1994 Lippincott Williams &amp; Wilkins. <A href=\"http://www.lww.com/\" target=_blank>www.lww.com</A>.</div><div id=\"graphicVersion\">Graphic 52010 Version 9.0</div></div></div>"},"52011":{"type":"graphic_diagnosticimage","displayName":"Cervical spinal stenosis","title":"Cervical spinal stenosis","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Cervical spinal stenosis</div><div class=\"cntnt\"><img style=\"width:271px; height:378px;\" src=\"images/PEDS/52011_Cervical_spinal_stenosis.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Note the lack of white cerebrospinal fluid surrounding the spinal cord at C3-C5.</div><div class=\"graphic_reference\">Courtesy of Jason E Decker, MD.</div><div id=\"graphicVersion\">Graphic 52011 Version 2.0</div></div></div>"},"52012":{"type":"graphic_table","displayName":"Knock-knees red flags","title":"Clues to pathologic causes of knock-knees in children","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Clues to pathologic causes of knock-knees in children</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td>Severe knock-knees (&#62;8 cm between the medial malleoli with patellas facing forward and femoral condyles together)</td> </tr> <tr> <td>Progressive knock-knees deformity (after age&nbsp;four to&nbsp;five years)</td> </tr> <tr> <td>Persistent knock-knees (after age&nbsp;seven years)</td> </tr> <tr> <td>Unilateral or asymmetric valgus deformity</td> </tr> <tr> <td>Medial thrust* with ambulation</td> </tr> <tr> <td>Short stature</td> </tr> <tr> <td>History of metabolic disease, lower-extremity fracture, infection, tumor, or joint swelling/warmth</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">* A brief medial knee-joint protrusion during the stance phase of gait, which suggests incompetence of the knee ligaments.</div><div id=\"graphicVersion\">Graphic 52012 Version 5.0</div></div></div>"},"52013":{"type":"graphic_table","displayName":"Survival info DM","title":"Survival information for diabetes self management education","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Survival information for diabetes self management education</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td>Skills</td> <td> <p>&#8226; Blood glucose monitoring</p> <p>&#8226; Medication taking guidelines</p> <p>&#8226; Mixing and injecting insulin, if required</p> <p>&#8226; Using insulin pen</p> </td> </tr> <tr> <td>Supplies</td> <td> <p>&#8226; How to obtain necessary supplies and medication</p> <p>&#8226; Guidelines for working with insurance plans</p> <p>&#8226; Working with a pharmacist</p> </td> </tr> <tr> <td>Simple pathophysiology</td> <td> <p>&#8226; What is diabetes</p> <p>&#8226; Diabetes risk factors</p> <p>&#8226; Glycemic targets</p> <p>&#8226; Balance of medication and exercise with nutrition and stress</p> </td> </tr> <tr> <td>Simple meal planning</td> <td> <p>&#8226; Portion sizes</p> <p>&#8226; Frequency of meals and snacks</p> <p>&#8226; Composition of meals (carbohydrates, protein, fats)</p> </td> </tr> <tr> <td>SOS (emergency measures)</td> <td> <p>&#8226; What is an emergency?</p> <p>&#8226; Who to call for help</p> <p>&#8226; When to call for help</p> </td> </tr> </tbody></table></div><div class=\"graphic_reference\">Courtesy of: Dr. Barbara Schreiner.</div><div id=\"graphicVersion\">Graphic 52013 Version 3.0</div></div></div>"},"52015":{"type":"graphic_algorithm","displayName":"Management of severe asthma in children","title":"Management of severe asthma in children","html":"<div class=\"graphic\"><div style=\"width: 479px\" class=\"figure\"><div class=\"ttl\">Management of severe asthma in children</div><div class=\"cntnt\"><img style=\"width:459px; height:468px;\" src=\"images/PEDS/52015_Severe_asthma_child_ED2.gif\" alt=\"Image\"/></div><div class=\"graphic_footnotes\">IM: intramuscular; SC: subcutaneous; IV: intravenous.</div><div class=\"graphic_reference\">Courtesy of Richard Scarfone, MD, FAAP.</div><div id=\"graphicVersion\">Graphic 52015 Version 5.0</div></div></div>"},"52016":{"type":"graphic_table","displayName":"Comparison of aerosol devices","title":"Comparison of pressurized metered dose inhalers with holding chamber, dry powder inhalers, and nebulizers as aerosol delivery devices","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Comparison of pressurized metered dose inhalers with holding chamber, dry powder inhalers, and nebulizers as aerosol delivery devices</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup width=\"70%\"></colgroup><colgroup span=\"3\" width=\"10%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\">&nbsp;</td> <td class=\"subtitle1\">pMDI/HC</td> <td class=\"subtitle1\">DPIs</td> <td class=\"subtitle1\">Nebulizer</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"4\">Performance</td> </tr> <tr> <td class=\"indent1\">Majority of aerosol particles &#60;5&nbsp;micrometers in size</td> <td class=\"centered\">+</td> <td class=\"centered\">+</td> <td class=\"centered\">&#177;</td> </tr> <tr> <td class=\"indent1\">High pulmonary deposition</td> <td class=\"centered\">+</td> <td class=\"centered\">&#177;</td> <td class=\"centered\">&#177;</td> </tr> <tr> <td class=\"indent1\">Low mouth deposition</td> <td class=\"centered\">+</td> <td class=\"centered\">&#177;</td> <td class=\"centered\">&ndash;</td> </tr> <tr> <td class=\"indent1\">Reliability of dose</td> <td class=\"centered\">+</td> <td class=\"centered\">&#177;</td> <td class=\"centered\">&#177;</td> </tr> <tr> <td class=\"indent1\">Not compromised&nbsp;by humidity</td> <td class=\"centered\">+</td> <td class=\"centered\">&ndash;</td> <td class=\"centered\">+</td> </tr> <tr> <td class=\"indent1\">Physical and chemical stability</td> <td class=\"centered\">+</td> <td class=\"centered\">+</td> <td class=\"centered\">+</td> </tr> <tr> <td class=\"indent1\">Breath actuated</td> <td class=\"centered\">&ndash;</td> <td class=\"centered\">+</td> <td class=\"centered\">&ndash;</td> </tr> <tr> <td class=\"indent1\">Low risk of contamination</td> <td class=\"centered\">+</td> <td class=\"centered\">+</td> <td class=\"centered\">&ndash;</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"4\">Convenience</td> </tr> <tr> <td class=\"indent1\">Lightweight, compact</td> <td class=\"centered\">+</td> <td class=\"centered\">+</td> <td class=\"centered\">&ndash;</td> </tr> <tr> <td class=\"indent1\">Multiple doses</td> <td class=\"centered\">+</td> <td class=\"centered\">+</td> <td class=\"centered\">&ndash;</td> </tr> <tr> <td class=\"indent1\">Dose counter</td> <td class=\"centered\">&#177;</td> <td class=\"centered\">+</td> <td class=\"centered\">&ndash;</td> </tr> <tr> <td class=\"indent1\">Easy and quick operation</td> <td class=\"centered\">&#177;</td> <td class=\"centered\">&#177;</td> <td class=\"centered\">&ndash;</td> </tr> <tr> <td class=\"indent1\">Suitable for all ages</td> <td class=\"centered\">+</td> <td class=\"centered\">&ndash;</td> <td class=\"centered\">+</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">pMDI: pressurized metered-dose inhaler; HC: holding chamber; DPI: dry powder inhaler.</div><div class=\"graphic_reference\">Reproduced with permission from: Rubin BK, Fink JB. Aerosol therapy for children. Respir Care Clin N Am 2001; 7:175. Copyright &copy; 2001 Elsevier Science (USA).</div><div id=\"graphicVersion\">Graphic 52016 Version 9.0</div></div></div>"},"52017":{"type":"graphic_figure","displayName":"Fish-hook structure","title":"Structure of a fish-hook","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Structure of a fish-hook</div><div class=\"cntnt\"><img style=\"width:259px; height:288px;\" src=\"images/PEDS/52017_Fish-hook_structure.jpg\" alt=\"Image\"/></div><div id=\"graphicVersion\">Graphic 52017 Version 1.0</div></div></div>"},"52021":{"type":"graphic_table","displayName":"Etiologic clues to pediatric pneumonia","title":"Clinical and radiographic clues to the etiology of pneumonia in children*","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Clinical and radiographic clues to the etiology of pneumonia in children*</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup width=\"25%\"></colgroup><colgroup width=\"50%\"></colgroup><colgroup width=\"25%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\">Etiology</td> <td class=\"subtitle1\">Clinical features</td> <td class=\"subtitle1\">Radiographic features</td> </tr> <tr class=\"divider_bottom\"> <td>Bacteria<br /> (most commonly <em>Streptococcus pneumoniae</em>)</td> <td> <ul> <li>Children of all ages </li> <li>Abrupt onset </li> <li>Ill-appearance </li> <li>Chills </li> <li>Moderate to severe respiratory distress </li> <li>Focal auscultatory findings </li> <li>Localized chest pain </li> <li>WBC count &#62;15,000/microL (if obtained) </li> <li>Elevated acute phase reactants (if obtained) </li> </ul> </td> <td> <ul> <li>Alveolar infiltrates </li> <li>Segmental consolidation </li> <li>Lobar consolidation </li> <li>\"Round\" pneumonia </li> </ul> <br /> Complications: <ul> <li>Pleural effusion/empyema </li> <li>Lung abscess </li> <li>Necrotizing pneumonia </li> <li>Pneumatocele </li> </ul> </td> </tr> <tr class=\"divider_bottom\"> <td>Atypical bacterial<br /> (<em>Mycoplasma pneumoniae</em>, <em>Chlamydia pneumoniae</em>)</td> <td> <ul> <li>Children of all ages (most common in children &#62;5 years) </li> <li>Abrupt onset with constitutional findings (malaise, myalgia, headache, rash, conjunctivitis, photophobia, sore throat, headache) </li> <li>Gradually worsening nonproductive cough </li> <li>Wheezing </li> <li>Extrapulmonary manifestations or complications (eg, Stevens-Johnson syndrome, hemolytic anemia, hepatitis, etc) </li> </ul> </td> <td>Interstitial infiltrates</td> </tr> <tr class=\"divider_bottom\"> <td>Viral</td> <td> <ul> <li>Usually children &#60;5 years </li> <li>Gradual onset </li> <li>Preceding upper airway symptoms </li> <li>Nontoxic appearing </li> <li>Diffuse, bilateral auscultatory findings </li> <li>Wheezing </li> <li>May have associated rash (eg, measles, varicella) </li> </ul> </td> <td>Interstitial infiltrates</td> </tr> <tr class=\"divider_bottom\"> <td>Afebrile pneumonia of infancy (most commonly <em>Chlamydia trachomatis</em>)</td> <td> <ul> <li>Usually in infants 2 weeks to 4 months </li> <li>Insidious onset </li> <li>Rhinorrhea </li> <li>Staccato cough pattern </li> <li>Peripheral eosinophilia (if CBC obtained) </li> </ul> </td> <td>Hyperinflation with interstitial process</td> </tr> <tr class=\"divider_bottom\"> <td>Fungal</td> <td> <ul> <li>Appropriate geographic or environmental exposure </li> </ul> </td> <td>Mediastinal or hilar adenopathy</td> </tr> <tr> <td><em>Mycobacterium tuberculosis</em></td> <td> <ul> <li>Children of any age </li> <li>Chronic cough </li> <li>Constitutional symptoms </li> <li>Exposure history </li> </ul> </td> <td>Mediastinal or hilar adenopathy</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">WBC: white blood cell; CBC: complete blood count.<br />* The clinical features frequently overlap and cannot reliably distinguish between bacterial, atypical bacterial, and viral etiologies; up to one-half of community-acquired pneumonias in children may be mixed bacterial/viral infections. Chest radiography generally is not helpful in determining the potential causative agent of pneumonia. Nonetheless, these features may facilitate decisions regarding empiric therapy.</div><div class=\"graphic_reference\">Data from: &#xD;&#xA;<OL>&#xD;&#xA;<LI>Bartlett JG, Mundy LM. Community-acquired pneumonia. N Engl J Med 1995; 333:1618. </LI>&#xD;&#xA;<LI>Boyer KM. Nonbacterial pneumonia. In: Textbook of Pediatric Infectious Diseases, 6<SUP>th</SUP> ed, Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL (Eds), Saunders, Philadelphia 2009. p.289. </LI>&#xD;&#xA;<LI>Broughton RA. Infections due to Mycoplasma pneumoniae in childhood. Pediatr Infect Dis 1986; 5:71. </LI>&#xD;&#xA;<LI>McIntosh K. Community-acquired pneumonia in children. N Engl J Med 2002; 346:429. </LI></OL></div><div id=\"graphicVersion\">Graphic 52021 Version 10.0</div></div></div>"},"52022":{"type":"graphic_figure","displayName":"Head thrust test","title":"Head thrust test","html":"<div class=\"graphic\"><div style=\"width: 525px\" class=\"figure\"><div class=\"ttl\">Head thrust test</div><div class=\"cntnt\"><img style=\"width:505px; height:494px;\" src=\"images/NEURO/52022_Head_thrust_test.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">At rest, the patient is asked to fixate on a distant target. The patient's head is rotated rapidly by the examiner, first to the left (A to B), then to the right (C to D). In a normal response, the eyes remain on target (B). In an abnormal response, the eyes are dragged off target (D), followed by a saccade back to the target (E). This response implies a peripheral vestibular lesion on the right.</div><div id=\"graphicVersion\">Graphic 52022 Version 4.0</div></div></div>"},"52023":{"type":"graphic_figure","displayName":"Hepatic resection","title":"Hepatic resection","html":"<div class=\"graphic\"><div style=\"width: 511px\" class=\"figure\"><div class=\"ttl\">Hepatic resection</div><div class=\"cntnt\"><img style=\"width:491px; height:368px;\" src=\"images/SURG/52023_Hepaticresection.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The dissection plane is identified with the aid of intraoperative ultrasound and marked on the surface with electrocautery (white line). Vertical mattress sutures are placed into the liver tissue on either side of the dissection plane to compress the liver parenchyma and minimize bleeding. Resection is started at the inferior margin edge of the liver.</div><div id=\"graphicVersion\">Graphic 52023 Version 2.0</div></div></div>"},"52024":{"type":"graphic_figure","displayName":"Hematopoiesis regulation","title":"Regulation of hematopoiesis via growth factors and cytokines","html":"<div class=\"graphic\"><div style=\"width: 626px\" class=\"figure\"><div class=\"ttl\">Regulation of hematopoiesis via growth factors and cytokines</div><div class=\"cntnt\"><img style=\"width:606px; height:786px;\" src=\"images/HEME/52024_Hematopoiesisreguledt.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">This figure illustrates the hierarchical relationships of multipotent hematopoietic stem cells, progenitors, and mature cells of the myelopoietic, erythrocyte, and platelet lineages together with major growth factors, cytokines, and their actions. The involved growth factors and cytokines have overlapping actions during hematopoietic differentiation, as indicated, and, for most lineages, optimal development requires a combination of early- and late-acting factors. Refer to UpToDate topics on hematopoietic stem cells and myelopoiesis for further details.</div><div class=\"graphic_footnotes\">LTR-HSC: long-term repopulating hematopoietic stem cell; STR-HSC: short-term repopulating hematopoietic stem cell; SCF: stem cell factor: IL: interleukin; CMP: common myeloid progenitor; CLP: common lymphoid progenitor; MEP: megakaryocyte-erythroid progenitor; GMP: granulocyte-myeloid progenitor; CFU: colony-forming unit; BFU: blast-forming unit; Epo: erythropoietin; Tpo: thrombopoietin; G-CSF: granulocyte colony-stimulating factor; M-CSF: monocyte/macrophage colongy-stimulating factor; GM-CSF: granulocyte-macrophage colony-stimulating factor; TNF: tumor necrosis factor.</div><div class=\"graphic_reference\">Reproduced from: Sieff CA, Zon LI. Anatomy and Physiology of Hematopoiesis. In: Nathan and Oski's Hematology of Infancy and Childhood, 7th ed, Orkin S, Fisher D, Look AT, et al. (Eds), Elsevier, Philadelphia 2009. Illustration used with the permission of Elsevier Inc. All rights reserved.</div><div id=\"graphicVersion\">Graphic 52024 Version 6.0</div></div></div>"},"52025":{"type":"graphic_table","displayName":"5As of smoking prevention counseling children and adolescents","title":"5As of counseling to prevent smoking initiation in children and adolescents","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">5As of counseling to prevent smoking initiation in children and adolescents</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup width=\"10%\"></colgroup><colgroup width=\"15%\"></colgroup><colgroup span=\"2\" width=\"22%\"></colgroup><colgroup span=\"2\" width=\"15%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\">Child's age</td> <td class=\"subtitle1\">Ask</td> <td class=\"subtitle1\">Advise</td> <td class=\"subtitle1\">Assess</td> <td class=\"subtitle1\">Assist</td> <td class=\"subtitle1\">Arrange</td> </tr> <tr> <td> <p>Early childhood</p> <p>(0 to 4 years)</p> </td> <td> <p><strong>Ask</strong> parents</p> <ul class=\"decimal_heading\"> <li>about their smoking habits and those of other household members </li> </ul> (Forms to assist in screening available from CEASE website)*</td> <td> <p><strong>Advise</strong> parents to maintain a smoke-free environment. Message should include health risks to parent and child, and importance of parents as role models for child.</p> (Educational and motivational materials available from CEASE website)*</td> <td><strong>Assess</strong> readiness to quit among parents or other household smokers.</td> <td> <p><strong>Assist</strong> parents in quit attempt, by referral to self-help materials and/or to their own clinician.</p> <p>Quit support:<sup>&#182;</sup></p> <ul class=\"decimal_heading\"> <li>smokefree.gov<br /> (800-QUIT-NOW) </li> <li>National Cancer Institute<br /> (877-44U-QUIT) </li> </ul> </td> <td><strong>Arrange</strong> follow up visit within 3 months if a parent smokes; check on parents' progress at each pediatric follow-up visit.</td> </tr> <tr class=\"divider_top\"> <td> <p>School age</p> (5 to 12 years)</td> <td> <p><strong>Ask</strong> child</p> <ul class=\"decimal_heading\"> <li>how do you feel when someone is smoking near you, and what you do about it? </li> <li>do you think that it is harmful to try smoking and do you think that you will smoke when you are older? </li> <li>have you tried smoking, and do you have friends who smoke? </li> </ul> </td> <td> <p><strong>Advise</strong> child to stop experimenting, or give praise for remaining a non-smoker and/or making an effort to avoid smoke exposure. Remind child of the negative short-term effects of tobacco use, including smell and decreased athletic performance, and personalized health risks (eg, exacerbation of asthma).</p> <p><strong>Advise</strong> parents to quit if they are smokers, and to give clear anti-smoking messages to their children.</p> (Educational and motivational materials available from CEASE website)*</td> <td><strong>Assess</strong> risk factors for initiating smoking or progressing to regular smoking, including level of experimentation, smoking among peers, depressive symptoms, school performance and attendance, and adverse experiences.</td> <td> <p><strong>Assist</strong> parents in quit attempt if needed.<sup>&#182;</sup></p> <p><strong>Assist</strong> child in developing refusal skills and avoiding exposure.</p> <strong>Assist</strong> parents in efforts to prevent smoking in their children, through modeling, firm anti-smoking messages, and smoking bans.</td> <td> <p><strong>Arrange</strong> follow up visit within 1 to 2 months for any child who is experimenting with smoking or has concerning risk factors for smoking.</p> Refer as needed for any identified risk factors such as social or learning difficulties, or mental health issues.</td> </tr> <tr class=\"divider_top\"> <td>Adolescents and young adults</td> <td> <p><strong>Ask</strong> adolescent</p> <ul class=\"decimal_heading\"> <li>about smoking behavior in a confidential setting </li> <li>about smoking among peers </li> <li>about use of smokeless tobacco </li> </ul> </td> <td> <p><strong>Advise</strong> teens who are smoking to quit, reinforcing personalized health risks and danger of addiction.</p> Praise teens who are not smoking and remind them of health risks.</td> <td> <p><strong>Assess</strong> motivation and symptoms of tobacco dependence in teens who are smoking.</p> <strong>Assess</strong> risk factors for smoking initiation among those who are not smoking.</td> <td> <p><strong>Assist</strong> teens who are smoking in quit attempt; include nicotine replacement and referrals as needed.<sup>&#916;</sup></p> <strong>Assist</strong> parents in efforts to prevent smoking in their children, through modeling, firm anti-smoking messages, and smoking bans.</td> <td> <p><strong>Arrange</strong> follow up visit within 1 month for any teen who is smoking, to support quit attempt or assess motivation and barriers to quitting.<sup>&#916;</sup></p> Refer as needed for any identified risk factors such as social or learning difficulties, or mental health issues.</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">* CEASE (clinical effort against secondhand smoke exposure). Available at: www2.massgeneral.org/ceasetobacco/index.htm.<br />&para; See topic review, \"Management of smoking cessation in adults\".<br />&Delta; See topic review, \"Management of smoking cessation in adolescents\".</div><div class=\"graphic_reference\">Guidance based on Klein JD, Camenga DR. Pediatrics in review 2004; 25:17.</div><div id=\"graphicVersion\">Graphic 52025 Version 13.0</div></div></div>"},"52027":{"type":"graphic_picture","displayName":"Erythema ab igne hyperpigmentation","title":"Erythema ab igne with residual hyperpigmentation","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Erythema ab igne with residual hyperpigmentation</div><div class=\"cntnt\"><img style=\"width:432px; height:333px;\" src=\"images/DERM/52027_Eryth_ab_igne_hyperpig.jpg\" alt=\"Image\"/></div><div class=\"graphic_reference\">Reproduced with permission from: Berg D, Worzala K. Atlas of Adult Physical Diagnosis. Philadelphia: Lippincott Williams &amp; Wilkins, 2006. Copyright &#169; 2006 Lippincott Williams &amp; Wilkins.</div><div id=\"graphicVersion\">Graphic 52027 Version 2.0</div></div></div>"},"52028":{"type":"graphic_picture","displayName":"Heller myotomy and fundoplication","title":"Heller myotomy and fundoplication","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Heller myotomy and fundoplication</div><div class=\"cntnt\"><img style=\"width:360px; height:332px;\" src=\"images/SURG/52028_Heller_myotomy_fund.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">This is an intraoperative photograph of the anterior fundus of the stomach folded over the esophageal myotomy.</div><div id=\"graphicVersion\">Graphic 52028 Version 1.0</div></div></div>"},"52029":{"type":"graphic_picture","displayName":"Herpetic whitlow finger","title":"Herpetic whitlow","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Herpetic whitlow</div><div class=\"cntnt\"><img style=\"width:432px; height:324px;\" src=\"images/ID/52029_Herpetic_Whitlow_finger.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Grouped vesicles on an intensely erythematous base are characteristic of herpes simplex infection. The lesion is usually monolateral and is more often painful than pruritic.</div><div class=\"graphic_reference\">Reproduced with permission from: <a href=\"http://www.visualdx.com/\" target=\"_blank\">www.visualdx.com</a>. Copyright Logical Images, Inc.</div><div id=\"graphicVersion\">Graphic 52029 Version 7.0</div></div></div>"},"52030":{"type":"graphic_diagnosticimage","displayName":"Fibrous pleural tumor IV CT","title":"Fibrous tumor of the pleura","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Fibrous tumor of the pleura</div><div class=\"cntnt\"><img style=\"width:360px; height:209px;\" src=\"images/PULM/52030_Fibrous_pleural_tumor_IV_CT.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">CT scan shows a large retrosternal mass with heterogeneous enhancement.</div><div class=\"graphic_footnotes\">CT: computed tomography.</div><div class=\"graphic_reference\">Courtesy of Paul Stark, MD.</div><div id=\"graphicVersion\">Graphic 52030 Version 4.0</div></div></div>"},"52032":{"type":"graphic_table","displayName":"Previous classifications IIP","title":"Previous classifications of idiopathic interstitial pneumonias","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Previous classifications of idiopathic interstitial pneumonias</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup span=\"4\" width=\"25%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\">Liebow and Carrington (1969)</td> <td class=\"subtitle1\">Katzenstein (1997)</td> <td class=\"subtitle1\">M&#252;ller and Colby (1997)</td> <td class=\"subtitle1\">ATS/ERS (2002)</td> </tr> <tr> <td> <ul> <li>Usual interstitial pneumonia </li> <li>Desquamative interstitial pneumonia </li> <li>Bronchiolitis obliterans interstitial pneumonia and diffuse alveolar damage </li> <li>Lymphoid interstitial pneumonia </li> <li>Giant cell interstitial pneumonia </li> </ul> </td> <td> <ul> <li>Usual interstitial pneumonia </li> <li>Desquamative interstitial pneumonia/respiratory bronchiolitis interstitial lung disease </li> <li>Acute interstitial pneumonia </li> <li>Nonspecific interstitial pneumonia </li> </ul> </td> <td> <ul> <li>Usual interstitial pneumonia </li> <li>Desquamative interstitial pneumonia </li> <li>Bronchiolitis obliterans organizing pneumonia </li> <li>Acute interstitial pneumonia </li> <li>Nonspecific interstitial pneumonia </li> </ul> </td> <td> <ul> <li>Idiopathic pulmonary fibrosis/cryptogenic fibrosing alveolitis </li> <li>Desquamative interstitial pneumonia </li> <li>Cryptogenic organizing pneumonia </li> <li>Respiratory bronchiolitis interstitial lung disease </li> <li>Acute interstitial pneumonia </li> <li>Nonspecific interstitial pneumonia </li> <li>Lymphoid interstitial pneumonia </li> </ul> </td> </tr> </tbody></table></div><div class=\"graphic_reference\">References:&#xD;&#xA;<ol>&#xD;&#xA;    <li>Liebow AA, Carrington CB. The interstitial pneumonias. In: Simon M, Potchen EJ, LeMay M, editors. Frontiers of pulmonary radiology, 1st edition. New York: Grune &amp; Stratton; 1969. p.102-141.</li>&#xD;&#xA;    <li>Katzenstein A-LA. Katzenstein and Askin's surgical pathology of nonneoplastic lung disease. Philadelphia: W.B. Saunders; 1997. </li>&#xD;&#xA;    <li>M&uuml;ller NL, Colby TV. Idiopathic interstitial pneumonias: high-resolution CT and histologic findings. Radiographics 1997; 17:1016. </li>&#xD;&#xA;</ol>&#xD;&#xA;Adapted with permission of the American Thoracic Society. Copyright &copy; 2014 American Thoracic Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002; 165:277. Official Journal of the American Thoracic Society. This document was published in January 2002. Certain aspects of this document may be out of date and caution should be used when applying the information in clinical practice and other usages.</div><div id=\"graphicVersion\">Graphic 52032 Version 2.0</div></div></div>"},"52034":{"type":"graphic_table","displayName":"Diseases assoc with cryos II","title":"Types of cryoglobulinemia and their clinical associations (continued)","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Types of cryoglobulinemia and their clinical associations (continued)</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1_single\">Autoimmune (continued)</td> </tr> <tr> <td class=\"subtitle2_single\">Dermatological disease</td> </tr> <tr> <td class=\"indent1\">Cold-induced urticaria</td> </tr> <tr> <td class=\"indent1\">Cutaneous vasculitis</td> </tr> <tr> <td class=\"indent1\">Epidermolysis bullosa acquisita</td> </tr> <tr> <td class=\"indent1\">Erythema elevatum diutinum</td> </tr> <tr> <td class=\"indent1\">Erythema multiforme</td> </tr> <tr> <td class=\"indent1\">Pemphigus vulgaris</td> </tr> <tr> <td class=\"indent1\">Pyoderma gangrenosum</td> </tr> <tr> <td class=\"subtitle2_single\">Inflammatory bowel disease</td> </tr> <tr> <td class=\"indent1\">Celiac disease</td> </tr> <tr> <td class=\"indent1\">Crohn's disease</td> </tr> <tr> <td class=\"indent1\">Ulcerative colitis</td> </tr> <tr> <td class=\"subtitle1_single\">Paraneoplastic</td> </tr> <tr> <td>Atrial myxoma</td> </tr> <tr> <td>Bone marrow transplantation</td> </tr> <tr> <td>Lung cancer</td> </tr> <tr> <td class=\"sublist1_start\">Lymphoproliferative disease</td> </tr> <tr> <td class=\"sublist1\">Leukemia</td> </tr> <tr> <td class=\"sublist2\">Chronic lymphocytic leukemia</td> </tr> <tr> <td class=\"sublist2\">Chronic meylocytic leukemia</td> </tr> <tr> <td class=\"sublist2\">Hairy cell leukemia</td> </tr> <tr> <td class=\"sublist1\">Lymphoma: Hodgkin and non-Hodgkin</td> </tr> <tr> <td class=\"sublist1\">Plasma cell disorders</td> </tr> <tr> <td class=\"sublist2\">Dysproteinemias</td> </tr> <tr> <td class=\"sublist2\">Macroglobulinemia, primary or secondary (eg, Waldenstr&#246;m)</td> </tr> <tr> <td class=\"sublist2\">Multiple myeloma</td> </tr> <tr> <td class=\"sublist2\">POEMS syndrome</td> </tr> <tr> <td class=\"sublist1\">Angioimmunoblastic lymphadenopathy</td> </tr> <tr> <td>Kaposi sarcoma</td> </tr> <tr> <td>Mycosis fungoides</td> </tr> <tr> <td>Nasopharyngeal carcinoma</td> </tr> <tr> <td class=\"subtitle1_single\">Renal disease</td> </tr> <tr> <td>Idiopathic membranoproliferative glomerulonephritis</td> </tr> <tr> <td class=\"subtitle1_single\">Iatrogenic</td> </tr> <tr> <td>Bacille Calmette-Guerin administration</td> </tr> <tr> <td>Influenza vaccine</td> </tr> <tr> <td>Pneumococcal vaccine</td> </tr> <tr> <td class=\"subtitle1_single\">Miscellaneous</td> </tr> <tr> <td class=\"sublist1_start\">Cirrhosis</td> </tr> <tr> <td class=\"sublist1\">Biliary, La&#235;nnec's, postnecrotic</td> </tr> <tr> <td>Endomyocardial fibrosis</td> </tr> </tbody></table></div><div class=\"graphic_reference\">Reproduced with permission from: Dispenzieri, A, Gorevic, PD. Cryoglobulinemia. Hematology-Oncology Clinics of North America 1999; 42:2507. Copyright Â© 1999 W.B. Saunders Company.</div><div id=\"graphicVersion\">Graphic 52034 Version 3.0</div></div></div>"},"52035":{"type":"graphic_picture","displayName":"Scleral thinning RPC","title":"Scleral thinning in relapsing polychondritis","html":"<div class=\"graphic\"><div style=\"width: 524px\" class=\"figure\"><div class=\"ttl\">Scleral thinning in relapsing polychondritis</div><div class=\"cntnt\"><img style=\"width:504px; height:335px;\" src=\"images/RHEUM/52035_Scleral_thinning_RPC.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The dark area in the sclera is typical of the scleromalacia that may occur in patients with relapsing polychondritis. This darkening results from thinning of the sclera, which allows the pigment of the underlying choroid to be seen. Inflammatory manifestations such as episcleritis, scleritis, conjunctivitis, and iritis may precede scleromalacia.</div><div class=\"graphic_reference\">Copyright Â© 2017 American College of Rheumatology. Used with permission.</div><div id=\"graphicVersion\">Graphic 52035 Version 13.0</div></div></div>"},"52036":{"type":"graphic_picture","displayName":"Tularemia adenitis","title":"Tularemia adenitis","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Tularemia adenitis</div><div class=\"cntnt\"><img style=\"width:369px; height:277px;\" src=\"images/PEDS/52036_Tularemia_adenitis.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Ulceroglandular tularemia involving the submental node characterized by a papular lesion in the drainage field of the inflamed lymph node.</div><div id=\"graphicVersion\">Graphic 52036 Version 1.0</div></div></div>"},"52037":{"type":"graphic_table","displayName":"Complications refractive surg","title":"Complications of laser refractive surgery","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Complications of laser refractive surgery</div><div class=\"cntnt\"><table class=\"container\" cellspacing=\"0\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td class=\"container\">\n\t\t\t\t<table cellspacing=\"0\">\n\t\t\t\t\t<tbody>\n\t\t\t\t\t\t<tr><td class=\"subtitle1_single\">PRK/LASIK/LASEK</td></tr>\n\t\t\t\t\t\t<tr><td>Overcorrection/undercorrection</td></tr>\n\t\t\t\t\t\t<tr><td>Astigmatism</td></tr>\n\t\t\t\t\t\t<tr><td>Regression </td></tr>\n\t\t\t\t\t\t<tr><td>Glare, halo, monocular diplopia</td></tr>\n\t\t\t\t\t\t<tr><td>Dry eye symptoms </td></tr>\n\t\t\t\t\t\t<tr><td>Reduced contrast sensitivity</td></tr>\n\t\t\t\t\t</tbody>\n\t\t\t\t</table>\n\t\t\t</td>\n\t\t\t<td class=\"container\">\n\t\t\t\t<table cellspacing=\"0\">\n\t\t\t\t\t<tbody>\n\t\t\t\t\t\t<tr><td class=\"subtitle1_single\">More common in PRK</td></tr>\n\t\t\t\t\t\t<tr><td>Postoperative pain</td></tr>\n\t\t\t\t\t\t<tr><td>Delayed epithelial healing</td></tr>\n\t\t\t\t\t\t<tr><td>Infection</td></tr>\n\t\t\t\t\t\t<tr><td>Scarring/stromal haze</td></tr>\n\t\t\t\t\t</tbody>\n\t\t\t\t</table>\n\t\t\t</td>\n\t\t\t<td class=\"container\">\n\t\t\t\t<table cellspacing=\"0\">\n\t\t\t\t\t<tbody>\n\t\t\t\t\t\t<tr><td class=\"subtitle1_single\">More common in LASIK</td></tr>\n\t\t\t\t\t\t<tr><td>Flap complications</td></tr>\n\t\t\t\t\t\t<tr><td>Epithelial ingrowth</td></tr>\n\t\t\t\t\t\t<tr><td>Diffuse lamellar keratitis (Sands of Sahara)</td></tr>\n\t\t\t\t\t</tbody>\n\t\t\t\t</table>\n\t\t\t</td>\n\t\t\t<td class=\"container\">\n\t\t\t\t<table cellspacing=\"0\">\n\t\t\t\t\t<tbody>\n\t\t\t\t\t\t<tr><td class=\"subtitle1_single\">More common in LASEK</td></tr>\n\t\t\t\t\t\t<tr><td>Postoperative pain</td></tr>\n\t\t\t\t\t\t<tr><td>Stromal haze</td></tr>\n\t\t\t\t\t\t<tr><td>Flap complications</td></tr>\n\t\t\t\t\t</tbody>\n\t\t\t\t</table>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table></div><div class=\"graphic_footnotes\">PRK: photorefractive keratectomy; LASIK: laser-assisted in situ keratomileusis; LASEK: laser epithelial keratomileusis.</div><div id=\"graphicVersion\">Graphic 52037 Version 1.0</div></div></div>"},"52038":{"type":"graphic_picture","displayName":"Isometric test supraspinatus","title":"Isometric testing of the supraspinatus tendon in midarc","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Isometric testing of the supraspinatus tendon in midarc</div><div class=\"cntnt\"><img style=\"width:424px; height:331px;\" src=\"images/EM/52038_Isometric_test_supraspinatu.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">This maneuver assesses the strength and integrity of the supraspinatus tendon. The patient's arm is abducted to 45 degrees. The patient is asked to actively abduct the arm against the resistance of the examiner's hand placed at the elbow. The effort, strength, and discomfort are noted.</div><div class=\"graphic_reference\">Courtesy of Bruce C Anderson, MD.</div><div id=\"graphicVersion\">Graphic 52038 Version 2.0</div></div></div>"},"52039":{"type":"graphic_table","displayName":"Resistance to insulin therapy","title":"Addressing patient resistance to insulin therapy for patients with type 2 diabetes","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Addressing patient resistance to insulin therapy for patients with type 2 diabetes</div><div class=\"cntnt\"><table cellspacing=\"0\">\n<tbody>\n\n<tr>\n<td class=\"subtitle1_single\">Patient concerned with pain from injection</td>\n</tr>\n<tr>\n<td>Minimal with thinner, smaller needles</td>\n</tr>\n<tr>\n<td>Use of insulin pens</td>\n</tr>\n<tr>\n<td class=\"subtitle1_single\">Patient worried that starting insulin signifies worsening diabetes</td>\n</tr>\n<tr>\n<td>Diabetes is a progressive disease</td>\n</tr>\n<tr>\n<td>Taking insulin will control blood glucose and help prevent complications</td>\n</tr>\n<tr>\n<td>Taking insulin may slow down the rate of beta cell failure</td>\n</tr>\n<tr>\n<td class=\"subtitle1_single\">Patient believes that need for insulin signifies patient failure to follow treatment regimen</td>\n</tr>\n<tr>\n<td>Diabetes is a progressive disease; beta cell activity declines over time</td>\n</tr>\n<tr>\n<td>Not related to patient compliance</td>\n</tr>\n<tr>\n<td class=\"subtitle1_single\">Patient fears low blood sugar reactions</td>\n</tr>\n<tr>\n<td>Explain that severe hypoglycemia is rare in type 2 diabetes</td>\n</tr>\n<tr>\n<td>Self-monitoring glucose levels</td>\n</tr>\n<tr>\n<td>Explain how to avoid and how to treat hypoglycemia</td>\n</tr>\n<tr>\n<td class=\"subtitle1_single\">Patient concerned that taking insulin will upset daily routine</td>\n</tr>\n<tr>\n<td>Address specific concerns</td>\n</tr>\n<tr>\n<td>Taking insulin may be less intrusive than complicated drug regimens</td>\n</tr>\n<tr>\n<td class=\"subtitle1_single\">Patient believes that insulin will decrease his/her quality of life</td>\n</tr>\n<tr>\n<td>Benefits from glucose control: more energy, better sleep, overall well-being</td>\n</tr>\n<tr>\n<td class=\"subtitle1_single\">Patient thinks insulin will lead to diabetic complications</td>\n</tr>\n<tr>\n<td>Discuss role of insulin in reducing risk of diabetic complications</td>\n</tr>\n<tr>\n<td class=\"subtitle1_single\">Patient concerned that he/she will be treated differently by friends and family</td>\n</tr>\n<tr>\n<td>Educate friends and family: offer reading materials on diabetes, support groups for family</td>\n</tr>\n<tr>\n<td class=\"subtitle1_single\">Patient has heard insulin causes weight gain</td>\n</tr>\n<tr>\n<td>Role of diet and exercise</td>\n</tr>\n<tr>\n<td class=\"subtitle1_single\">Patient wants a more natural alternative therapy</td>\n</tr>\n<tr>\n<td>Insulin is the most natural therapy for diabetes. It is replacing the hormone that the patient does not make enough of.</td>\n</tr>\n\n</tbody>\n</table></div><div class=\"graphic_reference\">Data from: Brunton S, Carmichael B, Funnell M, et al. Type 2 diabetes: the role of insulin. J Fam Pract 2005; 54:445.</div><div id=\"graphicVersion\">Graphic 52039 Version 2.0</div></div></div>"},"52040":{"type":"graphic_picture","displayName":"Acute rejection airway II","title":"Airway pattern of acute lung transplant rejection","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Airway pattern of acute lung transplant rejection</div><div class=\"cntnt\"><img style=\"width:360px; height:240px;\" src=\"images/PULM/52040_Acute_rejection_airway_II.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Photomicrograph demonstrating an inflammatory response surrounding the airway.</div><div class=\"graphic_reference\">Courtesy of L Kobzik, MD.</div><div id=\"graphicVersion\">Graphic 52040 Version 1.0</div></div></div>"},"52041":{"type":"graphic_diagnosticimage","displayName":"Chronic EAA CT","title":"Chronic hypersensitivity pneumonia (extrinsic allergic alveolitis)","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Chronic hypersensitivity pneumonia (extrinsic allergic alveolitis)</div><div class=\"cntnt\"><img style=\"width:357px; height:228px;\" src=\"images/PULM/52041_Chronic_EAA_CT.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Chronic phase of hypersensitivity pneumonia (extrinsic allergic alveolitis) due to birds. Focal honeycombing is present in the right upper lobe and mild bilateral cylindrical bronchiectasis is visible.</div><div class=\"graphic_reference\">Courtesy of Paul Stark, MD.</div><div id=\"graphicVersion\">Graphic 52041 Version 4.0</div></div></div>"},"52044":{"type":"graphic_diagnosticimage","displayName":"Sonogram normal fetal foot","title":"Sonogram of normal fetal foot","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Sonogram of normal fetal foot</div><div class=\"cntnt\"><img style=\"width:370px; height:277px;\" src=\"images/OBGYN/52044_Sonogram_normal_fetal_foot.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">When the foot is normally oriented, the bones of the lower leg and plantar surface of the foot cannot be visualized in the same plane.</div><div class=\"graphic_reference\">Courtesy of Urania Magriples, MD.</div><div id=\"graphicVersion\">Graphic 52044 Version 3.0</div></div></div>"},"52046":{"type":"graphic_diagnosticimage","displayName":"Dysostosis lumbar vertebrae","title":"Dysostosis lumbar vertebrae","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Dysostosis lumbar vertebrae</div><div class=\"cntnt\"><img style=\"width:292px; height:349px;\" src=\"images/PEDS/52046_Dysostosis_lumbar_vertebrae.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Dysostosis multiplex, with hypoplasia of the anterosuperior areas of the lower thoracic and upper lumbar vertebral bodies, resulting in prominent beaking of one of the lumbar vertebral bodies (arrow).</div><div class=\"graphic_reference\">Courtesy of Ed Wraith, MD.</div><div id=\"graphicVersion\">Graphic 52046 Version 2.0</div></div></div>"},"52047":{"type":"graphic_figure","displayName":"Pubertal events girls","title":"Sequence of puberty in girls","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Sequence of puberty in girls</div><div class=\"cntnt\"><img style=\"width:408px; height:496px;\" src=\"images/PEDS/52047_Pubertaleventsgirls.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Sequence of events in girls with average timing of pubertal development in the United States. African American girls tend to reach a milestone at a younger age (left-hand side of the bracket) than Caucasian girls (right-hand side of the bracket). The median length of time between the onset of puberty (breast Tanner stage 2) and menarche is 2.6 years, and the 95<SUP>th</SUP> percentile is 4.5 years.</div><div class=\"graphic_reference\">Data from: Biro FM, Huang B, Lucky AW, et al. Pubertal correlates in black and white US girls. J Pediatr 2006; 148:234, and from: Tanner JM, Davies PS. J Pediatr 1985; 107:317.</div><div id=\"graphicVersion\">Graphic 52047 Version 8.0</div></div></div>"},"52048":{"type":"graphic_table","displayName":"Causes of primary adrenal insufficiency","title":"Causes of adrenal insufficiency (Addison's disease)","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Causes of adrenal insufficiency (Addison's disease)</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1_single\">Autoimmune adrenalitis</td> </tr> <tr> <td>Isolated adrenal insufficiency</td> </tr> <tr> <td>Polyglandular autoimmune syndrome type I</td> </tr> <tr> <td>Polyglandular autoimmune syndrome type II</td> </tr> <tr> <td class=\"subtitle1_single\">Infectious adrenalitis</td> </tr> <tr> <td>Tuberculosis</td> </tr> <tr> <td class=\"sublist1_start\">Disseminated fungal infection</td> </tr> <tr> <td class=\"sublist1\">Histoplasmosis</td> </tr> <tr> <td class=\"sublist1\">Paracoccidioidomycosis</td> </tr> <tr> <td>HIV infection and AIDS</td> </tr> <tr> <td>Syphilis</td> </tr> <tr> <td>African trypanosomiasis</td> </tr> <tr> <td class=\"subtitle1_single\">Metastatic cancer</td> </tr> <tr> <td>Primarily lung, breast, stomach and colon cancer or lymphoma</td> </tr> <tr> <td class=\"subtitle1_single\">Adrenal hemorrhage or infarction</td> </tr> <tr> <td class=\"subtitle1_single\">Drugs</td> </tr> <tr> <td>Ketoconazole</td> </tr> <tr> <td>Fluconazole</td> </tr> <tr> <td>Rifampin</td> </tr> <tr> <td>Phenytoin</td> </tr> <tr> <td>Barbiturates</td> </tr> <tr> <td>Megestrol acetate</td> </tr> <tr> <td>Other: aminoglutethimide, etomidate, metyrapone, suramin, mitotane</td> </tr> <tr> <td class=\"subtitle1_single\">Other</td> </tr> <tr> <td>Adrenoleukodystrophy and adrenomyeloneuropathy</td> </tr> <tr> <td>Congenital adrenal hypoplasia</td> </tr> <tr> <td>Familial glucocorticoid deficiency</td> </tr> <tr> <td>Familial glucocorticoid resistance</td> </tr> <tr> <td>Defective cholesterol metabolism</td> </tr> </tbody></table></div><div id=\"graphicVersion\">Graphic 52048 Version 4.0</div></div></div>"},"52049":{"type":"graphic_figure","displayName":"Choosing shape of conization","title":"Choosing the shape of cervical (uterine cervix) conization based upon configuration of the lesion","html":"<div class=\"graphic\"><div style=\"width: 510px\" class=\"figure\"><div class=\"ttl\">Choosing the shape of cervical (uterine cervix) conization based upon configuration of the lesion</div><div class=\"cntnt\"><img style=\"width:490px; height:326px;\" src=\"images/OBGYN/52049_Choosing_shape_of_conizatio.jpg\" alt=\"Image\"/></div><div class=\"graphic_reference\">Courtesy of William J Mann, Jr, MD.</div><div id=\"graphicVersion\">Graphic 52049 Version 2.0</div></div></div>"},"52050":{"type":"graphic_table","displayName":"HCV information resources","title":"Hepatitis C virus information resources","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Hepatitis C virus information resources</div><div class=\"cntnt\"><table cellspacing=\"0\">\n<tbody>\n\n<tr>\n<td class=\"subtitle1_single\">American Association for the Study of Liver Diseases</td>\n</tr>\n<tr>\n<td>6900 Grove Rd.</td>\n</tr>\n<tr>\n<td>Thorofare, NJ 08086</td>\n</tr>\n<tr>\n<td>(609) 848-1000</td>\n</tr>\n<tr>\n<td>www.hepar-sfgh.ucsf.edu</td>\n</tr>\n<tr>\n<td class=\"subtitle1_single\">American College of Gastroenterology</td>\n</tr>\n<tr>\n<td>4900B South 31st Street</td>\n</tr>\n<tr>\n<td>Arlington, VA 22206</td>\n</tr>\n<tr>\n<td>(703) 820-7400</td>\n</tr>\n<tr>\n<td>FAX: (703) 931-4520</td>\n</tr>\n<tr>\n<td>www.acg.gi.org</td>\n</tr>\n<tr>\n<td class=\"subtitle1_single\">American Liver Foundation</td>\n</tr>\n<tr>\n<td>1425 Pompton Ave.</td>\n</tr>\n<tr>\n<td>Cedar Grove, NJ 07009</td>\n</tr>\n<tr>\n<td>1-800-GOLIVER (1-800-465-4837) or 1-8884HepABC (1-888-443-7222)</td>\n</tr>\n<tr>\n<td>www.liverfoundation.org</td>\n</tr>\n<tr>\n<td class=\"subtitle1_single\">Centers for Disease Control and Prevention</td>\n</tr>\n<tr>\n<td>Hepatitis Branch, Mailstop G-37</td>\n</tr>\n<tr>\n<td>1600 Clifton Rd, NE</td>\n</tr>\n<tr>\n<td>Atlanta, GA 30333</td>\n</tr>\n<tr>\n<td>1-888-4HEPCDC (1-888-443-7232)</td>\n</tr>\n<tr>\n<td>www.cdc.gov/ncidod/diseases/hepatitis.htm</td>\n</tr>\n<tr>\n<td class=\"subtitle1_single\">Hepatitis Foundation International</td>\n</tr>\n<tr>\n<td>30 Sunrise Terrace</td>\n</tr>\n<tr>\n<td>Cedar Grove, NJ 07009-1432</td>\n</tr>\n<tr>\n<td>1-800-891-0707</td>\n</tr>\n<tr>\n<td>E-mail: hfi@intac.com</td>\n</tr>\n<tr>\n<td>www.hepfi.org</td>\n</tr>\n</tbody>\n</table></div><div id=\"graphicVersion\">Graphic 52050 Version 1.0</div></div></div>"},"52051":{"type":"graphic_algorithm","displayName":"Algorithm for management of new onset AF","title":"Management of new onset (hemodynamically stable) atrial fibrillation","html":"<div class=\"graphic\"><div style=\"width: 574px\" class=\"figure\"><div class=\"ttl\">Management of new onset (hemodynamically stable) atrial fibrillation</div><div class=\"cntnt\"><img style=\"width:554px; height:605px;\" src=\"images/CARD/52051_AlgomangnewonsetAFedt4.gif\" alt=\"Image\"/></div><div class=\"graphic_footnotes\">AF: atrial fibrillation; TEE: transesophageal echocardiography. <br />* Consider systemic anticoagulation with heparin or a&nbsp;non-vitamin K&nbsp;oral anticoagulant (eg, rivaroxaban, edoxaban, apixaban, or dabigatran) depending on the patient's stroke risk factors and AF duration.<br />Â¶ This strategy includes the need for short-term anticoagulation with heparin or warfarin.<br />Î Oral anticoagulation may be dabigatran, edoxaban, apixaban, rivaroxaban, or warfarin.<br /><FONT class=lozenge>â</FONT> At least four weeks of oral anticoagulation after cardioversion in those whose AF was &gt;48 h.</div><div id=\"graphicVersion\">Graphic 52051 Version 11.0</div></div></div>"},"52053":{"type":"graphic_diagnosticimage","displayName":"Malignant mesothelioma I CT","title":"Malignant mesothelioma","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Malignant mesothelioma</div><div class=\"cntnt\"><img style=\"width:323px; height:309px;\" src=\"images/PULM/52053_Malignant_mesothelioma_I_CT.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">CT scan shows right-sided nodular circumferential pleural thickening exceeding 1 cm in thickness, typical of a malignant process (arrows). No clear cut invasion of the chest wall is present. A slightly enlarged pretracheal lymph node proved to be reactive in nature.</div><div class=\"graphic_footnotes\">CT: computed tomography.</div><div class=\"graphic_reference\">Courtesy of Paul Stark, MD.</div><div id=\"graphicVersion\">Graphic 52053 Version 3.0</div></div></div>"},"52054":{"type":"graphic_table","displayName":"Writing strategy instruction","title":"Example of writing strategy instructions for a child with a writing disability","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Example of writing strategy instructions for a child with a writing disability</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1\">Stage</td> <td class=\"subtitle1\">Description</td> </tr> <tr> <td rowspan=\"5\"><strong>Stage 1:</strong> Build background knowledge</td> <td>The teacher and student work together to develop background knowledge about the strategy by:</td> </tr> <tr> <td class=\"indent1\">&#8226; Identifying vocabulary words that are used in writing in general (\"character,\" \"setting\").</td> </tr> <tr> <td class=\"indent1\">&#8226; Identifying the words associated with the strategy (\"Pick your idea,\" \"Organize your notes,\" etc; the \"POW\" and \"TREE\" mnemonics are discussed in their own table).</td> </tr> <tr> <td class=\"indent1\">&#8226; Identifying information that might need to be included in the composition.</td> </tr> <tr> <td class=\"indent1\">&#8226; Using graphic organizers, such as thinking maps, to organize ideas.</td> </tr> <tr class=\"divider_top\"> <td rowspan=\"3\"><strong>Stage 2:</strong> Discuss it</td> <td>Benefits and limitations of the strategy are identified (eg, \"this strategy is good for writing a story\").</td> </tr> <tr> <td>Goals are discussed and determined.</td> </tr> <tr> <td>The student is asked to think about his or her own personal understanding of the strategy as the teacher describes the strategy and explains each step.</td> </tr> <tr class=\"divider_top\"> <td rowspan=\"2\"><strong>Stage 3:</strong> Model it</td> <td>The student observes a teacher or peer models the strategy and self-instructions.</td> </tr> <tr> <td>The student personalizes the strategy and self-instructions. Self-instructions include statements, such as \"Which step in the strategy am I using?\" and \"When I'm frustrated, I should remember that I have a strategy and that I can use it,\" and self-reinforcing statements, such as \"I am good at this part\" or \"I like what I wrote here.\" Self-statements are modeled, as is the completion of each of the steps of the strategy.</td> </tr> <tr class=\"divider_top\"> <td rowspan=\"2\"><strong>Stage 4:</strong> Memorize it</td> <td>The student memorizes the steps of the strategy and the meaning of any mnemonics (eg, \"POW,\" \"TREE\") used to represent strategy steps (the \"POW\" and \"TREE\" mnemonics are discussed in their own table).</td> </tr> <tr> <td>The student memorizes one or more of the self-instructions generated in stage 3.</td> </tr> <tr class=\"divider_top\"> <td rowspan=\"3\"><strong>Stage 5:</strong> Support it </td> <td>The teacher continues to scaffold the student's strategy use as the strategy is practiced on transfer tasks.</td> </tr> <tr> <td>Additional self-regulatory procedures, such as goal-setting, self-monitoring, or self-reinforcement, can be discussed, determined, and implemented on an individual basis.</td> </tr> <tr> <td>Prompts, interaction, and guidance are phased out at an appropriate pace. This stage is often the longest of the stages for struggling writers.</td> </tr> <tr class=\"divider_top\"> <td rowspan=\"3\"><strong>Stage 6:</strong> Independent performance</td> <td>The student makes the transition to covert use of self-instructions as he or she uses the strategy independently.</td> </tr> <tr> <td>The teacher and student individually evaluate the strategy effectiveness and the student's performance.</td> </tr> <tr> <td>To ensure that the strategy is incorporated into the student's repertoire, plans for maintenance and generalization are implemented.</td> </tr> </tbody></table></div><div class=\"graphic_reference\">Data from: Harris K, Graham S, Mason L. Self-regulated strategy development in the classroom: Part of a balanced approach to writing instruction for students with disabilities. Focus on Exceptional Children 2003; 35:1.</div><div id=\"graphicVersion\">Graphic 52054 Version 7.0</div></div></div>"},"52055":{"type":"graphic_figure","displayName":"Pressure derived fractional flow reserve","title":"Pressure derived fractional flow reserve","html":"<div class=\"graphic\"><div style=\"width: 549px\" class=\"figure\"><div class=\"ttl\">Pressure derived fractional flow reserve</div><div class=\"cntnt\"><img style=\"width:529px; height:449px;\" src=\"images/CARD/52055_Pressure_deriv_frac_flow.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">A mild resting gradient shown by the difference in the aortic (Pa) and coronary (Pd) pressures becomes bigger with hyperemia. The hyperemic blood flow signal is shown under the yellow shaded band. Coronary vasodilatory reserve, CVR is 2.2 and FFR 0.78. Intracoronary adenosine was given at the black arrow.</div><div id=\"graphicVersion\">Graphic 52055 Version 2.0</div></div></div>"},"52056":{"type":"graphic_picture","displayName":"Acanthosis nigricans on the nipple","title":"Acanthosis nigricans","html":"<div class=\"graphic\"><div style=\"width: 524px\" class=\"figure\"><div class=\"ttl\">Acanthosis nigricans</div><div class=\"cntnt\"><img style=\"width:504px; height:378px;\" src=\"images/DERM/52056_Acanth_nigricans_nipple.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">A hyperpigmented plaque with a verrucous surface is present on the nipple.</div><div class=\"graphic_reference\">Reproduced with permission from: <A style=\"FONT-STYLE: italic\" href=\"http://www.visualdx.com/\" target=_blank>www.visualdx.com</A>. Copyright Logical Images, Inc.</div><div id=\"graphicVersion\">Graphic 52056 Version 3.0</div></div></div>"},"52057":{"type":"graphic_diagnosticimage","displayName":"Bowing and greenstick fracture","title":"Ulnar bowing with a radial greenstick fracture","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Ulnar bowing with a radial greenstick fracture</div><div class=\"cntnt\"><img style=\"width:442px; height:454px;\" src=\"images/EM/52057_Bowing_and_greenstick_fx.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Bowed ulna and fractured radius in a 3-year-old.</div><div class=\"graphic_reference\">Courtesy of Paula Schweich, MD.</div><div id=\"graphicVersion\">Graphic 52057 Version 3.0</div></div></div>"},"52058":{"type":"graphic_table","displayName":"Oral regimens P. falciparum malaria in pregnancy","title":"Oral regimens for treatment of <EM>Plasmodium falciparum </EM>malaria in pregnant women*","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Oral regimens for treatment of <EM>Plasmodium falciparum </EM>malaria in pregnant women*</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup width=\"30%\"></colgroup><colgroup width=\"10%\"></colgroup><colgroup width=\"60%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\">Type of infection</td> <td class=\"subtitle1\">Trimester</td> <td class=\"subtitle1\">Drug and dose</td> </tr> <tr> <td class=\"divider_bottom\" rowspan=\"10\"> <p><strong>Chloroquine-resistant <em>Plasmodium falciparum</em> infection<sup>&#182;</sup></strong></p> <p>All malarious regions except those specified as chloroquine sensitive listed in the box below.</p> Middle Eastern countries with chloroquine-resistant <em>P. falciparum</em> include Iran, Oman, Saudi Arabia, and Yemen.</td> <td rowspan=\"5\"><strong>First trimester</strong></td> <td><strong>Quinine PLUS clindamycin</strong></td> </tr> <tr> <td class=\"sublist1\">Quinine: 542 mg base (= 650 mg salt) orally three times daily for seven days.<sup>&#916;</sup></td> </tr> <tr> <td class=\"sublist1\">Clindamycin: 20 mg base/kg/day (up to 1.8 grams) orally divided three times daily for seven days.</td> </tr> <tr> <td class=\"sublist2\"><strong>OR</strong></td> </tr> <tr> <td class=\"sublist1\">Artemisinin combination therapy (doses below) can be used as alternate therapy in first trimester if quinine + clindamycin is unavailable or treatment failure.</td> </tr> <tr> <td class=\"divider_bottom\" rowspan=\"5\"><strong>Second or third trimester</strong></td> <td><strong>Artemisinin combination therapy:</strong> One of the following:<sup>&#9674;</sup></td> </tr> <tr> <td class=\"sublist1\"><strong>Artemether-lumefantrine:</strong> 1 tablet = 20 mg artemether and 120 mg lumefantrine. A three-day treatment schedule with a total of six oral doses is recommended based on weight (25 to 34 kg: 3 tablets per dose; &#8805;35 kg: 4 tablets per dose). The patient should receive the initial dose, followed by the second dose 8 hours later, then 1 dose orally twice daily for the following two days. Take after a full meal or whole milk.</td> </tr> <tr> <td class=\"sublist1\"><strong>Artesunate-amodiaquine:</strong> 1 tablet = 100 mg artesunate and 270 mg amodiaquine. Dosing for patients &#8805;36 kg consists of 2 tablets per day orally for three days.</td> </tr> <tr> <td class=\"sublist1\"><strong>Artesunate-mefloquine:</strong> 1 tablet = 100 mg artesunate and 220 mg mefloquine hydrochloride per tablet. Dosing for patients &#8805;30 kg consists of 2 tablets per day orally for three days.</td> </tr> <tr class=\"divider_bottom\"> <td class=\"sublist1\"><strong>Dihydroartemisinin-piperaquine:<sup>&#167;</sup></strong> 1 tablet = 40 mg of dihydroartemisinin and 320 mg of piperaquine phosphate. Dosing for patients 36 to &#60;60 kg consists of 3 tablets per day for three days. Dosing for patients 60 to &#60;80 kg consists of 4 tablets per day for three days.</td> </tr> <tr> <td rowspan=\"5\"> <p><strong>Chloroquine-sensitive <em>Plasmodium falciparum</em> infection</strong></p> <p>Central America west of Panama Canal; Haiti; the Dominican Republic; and most of the Middle East.</p> Infections acquired in the Newly Independent States of the former Soviet Union and Korea to date have been uniformly caused by <em>Plasmodium vivax</em> and should therefore be treated as chloroquine-sensitive infections.</td> <td rowspan=\"5\"><strong>Any trimester</strong></td> <td><strong>Chloroquine</strong></td> </tr> <tr> <td class=\"sublist1\">600 mg base (= 1000 mg salt) orally immediately, followed by 300 mg base (= 500 mg salt) orally at 6, 24, and 48 hours. Total dose: 1500 mg base (= 2500 mg salt).<sup>&#165;</sup></td> </tr> <tr> <td class=\"sublist2\"><strong>OR</strong></td> </tr> <tr> <td><strong>Hydroxychloroquine</strong></td> </tr> <tr> <td class=\"sublist1\">620 mg base (= 800 mg salt) orally immediately, followed by 310 mg base (= 400 mg salt) orally at 6, 24, and 48 hours. Total dose: 1550 mg base (= 2000 mg salt).</td> </tr> </tbody></table></div><div class=\"graphic_lgnd\">The dosing regimens listed in this table are generally consistent with the World Health Organization 2015 guidelines (3rd edition) for the treatment of uncomplicated <em>P. falciparum</em> malaria and the United States Centers for Disease Control and Prevention guidelines for the treatment of uncomplicated malaria in the United States (as revised July 2013) and may differ from dosing recommended in approved product information. Product availability varies by locality.</div><div class=\"graphic_footnotes\">* These regimens may be used for treatment of uncomplicated <EM>Plasmodium falciparum</EM> malaria in pregnant women or&nbsp;for completion of treatment for severe malaria following administration of parenteral therapy (for at least 24 hours and until oral medication can be tolerated). (Refer&nbsp;to the UpToDate&nbsp;table summarizing parenteral regimens for treatment of severe malaria in pregnancy.)<br />Â¶&nbsp;Issues related to antimalarial selection for pregnant women are discussed further in the text. For pregnant women with uncomplicated chloroquine-resistant <EM>P. falciparum</EM> malaria, atovaquone-proguanil or mefloquine-based regimens may be used if other treatment options are not available or are not tolerated and if the potential benefit is judged to outweigh the potential risks. Similarly, for pregnant women with uncomplicated chloroquine-resistant <EM>P. falciparum</EM> or chloroquine-resistant <EM>P. vivax</EM> infection, doxycycline or tetracycline may be used in combination with quinine (as recommended for nonpregnant adults) if other treatment options are not available or are not tolerated and if the benefit is judged to outweigh the risks. Refer to the UpToDate topic on treatment of uncomplicated malaria in pregnancy for further discussion.<br />Î&nbsp;For infections acquired in Southeast Asia, quinine treatment should continue for 7 days. For infections acquired elsewhere, quinine treatment should continue for 3 days. In the United States, quinine is encapsulated in a 324 mg (sulfate salt) dose; therefore, for adult dosing, 2 capsules are sufficient.<br />â&nbsp;Oral artesunate and clindamycin are also an alternate therapy in any trimester of pregnancy; however, combination tablets are not available.<br />Â§&nbsp;Piperaquine component prolongs the QT interval by approximately the same amount as chloroquine but by less than quinine; avoid use in patients with congenital QT prolongation or who are on medications that prolong the QT interval. Dihydroartemisinin-piperaquine may be taken with food but should not be taken with a high-fat meal.<br />Â¥&nbsp;The dosing for chloroquine summarized in the table is based on the recommendations of the United States Centers for Disease Control and Prevention. The dosing for chloroquine recommended by the World Health Organization consists of the following: Total dose: 25 mg base/kg, administered as 10 mg base/kg orally on day 1 followed by 10 mg/kg orally on day 2, and 5 mg/kg base on day 3.</div><div class=\"graphic_reference\">Data from:&#xD;&#xA;<ol>&#xD;&#xA;    <li>United States Centers for Disease Control guidelines for treatment of malaria <a href=\"http://www.cdc.gov/malaria/resources/pdf/treatmenttable.pdf\" target=\"_blank\">http://www.cdc.gov/malaria/resources/pdf/treatmenttable.pdf</a>. (Accessed on March 23, 2016.)</li>&#xD;&#xA;    <li>World Health Organization. Guidelines for the treatment of malaria, 3rd ed. WHO, Geneva 2015. http://www.who.int/malaria/publications/atoz/9789241549127/en/ (Accessed on March 23, 2016).</li>&#xD;&#xA;</ol></div><div id=\"graphicVersion\">Graphic 52058 Version 12.0</div></div></div>"},"52060":{"type":"graphic_waveform","displayName":"MEG - magnetoencephalography recording","title":"Simultaneous magnetoencephalography (MEG) and electroencephalography (EEG) recordings","html":"<div class=\"graphic\"><div style=\"width: 597px\" class=\"figure\"><div class=\"ttl\">Simultaneous magnetoencephalography (MEG) and electroencephalography (EEG) recordings</div><div class=\"cntnt\"><img style=\"width:577px; height:515px;\" src=\"images/NEURO/52060_MEG.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Simultaneous MEG (black) and EEG (green) recordings: Three sample clips on the MEG showing typical spike discharges (red boxes). Note the high frequency activity in the right frontal quadrant preceding the spike on the left, and the bisynchronous spike on the far right.</div><div class=\"graphic_reference\">Courtesy of Catherine Schevon, MD.</div><div id=\"graphicVersion\">Graphic 52060 Version 5.0</div></div></div>"},"52061":{"type":"graphic_diagnosticimage","displayName":"Sequestration ultrasound","title":"Sequestration","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Sequestration</div><div class=\"cntnt\"><img style=\"width:380px; height:380px;\" src=\"images/OBGYN/52061_Sequestration_ultrasound.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Transverse view of upper abdomen at 32 weeks gestational age shows a well-defined echogenic mass (arrow) in the left upper quadrant adjacent to the spine.</div><div class=\"graphic_reference\">Courtesy of Deborah Levine, MD.</div><div id=\"graphicVersion\">Graphic 52061 Version 2.0</div></div></div>"},"52062":{"type":"graphic_picture","displayName":"Clinical images of typical juvenile dermatomyositis","title":"Clinical images of typical juvenile dermatomyositis","html":"<div class=\"graphic\"><div style=\"width: 581px\" class=\"figure\"><div class=\"ttl\">Clinical images of typical juvenile dermatomyositis</div><div class=\"cntnt\"><img style=\"width:561px; height:264px;\" src=\"images/PEDS/52062_Rash_JDM.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">(A) Heliotrope discoloration of the eyelids and malar or facial erythema.<br />(B) Scaly, red rash on the knuckles with Gottron's papules (erythematous, papulosquamous eruption over the dorsal surfaces of the knuckles).</div><div class=\"graphic_reference\">Reproduced with permission from: Feldman BM, Rider LG, Reed AM, Pachman LM. Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Lancet 2008; 371:2201. Illustration used with permission of Elsevier Inc. All rights reserved. Copyright Â©2008 Elsevier Inc.</div><div id=\"graphicVersion\">Graphic 52062 Version 5.0</div></div></div>"},"52063":{"type":"graphic_table","displayName":"Exchange lists","title":"Calories and macronutrient content of exchange lists","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Calories and macronutrient content of exchange lists</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1\">Group</td> <td class=\"subtitle1\">Carbohydrate, grams</td> <td class=\"subtitle1\">Protein, grams</td> <td class=\"subtitle1\">Fat, grams</td> <td class=\"subtitle1\">Calories, grams</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"5\">Carbohydrate group</td> </tr> <tr> <td class=\"indent1\">Starch</td> <td>15</td> <td>3</td> <td>0 to 1</td> <td>80</td> </tr> <tr> <td class=\"indent1\">Fruit</td> <td>15</td> <td>0</td> <td>0</td> <td>60</td> </tr> <tr> <td class=\"indent1\">Milk</td> <td>12</td> <td>8</td> <td>varies</td> <td>90 to 150</td> </tr> <tr> <td class=\"indent1\">Other carbohydrates</td> <td>15</td> <td>varies</td> <td>varies</td> <td>varies</td> </tr> <tr> <td class=\"indent1\">Non-starchy vegetables</td> <td>5</td> <td>2</td> <td>0</td> <td>25</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"5\">Meat and meat substitutes</td> </tr> <tr> <td class=\"indent1\">Very lean</td> <td>0</td> <td>7</td> <td>0 to 1</td> <td>35</td> </tr> <tr> <td class=\"indent1\">Lean</td> <td>0</td> <td>7</td> <td>3</td> <td>55</td> </tr> <tr> <td class=\"indent1\">Medium fat</td> <td>0</td> <td>7</td> <td>5</td> <td>75</td> </tr> <tr> <td class=\"indent1\">High fat</td> <td>0</td> <td>7</td> <td>8</td> <td>100</td> </tr> <tr> <td class=\"subtitle2_left\">Fat group</td> <td>0</td> <td>0</td> <td>5</td> <td>45</td> </tr> </tbody></table></div><div id=\"graphicVersion\">Graphic 52063 Version 3.0</div></div></div>"},"52066":{"type":"graphic_table","displayName":"Causes of ovarian torsion","title":"Most common etiologies of torsion in different populations","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Most common etiologies of torsion in different populations</div><div class=\"cntnt\"><table cellspacing=\"0\">\n\n  <tbody>\n\n\n    <tr>\n\n      <td class=\"subtitle1_single\">Fetus/neonate</td>\n\n    </tr>\n\n    <tr>\n      <td>Ovarian cysts</td>\n    </tr>\n    <tr>\n\n      <td class=\"subtitle1_single\">Premenarchal girls</td>\n\n    </tr>\n\n    <tr>\n      <td>Ovarian cysts and neoplasms</td>\n    </tr>\n    <tr>\n      <td>Elongated utero-ovarian ligament</td>\n    </tr>\n    <tr>\n\n      <td class=\"subtitle1_single\">Premenopausal women</td>\n\n    </tr>\n\n    <tr>\n      <td>Ovarian cysts and neoplasms (includes ovarian hyperstimulation syndrome) </td>\n    </tr>\n    <tr>\n      <td>Pregnancy</td>\n    </tr>\n    <tr>\n\n      <td class=\"subtitle1_single\">Postmenopausal women</td>\n\n    </tr>\n    <tr>\n      <td>Ovarian cysts and neoplasms</td>\n    </tr>\n\n  </tbody>\n</table></div><div id=\"graphicVersion\">Graphic 52066 Version 1.0</div></div></div>"},"52067":{"type":"graphic_table","displayName":"Asthma trigger guide","title":"How to control things that make your asthma worse","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">How to control things that make your asthma worse</div><div class=\"cntnt\"><table class=\"container\" cellspacing=\"0\">\n<tbody>\n\t\n<tr>\n\t<td class=\"container\">\n\t<table cellspacing=\"0\">\n\n\t\t<tr>\n\t\t\t\t\t\t<td>You can help prevent asthma episodes by staying away from things that make your asthma worse. This guide suggests many ways to help you do this.</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td>You need to find out what makes your asthma worse. Some things that make asthma worse for some people are not a problem for others. You do not need to do all of the things listed in this guide.</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td>Look at the things listed in dark print below. Put a check next to the ones that you know make your asthma worse, particularly if you are allergic to the things. Then, decide with your doctor what steps you will take. Start with the things in your bedroom that bother your asthma. Try something simple first.</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td class=\"subtitle1_single\">Tobacco smoke</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td>If you smoke, ask your doctor for ways to help you quit. Ask family members to quit smoking, too.</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td>Do not allow smoking in your home, car, or around you.</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td>Be sure no one smokes at a child's daycare center or school.</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td class=\"subtitle1_single\">Dust mites</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td>Many people who have asthma are allergic to dust mites. Dust mites are like tiny \"bugs\" you cannot see that live in cloth or carpet.</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td class=\"sublist1_start\">Things that will help the most:</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td class=\"sublist1\">Encase your mattress in a special dust miteproof cover.*</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td class=\"sublist1\">Encase your pillow in a special dust mite-proof cover* or wash the pillow each week in hot water. Water must be hotter than 130&#176;F to kill the mites. Cooler water used with detergent and bleach can also be effective.</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td class=\"sublist1\">Wash the sheets and blankets on your bed each week in hot water.</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td class=\"sublist1_start\">Other things that can help:</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td class=\"sublist1\">Reduce indoor humidity to or below 60 percent; ideally 30-50 percent. Dehumidifiers or central air conditioners can do this.</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td class=\"sublist1\">Try not to sleep or lie on cloth-covered cushions or furniture.</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td class=\"sublist1\">Remove carpets from your bedroom and those laid on concrete, if you can.</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td class=\"sublist1\">Keep stuffed toys out of the bed, or wash the toys weekly in hot water or in cooler water with detergent and bleach. Placing toys weekly in a dryer or freezer may help. Prolonged exposure to dry heat or freezing can kill mites but does not remove allergen.</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td class=\"subtitle1_single\">Animal dander</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td>Some people are allergic to the flakes of skin or dried saliva from animals.</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td class=\"sublist1_start\">The best thing to do:</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td class=\"sublist1\">Keep animals with fur or hair out of your home.</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td class=\"sublist1_start\">If you can't keep the pet outdoors, then:</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td class=\"sublist1\">Keep the pet out of your bedroom, and keep the bedroom door closed.</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td class=\"sublist1\">Remove carpets and furniture covered with cloth from your home. If that is not possible, keep the pet out of the rooms where these are.</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td class=\"subtitle1_single\">Cockroach</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td class=\"sublist1_start\">Many people with asthma are allergic to the dried droppings and remains of cockroaches.</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td class=\"sublist1\">Keep all food out of your bedroom.</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td class=\"sublist1\">Keep food and garbage in closed containers (never leave food out).</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td class=\"sublist1\">Use poison baits, powders, gels, or paste (for example, boric acid). You can also use traps.</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td class=\"sublist1\">If a spray is used to kill roaches, stay out of the room until the odor goes away.</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t</table>\n\t\t\t\t\t</td>\n\t\t\t\t\t\n\t\t\t\t\t<td class=\"container\">\n\t\t\t\t\t<table cellspacing=\"0\">\n\t\t\t\t\t\t\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td class=\"subtitle1_single\">Vacuum cleaning</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td>Try to get someone else to vacuum for you once or twice a week, if you can. Stay out of rooms while they are being vacuumed and for a short while afterward.</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td>If you vacuum, use a dust mask (from a hardware store), a central cleaner with the collecting bag outside the home, or a vacuum cleaner with a HEPA filter or a double-layered bag.*</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td class=\"subtitle1_single\">Indoor mold</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td>Fix leaking faucets, pipes, or other sources of water.</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td>Clean moldy surfaces.</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td>Dehumidify basements if possible.</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td class=\"subtitle1_single\">Pollen and outdoor mold</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td class=\"sublist1_start\">During your allergy season (when pollen or mold spore counts are high):</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td class=\"sublist1\">Try to keep your windows closed.</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td class=\"sublist1\">If possible, stay indoors with windows closed during the midday and afternoon, if you can. Pollen and some mold spore counts are highest at that time.</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td class=\"sublist1\">Ask your doctor whether you need to take or increase anti-inflammatory medicine before your allergy season starts.</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td class=\"subtitle1_single\">Smoke, strong odors, and sprays</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td>If possible, do not use a wood-burning stove, kerosene heater, fireplace, unvented gas stove, or heater.</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td>Try to stay away from strong odors and sprays, such as perfume, talcum powder, hair spray, paints, new carpet, or particle board.</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td class=\"subtitle1_single\">Exercise or sports</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td>You should be able to be active without symptoms. See your doctor if you have asthma symptoms when you are active-such as when you exercise, do sports, play, or work hard.</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td>Ask your doctor about taking medicine before you exercise to prevent symptoms.</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td>Warm up for a period before you exercise.</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td>Check the air quality index and try not to work or play hard outside when the air pollution or pollen levels (if you are allergic to the pollen) are high.</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td class=\"subtitle1_single\">Other things that can make asthma worse</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td>Sulfites in foods: do not drink beer or wine or eat shrimp, dried fruit, or processed potatoes if they cause asthma symptoms.</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td>Cold air: cover your nose and mouth with a scarf on cold or windy days.</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td>Other medicines: tell your doctor about all the medicines you may take. Include cold medicines, aspirin, and even eye drops.</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t</table>\n\t\t\t\t\t</td>\n\t\t\t\t\t</tr>\n\n</tbody>\n</table></div><div class=\"graphic_footnotes\"><strong>* To find out where to get products mentioned in this guide, call:</strong><br> Asthma and Allergy Foundation of America (800-727-8462).<br> Allergy and Asthma Network/Mothers of Asthmatics, Inc. (800-878-4403).<br> American Academy of Allergy, Asthma, and Immunology (800-822-2762).<br> National Jewish Medical and Research Center (Lung Line) (800-222-5864).<br> American College of Allergy, Asthma, and Immunology (800-842-7777).</div><div class=\"graphic_reference\">Reproduced from: National Heart, Blood, and Lung Institute Expert Panel Report 3 (EPR 3): Guidelines for the Diagnosis and Management of Asthma. NIH Publication no. 08-4051, 2007.</div><div id=\"graphicVersion\">Graphic 52067 Version 1.0</div></div></div>"},"52068":{"type":"graphic_diagnosticimage","displayName":"Lymphomatoid gran CT I","title":"35-year-old man who presented with cerebral symptoms with enhancing brain mass on CT","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">35-year-old man who presented with cerebral symptoms with enhancing brain mass on CT</div><div class=\"cntnt\"><img style=\"width:445px; height:451px;\" src=\"images/PULM/52068_Lymphomatoid_gran_CT_I.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">CT image shows well-defined and poorly defined nodules throughout lung. Most nodules are smaller than 1 cm. Nodules are located along bronchovascular structures or interlobular septa.</div><div class=\"graphic_footnotes\">CT: computed tomography.</div><div class=\"graphic_reference\">From: Lee JS, Tuder R, Lynch DA. Lymphomatoid granulomatosis: Radiologic features and pathologic correlations. Am J Roentgenol 2000; 175:1335. Reprinted with permission from the American Journal of Roentgenology.</div><div id=\"graphicVersion\">Graphic 52068 Version 11.0</div></div></div>"},"52069":{"type":"graphic_table","displayName":"Medical screening by BMI category","title":"Medical screening for children with obesity, by BMI category","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Medical screening for children with obesity, by BMI category</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup span=\"2\" width=\"20%\"></colgroup><colgroup width=\"60%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\">BMI percentile</td> <td class=\"subtitle1\">Physical examination</td> <td class=\"subtitle1\">Laboratory tests</td> </tr> <tr> <td class=\"divider_bottom\" rowspan=\"2\">85th-94th percentile</td> <td class=\"divider_bottom\" rowspan=\"2\">Blood pressure, full exam</td> <td>Fasting lipid profile*</td> </tr> <tr class=\"divider_bottom\"> <td>Conditional testing for abnormalities in blood glucose or liver function<sup>&#182;</sup></td> </tr> <tr> <td rowspan=\"3\">&#8805;95th percentile</td> <td rowspan=\"3\">Blood pressure, full exam</td> <td>Fasting lipid profile*</td> </tr> <tr> <td>Hemoglobin A1c or fasting glucose level every two years<sup>&#916;</sup></td> </tr> <tr> <td>ALT and AST levels every two years</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">* If results of the fasting lipid profile are normal, we suggest repeating the screening every three to five years. If the results are abnormal, annual monitoring usually is appropriate. (Refer to UpToDate topic on Pediatric prevention of adult cardiovascular disease).<br />Â¶ In this weight category, screening for abnormalities in blood glucose or hemoglobin A1c, AST and ALT is recommended if the patient is 10 years or older, and has one or more of the following risk factors: personal history of elevated blood pressure, lipid levels, tobacco use, or family history of obesity-related diseases (type 2 diabetes, lipid abnormalities, heart disease).<br />Î Hemoglobin A1c is now an accepted approach to screening for diabetes mellitus in adults; a hemoglobin A1c level â¥6.5 percent on two occasions can be used to diagnose diabetes, and patients with A1c values between 5.7 and 6.4 percent are at high risk for developing diabetes. The utility of hemoglobin A1c as a screening tool in children and adolescents has not been fully evaluated.</div><div class=\"graphic_reference\">Recommendations based on: Krebs NF. Assessment of child and adolescent overweight and obesity. Pediatrics 2007; 120:S193.</div><div id=\"graphicVersion\">Graphic 52069 Version 12.0</div></div></div>"},"52070":{"type":"graphic_diagnosticimage","displayName":"Esophageal dilation after gastric banding","title":"Esophageal dilation after gastric banding","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Esophageal dilation after gastric banding</div><div class=\"cntnt\"><img style=\"width:432px; height:430px;\" src=\"images/SURG/52070_Esoph_dilation_gast_banding.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The esophagram demonstrates the appearance of esophageal dilation from a gastric band that is too tight. Note the very small amount of contrast material passing distal to the band.</div><div id=\"graphicVersion\">Graphic 52070 Version 6.0</div></div></div>"},"52071":{"type":"graphic_picture","displayName":"Rectal prolapse - complete","title":"Rectal prolapse - complete","html":"<div class=\"graphic\"><div style=\"width: 524px\" class=\"figure\"><div class=\"ttl\">Rectal prolapse - complete</div><div class=\"cntnt\"><img style=\"width:504px; height:378px;\" src=\"images/SURG/52071_Rectal_prolapse_complete.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">This picture shows a full thickness, complete rectal prolapse.</div><div id=\"graphicVersion\">Graphic 52071 Version 1.0</div></div></div>"},"52072":{"type":"graphic_diagnosticimage","displayName":"C7 burst fracture","title":"C7 burst fracture and C6 flexion teardrop","html":"<div class=\"graphic\"><div style=\"width: 527px\" class=\"figure\"><div class=\"ttl\">C7 burst fracture and C6 flexion teardrop</div><div class=\"cntnt\"><img style=\"width:507px; height:252px;\" src=\"images/EM/52072_C7_burst_fx.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Vertical compression injuries such as burst fractures occur in the cervical spine when axial loads are exerted on the spine. When the nucleus pulposus of the intervertebral disk is forced into the vertebral body, the body shatters outward, resulting in a burst fracture. Note the fracture fragment on the CT image above (arrow) that is displaced into the spinal canal.</div><div class=\"graphic_footnotes\">CT: computed tomography.</div><div class=\"graphic_reference\">Courtesy of Mary Hochman, MD.</div><div id=\"graphicVersion\">Graphic 52072 Version 3.0</div></div></div>"},"52073":{"type":"graphic_figure","displayName":"Australia and New Zealand","title":"Australia and New Zealand","html":"<div class=\"graphic\"><div style=\"width: 540px\" class=\"figure\"><div class=\"ttl\">Australia and New Zealand</div><div class=\"cntnt\"><img style=\"width:520px; height:381px;\" src=\"images/ID/52073_Australia_and_New_Zealand.jpg\" alt=\"Image\"/></div><div id=\"graphicVersion\">Graphic 52073 Version 1.0</div></div></div>"},"52076":{"type":"graphic_table","displayName":"Common medical complications of stroke","title":"Common medical complications of stroke","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Common medical complications of stroke</div><div class=\"cntnt\"><table cellspacing=\"0\">\n<tbody>\n\n<tr>\n<td class=\"subtitle1\">Complication</td>\n<td class=\"subtitle1\">Percent</td>\n</tr>\n<tr>\n<td>Falls</td>\n<td>25</td>\n</tr>\n<tr>\n<td>Urinary tract infection</td>\n<td>24</td>\n</tr>\n<tr>\n<td>Chest infection</td>\n<td>22</td>\n</tr>\n<tr>\n<td>Pressure sores</td>\n<td>21</td>\n</tr>\n<tr>\n<td>Depression</td>\n<td>16</td>\n</tr>\n<tr>\n<td>Shoulder pain</td>\n<td>9</td>\n</tr>\n<tr>\n<td>Deep venous thrombosis</td>\n<td>2</td>\n</tr>\n<tr>\n<td>Pulmonary embolism</td>\n<td>1</td>\n</tr>\n</tbody>\n</table></div><div class=\"graphic_footnotes\">Medical complications of stroke were frequent in a prospective multicenter study of 311 patients followed weekly through hospital discharge and again at 6, 18, and 30 months after stroke.</div><div class=\"graphic_reference\">Data from: Langhorne, P, Stott, DJ, Robertson, L, et al. Medical complications after stroke: a multicenter study. Stroke 2000; 31:1223.</div><div id=\"graphicVersion\">Graphic 52076 Version 2.0</div></div></div>"},"52077":{"type":"graphic_table","displayName":"Long duration chronic daily headache","title":"Chronic daily headaches of long duration","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Chronic daily headaches of long duration</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td colspan=\"2\">Chronic daily headaches of long duration are characterized by headache duration &#8805;4 hours a day with headaches occurring &#8805;15 days per month for &#62;3 months</td> </tr> <tr> <td><strong>Chronic tension-type headache:</strong></td> <td>Bilateral, gradual onset, muscle tenderness common</td> </tr> <tr> <td><strong>Chronic migraine:</strong></td> <td>Daily or near-daily headaches of low to moderate intensity and mild migrainous features with superimposed severe intensity headaches with more prominent migrainous features</td> </tr> <tr> <td><strong>Medication overuse headache:</strong></td> <td>Usually preceded by an episodic headache disorder, typically migraine or tension-type headache, that has been treated with frequent and excessive amounts of acute symptomatic medications; often manifests as a headache that is present or develops upon awakening</td> </tr> <tr> <td><strong>New daily persistent headache:</strong></td> <td>Sudden onset, usually bilateral, typically unresponsive to treatment</td> </tr> <tr> <td><strong>Hemicrania continua:</strong></td> <td>Strictly unilateral, unremitting without pain-free intervals but with variable intensity, autonomic features ipsilateral to the side of pain, responsive to indomethacin</td> </tr> </tbody></table></div><div class=\"graphic_reference\">Modified from: Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology 1996; 47:871.</div><div id=\"graphicVersion\">Graphic 52077 Version 3.0</div></div></div>"},"52078":{"type":"graphic_table","displayName":"TNM staging esoph adenoCA including EGJ","title":"TNM staging of esophageal and esophagogastric junction (EGJ) adenocarcinoma","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">TNM staging of esophageal and esophagogastric junction (EGJ) adenocarcinoma</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1_single\" colspan=\"5\">Primary tumor (T)<sup>* </sup></td> </tr> <tr> <td>TX </td> <td colspan=\"4\">Primary tumor cannot be assessed </td> </tr> <tr> <td>T0 </td> <td colspan=\"4\">No evidence of primary tumor </td> </tr> <tr> <td>Tis </td> <td colspan=\"4\">High-grade dysplasia<sup>&#182;</sup></td> </tr> <tr> <td class=\"sublist1_start\">T1 </td> <td class=\"sublist_other_start\" colspan=\"4\">Tumor invades lamina propria, muscularis mucosae, or submucosa </td> </tr> <tr> <td class=\"sublist1\">T1a </td> <td class=\"sublist_other\" colspan=\"4\">Tumor invades lamina propria or muscularis mucosae </td> </tr> <tr> <td class=\"sublist1\">T1b </td> <td class=\"sublist_other\" colspan=\"4\">Tumor invades submucosa </td> </tr> <tr> <td>T2 </td> <td colspan=\"4\">Tumor invades muscularis propria </td> </tr> <tr> <td>T3 </td> <td colspan=\"4\">Tumor invades adventitia </td> </tr> <tr> <td class=\"sublist1_start\">T4 </td> <td class=\"sublist_other_start\" colspan=\"4\">Tumor invades adjacent structures </td> </tr> <tr> <td class=\"sublist1\">T4a </td> <td class=\"sublist_other\" colspan=\"4\">Resectable tumor invading pleura, pericardium, or diaphragm </td> </tr> <tr> <td class=\"sublist1\">T4b </td> <td class=\"sublist_other\" colspan=\"4\">Unresectable tumor invading other adjacent structures, such as aorta, vertebral body, trachea, etc. </td> </tr> <tr> <td class=\"subtitle1_single\" colspan=\"5\">Regional lymph nodes (N)<sup>&#916;</sup></td> </tr> <tr> <td>NX </td> <td colspan=\"4\">Regional lymph node(s) cannot be assessed </td> </tr> <tr> <td>N0 </td> <td colspan=\"4\">No regional lymph node metastasis </td> </tr> <tr> <td>N1 </td> <td colspan=\"4\">Metastasis in 1-2 regional lymph nodes </td> </tr> <tr> <td>N2 </td> <td colspan=\"4\">Metastasis in 3-6 regional lymph nodes </td> </tr> <tr> <td>N3 </td> <td colspan=\"4\">Metastasis in seven or more regional lymph nodes </td> </tr> <tr> <td class=\"subtitle1_single\" colspan=\"5\">Distant metastasis (M) </td> </tr> <tr> <td>M0 </td> <td colspan=\"4\">No distant metastasis </td> </tr> <tr> <td>M1 </td> <td colspan=\"4\">Distant metastasis </td> </tr> <tr> <td class=\"subtitle1_single\" colspan=\"5\">Histologic grade (G) </td> </tr> <tr> <td>GX </td> <td colspan=\"4\">Grade cannot be assessed - stage grouping as G1 </td> </tr> <tr> <td>G1 </td> <td colspan=\"4\">Well differentiated </td> </tr> <tr> <td>G2 </td> <td colspan=\"4\">Moderately differentiated </td> </tr> <tr> <td>G3 </td> <td colspan=\"4\">Poorly differentiated </td> </tr> <tr> <td>G4 </td> <td colspan=\"4\">Undifferentiated - stage grouping as G3 squamous </td> </tr> <tr> <td class=\"subtitle1_single\" colspan=\"5\">Anatomic stage/prognostic groups </td> </tr> <tr> <td class=\"subtitle2_single\" colspan=\"5\">Adenocarcinoma carcinoma </td> </tr> <tr> <td class=\"subtitle4\">Stage </td> <td class=\"subtitle4\">T </td> <td class=\"subtitle4\">N </td> <td class=\"subtitle4\">M </td> <td class=\"subtitle4\">Grade </td> </tr> <tr> <td>0</td> <td>Tis (HGD)</td> <td>N0</td> <td>M0</td> <td>1, X</td> </tr> <tr> <td>IA</td> <td>T1</td> <td>N0</td> <td>M0</td> <td>1-2, X</td> </tr> <tr> <td rowspan=\"2\">IB </td> <td>T1</td> <td>N0</td> <td>M0</td> <td>3</td> </tr> <tr> <td>T2</td> <td>N0</td> <td>M0</td> <td>1-2, X</td> </tr> <tr> <td>IIA</td> <td>T2</td> <td>N0</td> <td>M0</td> <td>3</td> </tr> <tr> <td rowspan=\"2\">IIB </td> <td>T3</td> <td>N0</td> <td>M0</td> <td>Any</td> </tr> <tr> <td>T1-2</td> <td>N1</td> <td>M0</td> <td>Any</td> </tr> <tr> <td rowspan=\"3\">IIIA </td> <td>T1-2</td> <td>N2</td> <td>M0</td> <td>Any</td> </tr> <tr> <td>T3</td> <td>N1</td> <td>M0</td> <td>Any</td> </tr> <tr> <td>T4a</td> <td>N0</td> <td>M0</td> <td>Any</td> </tr> <tr> <td>IIIB</td> <td>T3</td> <td>N2</td> <td>M0</td> <td>Any</td> </tr> <tr> <td rowspan=\"3\">IIIC </td> <td>T4a</td> <td>N1-2</td> <td>M0</td> <td>Any</td> </tr> <tr> <td>T4b</td> <td>Any</td> <td>M0</td> <td>Any</td> </tr> <tr> <td>Any</td> <td>N3</td> <td>M0</td> <td>Any</td> </tr> <tr> <td>IV</td> <td>Any</td> <td>Any</td> <td>M1</td> <td>Any</td> </tr> </tbody></table></div><div class=\"graphic_lgnd\">Note: cTNM is the clinical classification, pTNM is the pathologic classification.</div><div class=\"graphic_footnotes\">* At least maximal dimension of the tumor must be recorded and multiple tumors require the T(m) suffix.<br />Â¶&nbsp;High-grade dysplasia (HGD) includes all noninvasive neoplastic epithelia that was formerly called carcinoma in situ, a diagnosis that is no longer used for columnar mucosae anywhere in the gastrointestinal tract.<br />Î Number must be recorded for total number of regional nodes sampled and total number of reported nodes with metastasis.</div><div class=\"graphic_reference\">Used with the permission of the American Joint Committee on Cancer (AJCC), Chicago, Illinois. The original source for this material is the AJCC Cancer Staging Manual, Seventh Edition (2010) published by Springer New York, Inc.</div><div id=\"graphicVersion\">Graphic 52078 Version 6.0</div></div></div>"},"52079":{"type":"graphic_figure","displayName":"Variations of retroduodenal bile duct anatomy","title":"Variations of retroduodenal bile duct anatomy","html":"<div class=\"graphic\"><div style=\"width: 536px\" class=\"figure\"><div class=\"ttl\">Variations of retroduodenal bile duct anatomy</div><div class=\"cntnt\"><img style=\"width:516px; height:628px;\" src=\"images/SURG/52079_Variations-of-retroduodenal-bile-duct-anatomy.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Variations of the retropancreatic segment of the common bile duct.<br> (A) The duct is partially covered by pancreatic tissue.<br> (B) The duct is completely covered by pancreas.<br> (C) The duct runs freely behind the pancreas.</div><div id=\"graphicVersion\">Graphic 52079 Version 3.0</div></div></div>"},"52081":{"type":"graphic_figure","displayName":"Assess aspiration risk","title":"Prudent limits of targeted depth and length of ED procedural sedation and analgesia according to presedation assessment of aspiration risk","html":"<div class=\"graphic\"><div style=\"width: 562px\" class=\"figure\"><div class=\"ttl\">Prudent limits of targeted depth and length of ED procedural sedation and analgesia according to presedation assessment of aspiration risk</div><div class=\"cntnt\"><img style=\"width:542px; height:771px;\" src=\"images/EM/52081_Assess_aspiration_risk.gif\" alt=\"Image\"/></div><div class=\"graphic_footnotes\">* Higher-risk patients are those with one or more of the following present to a degree individually or cumulatively judged clinically important by the treating physician: potential for difficult or prolonged assisted ventilation should an airway complication occur (eg, short neck, small mandible/micrognathia, large tongue, tracheomalacia, laryngomalacia, history of difficult intubation, congenital anomalies of the airway and neck, sleep apnea). Conditions predisposing to esophageal reflux (eg, elevated intracranial pressure, esophageal disease, hiatal hernia, peptic ulcer disease, gastritis, bowel obstruction, ileus, tracheo-esophageal fistula). Extremes of age (eg, &gt;70 years or &lt;6 months). Severe systemic disease with definite functional limitation (ie, ASA physical status 3 or greater). Other clinical findings leading the&#160;emergency&#160;clinician&#160;to judge the patient to be at higher than standard risk (eg, altered level of consciousness, frail appearance).<br> <span class=bullet>&#8226;</span> Procedural urgency: emergent (eg, cardioversion for life-threatening dysrhythmia, reduction of markedly angulated fracture or dislocation with soft tissue or vascular compromise, intractable pain or suffering). Urgent (eg, care of dirty wounds and lacerations, animal and human bites, abscess incision and drainage, fracture reduction, hip reduction, lumbar puncture for suspected meningitis, arthrocentesis, neuroimaging for trauma). Semi-urgent (eg, care of clean wounds and lacerations, shoulder reduction, neuroimaging for new-onset seizure, foreign body removal, sexual assault examination). Non-urgent or elective (eg, non-vegetable foreign body in external auditory canal, chronic embedded soft tissue foreign body, ingrown toenail).<br> &#916; Procedural sedation and analgesia terminology and definitions:&#160;see &quot;Preparation for procedural sedation in children outside of the operating room&quot;, section on 'Definitions'.</div><div class=\"graphic_reference\">Reproduced with permission from: Green, SM, Roback, MG, Miner, JG, et al. Fasting and Emergency Department Procedural Sedation and Analgesia. A Consensus-Based Clinical Proactive Advisory. Annals of Emergency Medicine 2007; 49:454. Copyright &#169; 2007 Elsevier Science, Inc.</div><div id=\"graphicVersion\">Graphic 52081 Version 4.0</div></div></div>"},"52082":{"type":"graphic_table","displayName":"Response definitions CML","title":"Definitions of hematologic, cytogenetic, and molecular response in chronic myeloid leukemia<sup>[1,2]</sup>","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Definitions of hematologic, cytogenetic, and molecular response in chronic myeloid leukemia<sup>[1,2]</sup></div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup width=\"20%\"></colgroup><colgroup width=\"80%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\">Response by type</td> <td class=\"subtitle1\">Definitions</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"2\">Hematologic</td> </tr> <tr> <td class=\"indent1\" rowspan=\"5\">Complete</td> <td>WBC &#60;10 x 10<sup>9</sup>/L</td> </tr> <tr> <td>Basophils &#60;5 percent</td> </tr> <tr> <td>No myelocytes, promyelocytes, myeloblasts in the differential</td> </tr> <tr> <td>Platelet count &#60;450 x 10<sup>9</sup>/L</td> </tr> <tr> <td>Spleen nonpalpable</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"2\">Cytogenetic*</td> </tr> <tr> <td class=\"indent1\" rowspan=\"2\">Major</td> <td>Complete: No Ph+ metaphases or &#60;1 percent BCR-ABL1-positive nuclei of at least 200 nuclei on FISH</td> </tr> <tr> <td>Partial: 1 to 35 percent Ph+ metaphases</td> </tr> <tr> <td class=\"indent1\">Minor</td> <td>36 to 65 percent Ph+ metaphases</td> </tr> <tr> <td class=\"indent1\">Minimal</td> <td>66 to 95 percent Ph+ metaphases</td> </tr> <tr> <td class=\"indent1\">None</td> <td>&#62;95 percent Ph+ metaphases</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"2\">Molecular<sup>&#182;</sup></td> </tr> <tr> <td class=\"indent1\">MR<sup>4.5</sup></td> <td> <p>Detectable disease with ratio of BCR-ABL1 to ABL1 (or other housekeeping genes) &#8804;0.0032 percent (&#8805;4.4 log reduction) on the international scale (IS)</p> <p><strong>or</strong></p> Undetectable disease in cDNA with &#8805;32,000 ABL1 transcripts</td> </tr> <tr> <td class=\"indent1\">MR<sup>4</sup></td> <td> <p>Detectable disease with ratio of BCR-ABL1 to ABL1 &#8804;0.01 percent (&#8805;4 log reduction) on the IS</p> <p><strong>or</strong></p> Undetectable disease in cDNA with &#8805;10,000 ABL1 transcripts</td> </tr> <tr> <td class=\"indent1\">MR<sup>3</sup></td> <td>Detectable disease with ratio of BCR-ABL1 to ABL1 (or other housekeeping genes) &#8804;0.1 percent (&#8805;3 log reduction) on the IS</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">WBC: white blood cell; Ph+: Philadelphia chromosome positive; FISH: fluorescence in situ hybridization; IS: international scale.<br />* Chromosome banding analysis of at least 20 bone marrow cell metaphases is necessary to determine the degree of cytogenetic response. If marrow cell metaphases cannot be obtained or evaluated by chromosome banding analysis, the definition of CCgR may be based on interphase fluorescent in situ hybridization of blood cells, provided that it is performed with BCR-ABL1 extrasignal, dual color, dual fusion, or in situ hybridization probes, and that at least 200 nuclei are scored.<br />&para; Molecular responses are, in general, reported on the evaluation of blood, not marrow samples. For a standardized assessment of the MolR, the conversion of each laboratory datum to the international scale is recommended, to correct for the variability of the assays in different laboratories. To allow for intralaboratory variations, a fluctuation of less than one log requires confirmation.</div><div class=\"graphic_reference\">Data from:&#xD;&#xA;<ol>&#xD;&#xA;    <li>Baccarani M, Cortes J, Pane F, et al. Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet. J Clin Oncol 2009; 27:6041.</li>&#xD;&#xA;    <li>Baccarani M, Deininger MW, Rosti G, et al. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013. Blood 2013; 122:872.</li>&#xD;&#xA;</ol></div><div id=\"graphicVersion\">Graphic 52082 Version 11.0</div></div></div>"},"52083":{"type":"graphic_picture","displayName":"Double football hold","title":"Double football hold","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Double football hold</div><div class=\"cntnt\"><img style=\"width:432px; height:330px;\" src=\"images/PEDS/52083_Double_football_hold.jpg\" alt=\"Image\"/></div><div class=\"graphic_reference\">Courtesy of Nancy Hurst, MD.</div><div id=\"graphicVersion\">Graphic 52083 Version 4.0</div></div></div>"},"52087":{"type":"graphic_figure","displayName":"Change in sCr versus change in IAP","title":"Change in serum creatinine versus change in intra-abdominal pressure","html":"<div class=\"graphic\"><div style=\"width: 533px\" class=\"figure\"><div class=\"ttl\">Change in serum creatinine versus change in intra-abdominal pressure</div><div class=\"cntnt\"><img style=\"width:513px; height:375px;\" src=\"images/CARD/52087_Change_in_sCr_IAP.gif\" alt=\"Image\"/></div><div class=\"graphic_footnotes\">sCr: serum creatinine; IAP: intra-abdominal pressure.</div><div class=\"graphic_reference\">Adapted from: Mullens W, Abrahams Z, Skouri HN, et al. Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function? J Am Coll Cardiol 2008; 51:300, courtesy of the authors.</div><div id=\"graphicVersion\">Graphic 52087 Version 3.0</div></div></div>"},"52088":{"type":"graphic_diagnosticimage","displayName":"Obstructed biliopancreatic limb after gastric bypass","title":"Obstructed biliopancreatic limb after gastric bypass","html":"<div class=\"graphic\"><div style=\"width: 496px\" class=\"figure\"><div class=\"ttl\">Obstructed biliopancreatic limb after gastric bypass</div><div class=\"cntnt\"><img style=\"width:476px; height:579px;\" src=\"images/SURG/52088_Obstr_biliopancreatic_limb.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">(A) Arrows point to distended gastric remnant. These loops of bowel are non-contrast filled because it is the biliopancreatic limb and bypassed stomach.<br> (B) This abdominal flat plate one day after an esophagram shows retrograde filling of the biliopancreatic limb and pathologic distention of the remnant stomach in a gastric bypass patient.</div><div id=\"graphicVersion\">Graphic 52088 Version 4.0</div></div></div>"},"52091":{"type":"graphic_picture","displayName":"Dermatochalasis","title":"Dermatochalasis","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Dermatochalasis</div><div class=\"cntnt\"><img style=\"width:432px; height:112px;\" src=\"images/NEURO/52091_Dermatochalasis.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Redundant skin overflows past the upper eyelid margin. The clinician must lift the excess skin in order to find the eyelid margin.</div><div class=\"graphic_reference\">Courtesy of Michael S Lee, MD.</div><div id=\"graphicVersion\">Graphic 52091 Version 1.0</div></div></div>"},"52092":{"type":"graphic_table","displayName":"Seizure susceptibility in the developing brain","title":"Factors promoting increased seizure susceptibility in the developing brain","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Factors promoting increased seizure susceptibility in the developing brain</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup span=\"2\" width=\"50%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\">Factor</td> <td class=\"subtitle1\">Consequence</td> </tr> <tr> <td>Input resistance and time constant: Increased in immature neurons</td> <td>Small inputs result in relatively large voltage changes</td> </tr> <tr> <td>Voltage-gated ion channels: Earlier maturation of sodium and calcium channels, delayed development of potassium channels</td> <td>Longer action potentials, shorter refractory periods, increased neuron firing</td> </tr> <tr> <td>Synapse development: Excitatory synapses appear before inhibitory synapses</td> <td>Relative predominance of excitation over inhibition early in development</td> </tr> <tr> <td>Synapse development: Over expression of excitatory synapses during critical period</td> <td>Corresponds to window of heightened seizure susceptibility</td> </tr> <tr> <td>Developmental changes in glutamate receptor subunits: NR2B/NR2A ratio favors prolonged depolarizing responses; NR2D relative over expression reduces Mg<sup>++</sup> block</td> <td>Favor relative hyperexcitability</td> </tr> <tr> <td>Late appearance of functional inhibitory synapses</td> <td>Along with other factors favoring excitation, contributes to neuronal excitatory drive and lack of functional inhibition</td> </tr> <tr> <td>Developmental changes in GABA<sub>A</sub> receptor function and Cl<sup>&ndash;</sup> gradient due to differential development of the K<sup>+</sup>/Cl<sup>&ndash;</sup> co-transporters</td> <td>GABA is depolarizing early in life, enhancing excitability</td> </tr> <tr> <td>Developmental changes in GABA<sub>A</sub> receptor subunits</td> <td>Partially accounts for developmental differences in inhibitory effectiveness and benzodiazepine responsiveness</td> </tr> <tr> <td>Developmental sensitivity to glutamate toxicity</td> <td>Less glutamate-induced excitotoxicity early in development</td> </tr> <tr> <td>Immature GABA<sub>A</sub> binding pattern in substantia nigra</td> <td>Proconvulsant effect</td> </tr> <tr> <td>Electrical synapses: More common early in development</td> <td>Mechanism for enhanced synchrony of neuronal networks</td> </tr> <tr> <td>Immature homeostatic mechanisms: NaK-ATPase, glial K<sup>+</sup> regulation, K<sup>+</sup>/Cl<sup>&ndash;</sup> co-transporters</td> <td>Prolonged exposure to elevated extracellular K<sup>+</sup> leads to further neuronal depolarization</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">GABA<SUB>A</SUB>: gamma-aminobutyric acid A; NaK-ATPase: sodium-potassium adenosine triphosphatase.</div><div class=\"graphic_reference\">Reproduced with permission from: Rho JM, Stafstrom CE. Neurophysiology of epilepsy. In: Pediatric Neurology: Principles and Practice, 4th ed, Swaiman KF, Ashwal S, Ferreiro DM (Eds). Mosby Elsevier. Philadelphia 2006. Copyright &copy; 2006.</div><div id=\"graphicVersion\">Graphic 52092 Version 2.0</div></div></div>"},"52093":{"type":"graphic_table","displayName":"DTP adverse reaction rates","title":"Estimated rates of moderate and severe adverse reactions after diphtheria-tetanus-whole cell pertussis (DTwP) and diphtheria-tetanus-acellular pertussis (DTaP) vaccines","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Estimated rates of moderate and severe adverse reactions after diphtheria-tetanus-whole cell pertussis (DTwP) and diphtheria-tetanus-acellular pertussis (DTaP) vaccines</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup span=\"3\" width=\"33%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\">Adverse reaction</td> <td class=\"subtitle1\">DTwP</td> <td class=\"subtitle1\">DTaP</td> </tr> <tr> <td>Entire limb swelling</td> <td>&nbsp;</td> <td>1 in 33 to 1 in 50 children after the fourth or fifth dose</td> </tr> <tr> <td>Persistent inconsolable crying (&#8805;3 hours)</td> <td>1 in 100 doses</td> <td>1 to 2&nbsp;in 1000 children</td> </tr> <tr> <td>Hypotonic-hyporesponsive episode (collapse, shock-like state)</td> <td>1 in 1750 doses (range 1 in 344 to 1 in 28,570)</td> <td>Less than 1 per 10,000 children (range 1 in 714 to 1 in 25,000)</td> </tr> <tr> <td>Seizures (febrile)</td> <td>1 in 1750 doses</td> <td>1 in 14,000 children</td> </tr> <tr> <td>Fever &#8805;105&#176;F (40.5&#176;C)</td> <td>1 in 333 doses</td> <td>1 in 16,000 children</td> </tr> <tr> <td>Anaphylaxis</td> <td>1 in 50,000 doses</td> <td>Less than 1 in 1 million doses</td> </tr> </tbody></table></div><div class=\"graphic_reference\">Data from: &#xD;&#xA;<OL>&#xD;&#xA;<LI>American Academy of Pediatrics. Pertussis (whooping cough). In: Red Book: 2015 Report of the Committee on Infectious Diseases, 30<SUP>th</SUP> ed, Kimberlin DW, Brady MT, Jackson MA, Long SS. (Eds), American Academy of Pediatrics, Elk Grove Village, IL 2015. p.609.</LI>&#xD;&#xA;<LI>US Department of Health and Human Services. Centers for Disease Control and Prevention. Vaccine Information Statement DTaP (5/17/07). Available at: www.cdc.gov/vaccines/pubs/vis/default.htm#dtap. Accessed on June 25, 2012.</LI>&#xD;&#xA;<LI>Centers for Disease Control and Prevention. Pertussis. In: Epidemiology and Prevention of Vaccine-Preventable Diseases. The Pink Book, 12<SUP>th</SUP> ed. Atkinson W, Wolfe S, Hamborsky J (Eds). Public Health Foundation, Washington, DC 2012. Available at: www.cdc.gov/vaccines/pubs/pinkbook/index.html. Accessed on June 25, 2012.</LI>&#xD;&#xA;<LI>Gold MS. Hypotonic-hyporesponsive episodes following pertussis vaccination:&nbsp;A cause for concern? Drug Saf 2002; 25:85.</LI></OL></div><div id=\"graphicVersion\">Graphic 52093 Version 5.0</div></div></div>"},"52094":{"type":"graphic_table","displayName":"Primary secondary GN child","title":"Causes of glomerulonephritis in children","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Causes of glomerulonephritis in children</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1_single\">Primary glomerulonephritis</td> </tr> <tr> <td>Membranous glomerulonephritis</td> </tr> <tr> <td>Membranoproliferative glomerulonephritis type I</td> </tr> <tr> <td>Membranoproliferative glomerulonephritis type II (dense deposit disease)</td> </tr> <tr> <td>IgA nephropathy</td> </tr> <tr> <td>Anti-glomerular basement membrane disease</td> </tr> <tr> <td>Idiopathic crescentic glomerulonephritis</td> </tr> <tr> <td class=\"subtitle1_single\">Secondary glomerulonephritis</td> </tr> <tr> <td>Post-streptococcal glomerulonephritis</td> </tr> <tr> <td>Other post-infectious glomerulonephritis</td> </tr> <tr> <td>Henoch-Sch&#246;nlein purpura nephritis</td> </tr> <tr> <td>Systemic lupus erythematosus nephritis</td> </tr> <tr> <td>Microscopic polyangiitis</td> </tr> <tr> <td>Wegener granulomatosus</td> </tr> </tbody></table></div><div class=\"graphic_reference\">Original figure modified for this publication. Reproduced with permission from: Niaudet P. Nephritic Syndrome. In: Comprehensive Pediatric Nephrology, Geary DF, Schaefer F (Eds), Mosby, Philadelphia 2008. Illustration used with the permission of Elsevier Inc. All rights reserved.</div><div id=\"graphicVersion\">Graphic 52094 Version 2.0</div></div></div>"},"52095":{"type":"graphic_diagnosticimage","displayName":"Transverse ultrasound scan of needle with echoes","title":"Transverse ultrasound scan of needle with echoes beneath","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Transverse ultrasound scan of needle with echoes beneath</div><div class=\"cntnt\"><img style=\"width:380px; height:312px;\" src=\"images/RHEUM/52095_Transverse_US_needle_echoes.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Transverse ultrasound scan of a needle, showing only a point (arrowhead) with numerous echoes beneath.</div><div class=\"graphic_reference\">Reproduced with permission from: Introductory Guide to Musculoskeletal Ultrasound for the Rheumatologist, Second Edition. ISBN 978-90-313-9206-3; Bohn Stafleu van Loghum, Houten 2012. Copyright &#169; 2012.</div><div id=\"graphicVersion\">Graphic 52095 Version 1.0</div></div></div>"},"52096":{"type":"graphic_picture","displayName":"Bimanual laryngoscopy","title":"Bimanual laryngoscopy","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Bimanual laryngoscopy</div><div class=\"cntnt\"><img style=\"width:432px; height:325px;\" src=\"images/EM/52096_Bimanuallaryngoscopy.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Once the optimal glottic view is obtained with external laryngeal manipulation, the laryngoscopist instructs an assistant to place their fingers in exactly the same spot on the thyroid cartilage, using the same direction and degree of force.</div><div class=\"graphic_reference\">Reproduced with permission from: Orebaugh SL. Direct laryngoscopy. In: Atlas of Airway Management: Techniques and Tools, Lippincott Williams &amp; Wilkins, Philadelphia 2007. Copyright Â© 2007 Lippincott Williams &amp; Wilkins. <A href=\"http://www.lww.com/\" target=_blank>www.lww.com</A>.</div><div id=\"graphicVersion\">Graphic 52096 Version 10.0</div></div></div>"},"52097":{"type":"graphic_figure","displayName":"Closure rectovaginal fistula","title":"Repair of a small rectovaginal fistula through a transvaginal approach","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Repair of a small rectovaginal fistula through a transvaginal approach</div><div class=\"cntnt\"><img style=\"width:406px; height:415px;\" src=\"images/OBGYN/52097_Closure_rectovaginal_fistul.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The rectal mucosa is closed using a delayed absorbable suture. Note that the suture line is begun at least 5 mm above the apex of the fistula.</div><div id=\"graphicVersion\">Graphic 52097 Version 2.0</div></div></div>"},"52098":{"type":"graphic_picture","displayName":"Hemozoin in monocyte","title":"Malarial pigment (hemozoin) in a monocyte","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Malarial pigment (hemozoin) in a monocyte</div><div class=\"cntnt\"><img style=\"width:396px; height:396px;\" src=\"images/HEME/52098_Hemozoin_in_monocyte.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Malarial pigment in a monocyte - Peripheral blood smear taken from a patient presenting with signs and symptoms suggestive of cerebral malaria due to infection with P. falciparum. It shows a monocyte with several dark, irregular, pigmented inclusions (arrows), representing hemoglobin from the patient's red cells incompletely degraded by the parasite (malarial pigment, hemozoin), released into the circulation during schizony, and phagocytosed by cells of the monocyte-macrophage system.</div><div class=\"graphic_reference\">Kindly provided by Dr. German Pihan, Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA.</div><div id=\"graphicVersion\">Graphic 52098 Version 2.0</div></div></div>"},"52099":{"type":"graphic_picture","displayName":"Mandibular advancement splint","title":"Mandibular advancement splint","html":"<div class=\"graphic\"><div style=\"width: 562px\" class=\"figure\"><div class=\"ttl\">Mandibular advancement splint</div><div class=\"cntnt\"><img style=\"width:542px; height:287px;\" src=\"images/PULM/52099_Mandibular_advance_splint.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">This mandibular advancement splint is manufactured in a laboratory from dental impressions (Klearway appliance, Great Lakes Orthodontics, Inc, Tonawanda, NY). Special features stressed by the manufacturer are the full dental coverage, the low profile of the appliance, and adjustability of mandibular position by means of a screw.</div><div id=\"graphicVersion\">Graphic 52099 Version 3.0</div></div></div>"},"52100":{"type":"graphic_table","displayName":"Normal adult echocardiographic dimensions","title":"Normal adult echocardiographic dimensions","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Normal adult echocardiographic dimensions</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1_left\" colspan=\"2\">Aorta</td> </tr> <tr> <td>Sinus level</td> <td>M: &#8804;4 cm; F: &#8804;3.6 cm</td> </tr> <tr> <td>Ascending</td> <td>M: &#8804;3.8 cm; F: &#8804;3.5 cm</td> </tr> <tr> <td>Transverse</td> <td>&#8804;3.0 cm</td> </tr> <tr> <td>Descending</td> <td>&#8804;2.5 cm</td> </tr> <tr> <td class=\"subtitle1_left\" colspan=\"2\">Left atrium</td> </tr> <tr> <td>Anteroposterior dimension (parasternal long axis)</td> <td>M: 3-4 cm; F: 2.7-3.8 cm</td> </tr> <tr> <td>Indexed volume</td> <td>16-34 mL/m2</td> </tr> <tr> <td class=\"subtitle1_left\" colspan=\"2\">Left ventricle</td> </tr> <tr> <td>Septum</td> <td>6-11 mm</td> </tr> <tr> <td>Posterior&nbsp;wall</td> <td>6-11 mm</td> </tr> <tr> <td>End-diastolic dimension </td> <td>M: 4.2-5.8 cm; F: 3.8-5.2 cm</td> </tr> <tr> <td class=\"subtitle1_left\" colspan=\"2\">Pulmonary artery</td> </tr> <tr> <td>Main</td> <td>&#8804;3.0 cm</td> </tr> <tr> <td class=\"subtitle1_left\" colspan=\"2\">Inferior vena cava</td> </tr> <tr> <td>1-2 cm from right atrial junction</td> <td>&#8804;2.1 cm</td> </tr> <tr> <td class=\"subtitle1_left\">Coronary sinus</td> <td>&#8804;1 cm</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">M: male; F: female.</div><div id=\"graphicVersion\">Graphic 52100 Version 3.0</div></div></div>"},"52101":{"type":"graphic_figure","displayName":"Ventilatory response to hypercapnia","title":"Ventilatory response to hypercapnia","html":"<div class=\"graphic\"><div style=\"width: 541px\" class=\"figure\"><div class=\"ttl\">Ventilatory response to hypercapnia</div><div class=\"cntnt\"><img style=\"width:521px; height:305px;\" src=\"images/PULM/52101_Ventilatorresponsehyperca.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Beginning at a normal ventilation of 5 to 8 L/min and a PaCO<sub>2</sub> equal to 40 mmHg, ventilation increases linearly as PCO<sub>2</sub> rises. In normal individuals there is a range of responsiveness between 2 and 5 L/min/mmHg rise in PCO<sub>2</sub>. Hypoxemia heightens the response and shifts the curve up and to the left.</div><div id=\"graphicVersion\">Graphic 52101 Version 3.0</div></div></div>"},"52102":{"type":"graphic_table","displayName":"Examination of thumb","title":"Examination of the thumb","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Examination of the thumb</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1\">Thumb motion</td> <td class=\"subtitle1\">Patient</td> <td class=\"subtitle1\">Examiner</td> </tr> <tr> <td>Extension at MCP</td> <td>Extend thumb fully.</td> <td>Push on proximal phalanx, trying to flex thumb at MCP joint.</td> </tr> <tr> <td>Extension at IP</td> <td>Extend thumb fully.</td> <td>Push on distal phalanx, trying to flex thumb at IP joint. Stabilize the proximal phalanx with other hand.</td> </tr> <tr> <td>Flexion at MCP</td> <td>Touch thumb to hypothenar eminence.</td> <td>Grasp thumb distally and try to pull out of flexion.</td> </tr> <tr> <td>Flexion at IP</td> <td>Flex thumb at IP joint and hold position.</td> <td>Try to pull distal phalanx into extension.</td> </tr> <tr> <td>Palmar abduction</td> <td>With thumb and fingers aligned, in the same plane, abduct thumb to position perpendicular to palm.</td> <td>Push distally on thumb trying to return it to the plane of the palm.</td> </tr> <tr> <td>Palmar adduction</td> <td>From position of palmar abduction, move thumb to plan of palm.</td> <td>Push distally on thumb resisting movement toward the plane of the palm.</td> </tr> <tr> <td>Opposition</td> <td>Touch thumb tip to tip of little finger and maintain \"circle\" shape. This method isolates OP muscle. Can also be tested using index finger, which involves both OP and first IO muscles.</td> <td>Hook a finger into the circle and try to disrupt the \"pinch.\"</td> </tr> <tr> <td>Adduction</td> <td>Align fingers and thumb parallel and in same plane, and hold this position.</td> <td>Grasp thumb and attempt to pull it out of adduction to position in plane of palm but at a 45 degree angle with the axis of the palm and fingers.</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">IP: interphalangeal; MCP: metacarpophalangeal.</div><div id=\"graphicVersion\">Graphic 52102 Version 1.0</div></div></div>"},"52103":{"type":"graphic_table","displayName":"Commonly ingested nontoxic plants and minimally toxic plants","title":"Commonly ingested nontoxic plants and minimally toxic plants","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Commonly ingested nontoxic plants and minimally toxic plants</div><div class=\"cntnt\"><table class=\"container\" cellspacing=\"0\"><tbody> <tr> <td class=\"container\"> <table cellspacing=\"0\"> <tbody> <tr> <td class=\"subtitle1_single\">Nontoxic plants</td> </tr> <tr> <td>Abelia</td> </tr> <tr> <td>African daisy</td> </tr> <tr> <td>African violet</td> </tr> <tr> <td>Aralia</td> </tr> <tr> <td>Aspidistra</td> </tr> <tr> <td>Aster</td> </tr> <tr> <td>Baby's tears</td> </tr> <tr> <td>Bachelor buttons</td> </tr> <tr> <td>Begonia</td> </tr> <tr> <td>Bird's nest fern</td> </tr> <tr> <td>Blood leaf plant</td> </tr> <tr> <td>Boston ferns</td> </tr> <tr> <td>Bougainvillea</td> </tr> <tr> <td>California holly</td> </tr> <tr> <td>Camelia</td> </tr> <tr> <td>Christmas cactus</td> </tr> <tr> <td>Dahlia</td> </tr> <tr> <td>Daisies</td> </tr> <tr> <td>Dandelion</td> </tr> <tr> <td>Day lily</td> </tr> <tr> <td>Easter lily</td> </tr> <tr> <td>Echeveria</td> </tr> <tr> <td>Eugenia</td> </tr> <tr> <td>Gardenia</td> </tr> <tr> <td>Hedge apples</td> </tr> <tr> <td>Honeysuckle</td> </tr> <tr> <td>Impatiens</td> </tr> <tr> <td>Jade plant</td> </tr> <tr> <td>Magnolia</td> </tr> <tr> <td>Marigold</td> </tr> <tr> <td>Petunia</td> </tr> <tr> <td>Prayer plant</td> </tr> <tr> <td>Pyracantha (leaf or flower)</td> </tr> <tr> <td>Rose</td> </tr> <tr> <td>Schefflera</td> </tr> <tr> <td>Spider plant</td> </tr> <tr> <td>Swedish ivy</td> </tr> <tr> <td>Violets</td> </tr> <tr> <td>Wandering Jew</td> </tr> <tr> <td>Weeping fig</td> </tr> <tr> <td>Weeping willow</td> </tr> <tr> <td>Wild onion</td> </tr> </tbody> </table> </td> <td class=\"container\"> <table cellspacing=\"0\"> <tbody> <tr> <td class=\"subtitle1_single\">Minimally toxic plants</td> </tr> <tr> <td class=\"subtitle2_single\">Mucosal irritation*</td> </tr> <tr> <td class=\"indent1\">Dieffenbachia</td> </tr> <tr> <td class=\"indent1\">Elephant ear</td> </tr> <tr> <td class=\"indent1\">Jack-in-the-pulpit</td> </tr> <tr> <td class=\"indent1\">Peace lily</td> </tr> <tr> <td class=\"indent1\">Philodendron</td> </tr> <tr> <td class=\"indent1\">Skunk cabbage</td> </tr> <tr> <td class=\"subtitle2_single\">Minor gastrointestional irritation</td> </tr> <tr> <td class=\"indent1\">Amaryllis bulb</td> </tr> <tr> <td class=\"indent1\">American mistletoe berries</td> </tr> <tr> <td class=\"indent1\">Daffodil bulb</td> </tr> <tr> <td class=\"indent1\">Holly berries</td> </tr> <tr> <td class=\"indent1\">Poinsettia</td> </tr> <tr> <td class=\"indent1\">Pyracantha berries</td> </tr> </tbody> </table> </td> </tr> </tbody></table><html xmlns:mso=\"urn:schemas-microsoft-com:office:office\" xmlns:msdt=\"uuid:C2F41010-65B3-11d1-A29F-00AA00C14882\"><head>\r\n<!--[if gte mso 9]><xml>\n<mso:CustomDocumentProperties>\r\n<mso:Specialty msdt:dt=\"string\">3</mso:Specialty>\r\n<mso:Edit_Table msdt:dt=\"string\">&lt;a href=&quot;/Graphics/Pages/TableEditor.aspx?SPID=94167&amp;amp;Mode=Edit&quot;&gt;&lt;img alt=&quot;&quot; border=0 src=&quot;/_layouts/IMAGES/ICGEN.gif&quot;&gt;Edit Table&lt;/a&gt;</mso:Edit_Table>\r\n</mso:CustomDocumentProperties>\n</xml><![endif]-->\r\n</head></div><div class=\"graphic_footnotes\">* Rarely, significant mucosal irritation with drooling, dysphagia, and/or airway obstruction can occur.</div><div class=\"graphic_reference\">Reproduced with permission from: Osterhoudt KC, Burns Ewald M, Shannon M, Henretig FM. Toxicologic emergencies. In: Textbook of Pediatric Emergency Medicine, 6th edition, Fleisher GR, Ludwig S (Eds), Lippincott Williams &amp; Wilkins, Philadelphia, 2010. Copyright Â© 2010 Lippincott Williams &amp; Wilkins. <A href=\"http://www.lww.com/\" target=_blank>www.lww.com</A>.</div><div id=\"graphicVersion\">Graphic 52103 Version 9.0</div></div></div>"},"52104":{"type":"graphic_figure","displayName":"2-thumb method PI","title":"Infant CPR: 2-thumb method","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Infant CPR: 2-thumb method</div><div class=\"cntnt\"><img style=\"width:408px; height:524px;\" src=\"images/PI/52104_Two_thumb_method_PI.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Pressing on the chest for CPR is called doing &quot;compressions.&quot; To do compressions on an infant using the 2-thumb method, hold the infant with your hands around his or her chest. Then place the tips of your thumbs (side-by-side) on the victim's breastbone, just below the nipples. With each compression, make sure the victim's chest drops down at least 1.5 inches (3.8 centimeters). Between compressions, lift all pressure off the victim's chest so that his or her chest goes back to where it was.</div><div id=\"graphicVersion\">Graphic 52104 Version 3.0</div></div></div>"},"52105":{"type":"graphic_picture","displayName":"Borderline lepromatous leprosy","title":"Borderline lepromatous leprosy (BL/MB)","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Borderline lepromatous leprosy (BL/MB)</div><div class=\"cntnt\"><img style=\"width:432px; height:292px;\" src=\"images/ID/52105_Borderline_lepromatous_lepr.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Borderline lepromatous case showing borderline tuberculoid and \"punched out\" mid-borderline lesions together with papular and nodular lesions more typical of lepromatous disease.</div><div class=\"graphic_reference\">Courtesy of James L Krahenbuhl, PhD, and Robert R Jacobson, MD, PhD.</div><div id=\"graphicVersion\">Graphic 52105 Version 2.0</div></div></div>"},"52106":{"type":"graphic_figure","displayName":"Atrial septal defect anatomy","title":"Atrial septal defects","html":"<div class=\"graphic\"><div style=\"width: 475px\" class=\"figure\"><div class=\"ttl\">Atrial septal defects</div><div class=\"cntnt\"><img style=\"width:455px; height:544px;\" src=\"images/CARD/52106_Atrial_septal_defect_anatom.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The normal atrial septum (panel A) as well as various types of atrial septal defects (ASD) are shown. Panel B: secundum ASD is formed by the poor growth of the septum secundum or excessive absorption of the septum primum. Panel C: Primum ASD is formed by the failure of the septum primum to fuse with the endocardial cushions. The fossa ovalis is normal. The frontal view of the primum ASD shows the caudal location of the ASD just above the endocardial cushion. Panel D: Sinus venosus ASD is caused by the malposition of the insertion of the superior or inferior vena cava and is outside the area of the fossa ovalis.</div><div id=\"graphicVersion\">Graphic 52106 Version 1.0</div></div></div>"},"52107":{"type":"graphic_picture","displayName":"Acute meningococcemia","title":"Acute meningococcemia","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Acute meningococcemia</div><div class=\"cntnt\"><img style=\"width:249px; height:360px;\" src=\"images/ID/52107_Purpura_fulminans.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Skin lesions in acute meningococcemia can begin as papules but quickly progress to petechiae and purpura. As seen here, the purpuric lesions can coalesce.</div><div class=\"graphic_reference\">Courtesy of Charles V Sanders. (The Skin and Infection: A Color Atlas and Text, Sanders CV, Nesbitt, LT Jr [Eds], Williams &amp; Wilkins, Baltimore, 1995).</div><div id=\"graphicVersion\">Graphic 52107 Version 5.0</div></div></div>"},"52108":{"type":"graphic_table","displayName":"Strep bovis susceptibilities II","title":"Representative susceptibilities of <EM>Streptococcus bovis</EM> to antibiotics","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Representative susceptibilities of <EM>Streptococcus bovis</EM> to antibiotics</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1\">Antimicrobial</td> <td class=\"subtitle1\">MIC range, mcg/mL*</td> <td class=\"subtitle1\">MIC50 range, mcg/mL<sup>&#182;</sup></td> <td class=\"subtitle1\">MIC90 range, mcg/mL<sup>&#182;</sup></td> <td class=\"subtitle1\">References</td> </tr> <tr> <td>Meropenem</td> <td>0.015 to 0.12</td> <td>0.12</td> <td>0.12</td> <td>Schouten, 1997; Hoogkamp-Korstanje, 2000</td> </tr> <tr> <td>Vancomycin</td> <td>0.13 to 2</td> <td>0.25 to 0.5</td> <td>0.5 to 1</td> <td>Eggers, 1992; Mouton, 1997; Fass, 1991; Schouten, 1997; Kerwala, 2001; Hoogkamp-Korstanje, 2000; Streit, 2005; Moet, 2007</td> </tr> <tr> <td>Erythromycin</td> <td>&#8804;0.008 to &#62;256</td> <td>0.03 to &#62;256</td> <td>1 to &#62;32</td> <td>Pfaller, 1997; Mouton, 1997; Schouten, 1997; Fass, 1993; Hoogkamp-Korstanje, 2000; Streit, 2005; Moet, 2007</td> </tr> <tr> <td>Clarithromycin</td> <td>&#8804;0.015 to &#62;32</td> <td>&#60;0.125</td> <td>0.5 to &#62;32</td> <td>Mouton, 1997; Fass, 1993; Hoogkamp-Korstanje, 2000</td> </tr> <tr> <td>Clindamycin</td> <td>&#8804;0.008 to &#62;16</td> <td>0.03 to 0.125</td> <td>&#62;16</td> <td>Mouton, 1997; Streit, 2005; Moet, 2007</td> </tr> <tr> <td>Quinupristin-dalfopristin</td> <td>0.015 to 16</td> <td>0.5 to 2</td> <td>1 to 16</td> <td>Mouton, 1997; Fass, 1991; Schouten, 1997; Barrett, 1996; Streit, 2005</td> </tr> <tr> <td>Rifampin</td> <td>&#8804;0.015 to 0.25</td> <td>0.125</td> <td>0.12 to 0.25</td> <td>Fass, 1991; Schouten, 1997</td> </tr> <tr> <td>Tetracycline</td> <td>0.25 to &#8805;32</td> <td>&#62;8</td> <td>&#62;8 to &#8805;32</td> <td>Kerwala, 2001; Streit, 2005; Moet, 2007</td> </tr> <tr> <td>Ciprofloxacin</td> <td>0.25 to &#8805;32</td> <td>1 to 4</td> <td>2 to 4</td> <td>Eggers, 1992; Fass, 1991; Fass, 1993; Etienne, 1988; Schouten, 1997; Neu, 1994; Kerwala, 2001; Hoogkamp-Korstanje, 2000</td> </tr> <tr> <td>Levofloxacin</td> <td>0.5 to &#8805;32</td> <td>1 to 4</td> <td>2 to 4</td> <td>Kerwala, 2001; Hoogkamp-Korstanje, 2000</td> </tr> <tr> <td>Moxifloxacin</td> <td>0.06 to 0.5</td> <td>0.12</td> <td>0.25</td> <td>Hoogkamp-Korstanje, 2000</td> </tr> <tr> <td>Daptomycin</td> <td>0.03 to 0.25</td> <td>0.03</td> <td>0.06</td> <td>Streit, 2005</td> </tr> <tr> <td>Linezolid</td> <td>0.5 to 2</td> <td>1</td> <td>1</td> <td>Streit, 2005; Moet, 2007</td> </tr> <tr> <td>Tigecycline</td> <td>&#8804;0.06</td> <td>&#8804;0.06</td> <td>&#8804;0.06</td> <td>Moet, 2007</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">MIC: minimum inhibitory concentration.<br />* Minimum and maximum values of MIC ranges given.<br />Â¶ Range of concentrations inhibiting 50 percent (MIC50) and 90 percent (MIC90) of isolates.</div><div id=\"graphicVersion\">Graphic 52108 Version 4.0</div></div></div>"},"52111":{"type":"graphic_figure","displayName":"Basement membrane zone","title":"Schematic of the basement membrane (BMZ) zone and intercellular desmosomal adhesion","html":"<div class=\"graphic\"><div style=\"width: 704px\" class=\"figure\"><div class=\"ttl\">Schematic of the basement membrane (BMZ) zone and intercellular desmosomal adhesion</div><div class=\"cntnt\"><img style=\"width:684px; height:297px;\" src=\"images/DERM/52111_Dermal_epidermal_junct_edit.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Intermediate filaments composed of keratin 5 and 14 insert on the keratin (cytoskeletal) linker proteins plectin and BPAG1 (BP230) at the superior aspect of the BMZ. Plectin and BPAG1 interact with transmembrane a6b4 integrin and type XVII collagen (BP180/BPAG2), forming hemidesmosomes that attach basal keratinocytes to the underlying basement membrane. Anchoring filaments jut out below the hemidesmosome and include laminin-332 and laminin-311 that associate with type XVII collagen and a6b4 integrin, but also laminin-511, type IV collagen, and nidogen, thereby forming the lamina densa. Anchoring fibrils extend perpendicularly as banded projections from the lamina densa and contain polymeric associations of type VII collagen molecules that intertwine between dermal interstitial collagen fibrils. Type VII collagen triple helices attach the lamina densa to papillary dermis and are critical for the integrity of the epidermal-dermal junction through their ability to bind laminin-332. Intercellular junction is mediated by desmosomes whose intracellular protein components include desmoplakin (interacting with intermediate filament network), plakophilin as well as plakoglobin, the last two of which connect to the transmembrane cadherin tails (composed of desmoglein, desmocollin).</div><div id=\"graphicVersion\">Graphic 52111 Version 5.0</div></div></div>"},"52112":{"type":"graphic_picture","displayName":"Sunburn blistering","title":"Sunburn","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Sunburn</div><div class=\"cntnt\"><img style=\"width:396px; height:324px;\" src=\"images/DERM/52112_Sunburn_blistering.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Erythema, edema, and bullae are present on this child with a severe sunburn.</div><div class=\"graphic_reference\">Reproduced with permission from: Fleisher, GR, Ludwig, S, Baskin, MN. Atlas of Pediatric Emergency Medicine, Lippincott Williams &amp; Wilkins, Philadelphia 2004. Copyright &#169; 2004 Lippincott Williams &amp; Wilkins.</div><div id=\"graphicVersion\">Graphic 52112 Version 1.0</div></div></div>"},"52113":{"type":"graphic_diagnosticimage","displayName":"Endometrioma sonogram Doppler","title":"Endometrioma with color doppler","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Endometrioma with color doppler</div><div class=\"cntnt\"><img style=\"width:432px; height:328px;\" src=\"images/OBGYN/52113_Endometrioma_sonogram_Doppl.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Transvaginal ultrasound with color Doppler image of the left adnexa showing a benign endometrioma of the left ovary viewed with color Doppler imaging. No flow within the cyst can be demonstrated; however, blood flow is demonstrated within the wall of the cyst in the ovarian tissue itself (long arrow). Also identified within the left ovary is a small follicle (short arrow).</div><div class=\"graphic_reference\">Reproduced with permission from: Thomas D Shipp, MD. Copyright Â© Thomas D Shipp, MD.</div><div id=\"graphicVersion\">Graphic 52113 Version 2.0</div></div></div>"},"52114":{"type":"graphic_table","displayName":"MGUS cytogenic changes","title":"Primary cytogenetic changes in monoclonal gammopathy of undetermined significance (MGUS)","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Primary cytogenetic changes in monoclonal gammopathy of undetermined significance (MGUS)</div><div class=\"cntnt\"><table cellspacing=\"0\">\n<tbody>\n\n  <tr>\n    <td class=\"subtitle1\">Cytogenetic abnormality</td>\n    <td class=\"subtitle1\">Approximate percent of MGUS</td>\n    <td class=\"subtitle1\">Genes dysregulated by cytogenetic changes</td>\n  </tr>\n  <tr>\n    <td class=\"subtitle2_left\" colspan=\"3\">Primary IgH translocations involving chromosome 14q32 (non-hyperdiploid MGUS)</td>\n  </tr>\n  <tr>\n    <td class=\"indent1\">t(11;14)(q13;q32)</td>\n    <td>25 percent</td>\n    <td>CCND1 (cyclin D1)</td>\n  </tr>\n  <tr>\n    <td class=\"indent1\">t(4;14)(p16;q32)</td>\n    <td>15 percent</td>\n    <td>FGFR-3 and MMSET</td>\n  </tr>\n  <tr>\n    <td class=\"indent1\">t(14;16)(q32;q23)</td>\n    <td>5 percent</td>\n    <td>C-MAF</td>\n  </tr>\n  <tr>\n    <td class=\"indent1\">t(6;14)(p21;q32)</td>\n    <td>3 percent</td>\n    <td>CCND3 (cyclin D3)</td>\n  </tr>\n  <tr>\n    <td class=\"indent1\">t(14;20)(q32;q11)</td>\n    <td>2 percent</td>\n    <td>MAFB</td>\n  </tr>\n  <tr>\n    <td><strong>Hyperdiploidy (hyperdiploid MGUS)</strong></td>\n    <td>45 percent</td>\n    <td>Multiple genes dysregulated due to recurrent trisomies involving odd-numbered chromosomes with exception of chromosomes 1, 13, and 21</td>\n  </tr>\n  <tr>\n    <td><strong>Unknown</strong></td>\n    <td>&#60;5 percent</td>\n    <td>Neither IgH translocation nor hyperdiploidy</td>\n  </tr>\n\n</tbody>\n</table></div><div id=\"graphicVersion\">Graphic 52114 Version 1.0</div></div></div>"},"52116":{"type":"graphic_table","displayName":"Airway obstruction children","title":"Anatomic factors contributing to upper airway obstruction in children","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Anatomic factors contributing to upper airway obstruction in children</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1_single\">Nose</td> </tr> <tr> <td>Deviated septum</td> </tr> <tr> <td>Rhinitis (allergic or non-allergic)</td> </tr> <tr> <td>Choanal atresia</td> </tr> <tr> <td>Nasal polyps</td> </tr> <tr> <td class=\"subtitle1_single\">Oropharynx</td> </tr> <tr> <td>Tonsillar hypertrophy*</td> </tr> <tr> <td>Macroglossia</td> </tr> <tr> <td>Retro/micrognathia</td> </tr> <tr> <td>Infiltration by mucopolysaccarides (Hunter/Hurler syndromes)</td> </tr> <tr> <td>Obesity</td> </tr> <tr> <td>Oropharyngeal burns</td> </tr> <tr> <td>Acute skull base angle</td> </tr> <tr> <td>Pharyngeal flap</td> </tr> <tr> <td>High arched palate</td> </tr> <tr> <td class=\"subtitle1_single\">Nasopharynx</td> </tr> <tr> <td>Midfacial hypoplasia</td> </tr> <tr> <td>Adenoidal hypertrophy*</td> </tr> <tr> <td class=\"subtitle1_single\">Hypopharynx</td> </tr> <tr> <td>Laryngotracheomalacia</td> </tr> <tr> <td>Vocal cord paralysis</td> </tr> <tr> <td>Vascular ring</td> </tr> <tr> <td>Subglottic stenosis</td> </tr> <tr> <td>Hemangioma</td> </tr> <tr> <td>Neurofibroma</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">* Most common factors.</div><div id=\"graphicVersion\">Graphic 52116 Version 2.0</div></div></div>"},"52117":{"type":"graphic_figure","displayName":"Mitral annular sample sites","title":"Mitral annular sampling sites","html":"<div class=\"graphic\"><div style=\"width: 493px\" class=\"figure\"><div class=\"ttl\">Mitral annular sampling sites</div><div class=\"cntnt\"><img style=\"width:473px; height:283px;\" src=\"images/CARD/52117_Mitral_annular_sample_sites.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Shown are three standard apical two dimensional echocardiographic views and six mitral annular sampling sites for tissue Doppler examination.</div><div id=\"graphicVersion\">Graphic 52117 Version 1.0</div></div></div>"},"52118":{"type":"graphic_diagnosticimage","displayName":"M mode echo aortic root Marfan","title":"M-mode echocardiogram of aortic regurgitation","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">M-mode echocardiogram of aortic regurgitation</div><div class=\"cntnt\"><img style=\"width:411px; height:252px;\" src=\"images/CARD/52118_M_mode_echo_aortic_root_Mar.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The M-mode echocardiographic findings in aortic regurgitation, due to the Marfan syndrome in this case, include fluttering of the mitral valve (MV) (panel A) and a greatly dilated aortic root (Ao), measuring 48 mm, in relationship to a small appearing left atrium (LA) (panel B), which measures 27 mm. The aortic to atrial diameter ratio has been used as a sign of the Marfan syndrome.</div><div id=\"graphicVersion\">Graphic 52118 Version 3.0</div></div></div>"},"52119":{"type":"graphic_picture","displayName":"IPH alveolar macrophages","title":"Bronchoalveolar lavage in idiopathic pulmonary hemosiderosis","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Bronchoalveolar lavage in idiopathic pulmonary hemosiderosis</div><div class=\"cntnt\"><img style=\"width:387px; height:263px;\" src=\"images/PULM/52119_IPH_alveolar_macrophages.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Staining for iron shows numerous hemosiderin-laden alveolar macrophages in bronchoalveolar lavage fluid recovered from a patient with idiopathic pulmonary hemosiderosis.</div><div class=\"graphic_reference\">Courtesy of Per Praetorius Clausen, MD.</div><div id=\"graphicVersion\">Graphic 52119 Version 1.0</div></div></div>"},"52120":{"type":"graphic_table","displayName":"HCT outcomes in thalassemia (EBMT)","title":"Outcomes of hematopoietic cell transplantation in thalassemia from the EBMT, 2000 to 2010","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Outcomes of hematopoietic cell transplantation in thalassemia from the EBMT, 2000 to 2010</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1\">Recipient age and donor characteristics</td> <td class=\"subtitle1\">Two-year overall survival<br /> (%)</td> <td class=\"subtitle1\">Two-year thalassemia-free survival<br /> (%)</td> </tr> <tr> <td>Recipient age &#60;14 years</td> <td class=\"centered\">90 to 96</td> <td class=\"centered\">83 to 93</td> </tr> <tr> <td>Recipient age 14 years or older</td> <td class=\"centered\">80 to 82</td> <td class=\"centered\">74 to 76</td> </tr> <tr> <td>Matched sibling donor</td> <td class=\"centered\">91&nbsp;</td> <td class=\"centered\">83</td> </tr> <tr> <td>Matched family donor other than sibling</td> <td class=\"centered\">88</td> <td class=\"centered\">78</td> </tr> <tr> <td>Mismatched family donor</td> <td class=\"centered\">68&nbsp;</td> <td class=\"centered\">68&nbsp;</td> </tr> <tr> <td>Matched unrelated donor</td> <td class=\"centered\">77</td> <td class=\"centered\">77</td> </tr> </tbody></table></div><div class=\"graphic_lgnd\">Refer to UpToDate for further information about the use of HCT in thalassemia.</div><div class=\"graphic_footnotes\">EBMT: European&nbsp;Society for Blood and Marrow Transplantation; HCT: Hematopoietic cell transplant.</div><div class=\"graphic_reference\">Data from: Baronciani D, Angelucci E, Potschger U, et al. Hemopoietic stem cell transplantation in thalassemia:&nbsp;A report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry, 2000-2010. Bone Marrow Transplant 2016; 51:536.</div><div id=\"graphicVersion\">Graphic 52120 Version 8.0</div></div></div>"},"52122":{"type":"graphic_diagnosticimage","displayName":"Chronic lung melioidosis","title":"Chest radiograph of chronic pulmonary melioidosis","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Chest radiograph of chronic pulmonary melioidosis</div><div class=\"cntnt\"><img style=\"width:320px; height:316px;\" src=\"images/ID/52122_Chronic_lung_melioidosis.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Chronic melioidosis in the lung mimicking tuberculosis.</div><div class=\"graphic_reference\">Courtesy of Bart Currie, FRACP.</div><div id=\"graphicVersion\">Graphic 52122 Version 4.0</div></div></div>"},"52123":{"type":"graphic_waveform","displayName":"AV dissociation tutorial","title":"Atrioventricular dissociation","html":"<div class=\"graphic normal\"><div style=\"width: 522px\" class=\"figure\"><div class=\"ttl\">Atrioventricular dissociation</div><div class=\"cntnt\"><img style=\"width:502px; height:124px;\" src=\"images/CARD/52123_AV_dissociation_tutorial.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Independent activation of the atria and ventricles results in no fixed relationship between the P waves (arrows) and the QRS complexes; the PR intervals are variable in a random fashion.</div><div id=\"graphicVersion\">Graphic 52123 Version 2.0</div></div><div style=\"width: 450px\" class=\"figure\"><div class=\"ttl\">Normal rhythm strip</div><div class=\"cntnt\"><img style=\"width:432px; height:165px;\" src=\"images/CARD/59022_Normal_rhythm_strip.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Normal rhythm strip in lead II. The PR interval is 0.15 sec and the QRS duration is 0.08 sec. Both the P and T waves are upright.</div><div class=\"graphic_reference\">Courtesy of Morton F Arnsdorf, MD.</div><div id=\"graphicVersion\">Graphic 59022 Version 3.0</div></div></div>"},"52126":{"type":"graphic_algorithm","displayName":"Evaluation of suspected urea cycle deficiencies","title":"Diagnostic algorithm for initial evaluation of suspected urea cycle deficiencies in patients with hyperammonemia","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Diagnostic algorithm for initial evaluation of suspected urea cycle deficiencies in patients with hyperammonemia</div><div class=\"cntnt\"><img style=\"width:412px; height:478px;\" src=\"images/PEDS/52126_Evaluation_hyperammonemia_e.gif\" alt=\"Image\"/></div><div class=\"graphic_footnotes\">ASA: argininosuccinic aciduria; CPS: carbamyl phosphate synthetase; OTC: ornithine transcarbamylase.</div><div id=\"graphicVersion\">Graphic 52126 Version 6.0</div></div></div>"},"52127":{"type":"graphic_diagnosticimage","displayName":"Pancreatogram suggesting mid-duct stricture","title":"Pancreatogram suggesting mid-duct stricture","html":"<div class=\"graphic\"><div style=\"width: 488px\" class=\"figure\"><div class=\"ttl\">Pancreatogram suggesting mid-duct stricture</div><div class=\"cntnt\"><img style=\"width:468px; height:459px;\" src=\"images/GAST/52127_Pancreato_midduct_strict_PR.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Pancreatogram showing a stricture of the mid-pancreatic duct.</div><div id=\"graphicVersion\">Graphic 52127 Version 2.0</div></div></div>"},"52128":{"type":"graphic_picture","displayName":"Pyogenic granuloma 2","title":"Pyogenic granuloma on the finger","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Pyogenic granuloma on the finger</div><div class=\"cntnt\"><img style=\"width:420px; height:273px;\" src=\"images/DERM/52128_Pyogenic_granuloma_2.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">A rapidly growing, red, dome-shaped, friable papule with a collarette of scale is consistent with a pyogenic granuloma.</div><div class=\"graphic_reference\">Reproduced with permission from: Fleisher GR, Ludwig S, Baskin MN. Atlas of Pediatric Emergency Medicine, Lippincott Williams &amp; Wilkins, Philadelphia 2004. Copyright Â© 2004 Lippincott Williams &amp; Wilkins.</div><div id=\"graphicVersion\">Graphic 52128 Version 2.0</div></div></div>"},"52130":{"type":"graphic_figure","displayName":"Iron absorption model","title":"Control of iron absorption","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Control of iron absorption</div><div class=\"cntnt\"><img style=\"width:296px; height:395px;\" src=\"images/HEME/52130_Iron_absorption_model.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">In this preliminary model, body iron status is sensed by duodenal crypt cells via an interaction between circulating transferrin-bound iron and the transferrin receptor (T, step 1), facilitated by a complex between the HFE protein (H) and beta 2-microglobulin (B). When body iron stores are sensed as &quot;low&quot; there is an upregulation of mRNA expression for the divalent metal transporter 1 (D, step 2). As the crypt cells migrate up the villus and mature into absorptive villus enterocytes, the amount of divalent metal transporter 1 protein is increased at the apical surface, facilitating iron absorption from the intestinal lumen (step 3). Absorbed iron is exported into the circulation via ferroportin (E, step 4), the activity of which is inhibited by hepcidin, an iron regulatory molecule produced in the liver and possibly influenced by the iron status of adjacent macrophages. This absorptive mechanism is disrupted in hereditary hemochromatosis when one or more genes in this pathway (eg, HFE, ferroportin, hepcidin) is mutated.</div><div id=\"graphicVersion\">Graphic 52130 Version 1.0</div></div></div>"},"52131":{"type":"graphic_picture","displayName":"Mycosis fungoides plaques","title":"Mycosis fungoides - plaque stage","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Mycosis fungoides - plaque stage</div><div class=\"cntnt\"><img style=\"width:432px; height:311px;\" src=\"images/HEME/52131_Mycosis_fungoides_plaques.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Erythematous, scaly plaques are visible on this patient with plaque stage mycosis fungoides.</div><div class=\"graphic_reference\">Reproduced with permission from: <A style=\"FONT-STYLE: italic\" href=\"http://www.visualdx.com/\" target=_blank>www.visualdx.com</A>. Copyright Logical Images, Inc.</div><div id=\"graphicVersion\">Graphic 52131 Version 4.0</div></div></div>"},"52132":{"type":"graphic_table","displayName":"Treatment for severe pediatric lead poisoning ","title":"Treatment for children with symptomatic lead poisoning or blood lead level 70 mcg/dL or greater","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Treatment for children with symptomatic lead poisoning or blood lead level 70 mcg/dL or greater</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1\" colspan=\"2\">Symptomatic or asymptomatic with blood lead level &#8805;70 mcg/dL (3.38 micromol/L)</td> </tr> <tr> <td>(a)</td> <td>The children should be hospitalized immediately.</td> </tr> <tr> <td>(b)</td> <td>Report the case as well as any other children at possible risk of lead poisoning to appropriate health authorities.</td> </tr> <tr> <td>(c)</td> <td> <p>Perform history, physical examination and baseline studies (abdominal radiograph, CBC with differential, blood&nbsp;lead level, erythrocyte protoporphyrin, serum electrolytes, BUN, creatinine, serum calcium, AST, ALT, urinalysis, and, in patients with encephalopathy, computed tomography of the head).</p> </td> </tr> <tr> <td>(d)&nbsp;</td> <td>In consultation with an expert in the management of pediatric lead poisoning, administer BAL to symptomatic patients. Asymptomatic patients may receive succimer.<sup>&#182;</sup> </td> </tr> <tr> <td>(e)&nbsp;</td> <td>In symptomatic patients, after BAL is started, and once urine output is established, begin CaNa<sub>2</sub>EDTA intravenously. In asymptomatic patients, begin CaNa<sub>2</sub>EDTA intravenously 48 hours after succimer is started.<sup>&#182;</sup> </td> </tr> <tr> <td>(f)</td> <td>During chelation, monitor serum electrolytes, calcium, BUN, creatinine, complete blood count, AST, ALT and urinalysis daily; measure blood&nbsp;lead&nbsp;level on day 3 and, if applicable, day 5.</td> </tr> <tr> <td>(g) </td> <td>Wait&nbsp;two days after completion, recheck&nbsp;lead levels, and administer a second course if Pb levels &#62;45 mcg/dL (2.17 micromol/L). A third course may be necessary if lead levels remain elevated &#62;45 mcg/dL (2.17 micromol/L)&nbsp;5-7 days after the second course.</td> </tr> <tr> <td>(h)&nbsp;</td> <td>Succimer alone may be used for the second or third course of chelation in patients who are asymptomatic and whose lead levels are between 45 (2.17 micromol/L) and 70 mcg/dL&nbsp;(3.38 micromol/L)&nbsp;if they are cooperative, lead-safe housing is assured,&nbsp;and good compliance is anticipated.<sup>&#182;</sup></td> </tr> <tr> <td>(i)</td> <td>Provide parents with educational and nutritional counseling.</td> </tr> <tr> <td>(j)</td> <td>Do not discharge until environmental investigation is completed and recommendations on care at home are made. Patients must be discharged to a lead-safe environment.</td> </tr> <tr> <td>(k) </td> <td>Ensure monitoring of&nbsp;lead levels after discharge by a clinician with expertise in pediatric lead poisoning.</td> </tr> </tbody></table></div><div class=\"graphic_lgnd\">CBC: complete blood count; BAL: British anti-Lewisite (dimercaprol); IM: intramuscular; CaNa2EDTA: calcium disodium edetate; Pb: lead; BUN: blood urea nitrogen; AST: aspartate aminotransferase; ALT: alanine aminotransferase.</div><div class=\"graphic_footnotes\">*For suggested laboratory studies during the initial evaluation of children with severe lead poisoning, refer to UpToDate topics on the management of childhood lead poisoning . <br /><SUP>âÂ¶</SUP>For dosing and administration of chelation agents for children with severe lead poisoning, refer to UpToDate topics on the management of childhood lead poisoning. </div><div id=\"graphicVersion\">Graphic 52132 Version 9.0</div></div></div>"},"52133":{"type":"graphic_picture","displayName":"Hand inspection","title":"General inspection of the hands","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">General inspection of the hands</div><div class=\"cntnt\"><img style=\"width:370px; height:275px;\" src=\"images/RHEUM/52133_Hand_inspection.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The hands are inspected in the palms-down and palms-up position for alignment, fusiform swelling, bony enlargement, joint deformity (including ankylosis and contracture), and the presence of any cyst or nodules.</div><div class=\"graphic_reference\">Courtesy of Bruce C Anderson, MD.</div><div id=\"graphicVersion\">Graphic 52133 Version 5.0</div></div></div>"},"52134":{"type":"graphic_figure","displayName":"Mechanisms of reentry","title":"Mechanisms of reentry in cardiac arrhythmias","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Mechanisms of reentry in cardiac arrhythmias</div><div class=\"cntnt\"><img style=\"width:396px; height:217px;\" src=\"images/CARD/52134_mechanismsofreentry.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Schematic representation of possible reentrant circuits. The thick black arrow represents the circulating impulse; thin black lines represent advancing wavefronts in completely refractory tissue; speckled areas are partially refractory tissue; white areas are fully excitable tissue. A is the original model of circus movement around a fixed obstacle. There is a fully excitable gap, and the length and location of the circuit are fixed. B represents circus movement around two fixed anatomic obstacles. A fully excitable gap is present. C represents rapidly conducting bundles forming closed loops that serve as preferential circuits through which the impulse may travel. D is the leading circle type of reentry which does not require an anatomic obstacle. Instead, the impulse propagates around a functionally refractory core and among neighboring fibers that have different electrophysiologic properties. Since the refractoriness of the core is variable, the circuit size changes but will be the smallest possible circuit that can continue to propagate an impulse. Functional circuits tend to be small, rapid, and unstable. E represents reentry around a fixed anatomic obstacle, but a fully excitable gap is absent. F demonstrates an area of slowed conduction (hatched lines) between anatomic boundaries, while in G all areas of slowed conduction neighbor an anatomic obstacle. H represents anisotropic reentry. There are differences in the conduction of a single impulse in various fibers as a result of differences in their orientation.</div><div id=\"graphicVersion\">Graphic 52134 Version 4.0</div></div></div>"},"52137":{"type":"graphic_picture","displayName":"Keratin in thymoma","title":"Thymoma","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Thymoma</div><div class=\"cntnt\"><img style=\"width:360px; height:237px;\" src=\"images/PULM/52137_Keratin_in_thymoma.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Immunoperoxidase stain for keratin highlights the epithelial cells in thymoma. (Magnification 50x).</div><div class=\"graphic_reference\">Courtesy of William Travis, MD.</div><div id=\"graphicVersion\">Graphic 52137 Version 1.0</div></div></div>"},"52139":{"type":"graphic_picture","displayName":"Disseminated candidiasis kidney","title":"Disseminated candidiasis","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Disseminated candidiasis</div><div class=\"cntnt\"><img style=\"width:360px; height:224px;\" src=\"images/ID/52139_Disseminated_candidiasis_ki.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Numerous small abscesses can be seen studding the surface of the kidney in a patient who developed disseminated candidiasis.</div><div class=\"graphic_reference\">Courtesy of Carol A Kauffman, MD.</div><div id=\"graphicVersion\">Graphic 52139 Version 2.0</div></div></div>"},"52140":{"type":"graphic_table","displayName":"Antifungal susceptibility testing indications","title":"Indications for antifungal susceptibility testing","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Indications for antifungal susceptibility testing</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1\">Clinical setting</td> <td class=\"subtitle1\">Recommendation</td> </tr> <tr> <td rowspan=\"7\">Routine</td> <td>&#8226; Species level identification of all <em>Candida</em> isolates from deep sites (eg, blood, normally sterile fluids, tissues, abscesses).</td> </tr> <tr> <td>&#8226; Species level identification of <em>Aspergillus</em>, genus level for all other molds.</td> </tr> <tr> <td>&#8226; Species level (if possible) identification of non-candidal yeast isolates from deep sites (eg, blood, normally sterile fluids, tissues, abscesses).</td> </tr> <tr> <td>&#8226; Selection of therapy is generally based on published consensus guidelines and review of survey data on the organism-drug combination in question.</td> </tr> <tr> <td>&#8226; Routine susceptibility testing of fluconazole, voriconazole,&nbsp;and&nbsp;an echinocandin&nbsp;against <em>C. glabrata</em> and fluconazole against non-candidal yeast isolates from deep sites (eg, blood, normally sterile fluids, tissues, abscesses).</td> </tr> <tr> <td>&#8226; Susceptibility testing of fluconazole, voriconazole, an echinocandin, and flucytosine against other species of <em>Candida</em> may be helpful in special circumstances, but not routinely, since susceptibility is usually predictable.</td> </tr> <tr> <td>&#8226; Susceptibility of <em>Candida</em> spp other than <em>C. glabrata </em>to echinocandins may be assumed unless initial response is suboptimal. Susceptibility testing of isolates to an echinocandin should be considered if there is a prior history of exposure to this class of agents.</td> </tr> <tr class=\"divider_top\"> <td>Mucosal&nbsp;candidiasis</td> <td>&#8226; Susceptibility testing may be useful for patients unresponsive to therapy.</td> </tr> <tr class=\"divider_top\"> <td rowspan=\"5\">Invasive disease with clinical failure of initial therapy</td> <td class=\"sublist1_start\">&#8226; Consider susceptibility testing.</td> </tr> <tr> <td class=\"sublist1\">- <em>Candida</em> spp: amphotericin B, flucytosine, fluconazole, voriconazole, echinocandins</td> </tr> <tr> <td class=\"sublist1\">- <em>C. neoformans</em>: fluconazole, amphotericin B, flucytosine</td> </tr> <tr> <td class=\"sublist1\">- <em>Aspergillus</em> species: amphotericin B, posaconazole, itraconazole, voriconazole</td> </tr> <tr> <td>&#8226; Consultation with an experienced microbiologist recommended</td> </tr> <tr class=\"divider_top\"> <td rowspan=\"12\">Infection with species with high rates of intrinsic or acquired resistance</td> <td class=\"sublist1_start\">&#8226; Susceptibility testing not necessary when intrinsic resistance is known.</td> </tr> <tr> <td class=\"sublist1\">- <em>A. terreus</em>: amphotericin B</td> </tr> <tr> <td class=\"sublist1\">- <em>C. krusei</em>: fluconazole, flucytosine</td> </tr> <tr> <td class=\"sublist1\">- <em>Cryptococcus</em> and <em>Trichosporon</em>: echinocandins</td> </tr> <tr> <td class=\"sublist1\">- <em>Rhodotorula</em>: azoles, echinocandins</td> </tr> <tr> <td class=\"sublist1\">- <em>Mucorales</em>: voriconazole, echinocandins</td> </tr> <tr> <td class=\"sublist1_start\">&#8226; For species with significant rates of acquired resistance, monitor closely for signs of failure and perform susceptibility testing as needed.</td> </tr> <tr> <td class=\"sublist1\">- <em>C. glabrata</em>: fluconazole, voriconazole, amphotericin B, echinocandins</td> </tr> <tr> <td class=\"sublist1\">- <em>C. krusei</em>: amphotericin B</td> </tr> <tr> <td class=\"sublist1\">- <em>C. lusitaniae</em>: amphotericin B</td> </tr> <tr> <td class=\"sublist1\">- <em>C. rugosa</em>: amphotericin B, fluconazole</td> </tr> <tr> <td class=\"sublist1\">- <em>Candida</em> spp: flucytosine, when used for endocarditis</td> </tr> <tr class=\"divider_top\"> <td>Unusual organisms</td> <td>&#8226; Susceptibility testing may be helpful when treating patients infected with unusual organisms for which susceptibility patterns have not been well established or are unpredictable.</td> </tr> <tr class=\"divider_top\"> <td rowspan=\"4\">Mold infections</td> <td>&#8226; Species level identification of <em>Aspergillus</em>, genus level for all other molds.</td> </tr> <tr> <td>&#8226; Routine susceptibility testing not recommended.</td> </tr> <tr> <td>&#8226; Susceptibility of <em>Aspergillus</em> species to itraconazole, voriconazole, isavuconazole, and posaconazole may help to determine cross-resistance.</td> </tr> <tr> <td>&#8226; Clinical interpretive criteria have not been established for any agents.</td> </tr> </tbody></table></div><div class=\"graphic_reference\">Data from:<br> <ol> <li>Pfaller MA. Antifungal susceptibility testing methods. Curr Drug Targets 2005; 6:929. </li> <li>Rex JH, Pfaller MA. Has antifungal susceptibility testing come of age? Clin Infect Dis 2002; 35:982. </li> <li>Pappas PG, Kauffman CA, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48:503. </li> <li>Pfaller MA, Wu WL. Antifungal susceptibility testing: new technology and clinical applications. Infect Dis Clin N Am 2001; 15:1227. </li> <li>Spellberg BJ, Filler SG, Edwards JE Jr. Current treatment strategies for disseminated candidiasis. Clin Infect Dis 2006; 42:244. </li> </ol></div><div id=\"graphicVersion\">Graphic 52140 Version 8.0</div></div></div>"},"52141":{"type":"graphic_picture","displayName":"Splinter hemorrhage trichinosis","title":"Subungual splinter hemorrhages","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Subungual splinter hemorrhages</div><div class=\"cntnt\"><img style=\"width:441px; height:288px;\" src=\"images/ID/52141_Splinter_hems_trichinosis.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Subungual splinter hemorrhages in a patient with <EM>Trichinella papuae</EM>.</div><div class=\"graphic_reference\">Courtesy of Peter F Weller, MD.</div><div id=\"graphicVersion\">Graphic 52141 Version 4.0</div></div></div>"},"52143":{"type":"graphic_table","displayName":"FDA classification","title":"FDA classification of soft contact lenses","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">FDA classification of soft contact lenses</div><div class=\"cntnt\"><table  cellspacing=\"0\">\r\n \r\n   <tr>\r\n  \r\n   <td  class=\"subtitle1_single\">\r\n  \r\n   Group 1\r\n  \r\n   </td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Low water content (&#60;50 percent)</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Non-ionic polymer</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>HEMA hydrogels</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Silicone hydrogels</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"subtitle1_single\">\r\n  \r\n   Group 2\r\n  \r\n   </td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>High water content (&#62;50 percent)</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Non-ionic polymer</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>HEMA hydrogels only</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"subtitle1_single\">\r\n  \r\n   Group 3\r\n  \r\n   </td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Low water content (&#60;50 percent)</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Non-ionic polymer</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>HEMA hydrogels</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Silicone hydrogels</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"subtitle1_single\">\r\n  \r\n   Group 4\r\n  \r\n   </td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>High water content (&#62;50 percent)</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Non-ionic polymer</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>HEMA hydrogels only</td>\r\n  \r\n   </tr>\r\n </table></div><div class=\"graphic_reference\">Reproduced from: US Food and Drug Administration, www.fda.gov/cdrh/contactlenses/lenslist.html.</div><div id=\"graphicVersion\">Graphic 52143 Version 1.0</div></div></div>"},"52144":{"type":"graphic_table","displayName":"Newer platelet function tests","title":"List of new platelet function tests","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">List of new platelet function tests</div><div class=\"cntnt\"><table  cellspacing=\"0\">\r\n \r\n   <tr>\r\n  \r\n   <td   class=\"subtitle1\">\r\n  \r\n   Platelet function test\r\n  \r\n   </td>\r\n  \r\n   <td   class=\"subtitle1\">\r\n  \r\n   Aspects of platelet function measured\r\n  \r\n   </td>\r\n  \r\n   <td   class=\"subtitle1\">\r\n  \r\n   Advantages\r\n  \r\n   </td>\r\n  \r\n   <td   class=\"subtitle1\">\r\n  \r\n   Disadvantages\r\n  \r\n   </td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Clot Signature Analyser (CSA)</td>\r\n  \r\n   <td>Global Haemostasis High Shear platelet function</td>\r\n  \r\n   <td>Measures Global Hemostatic Function</td>\r\n  \r\n   <td>Cost of cartridges</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Cone &#38; Plate Analyser (CPA)</td>\r\n  \r\n   <td>High shear platelet adhesion/aggregation</td>\r\n  \r\n   <td>Small volume of blood, physiological</td>\r\n  \r\n   <td>Requires image analysis</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Flow Cytometry</td>\r\n  \r\n   <td>Platelet glycoproteins, activation markers, platelet function</td>\r\n  \r\n   <td>Whole blood test, flexible, wide variety of tests, powerful</td>\r\n  \r\n   <td>Specialized operator, expensive equipment</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>ICHOR (Plateletworks)</td>\r\n  \r\n   <td>Platelet counting pre- and post platelet activation</td>\r\n  \r\n   <td>Simple point of care</td>\r\n  \r\n   <td>Preparation of Reagents</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Haemodyne</td>\r\n  \r\n   <td>Platelet Contractile force</td>\r\n  \r\n   <td>Rapid and Simple</td>\r\n  \r\n   <td>Measures clot properties only</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Hemostasus Device activity</td>\r\n  \r\n   <td>Platelet procoagulant function</td>\r\n  \r\n   <td>Simple</td>\r\n  \r\n   <td>Insensitive to aspirin and GpIb</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Laser Platelet Aggregometer (PA-200)</td>\r\n  \r\n   <td>Platelet micro-aggregates</td>\r\n  \r\n   <td>Sensitive, study hyperfunction</td>\r\n  \r\n   <td>Little widespread experience</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Platelet Function Analyser (PFA-100)</td>\r\n  \r\n   <td>High Shear adhesion/aggregation</td>\r\n  \r\n   <td>Rapid and simple screening, In vitro bleeding time, Potential point of care instrument</td>\r\n  \r\n   <td>Inflexible</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Thrombotic Status Analyser (TSA)</td>\r\n  \r\n   <td>High shear platelet function</td>\r\n  \r\n   <td>Simple</td>\r\n  \r\n   <td>Little widespread experience</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Thromboelastometry (ROTEM)</td>\r\n  \r\n   <td>Measures global hemostasis</td>\r\n  \r\n   <td>Can predict bleeding</td>\r\n  \r\n   <td>Insensitive to aspirin</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td   rowspan=\"3\">\r\n  \r\n   Verify Now Test (rapid platelet function analyzer)\r\n  \r\n   </td>\r\n  \r\n   <td>GP IIb/IIIa dependent aggregation</td>\r\n  \r\n   <td   rowspan=\"3\">\r\n  \r\n   Simple test for monitoring drug effect using three different cartridges\r\n  \r\n   </td>\r\n  \r\n   <td   rowspan=\"3\">\r\n  \r\n   Inflexible\r\n  \r\n   </td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Aspirin effect</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>P2Y12 blockade</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  rowspan=\"2\">\r\n  \r\n   Placor PRT\r\n  \r\n   </td>\r\n  \r\n   <td  rowspan=\"2\">\r\n  \r\n   Platelet hyperfunction\r\n  \r\n   </td>\r\n  \r\n   <td  rowspan=\"2\">\r\n  \r\n   Rapid point of care test using fingerprick blood\r\n  \r\n   </td>\r\n  \r\n   <td>Little widespread experience</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Platelets will be activated by finger wound</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Thrombovision T guide</td>\r\n  \r\n   <td>Platelet aggregation in response to agonists by light scatter</td>\r\n  \r\n   <td>Automated point of care test</td>\r\n  \r\n   <td>Little widespread experience</td>\r\n  \r\n   </tr>\r\n </table>\r\n\r\n\r\n<html xmlns:mso=\"urn:schemas-microsoft-com:office:office\" xmlns:msdt=\"uuid:C2F41010-65B3-11d1-A29F-00AA00C14882\"><head>\r\n<!--[if gte mso 9]><xml>\n<mso:CustomDocumentProperties>\r\n<mso:Specialty msdt:dt=\"string\">7.00000000000000</mso:Specialty>\r\n<mso:Media_Type msdt:dt=\"string\">Table</mso:Media_Type>\r\n<mso:Media_Notes msdt:dt=\"string\">4/17/2001 -perm requested - jm\r\n4/25/2001 -refaxed to UK office -jm\r\n6/26/2001- perm granted, gave to chris &amp;amp; lisa  -jm\r\n\r\n7/15/2008--ï¿½116.00 converted into $232.96, then divided by two figures (JD).\r\n\r\n The total fee of $&amp;quot;116.48&amp;quot;was originally charged to\r\nPlatelet_function_tests\r\nNewer_platelet_function_tests</mso:Media_Notes>\r\n<mso:Edit_Table msdt:dt=\"string\">&lt;a href=&quot;/Graphics/Pages/TableEditor.aspx?SPID=26071&amp;amp;Mode=Edit&quot;&gt;&lt;/a&gt;</mso:Edit_Table>\r\n</mso:CustomDocumentProperties>\n</xml><![endif]-->\r\n<title>Newer_platelet_function_tes.htm</title></head></div><div class=\"graphic_reference\">Modified and reproduced with permission from: Harrison P. Progress in the Assessment of Platelet Function. Br J Haematol 2000; 111:733. Copyright Â© 2000 Blackwell Science. <A spellcheck=true href=\"http://www.wiley.com/wiley-blackwell\" target=_blank>http://www.blackwell-science.com</A>.</div><div id=\"graphicVersion\">Graphic 52144 Version 2.0</div></div></div>"},"52145":{"type":"graphic_figure","displayName":"Angle of Doppler beam","title":"Angle of Doppler beam in relationship to direction of blood flow","html":"<div class=\"graphic\"><div style=\"width: 473px\" class=\"figure\"><div class=\"ttl\">Angle of Doppler beam in relationship to direction of blood flow</div><div class=\"cntnt\"><img style=\"width:453px; height:272px;\" src=\"images/CARD/52145_Angle_of_Doppler_beam.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The diagram illustrates a situation in which the interrogating or insonocating beam lies at an angle to the flow of blood. Ideally, the Doppler beam should be placed parallel to blood flow. When the beam does not lie parallel, it is possible to introduce a correction into the calculation of flow velocity by measuring the cosine of the angle of interrogation and introducing this value into the Doppler equation.</div><div id=\"graphicVersion\">Graphic 52145 Version 4.0</div></div></div>"},"52148":{"type":"graphic_diagnosticimage","displayName":"Congen pulm airways malform CXR III","title":"Congenital pulmonary airways malformation of the left lower lobe in 30-year-old man with recurrent pneumonia","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Congenital pulmonary airways malformation of the left lower lobe in 30-year-old man with recurrent pneumonia</div><div class=\"cntnt\"><img style=\"width:360px; height:376px;\" src=\"images/PULM/52148_Adenomatoid_malform_CXR_III.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">A frontal chest radiograph shows a mass-like consolidation involving primarily the superior segment of the left lower lobe.</div><div class=\"graphic_reference\">Courtesy of Paul Stark, MD.</div><div id=\"graphicVersion\">Graphic 52148 Version 3.0</div></div></div>"},"52149":{"type":"graphic_table","displayName":"Asthma control 0 to 4 yrs","title":"Assessing asthma control in children 0-4 years of age","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Assessing asthma control in children 0-4 years of age</div><div class=\"cntnt\"><table cellspacing=\"0\">\n<tbody>\n\n\t<tr>\n\t\t\t\t\t<td class=\"subtitle1\" rowspan=\"2\" colspan=\"2\">Components of control</td>\n\t\t\t\t\t<td class=\"subtitle1\" colspan=\"3\">Classification of asthma control (children 0-4 years of age)</td>\n\t\t\t\t</tr>\n\t\t\t\t<tr>\n\t\t\t\t\t<td class=\"subtitle2\">Well-controlled</td>\n\t\t\t\t\t<td class=\"subtitle2\">Not-well controlled</td>\n\t\t\t\t\t<td class=\"subtitle2\">Very poorly controlled</td>\n\t\t\t\t</tr>\n\t\t\t\t<tr>\n\t\t\t\t\t<td rowspan=\"4\">Impairment</td>\n\t\t\t\t\t<td>Symptoms</td>\n\t\t\t\t\t<td>&#8804;2 days/week</td>\n\t\t\t\t\t<td>&#62;2 days/week</td>\n\t\t\t\t\t<td>Throughout the day</td>\n\t\t\t\t</tr>\n\t\t\t\t<tr>\n\t\t\t\t\t<td>Nighttime awakenings</td>\n\t\t\t\t\t<td>1x/month</td>\n\t\t\t\t\t<td>&#62;1x/month</td>\n\t\t\t\t\t<td>&#62;1x/week</td>\n\t\t\t\t</tr>\n\t\t\t\t<tr>\n\t\t\t\t\t<td>Interference with normal activity</td>\n\t\t\t\t\t<td>None</td>\n\t\t\t\t\t<td>Some limitation</td>\n\t\t\t\t\t<td>Extremely limited</td>\n\t\t\t\t</tr>\n\t\t\t\t<tr>\n\t\t\t\t\t<td>Short-acting beta<sub>2</sub>-agonist use for symptom control (not prevention of EIB)</td>\n\t\t\t\t\t<td>&#8804;2 days/week</td>\n\t\t\t\t\t<td>&#62;2 days/week</td>\n\t\t\t\t\t<td>Several times per day</td>\n\t\t\t\t</tr>\n\t\t\t\t<tr>\n\t\t\t\t\t<td rowspan=\"2\">Risk</td>\n\t\t\t\t\t<td><strong>Exacerbations requiring oral systemic corticosteroids</strong></td>\n\t\t\t\t\t<td><strong>0-1/year</strong></td>\n\t\t\t\t\t<td><strong>2-3/year</strong></td>\n\t\t\t\t\t<td><strong>&#62;3/year</strong></td>\n\t\t\t\t</tr>\n\t\t\t\t<tr>\n\t\t\t\t\t<td>Treatment-related adverse effects</td>\n\t\t\t\t\t<td colspan=\"3\">Medication side effects can vary in intensity from none to very troublesome and worrisome. The level of intensity does not correlate to specific levels of control but should be considered in the overall assessment of risk.</td>\n\t\t\t\t</tr>\n\n</tbody>\n</table></div><div class=\"graphic_lgnd\">The level of control is based on the most severe impairment or risk category. Assess impairment domain by caregiver's recall of previous 2-4 weeks. Symptom assessment for longer periods should reflect a global assessment, such as inquiring whether the patient's asthma is better or worse since the last visit. At present, there are inadequate data to correspond frequencies of exacerbations with different levels of asthma control. In general, more frequent and intense exacerbations (eg, requiring urgent, unscheduled care, hospitalization, or ICU admission) indicate poorer disease control. For treatment purposes, patients who had &#8805;2 exacerbations requiring oral systemic corticosteroids in the past year may be considered the same as patients who have not-well-controlled asthma, even in the absence of impairment levels consistent with persistent asthma.</div><div class=\"graphic_footnotes\">EIB: exercise-induced bronchospasm; ICU: intensive care unit.</div><div class=\"graphic_reference\">Reproduced from: National Heart, Blood, and Lung Institute Expert Panel Report 3 (EPR 3): Guidelines for the Diagnosis and Management of Asthma. NIH Publication no. 08-4051, 2007.</div><div id=\"graphicVersion\">Graphic 52149 Version 1.0</div></div></div>"},"52150":{"type":"graphic_table","displayName":"Recommendations for diagnostic criteria for Proteus syndrome","title":"Recommendations for diagnostic criteria for Proteus syndrome*","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Recommendations for diagnostic criteria for Proteus syndrome*</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1\">Manifestations</td> <td class=\"subtitle1\">Category</td> </tr> <tr> <td>Connective tissue nevus</td> <td>A</td> </tr> <tr> <td>Epidermal nevus</td> <td>B</td> </tr> <tr> <td>Disproportionate overgrowth of one or more of the following: <ul> <li>Limbs (arms, legs, hands, feet, digits) </li> <li>Skull (hyperostoses) </li> <li>External auditory meatus (hyperostosis) </li> <li>Vertebrae (megaspondylodysplasia) </li> <li>Viscera (spleen, thymus) </li> </ul> </td> <td>B</td> </tr> <tr> <td>Bilateral ovarian cystadenomas or parotid monomorphic adenoma&nbsp;before end of second decade</td> <td>B</td> </tr> <tr> <td>Dysregulated adipose tissue (either lipomas or regional absence of fat)</td> <td>C</td> </tr> <tr> <td>Vascular malformations (capillary, venous, and/or lymphatic)</td> <td>C</td> </tr> <tr> <td>Characteristic facial phenotype (dolichocephaly, long face, minor downslanting of palpebral fissures and/or minor ptosis, low nasal bridge, wide or anteverted nares, open mouth at rest)</td> <td>C</td> </tr> </tbody></table></div><div class=\"graphic_lgnd\">Diagnostic criteria: sporadic occurrence, mosaic distribution, and progressive course, plus one category A, two B, or three C signs.</div><div class=\"graphic_footnotes\">* Consensus opinion derived from the 1st National Conference on Proteus Syndrome for Parents and Families, National Institutes of Health, March 18th through 20th, 1998 (Biesecker L, et al. Am J Med Genet 1999; 84:389).</div><div id=\"graphicVersion\">Graphic 52150 Version 1.0</div></div></div>"},"52152":{"type":"graphic_figure","displayName":"Atrial electrograms in AF","title":"Atrial electogram morphology in atrial fibrillation","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Atrial electogram morphology in atrial fibrillation</div><div class=\"cntnt\"><img style=\"width:364px; height:468px;\" src=\"images/CARD/52152_Atrial_electrograms_in_AF.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The morphology of unipolar electrograms recorded during atrial fibrillation reflect different patterns of conduction, as demonstrated by the isochrone maps. Black arrows indicate the direction of activation. Single potentials are indicative of rapid uniform conduction. Short doubles result from collision of the wavefronts along a line of collision (map A). Long doubles are due to conduction block (Map B). Fragmented electrograms refect multiple discrete deflections that may result from impulse conduction around a pivotal point (map C) or from slow or delayed conduction (map D).</div><div class=\"graphic_reference\">Reproduced with permission from Konings KTS, Smeets JLRM, Penn OC, et al. Circulation 1997; 95:1231.</div><div id=\"graphicVersion\">Graphic 52152 Version 2.0</div></div></div>"},"52153":{"type":"graphic_diagnosticimage","displayName":"CNS nocardiosis CT","title":"Central nervous system nocardiosis","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Central nervous system nocardiosis</div><div class=\"cntnt\"><img style=\"width:338px; height:360px;\" src=\"images/ID/52153_CNS_nocardiosis_CT.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Computed tomography (CT) scan shows a single cerebellar abscess (arrow) due to disseminated nocardiosis in a patient with pulmonary infiltrates.</div><div class=\"graphic_reference\">Courtesy of Stanley W Chapman, MD.</div><div id=\"graphicVersion\">Graphic 52153 Version 3.0</div></div></div>"},"52154":{"type":"graphic_table","displayName":"Diagnosis of Scedosporium and Lomentospora infections","title":"Diagnostic tools for<EM> Scedosporium</EM> and <EM>Lomentospora</EM> infections","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Diagnostic tools for<EM> Scedosporium</EM> and <EM>Lomentospora</EM> infections</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1\">Diagnostic tool</td> <td class=\"subtitle1\">Comments</td> </tr> <tr> <td rowspan=\"2\">Radiographic appearance</td> <td>Lung: variable; alveolar or reticulonodular infiltrates</td> </tr> <tr> <td>Brain: hypodense lesions</td> </tr> <tr> <td>Microscopy</td> <td>Potassium hydroxide &#177; calcoflour white stains: septate, branching hyphae at 45&#176; angles</td> </tr> <tr> <td class=\"sublist1_start\" colspan=\"2\">Culture</td> </tr> <tr> <td class=\"sublist1\" rowspan=\"2\">Macroscopic appearance</td> <td class=\"sublist_other\"><em>Scedosporium apiospermum</em>: rapid growing, cottony, white or gray, then gray or brown with age</td> </tr> <tr> <td class=\"sublist_other\"><em>Lomentospora&nbsp;prolificans</em>: white, cottony, with a greenish-gray to dark green reverse</td> </tr> <tr> <td class=\"sublist1\" rowspan=\"2\">Microscopic appearance</td> <td class=\"sublist_other\"><em>S. apiospermum</em>: cylindrical, single, uninucleate, nonpigmented conidiogenous cells; cleistothecia may be produced</td> </tr> <tr> <td class=\"sublist_other\"><em>L. prolificans</em>: flask-shaped, basally swollen or inflated, clustered, nonpigmented conidiogenous cells</td> </tr> <tr> <td>Histopathology</td> <td>Septate hyphae branching at 45&#176; angle in inflammation, including granulomata and necrosis; adventitious sporulation may be present</td> </tr> <tr> <td>Molecular methods</td> <td>Investigational; PCR and sequencing have been used for laboratory identification and outbreak investigations</td> </tr> <tr> <td>MALDI-TOF mass spectroscopy</td> <td>Able to identify and discriminate among different <em>Scedosporium</em> and <em>Lomentospora</em> species but requires a database of fungal species</td> </tr> <tr> <td>Antigen detection</td> <td>1,3-beta-D-glucan antigen testing may be helpful but needs further validation; this assay may be positive in the setting of a variety of invasive fungal infections</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">PCR: polymerase chain reaction; MALDI-TOF: matrix-assisted laser desorption/ionization time-of-flight.</div><div id=\"graphicVersion\">Graphic 52154 Version 4.0</div></div></div>"},"52158":{"type":"graphic_table","displayName":"Pediatric calorie needs","title":"Pediatric daily calorie needs based on age, gender, and physical activity level*","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Pediatric daily calorie needs based on age, gender, and physical activity level*</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup span=\"2\" width=\"15%\"></colgroup><colgroup span=\"3\" width=\"23%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\">Gender</td> <td class=\"subtitle1\">Age (years)</td> <td class=\"subtitle1\">Calorie requirements (kcals) for sedentary level of activity<sup>&#182;</sup></td> <td class=\"subtitle1\">Calorie requirements (kcals) for moderate activity<sup>&#182;</sup></td> <td class=\"subtitle1\">Calorie requirements (kcals) for active activity<sup>&#182;</sup></td> </tr> <tr> <td>Child</td> <td>2 to 3</td> <td>1000 to 1200</td> <td>1000 to 1400<sup>&#916;</sup></td> <td>1000 to 1400<sup>&#916;</sup></td> </tr> <tr> <td>Female<sup>&#9674;</sup></td> <td>4 to 8</td> <td>1200 to 1400</td> <td>1400 to 1600</td> <td>1400 to 1800</td> </tr> <tr> <td>Female<sup>&#9674;</sup></td> <td>9 to 13</td> <td>1400 to 1600</td> <td>1600 to 2000</td> <td>1800 to 2200</td> </tr> <tr> <td>Female<sup>&#9674;</sup></td> <td>14 to 18</td> <td>1800</td> <td>2000</td> <td>2400</td> </tr> <tr> <td>Female<sup>&#9674;</sup></td> <td>19 to 30</td> <td>1800 to 2000</td> <td>2000 to 2200</td> <td>2400</td> </tr> <tr> <td>Male</td> <td>4 to 8</td> <td>1200 to 1400</td> <td>1400 to 1600</td> <td>1600 to 2000</td> </tr> <tr> <td>Male</td> <td>9 to 13</td> <td>1600 to 2000</td> <td>1800 to 2200</td> <td>2000 to 2600</td> </tr> <tr> <td>Male</td> <td>14 to 18</td> <td>2000 to 2400</td> <td>2400 to 2800</td> <td>2800 to 3200</td> </tr> <tr> <td>Male</td> <td>19 to 30</td> <td>2400 to 2600</td> <td>2600 to 2800</td> <td>3000</td> </tr> </tbody></table></div><div class=\"graphic_lgnd\">Estimated number of calories needed to maintain caloric balance for various gender and age groups at three different levels of physical activity. The estimates are rounded to the nearest 200 calories. An individual's calorie needs may be higher or lower than these average estimates.</div><div class=\"graphic_footnotes\">* Based on Estimated Energy Requirements (EER) equations, using reference heights (average) and reference weights (health) for each age/gender group. For children and adolescents, reference height and weight vary. For adults, the reference man is 5 feet 10 inches tall and weighs 154 pounds. The reference woman is 5 feet 4 inches tall and weighs 126 pounds. EER equations are from the Institute of Medicine. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. Washington (DC): The National Academies Press; 2002.<br />Â¶ Sedentary means a lifestyle that includes only the light physical activity associated with typical day-to-day life. Moderately active means a lifestyle that includes physical activity equivalent to walking about 1.5 to 3 miles per day at 3 to 4 miles per hour, in addition to the light physical activity associated with typical day-to-day life. Active means a lifestyle that includes physical activity equivalent to walking more than 3 miles per day at 3 to 4 miles per hour, in addition to the light physical activity associated with typical day-to-day life.<br />Î The calorie ranges shown are to accommodate needs of different ages within the group. For children and adolescents, more calories are needed at older ages. For adults, fewer calories are needed at older ages.<br /><FONT class=lozenge>â</FONT> Estimates for females do not include women who are pregnant or breastfeeding.</div><div class=\"graphic_reference\">Modified from: Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report. Available at:&nbsp;<A href=\"https://www.nhlbi.nih.gov/node/80139\">https://www.nhlbi.nih.gov/node/80139</A>&nbsp;(Accessed January 3, 2012).</div><div id=\"graphicVersion\">Graphic 52158 Version 5.0</div></div></div>"},"52159":{"type":"graphic_figure","displayName":"Benefit of ACE inhibitors in acute MI","title":"Benefit of ACE inhibitors in all patients with acute MI","html":"<div class=\"graphic\"><div style=\"width: 572px\" class=\"figure\"><div class=\"ttl\">Benefit of ACE inhibitors in all patients with acute MI</div><div class=\"cntnt\"><img style=\"width:552px; height:245px;\" src=\"images/CARD/52159_ACEI_in_MI_GISSI_3_and_ISIS.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Reduction in deaths with the use of lisinopril or captopril (red and green bars) versus control (blue solid bars) after acute myocardial infarction in the GISSI-3 and ISIS-4 trials. The numbers in parentheses refer to the portion of mortality reduction attributable to the ACE inhibitor for each of the three time periods shown; approximately 30 percent of the total mortality reduction occurred within the first 24 hours following symptom onset, supporting the early use of these agents in acute myocardial infarction.</div><div class=\"graphic_reference\">Data from Latini R, Maggioni AP, Flather M, et al. Circulation 1995; 92:3132.</div><div id=\"graphicVersion\">Graphic 52159 Version 3.0</div></div></div>"},"52160":{"type":"graphic_figure","displayName":"Amplatzer septal occluder","title":"Amplatzer septal occluder and measurements of its profile","html":"<div class=\"graphic\"><div style=\"width: 483px\" class=\"figure\"><div class=\"ttl\">Amplatzer septal occluder and measurements of its profile</div><div class=\"cntnt\"><img style=\"width:463px; height:227px;\" src=\"images/CARD/52160_Amplatzer_septal_occluder.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">In the lateral view the Amplatzer septal occluder has a waist between the left and right atrial discs; the left atrial disc is slightly larger than the right one. Broken lines and red arrows indicate measurement sites.</div><div class=\"graphic_reference\">Reproduced with permission from Cao Q, Du Z, Joseph A. Am J Cardiol 2001; 88:754. Copyright Â© 2001 Excerpta Medica Inc.</div><div class=\"contractual\"><br/><a href=\"http://www.elsevier.com/locate/jacc\">http://www.elsevier.com/locate/jacc</a><br/><a href=\"http://www.sciencedirect.com/\"> http://www.sciencedirect.com</a></div><div id=\"graphicVersion\">Graphic 52160 Version 2.0</div></div></div>"},"52161":{"type":"graphic_table","displayName":"Effects pretransplant dialysis","title":"Effects of pretransplant dialysis modality on outcomes early vs late after kidney transplantation","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Effects of pretransplant dialysis modality on outcomes early vs late after kidney transplantation</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1\" rowspan=\"2\">Posttransplant period</td> <td class=\"subtitle1\" colspan=\"3\">Relative risk (95 percent CI) PD:HD</td> </tr> <tr> <td class=\"subtitle2\">Graft failure</td> <td class=\"subtitle2\">Death-censored graft failure</td> <td class=\"subtitle2\">Death</td> </tr> <tr> <td>During the first three months</td> <td>1.23 (1.09-1.39)*</td> <td>1.33 (1.16-1.53)<sup>&#182;</sup></td> <td>1.03 (0.81-1.3)</td> </tr> <tr> <td>Beyond the first three months</td> <td>0.96 (0.87-1.05)</td> <td>1.02 (0.89-1.16)</td> <td>0.91 (0.8-1.04)</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">PD: peritoneal dialysis; HD: hemodialysis.<br />* p&lt;0.001.<br />Â¶ p&lt;0.0001.</div><div class=\"graphic_reference\">Reproduced with permission from: Snyder JJ, Kasiske BL, Gilbertson DT, Collins AJ. A comparison of transplant outcomes in peritoneal and hemodialysis patients. Kidney Int 2002; 62:1423. Copyright &copy; 2002 Blackwell Publishing.</div><div id=\"graphicVersion\">Graphic 52161 Version 3.0</div></div></div>"},"52162":{"type":"graphic_waveform","displayName":"LA enlargement tutorial","title":"Left atrial enlargement","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Left atrial enlargement</div><div class=\"cntnt\"><img style=\"width:241px; height:125px;\" src=\"images/CARD/52162_LA_enlargement_tutorial.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The P wave in lead II is broad and substantially notched, while V1 reveals a deeply inverted (negative) P wave.</div><div id=\"graphicVersion\">Graphic 52162 Version 2.0</div></div></div>"},"52163":{"type":"graphic_picture","displayName":"Flexural atopic dermatitis","title":"Flexural atopic dermatitis","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Flexural atopic dermatitis</div><div class=\"cntnt\"><img style=\"width:218px; height:324px;\" src=\"images/PC/52163_Flexuralatopicdermatitis.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Typical appearance of atopic dermatitis in flexural areas of the legs.</div><div class=\"graphic_reference\">Courtesy of James C Shaw, MD.</div><div id=\"graphicVersion\">Graphic 52163 Version 2.0</div></div></div>"},"52164":{"type":"graphic_figure","displayName":"Hybridization","title":"Hybridization","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Hybridization</div><div class=\"cntnt\"><img style=\"width:403px; height:308px;\" src=\"images/PC/52164_Hybridization.jpg\" alt=\"Image\"/></div><div class=\"graphic_reference\">Reproduced from Wikipedia. Available at: http://en.wikipedia.org/wiki/File:NA_hybrid.svg.</div><div id=\"graphicVersion\">Graphic 52164 Version 1.0</div></div></div>"},"52167":{"type":"graphic_table","displayName":"DDx of rash by appearance 1","title":"Differential diagnosis of fever and rash based upon appearance of the rash","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Differential diagnosis of fever and rash based upon appearance of the rash</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup span=\"4\" width=\"25%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\">Macules, papules, nodules, or plaques</td> <td class=\"subtitle1\">Vesicles, bullae, or pustules</td> <td class=\"subtitle1\">Purpuric macules, purpuric papules, or purpuric vesicles</td> <td class=\"subtitle1\">Followed widespread erythema with or without edema by desquamation</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"4\">Bacterial</td> </tr> <tr> <td class=\"indent1\"> <p><em>Arcanobacterium haemolyticum</em></p> <p><em>Bacillus anthracis</em></p> <p><em>Bartonella bacilliformis</em></p> <p><em>Bartonella henselae </em>(cat scratch disease)</p> <p><em>Bartonella quintana</em> (trench fever)</p> <p><em>Borrelia burgdorferi </em>(Lyme disease)*</p> <p><em>Borrelia</em> spp (relapsing fever)</p> <p><em>Brucella</em> spp (brucellosis)*</p> <p><em>Calymmatobacterium granulomatis </em>(donovanosis)*</p> <p><em>Chlamydia psittaci</em> (psittacosis)</p> <p>Ehrlichiosis*</p> <p><em>Ehrlichia chafeensis </em>(HME)</p> <p>Human granulocytic erlichiosis</p> <p><em>Erysipelothrix rhusiopathiae</em> (erysipeloid)</p> <p><em>Francisella tularensis</em> (tularemia)</p> <p><em>Listeria monocytogenes</em></p> <p><em>Leptospira</em> spp (leptospirosis)*</p> <p><em>Mycobacterium leprae</em>*</p> <p><em>Mycobacterium marinum</em>*</p> <p><em>Mycobacterium tuberculosis</em></p> <p><em>Mycoplasma pneumoniae</em></p> <p><em>Neisseria gonorrhoeae</em> (gonorrhea)*</p> <p><em>Neisseria meningitidis</em> (meningococcemia)*</p> <p><em>Pseudomonas aeruginosa</em></p> <p><em>Rickettsia akari</em> (rickettsialpox)</p> <p><em>Rickettsia prowazekii</em> (epidemic/louse-borne typhus)</p> <p><em>Rickettsia rickettsii</em> (RMSF-early lesions)*<sup>&#182;</sup></p> <p><em>Rickettsia orientalis</em>/<em>tsutsugamushi</em> (scrub typhus)</p> <p><em>Rickettsia typhi</em> (endemic/murine typhus)</p> <p><em>Salmonella typhi</em> (typhoid fever)*</p> <p><em>Spirillum minor</em> (rat-bite fever)</p> </td> <td> <p><em>Bacillus anthracis</em></p> <p><em>Ehrlichia canis</em></p> <p><em>Listeria monocytogenes</em></p> <p><em>Mycoplasma pneumoniae</em></p> <p><em>Neisseria gonorrhoeae</em>*</p> <p><em>Neisseria meningitidis</em>*</p> <p><em>Pseudomonas aeruginosa</em></p> <p><em>Rickettsia akari</em></p> <p><em>Rickettsia rickettsii</em>*</p> <p><em>Staphylococcus aureus</em> (TSS, SSSS)</p> <p><em>Streptococcus </em>group A</p> <p><em>Treponema pallidum</em> (secondary syphilis)</p> <p><em>Vibrio vulnificus</em></p> </td> <td> <p>Bacteremia<sup>&#916;</sup></p> <p><em>Borrelia</em> spp</p> <p><em>Clostridium</em> spp</p> <p>Infective endocarditis (many species)</p> <p><em>Haemophilus influenzae</em> type B</p> <p><em>Neisseria gonorrhoeae</em> (disseminated gonococcal infection)*<sup>&#182;</sup></p> <p><em>Neisseria meningitidis</em> (acute or chronic meningococcemia)*<sup>&#182;</sup></p> <p><em>Pseudomonas aeruginosa</em></p> <p><em>Rickettsia prowazekii</em></p> <p><em>Rickettsia rickettsii</em><sup>&#182;</sup></p> <p><em>Spirillum minor</em></p> <p><em>Staphylococcus aureus</em> (bacteremia)</p> <p><em>Streptobacillus moniliformis</em></p> <p><em>Streptococcus</em> group A (streptococcal toxic shock syndrome, scarlet fever)</p> <p><em>Streptococcus pneumoniae</em> (asplenic patient)</p> <p><em>Vibrio vulnificus</em></p> <p><em>Yersinia pestis</em></p> </td> <td> <p><em>Streptococcus </em>group A (scarlet fever, streptococcal toxic shock syndrome)</p> <p><em>Stapylococcus</em> aureus (TSS, SSSS)</p> </td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">HME: human monocytic ehrlichiosis; RMSF: Rocky Mountain spotted fever; TSS: toxic shock syndrome. SSSS: staphylococcal scalded skin syndrome.&nbsp;<br />* Reportable disease.<br />Â¶ May have arthralgia or musculoskeletal pain.<br />Î Specific therapy available.</div><div class=\"graphic_reference\">Adapted with permission from: Sanders CV. Diagnosis of the patient with fever and rash. In: The Skin and Infection: A Color Atlas and Text, Sanders CV, Nesbitt LT (Eds), Williams &amp; Wilkins, Baltimore, 1995. Originally modified with permission from Fitzpatrick TB, et al: Color Atlas &amp; Synopsis of Clinical Dermatology - Common and Serious Diseases. Fitzgerald TB, et al (Eds), McGraw-Hill, New York, 1992.</div><div id=\"graphicVersion\">Graphic 52167 Version 8.0</div></div></div>"},"52168":{"type":"graphic_table","displayName":"Causes of cardiomyopathy II","title":"Etiologic classification of cardiomyopathy-II","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Etiologic classification of cardiomyopathy-II</div><div class=\"cntnt\"><table class=\"container\" cellspacing=\"0\"><tbody> <tr> <td class=\"container\"> <table cellspacing=\"0\"> <tbody> <tr> <td class=\"subtitle1_single\">Genetic</td> </tr> <tr> <td>Genetic hypertrophic cardiomyopathy*<sup>&#182;</sup></td> </tr> <tr> <td>Genetic dilated cardiomyopathy<sup>&#916;</sup></td> </tr> <tr> <td class=\"subtitle1_single\">Metabolic</td> </tr> <tr> <td class=\"subtitle2_single\">Endocrine</td> </tr> <tr> <td class=\"indent1\">Acromegaly*<sup>&#182;</sup><sup>&#916;</sup></td> </tr> <tr> <td class=\"indent1\">Thyrotoxicosis<sup>&#916;</sup></td> </tr> <tr> <td class=\"indent1\">Hypothyroidism*<sup>&#182;</sup><sup>&#916;</sup></td> </tr> <tr> <td class=\"indent1\">Pheochromocytoma*<sup>&#182;</sup><sup>&#916;</sup></td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">Diabetes melllitus</td> </tr> <tr> <td class=\"subtitle2_single\">Familial storage diseases</td> </tr> <tr> <td class=\"indent1\">Glycogen storage diseases*<sup>&#916;</sup></td> </tr> <tr> <td class=\"indent1\">Refsum disease</td> </tr> <tr> <td class=\"indent1\">Niemann-Pick disease</td> </tr> <tr> <td class=\"indent1\">Hand-Schuller-Christian disease</td> </tr> <tr> <td class=\"indent1\">Fabry's disease*<sup>&#916;</sup></td> </tr> <tr> <td class=\"indent1\">Gangliosiderosis</td> </tr> <tr> <td class=\"indent1\">Gaucher's disease<sup>&#182;</sup><sup>&#916;</sup></td> </tr> <tr> <td class=\"indent1\">Sandhoff's disease<sup>&#916;</sup></td> </tr> <tr> <td class=\"indent1\">Mucopolysaccharidosis<sup>&#916;</sup></td> </tr> <tr> <td class=\"indent1\">Hunter's syndrome</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">Hurler's syndrome</td> </tr> <tr> <td class=\"subtitle2_single\">Nutritional</td> </tr> <tr> <td class=\"indent1\">Beriberi<sup>&#916;</sup></td> </tr> <tr> <td class=\"indent1\">Kwashiokor<sup>&#916;</sup></td> </tr> <tr> <td class=\"indent1\">Pellagra</td> </tr> <tr> <td class=\"indent1\">Selenium deficiency</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">(Keshan's disease)<sup>&#916;</sup></td> </tr> <tr> <td class=\"subtitle2_single\">Other</td> </tr> <tr> <td class=\"indent1\">Hypokalemia<sup>&#916;</sup></td> </tr> <tr> <td class=\"indent1\">Carnitine deficiency<sup>&#916;</sup></td> </tr> <tr> <td class=\"indent1\">Uremia<sup>&#916;</sup></td> </tr> </tbody> </table> </td> <td class=\"container\"> <table cellspacing=\"0\"> <tbody> <tr> <td class=\"subtitle1_single\">Hematologic/oncologic</td> </tr> <tr> <td class=\"subtitle2_single\">Hematologic disorders</td> </tr> <tr> <td class=\"indent1\">Leukemia<sup>&#916;</sup></td> </tr> <tr> <td class=\"indent1\">Myeloma</td> </tr> <tr> <td class=\"indent1\">Sickle cell anemia<sup>&#916;</sup></td> </tr> <tr> <td class=\"indent1\">Anemia<sup>&#916;</sup></td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">Henoch-Schonlein purpura<sup>&#916;</sup></td> </tr> <tr> <td class=\"subtitle2_single\">Neoplastic diseases</td> </tr> <tr> <td class=\"indent1\">Primary neoplasms<sup>&#182;</sup></td> </tr> <tr> <td class=\"indent1\">Metastatic neoplasms<sup>&#182;</sup></td> </tr> <tr> <td class=\"subtitle1_single\">Deposits</td> </tr> <tr> <td>Hemochromatosis<sup>&#182;</sup><sup>&#916;</sup></td> </tr> <tr> <td>Oxalosis</td> </tr> <tr> <td>Ochronosis</td> </tr> <tr> <td>Amyloid disease<sup>&#182;</sup></td> </tr> <tr> <td class=\"subtitle1_single\">Heredofamilial neurologic and neuromuscular diseases</td> </tr> <tr> <td>Progressive muscular dystrophy (Duchenne)<sup>&#916;</sup></td> </tr> <tr> <td>Limb-girdle muscular dystrophy (Erb)<sup>&#916;</sup></td> </tr> <tr> <td>Fascioscapulohumeral dystrophy (Landouzy-Dejerine)</td> </tr> <tr> <td>Humeroperoneal ataxia</td> </tr> <tr> <td>Friedreich's ataxia*</td> </tr> <tr> <td>Myotonia atrophica (Steinert)<sup>&#916;</sup></td> </tr> <tr> <td>Myasthenia gravis</td> </tr> <tr> <td>Chronic progressive external opthmoplegia (Kearns-Savre)</td> </tr> <tr> <td>Familial centronuclear myopathy</td> </tr> <tr> <td>Juvenile progressive spinal muscular atrophy (Kugelberg-Welander)</td> </tr> <tr> <td>Neurofibromatosis*</td> </tr> </tbody> </table> </td> <td class=\"container\"> <table cellspacing=\"0\"> <tbody> <tr> <td class=\"subtitle1_single\">Endomyocardial diseases</td> </tr> <tr> <td>Endomyocardial fibrosis<sup>&#182;</sup><sup>&#916;</sup></td> </tr> <tr> <td>Hypereosiinophilic heart disease</td> </tr> <tr> <td>(Loffler's)<sup>&#182;</sup></td> </tr> <tr> <td>Endocardial fibroelastosis<sup>&#182;</sup><sup>&#916;</sup></td> </tr> <tr> <td class=\"subtitle1_single\">Inflammatory</td> </tr> <tr> <td class=\"subtitle2_single\">Connective tissue diseases</td> </tr> <tr> <td class=\"indent1\">Rheumatoid heart disease<sup>&#916;</sup></td> </tr> <tr> <td class=\"indent1\">Ankylosing spondylitis</td> </tr> <tr> <td class=\"indent1\">Systemic lupus erythematosus<sup>&#916;</sup></td> </tr> <tr> <td class=\"indent1\">Scleroderma<sup>&#182;</sup><sup>&#916;</sup></td> </tr> <tr> <td class=\"indent1\">Dermatomyositis<sup>&#916;</sup></td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">Periarteritis nodosa</td> </tr> <tr> <td class=\"subtitle2_single\">Granulomatous</td> </tr> <tr> <td class=\"indent1\">Sarcoid<sup>&#916;</sup></td> </tr> <tr> <td class=\"indent1\">Wegener's granulomatosis<sup>&#916;</sup></td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">Granulomatous myocarditis<sup>&#916;</sup></td> </tr> <tr> <td class=\"subtitle2_single\">Other inflammation</td> </tr> <tr> <td class=\"indent1\">Giant cell myocarditis<sup>&#916;</sup></td> </tr> <tr> <td class=\"indent1\">Hypersensitivity myocarditis<sup>&#916;</sup></td> </tr> </tbody> </table> </td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">* Conditions that may manifest clinically as hypertrophic cardiomyopathy. (These designations are neither obligatory nor exclusive).<br />Â¶ Conditions that may manifest clinically as restrictive cardiomyopathy.<br />Î Conditions that may manifest clinically as dilated cardiomyopathy.</div><div class=\"graphic_reference\">Adapted with permission from: Abelmann WH. Introduction to Atlas of Heart Diseases, Vol. II: Cardiomyopathies, Myocarditis and Pericardial disease, Abelmann, WH (Ed), Current Medicine, Philadelphia, 1995, p.1.</div><div id=\"graphicVersion\">Graphic 52168 Version 5.0</div></div></div>"},"52170":{"type":"graphic_picture","displayName":"Optic disc Frisen grade 4","title":"Optic disc FrisÃ©n Grade IV","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Optic disc Fris&#233;n Grade IV</div><div class=\"cntnt\"><img style=\"width:450px; height:338px;\" src=\"images/NEURO/52170_Optic_disc_Frisen_grade_4.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Fris&#233;n Grade IV showing obscuration of a major vessel on the optic disc (arrow).</div><div class=\"graphic_reference\">Courtesy of Michael Wall, MD.</div><div id=\"graphicVersion\">Graphic 52170 Version 1.0</div></div></div>"},"52171":{"type":"graphic_picture","displayName":"Prostate adenocarcinoma4 light","title":"Prostate adenocarcinoma","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Prostate adenocarcinoma</div><div class=\"cntnt\"><img style=\"width:369px; height:278px;\" src=\"images/ONC/52171_Prostate_adenocarcinoma4_li.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">This low-power photomicrograph of an hematoxylin- and eosin-stained section of the prostate gland demonstrates the characteristic blue-tinged mucin and amorphic secretion in the malignant glands (arrows).</div><div class=\"graphic_reference\">Courtesy of Ximing Yang, MD.</div><div id=\"graphicVersion\">Graphic 52171 Version 2.0</div></div></div>"},"52172":{"type":"graphic_table","displayName":"Coagulation test Fullterm NB","title":"Reference values for coagulation tests in the healthy full-term infant during the first 6 months of life","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Reference values for coagulation tests in the healthy full-term infant during the first 6 months of life</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup span=\"7\" width=\"14%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\">Tests</td> <td class=\"subtitle1\">Day 1 (n)</td> <td class=\"subtitle1\">Day 5 (n)</td> <td class=\"subtitle1\">Day 30 (n)</td> <td class=\"subtitle1\">Day 90 (n)</td> <td class=\"subtitle1\">Day 180 (n)</td> <td class=\"subtitle1\">Adult (n)</td> </tr> <tr> <td>PT (s)</td> <td>13.0 &#177; 1.43 (61)*</td> <td>12.4 &#177; 1.46 (77)*<sup>&#182;</sup></td> <td>11.8 &#177; 1.25 (67)*<sup>&#182;</sup></td> <td>11.9 &#177; 1.15 (62)*</td> <td>12.3 &#177; 0.79 (47)*</td> <td>12.4 &#177; 0.78 (29)</td> </tr> <tr> <td>APTT (s)</td> <td>42.9 &#177; 5.80 (61)</td> <td>42.6 &#177; 8.62 (76)</td> <td>40.4 &#177; 7.42 (67)</td> <td>37.1 &#177; 6.52 (62)*</td> <td>35.5 &#177; 3.71 (47)*</td> <td>33.5 &#177; 3.44 (29)</td> </tr> <tr> <td>TCT (s)</td> <td>23.5 &#177; 2.38 (58)*</td> <td>23.1 &#177; 3.07 (64)<sup>&#182;</sup></td> <td>24.3 &#177; 2.44 (53)*</td> <td>25.1 &#177; 2.32 (52)*</td> <td>25.5 &#177; 2.86 (41)*</td> <td>25.0 &#177; 2.66 (19)</td> </tr> <tr> <td>Fibrinogen (g/L)</td> <td>2.83 &#177; 0.58 (61)*</td> <td>3.12 &#177; 0.75 (77)*</td> <td>2.70 &#177; 0.54 (67)*</td> <td>2.43 &#177; 0.68 (60)*<sup>&#182;</sup></td> <td>2.51 &#177; 0.68 (47)*<sup>&#182;</sup></td> <td>2.78 &#177; 0.61 (29)</td> </tr> <tr> <td>II (U/mL)</td> <td>0.48 &#177; 0.11 (61)</td> <td>0.63 &#177; 0.15 (76)</td> <td>0.68 &#177; 0.17 (67)</td> <td>0.75 &#177; 0.15 (62)</td> <td>0.88 &#177; 0.14 (47)</td> <td>1.08 &#177; 0.19 (29)</td> </tr> <tr> <td>V (U/mL)</td> <td>0.72 &#177; 0.18 (61)</td> <td>0.95 &#177; 0.25 (76)</td> <td>0.98 &#177; 0.18 (67)</td> <td>0.90 &#177; 0.21 (62)</td> <td>0.91 &#177; 0.18 (47)</td> <td>1.06 &#177; 0.22 (29)</td> </tr> <tr> <td>VII (U/mL)</td> <td>0.66 &#177; 0.19 (60)</td> <td>0.89 &#177; 0.27 (75)</td> <td>0.90 &#177; 0.24 (67)</td> <td>0.91 &#177; 0.26 (62)</td> <td>0.87 &#177; 0.20 (47)</td> <td>1.05 &#177; 0.19 (29)</td> </tr> <tr> <td>VIII (U/mL)</td> <td>1.00 &#177; 0.39 (60)*<sup>&#182;</sup></td> <td>0.88 &#177; 0.33 (75)*<sup>&#182;</sup></td> <td>0.91 &#177; 0.33 (67)*<sup>&#182;</sup></td> <td>0.79 &#177; 0.23 (62)*<sup>&#182;</sup></td> <td>0.73 &#177; 0.18 (47)<sup>&#182;</sup></td> <td>0.99 &#177; 0.25 (29)</td> </tr> <tr> <td>vWF (U/mL)</td> <td>1.53 &#177; 0.67 (40)<sup>&#182;</sup></td> <td>1.40 &#177; 0.57 (3)<sup>&#182;</sup></td> <td>1.28 &#177; 0.59 (40)<sup>&#182;</sup></td> <td>1.18 &#177; 0.44 (40)<sup>&#182;</sup></td> <td>1.07 &#177; 0.45 (46)<sup>&#182;</sup></td> <td>0.92 &#177; 0.33 (29)<sup>&#182;</sup></td> </tr> <tr> <td>IX (U/mL)</td> <td>0.53 &#177; 0.19 (59)</td> <td>0.53 &#177; 0.19 (75)</td> <td>0.51 &#177; 0.15 (67)</td> <td>0.67 &#177; 0.23 (62)</td> <td>0.86 &#177; 0.25 (47)</td> <td>1.09 &#177; 0.27 (29)</td> </tr> <tr> <td>X (U/mL)</td> <td>0.40 &#177; 0.14 (60)</td> <td>0.49 &#177; 0.15 (76)</td> <td>0.59 &#177; 0.14 (67)</td> <td>0.71 &#177; 0.18 (62)</td> <td>0.78 &#177; 0.20 (47)</td> <td>1.06 &#177; 0.23 (29) </td> </tr> <tr> <td>XI (U/mL)</td> <td>0.38 &#177; 0.14 (60)</td> <td>0.55 &#177; 0.16 (74)</td> <td>0.53 &#177; 0.13 (67)</td> <td>0.69 &#177; 0.14 (62)</td> <td>0.86 &#177; 0.24 (47)</td> <td>0.97 &#177; 0.15 (29)</td> </tr> <tr> <td>XII (U/mL)</td> <td>0.53 &#177; 0.20 (60)</td> <td>0.47 &#177; 0.18 (75)</td> <td>0.49 &#177; 0.16 (67)</td> <td>0.67 &#177; 0.21 (62)</td> <td>0.77 &#177; 0.19 (47) </td> <td>1.08 &#177; 0.28 (29)</td> </tr> <tr> <td>PK (U/mL)</td> <td>0.37 &#177; 0.16 (45)<sup>&#182;</sup></td> <td>0.48 &#177; 0.14 (51)</td> <td>0.57 &#177; 0.17 (48)</td> <td>0.73 &#177; 0.16 (46)</td> <td>0.86 &#177; 0.15 (43)</td> <td>1.12 &#177; 0.25 (29)</td> </tr> <tr> <td>HMW-K (U/mL)</td> <td>0.54 &#177; 0.24 (47)</td> <td>0.74 &#177; 0.28 (63)</td> <td>0.77 &#177; 0.22 (50)*</td> <td>0.82 &#177; 0.32 (46)*</td> <td>0.82 &#177; 0.23 (48)*</td> <td>0.92 &#177; 0.22 (29)</td> </tr> <tr> <td>XIIIa (U/mL)</td> <td>0.79 &#177; 0.26 (44)</td> <td>0.94 &#177; 0.25 (49)*</td> <td>0.93 &#177; 0.27 (44)*</td> <td>1.04 &#177; 0.34 (44)*</td> <td>1.04 &#177; 0.29 (41)*</td> <td>1.05 &#177; 0.25 (29)</td> </tr> <tr> <td>XIIIb (U/mL)</td> <td>0.76 &#177; 0.23 (44)</td> <td>1.06 &#177; 0.37 (47)*</td> <td>1.11 &#177; 0.36 (45)*</td> <td>1.16 &#177; 0.34 (44)*</td> <td>1.10 &#177; 0.30 (41)*</td> <td>0.97 &#177; 0.20 (29)</td> </tr> <tr> <td>Plasminogen (CTA, U/mL)</td> <td>1.95 &#177; 0.35 (44)</td> <td>2.17 &#177; 0.38 (60)</td> <td>1.98 &#177; 0.36 (52)</td> <td>2.48 &#177; 0.37 (44)</td> <td>3.01 &#177; 0.40 (47)</td> <td>3.36 &#177; 0.44 (29)</td> </tr> </tbody></table></div><div class=\"graphic_lgnd\">All factors except fibrinogen and plasminogen are expressed as units per milliliter where pooled plasma contains 1.0 U/mL. Plasminogen units are those recommended by the Committee on Thrombolytic Agents (CTA). AU values are expressed as mean &plusmn; 1 SD.</div><div class=\"graphic_footnotes\">VIII: factor VIII procoagulant.<br />* Values that do not differ statistically from the adult values.<br />Â¶ These measurements are skewed because of a disproportionate number of high values. The lower limit that excludes the lower 2.5th percentile of the population has been given in the respective figure. The lower limit for factor VIII was 0.50 U/mL at all time points for the infant.</div><div class=\"graphic_reference\">Reprinted from: Andrew, M, Paes, B, Milner, R, et al. Development of the Human Coagulation System in the Full-Term Infant. Blood 1987; 70:165. Copyright &copy; American Society of Hematology.</div><div id=\"graphicVersion\">Graphic 52172 Version 2.0</div></div></div>"},"52173":{"type":"graphic_table","displayName":"Classification of G proteins","title":"Classification of G protein-coupled receptors","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Classification of G protein-coupled receptors</div><div class=\"cntnt\"><table cellspacing=\"0\">\n<tbody>\n\n<tr>\n<td class=\"subtitle1_single\">Class I</td>\n</tr>\n<tr>\n<td>Catecholamines, acetylcholine, serotonin</td>\n</tr>\n<tr>\n<td>Gastrin/CCK, neuropeptide Y, substance P</td>\n</tr>\n<tr>\n<td class=\"subtitle1_single\">Class II</td>\n</tr>\n<tr>\n<td>Secretin, glucagon, vasoactive intestinal polypeptide, glucagon-like peptide 1</td>\n</tr>\n<tr>\n<td class=\"subtitle1_single\">Class III</td>\n</tr>\n<tr>\n<td>Glutamate-metabotrophic receptors, calcium receptors</td>\n</tr>\n</tbody>\n</table>\n\r\n\r\n<html xmlns:mso=\"urn:schemas-microsoft-com:office:office\" xmlns:msdt=\"uuid:C2F41010-65B3-11d1-A29F-00AA00C14882\"><head>\n<!--[if gte mso 9]><xml>\n<mso:CustomDocumentProperties>\n<mso:Specialty msdt:dt=\"string\">6.00000000000000</mso:Specialty>\n<mso:Media_Type msdt:dt=\"string\">Table</mso:Media_Type>\n<mso:Edit_Table msdt:dt=\"string\">&lt;a href=&quot;/Graphics/Pages/TableEditor.aspx?SPID=17509&amp;amp;Mode=Edit&quot;&gt;&lt;/a&gt;</mso:Edit_Table>\n</mso:CustomDocumentProperties>\n</xml><![endif]-->\n<title>Classification_of_G_protein.htm</title></head></div><div class=\"graphic_footnotes\">CCK: cholecystokinin.</div><div id=\"graphicVersion\">Graphic 52173 Version 2.0</div></div></div>"},"52175":{"type":"graphic_picture","displayName":"Papillary muscle rupture after MI","title":"Papillary muscle rupture after MI","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Papillary muscle rupture after MI</div><div class=\"cntnt\"><img style=\"width:229px; height:304px;\" src=\"images/CARD/52175_Pap_muscle_rupture_post_MI.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Pathologic specimen showing complete transection of papillary muscle (arrow) after an acute myocardial infarction. The patient died with severe mitral regurgitation.</div><div class=\"graphic_reference\">Photograph courtesy of Dr William D Edwards. From Reeder, GS, Gersh, BJ, Acute myocardial infarction. In: Internal Medicine, 4th ed, Stein, JH, Hutton, JJ, Kohler, PO, et al (Eds), Mosby-Year Book, St Louis, 1994, pp. 169-189. By permission.</div><div id=\"graphicVersion\">Graphic 52175 Version 3.0</div></div></div>"},"52176":{"type":"graphic_table","displayName":"Differential DX RA 1","title":"Confirming a diagnosis of rheumatoid arthritis (RA)*: Differential diagnosis","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Confirming a diagnosis of rheumatoid arthritis (RA)*: Differential diagnosis</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup span=\"4\" width=\"12%\"></colgroup><colgroup width=\"52%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\">Diagnosis</td> <td class=\"subtitle1\">Sex</td> <td class=\"subtitle1\">Age</td> <td class=\"subtitle1\">Lab tests</td> <td class=\"subtitle1\">Comments</td> </tr> <tr class=\"divider_bottom\"> <td>Undifferentiated seronegative polyarthritis</td> <td>F &#62; M</td> <td>35-65</td> <td>10-15 percent RF+</td> <td>Chronic seronegative inflammatory polyarthritis, atypical of RA or fails to meet classification criteria for RA. Up to 20 percent of cases may evolve into RA; nearly 50 percent will go into remission.</td> </tr> <tr class=\"divider_bottom\"> <td>Psoriatic arthritis</td> <td>M = F</td> <td>30-55</td> <td>&#60;20 percent RF+</td> <td>10 percent of those with psoriatic arthritis will have an RA-like distribution (MCPs, PIPs, wrists). Cutaneous psoriasis will be evident in the vast majority of cases.</td> </tr> <tr> <td class=\"divider_bottom\" rowspan=\"2\">Tophaceous gout</td> <td>M &#62; F</td> <td>25-70 M</td> <td>95 percent RF&ndash;</td> <td class=\"divider_bottom\" rowspan=\"2\">Intermittent inflammatory arthritis during the onset, with evolution of tophi and chronic inflammatory polyarthritis. Elevated serum urate and tophi help distiguish from RA.</td> </tr> <tr class=\"divider_bottom\"> <td>F</td> <td>&#62;45</td> <td>&#62;95 percent &#8593; serum urate</td> </tr> <tr class=\"divider_bottom\"> <td>Erosive inflammatory OA</td> <td>F &#62; M</td> <td>&#62;60</td> <td>RF&ndash; (or normal for age)</td> <td>Chronic polyarthritis with intermittent or sustained inflammation affecting PIP and DIP joints. Radiographs demonstrate distinctive erosions and evidence of OA.</td> </tr> <tr class=\"divider_bottom\"> <td>Pseudogout</td> <td>F = M</td> <td>&#62;60</td> <td>5-10 percent RF+</td> <td>5 percent of patients will have \"rheumatoid-like\" inflammatory arthritis with stiffness, fatigue, synovitis, and elevated ESR, often lasting four weeks to several months.</td> </tr> <tr class=\"divider_bottom\"> <td> <p>Reactive arthritis</p> (formerly known as Reiter's syndrome)</td> <td>M &#62; F</td> <td>16-50</td> <td>95 percent RF&ndash;; 50-80 percent HLA-B27+</td> <td>See criteria for spondyloarthropathies; often associated with low back pain, ocular, genitourinary, or GI symptomatology and enthesitis (heel pain).</td> </tr> <tr class=\"divider_bottom\"> <td>Enteropathic arthritis</td> <td>M = F</td> <td>All ages</td> <td>95 percent RF&ndash;</td> <td>20 percent of patients with Crohn's disease or ulcerative colitis will develop peripheral arthritis. Diagnosis may be difficult until GI involvment becomes apparent. Associated with oral ulcerations, GI symptoms or other features of spondyloarthropathy.</td> </tr> <tr class=\"divider_bottom\"> <td>Systemic lupus erythematosus</td> <td>F &#62; M</td> <td>15-40</td> <td>10-15 percent RF+; usually ANA+</td> <td>Chronic nondeforming inflammatory polyarthritis associated with ANA positivity and other features of SLE.</td> </tr> <tr class=\"divider_bottom\"> <td>Polymyositis/ dermatomyositis</td> <td>F &#62; M</td> <td>30-60</td> <td>95 percent RF&ndash;; 50 percent ANA+; 70 percent &#8593; CK</td> <td>Chronic inflammatory arthritis uncommonly occurs early in course of PM/DM. Features of proximal muscle weakness, bulbar dysphagia, muscle enzyme elevation, or skin involvement (ie, Gottron's papules) should be sought.</td> </tr> <tr class=\"divider_bottom\"> <td>Scleroderma</td> <td>F &#62; M</td> <td>30-50</td> <td>95 percent RF&ndash;; &#62;90 percent ANA+</td> <td>Chronic inflammatory polyarthritis may predominate over skin changes early in the disease. Associated with Raynaud's phenomenon, sclerodactyly, dysphagia, hypertension, or renal abnormalities.</td> </tr> <tr class=\"divider_bottom\"> <td>Sarcoid arthritis</td> <td>F &#62; M</td> <td>20-40</td> <td>25 percent RF+</td> <td>15 percent of patients with sarcoidosis will develop arthritis. Early in the disease a chronic inflammatory oligo or polyarthritis lasting weeks to months may develop and typically involve the ankles and knees. Other features of sarcoidosis (ie, erythema nodosum, hilar adenopathy) are usually apparent.</td> </tr> <tr class=\"divider_bottom\"> <td>Parvovirus B19-associated arthritis</td> <td>F &#62; M</td> <td>Any age</td> <td>&#60;10 percent RF+; &#62;80 percent anti-B19 IgM antibodies (acutely)</td> <td>Adults manifest a flu-like picture, seldom develop the \"slapped-cheek\" rash; arthralgias are more common than arthritis. Arthritis is an acute inflammatory polyarthritis with an RA-like distribution lasting two weeks. Less than 10 percent develop a chronic inflammatory arthritis.</td> </tr> <tr> <td>Polymyalgia rheumatica</td> <td>F &#62; M</td> <td>&#62;50</td> <td>90 percent RF&ndash;; &#62;95 percent &#8593;&#8593; ESR</td> <td>Proximal girdle pain and stiffness without synovitis.</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">ANA: antinuclear antibody; DIP: distal interphalangeal; DM: dermatomyositis; ESR: erythrocyte sedimentation rate; GI: gastrointestinal; MCP: metacarpophalangeal; OA: osteoarthritis; PIP: proximal interphalangeal; PM: polymyositis; RA: rheumatoid arthritis; SLE: systemic lupus erythematosus.<br />* 1. RA often begins insidiously with vague constitutional and musculoskeletal symptoms that may last for weeks or months before synovitis becomes apparent.<br />2. During the first six months of RA, &lt;50 percent of patients will be RF-positive, and the sensitivity of the 1987 ACR criteria is reduced.<br />3. A variety of less common chronic inflammatory seronegative articular conditions may clinically resemble early RA. It may be necessary to observe and evaluate the patient repeatedly for evolution of the disorder and manifestation of features that will distinguish them from RA. The above disorders can mimic RA.</div><div class=\"graphic_reference\">Data from: Lipsky P. Algorithms for the diagnosis and management of musculoskeletal complaints: A new tool for the primary-care provider. (See www.swmed.edu/home_pages/cme/endurmat/lipsky/index.html.)</div><div id=\"graphicVersion\">Graphic 52176 Version 5.0</div></div></div>"},"52178":{"type":"graphic_picture","displayName":"Cutaneous squamous cell carcinoma - leg","title":"Cutaneous squamous cell carcinoma","html":"<div class=\"graphic\"><div style=\"width: 524px\" class=\"figure\"><div class=\"ttl\">Cutaneous squamous cell carcinoma</div><div class=\"cntnt\"><img style=\"width:504px; height:378px;\" src=\"images/DERM/52178_Cutan_squamous_leg.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">An erythematous scaly papule is present on the lower leg.</div><div class=\"graphic_reference\">Reproduced with permission from: <A style=\"FONT-STYLE: italic\" href=\"http://www.visualdx.com/\" target=_blank>www.visualdx.com</A>. Copyright Logical Images, Inc.</div><div id=\"graphicVersion\">Graphic 52178 Version 3.0</div></div></div>"},"52179":{"type":"graphic_figure","displayName":"Insertion of anvil of circular stapler into ileum","title":"Insertion of anvil of circular stapler into ileum","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Insertion of anvil of circular stapler into ileum</div><div class=\"cntnt\"><img style=\"width:363px; height:357px;\" src=\"images/SURG/52179_Anvil-into-ileum.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The anvil is secured to the ileum with a purse string suture.</div><div id=\"graphicVersion\">Graphic 52179 Version 1.0</div></div></div>"},"52180":{"type":"graphic_table","displayName":"Antithyroid drug controversies","title":"Controversies about antithyroid drug use","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Controversies about antithyroid drug use</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1\">Controversy</td> <td class=\"subtitle1\">Best available answer</td> </tr> <tr> <td>For how long should patients be treated?</td> <td>12 to 18 months</td> </tr> <tr> <td>Does the dose influence the chances of remission?</td> <td>Probably not</td> </tr> <tr> <td>Do higher doses bring the disease under more rapid control?</td> <td>Yes</td> </tr> <tr> <td>Does the coadministration or subsequent use of T4 or T3 improve remission rates?</td> <td>No</td> </tr> <tr> <td>Are there baseline predictors of the likelihood of remission?</td> <td>Severe disease, large goiter, high anti-TRAb titers may be predictive of failure, but only in extreme cases</td> </tr> <tr> <td>Does pretreatment with antithyroid drugs decrease the chances of thyroid storm or other adverse outcomes after radioiodine therapy?</td> <td>Possibly, but only because thyroid hormone levels are lower after therapy in those few patients who exhibit an exacerbation</td> </tr> <tr> <td>Will antithyroid drug therapy after radioiodine lead to more rapid disease control?</td> <td>Propylthiouracil, no (at six weeks); methimazole, yes</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">T3: liothyronine; T4: levothyroxine; TRAb: thyrotropin receptor antibody.</div><div class=\"graphic_reference\">Adapted with permission from: Cooper DC. Antithyroid drugs in the management of patients with Graves' disease: An evidence-based approach to therapeutic controversies. J Clin Endocrinol Metab 2003; 88:3474. http://jcem.endojournals.org/. Copyright Â© 2003 The Endocrine Society.</div><div id=\"graphicVersion\">Graphic 52180 Version 7.0</div></div></div>"},"52181":{"type":"graphic_table","displayName":"Antigenic subtypes of influenza","title":"Antigenic subtypes of influenza A virus associated with pandemics or epidemics","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Antigenic subtypes of influenza A virus associated with pandemics or epidemics</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1\">Year</td> <td class=\"subtitle1\">Subtype</td> <td class=\"subtitle1\">Severity of outbreak</td> </tr> <tr> <td>1889 to 1890</td> <td>H2N8*</td> <td>Severe pandemic</td> </tr> <tr> <td>1900 to 1903</td> <td>H3N8*</td> <td>Moderate epidemic, probable</td> </tr> <tr> <td>1918 to 1919</td> <td>H1N1, formerly HswN1<sup>&#182;</sup></td> <td>Severe pandemic</td> </tr> <tr> <td>1933 to 1935</td> <td>H1N1, formerly H0N1<sup>&#182;</sup></td> <td>Mild epidemic</td> </tr> <tr> <td>1946 to 1947</td> <td>H1N1</td> <td>Mild epidemic</td> </tr> <tr> <td>1957 to 1958</td> <td>H2N2</td> <td>Severe pandemic</td> </tr> <tr> <td>1968 to 1969</td> <td>H3N2</td> <td>Moderate pandemic</td> </tr> <tr> <td>1977 to 1978</td> <td>H1N1</td> <td>Mild pandemic</td> </tr> <tr> <td>2009 to 2010</td> <td>H1N1</td> <td>Mild to moderate pandemic<sup>&#916;</sup></td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">* As determined by retrospective serologic survey of individuals alive during those years.<br />Â¶ Hemagglutinins formerly designated as Hsw and H0 are now classified as variants of H1.<br />Î During the 2009 to 2010 H1N1 influenza A pandemic, mortality was relatively high among individuals &lt;65 years of age and relatively low among those â¥65 years of age.<SUP>[1]</SUP> </div><div class=\"graphic_reference\">Reference:<br /><OL>&#xD;&#xA;<LI>Armstrong GL, Brammer L, Finelli L. Timely assessment of the severity of the 2009 H1N1 influenza pandemic. Clin Infect Dis 2011; 52 [Suppl 1]:S83.</LI></OL>Data adapted from: Dolin R. Influenza. In: Harrison's Principles of Internal Medicine, 17th ed, Braunwald E, Fauci AS, Kasper DL, et al (Eds), McGraw Hill Book Company. New York 2008. p.1127.</div><div id=\"graphicVersion\">Graphic 52181 Version 11.0</div></div></div>"},"52183":{"type":"graphic_figure","displayName":"Relationship between transmembrane pressure and filtration","title":"FigureÂ showing the direct relationship between transmembrane pressure and filtration rate when plasmapheresis is performed with hemodialysis equipment","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Figure&nbsp;showing the direct relationship between transmembrane pressure and filtration rate when plasmapheresis is performed with hemodialysis equipment</div><div class=\"cntnt\"><img style=\"width:382px; height:290px;\" src=\"images/NEPH/52183_Filtration_rate_during_pher.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">In contrast to the usual practice, filtration rate is graphed as the independent variable, and transmembrane pressure is the dependent variable. The maximum filtration rate is achieved at a relatively low transmembrane pressure of&nbsp;approximately 40 mmHg (arrow).</div><div class=\"graphic_reference\">Data from: Gurland HJ, Lysaght MJ, Samtleben W, Schmidt B. Comparative evaluation of filters used in membrane plasmapheresis.&nbsp;Nephron 1984; 36:173.</div><div id=\"graphicVersion\">Graphic 52183 Version 5.0</div></div></div>"},"52184":{"type":"graphic_diagnosticimage","displayName":"38-year-old MS brain MRI","title":"Brain MRI of a 38-year-old woman with multiple sclerosis","html":"<div class=\"graphic\"><div style=\"width: 539px\" class=\"figure\"><div class=\"ttl\">Brain MRI of a 38-year-old woman with multiple sclerosis</div><div class=\"cntnt\"><img style=\"width:519px; height:313px;\" src=\"images/NEURO/52184_38_yo_MS_brain_MRI.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Axial flair image (A) show two plaques in the internal capsule, one in the anterior limb and one in the posterior limb. Diffusion tensor fractional anisotropy map (B) shows asymmetric hypointensity (decreased anisotropy) in these regions (arrows), consistent with loss of axonal integrity.</div><div id=\"graphicVersion\">Graphic 52184 Version 4.0</div></div></div>"},"52188":{"type":"graphic_figure","displayName":"Lateral approach to popliteal nerve block","title":"Lateral approach to popliteal nerve block","html":"<div class=\"graphic\"><div style=\"width: 554px\" class=\"figure\"><div class=\"ttl\">Lateral approach to popliteal nerve block</div><div class=\"cntnt\"><img style=\"width:534px; height:550px;\" src=\"images/SURG/52188_Poplitealblocklat.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">For the lateral approach using a nerve stimulator, the patient remains in the supine position. The needle is directed to the femur between the vastus lateralus and the biceps femoris. It is then withdrawn to the skin, reoriented, and reinserted while looking for nerve response. Local anesthetic is then injected. Ultrasound-guided block using a lateral approach can be performed with the patient in the supine or lateral position. A linear transducer is placed parallel to the popliteal crease, and the needle is directed towards the hyperechoic nerve before it divides.</div><div id=\"graphicVersion\">Graphic 52188 Version 4.0</div></div></div>"},"52189":{"type":"graphic_picture","displayName":"Plaque sarcoidosis","title":"Plaque sarcoidosis","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Plaque sarcoidosis</div><div class=\"cntnt\"><img style=\"width:432px; height:324px;\" src=\"images/DERM/52189_Plaque_sarcoidosis.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Well demarcated, red-brown, infiltrated plaques are scattered on the back and posterior arm. Hypopigmentation is present at the periphery of some lesions.</div><div class=\"graphic_reference\">Reproduced with permission from: <A style=\"FONT-STYLE: italic\" href=\"http://www.visualdx.com/\" target=_blank>www.visualdx.com</A>. Copyright Logical Images, Inc. Original photo provided by NYU (Tisch) Department of Dermatology.</div><div id=\"graphicVersion\">Graphic 52189 Version 5.0</div></div></div>"},"52190":{"type":"graphic_picture","displayName":"Skin necrosis with MRSA infection of the hand","title":"Skin necrosis with MRSA infection of the hand","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Skin necrosis with MRSA infection of the hand</div><div class=\"cntnt\"><img style=\"width:360px; height:540px;\" src=\"images/SURG/52190_Skin_necrosis_MRSA_infect.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">This photograph demonstrates the appearance of skin necrosis (dermonecrosis) as a result of a dorsal subaponeurotic MRSA infection.</div><div class=\"graphic_footnotes\">MRSA: methicillin-resistant <EM>Staphylococcus aureus</EM>. </div><div id=\"graphicVersion\">Graphic 52190 Version 3.0</div></div></div>"},"52191":{"type":"graphic_table","displayName":"Eligibility criteria for auto-HCT","title":"General eligibility criteria for autologous hematopoietic cell transplantation","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">General eligibility criteria for autologous hematopoietic cell transplantation</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td>Disease-related indication</td> </tr> <tr> <td>Karnofsky performance status &#8805;70</td> </tr> <tr> <td class=\"sublist1_start\">Renal function</td> </tr> <tr> <td class=\"sublist1\">Serum creatinine &#60;2 mg/dL (177 micromol/L), unless autologous HCT is for myeloma</td> </tr> <tr> <td class=\"sublist1_start\">Cardiac reserve</td> </tr> <tr> <td class=\"sublist1\">LVEF &#8805;40 percent if using the BEAM conditioning regimen and a LVEF &#8805;50 percent using chemotherapy regimens with known cardiac toxicity (eg, cyclophosphamide)</td> </tr> <tr> <td class=\"sublist1_start\">Pulmonary function</td> </tr> <tr> <td class=\"sublist1\">A corrected DLCO &#8805;50 percent</td> </tr> <tr> <td class=\"sublist1_start\">Liver function</td> </tr> <tr> <td class=\"sublist1\">No frank cirrhosis of the liver</td> </tr> <tr> <td>Adequate psychosocial and financial support</td> </tr> <tr> <td>No evidence of myelodysplasia on bone marrow examination</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">HCT: hematopoietic cell transplantation; LVEF: left ventricular ejection fraction; BEAM: BCNU, etoposide, cytarabine, and melphalan; DLCO: diffusing capacity of the lungs for carbon monoxide.</div><div id=\"graphicVersion\">Graphic 52191 Version 1.0</div></div></div>"},"52192":{"type":"graphic_picture","displayName":"Fixed drug eruption arm","title":"Fixed drug eruption","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Fixed drug eruption</div><div class=\"cntnt\"><img style=\"width:360px; height:353px;\" src=\"images/DERM/52192_Fixeddrugeruptionarm.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Fixed drug eruption. An oval lesion occurred at the identical site where it had occurred previously. In both episodes, the rash emerged after this patient ingested a sulfonamide antibiotic. Note the eroded blister in the center of the lesion.</div><div class=\"graphic_reference\">Reproduced with permission from: Goodheart HP. Goodheart's Photoguide of Common Skin Disorders, 2nd Edition, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright Â© 2003 Lippincott Williams &amp; Wilkins.</div><div id=\"graphicVersion\">Graphic 52192 Version 2.0</div></div></div>"},"52194":{"type":"graphic_figure","displayName":"Pneumonia hospitalization children","title":"Annual all-cause pneumonia hospitalization rates* among children aged <2 years and 2-4 years - Nationwide Inpatient Sample, United States, 1997-2006","html":"<div class=\"graphic\"><div style=\"width: 594px\" class=\"figure\"><div class=\"ttl\">Annual all-cause pneumonia hospitalization rates* among children aged &lt;2 years and 2-4 years - Nationwide Inpatient Sample, United States, 1997-2006</div><div class=\"cntnt\"><img style=\"width:574px; height:386px;\" src=\"images/PEDS/52194_Pneumonia_hosp_children.gif\" alt=\"Image\"/></div><div class=\"graphic_footnotes\">* Per 1000 population.<br> <span class=bullet>&#8226;</span> 95% confidence interval.<br> &#916; 7-valent pneumococcal conjugate vaccine licensed in February 2000.</div><div class=\"graphic_reference\">Data from: Centers for Disease Control and Prevention. Pneumonia Hospitalizations Among Young Children Before and After Introduction of Pneumococcal Conjugate Vaccine - United States, 1997-2006. MMWR 2009; 58:3.</div><div id=\"graphicVersion\">Graphic 52194 Version 4.0</div></div></div>"},"52196":{"type":"graphic_figure","displayName":"Location of Koch's triangle","title":"Koch's triangle and fast and slow pathways","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Koch's triangle and fast and slow pathways</div><div class=\"cntnt\"><img style=\"width:389px; height:276px;\" src=\"images/CARD/52196_Location_of_Kochs_triangle.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Schematic representation of Koch's triangle which is bounded by the tricuspid ring and the tendon of Todoro. The tendon of Todoro and the tricuspid ring are in close proximity forming the apex of the triangle near the His bundle at the membranous septum. Koch's triangle can be divided into thirds: the anterior contains the compact AV node; the posterior contains the coronary sinus; and the middle or mid-septal third is between the anterior and posterior portions. The anterior third is associated with fast pathways, and the middle and posterior thirds with slow pathways.</div><div id=\"graphicVersion\">Graphic 52196 Version 2.0</div></div></div>"},"52198":{"type":"graphic_table","displayName":"BAL drug induced lung disease","title":"Diagnostic value of bronchoalveolar lavage in drug-induced lung disease","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Diagnostic value of bronchoalveolar lavage in drug-induced lung disease</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1\">Typical findings in BAL</td> <td class=\"subtitle1\">Typical findings in BAL</td> <td class=\"subtitle1\">Drug</td> </tr> <tr> <td rowspan=\"3\">Cytotoxic reactions</td> <td>Atypical cells (cytomegaly, cytoplasmic eosinophilia, bizarre cell shape,&nbsp;nuclear&nbsp;hyperchromasia, prominent nucleoli, multinucleation)</td> <td rowspan=\"3\">Chemotherapeutic agents: bleomycin, methotrexate, nitrosoureas, busulfan, cyclophosphamide</td> </tr> <tr> <td>Increased eosinophils</td> </tr> <tr> <td>Extracellular lipoproteinaceous debris</td> </tr> <tr> <td rowspan=\"2\">Pulmonary hemorrhage</td> <td>Hemosiderin-laden alveolar macrophages</td> <td rowspan=\"2\">D-penicillamine, mineral oil, amphotericin B</td> </tr> <tr> <td>Red blood cells</td> </tr> <tr> <td rowspan=\"3\">Lymphocytic alveolitis </td> <td>40 to 50 percent lymphocytes </td> <td rowspan=\"2\">Methotrexate, nitrofurantoin, azathioprine, sulfasalazine, cyclophosphamide, amiodarone</td> </tr> <tr> <td>Increased CD8+ cells suggestive of hypersensitivity reactions</td> </tr> <tr> <td>Decreased CD4+ to CD8+ ratio</td> <td>BCG therapy, acebutolol, gold salts, propranolol, busulfan, nilutamide, bleomycin, flecainide</td> </tr> <tr> <td>Neutrophilic alveolitis</td> <td>Increased neutrophils</td> <td>Bleomycin, busulfan</td> </tr> <tr> <td>Eosinophilic alveolitis</td> <td>Allergic \"eosinophilic\" reactions</td> <td>Nitrofurantoin, penicillin, sulfasalazine, ampicillin, tetracycline, bleomycin, clotrimazole</td> </tr> <tr> <td>Lipoid pneumonia</td> <td>Alveolar macrophages contain large&nbsp;empty vacuoles stained by&nbsp;Oil-Red-O</td> <td>Mineral oil nose-drops or laxatives</td> </tr> <tr> <td rowspan=\"2\">Thesaurismosis</td> <td rowspan=\"2\">Accumulation of numerous large lamellar inclusions mainly in alveolar macrophages</td> <td>Amiodarone</td> </tr> <tr> <td>Potentially all amphiphilic drugs</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">BAL: bronchoalveolar lavage.</div><div class=\"graphic_reference\">Data from King TE, Jr. Interstitial Lung Disease. In: Feinsilver SH, Fein AM. (Eds), Textbook of Bronchoscopy, Williams &amp; Wilkins, Baltimore, 1995, p. 185-220.</div><div id=\"graphicVersion\">Graphic 52198 Version 2.0</div></div></div>"},"52202":{"type":"graphic_table","displayName":"Congenital myasthenic syndromes","title":"Congenital myasthenic syndromes","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Congenital myasthenic syndromes</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup span=\"2\" width=\"50%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\">CMS syndrome</td> <td class=\"subtitle1\">Gene</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"2\">Ubiquitously expressed proteins</td> </tr> <tr> <td class=\"subtitle3_left\" colspan=\"2\">N-glycosylation pathway</td> </tr> <tr> <td class=\"indent2\">GFPT1</td> <td>GFPT1</td> </tr> <tr> <td class=\"indent2\">DPAGT1</td> <td>DPAGT1</td> </tr> <tr> <td class=\"indent2\">ALG2*</td> <td>ALG2</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent2\">ALG14*</td> <td>ALG14</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent2\">GMPPB*</td> <td>GMPPB</td> </tr> <tr> <td class=\"subtitle3_left\" colspan=\"2\">Propyl-olygopeptidase</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent2\">PREPL*</td> <td>PREPL</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"2\">Proteins with defined neuromuscular junction function</td> </tr> <tr> <td class=\"subtitle3_left\" colspan=\"2\">Presynaptic</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent2\">Choline acetyltransferase</td> <td>CHAT</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent2\">Vesicular acetylcholine transporter*</td> <td>SLC18A3</td> </tr> <tr> <td class=\"subtitle3_left\" colspan=\"2\">Synaptic</td> </tr> <tr> <td class=\"indent2\">Endplate AChE deficiency</td> <td>COLQ</td> </tr> <tr> <td class=\"indent2\">Laminin &#946;2 deficiency*</td> <td>LAMB2</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent2\">Agrin*</td> <td>AGRN</td> </tr> <tr> <td class=\"subtitle3_left\" colspan=\"2\">Postsynaptic</td> </tr> <tr> <td class=\"indent2\">Primary AChR deficiency</td> <td>CHRNA, CHRNB, CHRND, CHRNE</td> </tr> <tr> <td class=\"indent2\">Escobar syndrome*</td> <td>CHRNG</td> </tr> <tr> <td class=\"indent2\">Rapsyn</td> <td>RAPSN</td> </tr> <tr> <td class=\"indent2\">DOK7</td> <td>DOK7</td> </tr> <tr> <td class=\"indent2\">Slow channel syndrome</td> <td>CHRNA, CHRNB, CHRND, CHRNE</td> </tr> <tr> <td class=\"indent2\">Fast channel syndrome</td> <td>CHRNA, CHRNB, CHRND, CHRNE</td> </tr> <tr> <td class=\"indent2\">Low conductance syndrome*</td> <td>CHRNE</td> </tr> <tr> <td class=\"indent2\">MuSK*</td> <td>MUSK</td> </tr> <tr> <td class=\"indent2\">Plectin deficiency*</td> <td>PLEC1</td> </tr> <tr> <td class=\"indent2\">Na-channel myasthenia*</td> <td>SCN4A</td> </tr> <tr> <td class=\"indent2\">LRP4*</td> <td>LRP4</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">CMS: congenital myasthenic syndromes.<br />* Accounts for extremely rare CMS syndromes.</div><div class=\"graphic_reference\">Modified from: RodrÃ­guez Cruz PM, Palace J, Beeson D. Congenital myasthenic syndromes and the neuromuscular junction. Curr Opin Neurol 2014; 27:566. DOI: <A spellcheck=true href=\"http://journals.lww.com/co-neurology/pages/articleviewer.aspx?year=2014&amp;issue=10000&amp;article=00010&amp;type=abstract\" target=_blank>10.1097/WCO.0000000000000134</A>. Reproduced with permission from Lippincott Williams &amp; Wilkins. Copyright Â© 2014. Unauthorized reproduction of this material is prohibited.</div><div id=\"graphicVersion\">Graphic 52202 Version 4.0</div></div></div>"},"52203":{"type":"graphic_picture","displayName":"OK sign to assess median nerve","title":"OK sign to assess median nerve","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">OK sign to assess median nerve</div><div class=\"cntnt\"><img style=\"width:244px; height:238px;\" src=\"images/EM/52203_OK_sign.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The OK sign evaluates the anterior interosseous branch of the median nerve by evaluating flexion at the distal interphalangeal (DIP)&nbsp;joint and &nbsp;testing the strength of the flexor pollicis longus and flexor digitorum profundus. The patient is asked to make the OK sign and then maintain&nbsp;it against resistance (pictured above). Patients with anterior interosseous nerve deficits will have flattening&nbsp;at the DIP joint and weakness of the muscles of apposition. </div><div id=\"graphicVersion\">Graphic 52203 Version 6.0</div></div></div>"},"52205":{"type":"graphic_table","displayName":"Opiate receptor activity","title":"Opiate receptor activity","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Opiate receptor activity</div><div class=\"cntnt\"><table cellspacing=\"0\">\n\n  <tbody>\n\n    <tr>\n\n      <td class=\"subtitle1\">Opiate receptor</td>\n\n      <td class=\"subtitle1\">Pharmacologic effect</td>\n\n    </tr>\n\n    <tr>\n\n      <td>mu (&#181;)</td>\n\n      <td>Analgesia, miosis, respiratory depression, euphoria,\nphysical dependence, suppression of opiate withdrawal</td>\n\n    </tr>\n\n    <tr>\n\n      <td>kappa (k)</td>\n\n      <td>Spinal analgesia, does not suppress opiate withdrawal</td>\n\n    </tr>\n\n    <tr>\n\n      <td>sigma (&#963;)</td>\n\n      <td>Dysphoria, hallucinations, respiratory and vasomotor\nstimulation</td>\n\n    </tr>\n\n    <tr>\n\n      <td>delta (&#916;)</td>\n\n      <td>Unclear</td>\n\n    </tr>\n\n  </tbody>\n</table>\n\n\r\n\r\n<html xmlns:mso=\"urn:schemas-microsoft-com:office:office\" xmlns:msdt=\"uuid:C2F41010-65B3-11d1-A29F-00AA00C14882\"><head>\n<!--[if gte mso 9]><xml>\n<mso:CustomDocumentProperties>\n<mso:Specialty msdt:dt=\"string\">14.0000000000000</mso:Specialty>\n<mso:Media_Type msdt:dt=\"string\">Table</mso:Media_Type>\n<mso:Edit_Table msdt:dt=\"string\">&lt;a href=&quot;/Graphics/Pages/TableEditor.aspx?SPID=67070&amp;amp;Mode=Edit&quot;&gt;&lt;/a&gt;</mso:Edit_Table>\n</mso:CustomDocumentProperties>\n</xml><![endif]-->\n<title>Opiate_receptor_activity.htm</title></head></div><div id=\"graphicVersion\">Graphic 52205 Version 2.0</div></div></div>"},"52208":{"type":"graphic_picture","displayName":"Mucous membrane pemphigoid lip","title":"Mucous membrane pemphigoid","html":"<div class=\"graphic\"><div style=\"width: 524px\" class=\"figure\"><div class=\"ttl\">Mucous membrane pemphigoid</div><div class=\"cntnt\"><img style=\"width:504px; height:378px;\" src=\"images/DERM/52208_Mucous_membrane_pemphigoid.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Irregular erosions and a blister on the mucosal surface of the lip.</div><div class=\"graphic_reference\">Reproduced with permission from: <A style=\"FONT-STYLE: italic\" href=\"http://www.visualdx.com/\" target=_blank>www.visualdx.com</A>. Copyright Logical Images, Inc.</div><div id=\"graphicVersion\">Graphic 52208 Version 4.0</div></div></div>"},"52209":{"type":"graphic_diagnosticimage","displayName":"Acute diaphyseal fracture of fifth metatarsal","title":"Acute diaphyseal fracture of fifth metatarsal","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Acute diaphyseal fracture of fifth metatarsal</div><div class=\"cntnt\"><img style=\"width:352px; height:365px;\" src=\"images/EM/52209_Acute_diaphyseal_fracture.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">This fracture demonstrates typical extension of the fracture line towards the intermetatarsal joint. Note the characteristics of an acute fracture: narrow fracture line, normal thin cortex adjacent to the fracture, and normal intramedullary canal.</div><div class=\"graphic_reference\">Courtesy of Robert L Hatch, MD, MPH.</div><div id=\"graphicVersion\">Graphic 52209 Version 4.0</div></div></div>"},"52211":{"type":"graphic_diagnosticimage","displayName":"Adrenal adenoma hypodense","title":"Hypodense adrenal adenoma","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Hypodense adrenal adenoma</div><div class=\"cntnt\"><img style=\"width:370px; height:277px;\" src=\"images/ENDO/52211_Adrenal_adenoma_hypodense.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Abdominal CT showing a 1.5 cm round hypodense left adrenal cortical adenoma (arrow).</div><div class=\"graphic_footnotes\">CT: computed tomography.</div><div class=\"graphic_reference\">Courtesy of William F Young, Jr, MD.</div><div id=\"graphicVersion\">Graphic 52211 Version 3.0</div></div></div>"},"52212":{"type":"graphic_diagnosticimage","displayName":"Hydrosalpinx","title":"Hydrosalpinx","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Hydrosalpinx</div><div class=\"cntnt\"><img style=\"width:432px; height:315px;\" src=\"images/OBGYN/52212_Hydrosalpinx.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Transvaginal ultrasound image of the adnexa showing a hydrosalpinx. There is a tubular fluid collection with low-level echoes. An incomplete septation is identified by the arrow.</div><div class=\"graphic_reference\">Reproduced with permission from: Thomas D Shipp, MD. Copyright Â© Thomas D Shipp, MD.</div><div id=\"graphicVersion\">Graphic 52212 Version 2.0</div></div></div>"},"52213":{"type":"graphic_picture","displayName":"Alopecia in secondary syphilis","title":"Patchy alopecia in secondary syphilis","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Patchy alopecia in secondary syphilis</div><div class=\"cntnt\"><img style=\"width:407px; height:251px;\" src=\"images/ID/52213_Alopecia_in_secondary_syphi.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Hair loss associated with secondary syphilis is usually patchy, producing a so-called moth-eaten appearance.</div><div class=\"graphic_reference\">Courtesy of Charles Hicks, MD.</div><div id=\"graphicVersion\">Graphic 52213 Version 1.0</div></div></div>"},"52215":{"type":"graphic_picture","displayName":"Neonate body stalk malformation","title":"Neonate with body stalk malformation","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Neonate with body stalk malformation</div><div class=\"cntnt\"><img style=\"width:302px; height:340px;\" src=\"images/OBGYN/52215_Neonate_body_stalk_malforma.jpg\" alt=\"Image\"/></div><div id=\"graphicVersion\">Graphic 52215 Version 2.0</div></div></div>"},"52216":{"type":"graphic_figure","displayName":"Abdominal aortic aneurysm anatomy PI","title":"Abdominal aortic aneurysm","html":"<div class=\"graphic\"><div style=\"width: 559px\" class=\"figure\"><div class=\"ttl\">Abdominal aortic aneurysm</div><div class=\"cntnt\"><img style=\"width:539px; height:550px;\" src=\"images/PI/52216_AAA_anatomy_PI_edt.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">An abdominal aortic aneurysm (or \"AAA\")&nbsp;is a bulge or a weakening in the \"abdominal aorta.\" The aorta is the main blood vessel that comes out of the heart.&nbsp;The abdominal aorta is the lower part of the aorta that supplies blood to the legs.</div><div id=\"graphicVersion\">Graphic 52216 Version 10.0</div></div></div>"},"52219":{"type":"graphic_figure","displayName":"Precision and validity","title":"Precision and validity","html":"<div class=\"graphic\"><div style=\"width: 574px\" class=\"figure\"><div class=\"ttl\">Precision and validity</div><div class=\"cntnt\"><img style=\"width:554px; height:348px;\" src=\"images/PC/52219_Targets_edt.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">(A) Dartboard illustrating high precision but low validity. The darts can be interpreted as representing studies attempting to measure the true effect (the bullseye). The studies closely approximate an estimate, but it is not the &quot;true&quot; effect.<br> (B) Dartboard illustrating low precision but high validity. As in the previous example, the darts can be interpreted as representing studies attempting to measure the &quot;true&quot; effect (the bullseye). In this case, the studies closely approximate the &quot;true&quot; effect (the bullseye), but the studies vary in their individual estimates. Interpretation of group of studies like this give a less confident assessment that they have revealed the &quot;truth&quot; compared with the group of studies that gave highly precise estimates (arrows tightly clustered within the bullseye).</div><div id=\"graphicVersion\">Graphic 52219 Version 4.0</div></div></div>"},"52220":{"type":"graphic_picture","displayName":"Melasma lip","title":"Melasma lip","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Melasma lip</div><div class=\"cntnt\"><img style=\"width:432px; height:325px;\" src=\"images/DERM/52220_Melasma_lip.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">A hyperpigmented patch is present on the upper lip in this patient with melasma.</div><div class=\"graphic_reference\">Reproduced with permission from: <A style=\"FONT-STYLE: italic\" href=\"http://www.visualdx.com/\" target=_blank>www.visualdx.com</A>. Copyright Logical Images, Inc.</div><div id=\"graphicVersion\">Graphic 52220 Version 4.0</div></div></div>"},"52221":{"type":"graphic_diagnosticimage","displayName":"Trans fracture of the medial sesamoid - B","title":"Transverse fracture of the medial sesamoid (white arrow)","html":"<div class=\"graphic\"><div style=\"width: 524px\" class=\"figure\"><div class=\"ttl\">Transverse fracture of the medial sesamoid (white arrow)</div><div class=\"cntnt\"><img style=\"width:504px; height:276px;\" src=\"images/EM/52221_Trans_fx_medial_sesamoid_B.jpg\" alt=\"Image\"/></div><div class=\"graphic_reference\">Courtesy of Robert L Hatch, MD, MPH.</div><div id=\"graphicVersion\">Graphic 52221 Version 3.0</div></div></div>"},"52224":{"type":"graphic_table","displayName":"MCV variation in children","title":"Mean corpuscular volume as a function of age in children","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Mean corpuscular volume as a function of age in children</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1\">Age</td> <td class=\"subtitle1\">MCV (95 percent confidence limits)</td> </tr> <tr> <td>Birth</td> <td>98 to 118</td> </tr> <tr> <td>1 to 3 days</td> <td>95 to 121</td> </tr> <tr> <td>2 weeks</td> <td>86 to 124</td> </tr> <tr> <td>2 months</td> <td>77 to 115</td> </tr> <tr> <td>3 to 6 months</td> <td>74 to 108</td> </tr> <tr> <td>0.5 to 2 years</td> <td>70 to 86</td> </tr> <tr> <td>2 to 6 years</td> <td>75 to 87</td> </tr> <tr> <td>6 to 12 years</td> <td>77 to 95</td> </tr> <tr> <td>12 to 18 years, females</td> <td>78 to 102</td> </tr> <tr> <td>12 to 18 years, males</td> <td>78 to 98</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">MCV: mean corpuscular volume. </div><div class=\"graphic_reference\">Adapted from: Nathan and Oski's Hematology of Infancy and Childhood, 7th edition, Nathan DG, Orkin SH (Eds), Saunders, Philadelphia, 2009.</div><div id=\"graphicVersion\">Graphic 52224 Version 5.0</div></div></div>"},"52227":{"type":"graphic_picture","displayName":"LIP with germinal centers","title":"Lymphocytic interstitial pneumonia","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Lymphocytic interstitial pneumonia</div><div class=\"cntnt\"><img style=\"width:363px; height:242px;\" src=\"images/PULM/52227_LIP_with_germinal_centers.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Low power photomicrograph shows an interstitial infiltrate of lymphocytes, plasma cells, and histiocytes and the presence of germinal centers.</div><div class=\"graphic_reference\">From Colby TV, Koss MN, Travis WD. Tumors of the Lower Respiratory Tract. Armed Forces Institute of Pathology, Washington, DC.</div><div id=\"graphicVersion\">Graphic 52227 Version 2.0</div></div></div>"},"52229":{"type":"graphic_diagnosticimage","displayName":"Tracheomalacia by CT","title":"Tracheomalacia by computed tomography (CT)","html":"<div class=\"graphic\"><div style=\"width: 532px\" class=\"figure\"><div class=\"ttl\">Tracheomalacia by computed tomography (CT)</div><div class=\"cntnt\"><img style=\"width:512px; height:175px;\" src=\"images/PULM/52229_Tracheomalacia_by_CT.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Axial CT airway imaging in (A) inspiration and (B) expiration and (C) dynamic expiration. There is excessive tracheal collapsibility on expiration. Note that in some cases the collapse cannot be demonstrated on end-exhalation, but is much more prominent on dynamic imaging. Reliance on in- and expiratory imaging alone can be a source for false negative examinations.</div><div class=\"graphic_reference\">Courtesy of Dr. P. Boiselle.</div><div id=\"graphicVersion\">Graphic 52229 Version 4.0</div></div></div>"},"52231":{"type":"graphic_figure","displayName":"Benefit of treatment of mild hypertension","title":"Cardiovascular benefit of treating mild hypertension","html":"<div class=\"graphic\"><div style=\"width: 506px\" class=\"figure\"><div class=\"ttl\">Cardiovascular benefit of treating mild hypertension</div><div class=\"cntnt\"><img style=\"width:486px; height:238px;\" src=\"images/NEPH/52231_BenefitofRxofmildHTN.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Reduced incidence of fatal and total coronary heart disease (CHD) events and strokes following antihypertensive therapy in 17 controlled studies involving almost 48,000 patients with mild to moderate hypertension. The number of patients having each of these events is depicted, with active treatment lowering the incidence of coronary events by 16 percent and stroke by 40 percent. However, the absolute benefit (as shown, in percent, by the numbers at the top of the graph) was much less. Treatment for approximately&nbsp;four to&nbsp;five years prevented a coronary event or a stroke in 2 percent of patients (0.7 + 1.3), including prevention of death in 0.8 percent.</div><div class=\"graphic_footnotes\">CVA: cerebrovascular accident (stroke).</div><div class=\"graphic_reference\">Data from: Hebert PR, Moser M, Mayer J, et al. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med 1993; 153:578.</div><div id=\"graphicVersion\">Graphic 52231 Version 8.0</div></div></div>"},"52232":{"type":"graphic_figure","displayName":"Dix-Hallpike maneuver","title":"Dix-Hallpike maneuver","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Dix-Hallpike maneuver</div><div class=\"cntnt\"><img style=\"width:360px; height:518px;\" src=\"images/NEURO/52232_Dix_hallpike_maneuver.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">With the patient sitting, the neck is extended and turned to one side. The patient is then placed supine rapidly, so that the head hangs over the edge of the bed. The patient is kept in this position and observed for nystagmus for 30 seconds. In patients with benign paroxysmal positional vertigo, nystagmus usually appears with a latency of a few seconds and lasts less than 30 seconds. It has a typical trajectory, beating upward and torsionally, with the upper poles of the eyes beating toward the ground. After it stops and the patient sits up, the nystagmus will recur but in the opposite direction. Therefore, the patient is returned to upright and again observed for nystagmus for 30 seconds. If nystagmus is not provoked, the maneuver is repeated with the head turned to the other side. If nystagmus is provoked, the patient should have the maneuver repeated to the same (provoked) side; with each repetition, the intensity and duration of nystagmus will diminish.</div><div id=\"graphicVersion\">Graphic 52232 Version 6.0</div></div></div>"},"52233":{"type":"graphic_table","displayName":"Template for dictation of placental findings","title":"Placental worksheet - template for dictation","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Placental worksheet - template for dictation</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1_single\">Sample pathologist's dictation for&nbsp;the pathology report of a&nbsp;singleton placenta:</td> </tr> <tr> <td class=\"indent1\">The specimen was received fresh labeled with the patient's name and unit number and consists of a singleton placenta.</td> </tr> <tr> <td class=\"indent1\">Cord insertion _____________ cm from margin (or _______ cm in membranes from margin)</td> </tr> <tr> <td class=\"indent1\">Cord length ___________ cm, cord diameter ____________ cm, number of coils _______</td> </tr> <tr> <td class=\"indent1\">Number of vessels ________</td> </tr> <tr> <td class=\"indent1\">Other cord findings ___________ (torsion, abnormal color, nodules, masses, etc)</td> </tr> <tr> <td class=\"indent1\">Cord color __________ (white, yellow, green, brown, etc)</td> </tr> <tr> <td class=\"indent1\">Membranes inserted ___________ % (marginally, circummarginately, circumvallate)</td> </tr> <tr> <td class=\"indent1\">Membrane color ____________</td> </tr> <tr> <td class=\"indent1\">Other membrane findings _______________ (nodules, hemorrhage, membranous vessels, etc)</td> </tr> <tr> <td class=\"indent1\">The trimmed placental weight is ______________ grams</td> </tr> <tr> <td class=\"indent1\">Disk measurement _________ cm in greatest diameter&nbsp;and &nbsp;_________ cm thick</td> </tr> <tr> <td class=\"indent1\">Fetal surface findings _____________ (nodules, masses, chorionic vascular thromboses, etc)</td> </tr> <tr> <td class=\"indent1\">Maternal surface ______________ (complete, disrupted, masses, calcification, fibrin, hematomas, indentations, etc)</td> </tr> <tr> <td class=\"indent1\">Parenchyma _____________________ (normal = beefy, spongy, red; lesions = number, size, % of mass involved, location)</td> </tr> <tr> <td class=\"indent1\">Summary: Placenta _______________ grams, approximately _____ percentile for _____ weeks gestational age with ____________</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">Cassettes: <ul class=\"decimal_heading\"> <li>A1: Cord and membranes </li> <li>A2-4: Parenchyma (put lesions in last cassette, add more if needed) </li> </ul> </td> </tr> <tr> <td class=\"subtitle1_single\">Sample pathologist's dictation for&nbsp;the pathology report of a&nbsp;twin placenta:</td> </tr> <tr> <td class=\"indent1\">The specimen was received fresh labeled with the patient's name and unit number is a <strong>fused/separate</strong> twin placenta, <strong>oriented/not oriented</strong> to birth order by cord clamps. (If fused &ndash; the vascular equator divides the placenta mass _____ % to twin A and ______ % to twin B. There <strong>are/are not</strong> surface vascular anastomoses [review with staff and describe if anastomoses are present &ndash; A-A, V-V, A-V direction]. The dividing membrane is <strong>thin/thick</strong> and <strong>clear/cloudy</strong>.)</td> </tr> <tr> <td class=\"indent1\">If separate placentas, describe each separately using singleton template. If fused, use:</td> </tr> <tr> <td class=\"indent2\">Twin A:</td> </tr> <tr> <td class=\"indent3\">One cord clamp, _______ % of the fused disk mass</td> </tr> <tr> <td class=\"indent3\">Cord insertion _____________ cm from margin (or _______ cm in membranes from margin)</td> </tr> <tr> <td class=\"indent3\">Cord length ___________ cm, cord diameter ____________ cm,&nbsp;number of&nbsp;coils ____________</td> </tr> <tr> <td class=\"indent3\">Number of vessels ________</td> </tr> <tr> <td class=\"indent3\">Other cord findings ___________ (torsion, abnormal color, nodules, masses, etc)</td> </tr> <tr> <td class=\"indent3\">Cord color __________ (white, yellow, green, brown, etc)</td> </tr> <tr> <td class=\"indent3\">Membranes inserted ___________ % (marginally, circummarginately, circumvallate)</td> </tr> <tr> <td class=\"indent3\">Membrane color ____________</td> </tr> <tr> <td class=\"indent3\">Other membrane findings _______________ (nodules, hemorrhage, membranous vessels, etc)</td> </tr> <tr> <td class=\"indent3\">Fetal surface findings _____________ (nodules, masses, chorionic vascular thromboses, etc)</td> </tr> <tr> <td class=\"indent3\">Maternal surface ______________ (complete, disrupted, masses, calcification, fibrin, hematomas, indentations, etc)</td> </tr> <tr> <td class=\"indent3\">Parenchyma _____________________ (normal = beefy, spongy, red; lesions = number, size, % of mass involved, location)</td> </tr> <tr> <td class=\"indent2\">Twin B:</td> </tr> <tr> <td class=\"indent3\">Two cord clamps, ______ % of the fused disk mass</td> </tr> <tr> <td class=\"indent3\">Cord insertion _____________ cm from margin (or _______ cm in membranes from margin)</td> </tr> <tr> <td class=\"indent3\">Cord length ___________ cm, cord diameter ____________ cm,&nbsp;number of&nbsp;coils ____________</td> </tr> <tr> <td class=\"indent3\">Number of vessels ________</td> </tr> <tr> <td class=\"indent3\">Other cord findings ___________ (torsion, abnormal color, nodules, masses, etc)</td> </tr> <tr> <td class=\"indent3\">Cord color __________ (white, yellow, green, brown, etc)</td> </tr> <tr> <td class=\"indent3\">Membranes inserted ___________ % (marginally, circummarginately, circumvallate)</td> </tr> <tr> <td class=\"indent3\">Membrane color ____________</td> </tr> <tr> <td class=\"indent3\">Other membrane findings _______________ (nodules, hemorrhage, membranous vessels, etc)</td> </tr> <tr> <td class=\"indent3\">Fetal surface findings _____________ (nodules, masses, chorionic vascular thromboses, etc)</td> </tr> <tr> <td class=\"indent3\">Maternal surface ______________ (complete, disrupted, masses, calcification, fibrin, hematomas, indentations, etc)</td> </tr> <tr> <td class=\"indent3\">Parenchyma _____________________ (normal = beefy, spongy, red; lesions = number, size, % of mass involved, location)</td> </tr> <tr> <td class=\"indent2\">Disk:</td> </tr> <tr> <td class=\"indent3\">The trimmed fused placental weight is ______________ grams</td> </tr> <tr> <td class=\"indent3\">Disk measurement _________ cm in greatest diameter&nbsp;and &nbsp;_________ cm thick</td> </tr> <tr> <td class=\"indent1\">Gross summary: Fused/separate twin placentas _______________ grams, approximately _____ percentile for _____ weeks gestational age with ______________</td> </tr> <tr> <td class=\"indent1\">Cassette key: <ul class=\"decimal_heading\"> <li>A1: Cord and membranes twin A </li> <li>A2-4: Parenchyma twin A </li> <li>A5: Cord and membranes twin B </li> <li>A6-8: Parenchyma twin B </li> <li>A9: Dividing membrane (if present) </li> </ul> </td> </tr> </tbody></table></div><div id=\"graphicVersion\">Graphic 52233 Version 4.0</div></div></div>"},"52234":{"type":"graphic_diagnosticimage","displayName":"US U funnel cervix","title":"Ultrasound U funnel cervix","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Ultrasound U funnel cervix</div><div class=\"cntnt\"><img style=\"width:450px; height:388px;\" src=\"images/OBGYN/52234_USUfunnelcervix.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">\"U\"-shaped cervix with membranes seen extending to the cerclage. Calipers measure the cervical length. Nearly completely effaced cervix, with \"U\"-shaped funnel. </div><div class=\"graphic_reference\">Courtesy of Jeffrey R Johnson, MD.</div><div id=\"graphicVersion\">Graphic 52234 Version 5.0</div></div></div>"},"52235":{"type":"graphic_table","displayName":"Symptoms of brain tumors","title":"Neurologic presentation of brain tumors","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Neurologic presentation of brain tumors</div><div class=\"cntnt\"><table cellspacing=\"0\">\n<tbody>\n\n<tr>\n<td class=\"subtitle1\">Generalized </td>\n<td class=\"subtitle1\">Focal</td>\n</tr>\n<tr><td class=\"indent1\">Headaches</td><td class=\"indent1\">Seizures</td></tr>\n<tr>\n<td class=\"indent1\">Seizures</td>\n<td class=\"indent1\">Weakness</td>\n</tr>\n<tr>\n<td class=\"indent1\">Nausea/vomiting</td>\n<td class=\"indent1\">Sensory loss</td>\n</tr>\n<tr>\n<td class=\"indent1\">Depressed level of consciousness</td>\n<td class=\"indent1\">Aphasia</td>\n</tr>\n<tr>\n<td class=\"indent1\">Neurocognitive dysfunction</td>\n<td class=\"indent1\">Visual spatial dysfunction</td>\n</tr>\n</tbody>\n</table></div><div id=\"graphicVersion\">Graphic 52235 Version 1.0</div></div></div>"},"52237":{"type":"graphic_figure","displayName":"Hot liquid balloon ablation","title":"Hot liquid balloon endometrial ablation ","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Hot liquid balloon endometrial ablation </div><div class=\"cntnt\"><img style=\"width:413px; height:248px;\" src=\"images/OBGYN/52237_Gynecare_thermachoice_syste.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Thermachoice system</div><div id=\"graphicVersion\">Graphic 52237 Version 4.0</div></div></div>"},"52239":{"type":"graphic_figure","displayName":"Compression bandage placement","title":"Compression bandage placement","html":"<div class=\"graphic\"><div style=\"width: 534px\" class=\"figure\"><div class=\"ttl\">Compression bandage placement</div><div class=\"cntnt\"><img style=\"width:514px; height:677px;\" src=\"images/SURG/52239_Compression-bandage-placement.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Shown is a basic example of the application of a compression bandage for the treatment of chronic venous insufficiency. The bandage is applied from the toes to the tibial tuberosity, moving from distal to proximal in an overlapping manner. Care is taken to avoid bunching or wrinkling of the dressing during application which can cause localized pressure. Multilayer compression bandages have two to four layers including a layer of soft padding and at least one elastic layer; each layer is applied in a similar manner.</div><div id=\"graphicVersion\">Graphic 52239 Version 3.0</div></div></div>"},"52240":{"type":"graphic_figure","displayName":"Location of transobturator midurethral sling","title":"Transobturator midurethral sling","html":"<div class=\"graphic\"><div style=\"width: 474px\" class=\"figure\"><div class=\"ttl\">Transobturator midurethral sling</div><div class=\"cntnt\"><img style=\"width:454px; height:350px;\" src=\"images/OBGYN/52240_Loc_transobtur_mid_sling.jpg\" alt=\"Image\"/></div><div id=\"graphicVersion\">Graphic 52240 Version 2.0</div></div></div>"},"52242":{"type":"graphic_table","displayName":"Toxic cyanide doses","title":"Toxic cyanide doses","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Toxic cyanide doses</div><div class=\"cntnt\"><table cellspacing=\"0\">\r\n<tbody>\r\n<tr>\r\n<td class=\"subtitle1\">Route of Exposure</td>\r\n<td class=\"subtitle1\">Toxic Dose</td>\r\n</tr>\r\n<tr>\r\n<td colspan=\"1\" rowspan=\"2\">Inhalation</td>\r\n<td>100 ppm x 30 min</td>\r\n</tr>\r\n<tr>\r\n<td>300 ppm x 5 min</td>\r\n</tr>\r\n<tr>\r\n<td colspan=\"1\" rowspan=\"2\">Oral</td>\r\n<td>50 mg (HCN)</td>\r\n</tr>\r\n<tr>\r\n<td>200 mg (KCN)</td>\r\n</tr>\r\n<tr>\r\n<td>Dermal</td>\r\n<td>100 mg/kg</td>\r\n</tr>\r\n<tr>\r\n<td>Intravenous</td>\r\n<td>5-10 &#181;g/ kg/ min x 3-10 hrs</td>\r\n</tr>\r\n\r\n</tbody>\r\n</table></div><div id=\"graphicVersion\">Graphic 52242 Version 2.0</div></div></div>"},"52243":{"type":"graphic_figure","displayName":"Effect activat mutation RET","title":"RET receptor tyrosine kinase: Effect of activating mutations","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">RET receptor tyrosine kinase: Effect of activating mutations</div><div class=\"cntnt\"><img style=\"width:429px; height:313px;\" src=\"images/ENDO/52243_Effect_activat_mutation_RET.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">(A) Effect of Cys634Arg mutation (MEN2A).<br />(B) Effect of Met918Thr mutation (MEN2B).</div><div class=\"graphic_footnotes\">GFRa: co-receptor glial cell line-derived neurotrophic factor-receptor family-a; TK-1: tyrosine kinase domain 1; TK-2: tyrosine kinase domain 2; MEN2A: multiple endocrine neoplasia type 2A; MEN2B: multiple endocrine neoplasia type 2B.</div><div id=\"graphicVersion\">Graphic 52243 Version 3.0</div></div></div>"},"52246":{"type":"graphic_figure","displayName":"Time course lacunar stroke","title":"Time course of lacunar infarction","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Time course of lacunar infarction</div><div class=\"cntnt\"><img style=\"width:393px; height:311px;\" src=\"images/NEURO/52246_Time_course_lacunar_stroke.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Penetrating artery occlusions usually cause symptoms that develop over a short period of time, hours or at most a few days, compared to large artery-related brain ischemia which can evolve over a longer period. A stuttering course may ensue, as with large artery thrombosis. This patient had a pure motor hemiparesis.</div><div id=\"graphicVersion\">Graphic 52246 Version 1.0</div></div></div>"},"52247":{"type":"graphic_figure","displayName":"Occiput transverse position","title":"Occiput transverse positions","html":"<div class=\"graphic\"><div style=\"width: 551px\" class=\"figure\"><div class=\"ttl\">Occiput transverse positions</div><div class=\"cntnt\"><img style=\"width:531px; height:189px;\" src=\"images/OBGYN/52247_Occiput_transverse_position.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">(A) Right occiput transverse (ROT).<br />(B) Left occiput transverse (LOT).</div><div id=\"graphicVersion\">Graphic 52247 Version 3.0</div></div></div>"},"52248":{"type":"graphic_diagnosticimage","displayName":"Necrotic hepatic met melanoma","title":"Necrotic metastases from melanoma","html":"<div class=\"graphic\"><div style=\"width: 471px\" class=\"figure\"><div class=\"ttl\">Necrotic metastases from melanoma</div><div class=\"cntnt\"><img style=\"width:451px; height:327px;\" src=\"images/ONC/52248_Necrotic_hepatic_met_melano.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Large hepatic metastasis with central necrosis in a patient with metastatic melanoma.</div><div class=\"graphic_reference\">Courtesy of Kevin Donohoe, MD.</div><div id=\"graphicVersion\">Graphic 52248 Version 2.0</div></div></div>"},"52249":{"type":"graphic_figure","displayName":"Sentinel node concept","title":"Sentinel node concept","html":"<div class=\"graphic\"><div style=\"width: 505px\" class=\"figure\"><div class=\"ttl\">Sentinel node concept</div><div class=\"cntnt\"><img style=\"width:485px; height:474px;\" src=\"images/ONC/52249_Sentinel_node_concept.gif\" alt=\"Image\"/></div><div class=\"graphic_reference\">Courtesy of Michael Stone, MD.</div><div id=\"graphicVersion\">Graphic 52249 Version 1.0</div></div></div>"},"52250":{"type":"graphic_table","displayName":"DDx horizontal gaze palsy","title":"Localization of lesions causing horizontal gaze palsy","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Localization of lesions causing horizontal gaze palsy</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1_single\">Frontal lobe lesions</td> </tr> <tr> <td>Defect in generating voluntary saccades</td> </tr> <tr> <td>Transient ipsilateral horizontal gaze deviation acutely</td> </tr> <tr> <td>Gaze palsy overcome with the oculocephalic (doll's eye) maneuver or caloric stimulation</td> </tr> <tr> <td class=\"subtitle1_single\">Epileptogenic lesions in the frontal eye fields</td> </tr> <tr> <td>Transient deviation of the eyes and head to the contralateral side</td> </tr> <tr> <td>Head and eye movements toward the same side during a seizure</td> </tr> <tr> <td class=\"subtitle1_single\">Unilateral parietal lesions</td> </tr> <tr> <td>Unilateral or bilateral increased saccade latencies</td> </tr> <tr> <td>Hypometria (shortened range) for contralateral saccades</td> </tr> <tr> <td>Saccadic slowing</td> </tr> <tr> <td class=\"subtitle1_single\">Bilateral parietal lesions</td> </tr> <tr> <td>Acquired ocular motor apraxia (inability to generate voluntary movements)</td> </tr> <tr> <td class=\"subtitle1_single\">Lesions in the corona radiata adjacent to the genu of the internal capsule</td> </tr> <tr> <td>Contralateral selective saccadic palsy</td> </tr> <tr> <td class=\"subtitle1_single\">Hemorrhages deep in a cerebral hemisphere, particularly the thalamus</td> </tr> <tr> <td>Eye deviation to the side of the hemiparesis (\"wrong-way eyes\")</td> </tr> <tr> <td class=\"subtitle1_single\">Mesencephalic lesions</td> </tr> <tr> <td>Paresis of contralateral saccades</td> </tr> <tr> <td>Supranuclear contralateral gaze palsies associated with ipsilateral oculomotor palsies</td> </tr> <tr> <td class=\"subtitle1_single\">Pontine lesions affecting the abducens nucleus and/or the PPRF</td> </tr> <tr> <td>Ipsilateral conjugate gaze palsy</td> </tr> <tr> <td>Doll's eye maneuver or cold caloric stimulation usually does not overcome gaze palsy</td> </tr> <tr> <td>Bilateral horizontal gaze palsies with bilateral lesions</td> </tr> </tbody></table></div><div class=\"graphic_reference\">Modified with permission from: Lee AG, Brazis PW. Clinical Pathways in Neuro-ophthalmology: An Evidence-based Approach, Thieme, New York 1998.</div><div id=\"graphicVersion\">Graphic 52250 Version 3.0</div></div></div>"},"52251":{"type":"graphic_picture","displayName":"Erythema infectiosum facial eruption","title":"Erythema infectiosum","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Erythema infectiosum</div><div class=\"cntnt\"><img style=\"width:378px; height:504px;\" src=\"images/DERM/52251_Eryt_infectiosum_fac_erupt.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Redness appears acutely on one or both cheeks (\"slapped cheek\" appearance). The redness may be reticulated.</div><div class=\"graphic_reference\">Reproduced with permission from: <a href=\"http://www.visualdx.com/\" target=\"_blank\">www.visualdx.com</a>. Copyright Logical Images, Inc.</div><div id=\"graphicVersion\">Graphic 52251 Version 5.0</div></div></div>"},"52252":{"type":"graphic_figure","displayName":"Esophageal foreign body sites","title":"Esophageal foreign body sites","html":"<div class=\"graphic\"><div style=\"width: 535px\" class=\"figure\"><div class=\"ttl\">Esophageal foreign body sites</div><div class=\"cntnt\"><img style=\"width:515px; height:305px;\" src=\"images/EM/52252_EsophagealFBsites.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Common sites of esophageal impaction of smooth foreign bodies.</div><div class=\"graphic_reference\">Reproduced with permission from: Schunk JE, Dudley NC. Management of esophageal foreign bodies. In: Textbook of Pediatric Emergency Procedures, 2nd ed, King C, Henretig FM (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2008. Copyright Â© 2008 Lippincott Williams &amp; Wilkins. <A href=\"http://www.lww.com/\" target=_blank>www.lww.com</A>.</div><div id=\"graphicVersion\">Graphic 52252 Version 10.0</div></div></div>"},"52253":{"type":"graphic_picture","displayName":"Larynx","title":"GlidescopeÂ® images of laryngeal inlet and inner larynx ","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Glidescope&#174; images of laryngeal inlet and inner larynx </div><div class=\"cntnt\"><img style=\"width:289px; height:412px;\" src=\"images/EM/52253_Vera_glidescope_larynx.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">These images clearly show how the epiglottis juts out, covering the inner laryngeal structures. During laryngoscopy, the epiglottis often casts a shadow over the inner larynx. The curvilinear structure on the right side of bottom image is the pharyngoepiglottic fold. The true vocal cord is marked with asterisks (**). The aryepiglottic fold in the bottom image is marked with plus signs (++).</div><div class=\"graphic_reference\">Reproduced with permission from: Levitan, RM, Kinkle, WC. Chapter 2, Laryngeal anatomy. In: Airway Cam Pocket Guide to Intubation, 2nd ed, Airway Cam Technologies, Wayne, PA 2007. Copyright &#169;2007 Airway Cam Technologies, Inc.</div><div id=\"graphicVersion\">Graphic 52253 Version 3.0</div></div></div>"},"52254":{"type":"graphic_picture","displayName":"Bleeding diverticulum endosc","title":"Blood vessel within a colonic diverticulum","html":"<div class=\"graphic normal\"><div style=\"width: 487px\" class=\"figure\"><div class=\"ttl\">Blood vessel within a colonic diverticulum</div><div class=\"cntnt\"><img style=\"width:467px; height:210px;\" src=\"images/GAST/52254_Bleeding_diverticulum_Endos.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Endoscopy showing a blood vessel within a diverticulum. The blood vessel is separated from the bowel lumen only by mucosa. Over time, the vessel wall is exposed to injury along its luminal aspect, possibly leading to segmental weakness which predisposes to rupture into the lumen.</div><div class=\"graphic_reference\">Courtesy of James B McGee, MD.</div><div id=\"graphicVersion\">Graphic 52254 Version 3.0</div></div><div style=\"width: 450px\" class=\"figure\"><div class=\"ttl\">Normal sigmoid colon</div><div class=\"cntnt\"><img style=\"width:216px; height:216px;\" src=\"images/GAST/55563_Normal_sigmoid_colon_Endosc.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Endoscopic appearance of the normal sigmoid colonic mucosa. The fine vasculature is easily visible, and the surface is shiny and smooth. The folds are of normal thickness.</div><div class=\"graphic_reference\">Courtesy of James B McGee, MD.</div><div id=\"graphicVersion\">Graphic 55563 Version 1.0</div></div></div>"},"52257":{"type":"graphic_picture","displayName":"Bullous eruption in skin mastocytosis","title":"Bullous eruption in skin mastocytosis","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Bullous eruption in skin mastocytosis</div><div class=\"cntnt\"><img style=\"width:256px; height:397px;\" src=\"images/RHEUM/52257_Bullous_eruption_in_SM.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Bullous eruption in a child with diffuse cutaneous mastocytosis.</div><div class=\"graphic_reference\">Reproduced with permission from: Soter AN. J Invest Derm 1991; 96:S32. Copyright Â© 1991 Blackwell Science. <A spellcheck=true href=\"http://www.wiley.com/wiley-blackwell\" target=_blank>http://www.blackwell-science.com</A>.</div><div id=\"graphicVersion\">Graphic 52257 Version 4.0</div></div></div>"},"52258":{"type":"graphic_figure","displayName":"Colonoscopy PI","title":"Colonoscopy","html":"<div class=\"graphic\"><div style=\"width: 519px\" class=\"figure\"><div class=\"ttl\">Colonoscopy</div><div class=\"cntnt\"><img style=\"width:499px; height:568px;\" src=\"images/PI/52258_Colonoscopy_PI_edt.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">During a colonoscopy, you lie on your side and the doctor or nurse puts a thin tube with a camera into your anus (from behind). Then the doctor or nurse advances the tube into the rectum and colon. The camera sends pictures from inside your colon to a television screen.</div><div id=\"graphicVersion\">Graphic 52258 Version 5.0</div></div></div>"},"52259":{"type":"graphic_algorithm","displayName":"P wave before QRS II","title":"P wave in front of each QRS complex: P wave and QRS related","html":"<div class=\"graphic\"><div style=\"width: 554px\" class=\"figure\"><div class=\"ttl\">P wave in front of each QRS complex: P wave and QRS related</div><div class=\"cntnt\"><img style=\"width:534px; height:228px;\" src=\"images/CARD/52259_P_wave_before_QRS_II.gif\" alt=\"Image\"/></div><div class=\"graphic_footnotes\">* P wave morphology and PR interval variable.</div><div id=\"graphicVersion\">Graphic 52259 Version 2.0</div></div></div>"},"52260":{"type":"graphic_figure","displayName":"Segmental anatomy of the liver","title":"Segmental anatomy of the liver","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Segmental anatomy of the liver</div><div class=\"cntnt\"><img style=\"width:448px; height:368px;\" src=\"images/GAST/52260_Segmental_liver_anat_edt.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Couinaud's segmental anatomy of the liver. Segments II to IV make up the left lobe and segments V to VIII constitute the right lobe.</div><div class=\"graphic_reference\">Reproduced with permission from: Mulholland MW, Lillemoe KD. Greenfield's Surgery: Scientific Principles And Practice, Fourth Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 2006. Copyright &#169; 2006 Lippincott Williams &amp; Wilkins.</div><div id=\"graphicVersion\">Graphic 52260 Version 4.0</div></div></div>"},"52261":{"type":"graphic_picture","displayName":"Pachyonychia congenita - nails","title":"Pachyonychia congenita","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Pachyonychia congenita</div><div class=\"cntnt\"><img style=\"width:432px; height:324px;\" src=\"images/DERM/52261_Pachyony_congenita_nails.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Thickened discolored nails are present in this patient with pachyonychia congenita.</div><div class=\"graphic_reference\">Reproduced with permission from: <A style=\"FONT-STYLE: italic\" href=\"http://www.visualdx.com/\" target=_blank>www.visualdx.com</A>. Copyright Logical Images, Inc.</div><div id=\"graphicVersion\">Graphic 52261 Version 3.0</div></div></div>"},"52262":{"type":"graphic_picture","displayName":"Livedoid vasculopathy - close view","title":"Livedoid vasculopathy","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Livedoid vasculopathy</div><div class=\"cntnt\"><img style=\"width:432px; height:324px;\" src=\"images/DERM/52262_Livedoid_vascu_close_view.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Punched-out ulcers and atrophic white scars on the lower legs are common features of livedoid vasculopathy.</div><div class=\"graphic_reference\">Reproduced with permission from: <A style=\"FONT-STYLE: italic\" href=\"http://www.visualdx.com/\" target=_blank>www.visualdx.com</A>. Copyright Logical Images, Inc.</div><div id=\"graphicVersion\">Graphic 52262 Version 4.0</div></div></div>"},"52265":{"type":"graphic_table","displayName":"Types of vacuum delivery cups","title":"Types of vacuum delivery suction-cup devices","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Types of vacuum delivery suction-cup devices</div><div class=\"cntnt\"><table  cellspacing=\"0\">\r\n \r\n   <tr>\r\n  \r\n   <td  class=\"subtitle1\">\r\n  \r\n   Name\r\n  \r\n   </td>\r\n  \r\n   <td  class=\"subtitle1\">\r\n  \r\n   Size\r\n  \r\n   </td>\r\n  \r\n   <td  class=\"subtitle1\">\r\n  \r\n   Material\r\n  \r\n   </td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"subtitle2_left\" colspan=\"3\">\r\n  \r\n   Soft cups (silicone or plastic)\r\n  \r\n   </td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"indent1\">\r\n  \r\n   Gentle Vac Bell\r\n  \r\n   </td>\r\n  \r\n   <td>60 mm</td>\r\n  \r\n   <td>Soft rubber</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"indent1\">\r\n  \r\n   Kiwi ProCup Bell\r\n  \r\n   </td>\r\n  \r\n   <td>65 mm</td>\r\n  \r\n   <td>Soft plastic</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"indent1\">\r\n  \r\n   Mityvac Bell\r\n  \r\n   </td>\r\n  \r\n   <td>60 mm</td>\r\n  \r\n   <td>Soft silicone</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"indent1\">\r\n  \r\n   Secure Cup Mushroom/Discoid\r\n  \r\n   </td>\r\n  \r\n   <td>63 mm</td>\r\n  \r\n   <td>Rubber</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"indent1\">\r\n  \r\n   Silc Cup\r\n  \r\n   </td>\r\n  \r\n   <td>50-60 mm</td>\r\n  \r\n   <td>Silicone rubber</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"indent1\">\r\n  \r\n   Soft Touch Bell\r\n  \r\n   </td>\r\n  \r\n   <td>60 mm</td>\r\n  \r\n   <td>Soft polyethylene</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"indent1\">\r\n  \r\n   Tender Touch Bell\r\n  \r\n   </td>\r\n  \r\n   <td>60 mm</td>\r\n  \r\n   <td>Soft silicone</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"indent1\">\r\n  \r\n   Vac-U-Nate\r\n  \r\n   </td>\r\n  \r\n   <td>65 mm</td>\r\n  \r\n   <td>Soft silicone</td>\r\n  \r\n   </tr>\r\n\r\n   <tr>\r\n  \r\n   <td  class=\"indent1\">Velvet Touch Bell</td>\r\n  \r\n   <td>65 mm</td>\r\n  \r\n   <td>Soft silicone</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"subtitle2_left\" colspan=\"3\">\r\n  \r\n   Rigid cups for occiput anterior position. All of the following cups are mushroom style.\r\n  \r\n   </td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"indent1\">\r\n  \r\n   Flex Cup\r\n  \r\n   </td>\r\n  \r\n   <td>60 mm</td>\r\n  \r\n   <td>Polyurethane</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"indent1\">\r\n  \r\n   Kiwi OmniCup\r\n  \r\n   </td>\r\n  \r\n   <td>50 mm</td>\r\n  \r\n   <td>Rigid plastic</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"indent1\">\r\n  \r\n   Malmstr&#246;m\r\n  \r\n   </td>\r\n  \r\n   <td>40-60 mm</td>\r\n  \r\n   <td>Metal</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"indent1\">\r\n  \r\n   Mityvac \"M\" Style\r\n  \r\n   </td>\r\n  \r\n   <td>50 mm</td>\r\n  \r\n   <td>Rigid polyethylene</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"subtitle2_left\" colspan=\"3\">\r\n  \r\n   Rigid cups for occiput posterior position. All of the following cups are mushroom style.\r\n  \r\n   </td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"indent1\">\r\n  \r\n   Bird Posterior Cup\r\n  \r\n   </td>\r\n  \r\n   <td>40-60 mm</td>\r\n  \r\n   <td>Metal</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"indent1\">\r\n  \r\n   Kiwi OmniCup\r\n  \r\n   </td>\r\n  \r\n   <td>50 mm</td>\r\n  \r\n   <td>Rigid plastic</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"indent1\">\r\n  \r\n   Mityvac \"M\" Select\r\n  \r\n   </td>\r\n  \r\n   <td>50 mm</td>\r\n  \r\n   <td>Rigid polyethylene</td>\r\n  \r\n   </tr>\r\n </table></div><div id=\"graphicVersion\">Graphic 52265 Version 1.0</div></div></div>"},"52268":{"type":"graphic_figure","displayName":"Mechanisms of commotio cordis","title":"Mechanisms of commotio cordis","html":"<div class=\"graphic\"><div style=\"width: 603px\" class=\"figure\"><div class=\"ttl\">Mechanisms of commotio cordis</div><div class=\"cntnt\"><img style=\"width:583px; height:363px;\" src=\"images/CARD/52268_Mechcommotiocordis.jpg\" alt=\"Image\"/></div><div class=\"graphic_reference\">From: Link MS, Estes NA. Athletes and arrhythmis. J Cardiovasc Electrophysiol 2010; 21:1184. Copyright Â© 2010. Reproduced with permission of John Wiley &amp; Sons, Inc.</div><div id=\"graphicVersion\">Graphic 52268 Version 2.0</div></div></div>"},"52270":{"type":"graphic_picture","displayName":"ANLL FAB M2 Auer rod","title":"Acute myeloid leukemia (AML FAB M2)","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Acute myeloid leukemia (AML FAB M2)</div><div class=\"cntnt\"><img style=\"width:422px; height:288px;\" src=\"images/HEME/52270_ANLL_FAB_M2_Auer_rod.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">High power (1000x) view of a bone marrow aspirate from a patient with AML of the M2 variant. At this magnification, the multiple nucleoli and cytoplasmic granules can be seen, along with an Auer rod (arrow). (Wright-Giemsa).</div><div class=\"graphic_reference\">Courtesy of David S Rosenthal, MD.</div><div id=\"graphicVersion\">Graphic 52270 Version 1.0</div></div></div>"},"52272":{"type":"graphic_table","displayName":"ATA risk stratification system","title":"ATA risk stratification system to estimate risk of persistent/recurrent disease","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">ATA risk stratification system to estimate risk of persistent/recurrent disease</div><div class=\"cntnt\"><table class=\"container\" cellspacing=\"0\"><tbody> <tr> <td class=\"container\"> <table cellspacing=\"0\"> <tbody> <tr> <td class=\"subtitle1_single\">Low risk</td> </tr> <tr> <td class=\"subtitle2_single\">Papillary thyroid cancer with all of the following present:</td> </tr> <tr> <td class=\"indent1\"> <ul> <li>No local or distant metastases </li> </ul> </td> </tr> <tr> <td class=\"indent1\"> <ul> <li>All macroscopic tumor has been resected </li> </ul> </td> </tr> <tr> <td class=\"indent1\"> <ul> <li>No invasion of locoregional tissues </li> </ul> </td> </tr> <tr> <td class=\"indent1\"> <ul> <li>Tumor does not have aggressive histology (aggressive histologies include&nbsp;tall cell, insular, columnar cell carcinoma, H&#252;rthle cell carcinoma, follicular thyroid cancer, hobnail variant) </li> </ul> </td> </tr> <tr> <td class=\"indent1\"> <ul> <li>No vascular invasion </li> </ul> </td> </tr> <tr> <td class=\"indent1\"> <ul> <li>No <sup>131</sup>I uptake outside the thyroid bed on the post-treatment scan, if done </li> </ul> </td> </tr> <tr> <td class=\"indent1\"> <ul> <li>Clinical N0 or &#8804;5 pathologic N1 micrometastases (&#60;0.2 cm in largest dimension)* </li> </ul> </td> </tr> <tr> <td class=\"subtitle2_single\"><span class=\"subtitle2_left\"></span><span class=\"subtitle2_single\"></span>Intrathyroidal, encapsulated follicular variant of papillary thyroid cancer*</td> </tr> <tr> <td class=\"subtitle2_single\">Intrathyroidal, well-differentiated follicular thyroid cancer with capsular invasion and no or minimal (&#60;4 foci) vascular invasion*</td> </tr> <tr> <td class=\"subtitle2_single\">Intrathyroidal, papillary microcarcinoma, unifocal or multifocal, including <em>BRAF </em>V600E&nbsp;mutated (if known)*</td> </tr> </tbody> </table> </td> <td class=\"container\"> <table cellspacing=\"0\"> <tbody> <tr> <td class=\"subtitle1_single\">Intermediate risk</td> </tr> <tr> <td class=\"subtitle2_single\">Any of the following present:</td> </tr> <tr> <td class=\"indent1\">Microscopic invasion into the perithyroidal soft tissues</td> </tr> <tr> <td class=\"indent1\">Cervical lymph node metastases or <sup>131</sup>I avid metastatic foci in the neck on the post-treatment scan done after thyroid remnant ablation</td> </tr> <tr> <td class=\"indent1\">Tumor with aggressive histology or vascular invasion (aggressive histologies include&nbsp;tall cell, insular, columnar cell carcinoma, H&#252;rthle cell carcinoma, follicular thyroid cancer, hobnail variant)</td> </tr> <tr> <td class=\"indent1\">Clinical N1 or &#62;5 pathologic N1 with all involved lymph nodes &#60;3 cm in largest dimension*</td> </tr> <tr> <td class=\"indent1\">Multifocal papillary thyroid microcarcinoma with extrathyroidal extension and <em>BRAF </em>V600E mutated (if known)*</td> </tr> </tbody> </table> </td> <td class=\"container\"> <table cellspacing=\"0\"> <tbody> <tr> <td class=\"subtitle1_single\">High risk</td> </tr> <tr> <td class=\"subtitle2_single\">Any of the following present:</td> </tr> <tr> <td class=\"indent1\">Macroscopic tumor invasion</td> </tr> <tr> <td class=\"indent1\">Incomplete tumor resection with gross residual disease</td> </tr> <tr> <td class=\"indent1\">Distant metastases</td> </tr> <tr> <td class=\"indent1\">Postoperative serum thyroglobulin suggestive of distant metastases</td> </tr> <tr> <td class=\"indent1\">Pathologic N1 with any metastatic lymph node &#8805;3 cm in largest dimension*</td> </tr> <tr> <td class=\"indent1\">Follicular thyroid cancer with extensive vascular invasion (&#62;4 foci of vascular invasion)*</td> </tr> </tbody> </table> </td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">ATA: American Thyroid Association;<SUP innerHtml> 131</SUP>I: iodine-131.<br />* Proposed modifications, not present in the original 2009 initial risk stratification system.</div><div class=\"graphic_reference\">Reproduced with permission from: Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016; 26:1. Copyright Â© 2016 Mary Ann Liebert, Inc.</div><div id=\"graphicVersion\">Graphic 52272 Version 8.0</div></div></div>"},"52273":{"type":"graphic_figure","displayName":"Microvascular endpoint and control","title":"Intensive glycemic control prevents microvascular disease in patients with type 2 diabetes","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Intensive glycemic control prevents microvascular disease in patients with type 2 diabetes</div><div class=\"cntnt\"><img style=\"width:448px; height:290px;\" src=\"images/ENDO/52273_Microvasc_endpoint_and_cont.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Kaplan-Meier plots of aggregate endpoints of microvascular disease in patients with type 2 diabetes mellitus in the United Kingdom Prospective Diabetes Study who were randomly assigned to receive either intensive therapy with a sulfonylurea or insulin or to conventional treatment with diet; drugs were added if the patients had hyperglycemic symptoms or fasting blood glucose concentrations greater than 270 mg/dL (15 mmol/L). Intensive therapy was associated with a 25 percent reduction (p = 0.01) in the development of microvascular disease, which was defined as renal failure, death from renal failure, retinal photocoagulation, or vitreous hemorrhage.</div><div class=\"graphic_reference\">Data from: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352:837.</div><div id=\"graphicVersion\">Graphic 52273 Version 3.0</div></div></div>"},"52275":{"type":"graphic_picture","displayName":"Gastrointestinal stromal tumor CPC Endosc","title":"Gastrointestinal stromal tumor (GIST)","html":"<div class=\"graphic\"><div style=\"width: 560px\" class=\"figure\"><div class=\"ttl\">Gastrointestinal stromal tumor (GIST)</div><div class=\"cntnt\"><img style=\"width:540px; height:243px;\" src=\"images/GAST/52275_GISTCPCEndosc.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Endoscopic view of an actively oozing 20 by 30 mm submucosal mass in the stomach body (left panel). Bleeding was controlled by injection of a 1:10,000 epinephrine solution and bipolar electrocautery (right panel).</div><div class=\"graphic_reference\">Courtesy of Kenneth Falchuk, MD and Andres Gelrud, MD.</div><div id=\"graphicVersion\">Graphic 52275 Version 3.0</div></div></div>"},"52276":{"type":"graphic_table","displayName":"Steroid compound dose equiv","title":"Dosing equivalents for common steroid compounds","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Dosing equivalents for common steroid compounds</div><div class=\"cntnt\"><table cellspacing=\"0\">\n<tbody>\n\n\t<tr>\n\t\t\t\t\t<td class=\"subtitle1\">Steroid compound</td>\n\t\t\t\t\t<td class=\"subtitle1\">Dose equivalent, mg</td>\n\t\t\t\t</tr>\n\t\t\t\t<tr>\n\t\t\t\t\t<td>Hydrocortisone</td>\n\t\t\t\t\t<td>20</td>\n\t\t\t\t</tr>\n\t\t\t\t<tr>\n\t\t\t\t\t<td>Prednisolone</td>\n\t\t\t\t\t<td>5</td>\n\t\t\t\t</tr>\n\t\t\t\t<tr>\n\t\t\t\t\t<td>Prednisone</td>\n\t\t\t\t\t<td>5</td>\n\t\t\t\t</tr>\n\t\t\t\t<tr>\n\t\t\t\t\t<td>Methylprednisolone</td>\n\t\t\t\t\t<td>4</td>\n\t\t\t\t</tr>\n\n</tbody>\n</table></div><div id=\"graphicVersion\">Graphic 52276 Version 1.0</div></div></div>"},"52278":{"type":"graphic_table","displayName":"Stillbirth evaluation","title":"Indications for special studies during perinatal autopsy","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Indications for special studies during perinatal autopsy</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1_single\">Hydrops fetalis and/or placentitis </td> </tr> <tr> <td>Viral cultures (fetus/placenta), request maternal screen</td> </tr> <tr> <td>Kleihaur-Betke</td> </tr> <tr> <td>Fetal blood smear if possible</td> </tr> <tr> <td>Fetal hematocrit if possible</td> </tr> <tr> <td>Freeze liver (at&nbsp;-20 or -80&nbsp;degrees Celsius) for possible metabolic studies</td> </tr> <tr> <td>Consider postmortem blood spot for standard neonatal screening</td> </tr> <tr> <td>Obtain tissue for karyotype</td> </tr> <tr> <td>Consider electron microscopy of liver for metabolic storage diseases</td> </tr> <tr> <td class=\"subtitle1_single\">Skeletal dysplasias (short limbs, any boney anomaly) </td> </tr> <tr> <td>Good radiographs</td> </tr> <tr> <td>Save fresh bone and skeletal muscle for biochemistry</td> </tr> <tr> <td>Obtain tissue for karyotype</td> </tr> <tr> <td> <p>Consider consultation with the UCLA International Skeletal Dysplasia Registry</p> <p><a href=\"http://ortho.ucla.edu/isdr\">http://ortho.ucla.edu/isdr</a></p> </td> </tr> </tbody></table></div><div id=\"graphicVersion\">Graphic 52278 Version 6.0</div></div></div>"},"52281":{"type":"graphic_diagnosticimage","displayName":"Round mammographic calcifications","title":"Round mammographic calcifications","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Round mammographic calcifications</div><div class=\"cntnt\"><img style=\"width:432px; height:324px;\" src=\"images/ONC/52281_Round_cals.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Magnified oblique mammogram showing scattered, well-defined, round calcifications that can be characterized as benign. These findings are benign and would be described as BIRADS-2.</div><div class=\"graphic_footnotes\">BIRADS: Breast Imaging Reporting and Data System.</div><div class=\"graphic_reference\">Courtesy of Lisa E Esserman, MD.</div><div id=\"graphicVersion\">Graphic 52281 Version 3.0</div></div></div>"},"52282":{"type":"graphic_table","displayName":"Ca P Mg needs PN infant","title":"Calcium, phosphorus, and magnesium requirements (mmol [mg/dL]) in infants who receive parenteral nutrition (PN)","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Calcium, phosphorus, and magnesium requirements (mmol [mg/dL]) in infants who receive parenteral nutrition (PN)</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup span=\"4\" width=\"25%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\">&nbsp;</td> <td class=\"subtitle1\">Term infants, usual short-term</td> <td class=\"subtitle1\">Premature infants, usual short-term</td> <td class=\"subtitle1\">All infants, long-term use</td> </tr> <tr> <td><strong>Calcium</strong></td> <td class=\"centered\">1.2 (48)</td> <td class=\"centered\">1.5 (60)</td> <td class=\"centered\">1.75 (70)</td> </tr> <tr> <td><strong>Phosphorus</strong></td> <td class=\"centered\">1.2 (37)</td> <td class=\"centered\">1.5 (47)</td> <td class=\"centered\">1.75 (54)</td> </tr> <tr> <td><strong>Magnesium</strong></td> <td class=\"centered\">0.21 (5)</td> <td class=\"centered\">0.25 (6)</td> <td class=\"centered\">0.25 (6)</td> </tr> </tbody></table></div><div class=\"graphic_lgnd\">Short-term: assumes PN with &ge;2.4 percent amino acids + cysteine.<br />Long-term: assumes PN with &gt;2.5 percent amino acids + cysteine.</div><div class=\"graphic_reference\">Adapted from:<br /><ol>&#xD;&#xA;    <li>Schanler RJ, Rifka M. Calcium, phosphorus, and magnesium needs for low birth weight infants. Acta Paediatr 1994; 83:111.</li>&#xD;&#xA;    <li>Greene HL, Hambidge KM, Schanler RJ, Tsang RC. Guidelines for the use of vitamins, trace elements, calcium, magnesium, and phosphorus in infants and children receiving total parenteral nutrition: report of the Subcommittee on Pediatric Parenteral Nutrient Requirements from the Committee on Clinical Practice Issues of The American Society for Clinical Nutrition. Am J Clin Nutr 1988; 48:1324.</li>&#xD;&#xA;    <li>Laine L, Shulman RJ, Pitre D, et al. Cysteine usage increases the need for acetate in neonates who receive total parenteral nutrition. Am J Clin Nutr 1991; 54:565.</li>&#xD;&#xA;</ol></div><div id=\"graphicVersion\">Graphic 52282 Version 3.0</div></div></div>"},"52283":{"type":"graphic_figure","displayName":"Cortisol production PI","title":"Normal cortisol production by the adrenal glands","html":"<div class=\"graphic\"><div style=\"width: 524px\" class=\"figure\"><div class=\"ttl\">Normal cortisol production by the adrenal glands</div><div class=\"cntnt\"><img style=\"width:504px; height:628px;\" src=\"images/PI/52283_Cortisol_production_PI.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Cortisol levels are normally regulated by the hypothalamus and pituitary gland. The hypothalamus sends corticotropin-releasing hormone (CRH) to the pituitary gland. The pituitary gland responds by producing several hormones, one of which is ACTH (corticotropin). ACTH stimulates the adrenal gland to produce cortisol. Cortisol levels help to control the pituitary's production of ACTH.</div><div id=\"graphicVersion\">Graphic 52283 Version 5.0</div></div></div>"},"52285":{"type":"graphic_table","displayName":"Cancer risk Lynch genotypes","title":"Lifetime cancer risk related to Lynch genotypes","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Lifetime cancer risk related to Lynch genotypes</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup width=\"20%\"></colgroup><colgroup span=\"8\" width=\"10%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\" rowspan=\"2\">Cancer site</td> <td class=\"subtitle1\" colspan=\"2\">MLH1</td> <td class=\"subtitle1\" colspan=\"2\">MSH2</td> <td class=\"subtitle1\" colspan=\"2\">MSH6</td> <td class=\"subtitle1\" colspan=\"2\">PMS2</td> </tr> <tr> <td class=\"subtitle2\">Men</td> <td class=\"subtitle2\">Women</td> <td class=\"subtitle2\">Men</td> <td class=\"subtitle2\">Women</td> <td class=\"subtitle2\">Men</td> <td class=\"subtitle2\">Women</td> <td class=\"subtitle2\">Men</td> <td class=\"subtitle2\">Women</td> </tr> <tr class=\"divider_bottom\"> <td><strong>Any Lynch cancer</strong></td> <td class=\"centered\"><strong>59%</strong></td> <td class=\"centered\"><strong>80%</strong></td> <td class=\"centered\"><strong>71%</strong></td> <td class=\"centered\"><strong>75%</strong></td> <td class=\"centered\"><strong>31%</strong></td> <td class=\"centered\"><strong>71%</strong></td> <td class=\"centered\"><strong>-</strong></td> <td class=\"centered\"><strong>-</strong></td> </tr> <tr class=\"divider_bottom\"> <td>Colorectal</td> <td class=\"centered\">34 to 47%</td> <td class=\"centered\">36 to 45%</td> <td class=\"centered\">37 to 47%</td> <td class=\"centered\">33 to 37%</td> <td class=\"centered\">14 to 22%</td> <td class=\"centered\">10 to 26%</td> <td class=\"centered\">19 to 20%</td> <td class=\"centered\">11 to 15%</td> </tr> <tr class=\"divider_bottom\"> <td>Endometrial</td> <td class=\"centered\">NA</td> <td class=\"centered\">18 to 54%</td> <td class=\"centered\">NA</td> <td class=\"centered\">21 to 51%</td> <td class=\"centered\">NA</td> <td class=\"centered\">16 to 49%</td> <td class=\"centered\">NA</td> <td class=\"centered\">12 to 24%</td> </tr> <tr class=\"divider_bottom\"> <td>Ovarian</td> <td class=\"centered\">NA</td> <td class=\"centered\">11 to 20%</td> <td class=\"centered\">NA</td> <td class=\"centered\">15%</td> <td class=\"centered\">NA</td> <td class=\"centered\">1%</td> <td class=\"centered\">NA</td> <td class=\"centered\">-</td> </tr> <tr class=\"divider_bottom\"> <td>Urinary tract</td> <td class=\"centered\">1.2%</td> <td class=\"centered\">3%</td> <td class=\"centered\">8%</td> <td class=\"centered\">10%</td> <td class=\"centered\" colspan=\"2\">0.7%</td> <td class=\"centered\" colspan=\"2\">-</td> </tr> <tr class=\"divider_bottom\"> <td>Gastric</td> <td class=\"centered\">20%</td> <td class=\"centered\">8%</td> <td class=\"centered\">2%</td> <td class=\"centered\">9%</td> <td class=\"centered\" colspan=\"2\">-</td> <td class=\"centered\" colspan=\"2\">-</td> </tr> <tr class=\"divider_bottom\"> <td>Small bowel</td> <td class=\"centered\" colspan=\"2\">0.4%*</td> <td class=\"centered\" colspan=\"2\">1.1%*</td> <td class=\"centered\" colspan=\"2\">-</td> <td class=\"centered\" colspan=\"2\">-</td> </tr> <tr class=\"divider_bottom\"> <td>Biliary/pancreatic</td> <td class=\"centered\" colspan=\"2\">1.9%*</td> <td class=\"centered\" colspan=\"2\">0.02%*</td> <td class=\"centered\" colspan=\"2\">-</td> <td class=\"centered\" colspan=\"2\">-</td> </tr> <tr> <td>Brain tumors (gliomas)</td> <td class=\"centered\" colspan=\"2\">1.7%*</td> <td class=\"centered\" colspan=\"2\">2.5%*</td> <td class=\"centered\" colspan=\"2\">-</td> <td class=\"centered\" colspan=\"2\">-</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">NA: not applicable.<br />* Not reported separately by sex.<br /></div><div class=\"graphic_reference\">Data from:&#xD;&#xA;<ol>&#xD;&#xA;    <li>Moller P, Seppala T, Bernstein I, et al. Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database. Gut 2017; 66:464.</li>&#xD;&#xA;    <li>Dowty JG, Win AK, Buchanan DD, et al. Cancer risks for MLH1 and MSH2 mutation carriers. Hum Mutat 2013; 34:490.</li>&#xD;&#xA;    <li>Baglietto L, Lindor NM, Dowty JG, et al. Risks of Lynch syndrome cancers for MSH6 mutation carriers. J Natl Cancer Inst 2010; 102:193.</li>&#xD;&#xA;    <li>Senter L, Clendenning M, Sotamaa K, et al. The clinical Phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology 2008; 135:419.</li>&#xD;&#xA;    <li>Bonadona V, Bonaiti B, Olschwang S, et al. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA 2011; 305:2304.</li>&#xD;&#xA;    <li>Ten Broeke SW, Brohet RM, Tops CM, et al. Lynch syndrome caused by germline PMS2 mutations: delineating the cancer risk. J Clin Oncol 2015; 33:319.</li>&#xD;&#xA;</ol></div><div id=\"graphicVersion\">Graphic 52285 Version 7.0</div></div></div>"},"52286":{"type":"graphic_picture","displayName":"Distal colon wildtype mouse","title":"Distal colon of a healthy wild-type mouse","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Distal colon of a healthy wild-type mouse</div><div class=\"cntnt\"><img style=\"width:432px; height:324px;\" src=\"images/GAST/52286_Distal_colon_wildtype_mouse.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Distal colon of a healthy wild-type mouse, universal Eub338 Cy3 probe, x400. Bacteria (orange fluorescence) are clearly separated from the colonic wall by a mucus layer. Bacterial concentrations within the colon are high. Water from the fecal stream softens the mucus layer, and mature mucus is carried away by the fecal stream. The mucus layer is continuously rebuilt, resulting in onion-like stratification on the border between stool and the mucus layer (arrows).</div><div class=\"graphic_reference\">Courtesy of Alexander Swidsinski, MD, and Vera Loening-Baucke, MD.</div><div id=\"graphicVersion\">Graphic 52286 Version 2.0</div></div></div>"},"52289":{"type":"graphic_picture","displayName":"Gastrocnemius stretch PI","title":"Gastrocnemius stretch","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Gastrocnemius stretch</div><div class=\"cntnt\"><img style=\"width:324px; height:434px;\" src=\"images/PI/52289_Gastrocnemius_stretch_PI.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The gastrocnemius muscles are the two muscles in the upper calf, just below the back of the knee. To stretch them, stand 18 to 24 inches away from a wall (facing the wall). Place hands on wall at head level. Bend left knee and move right foot about 12 inches backwards. Keep right leg straight and keep heel on the floor. Lean into the wall until you feel a stretch in the right calf (this should not hurt); do not bounce. Hold for a count of 10. Rest. Repeat 10 times with each leg.</div><div id=\"graphicVersion\">Graphic 52289 Version 4.0</div></div></div>"},"52291":{"type":"graphic_picture","displayName":"Pyoderma gangrenosum - close view of ulcer","title":"Pyoderma gangrenosum","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Pyoderma gangrenosum</div><div class=\"cntnt\"><img style=\"width:432px; height:324px;\" src=\"images/DERM/52291_Pyodgangcloseviewulcer.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">This purulent ulcer with a ragged and violaceous border is consistent with pyoderma gangrenosum.</div><div class=\"graphic_reference\">Reproduced with permission from: <A style=\"FONT-STYLE: italic\" href=\"http://www.visualdx.com/\" target=_blank>www.visualdx.com</A>. Copyright Logical Images, Inc.</div><div id=\"graphicVersion\">Graphic 52291 Version 4.0</div></div></div>"},"52294":{"type":"graphic_table","displayName":"Suggested apolipoprotein B or LDL-P treatment goals","title":"Suggested apolipoprotein B or LDL-P treatment goals","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Suggested apolipoprotein B or LDL-P treatment goals</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1_single\">apo B, mg/dL</td> <td class=\"subtitle1_single\">LDL-C, mg/dL</td> <td class=\"subtitle1_single\">Non-HDL-C, mg/dL</td> <td class=\"subtitle1_single\">LDL-P, nmol/L</td> </tr> <tr> <td>&nbsp;</td> <td>&#60;70</td> <td>&#60;80</td> <td>&nbsp;</td> </tr> <tr> <td>&#60;80</td> <td>&#60;100</td> <td>&#60;120</td> <td>&#60;1100</td> </tr> <tr> <td>&#60;100</td> <td>&#60;130</td> <td>&#60;150</td> <td>&#60;1400</td> </tr> </tbody></table></div><div class=\"graphic_reference\">Reproduced with permission from: Contois JH, McConnell JP, Sethi AA, et al. Apolipoprotein B and Cardiovascular Disease Risk: Position Statement from the AACC Lipoproteins and Vascular Disease Division Working Group on Best Practices. Clinical Chemistry 2009; 55:407. Copyright &#169; 2009 American Association for Clinical Chemistry. All rights reserved.</div><div id=\"graphicVersion\">Graphic 52294 Version 1.0</div></div></div>"},"52298":{"type":"graphic_figure","displayName":"Lymph nodes female","title":"Lymph node groups in women","html":"<div class=\"graphic\"><div style=\"width: 548px\" class=\"figure\"><div class=\"ttl\">Lymph node groups in women</div><div class=\"cntnt\"><img style=\"width:528px; height:584px;\" src=\"images/OBGYN/52298_Lymph_nodes_female.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The green dots indicate the location of lymph nodes, which are found throughout the body.</div><div id=\"graphicVersion\">Graphic 52298 Version 4.0</div></div></div>"},"52299":{"type":"graphic_table","displayName":"Chemo met carcinoid","title":"Selected chemotherapy trials in metastatic carcinoid tumors","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Selected chemotherapy trials in metastatic carcinoid tumors</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup span=\"5\" width=\"20%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\" colspan=\"5\">Phase II trials</td> </tr> <tr> <td class=\"subtitle2\">Regimen</td> <td class=\"subtitle2\">Number of patients*</td> <td class=\"subtitle2\">Tumor response rate, percent</td> <td class=\"subtitle2\">Median overall survival, months</td> <td class=\"subtitle2\">Reference</td> </tr> <tr> <td>Dacarbazine</td> <td>56</td> <td>16</td> <td>20</td> <td>Bukowski R; 1994</td> </tr> <tr> <td>Dacarbazine (second-line)</td> <td>61</td> <td>8</td> <td>11.9</td> <td>Sun W; 2005</td> </tr> <tr> <td>Etoposide</td> <td>17</td> <td>12</td> <td>NR</td> <td>Kelsen D; 1987</td> </tr> <tr> <td>Paclitaxel<sup>&#182;</sup></td> <td>24<sup>&#916;</sup></td> <td>8</td> <td>18</td> <td>Ansell S; 2001</td> </tr> <tr> <td>Docetaxel</td> <td>21</td> <td>0</td> <td>24</td> <td>Kulke M; 2004</td> </tr> <tr> <td>Gemcitabine</td> <td>18<sup>&#9674;</sup></td> <td>0</td> <td>11.5</td> <td>Kulke M; 2004</td> </tr> <tr> <td>Capecitabine</td> <td>19</td> <td>0</td> <td>36.5</td> <td>Medley L; 2011</td> </tr> <tr> <td>Streptozocin + fluorouracil + doxorubicin + cyclophosphamide</td> <td>56</td> <td>30</td> <td rowspan=\"2\">10.8</td> <td rowspan=\"2\">Bukowski R; 1987</td> </tr> <tr> <td>Streptozocin + fluorouracil + cyclophosphamide</td> <td>9</td> <td>22</td> </tr> <tr> <td>Streptozocin + fluorouracil + cisplatin</td> <td>33</td> <td>25</td> <td>31.5<sup>&#167;</sup></td> <td>Turner N; 2010</td> </tr> <tr> <td>Temozolomide + thalidomide</td> <td>15</td> <td>7</td> <td>NR</td> <td>Kulke M; 2006</td> </tr> <tr> <td>Gemcitabine + oxaliplatin</td> <td>18 (previously treated<sup>&#165;</sup>)</td> <td>17</td> <td>23.4</td> <td>Cassier P; 2009</td> </tr> <tr> <td class=\"subtitle1\" colspan=\"5\">Randomized trials</td> </tr> <tr> <td class=\"subtitle2\">Regimen</td> <td class=\"subtitle2\">Number of patients*</td> <td class=\"subtitle2\">Tumor response rate, percent</td> <td class=\"subtitle2\">Median overall survival, months</td> <td class=\"subtitle2\">Reference</td> </tr> <tr> <td> <p>Streptozocin + cyclophosphamide</p> <p><strong>versus</strong></p> Streptozocin + fluorouracil</td> <td> <p>47</p> 42</td> <td> <p>26*</p> 33*</td> <td> <p>12.5</p> 11.2</td> <td>Moertel C; 1979</td> </tr> <tr> <td> <p>Doxorubicin</p> <p><strong>versus</strong></p> Streptozocin + fluorouracil</td> <td> <p>81</p> 80</td> <td> <p>21</p> 22</td> <td> <p>11.1</p> 14.9</td> <td>Engstrom P; 1984</td> </tr> <tr> <td> <p>Doxorubicin + fluorouracil</p> <p><strong>versus</strong></p> Streptozocin + fluorouracil</td> <td> <p>88</p> 88</td> <td> <p>16</p> 16</td> <td> <p>15.7</p> 24.3 (p = 0.03)</td> <td>Sun W; 2005</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">NR: not reported.<br />* Response rates included both radiographic tumor regression and reduction urinary 5-HIAA levels.<br />Â¶ Patients also received granulocyte-colony-stimulating factor.<br />Î Includes patients with carcinoid (n = 14), pancreatic islet cell (n = 9), and anaplastic (n = 1) neuroendocrine tumors.<br /><FONT class=lozenge>â</FONT> Includes patients with carcinoid (n = 9), pancreatic (n = 7), and pheochromoctyoma (n = 2) neuroendocrine tumors.<br />Â§ Response rate is for nonpancreatic neuroendocrine tumors in a combined series with 47 pancreatic neuroendocrine tumors. Median survival is for the entire group.<br />Â¥ Includes patients with well differentiated neuroendocrine carcinoma, not otherwise specified.</div><div id=\"graphicVersion\">Graphic 52299 Version 4.0</div></div></div>"},"52301":{"type":"graphic_picture","displayName":"Anisakiasis worm","title":"Anisakiasis worm","html":"<div class=\"graphic\"><div style=\"width: 590px\" class=\"figure\"><div class=\"ttl\">Anisakiasis worm</div><div class=\"cntnt\"><img style=\"width:570px; height:308px;\" src=\"images/ID/52301_Anisakiasis_worm.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">(A) L3 larva of an anisakid worm.<br />(B) L3 larva of <em>Pseudoterranova</em> spp. Ten units = one centimeter.</div><div class=\"graphic_reference\">Reproduced from: Centers for Disease Control and Prevention. DPDx: Anisakiasis. Available at: <a href=\"http://www.cdc.gov/dpdx/anisakiasis/index.html\" target=\"_blank\">http://www.cdc.gov/dpdx/anisakiasis/index.html</a>.</div><div id=\"graphicVersion\">Graphic 52301 Version 5.0</div></div></div>"},"52302":{"type":"graphic_figure","displayName":"Renin in HF","title":"Humoral adaptation to experimental heart failure","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Humoral adaptation to experimental heart failure</div><div class=\"cntnt\"><img style=\"width:228px; height:644px;\" src=\"images/NEPH/52302_Renin_in_HF.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Sequential changes in mean aortic pressure, plasma renin activity, plasma aldosterone concentration, urinary sodium excretion, and plasma volume in a dog with moderate thoracic inferior vena cava constriction. There is initial hypotension, activation of the renin-angiotensin-aldosterone system, and a marked reduction in urinary Na+ excretion. By day 7, however, a new steady state is achieved in which renin and aldosterone levels and Na+ excretion have returned to baseline levels. The associated plasma volume expansion is responsible for restoring venous return to the heart, thereby allowing systemic hemodynamics to be normalized.</div><div class=\"graphic_reference\">Watkins L Jr, Burton JA, Haber E, et al. J Clin Invest 1976; 57:1606. Copyright permission of the American Society for Clinical Investigation.</div><div id=\"graphicVersion\">Graphic 52302 Version 3.0</div></div></div>"},"52304":{"type":"graphic_figure","displayName":"Uterosacral ligament suspension","title":"Uterosacral ligament uterine suspension","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Uterosacral ligament uterine suspension</div><div class=\"cntnt\"><img style=\"width:350px; height:423px;\" src=\"images/OBGYN/52304_Uterosacral_ligament_suspen.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The surgeon identifies the proximal portion of the uterosacral ligament and uses permanent sutures to bind it to the distal aspect of the ligament, near its insertion into the lower uterine segment and cervix.</div><div class=\"graphic_reference\">Courtesy of Peter L Rosenblatt, MD.</div><div id=\"graphicVersion\">Graphic 52304 Version 1.0</div></div></div>"},"52305":{"type":"graphic_diagnosticimage","displayName":"Varying patterns of normal breast density","title":"Varying patterns of normal breast density","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Varying patterns of normal breast density</div><div class=\"cntnt\"><img style=\"width:321px; height:538px;\" src=\"images/PC/52305_Breast_density.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The mammographic breast density results from varying proportions of fat, connective tissue, ductal and lobular elements. The mammogram report should mention the density pattern using the standard BIRADS classification into predominantly fatty (Panel A), scattered fibroglandular (Panel B), heterogenous (Panel C) or dense (Panel D) breast tissue.</div><div class=\"graphic_footnotes\">BIRADS: Breast Imaging Reporting and Data System.</div><div id=\"graphicVersion\">Graphic 52305 Version 4.0</div></div></div>"},"52306":{"type":"graphic_diagnosticimage","displayName":"Conglomerate shadows PA I","title":"Large opacities in pneumoconiosis","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Large opacities in pneumoconiosis</div><div class=\"cntnt\"><img style=\"width:370px; height:352px;\" src=\"images/PULM/52306_Conglomerate_shadows_PA_I.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Standard International Labor Office film for large C opacities in patient with either silicosis or coal worker's pneumoconiosis.</div><div class=\"graphic_reference\">Courtesy of Paul Stark, MD.</div><div id=\"graphicVersion\">Graphic 52306 Version 3.0</div></div></div>"},"52309":{"type":"graphic_figure","displayName":"SCD and clinical manifestations","title":"Risk of SCD is related to clinical manifestations of CHD","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Risk of SCD is related to clinical manifestations of CHD</div><div class=\"cntnt\"><img style=\"width:395px; height:276px;\" src=\"images/CARD/52309_SCD_and_clinical_manifestat.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">During a 38-year follow-up of subjects in the Framingham Heart Study, the annual incidence of sudden cardiac death (SCD) in both men and women was related to the clinical manifestations of coronary heart disease (CHD). It was highest in those with a myocardial infarction, intermediate in those with angina and no prior infarction, and lowest in those without overt CHD.</div><div class=\"graphic_reference\">Data from: Kannel WB, Wilson PWF, D'Agostino RB, et al. Am Heart J 1998; 136:205.</div><div id=\"graphicVersion\">Graphic 52309 Version 2.0</div></div></div>"},"52310":{"type":"graphic_picture","displayName":"Bronchoscopy brush","title":"Bronchoscopy brush","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Bronchoscopy brush</div><div class=\"cntnt\"><img style=\"width:309px; height:285px;\" src=\"images/PULM/52310_Bronchoscopybrush.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">A cytology/microbiology brush is shown, extending from its sheath.</div><div id=\"graphicVersion\">Graphic 52310 Version 1.0</div></div></div>"},"52311":{"type":"graphic_figure","displayName":"Pathogenesis of SBP","title":"Mechanisms that may be involved in the pathogenesis of spontaneous bacterial peritonitis","html":"<div class=\"graphic\"><div style=\"width: 484px\" class=\"figure\"><div class=\"ttl\">Mechanisms that may be involved in the pathogenesis of spontaneous bacterial peritonitis</div><div class=\"cntnt\"><img style=\"width:464px; height:577px;\" src=\"images/GAST/52311_Pathogenesis_of_SBP.gif\" alt=\"Image\"/></div><div class=\"graphic_footnotes\">BA: bactericidal activity; CNNA: culture-negative neutrocytic ascites; SBP: spontaneous bacterial peritonitis. </div><div class=\"graphic_reference\">Reproduced with permission from Such J. Clin Infect Dis 1998; 27:669. Copyright &#169; 1998 University of Chicago Press.</div><div id=\"graphicVersion\">Graphic 52311 Version 2.0</div></div></div>"},"52312":{"type":"graphic_table","displayName":"Short-acting versus long-acting CCBs","title":"Potentially harmful cardiovascular effects of short-acting calcium channel blockers","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Potentially harmful cardiovascular effects of short-acting calcium channel blockers</div><div class=\"cntnt\"><table cellspacing=\"0\">\n\n  <tbody>\n\n\n    <tr>\n\n      <td class=\"subtitle1\">Mechanism</td>\n\n      <td class=\"subtitle1\"> Short-acting nifedipine</td>\n\n      <td class=\"subtitle1\"> Long-acting agents</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Proischemic effect</td>\n\n      <td>+/-</td>\n\n      <td>-</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Negative inotropic effect</td>\n\n      <td>+</td>\n\n      <td>+/-</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Effects on rhythm</td>\n\n      <td>?</td>\n\n      <td>-</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Marked hypotension</td>\n\n      <td>+</td>\n\n      <td>-</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Reflex increase in sympathetic activity</td>\n\n      <td>+</td>\n\n      <td>-</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Prohemorrhagic effects</td>\n\n      <td>?</td>\n\n      <td>-</td>\n\n    </tr>\n\n  </tbody>\n</table>\n\n\r\n\r\n<html xmlns:mso=\"urn:schemas-microsoft-com:office:office\" xmlns:msdt=\"uuid:C2F41010-65B3-11d1-A29F-00AA00C14882\"><head>\n<!--[if gte mso 9]><xml>\n<mso:CustomDocumentProperties>\n<mso:Specialty msdt:dt=\"string\">9.00000000000000</mso:Specialty>\n<mso:Media_Type msdt:dt=\"string\">Table</mso:Media_Type>\n<mso:Edit_Table msdt:dt=\"string\">&lt;a href=&quot;/Graphics/Pages/TableEditor.aspx?SPID=28489&amp;amp;Mode=Edit&quot;&gt;&lt;/a&gt;</mso:Edit_Table>\n</mso:CustomDocumentProperties>\n</xml><![endif]-->\n<title>Short_versus_long_acting_CC.htm</title></head></div><div id=\"graphicVersion\">Graphic 52312 Version 2.0</div></div></div>"},"52315":{"type":"graphic_picture","displayName":"Chondro histology rare","title":"Histology of rare chondrosarcoma subtypes","html":"<div class=\"graphic\"><div style=\"width: 536px\" class=\"figure\"><div class=\"ttl\">Histology of rare chondrosarcoma subtypes</div><div class=\"cntnt\"><img style=\"width:516px; height:175px;\" src=\"images/ONC/52315_Chondro_histology_rare.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">A) Histology of dedifferentiated chondrosarcoma with a sharp interface between conventional chondrosarcoma (left) and anaplastic sarcoma (right). B) Mesenchymal chondrosarcoma with undifferentiated small blue round cells (below) and cartilage differentiation (top). C) Clear cell chondrosarcoma demonstrating chondrocytes with abundant clear cytoplasm, cartilaginous matrix, and deposition of osteoid (hematoxylin and eosin staining, â¼500X).</div><div class=\"graphic_reference\">Reproduced with permission from: Gelderblom H, Hogendoorn PCW, Dijkstra SD, et al. The clinical approach towards chondrosarcoma. Oncologist 2008; 13:320. Copyright Â©2008 AlphaMed Press.</div><div class=\"contractual\"><br/><a href=\"http://www.theoncologist.com/\">http://www.TheOncologist.com</a></div><div id=\"graphicVersion\">Graphic 52315 Version 3.0</div></div></div>"},"52317":{"type":"graphic_waveform","displayName":"Multifocal atrial tachycardia - two month old infant","title":"Chaotic (multifocal) atrial tachycardia - two month old infant","html":"<div class=\"graphic\"><div style=\"width: 545px\" class=\"figure\"><div class=\"ttl\">Chaotic (multifocal) atrial tachycardia - two month old infant</div><div class=\"cntnt\"><img style=\"width:525px; height:126px;\" src=\"images/PEDS/52317_Multifocal_AT_two_month.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">A rhythm strip from a two month old with chaotic (multifocal) atrial tachycardia. The numerals represent the different P wave morphologies, when discernible demonstrating the different foci.</div><div id=\"graphicVersion\">Graphic 52317 Version 5.0</div></div></div>"},"52318":{"type":"graphic_figure","displayName":"RV dilation and survival","title":"Right ventricular enlargement increases mortality in dilated cardiomyopathy","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Right ventricular enlargement increases mortality in dilated cardiomyopathy</div><div class=\"cntnt\"><img style=\"width:332px; height:260px;\" src=\"images/CARD/52318_RV_dilation_and_survival.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Among patients with an idiopathic dilated cardiomyopathy and left ventricular dysfunction, survival was much lower in those who also had right ventricular enlargement (p = 0.001).</div><div class=\"graphic_reference\">Data from Sun JP, James KB, Yang XS, et al. Am J Cardiol 1997; 80:1583.</div><div id=\"graphicVersion\">Graphic 52318 Version 2.0</div></div></div>"},"52319":{"type":"graphic_diagnosticimage","displayName":"Brain MRI two-year-old with Krabbe disease","title":"Brain MRI of a two-year-old with Krabbe disease","html":"<div class=\"graphic\"><div style=\"width: 482px\" class=\"figure\"><div class=\"ttl\">Brain MRI of a two-year-old with Krabbe disease</div><div class=\"cntnt\"><img style=\"width:462px; height:583px;\" src=\"images/NEURO/52319_Brain_MRI_2_year_old_Krabbe.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Brain MRI of a child age 2 years who presented with visual loss, showing axial T2 images from the level of the midbrain (A) to the thalamus (C). There is increased signal in the periventricular and deep white matter, predominantly involving the occipital and parietal lobes.</div><div class=\"graphic_reference\">Courtesy of Dr. Patricia Duffner.</div><div id=\"graphicVersion\">Graphic 52319 Version 7.0</div></div></div>"},"52321":{"type":"graphic_figure","displayName":"Self measurement of INR","title":"Correlation between self-measured INR and laboratory INR","html":"<div class=\"graphic\"><div style=\"width: 503px\" class=\"figure\"><div class=\"ttl\">Correlation between self-measured INR and laboratory INR</div><div class=\"cntnt\"><img style=\"width:483px; height:389px;\" src=\"images/HEME/52321_Self_measurement_of_INR.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The filled and open symbols represent self-measured and laboratory international normalized ratio (INR) from patients taking phenoprocoumon or acenocoumarol, respectively. The self-measured INR was determined from a capillary blood sample obtained and analyzed at home, while the laboratory-measured INR was determined from a venous blood sample assayed virtually simultaneously. The line of identity is shown in blue.</div><div class=\"graphic_reference\">Data from: Cromheecke ME, Levi M, Colly LP, et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet 2000; 356:97.</div><div id=\"graphicVersion\">Graphic 52321 Version 2.0</div></div></div>"},"52322":{"type":"graphic_figure","displayName":"Factors for TIMI grade flow","title":"Schematic of factors potentially influencing TIMI grade flow","html":"<div class=\"graphic\"><div style=\"width: 492px\" class=\"figure\"><div class=\"ttl\">Schematic of factors potentially influencing TIMI grade flow</div><div class=\"cntnt\"><img style=\"width:472px; height:360px;\" src=\"images/CARD/52322_Factors_for_TIMI_grade_flow.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">There are a number of factors, acting in concert, that determine the patency of the coronary artery after thrombolysis; these include hemodynamics, local artery anatomy, the thrombus, cellular mechanisms, and procedural issues. The TIMI flow grade, which has been determined at various points in time after thrombolysis, correlates with mortality after the infarction. (With permission from: Tan WA, Noliterno DJ. Am Heart J 1998; 136:570).</div><div class=\"graphic_footnotes\">DPB: diastolic blood pressure; EDP: left ventricular end-diastolic pressure.</div><div id=\"graphicVersion\">Graphic 52322 Version 3.0</div></div></div>"},"52323":{"type":"graphic_diagnosticimage","displayName":"Chest radiograph RDS","title":"Chest radiograph of neonatal respiratory distress syndrome","html":"<div class=\"graphic\"><div style=\"width: 527px\" class=\"figure\"><div class=\"ttl\">Chest radiograph of neonatal respiratory distress syndrome</div><div class=\"cntnt\"><img style=\"width:507px; height:251px;\" src=\"images/PEDS/52323_Chest_radiograph_RDS_NEW2.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Two radiographs that demonstrate severe (A) and moderate (B) neonatal respiratory distress syndrome. Both demonstrate the characteristic low lung volumes, and diffuse reticulogranular ground glass appearance with air bronchograms.</div><div id=\"graphicVersion\">Graphic 52323 Version 7.0</div></div></div>"},"52324":{"type":"graphic_table","displayName":"Syndromic hereditary neurop II","title":"Clinical features of hereditary peripheral neuropathies associated with other disorders-II","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Clinical features of hereditary peripheral neuropathies associated with other disorders-II</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup span=\"3\" width=\"20%\"></colgroup><colgroup width=\"40%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\">Disorder</td> <td class=\"subtitle1\">Inheritance</td> <td class=\"subtitle1\">Gene</td> <td class=\"subtitle1\">Clinical features</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"4\">Mitochondrial disorders</td> </tr> <tr> <td class=\"indent1\">Leigh syndrome</td> <td>AR or X-linked</td> <td>Mutations in nuclear genes (eg, SURF1) that cause respiratory chain complex deficiencies</td> <td>Onset in infancy or childhood, rarely in adulthood; developmental delay, psychomotor regression, brainstem dysfunction, ataxia, dystonia, external ophthalmoplegia, seizures, weakness, lactic acidosis</td> </tr> <tr> <td class=\"indent1\">Leigh syndrome</td> <td>Maternal</td> <td>Mutations in mitochondrial genes (eg, ATPase6)</td> <td>As above</td> </tr> <tr> <td class=\"indent1\">Leber hereditary optic neuropathy</td> <td>Maternal</td> <td>Mutations in mitochondrial genes that encode subunits of NADH dehydrogenase</td> <td>Affects young adult males, usual onset in late teens, severe permanent visual loss, tremor, multiple sclerosis-like illness, extrapyramidal syndrome, seizures, ataxia, spasticity, mental retardation, peripheral neuropathy</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"4\">DNA repair disorders</td> </tr> <tr> <td class=\"indent1\">Xeroderma pigmentosa</td> <td>AR</td> <td>XPA, XPB, XPC, XPD, XPE, XPF, XPG, XPV</td> <td>Peripheral neuropathy, photosensitivity, cutaneous malignancy, skin atrophy and telangiectasia, keratitis, opacification of the cornea, iritis</td> </tr> <tr> <td class=\"indent1\">Cockayne syndrome</td> <td>AR</td> <td> <p>Type A: ERCC8</p> Type B: ERCC6</td> <td>Progressive dementia, large ears and sunken eyes, physical and mental retardation, short stature, microcephaly, progressive neurologic dysfunction, optic atrophy, photosensitivity without increased frequency of cancer</td> </tr> <tr> <td class=\"indent1\">Ataxia-telangiectasia</td> <td>AR</td> <td>ATM</td> <td>Progressive cerebellar ataxia, oculocutaneous telangiectasias, immune deficiency, increased risk of malignancy, radiation sensitivity, diabetes mellitus</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"4\">Hereditary tyrosinemia</td> </tr> <tr> <td class=\"indent1\">Type I</td> <td>AR</td> <td>FAH</td> <td>Severe progressive liver disease, renal tubular dysfunction, peripheral neuropathy, extensor hypertonia</td> </tr> <tr> <td class=\"indent1\">Type II</td> <td>AR</td> <td>TAT</td> <td>Keratitis, palmoplantar hyperkeratosis, mental retardation, elevated blood tyrosine concentrations</td> </tr> <tr> <td class=\"indent1\">Type III</td> <td>AR</td> <td>HPD</td> <td>Hypertyrosinemia, mental retardation</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">AR: autosomal recessive.</div><div id=\"graphicVersion\">Graphic 52324 Version 4.0</div></div></div>"},"52325":{"type":"graphic_table","displayName":"Grain processing antigens in HP","title":"Hypersensitivity pneumonitides associated with grain and flour processing","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Hypersensitivity pneumonitides associated with grain and flour processing</div><div class=\"cntnt\"><table cellspacing=\"0\">\n<tbody>\n\n<tr>\n<td class=\"subtitle1\">Environmental source</td>\n<td class=\"subtitle1\">Major causative antigen</td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Grain measurer's lung</td>\n<td>Cereal grain (Sporobolomyces)</td>\n</tr>\n<tr>\n\n<td>Grain dust (mixture of dust, silica, fungi, insects, and mites)</td>\n</tr>\n<tr>\n<td>Miller's lung (dust-contaminated grain) </td>\n<td>Sitophilus granarius (ie, wheat weevil)</td>\n</tr>\n<tr>\n<td>Malt worker's disease (moldy barley) </td>\n<td>Aspergillus fumigatus, Aspergillus clavatus</td>\n</tr>\n</tbody>\n</table></div><div id=\"graphicVersion\">Graphic 52325 Version 1.0</div></div></div>"},"52326":{"type":"graphic_picture","displayName":"Second examination for metacarpal malrotation","title":"Second examination for metacarpal malrotation","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Second examination for metacarpal malrotation</div><div class=\"cntnt\"><img style=\"width:429px; height:323px;\" src=\"images/EM/52326_Exam_for_metacarpal_malro1.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">In this photograph, the hand is inspected for malrotation with the MCP joints flexed to 90 degrees while the PIP and DIP joints are fully extended. In the absence of malrotation, the plane of the fingernails should be aligned as it is in this normal hand. The injured and contralateral hands can be compared.</div><div class=\"graphic_footnotes\">MCP: metacarpophalangeal; PIP: proximal interphalangeal; DIP: distal interphalangeal.</div><div class=\"graphic_reference\">Courtesy of Kevin Burroughs, MD.</div><div id=\"graphicVersion\">Graphic 52326 Version 6.0</div></div></div>"},"52327":{"type":"graphic_picture","displayName":"AIDS-related Kaposis sarcoma - penis","title":"AIDS-related Kaposi's sarcoma","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">AIDS-related Kaposi's sarcoma</div><div class=\"cntnt\"><img style=\"width:432px; height:325px;\" src=\"images/DERM/52327_Kaposis_sarcoma_penis.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">A vascular papule consistent with Kaposi's sarcoma is present on the penis.</div><div class=\"graphic_reference\">Reproduced with permission from: <A style=\"FONT-STYLE: italic\" href=\"http://www.visualdx.com/\" target=_blank>www.visualdx.com</A>. Copyright Logical Images, Inc.</div><div id=\"graphicVersion\">Graphic 52327 Version 3.0</div></div></div>"},"52329":{"type":"graphic_figure","displayName":"LVH and cardiovascular risk","title":"Cardiovascular risk with LVH by echocardiography","html":"<div class=\"graphic\"><div style=\"width: 482px\" class=\"figure\"><div class=\"ttl\">Cardiovascular risk with LVH by echocardiography</div><div class=\"cntnt\"><img style=\"width:462px; height:236px;\" src=\"images/NEPH/52329_LVH_and_cardiovascular_risk.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Four-year, age-adjusted incidence of cardiovascular events in men and women in the Framingham Study according to left ventricular mass determined by echocardiography. Subjects with increased left ventricular mass (far right panel) had a marked increase in cardiovascular risk.</div><div class=\"graphic_footnotes\">LVH: left ventricular hypertrophy; CV: cardiovascular.</div><div class=\"graphic_reference\">Adapted from: Levy D, Garrison RJ, Savage DD, et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322:1561.</div><div id=\"graphicVersion\">Graphic 52329 Version 4.0</div></div></div>"},"52331":{"type":"graphic_diagnosticimage","displayName":"Stenosis venous anastomosis","title":"Stenosis at the venous anastomosis","html":"<div class=\"graphic\"><div style=\"width: 488px\" class=\"figure\"><div class=\"ttl\">Stenosis at the venous anastomosis</div><div class=\"cntnt\"><img style=\"width:468px; height:206px;\" src=\"images/NEPH/52331_Stenosis_venous_anastomosis.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The appearance of the lesion prior to therapy is shown on the left. Its appearance following angioplasty is on the right.</div><div class=\"graphic_reference\">Courtesy of Gerald Beathard, MD.</div><div id=\"graphicVersion\">Graphic 52331 Version 2.0</div></div></div>"},"52332":{"type":"graphic_waveform","displayName":"Doppler mitral inflow AR","title":"Restrictive mitral inflow Doppler patterns in severe aortic regurgitation","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Restrictive mitral inflow Doppler patterns in severe aortic regurgitation</div><div class=\"cntnt\"><img style=\"width:298px; height:491px;\" src=\"images/CARD/52332_DopplermitralinflowAR.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The hemodynamic mechanism for the restrictive mitral inflow pattern on continuous wave Doppler is the same as for early closure of the mitral valve seen on the M-mode echocardiogram (ie, rapid increase in left ventricular diastolic pressure). The continuous wave Doppler in panel A shows an abnormally short deceleration time (147 ms), measured along the line joining point A and B (arrow), and short pressure half-time (PHT) of 43 ms, a result of a rapid and early rise in left ventricular diastolic pressure due to competition for filling of the ventricle between the normal inflow, represented by the mitral inflow signal, and the regurgitant flow represented by diastolic \"noise\" in the background. The continuous wave Doppler of mitral inflow in severe aortic regurgitation obtained from transesophageal echocardiogram is seen on panel B.</div><div id=\"graphicVersion\">Graphic 52332 Version 4.0</div></div></div>"},"52333":{"type":"graphic_picture","displayName":"Diabetic foot ulcer 1 PI","title":"Superficial diabetic foot ulcer","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Superficial diabetic foot ulcer</div><div class=\"cntnt\"><img style=\"width:378px; height:232px;\" src=\"images/PI/52333_Diabetic_foot_ulcer_1_PI.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Foot from a diabetic patient showing a superficial ulcer (Wagner grade 1) that involves the full thickness of the skin but no underlying tissues. This lesion healed quickly with rest and local foot care.</div><div class=\"graphic_reference\">Courtesy of David McCulloch, MD.</div><div id=\"graphicVersion\">Graphic 52333 Version 3.0</div></div></div>"},"52334":{"type":"graphic_diagnosticimage","displayName":"ECD bone scan","title":"Multiple areas of increased uptake on bone scan in Erdheim-Chester disease","html":"<div class=\"graphic\"><div style=\"width: 487px\" class=\"figure\"><div class=\"ttl\">Multiple areas of increased uptake on bone scan in Erdheim-Chester disease</div><div class=\"cntnt\"><img style=\"width:467px; height:586px;\" src=\"images/HEME/52334_ECD_bone_scan_PR.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Bone scan showed multiple increased uptakes in both maxillae, mandible, right temporal bone, both radii, both ulnae, both distal femurs, both proximal and distal tibiae, both calcanei, left second rib, right ninth rib, both tenth ribs, left posterior iliac crest and right acetabulum.</div><div class=\"graphic_reference\">Reproduced with permission from: Kim MS, Kim CH, Choi SJ, et al. Erdheim-Chester disease. Ann Dermatol 2010; 22:439. Copyright Â© 2010 Korean Dermatological Association.</div><div id=\"graphicVersion\">Graphic 52334 Version 2.0</div></div></div>"},"52335":{"type":"graphic_table","displayName":"Suture selection for facial and scalp lacerations","title":"Suture selection, anesthetic options, and time to suture removal for facial and scalp lacerations","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Suture selection, anesthetic options, and time to suture removal for facial and scalp lacerations</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup span=\"5\" width=\"20%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\">Location</td> <td class=\"subtitle1\">Suture material*</td> <td class=\"subtitle1\">Size</td> <td class=\"subtitle1\">Anesthetic<sup>&#182;</sup></td> <td class=\"subtitle1\">Removal</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"5\">Scalp</td> </tr> <tr> <td class=\"indent1\">Galea</td> <td>Absorbable</td> <td>3.0 or 4.0</td> <td>Local</td> <td>None</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">Skin</td> <td>Staple, nonabsorbable<sup>&#916;</sup>, hair apposition</td> <td>Stainless steel (staples), 3.0 or 4.0 (sutures)</td> <td>Local</td> <td>7-14 days, none for hair apposition</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"5\">Forehead</td> </tr> <tr> <td class=\"indent1\">Frontalis</td> <td>Absorbable</td> <td>4.0</td> <td>Local</td> <td>None</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">Skin</td> <td>Nonabsorbable<sup>&#916;</sup></td> <td>5.0 or 6.0 (adults), 6.0 (children)</td> <td>Local/supraorbital</td> <td>5 days</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"5\">Cheek/face</td> </tr> <tr> <td class=\"indent1\">Muscle</td> <td>Absorbable</td> <td>4.0</td> <td>Local/infraorbital</td> <td>None</td> </tr> <tr> <td class=\"indent1\">Subcutaneous</td> <td>Absorbable</td> <td>4.0</td> <td>Local/infraorbital</td> <td>None</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">Skin</td> <td>Nonabsorbable<sup>&#916;</sup></td> <td>5.0 or 6.0 (adults), 6.0 (children)</td> <td>Local/infraorbital</td> <td>5 days</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"5\">Eyelids</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">Skin</td> <td>Absorbable</td> <td>6.0</td> <td>Supra/infraorbital</td> <td>3-5 days</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"5\">Nose</td> </tr> <tr> <td class=\"indent1\">Mucosa</td> <td>Absorbable</td> <td>4.0</td> <td>Local/intranasal pack</td> <td>None</td> </tr> <tr> <td class=\"indent1\">Cartilage</td> <td>Absorbable</td> <td>5.0</td> <td>Local/intranasal pack</td> <td>None</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">Skin</td> <td>Absorbable</td> <td>6.0</td> <td>Local/intranasal pack</td> <td>3-5 days</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"5\">Lip</td> </tr> <tr> <td class=\"indent1\">Muscle</td> <td>Absorbable</td> <td>4.0 or 5.0</td> <td>Infraorbital/mental</td> <td>None</td> </tr> <tr> <td class=\"indent1\">Mucosal skin</td> <td>Absorbable</td> <td>5.0 or 6.0 (adults), 6.0 (children)</td> <td>Infraorbital/mental</td> <td>None</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">Vermillion border</td> <td>Nonabsorbable<sup>&#916;</sup></td> <td>6.0</td> <td>Infraorbital/mental</td> <td>5 days</td> </tr> <tr class=\"divider_bottom\"> <td><strong>Intraoral mucosa</strong></td> <td>Absorbable</td> <td>4.0 or 5.0</td> <td>Local</td> <td>None</td> </tr> <tr class=\"divider_bottom\"> <td><strong>Tongue</strong></td> <td>Absorbable</td> <td>3.0 or 4.0</td> <td>Local</td> <td>None</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"5\">Chin</td> </tr> <tr> <td class=\"indent1\">Muscle</td> <td>Absorbable</td> <td>4.0</td> <td>Local/mental</td> <td>None</td> </tr> <tr> <td class=\"indent1\">Subcutaneous</td> <td>Absorbable</td> <td>4.0</td> <td>Local/mental</td> <td>None</td> </tr> <tr> <td class=\"indent1\">Skin</td> <td>Nonabsorbable<sup>&#916;</sup></td> <td>5.0 or 6.0</td> <td>Local/mental</td> <td>5 days</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">* Absorbable suture will resorb within 60 days. Subcutaneous absorbable sutures commonly used on facial lacerations include polyglactin 910 (Vicryl<SUP>Â®</SUP>), poliglecaprone 25 (Monocryl<SUP>Â®</SUP>), and polyglycolic acid (Dexon). Chromic gut is appropriate for surface sutures on mucosa. Fast-absorbing gut and, for scalp lacerations, coated polyglactin 910 [Vicryl RapideÂ®] are appropriate for skin sutures.<br />Nonabsorbable suture will not resorb within 60 days. Nylon (Dermalon<SUP>Â®</SUP>, Ethilon<SUP>Â®</SUP>), Polybutester (Novafil<SUP>Â®</SUP>), and polypropylene (Surgilene<SUP>Â®</SUP>, Prolene<SUP>Â®</SUP>) are commonly used.<br />Â¶ See \"Assessment and management of facial lacerations\", section on 'Facial nerve blocks' for instructions on how to perform supraorbital, infraorbital, and mental nerve blocks.<br />Î Fast-absorbing gut or, for scalp lacerations, coated polyglactin 910 [Vicryl RapideÂ®] may be used for skin closure without negatively impacting wound outcomes in young children to avoid the anxiety and difficulty of suture removal and in patients for whom followup for suture removal is not assured.</div><div id=\"graphicVersion\">Graphic 52335 Version 3.0</div></div></div>"},"52336":{"type":"graphic_picture","displayName":"Slit lamp beam width","title":"Slit lamp beam width","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Slit lamp beam width</div><div class=\"cntnt\"><img style=\"width:360px; height:490px;\" src=\"images/EM/52336_Slit_lamp_beam_width.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The slit width should be adjusted to make the beam as narrow as possible without causing the illumination to decrease.</div><div id=\"graphicVersion\">Graphic 52336 Version 2.0</div></div></div>"},"52338":{"type":"graphic_picture","displayName":"Healthy gingiva child","title":"Healthy gingiva in a 6-year-old child","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Healthy gingiva in a 6-year-old child</div><div class=\"cntnt\"><img style=\"width:324px; height:229px;\" src=\"images/PEDS/52338_Healthy_gingiva_child.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">No plaque is visible on the teeth at the gingival margin (gum line). The gingiva is uniformly pink without redness or edema.</div><div class=\"graphic_reference\">Courtesy of Ann Griffen, DDS, MS.</div><div id=\"graphicVersion\">Graphic 52338 Version 1.0</div></div></div>"},"52339":{"type":"graphic_table","displayName":"Performance Arozullah index","title":"Performance of the Arozullah respiratory failure index","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Performance of the Arozullah respiratory failure index</div><div class=\"cntnt\"><table cellspacing=\"0\">\n\n  <tbody>\n\n    <tr>\n\n      <td class=\"subtitle1\">Class</td>\n\n      <td class=\"subtitle1\">Point total</td>\n\n      <td class=\"subtitle1\">Percent respiratory failure</td>\n\n    </tr>\n\n    <tr>\n\n      <td>1</td>\n\n      <td>&#8804;10</td>\n\n      <td>0.5</td>\n\n    </tr>\n\n    <tr>\n\n      <td>2</td>\n\n      <td>11 to 19</td>\n\n      <td>1.8</td>\n\n    </tr>\n\n    <tr>\n\n      <td>3</td>\n\n      <td>20 to 27</td>\n\n      <td>4.2</td>\n\n    </tr>\n\n    <tr>\n\n      <td>4</td>\n\n      <td>28 to 40</td>\n\n      <td>10.1</td>\n\n    </tr>\n\n    <tr>\n\n      <td>5</td>\n\n      <td>&#62;40</td>\n\n      <td>26.6</td>\n\n    </tr>\n\n  </tbody>\n</table>\n\n\r\n\r\n<html xmlns:mso=\"urn:schemas-microsoft-com:office:office\" xmlns:msdt=\"uuid:C2F41010-65B3-11d1-A29F-00AA00C14882\"><head>\n<!--[if gte mso 9]><xml>\n<mso:CustomDocumentProperties>\n<mso:Specialty msdt:dt=\"string\">16.0000000000000</mso:Specialty>\n<mso:Media_Type msdt:dt=\"string\">Table</mso:Media_Type>\n<mso:Edit_Table msdt:dt=\"string\">&lt;a href=&quot;/Graphics/Pages/TableEditor.aspx?SPID=60383&amp;amp;Mode=Edit&quot;&gt;&lt;/a&gt;</mso:Edit_Table>\n</mso:CustomDocumentProperties>\n</xml><![endif]-->\n<title>Performance_Arozullah_index.htm</title></head></div><div class=\"graphic_reference\">Data from:&nbsp;Arozulla AM, Daley J, Henderson WG, Khuri SF. Multifactorial risk index for predicting postoperative respiratory failure in men after major noncardiac surgery. The National Veterans Administration Surgical Quality Improvement Program. Ann Surg 2000; 232:242.</div><div id=\"graphicVersion\">Graphic 52339 Version 4.0</div></div></div>"},"52340":{"type":"graphic_figure","displayName":"Superficial veins of lower leg posterior view","title":"Superficial veins of lower leg, posterior view","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Superficial veins of lower leg, posterior view</div><div class=\"cntnt\"><img style=\"width:386px; height:403px;\" src=\"images/PC/52340_Small_saphenous_vein.jpg\" alt=\"Image\"/></div><div id=\"graphicVersion\">Graphic 52340 Version 3.0</div></div></div>"},"52342":{"type":"graphic_waveform","displayName":"Pressures mitral stenosis I","title":"Pressure tracings in mitral stenosis","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Pressure tracings in mitral stenosis</div><div class=\"cntnt\"><img style=\"width:417px; height:182px;\" src=\"images/CARD/52342_Pressures_mitral_stenosis_I.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Pressures in a patient with mitral stenosis are recorded simultaneously from the left atrium (LA) and left ventricle (LV). There is a persistent pressure gradient throughout all of diastole (shaded area) as LA pressure is higher than that in the LV due to significant mitral stenosis. The pressure gradient is greatest during the initial part of diastole, is reduced during diastole as blood flows from LA into LV, and then increases at the end of diastole as a result of atrial contaction (A wave).</div><div class=\"graphic_reference\">Redrawn from Kern MJ (Ed). Hemodynamic Rounds: Interpretation of Cardiac Pathophysiology from Pressure Waveform Analysis. Wiley-Liss, New York, 1993.</div><div id=\"graphicVersion\">Graphic 52342 Version 3.0</div></div></div>"},"52343":{"type":"graphic_figure","displayName":"Palmar digit anatomy schema","title":"Palmar digit anatomy schema","html":"<div class=\"graphic\"><div style=\"width: 481px\" class=\"figure\"><div class=\"ttl\">Palmar digit anatomy schema</div><div class=\"cntnt\"><img style=\"width:461px; height:530px;\" src=\"images/SURG/52343_Burn_hand_anat_dig.jpg\" alt=\"Image\"/></div><div id=\"graphicVersion\">Graphic 52343 Version 5.0</div></div></div>"},"52344":{"type":"graphic_picture","displayName":"Leish bone marrow biopsy","title":"<em>Leishmania</em> amastigotes in bone marrow biopsy","html":"<div class=\"graphic\"><div style=\"width: 506px\" class=\"figure\"><div class=\"ttl\"><em>Leishmania</em> amastigotes in bone marrow biopsy</div><div class=\"cntnt\"><img style=\"width:486px; height:245px;\" src=\"images/ID/52344_Leish_bone_marrow_biopsy.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\"><EM>Leishmania</EM> amastigotes in bone marrow biopsy specimens from patients with visceral leishmaniasis. Note the nucleus and kinetoplast in each amastigote.</div><div class=\"graphic_reference\">Reproduced from: Centers for Disease Control and Prevention.</div><div id=\"graphicVersion\">Graphic 52344 Version 2.0</div></div></div>"},"52347":{"type":"graphic_table","displayName":"Liveborn chromosome abn rate","title":"Chromosomal abnormalities among livebirths","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Chromosomal abnormalities among livebirths</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup span=\"4\" width=\"25%\"></colgroup> <tbody> <tr class=\"divider_bottom\"> <td class=\"subtitle1_left\">Total livebirths</td> <td class=\"centered\">103,069</td> <td class=\"centered\">&nbsp;</td> <td class=\"centered\">&nbsp;</td> </tr> <tr class=\"divider_bottom\"> <td class=\"subtitle1_left\">Male livebirths</td> <td class=\"centered\">61,484</td> <td class=\"centered\">&nbsp;</td> <td class=\"centered\">&nbsp;</td> </tr> <tr class=\"divider_bottom\"> <td class=\"subtitle1_left\">Female livebirths</td> <td class=\"centered\">41,585</td> <td class=\"centered\">&nbsp;</td> <td class=\"centered\">&nbsp;</td> </tr> <tr> <td class=\"subtitle1_left\" colspan=\"2\">Type of abnormality</td> <td class=\"subtitle1_left\">Number of cases</td> <td class=\"subtitle1_left\">Rate</td> </tr> <tr> <td class=\"subtitle2_single\" colspan=\"4\">Autosomal trisomies</td> </tr> <tr> <td class=\"indent1\" colspan=\"2\">47, +21</td> <td>141</td> <td>1/730</td> </tr> <tr> <td class=\"indent1\" colspan=\"2\">47, +18</td> <td>19</td> <td>1/5424</td> </tr> <tr> <td class=\"indent1\" colspan=\"2\">47, +13</td> <td>6</td> <td>1/17,178</td> </tr> <tr> <td class=\"subtitle2_single\" colspan=\"4\">Sex chromosome abnormalities - males</td> </tr> <tr> <td class=\"indent1\" colspan=\"2\">47, XXY</td> <td>73</td> <td>1/842</td> </tr> <tr> <td class=\"indent1\" colspan=\"2\">47, XYY</td> <td>66</td> <td>1/931</td> </tr> <tr> <td class=\"subtitle2_single\" colspan=\"4\">Sex chromosome abnormalities - females</td> </tr> <tr> <td class=\"indent1\" colspan=\"2\">47, XXX</td> <td>45</td> <td>1/924</td> </tr> <tr> <td class=\"indent1\" colspan=\"2\">45, X</td> <td>15</td> <td>1/2772</td> </tr> <tr> <td class=\"subtitle2_single\" colspan=\"4\">Structural abnormalities</td> </tr> <tr> <td class=\"indent1\" colspan=\"2\">Balanced</td> <td>139</td> <td>1/490</td> </tr> <tr> <td class=\"indent1\" colspan=\"2\">Unbalanced</td> <td>43</td> <td>1/1516</td> </tr> <tr> <td class=\"indent1\" colspan=\"2\"><strong>Total abnormalities</strong></td> <td>736</td> <td>1/140</td> </tr> </tbody></table></div><div class=\"graphic_reference\">Data from: Hsu LYF. Prenatal diagnosis of chromosomal abnormalities through amniocentesis. In: Genetic Disorders and the Fetus, 4th ed, Milunsky A (Ed), Johns Hopkins University Press, Baltimore 1998. p.180.</div><div id=\"graphicVersion\">Graphic 52347 Version 4.0</div></div></div>"},"52349":{"type":"graphic_table","displayName":"Fiber in foods PI","title":"Amount of fiber in different foods","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Amount of fiber in different foods</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup width=\"60%\"></colgroup><colgroup span=\"2\" width=\"20%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\">Food</td> <td class=\"subtitle1\">Serving</td> <td class=\"subtitle1\">Grams of fiber</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"3\">Fruits</td> </tr> <tr> <td class=\"indent1\">Apple (with skin)</td> <td>1 medium apple</td> <td>4.4</td> </tr> <tr> <td class=\"indent1\">Banana</td> <td>1 medium banana</td> <td>3.1</td> </tr> <tr> <td class=\"indent1\">Oranges</td> <td>1 orange</td> <td>3.1</td> </tr> <tr> <td class=\"indent1\">Prunes</td> <td>1 cup, pitted</td> <td>12.4</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"3\">Juices</td> </tr> <tr> <td class=\"indent1\">Apple, unsweetened, with added ascorbic acid</td> <td>1 cup</td> <td>0.5</td> </tr> <tr> <td class=\"indent1\">Grapefruit, white, canned, sweetened</td> <td>1 cup</td> <td>0.2</td> </tr> <tr> <td class=\"indent1\">Grape, unsweetened, with added ascorbic acid</td> <td>1 cup</td> <td>0.5</td> </tr> <tr> <td class=\"indent1\">Orange</td> <td>1 cup</td> <td>0.7</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"3\">Vegetables</td> </tr> <tr> <td class=\"subtitle3_left\" colspan=\"3\">Cooked</td> </tr> <tr> <td class=\"indent2\">Green beans</td> <td>1 cup</td> <td>4.0</td> </tr> <tr> <td class=\"indent2\">Carrots</td> <td>1/2 cup sliced</td> <td>2.3</td> </tr> <tr> <td class=\"indent2\">Peas</td> <td>1 cup</td> <td>8.8</td> </tr> <tr> <td class=\"indent2\">Potato (baked, with skin)</td> <td>1 medium potato</td> <td>3.8</td> </tr> <tr> <td class=\"subtitle3_left\" colspan=\"3\">Raw</td> </tr> <tr> <td class=\"indent2\">Cucumber (with peel)</td> <td>1 cucumber</td> <td>1.5</td> </tr> <tr> <td class=\"indent2\">Lettuce</td> <td>1 cup shredded</td> <td>0.5</td> </tr> <tr> <td class=\"indent2\">Tomato</td> <td>1 medium tomato</td> <td>1.5</td> </tr> <tr> <td class=\"indent2\">Spinach</td> <td>1 cup</td> <td>0.7</td> </tr> <tr> <td class=\"subtitle3_left\" colspan=\"3\">Legumes</td> </tr> <tr> <td class=\"indent2\">Baked beans, canned, no salt added</td> <td>1 cup</td> <td>13.9</td> </tr> <tr> <td class=\"indent2\">Kidney beans, canned</td> <td>1 cup</td> <td>13.6</td> </tr> <tr> <td class=\"indent2\">Lima beans, canned</td> <td>1 cup</td> <td>11.6</td> </tr> <tr> <td class=\"indent2\">Lentils, boiled</td> <td>1 cup</td> <td>15.6</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"3\">Breads, pastas, flours</td> </tr> <tr> <td class=\"indent1\">Bran muffins</td> <td>1 medium muffin</td> <td>5.2</td> </tr> <tr> <td class=\"indent1\">Oatmeal, cooked</td> <td>1 cup</td> <td>4.0</td> </tr> <tr> <td class=\"indent1\">White bread</td> <td>1 slice</td> <td>0.6</td> </tr> <tr> <td class=\"indent1\">Whole-wheat bread</td> <td>1 slice</td> <td>1.9</td> </tr> <tr> <td class=\"subtitle3_left\" colspan=\"3\">Pasta and rice, cooked</td> </tr> <tr> <td class=\"indent2\">Macaroni</td> <td>1 cup</td> <td>2.5</td> </tr> <tr> <td class=\"indent2\">Rice, brown</td> <td>1 cup</td> <td>3.5</td> </tr> <tr> <td class=\"indent2\">Rice, white</td> <td>1 cup</td> <td>0.6</td> </tr> <tr> <td class=\"indent2\">Spaghetti (regular)</td> <td>1 cup</td> <td>2.5</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"3\">Nuts</td> </tr> <tr> <td class=\"indent1\">Almonds</td> <td>1/2 cup</td> <td>8.7</td> </tr> <tr> <td class=\"indent1\">Peanuts</td> <td>1/2 cup</td> <td>7.9</td> </tr> </tbody></table></div><div class=\"graphic_lgnd\">To learn how much fiber and other nutrients are in different foods, visit the United States Department of Agriculture (USDA) National Nutrient Database at: http://www.nal.usda.gov/fnic/foodcomp/search/.</div><div class=\"graphic_reference\">Created using data from the USDA National Nutrient Database for Standard Reference. Available at http://www.nal.usda.gov/fnic/foodcomp/search/.</div><div id=\"graphicVersion\">Graphic 52349 Version 4.0</div></div></div>"},"52350":{"type":"graphic_figure","displayName":"Components of Roux-en-Y gastric bypass procedure","title":"Components of Roux-en-Y gastric bypass procedure","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Components of Roux-en-Y gastric bypass procedure</div><div class=\"cntnt\"><img style=\"width:364px; height:537px;\" src=\"images/SURG/52350_Components-Roux-en-Y.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">This figure depicts the components of a Roux-en-Y gastric bypass (RYGB)&nbsp;procedure. RYGB involves the creation of a small gastric pouch and an anastomosis to a Roux limb of jejunum that bypasses 75 to 150 cm of small bowel, thereby restricting food and limiting absorption.</div><div id=\"graphicVersion\">Graphic 52350 Version 2.0</div></div></div>"},"52351":{"type":"graphic_table","displayName":"Shoulder range of motion","title":"Approximate normal shoulder range of motion","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Approximate normal shoulder range of motion</div><div class=\"cntnt\"><table cellspacing=\"0\">\n<tbody>\n\n<tr>\n<td>Abduction</td>\n<td>180&#186;</td>\n</tr>\n<tr>\n<td>Adduction</td>\n<td>45&#186;</td>\n</tr>\n<tr>\n<td>Flexion</td>\n<td>135&#186;</td>\n</tr>\n<tr>\n<td>Extension</td>\n<td>45&#186;</td>\n</tr>\n<tr>\n<td>Internal rotation</td>\n<td>70&#186;</td>\n</tr>\n<tr>\n<td>External rotation</td>\n<td>45&#186;</td>\n</tr>\n</tbody>\n</table></div><div id=\"graphicVersion\">Graphic 52351 Version 1.0</div></div></div>"},"52352":{"type":"graphic_picture","displayName":"Urticarial rash as a consequence of a serum sickness reaction","title":"Urticarial rash as a consequence of a serum sickness reaction","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Urticarial rash as a consequence of a serum sickness reaction</div><div class=\"cntnt\"><img style=\"width:252px; height:389px;\" src=\"images/ALLRG/52352_Serum_sickness_urticarial.jpg\" alt=\"Image\"/></div><div class=\"graphic_reference\">Copyright 2007 from Case Studies in Immunology by Geha &amp; Rosen. Reproduced by permission of Garland Science/Taylor &amp; Francis LLC.</div><div id=\"graphicVersion\">Graphic 52352 Version 2.0</div></div></div>"},"52353":{"type":"graphic_figure","displayName":"Laparoscopic cystectomy cd","title":"Laparoscopic ovarian cystectomy","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Laparoscopic ovarian cystectomy</div><div class=\"cntnt\"><img style=\"width:431px; height:267px;\" src=\"images/OBGYN/52353_Laparoscopic_cystectomy_cd.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">(C) Alternatively, the cyst wall can be grasped and rotated to separate it from the ovarian cortex. (D) The cyst is removed and the ovary is left to heal by secondary intention.</div><div class=\"graphic_reference\">Courtesy of William J Mann, Jr, MD.</div><div id=\"graphicVersion\">Graphic 52353 Version 3.0</div></div></div>"},"52354":{"type":"graphic_table","displayName":"Causes BMF","title":"Major causes of bone marrow failure","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Major causes of bone marrow failure</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1_single\">Inherited bone marrow failure syndromes</td> </tr> <tr> <td>Fanconi anemia</td> </tr> <tr> <td>Dyskeratosis congenita</td> </tr> <tr> <td>Shwachman-Diamond syndrome</td> </tr> <tr> <td>Amegakaryocytic thrombocytopenia</td> </tr> <tr> <td>Reticular dysgenesis</td> </tr> <tr> <td>Other</td> </tr> <tr> <td class=\"subtitle1_single\">Acquired causes of bone marrow failure</td> </tr> <tr> <td>Acquired aplastic anemia caused by drugs, chemicals, or radiation</td> </tr> <tr> <td>Acquired aplastic anemia associated with viral infection or immune disorder</td> </tr> <tr> <td>Myelodysplastic syndromes</td> </tr> <tr> <td>Paroxysmal nocturnal hemoglobinuria</td> </tr> <tr> <td>Large granular lymphocytic leukemia</td> </tr> </tbody></table></div><div class=\"graphic_lgnd\">Refer to UpToDate topics on bone marrow failure syndromes and pancytopenia for details.</div><div class=\"graphic_footnotes\">BMF: Bone marrow failure.</div><div id=\"graphicVersion\">Graphic 52354 Version 5.0</div></div></div>"},"52357":{"type":"graphic_table","displayName":"Sleep apnea clinical score","title":"Sleep apnea clinical score","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Sleep apnea clinical score</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup span=\"7\" width=\"14%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\" rowspan=\"2\">Neck circumference (cm)</td> <td class=\"subtitle1\" colspan=\"3\">Not hypertensive historical features*</td> <td class=\"subtitle1\" colspan=\"3\">Hypertensive historical features</td> </tr> <tr> <td class=\"subtitle2\">None</td> <td class=\"subtitle2\">One</td> <td class=\"subtitle2\">Both</td> <td class=\"subtitle2\">None</td> <td class=\"subtitle2\">One</td> <td class=\"subtitle2\">Both</td> </tr> <tr> <td class=\"centered\">28</td> <td class=\"centered\">0</td> <td class=\"centered\">0</td> <td class=\"centered\">1</td> <td class=\"centered\">0</td> <td class=\"centered\">1</td> <td class=\"centered\">2</td> </tr> <tr> <td class=\"centered\">30</td> <td class=\"centered\">0</td> <td class=\"centered\">0</td> <td class=\"centered\">1</td> <td class=\"centered\">1</td> <td class=\"centered\">2</td> <td class=\"centered\">4</td> </tr> <tr> <td class=\"centered\">32</td> <td class=\"centered\">0</td> <td class=\"centered\">1</td> <td class=\"centered\">2</td> <td class=\"centered\">1</td> <td class=\"centered\">3</td> <td class=\"centered\">5</td> </tr> <tr> <td class=\"centered\">34</td> <td class=\"centered\">1</td> <td class=\"centered\">2</td> <td class=\"centered\">3</td> <td class=\"centered\">2</td> <td class=\"centered\">4</td> <td class=\"centered\">8</td> </tr> <tr> <td class=\"centered\">36</td> <td class=\"centered\">1</td> <td class=\"centered\">3</td> <td class=\"centered\">5</td> <td class=\"centered\">4</td> <td class=\"centered\">6</td> <td class=\"centered\">11</td> </tr> <tr> <td class=\"centered\">38</td> <td class=\"centered\">2</td> <td class=\"centered\">4</td> <td class=\"centered\">7</td> <td class=\"centered\">5</td> <td class=\"centered\">9</td> <td class=\"centered highlight_gray_text\">16</td> </tr> <tr> <td class=\"centered\">40</td> <td class=\"centered\">3</td> <td class=\"centered\">6</td> <td class=\"centered\">10</td> <td class=\"centered\">8</td> <td class=\"centered\">13</td> <td class=\"centered highlight_gray_text\">22</td> </tr> <tr> <td class=\"centered\">42</td> <td class=\"centered\">5</td> <td class=\"centered\">8</td> <td class=\"centered\">14</td> <td class=\"centered\">11</td> <td class=\"centered highlight_gray_text\">18</td> <td class=\"centered highlight_gray_text\">30</td> </tr> <tr> <td class=\"centered\">44</td> <td class=\"centered\">7</td> <td class=\"centered\">12</td> <td class=\"centered highlight_gray_text\">20</td> <td class=\"centered highlight_gray_text\">15</td> <td class=\"centered highlight_gray_text\">25</td> <td class=\"centered highlight_gray_text\">42</td> </tr> <tr> <td class=\"centered\">46</td> <td class=\"centered\">10</td> <td class=\"centered highlight_gray_text\">16</td> <td class=\"centered highlight_gray_text\">28</td> <td class=\"centered highlight_gray_text\">21</td> <td class=\"centered highlight_gray_text\">35</td> <td class=\"centered highlight_gray_text\">58</td> </tr> <tr> <td class=\"centered\">48</td> <td class=\"centered\">14</td> <td class=\"centered highlight_gray_text\">23</td> <td class=\"centered highlight_gray_text\">38</td> <td class=\"centered highlight_gray_text\">29</td> <td class=\"centered highlight_gray_text\">48</td> <td class=\"centered highlight_gray_text\">80</td> </tr> <tr> <td class=\"centered\">50</td> <td class=\"centered highlight_gray_text\">19</td> <td class=\"centered highlight_gray_text\">32</td> <td class=\"centered highlight_gray_text\">53</td> <td class=\"centered highlight_gray_text\">40</td> <td class=\"centered highlight_gray_text\">66</td> <td class=\"centered highlight_gray_text\">110</td> </tr> </tbody></table></div><div class=\"graphic_lgnd\">Sleep apnea clinical score to predict the apnea-hypopnea index using the linear model of neck circumference, hypertension, and historical features of habitual snoring and partner's observation of nocturnal choking or gasping. Begin on the line of the patient's neck circumference and then choose the appropriate value based upon the presence or absence of hypertension and whether the patient has none, one, or both of the above historical features.<br />A clinical score of 15 or greater indicates a high risk of obstructive sleep apnea.</div><div class=\"graphic_footnotes\">* Historical features are habitual snoring and partner reports of nocturnal choking or gasping.</div><div class=\"graphic_reference\">Redrawn from: Flemons WW, Whitelaw WA, Brant R, Remmers JE. Am J Respir Crit Care Med 1994; 150:1279.</div><div id=\"graphicVersion\">Graphic 52357 Version 5.0</div></div></div>"},"52358":{"type":"graphic_figure","displayName":"Abdominal wall hernias","title":"Abdominal wall hernias","html":"<div class=\"graphic\"><div style=\"width: 503px\" class=\"figure\"><div class=\"ttl\">Abdominal wall hernias</div><div class=\"cntnt\"><img style=\"width:483px; height:615px;\" src=\"images/SURG/52358_Abdominal_wall_hernias.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Abdominal wall hernias include incisional hernias which occur along incisions from a prior surgery; umbical hernias; epigastric hernias, which occur between the umbilicus and xiphoid; spigelian hernias located at the arcuate line; lumbar hernias in the flank (not shown); and groin hernias (inguinal and femoral hernias).</div><div id=\"graphicVersion\">Graphic 52358 Version 3.0</div></div></div>"},"52360":{"type":"graphic_picture","displayName":"Seborrheic keratosis inflamed","title":"Inflamed seborrheic keratosis","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Inflamed seborrheic keratosis</div><div class=\"cntnt\"><img style=\"width:432px; height:324px;\" src=\"images/DERM/52360_Sebor_kerato_inflamed.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Inflamed and hyperpigmented seborrheic keratosis.</div><div class=\"graphic_reference\">Reproduced with permission from: <A style=\"FONT-STYLE: italic\" href=\"http://www.visualdx.com/\" target=_blank>www.visualdx.com</A>. Copyright Logical Images, Inc.</div><div id=\"graphicVersion\">Graphic 52360 Version 4.0</div></div></div>"},"52364":{"type":"graphic_diagnosticimage","displayName":"RBF in sickle cell disease","title":"Microradiographs showing renal vasculature in sickle cell disease","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Microradiographs showing renal vasculature in sickle cell disease</div><div class=\"cntnt\"><img style=\"width:378px; height:184px;\" src=\"images/NEPH/52364_RBFinsicklecelldisease.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Injection microradiographs of kidneys from an individual with no hemoglobinopathy (A), sickle cell trait (B), and sickle cell disease (C). The renal cortex is at the top and the medullary pyramid is at the bottom of each picture.<br />(A) In the normal kidney, the vasa recta are visible radiating into the renal papilla (arrow), and the cortical vasculature is dense and uniform.<br />(B) In sickle cell trait, the cortical vasculature is somewhat decreased, and the vasa recta are attenuated and distorted.<br />(C) In sickle cell disease, there is a considerable decrease in the cortical vasculature, and the vasa recta are virtually absent.</div><div class=\"graphic_reference\">From Statius van Eps LW, Earley LE. In: Strauss and Welt's Diseases of the Kidney, 3rd ed, Earley LE, Gottschalk CW (Eds), Little, Brown, Boston 1979.</div><div id=\"graphicVersion\">Graphic 52364 Version 5.0</div></div></div>"},"52365":{"type":"graphic_waveform","displayName":"CW Doppler HCM with LVOT obstruction","title":"Continuous wave (CW) Doppler echocardiogram showing a 100 mmHg gradient across the left ventricular outflow tract (LVOT) in a patient with hypertrophic cardiomyopathy (HCM)","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Continuous wave (CW) Doppler echocardiogram showing a 100 mmHg gradient across the left ventricular outflow tract (LVOT) in a patient with hypertrophic cardiomyopathy (HCM)</div><div class=\"cntnt\"><img style=\"width:393px; height:195px;\" src=\"images/CARD/52365_HCM_CW_Doppler.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The continuous wave Doppler demonstrates the characteristic profile of dynamic left ventricular outflow tract obstruction; the peak velocity across the obstruction is 5 m/sec or a gradient of 100 mmHg. When severe, outflow tract signal can be difficult to distinguish between the mitral regurgitation that frequently accompanies systolic anterior motion of the mitral valve.</div><div class=\"graphic_reference\">Courtesy of Perry Elliot, MD.</div><div id=\"graphicVersion\">Graphic 52365 Version 3.0</div></div></div>"},"52366":{"type":"graphic_table","displayName":"Nutritional assessment for children with CKD","title":"Recommended parameters and frequency of nutritional assessment for children with CKD stages 2 to 5 and 5D","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Recommended parameters and frequency of nutritional assessment for children with CKD stages 2 to 5 and 5D</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1\" rowspan=\"3\">Measure</td> <td class=\"subtitle1\" colspan=\"10\">Minimum interval (month)</td> </tr> <tr> <td class=\"subtitle2\" colspan=\"3\">Age 0 to &#60;1 year</td> <td class=\"subtitle2\" colspan=\"3\">Age 1 to 3 years</td> <td class=\"subtitle2\" colspan=\"4\">Age &#62;3 years</td> </tr> <tr> <td class=\"subtitle3\">CKD 2 or 3</td> <td class=\"subtitle3\">CKD 4 or 5</td> <td class=\"subtitle3\">CKD 5D</td> <td class=\"subtitle3\">CKD 2 or 3</td> <td class=\"subtitle3\">CKD 4 or 5</td> <td class=\"subtitle3\">CKD 5D</td> <td class=\"subtitle3\">CKD 2</td> <td class=\"subtitle3\">CKD 3</td> <td class=\"subtitle3\">CKD 4 or 5</td> <td class=\"subtitle3\">CKD 5D</td> </tr> <tr> <td>Dietary intake</td> <td>0.5 to 3</td> <td>0.5 to 3</td> <td>0.5 to 2</td> <td>1 to 3</td> <td>1 to 3</td> <td>1 to 3</td> <td>6 to 12</td> <td>6</td> <td>3 to 4</td> <td>3 to 4</td> </tr> <tr> <td>Height or length-for-age percentile or SDS</td> <td>0.5 to 1.5</td> <td>0.5 to 1.5</td> <td>0.5 to 1</td> <td>1 to 3</td> <td>1 to 2</td> <td>1</td> <td>3 to 6</td> <td>3 to 6</td> <td>1 to 3</td> <td>1 to 3</td> </tr> <tr> <td>Height or length velocity-for-age percentile or SDS</td> <td>0.5 to 2</td> <td>0.5 to 2</td> <td>0.5 to 1</td> <td>1 to 6</td> <td>1 to 3</td> <td>1 to 2</td> <td>6</td> <td>6</td> <td>6</td> <td>6</td> </tr> <tr> <td>Estimated dry weight and weight-for-age percentile or SDS</td> <td>0.5 to 1.5</td> <td>0.5 to 1.5</td> <td>0.25 to 1</td> <td>1 to 3</td> <td>1 to 2</td> <td>0.5 to 1</td> <td>3 to 6</td> <td>3 to 6</td> <td>1 to 3</td> <td>1 to 3</td> </tr> <tr> <td>BMI-for-height-age percentile or SDS</td> <td>0.5 to 1.5</td> <td>0.5 to 1.5</td> <td>0.5 to 1</td> <td>1 to 3</td> <td>1 to 2</td> <td>1</td> <td>3 to 6</td> <td>3 to 6</td> <td>1 to 3</td> <td>1 to 3</td> </tr> <tr> <td>Head circumference-for-age percentile or SDS</td> <td>0.5 to 1.5</td> <td>0.5 to 1.5</td> <td>0.5 to 1</td> <td>1 to 3</td> <td>1 to 2</td> <td>1 to 2</td> <td>N/A</td> <td>N/A</td> <td>N/A</td> <td>N/A</td> </tr> <tr> <td>nPCR</td> <td>N/A</td> <td>N/A</td> <td>N/A</td> <td>N/A</td> <td>N/A</td> <td>N/A</td> <td>N/A</td> <td>N/A</td> <td>N/A</td> <td>1*</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">CKD: chronic kidney disease; SDS: standard deviations score; BMI: body mass index; N/A: not applicable; nPCR: normalized protein catabolic rate.<br />* Only applies to adolescents receiving hemodialysis.</div><div class=\"graphic_reference\">Reproduced with permission from: National Kidney Foundation. Recommendation 1: Evaluation of Growth and Nutritional Status. Am J Kid Dis 2009; 53:S16. Illustration used with permission of Elsevier Inc. All rights reserved.</div><div id=\"graphicVersion\">Graphic 52366 Version 5.0</div></div></div>"},"52367":{"type":"graphic_diagnosticimage","displayName":"Long axis scan aspiration extensor digitorum tenosynovitis","title":"Long axis scan aspiration extensor digitorum tenosynovitis","html":"<div class=\"graphic\"><div style=\"width: 524px\" class=\"figure\"><div class=\"ttl\">Long axis scan aspiration extensor digitorum tenosynovitis</div><div class=\"cntnt\"><img style=\"width:504px; height:239px;\" src=\"images/RHEUM/52367_Long_axis_scan_digit_tenosy.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Long axis scan of needle aspiration of extensor digitorum tenosynovitis.</div><div class=\"graphic_reference\">Reproduced with permission from: Introductory Guide to Musculoskeletal Ultrasound for the Rheumatologist, Second Edition. ISBN 978-90-313-9206-3; Bohn Stafleu van Loghum, Houten 2012. Copyright Â© 2012.</div><div id=\"graphicVersion\">Graphic 52367 Version 1.0</div></div></div>"},"52368":{"type":"graphic_picture","displayName":"Keratoacanthoma on eyelid","title":"Keratoacanthoma","html":"<div class=\"graphic\"><div style=\"width: 524px\" class=\"figure\"><div class=\"ttl\">Keratoacanthoma</div><div class=\"cntnt\"><img style=\"width:504px; height:379px;\" src=\"images/DERM/52368_keratoacanthoma_eye.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">A nodule with central hyperkeratosis on the lower eyelid.</div><div class=\"graphic_reference\">Reproduced with permission from: <A style=\"FONT-STYLE: italic\" href=\"http://www.visualdx.com/\" target=_blank>www.visualdx.com</A>. Copyright Logical Images, Inc.</div><div id=\"graphicVersion\">Graphic 52368 Version 4.0</div></div></div>"},"52370":{"type":"graphic_diagnosticimage","displayName":"Pelvic congestion syndrome 11a","title":"Left ovarian venogram","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Left ovarian venogram</div><div class=\"cntnt\"><img style=\"width:332px; height:475px;\" src=\"images/OBGYN/52370_Pelvic_congestion_syndrom1.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Left ovarian venogram in a 37-year-old woman with chronic pelvic congestion syndrome demonstrates dilated left ovarian vein and filling of uterine venous plexus.</div><div id=\"graphicVersion\">Graphic 52370 Version 2.0</div></div></div>"},"52371":{"type":"graphic_picture","displayName":"Facial features in adult with DiGeorge","title":"Facial features in an adult patient with 22q11DS (DiGeorge syndrome)","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Facial features in an adult patient with 22q11DS (DiGeorge syndrome)</div><div class=\"cntnt\"><img style=\"width:324px; height:460px;\" src=\"images/ALLRG/52371_DiGeorgeadultfacies.jpg\" alt=\"Image\"/></div><div class=\"graphic_reference\">Reproduced with permission from: Bassett AS, Chow EW, Husted J, et al. Clinical features of 78 adults with 22q11 Deletion Syndrome. Am J Med Genet A 2005; 138:307. Copyright Â©2005 John Wiley &amp; Sons, Inc.</div><div id=\"graphicVersion\">Graphic 52371 Version 3.0</div></div></div>"},"52373":{"type":"graphic_table","displayName":"Contributors major depression","title":"General medical conditions causing or contributing to major depression (\"secondary depression\")","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">General medical conditions causing or contributing to major depression (\"secondary depression\")</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1_single\">Drugs and poisons </td> </tr> <tr> <td>Alcohol, beta blockers, steroids, opiates, barbiturates, withdrawal from cocaine and amphetamines, heavy metal poisoning, cholinesterase inhibitors, cimetidine, chemotherapy agents</td> </tr> <tr> <td class=\"subtitle1_single\">Metabolic/endocrine </td> </tr> <tr> <td>Hyper- and hypothyroidism, severe anemia, hyperparathyroidism, hypokalemia, hyponatremia, Cushing disease, Addison disease, uremia, hypopituitarism, porphyria, Wilson Disease, Wernicke-Korsakoff syndrome</td> </tr> <tr> <td class=\"subtitle1_single\">Infectious diseases </td> </tr> <tr> <td>Tuberculosis, Epstein-Barr infection, HIV, pneumonia, postinfluenza, tertiary syphilis, encephalitis, and postencephalitic states</td> </tr> <tr> <td class=\"subtitle1_single\">Neurodegenerative and demyelinating diseases </td> </tr> <tr> <td>Alzheimer disease, multiple sclerosis, Parkinson disease, Huntington disease</td> </tr> <tr> <td class=\"subtitle1_single\">Other neurologic </td> </tr> <tr> <td>Subdural hematoma, normal pressure hydrocephalus, strokes, posttraumatic brain injury syndromes, cerebral tumors</td> </tr> <tr> <td class=\"subtitle1_single\">Neoplasia </td> </tr> <tr> <td>Carcinomatosis, cancers of the pancreas, lung, breast, and others</td> </tr> <tr> <td class=\"subtitle1_single\">Others </td> </tr> <tr> <td>Systemic lupus erythematosus, other collagen vascular disorders, other chronic inflammatory or autoimmune disorders, heart failure</td> </tr> </tbody></table></div><div class=\"graphic_reference\">Reproduced with permission from: Privitera MR, Lyness JM. Depression. In: The Practice of Geriatrics, 4th ed, Duthie E Jr, Katz PR, Malone ML (Eds), W.B. Saunders, 2007. Copyright Â© 2007 Elsevier.</div><div id=\"graphicVersion\">Graphic 52373 Version 3.0</div></div></div>"},"52374":{"type":"graphic_table","displayName":"Causes of DAH","title":"Causes of diffuse alveolar hemorrhage syndromes (DAH) based on histologic appearance","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Causes of diffuse alveolar hemorrhage syndromes (DAH) based on histologic appearance</div><div class=\"cntnt\"><table class=\"container\" cellspacing=\"0\"><colgroup span=\"2\" width=\"50%\"></colgroup> <tbody> <tr> <td class=\"container\"> <table cellspacing=\"0\"> <tbody> <tr> <td class=\"subtitle1_single\">Capillaritis</td> </tr> <tr> <td class=\"subtitle2_single\">Systemic vasculitides</td> </tr> <tr> <td class=\"indent1\">Beh&#231;et's syndrome</td> </tr> <tr> <td class=\"indent1\">Cryoglobulinemia</td> </tr> <tr> <td class=\"indent1\">Granulomatosis with polyangiitis (Wegener's)</td> </tr> <tr> <td class=\"indent1\">Henoch-Sch&#246;nlein purpura</td> </tr> <tr> <td class=\"indent1\">IgA nephropathy</td> </tr> <tr> <td class=\"indent1\">Microscopic polyangiitis</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">Pauci-immune glomerulonephritis</td> </tr> <tr> <td class=\"subtitle2_single\">Rheumatic diseases</td> </tr> <tr> <td class=\"indent1\">Mixed connective tissue disease</td> </tr> <tr> <td class=\"indent1\">Anti-GBM (Goodpasture) disease*</td> </tr> <tr> <td class=\"indent1\">Isolated pulmonary capillaritis (ANCA positive)</td> </tr> <tr> <td class=\"indent1\">Polymyositis</td> </tr> <tr> <td class=\"indent1\">Primary antiphospholipid antibody syndrome</td> </tr> <tr> <td class=\"indent1\">Rheumatoid arthritis</td> </tr> <tr> <td class=\"indent1\">Systemic lupus erythematosus*</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">Systemic sclerosis</td> </tr> <tr> <td class=\"subtitle2_single\">Drugs</td> </tr> <tr> <td class=\"indent1\">Carbimazole</td> </tr> <tr> <td class=\"indent1\">Differentiation (retinoic acid syndrome)</td> </tr> <tr> <td class=\"indent1\">Diphenylhydantoin</td> </tr> <tr> <td class=\"indent1\">Hydralazine</td> </tr> <tr> <td class=\"indent1\">Propylthiouracil</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">Tumor necrosis factor (TNF)-alpha antagonists</td> </tr> <tr> <td class=\"subtitle2_single\">Other</td> </tr> <tr> <td class=\"indent1\">Autologous hematopoietic cell transplantation</td> </tr> <tr> <td class=\"indent1\">Idiopathic pulmonary hemosiderosis*</td> </tr> <tr> <td class=\"indent1\">Infective endocarditis</td> </tr> <tr> <td class=\"indent1\">Isolated pulmonary capillaritis (ANCA negative)</td> </tr> <tr> <td class=\"indent1\">Leptospirosis</td> </tr> <tr> <td class=\"indent1\">Acute lung transplant rejection</td> </tr> <tr> <td class=\"indent1\">Ulcerative colitis</td> </tr> </tbody> </table> </td> <td class=\"container\"> <table cellspacing=\"0\"> <tbody> <tr> <td class=\"subtitle1_single\">Bland hemorrhage</td> </tr> <tr> <td class=\"subtitle2_single\">Connective tissue disease</td> </tr> <tr> <td class=\"indent1\">Anti-GBM (Goodpasture) disease*</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">Systemic lupus erythematosus*</td> </tr> <tr> <td class=\"subtitle2_single\">Drugs</td> </tr> <tr> <td class=\"indent1\">Anticoagulant therapy</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">Platelet glycoprotein IIB/IIIA inhibitors</td> </tr> <tr> <td class=\"subtitle2_single\">Other</td> </tr> <tr> <td class=\"indent1\">Thrombocytopenias (ITP, TTP, HUS)</td> </tr> <tr> <td class=\"indent1\">Idiopathic pulmonary hemosiderosis*</td> </tr> <tr> <td class=\"indent1\">Leptospirosis</td> </tr> <tr> <td class=\"indent1\">Mitral stenosis</td> </tr> <tr> <td class=\"indent1\">Promyelocytic leukemia</td> </tr> </tbody> </table> </td> <td class=\"container\"> <table cellspacing=\"0\"> <tbody> <tr> <td class=\"subtitle1_single\">Diffuse alveolar damage</td> </tr> <tr> <td class=\"subtitle2_single\">Infection</td> </tr> <tr> <td class=\"indent1\">Any infection causing ARDS (bacterial, viral)</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">Opportunistic infections in immunocompromised host</td> </tr> <tr> <td class=\"subtitle2_single\">Rheumatic diseases</td> </tr> <tr> <td class=\"indent1\">Polymyositis</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">Systemic lupus erythematosus</td> </tr> <tr> <td class=\"subtitle2_single\">Drugs and toxins</td> </tr> <tr> <td class=\"indent1\">Amiodarone</td> </tr> <tr> <td class=\"indent1\">Amphetamine</td> </tr> <tr> <td class=\"indent1\">Crack cocaine</td> </tr> <tr> <td class=\"indent1\">Cytotoxic drugs</td> </tr> <tr> <td class=\"indent1\">Isocyanates</td> </tr> <tr> <td class=\"indent1\">Nitrofurantoin</td> </tr> <tr> <td class=\"indent1\">Penicillamine</td> </tr> <tr> <td class=\"indent1\">Propylthiouracil</td> </tr> <tr> <td class=\"indent1\">Sirolimus</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">Trimellitic anhydride</td> </tr> <tr> <td class=\"subtitle2_single\">Other</td> </tr> <tr> <td class=\"indent1\">Acute interstitial pneumonia</td> </tr> <tr> <td class=\"indent1\">ARDS&nbsp;(any cause)</td> </tr> <tr> <td class=\"indent1\">Organizing pneumonia</td> </tr> <tr> <td class=\"indent1\">Pulmonary infarction</td> </tr> <tr> <td class=\"indent1\">Radiation therapy</td> </tr> </tbody> </table> </td> <td class=\"container\"> <table cellspacing=\"0\"> <tbody> <tr> <td class=\"subtitle1_single\">Miscellaneous</td> </tr> <tr> <td>Angiosarcoma</td> </tr> <tr> <td>Choriocarcinoma</td> </tr> <tr> <td>Epithelioid hemangioepithelioma</td> </tr> <tr> <td>Metastatic renal cell carcinoma</td> </tr> <tr> <td>Pulmonary vein stenosis</td> </tr> <tr> <td>Pulmonary veno-occlusive disease/pulmonary capillary hemangiomatosis</td> </tr> <tr> <td>Tuberous sclerosis/Lymphangioleiomyomatosis</td> </tr> </tbody> </table> </td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">IgA: immunoglobulin A; ANCA: antineutrophil cytoplasmic antibody; ITP: immune thrombocytopenia; TTP: thrombotic thrombocytopenic purpura; HUS: hemolytic uremic syndrome; ARDS: acute respiratory distress syndrome.<br />* Both capillaritis and bland hemorrhage can be seen in these conditions.</div><div id=\"graphicVersion\">Graphic 52374 Version 7.0</div></div></div>"},"52381":{"type":"graphic_table","displayName":"Example of 12-step desensitization protocol","title":"Example of 12-step desensitization protocol for 2000 mg of ceftazidime (250 mL per solution)","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Example of 12-step desensitization protocol for 2000 mg of ceftazidime (250 mL per solution)</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup span=\"7\" width=\"14%\"></colgroup> <tbody> <tr> <td class=\"subtitle2\">Solution</td> <td class=\"subtitle2\" colspan=\"2\">Total volume</td> <td class=\"subtitle2\" colspan=\"2\">Concentration</td> <td class=\"subtitle2\" colspan=\"2\">Dose</td> </tr> <tr> <td>Solution 1</td> <td colspan=\"2\">250 mL</td> <td colspan=\"2\">0.080 mg/mL</td> <td colspan=\"2\">20 mg</td> </tr> <tr> <td>Solution 2</td> <td colspan=\"2\">250 mL</td> <td colspan=\"2\">0.800 mg/mL</td> <td colspan=\"2\">200 mg</td> </tr> <tr> <td>Solution 3</td> <td colspan=\"2\">250 mL</td> <td colspan=\"2\">7.937 mg/mL</td> <td colspan=\"2\">2000 mg</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"7\">&nbsp;</td> </tr> <tr> <td class=\"subtitle1\">Step</td> <td class=\"subtitle1\">Solution</td> <td class=\"subtitle1\">Rate (mL/hour)</td> <td class=\"subtitle1\">Time (minutes)</td> <td class=\"subtitle1\">Volume infused per step (mL)</td> <td class=\"subtitle1\">Dose administered with this step (mg)</td> <td class=\"subtitle1\">Cumulative dose (mg)</td> </tr> <tr> <td>1</td> <td>1</td> <td>2.0</td> <td>15</td> <td>0.50</td> <td>0.040</td> <td>0.040</td> </tr> <tr> <td>2</td> <td>1</td> <td>5.0</td> <td>15</td> <td>1.25</td> <td>0.100</td> <td>0.140</td> </tr> <tr> <td>3</td> <td>1</td> <td>10.0</td> <td>15</td> <td>2.50</td> <td>0.200</td> <td>0.340</td> </tr> <tr> <td>4</td> <td>1</td> <td>20.0</td> <td>15</td> <td>5.00</td> <td>0.400</td> <td>0.740</td> </tr> <tr> <td>5</td> <td>2</td> <td>5.0</td> <td>15</td> <td>1.25</td> <td>1.000</td> <td>1.740</td> </tr> <tr> <td>6</td> <td>2</td> <td>10.0</td> <td>15</td> <td>2.50</td> <td>2.000</td> <td>3.740</td> </tr> <tr> <td>7</td> <td>2</td> <td>20.0</td> <td>15</td> <td>5.00</td> <td>4.000</td> <td>7.740</td> </tr> <tr> <td>8</td> <td>2</td> <td>40.0</td> <td>15</td> <td>10.00</td> <td>8.000</td> <td>15.740</td> </tr> <tr> <td>9</td> <td>3</td> <td>10.0</td> <td>15</td> <td>2.50</td> <td>19.843</td> <td>35.583</td> </tr> <tr> <td>10</td> <td>3</td> <td>20.0</td> <td>15</td> <td>5.00</td> <td>39.685</td> <td>75.268</td> </tr> <tr> <td>11</td> <td>3</td> <td>40.0</td> <td>15</td> <td>10.00</td> <td>79.370</td> <td>154.638</td> </tr> <tr> <td>12</td> <td>3</td> <td>80.0</td> <td>174.375</td> <td>232.50</td> <td>1845.362</td> <td>2000.000</td> </tr> <tr> <td colspan=\"7\"><strong>NOTE:</strong> Each step is administered over 15 minutes. At conclusion of protocol, observe patient for 30 minutes. Next dose can be full therapeutic dose given by the desired route.</td> </tr> <tr> <td colspan=\"7\">Total time = 339.37 minutes (5 hours 39 minutes).</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"7\">Desensitization protocol instructions:</td> </tr> <tr> <td class=\"indent1\" colspan=\"7\">1. Confirm written consent is in medical record.</td> </tr> <tr> <td class=\"indent1\" colspan=\"7\">2. Ensure preceding dose of beta-blockers was held, unless otherwise advised by supervising clinician.</td> </tr> <tr> <td class=\"indent1\" colspan=\"7\">3. Obtain IV access and vital signs (temperature, HR, BP, RR, oxygen saturation, peak flow).</td> </tr> <tr> <td class=\"indent1\" colspan=\"7\">4. Have at bedside: Epinephrine 0.3 mg (for adults) for IM injection, oxygen, normal saline, peak flow meter, and BP cuff, albuterol, injectable preparation of diphenhydramine, and methylprednisolone.</td> </tr> <tr> <td class=\"indent1\" colspan=\"7\">5. A nurse must closely observe the patient throughout the protocol (one-to-one).</td> </tr> <tr> <td colspan=\"7\"><strong>Administration:</strong> Hang each solution successively. Each step is administered over 15 minutes per protocol. There is no reason to wait between bags. Vital signs should be taken and recorded every 15 minutes and every 30 minutes during the last step.</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"7\">Monitoring and charting during desensitization:</td> </tr> <tr> <td class=\"sublist2_start\" colspan=\"7\">Clearly document any reaction, including:</td> </tr> <tr> <td class=\"sublist2\" colspan=\"7\">a. Patient's symptoms, vital signs, and physical findings.</td> </tr> <tr> <td class=\"sublist2\" colspan=\"7\">b. Exactly when the reaction occurred (ie, what step, how many minutes into that step).</td> </tr> <tr> <td class=\"sublist2\" colspan=\"7\">c. Treatment administered, how and when the reaction resolved, and when the protocol was restarted.</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"7\">Treatment of allergic reactions:</td> </tr> <tr> <td class=\"indent1\" colspan=\"7\"><strong>For mild reactions:</strong> In case of isolated itching, flushing, hives, mild chest tightness, nausea, abdominal pain, or back pain with normal vital signs, stop the infusion and treat with IV diphenhydramine. Observe patient until the reaction subsides, and then resume the protocol by repeating the step at which the reaction occurred.</td> </tr> <tr> <td class=\"indent1\" colspan=\"7\"><strong>For severe reactions:</strong> In case of hypotension, throat swelling, wheezing/respiratory distress, or decreased oxygen saturation, stop the infusion and treat with epinephrine 0.3 mg (adult dose) IM x 1, diphenhydramine and methylprednisolone IV, oxygen, inhaled albuterol for bronchospasm, and IV fluids (normal saline). Place patient in a recumbent position if hypotensive. Consider glucagon 1 to 2 mg IV bolus if patient has taken beta-blockers, followed by infusion at 1 to 5 mg/hour. <strong>Immediately alert the housestaff and supervising clinician.</strong> When the patient is stable, the protocol will be resumed as instructed by the supervising clinician.</td> </tr> <tr> <td colspan=\"7\"><strong>Contact the supervising clinician for ANY severe or prolonged reaction or any questions regarding the protocol, reactions, and appropriate management.</strong></td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">IV: intravenous; HR: heart rate; BP: blood pressure; RR: respiratory rate; IM: intramuscular.</div><div class=\"graphic_reference\">Reproduced with permission from: Legere HJ 3rd, Palis RI, Bouza TR, et al. A safe protocol for rapid desensitization in patients with cystic fibrosis and antibiotic hypersensitivity. J Cyst Fibros 2009; 8:418. Illustration used with the permission of Elsevier Inc. All rights reserved.<br />Instructions courtesy of Mariana Castells, MD, PhD.</div><div id=\"graphicVersion\">Graphic 52381 Version 10.0</div></div></div>"},"52382":{"type":"graphic_picture","displayName":"Frenulotomy","title":"Frenulotomy","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Frenulotomy</div><div class=\"cntnt\"><img style=\"width:432px; height:273px;\" src=\"images/PEDS/52382_Frenulotomy.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The tongue is elevated with two gloved fingers to expose the lingual frenulum. The frenulum is divided close to the underside of the tongue to avoid injury to the submandibular ducts (arrows) and lingual nerves.</div><div class=\"graphic_reference\">Courtesy of Glenn C Isaacson, MD, FAAP, FACS.</div><div id=\"graphicVersion\">Graphic 52382 Version 1.0</div></div></div>"},"52383":{"type":"graphic_picture","displayName":"Chronic nonhealing wound","title":"Chronic nonhealing wound","html":"<div class=\"graphic\"><div style=\"width: 601px\" class=\"figure\"><div class=\"ttl\">Chronic nonhealing wound</div><div class=\"cntnt\"><img style=\"width:581px; height:467px;\" src=\"images/SURG/52383_RYB_wound_class_PR.jpg\" alt=\"Image\"/></div><div class=\"graphic_reference\">Reproduced with permission from: Taylor C, Lillis C, LeMone P, Lynn P. Fundamentals of Nursing, The Art And Science Of Nursing Care, 6th Ed. Lippincott Williams &amp; Wilkins, Philadelphia 2008. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.</div><div id=\"graphicVersion\">Graphic 52383 Version 4.0</div></div></div>"},"52384":{"type":"graphic_diagnosticimage","displayName":"Pelvic vertical shear fracture","title":"Pelvic vertical shear fracture","html":"<div class=\"graphic\"><div style=\"width: 546px\" class=\"figure\"><div class=\"ttl\">Pelvic vertical shear fracture</div><div class=\"cntnt\"><img style=\"width:526px; height:415px;\" src=\"images/EM/52384_Pelvicvertshearfx.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Three images of a vertical shear fracture: (A) schematic; (B) AP radiograph; (C) 3-dimensional reconstruction from a CT scan.</div><div class=\"graphic_footnotes\">AP: anterior posterior; CT: computed tomography.</div><div class=\"graphic_reference\">Reproduced with permission from: Sagi C. Lower extremity: Pelvic ring fractures. In: Rockwood and Green's Fractures in Adults, 7th ed, Bucholz RW, Court-Brown CM, Heckman JD, Tornetta P (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2010. Copyright &copy; 2010 Lippincott Williams &amp; Wilkins. <a href=\"http://www.lww.com/\" target=\"_blank\">www.lww.com</a>.</div><div id=\"graphicVersion\">Graphic 52384 Version 12.0</div></div></div>"},"52385":{"type":"graphic_waveform","displayName":"ECG Accelerated idioventricular rhythm tutorial","title":"Single lead electrocardiogram (ECG) showing accelerated idioventricular rhythm","html":"<div class=\"graphic normal\"><div style=\"width: 535px\" class=\"figure\"><div class=\"ttl\">Single lead electrocardiogram (ECG) showing accelerated idioventricular rhythm</div><div class=\"cntnt\"><img style=\"width:515px; height:159px;\" src=\"images/CARD/52385_Accelerated_idioventr_tutor.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">An accelerated ventricular rhythm occurs in this case at a rate of 70 beats/minute. The P waves are dissociated from the QRS complexes and occur at rate which is slower than the RR interval.</div><div id=\"graphicVersion\">Graphic 52385 Version 4.0</div></div><div style=\"width: 450px\" class=\"figure\"><div class=\"ttl\">Normal rhythm strip</div><div class=\"cntnt\"><img style=\"width:432px; height:165px;\" src=\"images/CARD/59022_Normal_rhythm_strip.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Normal rhythm strip in lead II. The PR interval is 0.15 sec and the QRS duration is 0.08 sec. Both the P and T waves are upright.</div><div class=\"graphic_reference\">Courtesy of Morton F Arnsdorf, MD.</div><div id=\"graphicVersion\">Graphic 59022 Version 3.0</div></div></div>"},"52386":{"type":"graphic_picture","displayName":"Mucinous cystadenoma Light","title":"Pancreatic mucinous cystadenoma","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Pancreatic mucinous cystadenoma</div><div class=\"cntnt\"><img style=\"width:432px; height:325px;\" src=\"images/GAST/52386_Mucinous_cystadenoma_Light.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Microscopic appearance of a mucinous pancreatic cystadenoma. Note cystic spaces lined with columnar goblet cells and stroma which has &quot;ovarian-like&quot; appearance.</div><div class=\"graphic_reference\">Courtesy of Michael L Steer, MD.</div><div id=\"graphicVersion\">Graphic 52386 Version 2.0</div></div></div>"},"52387":{"type":"graphic_figure","displayName":"Ventilatory threshold","title":"Ventilatory threshold","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Ventilatory threshold</div><div class=\"cntnt\"><img style=\"width:408px; height:374px;\" src=\"images/PEDS/52387_Ventilatory_threshold.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The ventilatory threshold is the intensity at which ventilation begins to rise in excess of VO<sub>2</sub>. It is best demonstrated by plotting VE/VO<sub>2</sub> and VE/VCO<sub>2</sub> on the same graph (as above). The ventilatory threshold is the point just before VE/VO<sub>2</sub> begins to rise without a similar rise in VE/VCO<sub>2</sub>.</div><div class=\"graphic_footnotes\">VE: volume of gas expired (L/min); VO<sub>2</sub>: volume of oxygen consumed (L/min); VCO<sub>2</sub>: volume of carbon dioxide produced (L/min).</div><div id=\"graphicVersion\">Graphic 52387 Version 3.0</div></div></div>"},"52388":{"type":"graphic_table","displayName":"CEAP classification for chronic venous disorders","title":"CEAP classification for chronic venous disorders","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">CEAP classification for chronic venous disorders</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1_single\" colspan=\"2\">Clinical classification</td> </tr> <tr> <td>C<sub>0</sub></td> <td>No visible or palpable signs of venous disease</td> </tr> <tr> <td>C<sub>1</sub></td> <td>Telangiectasias, reticular veins, malleolar flares</td> </tr> <tr> <td>C<sub>2</sub></td> <td>Varicose veins</td> </tr> <tr> <td>C<sub>3</sub></td> <td>Edema without skin changes</td> </tr> <tr> <td class=\"sublist1_start\">C<sub>4</sub></td> <td class=\"sublist_other_start\">Skin changes ascribed to venous disease (eg, pigmentation, venous eczema, lipodermatosclerosis)</td> </tr> <tr> <td class=\"sublist1\">C<sub>4a</sub></td> <td class=\"sublist_other\">Pigmentation or eczema</td> </tr> <tr> <td class=\"sublist1\">C<sub>4b</sub></td> <td class=\"sublist_other\">Lipodermatosclerosis or atrophie blanche</td> </tr> <tr> <td>C<sub>5</sub></td> <td>Skin changes as defined above with healed ulceration</td> </tr> <tr> <td>C<sub>6</sub></td> <td>Skin changes as defined above with active ulceration</td> </tr> <tr> <td>S</td> <td>Symptomatic, including ache, pain, tightness, skin irritation, heaviness, and muscle cramps, and other complaints attributable to venous dysfunction</td> </tr> <tr> <td>A</td> <td>Asymptomatic</td> </tr> <tr> <td class=\"subtitle1_single\" colspan=\"2\">Etiologic classification</td> </tr> <tr> <td>Ec</td> <td>Congenital</td> </tr> <tr> <td>Ep</td> <td>Primary</td> </tr> <tr> <td>Es</td> <td>Secondary (post-thrombotic)</td> </tr> <tr> <td>En</td> <td>No venous cause identified</td> </tr> <tr> <td class=\"subtitle1_single\" colspan=\"2\">Anatomic classification</td> </tr> <tr> <td>As</td> <td>Superficial veins</td> </tr> <tr> <td>Ap</td> <td>Perforator veins</td> </tr> <tr> <td>Ad</td> <td>Deep veins</td> </tr> <tr> <td>An</td> <td>No venous location identified</td> </tr> <tr> <td class=\"subtitle1_single\" colspan=\"2\">Pathophysiologic classification</td> </tr> <tr> <td>Pr</td> <td>Reflux</td> </tr> <tr> <td>Po</td> <td>Obstruction</td> </tr> <tr> <td>Pr,o</td> <td>Reflux and obstruction</td> </tr> <tr> <td>Pn</td> <td>No venous pathophysiology identifiable</td> </tr> </tbody></table></div><div class=\"graphic_lgnd\">Limbs in higher categories have more severe signs of chronic venous disease and may have some or all of the findings defining a less severe clinical category. Each limb is further characterized as asymptomatic (A), for example, C0-6,A, or symptomatic (S), for example, C0-6,S. Symptoms that may be associated with telangiectatic, reticular, or varicose veins include lower extremity aching, pain, and skin irritation. Therapy may alter the clinical category of chronic venous disease. Limbs should therefore be reclassified after any form of medical or surgical treatment.</div><div class=\"graphic_reference\">Data from: Eklof B, Rutherford R, Bergan J, et al. Revision of the CEAP classification for chronic venous disorders: Consensus statement. J Vasc Surg 2004; 40:1248.</div><div id=\"graphicVersion\">Graphic 52388 Version 7.0</div></div></div>"},"52392":{"type":"graphic_table","displayName":"World Health Organization surgical safety checklist","title":"World Health Organization surgical safety checklist","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">World Health Organization surgical safety checklist</div><div class=\"cntnt\"><table class=\"container\" cellspacing=\"0\"><tbody> <tr> <td class=\"container\"> <table cellspacing=\"0\"> <tbody> <tr> <td class=\"subtitle1\" colspan=\"2\">Sign in</td> </tr> <tr> <td class=\"subtitle2\" colspan=\"2\">Before induction of anesthesia</td> </tr> <tr> <td>__</td> <td>Patient has confirmed: <ul> <li>Identity </li> <li>Site </li> <li>Procedure </li> <li>Consent </li> </ul> </td> </tr> <tr class=\"divider_top\"> <td>__</td> <td>Site marked/not applicable</td> </tr> <tr class=\"divider_top\"> <td>__</td> <td>Anesthesia safety check completed</td> </tr> <tr class=\"divider_top\"> <td>__</td> <td>Pulse oximeter on patient and functioning</td> </tr> <tr class=\"divider_top\"> <td colspan=\"2\"><strong>Does patient have a:</strong></td> </tr> <tr> <td colspan=\"2\">Known allergy?</td> </tr> <tr> <td>__ </td> <td>No</td> </tr> <tr> <td>__</td> <td>Yes</td> </tr> <tr> <td colspan=\"2\">Difficult airway/aspiration risk?</td> </tr> <tr> <td>__</td> <td>No</td> </tr> <tr> <td>__</td> <td>Yes, and equipment/assistance available</td> </tr> <tr> <td colspan=\"2\">Risk of &#62;500 mL blood loss (7 mL/kg in children)?</td> </tr> <tr> <td>__</td> <td>No</td> </tr> <tr> <td>__</td> <td>Yes, and adequate intravenous access and fluids planned</td> </tr> </tbody> </table> </td> <td class=\"container\"> <table cellspacing=\"0\"> <tbody> <tr> <td class=\"subtitle1\" colspan=\"2\">Time out</td> </tr> <tr> <td class=\"subtitle2\" colspan=\"2\">Before skin incision</td> </tr> <tr> <td>__</td> <td>Confirm all team members have introduced themselves by name and role</td> </tr> <tr class=\"divider_top\"> <td>__</td> <td>Surgeon, anesthesia professional, and nurse verbally confirm <ul> <li>Patient </li> <li>Site </li> <li>Procedure </li> </ul> </td> </tr> <tr class=\"divider_top\"> <td colspan=\"2\"><strong>Anticipated critical events</strong></td> </tr> <tr> <td>__</td> <td>Surgeon reviews: What are the critical or unexpected steps, operative duration, anticipated blood loss?</td> </tr> <tr> <td>__</td> <td>Anesthesia team reviews: Are there any patient-specific concerns?</td> </tr> <tr> <td>__</td> <td>Nursing team reviews: Has sterility (including indicator results) been confirmed? Are there equipment issues or any concerns?</td> </tr> <tr class=\"divider_top\"> <td colspan=\"2\">Has antibiotic prophylaxis been given within the last 60 minutes?</td> </tr> <tr> <td>__</td> <td>Yes</td> </tr> <tr> <td>__</td> <td>Not applicable</td> </tr> <tr> <td colspan=\"2\">Is essential imaging displayed?</td> </tr> <tr> <td>__</td> <td>Yes</td> </tr> <tr> <td>__</td> <td>Not applicable</td> </tr> </tbody> </table> </td> <td class=\"container\"> <table cellspacing=\"0\"> <tbody> <tr> <td class=\"subtitle1\" colspan=\"2\">Sign out</td> </tr> <tr> <td class=\"subtitle2\" colspan=\"2\">Before patient leaves operating room</td> </tr> <tr> <td colspan=\"2\"><strong>Nurse verbally confirms with the team:</strong></td> </tr> <tr> <td>__</td> <td>The name of the procedure recorded</td> </tr> <tr> <td>__</td> <td>That instrument, sponge, and needle counts are correct (or not applicable)</td> </tr> <tr> <td>__</td> <td>How the specimen is labeled (including patient name)</td> </tr> <tr> <td>__</td> <td>Whether there are any equipment problems to be addressed</td> </tr> <tr class=\"divider_top\"> <td>__</td> <td>Surgeon, anesthesia professional, and nurse review the key concerns for recovery and management of this patient</td> </tr> </tbody> </table> </td> </tr> </tbody></table></div><div class=\"graphic_lgnd\">This checklist is not intended to be comprehensive. Additions and modifications to fit local practice are encouraged.</div><div class=\"graphic_reference\">Reproduced with permission from: Weiser T, Haynes A, Dziekan G, et al. Effect of a 19-item surgical safety checklist during urgent operations in a global patient population. Ann Surg 2010; 251:976. Copyright Â© 2010 Lippincott Williams &amp; Wilkins.</div><div id=\"graphicVersion\">Graphic 52392 Version 12.0</div></div></div>"},"52393":{"type":"graphic_figure","displayName":"Bilirubin in hepatocytes","title":"Bilirubin throughput in hepatocytes","html":"<div class=\"graphic\"><div style=\"width: 480px\" class=\"figure\"><div class=\"ttl\">Bilirubin throughput in hepatocytes</div><div class=\"cntnt\"><img style=\"width:460px; height:471px;\" src=\"images/GAST/52393_Bilirubin_in_hepatocytes.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Schematic representation of the steps involved in bilirubin (B) throughput in hepatocytes: transport to the liver (primarily as albumin-bound bilirubin), uptake at the sinusoidal membrane, intracellular binding, conjugation (glucuronidation), and canalicular excretion. Sinusoidal bilirubin uptake requires inorganic anions such as chloride, and is thought to be mediated by carrier proteins. Within the hepatocyte, bilirubin binds to glutathione S-transferases (GSTs). GST-binding reduces the efflux of the internalized bilirubin, thereby increasing the net uptake. GSTs also bind bilirubin glucuronides (BG)&nbsp;prior to excretion. Bilirubin also enters hepatocytes by passive diffusion. Glucuronidation of bilirubin is mediated by a family of enzymes, termed uridine diphosphoglucuronosyltransferase (UGT), the most important of which is bilirubin-UGT-1 (UGT1A1). Conjugated bilirubin is secreted actively across the bile canalicular membrane of the hepatocyte against a concentration gradient that may reach 1:1000. The canalicular multi-drug resistance protein 2 (MRP2) appears to be the most important for the canalicular secretion of bilirubin. A portion of the conjugated bilirubin is transported into the sinusoidal blood via the ATP hydrolysis-couple pump, ABCC3, to undergo reuptake via OATP1B1 and OATP1B3 by hepatocytes downstream to the sinusoidal blood flow.</div><div class=\"graphic_footnotes\">UDP: uridine diphosphate; UDPGA: uridine 5'-diphosphoglucuronic acid; ABCC3: ATP-binding cassette subfamily C number 3; OATP1B1: organic anion-transporting polypeptide 1B1; OATP1B3: organic anion-transporting polypeptide 1B3.</div><div id=\"graphicVersion\">Graphic 52393 Version 4.0</div></div></div>"},"52395":{"type":"graphic_picture","displayName":"Advanced calciphylaxis","title":"Advanced calciphylaxis","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Advanced calciphylaxis</div><div class=\"cntnt\"><img style=\"width:384px; height:252px;\" src=\"images/NEPH/52395_Calciphylaxis_of_the_leg.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Calciphylaxis of the leg in a patient with end-stage renal disease. Ischemic necrosis has led to both violaceous lesions and black, leathery eschar-like lesions.</div><div id=\"graphicVersion\">Graphic 52395 Version 2.0</div></div></div>"},"52398":{"type":"graphic_waveform","displayName":"Intermediate case 12 answer","title":"Atrial flutter with 2:1 block","html":"<div class=\"graphic\"><div style=\"width: 553px\" class=\"figure\"><div class=\"ttl\">Atrial flutter with 2:1 block</div><div class=\"cntnt\"><img style=\"width:533px; height:267px;\" src=\"images/CARD/52398_Intermediate_case_12_answer.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Typical atrial flutter with 2:1 atrioventricular block. The flutter rate is approximately 300/min with a ventricular rate of 150/min. The flutter waves are best seen in leads II, III, and V1 (arrows). This patient also has low QRS voltage in the limb leads, a non-specific finding.</div><div class=\"graphic_reference\">Courtesy of Ary Goldberger, MD.</div><div id=\"graphicVersion\">Graphic 52398 Version 2.0</div></div></div>"},"52400":{"type":"graphic_figure","displayName":"Splenic platelet pooling","title":"Effect of spleen size on platelet pooling","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Effect of spleen size on platelet pooling</div><div class=\"cntnt\"><img style=\"width:388px; height:380px;\" src=\"images/HEME/52400_Splenic_platelet_pooling.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">This figure shows the two-hour recovery in the general circulation of radioactively-labeled platelets transfused to asplenic (red), normal (green), and splenomegalic (orange) patients. The vast majority of the splenomegalic patients had congestive splenomegaly secondary to cirrhosis with portal hypertension.</div><div class=\"graphic_reference\">Adapted from: Aster RH. Pooling of platelets in the spleen: role in the pathogenesis of 'hypersplenic' thrombocytopenia. J Clin Invest 1966; 45:645.</div><div id=\"graphicVersion\">Graphic 52400 Version 3.0</div></div></div>"},"52401":{"type":"graphic_picture","displayName":"Spurling test","title":"Spurling test","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Spurling test</div><div class=\"cntnt\"><img style=\"width:379px; height:270px;\" src=\"images/EM/52401_Spurling_test.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The Spurling test is performed by applying downward pressure to the patient's head with the patient's neck extended and rotated toward the involved side. This neck position narrows the intervertebral foramina on the affected side and reproduces the radiating pain if there is pathology at the root or foramen.</div><div class=\"graphic_reference\">Courtesy of Jason E Decker, MD.</div><div id=\"graphicVersion\">Graphic 52401 Version 3.0</div></div></div>"},"52402":{"type":"graphic_picture","displayName":"Mult sterile corneal infil","title":"Multiple sterile corneal infiltrates","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Multiple sterile corneal infiltrates</div><div class=\"cntnt\"><img style=\"width:323px; height:235px;\" src=\"images/PC/52402_Mult_sterile_corneal_infil.jpg\" alt=\"Image\"/></div><div id=\"graphicVersion\">Graphic 52402 Version 1.0</div></div></div>"},"52404":{"type":"graphic_table","displayName":"Ideal body weight table","title":"Revised ideal body weight table (1985) for persons aged 25 years and over","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Revised ideal body weight table (1985) for persons aged 25 years and over</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup span=\"6\" width=\"16%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\" colspan=\"2\">Height (no shoes)</td> <td class=\"subtitle1\" colspan=\"2\">Men</td> <td class=\"subtitle1\" colspan=\"2\">Women*</td> </tr> <tr> <td class=\"subtitle2\">Feet</td> <td class=\"subtitle2\">Inches</td> <td class=\"subtitle2\">Weight range</td> <td class=\"subtitle2\">Weight<sup>&#182;</sup> MRW=100</td> <td class=\"subtitle2\">Weight range</td> <td class=\"subtitle2\">Weight<sup>&#182;</sup> MRW=100</td> </tr> <tr> <td>4</td> <td>9</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>90-118</td> <td>100</td> </tr> <tr> <td>4</td> <td>10</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>92-121</td> <td>103</td> </tr> <tr> <td>4</td> <td>11</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>95-124</td> <td>106</td> </tr> <tr> <td>5</td> <td>0</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>98-127</td> <td>109</td> </tr> <tr> <td>5</td> <td>1</td> <td>105-134</td> <td>117</td> <td>101-130</td> <td>112</td> </tr> <tr> <td>5</td> <td>2</td> <td>108-137</td> <td>120</td> <td>104-134</td> <td>116</td> </tr> <tr> <td>5</td> <td>3</td> <td>111-141</td> <td>123</td> <td>107-138</td> <td>120</td> </tr> <tr> <td>5</td> <td>4</td> <td>114-145</td> <td>126</td> <td>110-142</td> <td>124</td> </tr> <tr> <td>5</td> <td>5</td> <td>117-149</td> <td>129</td> <td>114-146</td> <td>128</td> </tr> <tr> <td>5</td> <td>6</td> <td>121-154</td> <td>133</td> <td>118-150</td> <td>132</td> </tr> <tr> <td>5</td> <td>7</td> <td>125-159</td> <td>138</td> <td>122-154</td> <td>136</td> </tr> <tr> <td>5</td> <td>8</td> <td>129-163</td> <td>142</td> <td>126-159</td> <td>140</td> </tr> <tr> <td>5</td> <td>9</td> <td>133-167</td> <td>146</td> <td>130-164</td> <td>144</td> </tr> <tr> <td>5</td> <td>10</td> <td>137-172</td> <td>150</td> <td>134-169</td> <td>148</td> </tr> <tr> <td>5</td> <td>11</td> <td>141-177</td> <td>155</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr> <td>6</td> <td>0</td> <td>145-182</td> <td>159</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr> <td>6</td> <td>1</td> <td>149-187</td> <td>164</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr> <td>6</td> <td>2</td> <td>153-192</td> <td>169</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr> <td>6</td> <td>3</td> <td>157-197</td> <td>174</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">* For women between the ages of 18 and 25, subtract 1 lb for each year under 25.<br />&para; Midpoint of medium frame range used to compute MRW: MRW=[actual weight]/[midpoint of medium frame range] x 100.</div><div class=\"graphic_reference\">Redrawn from Simopoulos, AP, J Am Diet Assoc 1985; 85:419.</div><div id=\"graphicVersion\">Graphic 52404 Version 2.0</div></div></div>"},"52406":{"type":"graphic_picture","displayName":"Lymphocyte depletion diffuse fibrous type HL","title":"Lymphocyte depleted diffuse fibrous type Hodgkin lymphoma","html":"<div class=\"graphic\"><div style=\"width: 522px\" class=\"figure\"><div class=\"ttl\">Lymphocyte depleted diffuse fibrous type Hodgkin lymphoma</div><div class=\"cntnt\"><img style=\"width:502px; height:756px;\" src=\"images/HEME/52406_Lymphocytedeplediffibrs.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">There is a reticulin collagen fibrosis around single cells. Although the Hodgkin cells appear atypical, results of immunophenotyping studies were characteristic of Hodgkin lymphoma in this case.</div><div class=\"graphic_reference\">Reproduced with permission from: Weiss LM, Warnke RA, Hansmann ML, et al. Pathology of Hodgkin Lymphoma. In: Hodgkin Lymphoma, 2nd ed, Hoppe RT, Mauch PT, Armitage JO, et al (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2007. Copyright Â© 2007 Lippincott Williams &amp; Wilkins. <A href=\"http://www.lww.com/\" target=_blank>www.lww.com</A>.</div><div id=\"graphicVersion\">Graphic 52406 Version 8.0</div></div></div>"},"52407":{"type":"graphic_picture","displayName":"Adenopathy in cat scratch disease","title":"Adenopathy in cat scratch disease","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Adenopathy in cat scratch disease</div><div class=\"cntnt\"><img style=\"width:212px; height:324px;\" src=\"images/ID/52407_EnlargedlymphnodeinCSD.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Left axillary adenopathy in a patient with cat scratch disease. The enlarged, erythematous lymph node may go on to suppurate.</div><div class=\"graphic_reference\">Courtesy of David H Spach, MD.</div><div id=\"graphicVersion\">Graphic 52407 Version 3.0</div></div></div>"},"52408":{"type":"graphic_picture","displayName":"Fusobacterium nucleatum","title":"<EM>Fusobacterium nucleatum </EM>morphology","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\"><EM>Fusobacterium nucleatum </EM>morphology</div><div class=\"cntnt\"><img style=\"width:432px; height:329px;\" src=\"images/ID/52408_Fusobacterium_nucleatum.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Microscopic morphology of <EM>Fusobacterium nucleatum</EM>. Note delicate rods with tapered ends.</div><div class=\"graphic_reference\">Reproduced with permission from: Gorbach SL, Bartlett JG,&nbsp;et al. Infectious Diseases. Philadelphia: Lippincott Williams &amp; Wilkins, 2004. Copyright Â© 2004 Lippincott Williams &amp; Wilkins.</div><div id=\"graphicVersion\">Graphic 52408 Version 5.0</div></div></div>"},"52412":{"type":"graphic_table","displayName":"Initiating speech-language intervention","title":"Predictors of success and risk factors to consider when initiating speech-language intervention","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Predictors of success and risk factors to consider when initiating speech-language intervention</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1_single\">Predictors of success</td> </tr> <tr> <td>Language production</td> </tr> <tr> <td>Language comprehension</td> </tr> <tr> <td>Phonologic repertoire</td> </tr> <tr> <td>Imitation</td> </tr> <tr> <td>Play skills</td> </tr> <tr> <td>Use of gestures</td> </tr> <tr> <td>Social skills</td> </tr> <tr> <td class=\"subtitle1_single\">Risk factors for speech-language impairment</td> </tr> <tr> <td>Otitis media</td> </tr> <tr> <td>Familial history of language and learning problems</td> </tr> <tr> <td>Parental needs</td> </tr> </tbody></table></div><div class=\"graphic_reference\">Adapted from: Olswang LB, Rodriguez B, Timler G. Am J Speech Lang Pathol 1998; 7:23.</div><div id=\"graphicVersion\">Graphic 52412 Version 5.0</div></div></div>"},"52413":{"type":"graphic_figure","displayName":"Iliopsoas anatomy","title":"Iliopsoas anatomy","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Iliopsoas anatomy</div><div class=\"cntnt\"><img style=\"width:341px; height:536px;\" src=\"images/EM/52413_Iliopsoasanatomy.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The psoas muscle arises from the transverse processes of the lumbar spine, while the iliac muscle arises from the inner surface of the ilium. Both insert along the medial aspect of the proximal femur, primarily at the lesser trochanter, and act as the primary flexors of the hip.</div><div class=\"graphic_reference\">Reproduced with permission from: Novachek TF. Adductor and Iliopsoas Release. In: Operative Techniques in Orthopedic Surgery, Wiesel SW (Eds), Lippincott Williams &amp; Wilkins, Philadelphia, 2011. Copyright Â© 2011 Lippincott Williams &amp; Wilkins. <A href=\"http://www.lww.com/\" target=_blank>www.lww.com</A>.</div><div id=\"graphicVersion\">Graphic 52413 Version 11.0</div></div></div>"},"52415":{"type":"graphic_picture","displayName":"Scarlet fever rash - Pastias lines","title":"Scarlet fever rash - Pastia's lines","html":"<div class=\"graphic\"><div style=\"width: 524px\" class=\"figure\"><div class=\"ttl\">Scarlet fever rash - Pastia's lines</div><div class=\"cntnt\"><img style=\"width:504px; height:378px;\" src=\"images/ID/52415_SFR_Pastias_lines.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The rash of scarlet fever is marked in the skin folds of the inguinal, axillary, antecubital, and abdominal areas and about pressure points. It often exhibits a linear petechial character in the antecubital fossae and axillary folds, known as Pastia's lines.</div><div class=\"graphic_reference\">Reproduced with permission from: <a href=\"http://www.visualdx.com/\" target=\"_blank\">www.visualdx.com</a>. Copyright Logical Images, Inc.</div><div id=\"graphicVersion\">Graphic 52415 Version 4.0</div></div></div>"},"52416":{"type":"graphic_table","displayName":"Treatable conditions associated with cardiac arrest","title":"Treatable conditions associated with cardiac arrest","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Treatable conditions associated with cardiac arrest</div><div class=\"cntnt\"><table cellspacing=\"0\">\r\n            <tbody>\r\n                <tr>\r\n                    <td class=\"subtitle1\">Condition</td>\r\n                    <td class=\"subtitle1\">Common associated clinical settings</td>\r\n                </tr>\r\n                <tr>\r\n                    <td>Acidosis</td>\r\n                    <td>Diabetes, diarrhea, drug overdose, renal dysfunction, sepsis, shock</td>\r\n                </tr>\r\n                <tr>\r\n                    <td>Anemia</td>\r\n                    <td>Gastrointestinal bleeding, nutritional deficiencies, recent trauma</td>\r\n                </tr>\r\n                <tr>\r\n                    <td>Cardiac tamponade</td>\r\n                    <td>Post-cardiac surgery, malignancy, post-myocardial infarction, pericarditis, trauma</td>\r\n                </tr>\r\n                <tr>\r\n                    <td>Hyperkalemia</td>\r\n                    <td>Drug overdose, renal dysfunction, hemolysis, excessive potassium intake, rhabdomyolysis, major soft tissue injury, tumor lysis syndrome</td>\r\n                </tr>\r\n                <tr>\r\n                    <td>Hypokalemia*</td>\r\n                    <td>Alcohol abuse, diabetes mellitus, diuretics, drug overdose, profound gastrointestinal losses</td>\r\n                </tr>\r\n                <tr>\r\n                    <td>Hypothermia</td>\r\n                    <td>Alcohol intoxication, significant burns, drowning, drug overdose, elder patient, endocrine disease, environmental exposure, spinal cord disease, trauma</td>\r\n                </tr>\r\n                <tr>\r\n                    <td>Hypovolemia</td>\r\n                    <td>Significant burns, diabetes, gastrointestinal losses, hemorrhage, malignancy, sepsis, trauma</td>\r\n                </tr>\r\n                <tr>\r\n                    <td>Hypoxia</td>\r\n                    <td>Upper airway obstruction, hypoventilation (CNS dysfunction, neuromuscular disease), pulmonary disease</td>\r\n                </tr>\r\n                <tr>\r\n                    <td>Myocardial infarction</td>\r\n                    <td>Cardiac arrest</td>\r\n                </tr>\r\n                <tr>\r\n                    <td>Poisoning</td>\r\n                    <td>History of alcohol or drug abuse, altered mental status, classic toxidrome (eg, sympathomimetic), occupational exposure, psychiatric disease</td>\r\n                </tr>\r\n                <tr>\r\n                    <td>Pulmonary embolism</td>\r\n                    <td>Immobilized patient, recent surgical procedure (eg, orthopedic), peripartum, risk factors for thromboembolic disease, recent trauma, presentation consistent with acute pulmonary embolism</td>\r\n                </tr>\r\n                <tr>\r\n                    <td>Tension pneumothorax</td>\r\n                    <td>Central venous catheter, mechanical ventilation, pulmonary disease (eg, asthma, chronic obstructive pulmonary disease), thoracentesis, thoracic trauma</td>\r\n                </tr>\r\n            </tbody>\r\n        </table>\r\n        <!--[if gte mso 9]><xml>\r\n<mso:CustomDocumentProperties>\r\n<mso:Specialty msdt:dt=\"string\">2</mso:Specialty>\r\n<mso:Media_Notes msdt:dt=\"string\">7/27/2001-perm requested. 8/2/2001-perm granted. 10/15/2001 -faxed renewal request - jm; 10/26/2001 -renewal granted - jm 10/2/2002 Mailed renewal request -em; 12/11/2002 - emailed followup-jm; 12/11/2002- Jen is mailing today-jm; 12/24/2002 -renewal granted, gave to ajeah-jm 9/30/2003 renewal requested 10/3/2003 granted 10/12/2004 renewal requested 12/7/2004 granted 11/9/2005 renewal requested 1/26/2006 granted 10/10/2006 renewal requested 10/13/2006 granted 11/29/2007--renewal requested. EM 1/9/2008--renewal granted. EM 1/2/2009--Requested renewal (JD). 1/9/2009--Renewal granted; invoice to Susan (JD). 2/3/2010--Renewal requested (JD). 4/2/2010--Renewal granted; invoice to Jo for payment (JD). The total fee of $&#38;quot;250.00&#38;quot;was originally charged to Treatable_conditions_SCD_I Treatable_conditions_SCD_II</mso:Media_Notes>\r\n<mso:Edit_Table msdt:dt=\"string\">&#60;a href=&quot;/Graphics/Pages/TableEditor.aspx?SPID=8783&#38;amp;Mode=Edit&quot;&#62;&#60;/a&#62;</mso:Edit_Table>\r\n</mso:CustomDocumentProperties>\r\n</xml><![endif]--></div><div class=\"graphic_footnotes\">CNS: central nervous system.<br />* Hypomagnesemia should be assumed in the setting of hypokalemia, and both should be treated.</div><div class=\"graphic_reference\">Adapted from: Eisenberg MS, Mengert TJ. Cardiac resuscitation. N Engl J Med 2001; 344:1304.</div><div id=\"graphicVersion\">Graphic 52416 Version 8.0</div></div></div>"},"52417":{"type":"graphic_table","displayName":"Indications for invasive cardiac electrophysiology study","title":"Indications for invasive cardiac electrophysiologic study","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Indications for invasive cardiac electrophysiologic study</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1_single\">Diagnosis and management of bradyarrhythmias</td> </tr> <tr> <td>To acquire corroborative data in symptomatic patients with episodic bradyarrhythmia</td> </tr> <tr> <td>To define the level of atrioventricular (AV) conduction abnormality</td> </tr> <tr> <td class=\"subtitle1_single\">Diagnosis and management of tachyarrhythmias</td> </tr> <tr> <td>To define the mechanism of narrow-complex tachycardia</td> </tr> <tr> <td>To define the mechanism of wide-complex tachycardia</td> </tr> <tr> <td>To reproduce the clinically documented narrow or wide-complex tachycardia for mapping and transcatheter ablation</td> </tr> <tr> <td class=\"subtitle1_single\">Syncope of unknown etiology</td> </tr> <tr> <td>To assess the sinus node function, the AV conduction, and to search for inducible sustained ventricular tachyarrhythmias in patients with syncope and organic heart disease</td> </tr> <tr> <td class=\"subtitle1_single\">Primary prevention protocols</td> </tr> <tr> <td>To search for electrophysiologic-induced ventricular tachycardia&nbsp;or ventricular fibrillation in patients with coronary disease, depressed ventricular function, and nonsustained ventricular tachyarrhythmias who are candidates for implantable cardioverter-defibrillator (ICD) therapy</td> </tr> </tbody></table></div><div id=\"graphicVersion\">Graphic 52417 Version 4.0</div></div></div>"},"52418":{"type":"graphic_diagnosticimage","displayName":"Steeple sign","title":"Croup: Anteroposterior radiograph with \"steeple sign\"","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Croup: Anteroposterior radiograph with \"steeple sign\"</div><div class=\"cntnt\"><img style=\"width:300px; height:324px;\" src=\"images/PEDS/52418_Steeple_sign.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The anteroposterior (AP) view demonstrates tapering of the upper trachea, known as the \"steeple sign\" of croup. Note that the finding can be simulated by differing phases of respiration even in normal children.</div><div class=\"graphic_reference\">Courtesy of the Department of Diagnostic Imaging, Texas Children's Hospital.</div><div id=\"graphicVersion\">Graphic 52418 Version 2.0</div></div></div>"},"52419":{"type":"graphic_figure","displayName":"Mitosis","title":"Mitosis","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Mitosis</div><div class=\"cntnt\"><img style=\"width:399px; height:615px;\" src=\"images/PC/52419_Mitosis.jpg\" alt=\"Image\"/></div><div id=\"graphicVersion\">Graphic 52419 Version 2.0</div></div></div>"},"52420":{"type":"graphic_figure","displayName":"Types of lice","title":"Types of lice","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Types of lice</div><div class=\"cntnt\"><img style=\"width:267px; height:392px;\" src=\"images/PC/52420_Types_of_lice.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The three varieties of lice specifically parasitic for humans are <EM>Phthirus pubis</EM> (picture A, crab louse), <EM>Pediculosis humanus capitis</EM> (picture B, head louse), and <EM>Pediculosis humanus corporis</EM> (picture C, body louse).</div><div class=\"graphic_reference\">Courtesy of John T Crissey, MD.</div><div id=\"graphicVersion\">Graphic 52420 Version 7.0</div></div></div>"},"52421":{"type":"graphic_figure","displayName":"HP caused by Cladosporium","title":"Hypersensitivity pneumonitis caused by Cladosporium in an enclosed hot-tub","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Hypersensitivity pneumonitis caused by Cladosporium in an enclosed hot-tub</div><div class=\"cntnt\"><img style=\"width:450px; height:344px;\" src=\"images/PULM/52421_HP_caused_by_cladosporium.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Spirometry from a 48-year-old woman with an 18-month history of malaise and chronic cough, intermittent episodes of fever, chills, and pneumonic infiltrates. Removal of the patient from the home environment led to a resolution of symptoms within&nbsp;one week. Within&nbsp;four hours of reexposure to the hot-tub room, symptoms and signs and changes in leukocyte count and spirometric values again occurred. Bronchial provocation with a commercial extract of C. cladosporioides led to a similar pattern&nbsp;five hours after the initial challenge.</div><div class=\"graphic_reference\">Redrawn from: Jacobs RL, Thorner RE, Holcomb JR, et al. Ann Intern Med 1986; 105:204.</div><div id=\"graphicVersion\">Graphic 52421 Version 4.0</div></div></div>"},"52424":{"type":"graphic_figure","displayName":"Glucose and B blocker on K load","title":"Effects of glucose and beta-blockade on response to potassium load in normals and dialysis patients","html":"<div class=\"graphic\"><div style=\"width: 514px\" class=\"figure\"><div class=\"ttl\">Effects of glucose and beta-blockade on response to potassium load in normals and dialysis patients</div><div class=\"cntnt\"><img style=\"width:494px; height:241px;\" src=\"images/NEPH/52424_Glucose_and_B_blocker_on_K.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Peak increase in the plasma potassium concentration in normals and dialysis patients following the ingestion of 0.25 meq/kg of potassium alone (K) or with glucose (K+G), a beta blocker (K+Î²), or a beta blocker and glucose (K+Î²+G). The degree of hyperkalemia was minimized by glucose (via enhanced release of insulin), increased by a beta blocker, and made more prominent (by as much as 0.4 meq/L) with all interventions in dialysis patients, indicating decreased cell uptake of potassium in renal failure.</div><div class=\"graphic_reference\">Data from: Allon M, Dansby L, Shanklin N. Am J Med 1993; 94:475.</div><div id=\"graphicVersion\">Graphic 52424 Version 3.0</div></div></div>"},"52425":{"type":"graphic_picture","displayName":"Clue cell","title":"Clue cells","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Clue cells</div><div class=\"cntnt\"><img style=\"width:430px; height:515px;\" src=\"images/OBGYN/52425_Clue_cells1.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">(A) Wet mount showing characteristic clue cells. Note that the epithelial cells are so heavily covered by bacteria as to obscure the margins.<br> (B) A clue cell. The vaginal epithelial cell on the right has shaggy borders obscured by coccobacilli (1003 magnification). The more normal appearing epithelial cell on the left has sharper borders.</div><div class=\"graphic_reference\">(A) Reproduced with permission from: Sweet RL, Gibbs RS. Atlas of Infectious Diseases of the Female Genital Tract. Philadelphia: Lippincott Williams &amp; Wilkins, 2005. Copyright &#169; 2005 Lippincott Williams &amp; Wilkins.<br> (B) Reproduced with permission from: Fleisher GR, MD, Ludwig S, MD, Baskin MN, MD. Atlas of Pediatric Emergency Medicine. Philadelphia: Lippincott Williams &amp; Wilkins, 2004. Copyright &#169; 2004 Lippincott Williams &amp; Wilkins.</div><div id=\"graphicVersion\">Graphic 52425 Version 3.0</div></div></div>"},"52429":{"type":"graphic_picture","displayName":"Pyogenic granuloma collarette","title":"Pyogenic granuloma","html":"<div class=\"graphic\"><div style=\"width: 524px\" class=\"figure\"><div class=\"ttl\">Pyogenic granuloma</div><div class=\"cntnt\"><img style=\"width:504px; height:379px;\" src=\"images/DERM/52429_Pyogenic_granul_collarette.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Pyogenic granuloma: The epithelial \"collarette\" can be seen at the base of the lesion.</div><div class=\"graphic_reference\">Reproduced with permission from: <A style=\"FONT-STYLE: italic\" href=\"http://www.visualdx.com/\" target=_blank>www.visualdx.com</A>. Copyright Logical Images, Inc.</div><div id=\"graphicVersion\">Graphic 52429 Version 4.0</div></div></div>"},"52430":{"type":"graphic_picture","displayName":"Dermatosis papulosa nigra","title":"Dermatosis papulosa nigra","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Dermatosis papulosa nigra</div><div class=\"cntnt\"><img style=\"width:400px; height:371px;\" src=\"images/DERM/52430_Dermatosis_papulosa_nigra.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The lesions of this common inherited condition appear as small pigmented papules on the face that resemble seborrheic keratoses. This condition is most commonly seen in black individuals.</div><div class=\"graphic_reference\">Reproduced with permission from: Goodheart HP. Goodheart's Photoguide of Common Skin Disorders, 2nd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright Â© 2003 Lippincott Williams &amp; Wilkins.</div><div id=\"graphicVersion\">Graphic 52430 Version 2.0</div></div></div>"},"52433":{"type":"graphic_waveform","displayName":"Acute anteroapical MI tutorial","title":"Acute anteroapical transmural myocardial infarction","html":"<div class=\"graphic normal\"><div style=\"width: 550px\" class=\"figure\"><div class=\"ttl\">Acute anteroapical transmural myocardial infarction</div><div class=\"cntnt\"><img style=\"width:530px; height:166px;\" src=\"images/CARD/52433_Acute_anteroapical_MI_tutor.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">ST elevation is present in V3 and V4 in patients with an anteroapical infarct.</div><div id=\"graphicVersion\">Graphic 52433 Version 2.0</div></div><div style=\"width: 594px\" class=\"figure\"><div class=\"ttl\">Normal ECG</div><div class=\"cntnt\"><img style=\"width:594px; height:337px;\" src=\"images/CARD/76183_Normal_ECG.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Normal electrocardiogram showing normal sinus rhythm at a rate of 75 beats/min, a PR interval of 0.14 sec, a QRS interval of 0.10 sec, and a QRS axis of approximately 75Â°.</div><div class=\"graphic_reference\">Courtesy of Ary Goldberger, MD.</div><div id=\"graphicVersion\">Graphic 76183 Version 3.0</div></div></div>"},"52434":{"type":"graphic_figure","displayName":"Lifetime rate incarceration","title":"Prevalence of imprisonment in the US by race and gender","html":"<div class=\"graphic\"><div style=\"width: 530px\" class=\"figure\"><div class=\"ttl\">Prevalence of imprisonment in the US by race and gender</div><div class=\"cntnt\"><img style=\"width:510px; height:448px;\" src=\"images/PC/52434_Lifetime_rate_incarceration.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Rate of imprisonment in the United States by race and gender per 100,000 US residents.</div><div class=\"graphic_reference\">Data from: Carson EA. Prisoners in 2014. Bureau of Justice Statistics. US Department of Justice, 2015. Available at: <a href=\"http://www.bjs.gov/content/pub/pdf/p14.pdf\" target=\"_blank\">http://www.bjs.gov/content/pub/pdf/p14.pdf</a> (Accessed on May 23, 2016).</div><div id=\"graphicVersion\">Graphic 52434 Version 3.0</div></div></div>"},"52438":{"type":"graphic_picture","displayName":"Tinea versicolor chest 2","title":"Tinea versicolor chest","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Tinea versicolor chest</div><div class=\"cntnt\"><img style=\"width:432px; height:324px;\" src=\"images/DERM/52438_Tinea_versicolor_chest_2.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Hyperpigmented macules and patches are present on the chest in this patient with tinea versicolor.</div><div class=\"graphic_reference\">Photo courtesy of Paul S Matz, MD. Reproduced from: Chung EK, Boom JA, Datto GA, Matz PS (Eds). Visual Diagnosis in Pediatrics. Philadelphia: Lippincott Williams &amp; Wilkins, 2006. Copyright &#169; 2006.</div><div id=\"graphicVersion\">Graphic 52438 Version 1.0</div></div></div>"},"52440":{"type":"graphic_picture","displayName":"Herpes zoster rash A","title":"Herpes zoster","html":"<div class=\"graphic\"><div style=\"width: 488px\" class=\"figure\"><div class=\"ttl\">Herpes zoster</div><div class=\"cntnt\"><img style=\"width:468px; height:351px;\" src=\"images/ID/52440_Herpes_zoster_rash_A.jpg\" alt=\"Image\"/></div><div class=\"graphic_reference\">Courtesy of Vaibhav Parekh, MD, MBA.</div><div id=\"graphicVersion\">Graphic 52440 Version 1.0</div></div></div>"},"52442":{"type":"graphic_figure","displayName":"Perinatal stroke risk","title":"Perinatal stroke risk","html":"<div class=\"graphic\"><div style=\"width: 562px\" class=\"figure\"><div class=\"ttl\">Perinatal stroke risk</div><div class=\"cntnt\"><img style=\"width:542px; height:342px;\" src=\"images/NEURO/52442_Perinatal_stroke_risk.jpg\" alt=\"Image\"/></div><div id=\"graphicVersion\">Graphic 52442 Version 1.0</div></div></div>"},"52443":{"type":"graphic_diagnosticimage","displayName":"Doppler U-S choriocarcinoma","title":"Doppler ultrasound choriocarcinoma","html":"<div class=\"graphic\"><div style=\"width: 524px\" class=\"figure\"><div class=\"ttl\">Doppler ultrasound choriocarcinoma</div><div class=\"cntnt\"><img style=\"width:504px; height:497px;\" src=\"images/OBGYN/52443_DopplerUSchoriocarcinoma.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Choriocarcinoma: Ultrasound reveals a hyperechoic mass showing hypervascularity on color Doppler.</div><div class=\"graphic_reference\">Courtesy of Department of Radiology, Santa Clara Valley Medical Center.</div><div id=\"graphicVersion\">Graphic 52443 Version 3.0</div></div></div>"},"52444":{"type":"graphic_algorithm","displayName":"Evaluation of early contractures","title":"Evaluation of a child with early contractures (with or without mild muscle weakness) and no definite cardiac or respiratory abnormalities","html":"<div class=\"graphic\"><div style=\"width: 684px\" class=\"figure\"><div class=\"ttl\">Evaluation of a child with early contractures (with or without mild muscle weakness) and no definite cardiac or respiratory abnormalities</div><div class=\"cntnt\"><img style=\"width:664px; height:1094px;\" src=\"images/PEDS/52444_Algrthm_evlt_cntrct.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Algorithm for the evaluation of a sporadic patient with early contractures (with or without mild muscle weakness) and no definite cardiac abnormalities.</div><div class=\"graphic_footnotes\">AD: autosomal dominant; AR: autosomal recessive; CM: congenital myopathy; CMD: congenital muscular dystrophy; EDMD: Emery-Dreifuss muscular dystrophy; EMD: emerin gene; FHL1: four-and-a-half LIM domains 1 gene; IHC: immunohistochemistry; LMNA: lamin A/C gene; NGS: next generation sequencing; RSS: rigid spine syndrome; LGMD: limb-girdle muscular dystrophy; SEPN1: selenoprotein N 1 gene; SYNE1: spectrin repeat containing, nuclear envelope 1 gene; SYNE2: spectrin repeat containing, nuclear envelope 2 gene; TMEM43: transmembrane protein 43 gene.</div><div class=\"graphic_reference\">Modified with permission from: Deymeer F. Emery-Dreifuss muscular dystrophy. In: Neuromuscular Disorders of Infancy, Childhood, and Adolescence: A Clinician's Approach, Jones HR, De Vivo DC, Darras BT (Eds). Butterworth Heinemann, Philadelphia 2003. p.753. Copyright &copy; 2003 Elsevier.</div><div id=\"graphicVersion\">Graphic 52444 Version 6.0</div></div></div>"},"52445":{"type":"graphic_table","displayName":"Dietary sources of absorbable calcium","title":"Dietary sources of absorbable calcium, in comparison to milk","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Dietary sources of absorbable calcium, in comparison to milk</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup span=\"6\" width=\"16%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\">Food</td> <td class=\"subtitle1\">Serving size* (g)</td> <td class=\"subtitle1\">Calcium content<sup>&#182;</sup> (mg)</td> <td class=\"subtitle1\">Fractional absorption<sup>&#916;</sup>, (percent)</td> <td class=\"subtitle1\">Estimated absorbable calcium<sup>&#9674;</sup> (mg)</td> <td class=\"subtitle1\">Number of servings needed to equal 240 mL milk</td> </tr> <tr> <td>Milk</td> <td>240</td> <td>300</td> <td>32.1</td> <td>96.3</td> <td>1</td> </tr> <tr> <td class=\"sublist1_start\" colspan=\"6\">Beans</td> </tr> <tr> <td class=\"indent1 sublist1\">Pinto</td> <td class=\"sublist_other\">86</td> <td class=\"sublist_other\">44.7</td> <td class=\"sublist_other\">26.7</td> <td class=\"sublist_other\">11.9</td> <td class=\"sublist_other\">8.1</td> </tr> <tr> <td class=\"indent1 sublist1\">Red</td> <td class=\"sublist_other\">172</td> <td class=\"sublist_other\">40.5</td> <td class=\"sublist_other\">24.4</td> <td class=\"sublist_other\">9.9</td> <td class=\"sublist_other\">9.7</td> </tr> <tr> <td class=\"indent1 sublist1\">White</td> <td class=\"sublist_other\">110</td> <td class=\"sublist_other\">113</td> <td class=\"sublist_other\">21.8</td> <td class=\"sublist_other\">24.7</td> <td class=\"sublist_other\">3.9</td> </tr> <tr> <td>Bok choy</td> <td>85</td> <td>79</td> <td>53.8</td> <td>42.5</td> <td>2.3</td> </tr> <tr> <td>Broccoli</td> <td>71</td> <td>35</td> <td>61.3</td> <td>21.5</td> <td>4.5</td> </tr> <tr> <td>Cheddar cheese</td> <td>42</td> <td>303</td> <td>32.1</td> <td>97.2</td> <td>1</td> </tr> <tr> <td>Cheese food</td> <td>42</td> <td>241</td> <td>32.1</td> <td>77.4</td> <td>1.2</td> </tr> <tr> <td>Chinese cabbage flower leaves</td> <td>85</td> <td>239</td> <td>39.6</td> <td>94.7</td> <td>1</td> </tr> <tr> <td>Chinese mustard greens</td> <td>85</td> <td>212</td> <td>40.2</td> <td>85.3</td> <td>1.1</td> </tr> <tr> <td>Fruit punch with calcium citrate malate</td> <td>240</td> <td>300</td> <td>52</td> <td>156</td> <td>0.62</td> </tr> <tr> <td>Kale</td> <td>85</td> <td>61</td> <td>49.3</td> <td>30.1</td> <td>3.2</td> </tr> <tr> <td>Spinach</td> <td>85</td> <td>115</td> <td>5.1</td> <td>5.9</td> <td>16.3</td> </tr> <tr> <td>Sweet potatoes</td> <td>164</td> <td>44</td> <td>22.2</td> <td>9.8</td> <td>9.8</td> </tr> <tr> <td>Rhubarb</td> <td>120</td> <td>174</td> <td>8.54</td> <td>10.1</td> <td>9.5</td> </tr> <tr> <td>Tofu with calcium</td> <td>126</td> <td>258</td> <td>31</td> <td>80</td> <td>1.2</td> </tr> <tr> <td>Yogurt</td> <td>240</td> <td>300</td> <td>32.1</td> <td>96.3</td> <td>1</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">* Based on half-cup serving size (~85 g for green leafy vegetables) except for milk and fruit punch (1 cup or 240 mL) and cheese (1.5 ounces).<br />Â¶ From references 4 and 5 (averaged for beans and broccoli processed in different ways) except for the Chinese vegetables, which were analyzed in our laboratory.<br />Î Adjusted for load by using the equation for milk (fractional absorption = 0.889-0.0964 in load (6)) then adjusted for the ratio of calcium absorption of the test food relative to milk tested at the same load, the absorptive index. The absorptive index was taken from the literature for beans (7), bok choy (8), broccoli (8), Chinese vegetables (9), fruit punch with calcium citrate mulate (10), kale (8), sweet potatoes (9), rhubarb (9), tofu (11), and dairy products (12).<br />â Calculated as calcium content x fractional absorption.</div><div class=\"graphic_reference\">Reproduced with permission from: Weaver CM, Proulx WR, Heaney R. Choices for achieving adequate dietary calcium with a vegetarian diet. Am J Clin Nutr 1999; 70 (suppl):543S. Copyright &copy;1999, American Society for Clinical Nutrition.</div><div id=\"graphicVersion\">Graphic 52445 Version 5.0</div></div></div>"},"52446":{"type":"graphic_algorithm","displayName":"Pediatric bradycardia algorithm","title":"Pediatric bradycardia algorithm (with a pulse and poor perfusion)","html":"<div class=\"graphic\"><div style=\"width: 682px\" class=\"figure\"><div class=\"ttl\">Pediatric bradycardia algorithm (with a pulse and poor perfusion)</div><div class=\"cntnt\"><img style=\"width:662px; height:550px;\" src=\"images/EM/52446_Pediatricbradycardia.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">To help prevent medication errors, ratio expressions have been removed from epinephrine labels in the United States. Ampules, vials, and syringes of epinephrine with ratio expressions may, however, remain in inventory until replaced by products with revised labeling. Therefore, <STRONG>the 0.1 mg/mL concentration of epinephrine may be labeled as 1:10,000 and the 1 mg/mL concentration may be labeled as 1:1000</STRONG>.</div><div class=\"graphic_footnotes\">PALS: pediatric advanced life support; CPR: cardiopulmonary resuscitation; IO: intraosseous; IV: intravenous; HR: heart rate; AV: atrioventricular; ABC's: airway, breathing, circulation.</div><div class=\"graphic_reference\">Reprinted with permission. Pediatric Advanced Life Support: 2010. American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. &copy; 2010 American Heart Association, Inc. This algorithm remains unchanged in the 2015 update.</div><div id=\"graphicVersion\">Graphic 52446 Version 19.0</div></div></div>"},"52447":{"type":"graphic_figure","displayName":"Alendronate steroid BMD","title":"Benefit of alendronate in glucocorticoid-treated patients","html":"<div class=\"graphic\"><div style=\"width: 482px\" class=\"figure\"><div class=\"ttl\">Benefit of alendronate in glucocorticoid-treated patients</div><div class=\"cntnt\"><img style=\"width:462px; height:361px;\" src=\"images/ENDO/52447_Alendronate_steroid_BMD.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Effect of alendronate (5 or 10 mg/day) or placebo on bone mineral density in 477 patients receiving an average daily dose of at least 7.5 mg of prednisone per day or its equivalent. The mean bone mineral density of the lumbar spine increased by 2.1 and 2.9 percent over 48 weeks in the patients receiving 5 and 10 mg of alendronate daily, respectively, while decreasing 0.4 percent in the placebo group (top left panel). Femoral neck, trochanter, and total body bone mineral density also increased significantly in the alendronate groups.</div><div class=\"graphic_reference\">Data from: Saag KG, Emkey R, Schnitzer TJ, et al. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention&nbsp;Study Group.&nbsp;N Engl J Med 1998; 339:292.</div><div id=\"graphicVersion\">Graphic 52447 Version 2.0</div></div></div>"},"52448":{"type":"graphic_table","displayName":"Comparison of ileus and small bowel obstruction","title":"Comparison of ileus and small bowel obstruction","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Comparison of ileus and small bowel obstruction</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1\">Sign or symptom</td> <td class=\"subtitle1\">Ileus</td> <td class=\"subtitle1\">SBO</td> </tr> <tr> <td>Abdominal distention</td> <td>May be present</td> <td>May be present</td> </tr> <tr> <td>Bowel sounds</td> <td>Usually quiet or absent</td> <td>May be high-pitched, may be absent</td> </tr> <tr> <td>Obstipation</td> <td>May be present</td> <td>May be present</td> </tr> <tr> <td>Pain</td> <td>Mild and diffuse</td> <td>Moderate to severe, colicky</td> </tr> <tr> <td>Peritoneal signs</td> <td>Absent</td> <td>May be present</td> </tr> <tr> <td>Radiography</td> <td>Dilated loops of bowel, paucity of colonic gas</td> <td>Dilated loops of bowel, differential air-fluid levels, paucity&nbsp; or absence of colonic gas</td> </tr> <tr> <td>Fever, tachycardia</td> <td>Absent</td> <td>Should raise suspicion</td> </tr> <tr> <td>Vomiting</td> <td>May be present</td> <td>May be present, may be bilious or feculent</td> </tr> </tbody></table></div><div id=\"graphicVersion\">Graphic 52448 Version 3.0</div></div></div>"},"52450":{"type":"graphic_table","displayName":"Reviewing medications","title":"A step-wise approach to reviewing medications for older adults","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">A step-wise approach to reviewing medications for older adults</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1_single\">Approach</td> </tr> <tr> <td>Review current drug therapy</td> </tr> <tr> <td>Discontinue potentially unnecessary therapy</td> </tr> <tr> <td>Consider adverse drug events as a potential cause for any new symptom</td> </tr> <tr> <td>Consider nonpharmacologic approaches</td> </tr> <tr> <td>Substitute with safer alternatives</td> </tr> <tr> <td>Reduce the dose</td> </tr> <tr> <td>Use beneficial therapies when indicated</td> </tr> </tbody></table></div><div class=\"graphic_reference\">Reproduced with permission from: Rochon, P, JH, Gurwitz. Drug Therapy. The Lancet 1995; 346:32. Copyright Â© 1995 Elsevier.</div><div id=\"graphicVersion\">Graphic 52450 Version 3.0</div></div></div>"},"52451":{"type":"graphic_table","displayName":"Rx self-injurious behaviors","title":"Treatment of self-injurious behaviors","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Treatment of self-injurious behaviors</div><div class=\"cntnt\"><table  cellspacing=\"0\">\r\n \r\n   <tr>\r\n  \r\n   <td>Correct metabolic abnormalities</td>\r\n  \r\n   <td>Evaluate for somatic pain: ear, GI (constipation)</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Appropriate restricted diet: lactose, gluten</td>\r\n  \r\n   <td>Behavior modification program</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Evaluate for seizure activity</td>\r\n  \r\n   <td>Consistency and follow-through</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Increase activity levels if under-aroused</td>\r\n  \r\n   <td>Protective gear: gloves, helmet</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Reduce stimuli if over-aroused</td>\r\n  \r\n   <td>Appropriate use of medications</td>\r\n  \r\n   </tr>\r\n </table>\r\n\r\n\r\n<html xmlns:mso=\"urn:schemas-microsoft-com:office:office\" xmlns:msdt=\"uuid:C2F41010-65B3-11d1-A29F-00AA00C14882\"><head>\r\n<!--[if gte mso 9]><xml>\n<mso:CustomDocumentProperties>\r\n<mso:Specialty msdt:dt=\"string\">16.0000000000000</mso:Specialty>\r\n<mso:Media_Type msdt:dt=\"string\">Table</mso:Media_Type>\r\n<mso:Edit_Table msdt:dt=\"string\">&lt;a href=&quot;/Graphics/Pages/TableEditor.aspx?SPID=60967&amp;amp;Mode=Edit&quot;&gt;&lt;/a&gt;</mso:Edit_Table>\r\n</mso:CustomDocumentProperties>\n</xml><![endif]-->\r\n<title>Rx_self-injurious_behaviors.htm</title></head></div><div class=\"graphic_footnotes\">GI: gastrointestinal.</div><div id=\"graphicVersion\">Graphic 52451 Version 2.0</div></div></div>"},"52452":{"type":"graphic_picture","displayName":"Deforming arthritis in MCTD","title":"Joint deformity in mixed connective tissue disease (MCTD)","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Joint deformity in mixed connective tissue disease (MCTD)</div><div class=\"cntnt\"><img style=\"width:360px; height:237px;\" src=\"images/RHEUM/52452_Deforming_arthritis_in_MCTD.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Deforming arthritis in mixed connective tissue disease characterized by ulnar deviation and swan neck deformities. These abnormalities are also seen in rheumatoid arthritis.</div><div class=\"graphic_reference\">Courtesy of Robert M Bennett, MD.</div><div id=\"graphicVersion\">Graphic 52452 Version 2.0</div></div></div>"},"52454":{"type":"graphic_picture","displayName":"Early calciphylaxis","title":"Early calciphylaxis","html":"<div class=\"graphic\"><div style=\"width: 520px\" class=\"figure\"><div class=\"ttl\">Early calciphylaxis</div><div class=\"cntnt\"><img style=\"width:500px; height:437px;\" src=\"images/NEPH/52454_Early_calciphylaxis.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Ischemic changes observed clinically as livedo reticularis prior to development of necrotic ulcer with eschar that is clinically evident in the calciphylaxis lesion.</div><div class=\"graphic_reference\">Courtesy of Peter W Santos, DO.</div><div id=\"graphicVersion\">Graphic 52454 Version 2.0</div></div></div>"},"52455":{"type":"graphic_picture","displayName":"Totally dystrophic onychomycosis","title":"Totally dystrophic onychomycosis","html":"<div class=\"graphic\"><div style=\"width: 488px\" class=\"figure\"><div class=\"ttl\">Totally dystrophic onychomycosis</div><div class=\"cntnt\"><img style=\"width:468px; height:351px;\" src=\"images/DERM/52455_Totally_dystr_onychomycosis.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Total destruction of the nail with a ridged, hyperkeratotic nail bed is present in this patient with totally dystrophic onychomycosis.</div><div class=\"graphic_reference\">Reproduced with permission from: <A style=\"FONT-STYLE: italic\" href=\"http://www.visualdx.com/\" target=_blank>www.visualdx.com</A>. Copyright Logical Images, Inc.</div><div id=\"graphicVersion\">Graphic 52455 Version 4.0</div></div></div>"},"52457":{"type":"graphic_picture","displayName":"BRAO platelet fibrin embolus","title":"Platelet fibrin embolus causing branch retinal artery occlusion","html":"<div class=\"graphic\"><div style=\"width: 499px\" class=\"figure\"><div class=\"ttl\">Platelet fibrin embolus causing branch retinal artery occlusion</div><div class=\"cntnt\"><img style=\"width:479px; height:156px;\" src=\"images/NEURO/52457_BRAO_platelet_fibrin_embolu.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">A) Platelet-fibrin material in a branch retinal artery. B) The platelet-fibrin material seen in figure A has moved distally after several seconds.</div><div id=\"graphicVersion\">Graphic 52457 Version 2.0</div></div></div>"},"52458":{"type":"graphic_picture","displayName":"Herpes placentitis","title":"Herpes placentitis","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Herpes placentitis</div><div class=\"cntnt\"><img style=\"width:395px; height:258px;\" src=\"images/OBGYN/52458_Herpes_placentitis.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Intrauterine herpes simplex virus is associated lymphoplasmacytic villitis (arrows), a nonspecific finding.</div><div class=\"graphic_reference\">Courtesy of Drucilla J Roberts, MD.</div><div id=\"graphicVersion\">Graphic 52458 Version 3.0</div></div></div>"},"52459":{"type":"graphic_figure","displayName":"Echocardiogram instrumentation","title":"Instrumentation of echocardiographic imaging","html":"<div class=\"graphic\"><div style=\"width: 514px\" class=\"figure\"><div class=\"ttl\">Instrumentation of echocardiographic imaging</div><div class=\"cntnt\"><img style=\"width:494px; height:290px;\" src=\"images/CARD/52459_Echocardiogram_instrumentat.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The long axis plane of the left ventricle is obtained by placing the transducer on the chest wall, overlying the cardiac structures, directing a beam (broad shaded line) through the heart (upper row, left). As each structure is encountered it reflects ultrasound which is then detected by the instrument during its &quot;listening&quot; mode. These detected structures are displayed as a row of spike arranged according to their relative distances from the transducer; this is known as amplitude modulation or A-mode. The width of each spike at its base is proportional to the size of the structure creating it. When the object being imaged is viewed in real time, the spike will be seen to shift position. Since the A-mode display is not convenient for pattern recognition, its signal is modulated to brightness or B-mode. The height of each spike is expressed as dot brightness and its width as dot diameter. The dots, when played across a photosenstive strip chart or oscillographic display can leave a permanant paper or video tracing known as a time-motion mode record or M-mode echocardiogram. Various means of producing real time two dimensional images or sector scans are shown on the bottom row. A single beam of ultrasound is played back and forth through a sector; as the beam sweeps it leaves several thin lines of B-mode information. When viewed in video or digital format, these lines and dots are visually integrated and produce a real time tomographic cross section of information that precisely replicates an anatomic slice along plane.</div><div class=\"graphic_footnotes\">CW: chest wall; RVW: right ventricular wall; Sept: interventricular septum; AML: anterior mitral valve leaflet; PMV: posterior mitral valve leaflet; LVW: posterior wall of left ventricle.</div><div class=\"graphic_reference\">Courtesy of Dr. Norman H Silverman.</div><div id=\"graphicVersion\">Graphic 52459 Version 1.0</div></div></div>"},"52460":{"type":"graphic_picture","displayName":"RTT motor dysfunction","title":"Rett syndrome, motor dysfunction","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Rett syndrome, motor dysfunction</div><div class=\"cntnt\"><img style=\"width:252px; height:378px;\" src=\"images/PEDS/52460_RS_stage_III_motor_dysfunct.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">This child with RTT continued to ambulate, though she had an abnormal dyspraxic gait with toe walking.</div><div class=\"graphic_reference\">Reproduced with permission from: Glaze DG, Schultz RJ. Rett syndrome: Meeting the challenge of this gender-specific neurodevelopmental disorder. Medscape Women's Health 1997; 2. Copyright Â© 1997 Medscape.</div><div id=\"graphicVersion\">Graphic 52460 Version 4.0</div></div></div>"},"52461":{"type":"graphic_figure","displayName":"Dorsal foot anatomy scheme: arteries and nerves","title":"Dorsal foot anatomy scheme: arteries and nerves","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Dorsal foot anatomy scheme: arteries and nerves</div><div class=\"cntnt\"><img style=\"width:411px; height:541px;\" src=\"images/PC/52461_Dorsal_foot_anatomy.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The path of dorsal arteries (red) and nerves (green) to the toes is shown. Each digit is innervated by four digital nerves; the plantar arteries and nerves are not shown in this figure. In order to achieve a complete anesthetic effect, it is necessary to block all four nerves. For a complete block of the great toe, there are additional branches that come up the dorsal aspect of the great toe that can be missed if anesthetic is only injected laterally and medially.</div><div id=\"graphicVersion\">Graphic 52461 Version 4.0</div></div></div>"},"52462":{"type":"graphic_figure","displayName":"Three point cast molding","title":"Three-point cast molding","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Three-point cast molding</div><div class=\"cntnt\"><img style=\"width:301px; height:454px;\" src=\"images/EM/52462_Threepointcastmolding.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Interosseous mold technique.</div><div class=\"graphic_reference\">Reproduced with permission from: Mehlman CT, Wall EJ. Injuries to the shafts of the radius and ulna. In: Rockwood and Wilkins' Fractures in Children, 6th ed, Beaty JH, Kasser JR (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. Copyright Â© 2006 Lippincott Williams &amp; Wilkins. <A href=\"http://www.lww.com/\" target=_blank>www.lww.com</A>.</div><div id=\"graphicVersion\">Graphic 52462 Version 11.0</div></div></div>"},"52463":{"type":"graphic_picture","displayName":"Thyroid colloid FNA","title":"Colloid from a macrofollicular nodule: Findings on fine needle aspirate","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Colloid from a macrofollicular nodule: Findings on fine needle aspirate</div><div class=\"cntnt\"><img style=\"width:360px; height:239px;\" src=\"images/ENDO/52463_Thyroid_colloid_FNA.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Papanicolaou stain showing colloid, which is usually abundant in the background of macrofollicular lesions.</div><div id=\"graphicVersion\">Graphic 52463 Version 3.0</div></div></div>"},"52464":{"type":"graphic_figure","displayName":"Dividing bowel for colostomy","title":"Dividing bowel for colostomy","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Dividing bowel for colostomy</div><div class=\"cntnt\"><img style=\"width:234px; height:260px;\" src=\"images/OBGYN/52464_Dividing_bowel_for_colostom.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">After confirming the proximal and distal segments of sigmoid colon, the bowel is divided with a GIA (gastrointestinal anastomosis) stapler.</div><div id=\"graphicVersion\">Graphic 52464 Version 2.0</div></div></div>"},"52466":{"type":"graphic_picture","displayName":"Bland alveolar hemorrhage DAH","title":"Bland pulmonary hemorrhage","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Bland pulmonary hemorrhage</div><div class=\"cntnt\"><img style=\"width:360px; height:245px;\" src=\"images/PULM/52466_Bland_alveolar_hemorrhage_D.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Light micrograph of bland pulmonary hemorrhage in which the alveolar spaces are filled with red blood cells. The alveolar septa appear normal except for type II epithelial lining cell hyperplasia.</div><div class=\"graphic_reference\">Courtesy of Marvin I Schwarz, MD.</div><div id=\"graphicVersion\">Graphic 52466 Version 1.0</div></div></div>"},"52467":{"type":"graphic_diagnosticimage","displayName":"Left adrenal metastasis CT","title":"Intra-abdominal metastases from lung cancer","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Intra-abdominal metastases from lung cancer</div><div class=\"cntnt\"><img style=\"width:291px; height:247px;\" src=\"images/PULM/52467_Left_adrenal_metastasis_CT.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Computed tomography (CT) scan of the upper abdomen shows a large low attenuation necrotic left adrenal metastasis (small arrow) and another low attenuation necrotic metastatic focus in the pancreas (large arrow). </div><div class=\"graphic_reference\">Courtesy of Paul Stark, MD.</div><div id=\"graphicVersion\">Graphic 52467 Version 3.0</div></div></div>"},"52468":{"type":"graphic_picture","displayName":"Posterior synechiae","title":"Posterior synechiae","html":"<div class=\"graphic\"><div style=\"width: 512px\" class=\"figure\"><div class=\"ttl\">Posterior synechiae</div><div class=\"cntnt\"><img style=\"width:492px; height:319px;\" src=\"images/RHEUM/52468_Posterior_synechiae.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The pupil has an irregular shape due to posterior synechiae, which have bound the iris posteriorly to the lens.</div><div class=\"graphic_reference\">Courtesy of James T Rosenbaum, MD.</div><div id=\"graphicVersion\">Graphic 52468 Version 2.0</div></div></div>"},"52469":{"type":"graphic_figure","displayName":"Cytokine synovial interactions","title":"An overview of the cytokine-mediated regulation of synovial interactions","html":"<div class=\"graphic\"><div style=\"width: 653px\" class=\"figure\"><div class=\"ttl\">An overview of the cytokine-mediated regulation of synovial interactions</div><div class=\"cntnt\"><img style=\"width:633px; height:379px;\" src=\"images/RHEUM/52469_Cytokine_synovial_interactions.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The component cells of the inflamed rheumatoid synovial membrane are depicted in innate and adaptive predominant compartments of the inflammatory response. Pivotal cytokine pathways are depicted in which activation of dendritic cells (DCs), T cells, B cells, and macrophages underpins the dysregulated expression of cytokines that in turn drive activation of effector cells, including neutrophils, mast cells, endothelial cells and synovial fibroblasts. Bidirectional arrows represent a relationship between cells that is influenced by the cytokines listed.</div><div class=\"graphic_footnotes\">APRIL: a proliferation-inducing ligand; BAFF: B-cell activating factor; bFGF: basic fibroblast growth factor; CCL21: CC-chemokine ligand 21; CXCL13: CXC-chemokine ligand 13; FcgR: Fc receptor for IgG; IFN: interferon; IL: interleukin; LTÎ²: lymphotoxin-Î²; M-CSF: macrophage colony-stimulating factor; PAR2: protease-activated receptor 2; RANKL: receptor activator of nuclear factor-ÎºB (RANK) ligand; TGFÎ²: transforming growth factor-Î²; T<sub>H</sub>: T helper; TLR: toll-like receptor; TNF: tumor-necrosis factor; VEGF: vascular endothelial growth factor.</div><div class=\"graphic_reference\">Reprinted by permission from: Macmillan Publishers LTD: McInnes, IB, Schett, G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 2007; 6:429. Copyright Â© 2007.</div><div id=\"graphicVersion\">Graphic 52469 Version 3.0</div></div></div>"},"52470":{"type":"graphic_algorithm","displayName":"Maximal reduction in patient radiation exposure MPI","title":"Reducing radiation exposure in patients referred for myocardial perfusion imaging","html":"<div class=\"graphic\"><div style=\"width: 493px\" class=\"figure\"><div class=\"ttl\">Reducing radiation exposure in patients referred for myocardial perfusion imaging</div><div class=\"cntnt\"><img style=\"width:473px; height:525px;\" src=\"images/CARD/52470_Max_reduct_radiation_expos.gif\" alt=\"Image\"/></div><div class=\"graphic_footnotes\">AC: attenuation correction; HF: heart failure; MI: myocardial infarction; MPI: myocardial perfusion imaging; PET: positron emission tomography; SPECT: single photon emission computed tomography; Tc-99m: technetium-99m; Tl-201: thallium-201.</div><div class=\"graphic_reference\">Reproduced from: Cerqueira MD, Allman KC, Ficaro EP, et al. Recommendations for reducing radiation exposure in myocardial perfusion imaging. J Nucl Cardiol 2010; 17:709, with kind permission from Springer Science + Business Media B.V. Copyright Â© 2010.</div><div id=\"graphicVersion\">Graphic 52470 Version 6.0</div></div></div>"},"52471":{"type":"graphic_figure","displayName":"Nasal valves","title":"Nasal valves","html":"<div class=\"graphic\"><div style=\"width: 558px\" class=\"figure\"><div class=\"ttl\">Nasal valves</div><div class=\"cntnt\"><img style=\"width:538px; height:328px;\" src=\"images/ALLRG/52471_Nasal_valves.jpg\" alt=\"Image\"/></div><div id=\"graphicVersion\">Graphic 52471 Version 2.0</div></div></div>"},"52473":{"type":"graphic_movie","displayName":"Magnetic imaging colonoscopy","title":"Magnetic imaging colonoscopy","html":"<div class=\"graphic normal\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Magnetic imaging colonoscopy</div><div class=\"cntnt\"><div class=\"videoplayer\" h264=\"images/CARD/52473_magcolonconv.mp4\" style=\"width:168px;height:256px\"></div><img style=\"width:345px; height:257px;\" src=\"images/CARD/52473_magcolon.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Intubation from the splenic flexure to the cecal pole through an amazingly long and mobile proximal and sigmoid colon, with an unusual spiral or gamma loop in the transverse colon. See how the sigmoid colon is pushed up toward the diaphragm due to its remarkable elasticity.</div><div class=\"graphic_reference\">Courtesy of Christopher B Williams BM, FRCP, FRCS.</div><div id=\"graphicVersion\">Graphic 52473 Version 2.0</div></div></div>"},"52475":{"type":"graphic_table","displayName":"Drugs used to treat pericardial disease in pregnancy","title":"Anti-inflammatory and immunosuppressive drugs potentially useful in the treatment of pericardial disease","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Anti-inflammatory and immunosuppressive drugs potentially useful in the treatment of pericardial disease</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup span=\"4\" width=\"10%\"></colgroup><colgroup width=\"30%\"></colgroup><colgroup width=\"10%\"></colgroup><colgroup width=\"20%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\">Drug</td> <td class=\"subtitle1\">Pregnancy category*</td> <td class=\"subtitle1\">Transplacental passage</td> <td class=\"subtitle1\">Teratogenicity</td> <td class=\"subtitle1\">Potential fetal-neonatal adverse effects</td> <td class=\"subtitle1\">Long-term effects offspring</td> <td class=\"subtitle1\">Fertility impairment</td> </tr> <tr class=\"divider_bottom\"> <td>Aspirin (analgesic dosed) and non-selective NSAIDs</td> <td> <p>C (1st, 2nd T)</p> D (3rd T)</td> <td>Yes</td> <td>Yes</td> <td>No pattern of birth defects established; can be used safely during 1st and 2nd trimesters. Use in late pregnancy avoided due to concerns over possible effects on ductus arteriosus and renal function; refer to topic discussion. Rare adverse reports (eg, cardiac defects, gastroschisis, low birth weight) might be exposure related (all T).</td> <td>Unknown (none detected with low dose aspirin)</td> <td>Case descriptions of follicle rupture inhibition associated with prolonged use. May increase risk of spontaneous abortion if used at time of conception.</td> </tr> <tr class=\"divider_bottom\"> <td>Celecoxib</td> <td> <p>C (1st, 2nd T)</p> D (3rd T)</td> <td>Expected</td> <td> <p>Unknown (human)</p> Yes (animal)</td> <td>Unknown. Interferes with embryonic development in rats and rabbits. Avoid during pregnancy.</td> <td>Unknown</td> <td>Unknown. Interferes with fertility in murine models.</td> </tr> <tr class=\"divider_bottom\"> <td>Short-acting glucocorticoids (prednisone, prednisolone, methylprednisolone)</td> <td> <p>D (1st T)</p> C (2nd, 3rd T)</td> <td>Yes</td> <td>Yes</td> <td>May increase risk of orofacial clefting (1st T) and restrict fetal growth (all T). Hypoadrenalism may occur in neonate. Most data are reassuring when used at low to medium doses (ie, 10 to 20 mg orally per day).</td> <td>None detected</td> <td>Experience does not suggest impairment.</td> </tr> <tr class=\"divider_bottom\"> <td>Colchicine</td> <td>C</td> <td>Yes</td> <td> <p>No (human)</p> Yes (animal)</td> <td>Colchicine should not be used in pregnancy beyond compelling maternal indication (ie, FMF). It is generally tapered before conception and substituted with aspirin and/or low dose prednisone.</td> <td>Unknown</td> <td>Experience in women does not suggest impairment. Rarely associated with infertility in men.</td> </tr> <tr class=\"divider_bottom\"> <td>Azathioprine</td> <td>D</td> <td>Yes</td> <td> <p>No (human)</p> Yes (animal)</td> <td>Reports of hematologic abnormalities, immune impairment, growth restriction, and prematurity may be exposure related. May be rarely used in selected cases in pregnancy.</td> <td>Unknown</td> <td>Experience does not suggest impairment. May interfere with efficacy of intrauterine contraceptive devices.</td> </tr> <tr class=\"divider_bottom\"> <td>Methotrexate</td> <td>X</td> <td>Yes</td> <td>Yes</td> <td>Spectrum defects include skull, facial feature, and limb anomalies when exposed during organogenesis (1st T). CNS abnormalities also reported. Growth retardation and mortality may be elevated in 2nd and 3rd T exposure. Use in pregnancy is absolutely contraindicated.</td> <td>Developmental delay and intellectual impairment reported</td> <td>Oligospermia in men and amenorrhea in women when used for cancer chemotherapy in combination with other agents.</td> </tr> <tr class=\"divider_bottom\"> <td>Cyclophosphamide</td> <td>D</td> <td>Yes</td> <td>Yes</td> <td>Skeletal, palate, ocular, and limb defects associated with exposure during 1st T. 2nd and 3rd T exposure associated with smaller risk of malformations but hematologic abnormalities and growth restriction reported may be exposure related. Use in pregnancy is absolutely contraindicated.</td> <td>Unknown</td> <td>Gonadal toxicity established in dosage regimens for cancer chemotherapy.</td> </tr> <tr class=\"divider_bottom\"> <td>Cyclosporine</td> <td>C</td> <td>Yes</td> <td>No</td> <td>Experience, based on limited case reports, does not establish an increased risk of birth defects. Reports of growth restriction, miscarriage, and preterm delivery may be exposure related. May be rarely used in selected cases during pregnancy.</td> <td>Unknown</td> <td>Experience does not suggest impairment.</td> </tr> <tr> <td>Intravenous immunoglobulins (IVIG)</td> <td>C</td> <td>Yes</td> <td>No</td> <td>Experience does not suggest an increased risk of congenital anomalies or other adverse embryonic effects. May be rarely used in selected cases in pregnancy.</td> <td>Unknown</td> <td>Unknown</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">T: trimester of pregnancy; NSAID: nonsteroidal anti-inflammatory drug; FMF: familial Mediterranean fever; CNS: central nervous system.<br />* Description of the US Food &amp; Drug Administration (FDA) pregnancy risk categories is provided in a separate table available in UpToDate. In 2015, US FDA began overseeing the phase-out of pregnancy risk categories (A, B, C, D, and X ) from prescription drug labeling and began requiring information from available human and animal studies of (1) known or potential maternal or fetal adverse reactions, and (2) dose adjustments needed during pregnancy and the postpartum period. Additional information is available at the US FDA website: <A href=\"http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/Labeling/ucm093307.htm\" target=_blank>Pregnancy and Lactation Labeling Final Rule</A>.</div><div class=\"graphic_reference\">Data from:&#xD;&#xA;<ol>&#xD;&#xA;    <li>Briggs GG, Freeman RK. Drugs in pregnancy and lactation 10th ed. &copy;2015 Wolters Kluwer Health, Philadelphia PA. </li>&#xD;&#xA;    <li>United States FDA approved product information. http://dailymed.nlm.nih.gov/dailymed/index.cfm (Accessed November 25, 2014).</li>&#xD;&#xA;</ol></div><div id=\"graphicVersion\">Graphic 52475 Version 7.0</div></div></div>"},"52477":{"type":"graphic_picture","displayName":"Harlequin sign","title":"Harlequin sign and Horner's syndrome from right Pancoast tumor","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Harlequin sign and Horner's syndrome from right Pancoast tumor</div><div class=\"cntnt\"><img style=\"width:432px; height:308px;\" src=\"images/ONC/52477_Harlequin_sign.jpg\" alt=\"Image\"/></div><div class=\"graphic_reference\">Reproduced with permission from: Antoni DN, Jeung MY, Mennecier B, et al. A two-faced young woman. J Thorac Oncol 2009; 4:240. Copyright Â© 2009 Lippincott Williams &amp; Wilkins.</div><div id=\"graphicVersion\">Graphic 52477 Version 8.0</div></div></div>"},"52478":{"type":"graphic_waveform","displayName":"Intraatrial reentrant tachycardia","title":"Intraatrial reentrant tachycardia","html":"<div class=\"graphic\"><div style=\"width: 604px\" class=\"figure\"><div class=\"ttl\">Intraatrial reentrant tachycardia</div><div class=\"cntnt\"><img style=\"width:584px; height:370px;\" src=\"images/CARD/52478_Intraatrial_tachy.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">An electrocardiogram from a patient with a Fontan repair, demonstrating an intra-atrial reentrant tachycardia. The periods of higher grade AV block allow for easy identification of the P waves. Without these pauses, the atrial rhythm can be difficult to identify, as the P waves are frequently buried within the preceding QRS complex. This is most evident on the paced beats.</div><div id=\"graphicVersion\">Graphic 52478 Version 3.0</div></div></div>"},"52479":{"type":"graphic_diagnosticimage","displayName":"Pancreatogram following stone removal","title":"Pancreatogram following stone removal","html":"<div class=\"graphic\"><div style=\"width: 524px\" class=\"figure\"><div class=\"ttl\">Pancreatogram following stone removal</div><div class=\"cntnt\"><img style=\"width:504px; height:502px;\" src=\"images/GAST/52479_Pancreato_stone_removal_PR.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Pancreatogram showing no residual stones within the pancreatic duct following pancreatoscopy with lithotripsy.</div><div id=\"graphicVersion\">Graphic 52479 Version 2.0</div></div></div>"},"52481":{"type":"graphic_figure","displayName":"Test sites in diabetic foot","title":"Testing sites for pressure sensation in evaluation of diabetic foot","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Testing sites for pressure sensation in evaluation of diabetic foot</div><div class=\"cntnt\"><img style=\"width:282px; height:265px;\" src=\"images/ENDO/52481_Test_sites_in_diabetic_foot.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The monofilament used to evaluate pressure sensation should be tested at each of the 12 sites shown, which represent the most common sites of ulcer formation. Failure to detect cutaneous pressure at any site indicates that the patient is at high risk for future ulceration.</div><div id=\"graphicVersion\">Graphic 52481 Version 1.0</div></div></div>"},"52482":{"type":"graphic_table","displayName":"Hepatic hydrothorax features","title":"Characteristics of hepatic hydrothroax","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Characteristics of hepatic hydrothroax</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1_single\">Location</td> </tr> <tr> <td>Right side (73 to 85 percent)</td> </tr> <tr> <td>Left side (13 to 17&nbsp;percent)</td> </tr> <tr> <td>Bilateral (2 to 10 percent)</td> </tr> <tr> <td class=\"subtitle1_single\">Fluid</td> </tr> <tr> <td>Cell count &#60;250 polymorphonuclear cells per mm<sup>3</sup></td> </tr> <tr> <td>Protein &#60;2.5 g/dL</td> </tr> <tr> <td>Pleural fluid/serum total protein ratio &#60;0.5</td> </tr> <tr> <td>Pleural fluid/serum lacate dehydrogenase ratio &#60;0.6</td> </tr> <tr> <td>Serum-to-pleural fluid albumin gradient &#62;1.1 g/dL</td> </tr> <tr> <td>Pleural fluid/serum bilirubin ratio &#60;0.6</td> </tr> <tr> <td>pH &#62;7.4</td> </tr> <tr> <td>Glucose level similar to that of serum</td> </tr> </tbody></table></div><div class=\"graphic_reference\">Courtesy of Andres Cardenas, MD.</div><div id=\"graphicVersion\">Graphic 52482 Version 3.0</div></div></div>"},"52483":{"type":"graphic_picture","displayName":"Osler Weber Rendu","title":"Oral telangiectasias in Osler Weber Rendu syndrome (Hereditary hemorrhagic telangiectasia)","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Oral telangiectasias in Osler Weber Rendu syndrome (Hereditary hemorrhagic telangiectasia)</div><div class=\"cntnt\"><img style=\"width:360px; height:339px;\" src=\"images/PEDS/52483_OslerWeberRendu.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Osler Weber Rendu syndrome (also known as hereditary hemorrhagic telangiectasia). Note the multiple 1 to 2 mm, discrete, red macular and papular telangiectases on the lower lip and tongue.</div><div class=\"graphic_reference\">Reproduced with permission from: Fitzpatrick TB, Johnson RA, Wolff K, Suurmond D. Color Atlas &amp; Synopsis of Clinical Dermatology, 4th ed, McGraw Hill Medical Publishing, New York 2001. Copyright Â© 2001 McGraw-Hill.</div><div id=\"graphicVersion\">Graphic 52483 Version 4.0</div></div></div>"},"52484":{"type":"graphic_figure","displayName":"Applying stockings A","title":"Putting on compression stockings","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Putting on compression stockings</div><div class=\"cntnt\"><img style=\"width:421px; height:437px;\" src=\"images/PC/52484_Applying_stockings_A.jpg\" alt=\"Image\"/></div><div id=\"graphicVersion\">Graphic 52484 Version 1.0</div></div></div>"},"52485":{"type":"graphic_figure","displayName":"Damaging shear forces in ARDS","title":"Shear forces","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Shear forces</div><div class=\"cntnt\"><img style=\"width:439px; height:438px;\" src=\"images/PULM/52485_Damaging_shear_forces_in_AR.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">When lung units collapse, they may stretch adjacent, non- atelectatic lung units and create damaging shear forces</div><div id=\"graphicVersion\">Graphic 52485 Version 1.0</div></div></div>"},"52486":{"type":"graphic_table","displayName":"NYHA alter pulm thromboend","title":"Improvement in NYHA functional class after pulmonary thromboendarterectomy","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Improvement in NYHA functional class after pulmonary thromboendarterectomy</div><div class=\"cntnt\"><table cellspacing=\"0\">\n\n  <tbody>\n\n    <tr>\n      <td class=\"subtitle1\">NYHA class</td>\n      <td class=\"subtitle1\">Preoperative</td>\n      <td class=\"subtitle1\">Postoperative</td>\n    </tr>\n    <tr>\n\n      <td>IV</td>\n\n      <td>63</td>\n\n      <td>0</td>\n\n    </tr>\n\n    <tr>\n\n      <td>III</td>\n\n      <td>49</td>\n\n      <td>6</td>\n\n    </tr>\n\n    <tr>\n\n      <td>II</td>\n\n      <td>5</td>\n\n      <td>26</td>\n\n    </tr>\n\n    <tr>\n\n      <td>I</td>\n\n      <td>0</td>\n\n      <td>85</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Total</td>\n\n      <td>117</td>\n\n      <td>117</td>\n\n    </tr>\n\n\n\n  </tbody>\n</table></div><div class=\"graphic_lgnd\">Marked improvement in New York Heart Association (NYHA) functional class after pulmonary thromboendartectomy for chronic thromboembolic pulmonary hypertension in 117 of the first 150 patients evaluated at one year following surgery.</div><div id=\"graphicVersion\">Graphic 52486 Version 1.0</div></div></div>"},"52487":{"type":"graphic_figure","displayName":"Pathophysiology VSD","title":"Pathophysiology of ventricular septal defect","html":"<div class=\"graphic\"><div style=\"width: 518px\" class=\"figure\"><div class=\"ttl\">Pathophysiology of ventricular septal defect</div><div class=\"cntnt\"><img style=\"width:498px; height:446px;\" src=\"images/CARD/52487_Pathophysiology_VSD.jpg\" alt=\"Image\"/></div><div id=\"graphicVersion\">Graphic 52487 Version 3.0</div></div></div>"},"52488":{"type":"graphic_table","displayName":"Nasogastric tubes","title":"Nasogastric tubes","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Nasogastric tubes</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1\">Tube</td> <td class=\"subtitle1\">Sizes</td> <td class=\"subtitle1\">Length</td> <td class=\"subtitle1\">Lumen</td> <td class=\"subtitle1\">Function</td> <td class=\"subtitle1\">Material</td> <td class=\"subtitle1\">Comments</td> </tr> <tr> <td rowspan=\"3\">Salem-sump</td> <td rowspan=\"3\">6-18 F</td> <td rowspan=\"3\">60-122 cm</td> <td rowspan=\"3\">Double</td> <td>Gastric decompression</td> <td rowspan=\"3\">PVC</td> <td rowspan=\"3\">Second lumen vents to atmosphere to prevent suctioning of tube to gastric mucosa. Radio opaque line along its length.</td> </tr> <tr> <td>Medication delivery</td> </tr> <tr> <td>Enteral feeding</td> </tr> <tr class=\"divider_top\"> <td rowspan=\"3\">Levin tube</td> <td rowspan=\"3\">8-20 F</td> <td rowspan=\"3\">122 cm</td> <td rowspan=\"3\">Single</td> <td>Gastric decompression</td> <td rowspan=\"3\">PVC</td> <td rowspan=\"3\">Markings at 45, 55, 65, 75 cm. Radio opaque line along its length.</td> </tr> <tr> <td>Medication delivery</td> </tr> <tr> <td>Enteral feeding</td> </tr> <tr class=\"divider_top\"> <td rowspan=\"2\">Ryle's tube</td> <td rowspan=\"2\">8-20 F</td> <td rowspan=\"2\">105 cm</td> <td rowspan=\"2\">Single</td> <td>Gastric aspiration</td> <td rowspan=\"2\">PVC</td> <td rowspan=\"2\">Markings at 50, 60, 70 cm. Radio opaque line along its length. Weighted end.</td> </tr> <tr> <td>Enteral feeding</td> </tr> <tr class=\"divider_top\"> <td> <p>Enteral feeding tubes</p> <p>(Examples: Abbot Nutrition enteral feeding tube; Cook Endoscopy NJFT; Corpak Medical Systems CORFLO tubes; Covidien tubes; Teleflex Medical tubes)</p> </td> <td>3.5-12 F</td> <td>31-240 cm</td> <td>Single to triple</td> <td>Enteral feeding</td> <td>Polyurethane, silicone, PVC</td> <td>Various features may be present: <ul> <li>Stylet used for &#60;12 F tubes to stiffen the tube for insertion and confirm placement radiographically </li> <li>Radio opaque markers each cm </li> <li>Weighted tip to allow propulsion into duodenum by peristalsis </li> <li>Magnets to facilitate jejunal placement </li> <li>Suture loops to allow endoscopic placement </li> </ul> </td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">PVC: polyvinyl chloride.</div><div id=\"graphicVersion\">Graphic 52488 Version 2.0</div></div></div>"},"52489":{"type":"graphic_figure","displayName":"Anatomic classification biliary cancers","title":"Anatomic classification of cancers of the human biliary tract","html":"<div class=\"graphic\"><div style=\"width: 589px\" class=\"figure\"><div class=\"ttl\">Anatomic classification of cancers of the human biliary tract</div><div class=\"cntnt\"><img style=\"width:569px; height:459px;\" src=\"images/GAST/52489_Classification_biliary_cancers_edit.jpg\" alt=\"Image\"/></div><div class=\"graphic_reference\">Classifications defined by: American Joint Committee on Cancer (AJCC) Cancer Staging Manual, 8th Edition, Amin MB (Ed), Chicago: Springer Science+Business Media, LLC, 2017.</div><div id=\"graphicVersion\">Graphic 52489 Version 6.0</div></div></div>"},"52491":{"type":"graphic_table","displayName":"Adv main Rx prost CA","title":"The advantages of the main treatment options for early prostate cancer","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">The advantages of the main treatment options for early prostate cancer</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1_single\">External beam radiation therapy</td> </tr> <tr> <td class=\"indent1\">Effective long-term cancer control with high-dose treatments</td> </tr> <tr> <td class=\"indent1\">Very low risk of urinary incontinence</td> </tr> <tr> <td class=\"indent1\">Available for cure of patients over a wide range of ages and in those with significant comorbidity</td> </tr> <tr> <td class=\"subtitle1_single\">Brachytherapy</td> </tr> <tr> <td class=\"indent1\">Cancer control rates appear equal to surgery and EBRT for organ-confined tumors</td> </tr> <tr> <td class=\"indent1\">Quicker than EBRT (single treatment)</td> </tr> <tr> <td class=\"indent1\">Available for cure of patients over a wide range of ages and in those with some comorbidity</td> </tr> <tr> <td class=\"subtitle1_single\">Radical prostatectomy</td> </tr> <tr> <td class=\"indent1\">Effective long-term cancer control</td> </tr> <tr> <td class=\"indent1\">Predictions of prognosis can be more precise based on pathologic features in specimen</td> </tr> <tr> <td class=\"indent1\">Pelvic lymph node dissection is possible through the same incision</td> </tr> <tr> <td class=\"indent1\">PSA failure is easy to detect</td> </tr> <tr> <td class=\"subtitle1_single\">Active surveillance</td> </tr> <tr> <td class=\"indent1\">Reduces overtreatment</td> </tr> <tr> <td class=\"indent1\">Avoids or postpones treatment-associated complications</td> </tr> <tr> <td class=\"indent1\">Has no effect on work or social activities</td> </tr> </tbody></table></div><div class=\"graphic_reference\">Modified from: Vogelzang NJ, Scardino PT, Shipley WU, et al. Comprehensive textbook of genitourinary oncology, 3rd Edition, Lippincott Williams &amp; Wilkins 2005.</div><div id=\"graphicVersion\">Graphic 52491 Version 16.0</div></div></div>"},"52492":{"type":"graphic_table","displayName":"Motor features PD PI","title":"Motor features of Parkinson disease","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Motor features of Parkinson disease</div><div class=\"cntnt\"><table  cellspacing=\"0\">\n   <tr>\n   <td   class=\"subtitle1_single\">\n   Cardinal manifestations\n   </td>\n   </tr>\n   <tr>\n   <td>Tremor</td>\n   </tr>\n   <tr>\n   <td>Bradykinesia</td>\n   </tr>\n   <tr>\n   <td>Rigidity</td>\n   </tr>\n   <tr>\n   <td>Postural instability</td>\n   </tr>\n   <tr>\n   <td   class=\"subtitle1_single\">\n   Other motor features\n   </td>\n   </tr>\n   <tr>\n   <td   class=\"subtitle2_single\">\n   Craniofacial\n   </td>\n   </tr>\n   <tr>\n   <td   class=\"indent1\">\n   Hypomimia (masked facial expression)\n   </td>\n   </tr>\n   <tr>\n   <td   class=\"indent1\">\n   Decreased eye blinking\n   </td>\n   </tr>\n   <tr>\n   <td   class=\"indent1\">\n   Speech disturbances (hypokinetic dysarthria, hypophonia)\n   </td>\n   </tr>\n   <tr>\n   <td   class=\"indent1\">\n   Dysphagia\n   </td>\n   </tr>\n   <tr>\n   <td   class=\"indent1\">\n   Sialorrhea\n   </td>\n   </tr>\n   <tr>\n   <td   class=\"subtitle2_single\">\n   Visual\n   </td>\n   </tr>\n   <tr>\n   <td   class=\"indent1\">\n   Blurred vision\n   </td>\n   </tr>\n   <tr>\n   <td   class=\"indent1\">\n   Impaired contrast sensitivity\n   </td>\n   </tr>\n   <tr>\n   <td   class=\"indent1\">\n   Hypometric saccades\n   </td>\n   </tr>\n   <tr>\n   <td   class=\"indent1\">\n   Impaired vestibuloocular reflex\n   </td>\n   </tr>\n   <tr>\n   <td   class=\"indent1\">\n   Impaired upward gaze and convergence\n   </td>\n   </tr>\n   <tr>\n   <td   class=\"indent1\">\n   Lid apraxia\n   </td>\n   </tr>\n   <tr>\n   <td   class=\"subtitle2_single\">\n   Musculoskeletal\n   </td>\n   </tr>\n   <tr>\n   <td   class=\"indent1\">\n   Micrographia\n   </td>\n   </tr>\n   <tr>\n   <td   class=\"indent1\">\n   Dystonia\n   </td>\n   </tr>\n   <tr>\n   <td   class=\"indent1\">\n   Myoclonus\n   </td>\n   </tr>\n   <tr>\n   <td   class=\"indent1\">\n   Stooped posture\n   </td>\n   </tr>\n   <tr>\n   <td   class=\"indent1\">\n   Kyphosis\n   </td>\n   </tr>\n   <tr>\n   <td   class=\"indent1\">\n   Scoliosis\n   </td>\n   </tr>\n   <tr>\n   <td   class=\"indent1\">\n   Difficulty turning in bed\n   </td>\n   </tr>\n   <tr>\n   <td   class=\"subtitle2_single\">\n   Gait\n   </td>\n   </tr>\n   <tr>\n   <td   class=\"indent1\">\n   Shuffling, short-stepped gait\n   </td>\n   </tr>\n   <tr>\n   <td   class=\"indent1\">\n   Freezing\n   </td>\n   </tr>\n   <tr>\n   <td   class=\"indent1\">\n   Festination\n   </td>\n   </tr>\n </table></div><div id=\"graphicVersion\">Graphic 52492 Version 1.0</div></div></div>"},"52493":{"type":"graphic_table","displayName":"Pedi needs med attention PI","title":"When to take your child or infant to the doctor","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">When to take your child or infant to the doctor</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1_single\">Your child should be seen as soon as possible if he or she:</td> </tr> <tr> <td>Does not respond to you, has trouble waking up, or is limp</td> </tr> <tr> <td>Has trouble breathing</td> </tr> <tr> <td>Has blue lips, tongue, or nails</td> </tr> <tr> <td>Starts to lean forward and drool</td> </tr> <tr> <td>Is an infant, and the soft spot on his or her head seems to be bulging or caving in</td> </tr> <tr> <td>Has a stiff neck</td> </tr> <tr> <td>Has a severe headache</td> </tr> <tr> <td>Has severe belly pain</td> </tr> <tr> <td>Has a rash or purple spots that look like bruises on the skin (that were not there before he or she got sick)</td> </tr> <tr> <td>Refuses to drink anything or seems too sick to drink enough</td> </tr> <tr> <td>Will not stop crying</td> </tr> <tr> <td>Is very cranky or irritable</td> </tr> <tr> <td class=\"subtitle1_single\">Call or visit your child's doctor or nurse if your child:</td> </tr> <tr> <td>Has diarrhea that lasts more than two to three days or seems to be getting worse</td> </tr> <tr> <td>Has vomiting that goes on for more than one day</td> </tr> <tr> <td>Seems to be dehydrated (signs include urinating less than usual, not having tears when crying, being less alert and less active than usual)</td> </tr> <tr> <td>Has a specific symptom, such as a sore throat or ear pain</td> </tr> <tr> <td>Has pain when he or she urinates</td> </tr> </tbody></table></div><div id=\"graphicVersion\">Graphic 52493 Version 6.0</div></div></div>"},"52494":{"type":"graphic_figure","displayName":"Physical exam skin back","title":"Common disorders encountered during the physical examination of skin, back view","html":"<div class=\"graphic\"><div style=\"width: 500px\" class=\"figure\"><div class=\"ttl\">Common disorders encountered during the physical examination of skin, back view</div><div class=\"cntnt\"><img style=\"width:480px; height:674px;\" src=\"images/PC/52494_Physical_exam_skin_back.jpg\" alt=\"Image\"/></div><div class=\"graphic_reference\">Reproduced with permission from: Fitzpatrick TB, Bernhard JD, Copley TG. In: Dermatology in General Medicine, Freeberg IN, Eisin AZ, Wolff K, et al. (Eds), 5th ed, McGraw-Hill 1999. Copyright &copy; 1999 The McGraw-Hill Companies, Inc.</div><div id=\"graphicVersion\">Graphic 52494 Version 3.0</div></div></div>"},"52496":{"type":"graphic_picture","displayName":"Barretts esophagus with low grade dysplasia Light","title":"Barrett's esophagus with low grade dysplasia","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Barrett's esophagus with low grade dysplasia</div><div class=\"cntnt\"><img style=\"width:360px; height:270px;\" src=\"images/GAST/52496_Barretts_low_grade_Light.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Low power view of a biopsy specimen from the distal esophagus showing low grade dysplasia. The diagnosis of dysplasia is supported by the presence of glandular cells with enlarged and somewhat hyperchromatic nuclei that are confined to the basal half of the cell. Abnormal nuclei extend to the luminal surface of the specimen.</div><div class=\"graphic_reference\">Courtesy of Donald Antonioli, MD.</div><div id=\"graphicVersion\">Graphic 52496 Version 2.0</div></div></div>"},"52497":{"type":"graphic_picture","displayName":"Ulcers with low rebleeding risk","title":"Peptic ulcers at low risk for rebleeding","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Peptic ulcers at low risk for rebleeding</div><div class=\"cntnt\"><img style=\"width:395px; height:198px;\" src=\"images/GAST/52497_Ulcerslowrebleedingrisk.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Ulcers with a flat pigmented spot (Forrest classification IIc; panel A) or a clean base (Forrest classification III, panel B) are at low risk for rebleeding and do not need to be treated endoscopically.</div><div class=\"graphic_reference\">Courtesy of Rome Jutabha, MD and Dennis M Jensen, MD.</div><div id=\"graphicVersion\">Graphic 52497 Version 2.0</div></div></div>"},"52499":{"type":"graphic_picture","displayName":"Nasal CPAP masks","title":"Nasal CPAP masks","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Nasal CPAP masks</div><div class=\"cntnt\"><img style=\"width:360px; height:204px;\" src=\"images/PULM/52499_Nasal_CPAP_masks.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Standard nasal masks used for noninvasive positive pressure ventilation.</div><div id=\"graphicVersion\">Graphic 52499 Version 2.0</div></div></div>"},"52500":{"type":"graphic_diagnosticimage","displayName":"Gout of the foot radiograph","title":"Gout of the foot radiograph","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Gout of the foot radiograph</div><div class=\"cntnt\"><img style=\"width:353px; height:195px;\" src=\"images/RHEUM/52500_Gout_of_the_foot_x_ray.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Plain radiograph of the foot demonstrating features consistent with gout. There is soft tissue swelling and extensive erosions involving the first MTP joint, as well as calcifications within a tophus.</div><div class=\"graphic_footnotes\">MTP: metatarsophalangeal.</div><div class=\"graphic_reference\">Courtesy of Jonathan Kruskal, MD.</div><div id=\"graphicVersion\">Graphic 52500 Version 3.0</div></div></div>"},"52501":{"type":"graphic_picture","displayName":"Cutaneous mastocytosis: TMEP","title":"Cutaneous mastocytosis: Telangiectasia macularis eruptiva perstans","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Cutaneous mastocytosis: Telangiectasia macularis eruptiva perstans</div><div class=\"cntnt\"><img style=\"width:400px; height:256px;\" src=\"images/RHEUM/52501_Telang_macul_eruptiva_perst.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Telangiectasia macularis eruptiva perstans (TMEP) in a patient with cutaneous mastocytosis.</div><div class=\"graphic_reference\">Reproduced with permission from: Soter AN. J Invest Derm 1991; 96:S32. Copyright Â© 1991 Blackwell Science. <A spellcheck=true href=\"http://www.wiley.com/wiley-blackwell\" target=_blank>http://www.blackwell-science.com</A>.</div><div id=\"graphicVersion\">Graphic 52501 Version 5.0</div></div></div>"},"52502":{"type":"graphic_figure","displayName":"2nd trimester Down syn markers in affected and unaffected pregs","title":"Second trimester Down syndrome markers in affected and unaffected pregnancies","html":"<div class=\"graphic\"><div style=\"width: 695px\" class=\"figure\"><div class=\"ttl\">Second trimester Down syndrome markers in affected and unaffected pregnancies</div><div class=\"cntnt\"><img style=\"width:675px; height:852px;\" src=\"images/OBGYN/52502_2ndTDwnSmrkaffunafpreg.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The quadruple test for Down syndrome screening is performed in the early second trimester (optimally at 15 to 18 weeks of gestation) and consists of AFP, uE3, total/intact hCG or free beta hCG, and inhibin A measurements. Graphs show the overlapping distributions between affected and unaffected pregnancies.</div><div class=\"graphic_footnotes\">AFP: alpha-fetoprotein; uE3: unconjugated estriol; hCG: human chorionic gonadotropin.</div><div class=\"graphic_reference\">Courtesy of Glenn E Palomaki, PhD.</div><div id=\"graphicVersion\">Graphic 52502 Version 4.0</div></div></div>"},"52503":{"type":"graphic_table","displayName":"Differential diagnosis for medial elbow pain","title":"Differential diagnosis for medial elbow pain","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Differential diagnosis for medial elbow pain</div><div class=\"cntnt\"><table  cellspacing=\"0\">\r\n \r\n   <tr>\r\n\r\n   <td>Epicondylitis</td>\r\n\r\n   </tr>\r\n\r\n\t<tr>\r\n  \r\n   <td>Cubital tunnel syndrome</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Ulnar neuritis</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>UCL insufficiency</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Little league elbow</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Inflammatory arthritis</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Cervical radiculopathy</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Thoracic outlet syndrome</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Myofascial pain</td>\r\n  \r\n   </tr>\r\n </table></div><div class=\"graphic_footnotes\">UCL: ulnar collateral ligament</div><div id=\"graphicVersion\">Graphic 52503 Version 3.0</div></div></div>"},"52505":{"type":"graphic_diagnosticimage","displayName":"Fetal abdominal diameters","title":"Measurement of fetal abdominal diameters","html":"<div class=\"graphic\"><div style=\"width: 472px\" class=\"figure\"><div class=\"ttl\">Measurement of fetal abdominal diameters</div><div class=\"cntnt\"><img style=\"width:452px; height:452px;\" src=\"images/OBGYN/52505_Fetal_abdominal_diameters.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Axial image of the fetal abdomen of a late second trimester fetus. This measurement is taken at the level of the fetal stomach, liver, and umbilical vein. Calipers are used to measure the diameters of the fetal abdomen. These measurements can be averaged, or an abdominal circumference can be calculated. These measurements are used to assess gestational age and especially fetal weight.</div><div class=\"graphic_reference\">Courtesy of Thomas Shipp, MD.</div><div id=\"graphicVersion\">Graphic 52505 Version 3.0</div></div></div>"},"52506":{"type":"graphic_table","displayName":"Pregnancy outcome after trauma","title":"Pregnancy outcome in trauma patients","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Pregnancy outcome in trauma patients</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup span=\"4\" width=\"25%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\">&nbsp;</td> <td class=\"subtitle1\">Untraumatized controls, percent</td> <td class=\"subtitle1\">Delivery during hospitalization for traumatic event, percent<sup>&#182;</sup> (n = 2494)</td> <td class=\"subtitle1\">Delivery subsequent to hospitalization for traumatic event, percent (n = 7822)</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"4\">Maternal outcome</td> </tr> <tr> <td class=\"indent1\">Preterm labor</td> <td>7.1</td> <td>14.4</td> <td>18.4<sup>&#916;</sup></td> </tr> <tr> <td class=\"indent1\">Abruption</td> <td>0.9</td> <td>8</td> <td>1.5<sup>&#916;</sup></td> </tr> <tr> <td class=\"indent1\">Death</td> <td>0.01</td> <td>0.9</td> <td>0.06<sup>&#916;</sup></td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">Uterine rupture*</td> <td>0.01 to 0.06</td> <td>0.3 to 0.6</td> <td>0 to 0.04</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"4\">Infant outcome</td> </tr> <tr> <td class=\"indent1\">Preterm delivery</td> <td>10.6</td> <td>20.1</td> <td>13.7<sup>&#916;</sup></td> </tr> <tr> <td class=\"indent1\">Low birth weight</td> <td>5.9</td> <td>14.5</td> <td>9.2<sup>&#916;</sup></td> </tr> <tr> <td class=\"indent1\">Asphyxia</td> <td>0.5</td> <td>1.6</td> <td>0.5</td> </tr> <tr> <td class=\"indent1\">Fetal death</td> <td>0.4</td> <td>3.2</td> <td>0.5</td> </tr> <tr> <td class=\"indent1\">Neonatal death</td> <td>0.3</td> <td>1.5</td> <td>0.4</td> </tr> <tr> <td class=\"indent1\">Infant death</td> <td>0.5</td> <td>1.7</td> <td>0.7</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">* Range indicates before labor and during labor.<br />&para; All values significantly different from controls.<br />&Delta; Values significantly different from controls.</div><div class=\"graphic_reference\">Adapted from: El Kady D, Gilbert WM, Anderson J, et al. Am J Obstet Gynecol 2004; 190:1661.</div><div id=\"graphicVersion\">Graphic 52506 Version 4.0</div></div></div>"},"52509":{"type":"graphic_figure","displayName":"Vestibular system PI","title":"The vestibular system","html":"<div class=\"graphic\"><div style=\"width: 560px\" class=\"figure\"><div class=\"ttl\">The vestibular system</div><div class=\"cntnt\"><img style=\"width:540px; height:720px;\" src=\"images/PI/52509_Vestibular_system_PI.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Deep inside the ear there is a small network of tubes that are filled with fluid, called the \"semicircular canals.\" Floating inside that fluid are special calcium deposits, called \"otolith organs.\" Together these tubes and deposits make up the \"vestibular system.\" This system tells the brain what position the body is in. It also helps keep you balanced.</div><div id=\"graphicVersion\">Graphic 52509 Version 8.0</div></div></div>"},"52510":{"type":"graphic_table","displayName":"Important aspects of the history in a child with pneumonia","title":"Important aspects of the history in a child with pneumonia","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Important aspects of the history in a child with pneumonia</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup width=\"30%\"></colgroup><colgroup width=\"70%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\">Historical feature</td> <td class=\"subtitle1\">Possible significance</td> </tr> <tr> <td>Age of the child</td> <td> <p>Viral etiologies are most common in infants and preschool children</p> Atypical bacterial pathogens are more common in school-age children</td> </tr> <tr> <td>Recent viral upper respiratory tract infection</td> <td>May predispose to bacterial superinfection with <em>Streptococcus pneumoniae</em> or <em>Staphylococcus aureus</em></td> </tr> <tr> <td>Associated symptoms</td> <td><em>Mycoplasma pneumoniae</em> is often associated with extrapulmonary manifestations (eg, headache, photophobia, rash)</td> </tr> <tr> <td>Cough, chest pain, shortness of breath, difficulty breathing</td> <td>\"Classic\" features of pneumonia, but nonspecific</td> </tr> <tr> <td>Increased work of breathing in the absence of stridor or wheezing</td> <td>Suggestive of severe pneumonia</td> </tr> <tr> <td>Fluid and nutrition intake</td> <td>Difficulty or inability to feed suggests severe illness</td> </tr> <tr> <td>Choking episode</td> <td>May indicate foreign body aspiration</td> </tr> <tr> <td>Duration of symptoms</td> <td>Chronic cough (&#62;4 weeks) suggests etiology other than acute pneumonia (refer to UpToDate topic on causes of chronic cough in children)</td> </tr> <tr> <td>Previous episodes</td> <td>Recurrent episodes may indicate aspiration, congenital or acquired anatomic abnormality, cystic fibrosis, immunodeficiency, asthma, missed foreign body</td> </tr> <tr> <td>Immunization status</td> <td>Completion of the primary series of immunizations for <em>Haemophilus influenzae</em> type b, <em>S. pneumoniae</em>, <em>Bordetella pertussis</em>, and seasonal influenza decreases, but does not eliminate, the risk of infection with these organisms</td> </tr> <tr> <td>Previous antibiotic therapy</td> <td>Increases the likelihood of antibiotic-resistant bacteria</td> </tr> <tr> <td>Maternal history of chlamydia during pregnancy (for infants &#60;4 months of age)</td> <td>May indicate <em>Chlamydia trachomatis</em> infection</td> </tr> <tr> <td>Exposure to tuberculosis</td> <td>May indicate <em>Mycobacterium tuberculosis</em> infection</td> </tr> <tr> <td>Ill contacts</td> <td>More common with viral etiologies</td> </tr> <tr> <td>Travel to or residence in certain areas that suggest endemic pathogens</td> <td> <p>Measles: Developing world</p> <p>Coccidioidomycosis: Southwestern United States, northern Mexico, Central and South America</p> <p>Blastomycosis: Southeastern and Central United States; states bordering the Great Lakes</p> <p>Histoplasmosis: Ohio, Missouri, and Mississippi River valleys in the United States; Canada; Central America; eastern and southern Europe; parts of Africa; eastern Asia; and Australia</p> <p>Hantavirus: West of the Mississippi River; four corners region of United States (where borders of Colorado, New Mexico, Arizona, and Utah meet)</p> <p>Middle East respiratory syndrome (MERS): Countries in or near Arabian Peninsula</p> </td> </tr> <tr> <td>Animal exposure</td> <td>May indicate histoplasmosis, psittacosis, Q fever</td> </tr> <tr> <td>Day care center attendance</td> <td>Exposure to viruses and antibiotic-resistant bacteria</td> </tr> </tbody></table></div><div id=\"graphicVersion\">Graphic 52510 Version 10.0</div></div></div>"},"52511":{"type":"graphic_picture","displayName":"Seldinger technique for cricothyrotomy","title":"Seldinger technique for cricothyrotomy ","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Seldinger technique for cricothyrotomy </div><div class=\"cntnt\"><img style=\"width:312px; height:525px;\" src=\"images/EM/52511_CricSeldingerphotos.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">(A) Kit contents. <br />(B) Cuffed tube. <br />(C) Needle insertion. <br />(D) Wire placement through needle. <br />(E) Small incision. <br />(F) Airway with dilator inserted with wire guidance. <br />(G) Airway inserted to the hub using a gentle twisting motion.<br />(H) Wire and dilator removed as one.</div><div class=\"graphic_reference\">Reproduced with permission from: Walls RM. Manual of Emergency Airway Management. Lippincott Williams &amp; Wilkins, 2008. Copyright Â© 2008 Lippincott Williams &amp; Wilkins. <A href=\"http://www.lww.com/\" target=_blank>www.lww.com</A>.</div><div id=\"graphicVersion\">Graphic 52511 Version 11.0</div></div></div>"},"52512":{"type":"graphic_table","displayName":"Treatment guidelines osteoporosis","title":"Guidelines for pharmacologic intervention in postmenopausal women and men â¥50 years of age","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Guidelines for pharmacologic intervention in postmenopausal women and men â¥50 years of age</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td>History of hip or vertebral fracture.</td> </tr> <tr> <td>T-score &#8804;-2.5 (DXA) at the femoral neck or spine, after appropriate evaluation to exclude secondary causes.</td> </tr> <tr> <td>T-score between -1 and -2.5 at the femoral neck or spine, and a 10-year probability of hip fracture &#8805;3 percent or a 10-year probability of any major osteoporosis-related fracture &#8805;20 percent based upon the United States-adapted WHO algorithm.</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">DXA: dual-energy x-ray absorptiometry; WHO: World Health Organization.</div><div class=\"graphic_reference\">References:<br /><OL>&#xD;&#xA;<LI>Cosman F, de Beur SJ, LeBoff MS, et al.&nbsp;Clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int 2014; 25:2359.</LI>&#xD;&#xA;<LI>Watts NB, Adler RA, Bilezikian JP, et al. Osteoporosis in men: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2012; 97:1802.</LI></OL></div><div id=\"graphicVersion\">Graphic 52512 Version 7.0</div></div></div>"},"52515":{"type":"graphic_picture","displayName":"Mastoid bowl","title":"Squamous debris in the ear canal after a canal wall down mastoidectomy with creation of a mastoid bowl","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Squamous debris in the ear canal after a canal wall down mastoidectomy with creation of a mastoid bowl</div><div class=\"cntnt\"><img style=\"width:360px; height:360px;\" src=\"images/PEDS/52515_Mastoid_bowl.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">When it is necessary to sacrifice the ear canal during mastoidectomy (canal wall down mastoidectomy), a common cavity (mastoid bowl) is created between the ear canal and the mastoid. Squamous debris must be periodically cleared from the mastoid bowl by an otolaryngologist throughout the patient's life.</div><div class=\"graphic_reference\">Courtesy of Glenn C Isaacson, MD, FAAP, FACS.</div><div id=\"graphicVersion\">Graphic 52515 Version 2.0</div></div></div>"},"52517":{"type":"graphic_diagnosticimage","displayName":"Scapholunate dissociation","title":"Scapholunate dissociation","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Scapholunate dissociation</div><div class=\"cntnt\"><img style=\"width:324px; height:410px;\" src=\"images/RHEUM/52517_Scapholunate_dissociation.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">This anteroposterior radiograph of the wrist shows a &gt;3 mm separation (arrow) between the scaphoid and lunate (Terry Thomas sign) that indicates a scapholunate dissociation (tear). This patient also had a distal radius fracture.</div><div class=\"graphic_reference\">Courtesy of Kevin E Burroughs, MD.</div><div id=\"graphicVersion\">Graphic 52517 Version 3.0</div></div></div>"},"52518":{"type":"graphic_picture","displayName":"ABCs of melanoma PI","title":"Is it a mole or melanoma?","html":"<div class=\"graphic\"><div style=\"width: 576px\" class=\"figure\"><div class=\"ttl\">Is it a mole or melanoma?</div><div class=\"cntnt\"><img style=\"width:556px; height:521px;\" src=\"images/PI/52518_ABCs_of_melanoma_edt.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Another thing to watch for in a mole is whether it is changing, or \"evolving.\" So remember:<br />A is for asymmetry<br />B is for border<br />C is for color<br />D is for diameter<br />E is for evolving</div><div class=\"graphic_reference\">Reproduced from: the National Cancer Institute (<a href=\"http://www.cancer.gov/\" target=\"_blank\">http://www.cancer.gov</a>).</div><div id=\"graphicVersion\">Graphic 52518 Version 5.0</div></div></div>"},"52520":{"type":"graphic_figure","displayName":"Anatomy of the presacral venous plexus","title":"Anatomy of the presacral venous plexus","html":"<div class=\"graphic\"><div style=\"width: 551px\" class=\"figure\"><div class=\"ttl\">Anatomy of the presacral venous plexus</div><div class=\"cntnt\"><img style=\"width:531px; height:538px;\" src=\"images/SURG/52520_Anatomy_of_the_presacral_venous_plexus_edit.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">This figure illustrates the relationship of the presacral venous plexus with the sacral aperatures. The veins are vulnerable to injury with pelvic dissections.</div><div id=\"graphicVersion\">Graphic 52520 Version 2.0</div></div></div>"},"52521":{"type":"graphic_diagnosticimage","displayName":"CT locally advanced bladder CA","title":"Locally advanced bladder cancer","html":"<div class=\"graphic\"><div style=\"width: 534px\" class=\"figure\"><div class=\"ttl\">Locally advanced bladder cancer</div><div class=\"cntnt\"><img style=\"width:514px; height:298px;\" src=\"images/ONC/52521_CT_locally_advanced_bladder.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">CT scan images of the abdomen (A) and pelvis (B) demonstrating a locally advanced bladder tumor (arrows, right panels) and obstructing both ureters (arrowheads, left panel).</div><div class=\"graphic_reference\">Courtesy of Machele Donat, MD.</div><div id=\"graphicVersion\">Graphic 52521 Version 3.0</div></div></div>"},"52523":{"type":"graphic_diagnosticimage","displayName":"C difficile sonogram","title":"Abnormal ultrasound in a child with <em>Clostridium difficile</em> colitis","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Abnormal ultrasound in a child with <em>Clostridium difficile</em> colitis</div><div class=\"cntnt\"><img style=\"width:394px; height:313px;\" src=\"images/PEDS/52523_C_difficile_sonogram.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Right lower quadrant intestinal ultrasound, 13-year-old girl with Down syndrome and acute lymphoblastic leukemia. This was her third episode of frequent voluminous watery diarrhea without blood or mucus following initiation of intravenous antimicrobial treatment for fever and neutropenia. <em>C. difficile</em> toxin A/B enzyme immunoassay was positive for both of the previous episodes. It was negative on the first two days of the present admission, then positive on day three when diarrhea worsened. Plain films showed marked paucity of intestinal gas; ultrasound showed up to 4 mm of bowel wall thickening in both right (above) and left lower quadrants.</div><div class=\"graphic_reference\">Courtesy of Dana Mazuru, MD, Department of Radiology, University of Missouri Health Care.</div><div id=\"graphicVersion\">Graphic 52523 Version 2.0</div></div></div>"},"52524":{"type":"graphic_diagnosticimage","displayName":"Multiple magnets GI tract","title":"Multiple magnets in the gastrointestinal tract of a child","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Multiple magnets in the gastrointestinal tract of a child</div><div class=\"cntnt\"><img style=\"width:418px; height:252px;\" src=\"images/PEDS/52524_Multiple_magnets_GI_tract.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Abdominal radiograph of a boy aged&nbsp;three years, noting three attached magnets that resulted in volvulus (twisting of the bowel) and multiple bowel perforations.</div><div class=\"graphic_reference\">Courtesy of Morbidity and Mortality Weekly Report 2006; 55:1296.</div><div id=\"graphicVersion\">Graphic 52524 Version 4.0</div></div></div>"},"52525":{"type":"graphic_figure","displayName":"Virilization external view","title":"Virilization (external view)","html":"<div class=\"graphic\"><div style=\"width: 524px\" class=\"figure\"><div class=\"ttl\">Virilization (external view)</div><div class=\"cntnt\"><img style=\"width:504px; height:243px;\" src=\"images/PEDS/52525_Virilization_external_view.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Normal and abnormal differentiation of the external genitalia. Diagrams of normal female and male anatomy flank a series of schematic representations of different degrees of virilization, graded using the scale developed by Prader.</div><div class=\"graphic_reference\">Reproduced with permission from: White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000; 21:245. http://edrv.endojournals.org/. Copyright &#169; 2000 The Endocrine Society.</div><div id=\"graphicVersion\">Graphic 52525 Version 6.0</div></div></div>"},"52526":{"type":"graphic_table","displayName":"Efficacy of treatment in HPS","title":"Categories of treatment of the hepatopulmonary syndrome","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Categories of treatment of the hepatopulmonary syndrome</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1\">Treatment</td> <td class=\"subtitle1\">Efficacy for improving gas exchange in the hepatopulmonary syndrome</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"2\">Physically occlude IPVDs</td> </tr> <tr> <td class=\"indent1\">Spring coil embolization</td> <td>Modest if technically possible</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"2\">Oppose circulating vasodilators</td> </tr> <tr> <td class=\"indent1\">Octreotide (somatostatin analog)</td> <td>Variable</td> </tr> <tr> <td class=\"indent1\">Nitric oxide synthase inhibitors</td> <td>Variable</td> </tr> <tr> <td class=\"indent1\">Indomethacin</td> <td>Poor</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"2\">Improve V/Q matching</td> </tr> <tr> <td class=\"indent1\">Almitrine bismesylate</td> <td>Slight</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"2\">Treat underlying liver disease</td> </tr> <tr> <td class=\"indent1\">Chemotherapy and corticosteroids</td> <td>Helpful in one patient</td> </tr> <tr> <td class=\"indent1\">Liver transplantation</td> <td>Moderately good but variable response</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"2\">Treat portal hypertension</td> </tr> <tr> <td class=\"indent1\">TIPS (transjugular intrahepatic portosystemic shunt)</td> <td>Variable</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"2\">Other (miscellaneous)</td> </tr> <tr> <td class=\"indent1\">Methylene blue</td> <td>Variable in the few patients described</td> </tr> <tr> <td class=\"indent1\">Allium sativum (garlic)</td> <td>Variable</td> </tr> <tr> <td class=\"indent1\">Propranolol</td> <td>None</td> </tr> <tr> <td class=\"indent1\">Plasma exchange</td> <td>None</td> </tr> <tr> <td class=\"indent1\">Sympathomimetics</td> <td>None</td> </tr> <tr> <td class=\"indent1\">Aspirin</td> <td>&nbsp;</td> </tr> <tr> <td class=\"indent1\">Pentoxifylline </td> <td>&nbsp;</td> </tr> <tr> <td class=\"indent1\">Antibiotics</td> <td>&nbsp;</td> </tr> <tr> <td class=\"indent1\">Mycophenolate mofetil</td> <td>&nbsp;</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">IPVDs: intrapulmonary vascular dilatations.</div><div class=\"graphic_reference\">Adapted from: Lange PA, Stoller JK. The hepatopulmonary syndrome. Ann Intern Med 1995; 122:521.</div><div id=\"graphicVersion\">Graphic 52526 Version 4.0</div></div></div>"},"52528":{"type":"graphic_picture","displayName":"Pyoderma gangrenosum cribriform","title":"Pyoderma gangrenosum","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Pyoderma gangrenosum</div><div class=\"cntnt\"><img style=\"width:282px; height:320px;\" src=\"images/GAST/52528_Pyoderma_gangrenosum_cribri.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Multiple active and healing lesions of pyoderma gangrenosum with cribriform scarring in patient with inflammatory bowel disease.</div><div class=\"graphic_reference\">Courtesy of Samuel Moschella, MD.</div><div id=\"graphicVersion\">Graphic 52528 Version 1.0</div></div></div>"},"52529":{"type":"graphic_picture","displayName":"Placental site troph tumor","title":"Placental site trophoblastic tumor histology","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Placental site trophoblastic tumor histology</div><div class=\"cntnt\"><img style=\"width:432px; height:298px;\" src=\"images/OBGYN/52529_Placental_site_troph_tumor.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Placental site trophoblastic tumor showing characteristic bright pink fibrinoid deposition and proliferation of extravillous trophoblasts showing variable atypia and splitting apart muscle fibers. H&amp;E stain, original magnification 10x.</div><div class=\"graphic_reference\">Courtesy of Rebecca N Baergen, MD.</div><div id=\"graphicVersion\">Graphic 52529 Version 1.0</div></div></div>"},"52531":{"type":"graphic_figure","displayName":"Carpometacarpal arthrocentesis","title":"First carpometacarpal arthrocentesis","html":"<div class=\"graphic\"><div style=\"width: 507px\" class=\"figure\"><div class=\"ttl\">First carpometacarpal arthrocentesis</div><div class=\"cntnt\"><img style=\"width:487px; height:215px;\" src=\"images/RHEUM/52531_Carpometacarpal_arthrocente.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The thumb is flexed across the palm toward the tip of the fifth finger. The needle is inserted at the base of the metacarpal bone away from the border of the snuff box. It is then directed toward the proximal end of the fourth metacarpal.</div><div class=\"graphic_reference\">Reproduced from Owen DS. Aspiration and injection of joints in soft tissue. In: Textbook of Rheumatology, 4th edition, Kelley WN, Harris ED Jr, Ruddy S, et al (Eds), WB Saunders, Philadelphia 1993. p.545.</div><div id=\"graphicVersion\">Graphic 52531 Version 2.0</div></div></div>"},"52533":{"type":"graphic_diagnosticimage","displayName":"Prenatal ultrasound image of jejunal atresia","title":"Prenatal ultrasound image of jejunal atresia","html":"<div class=\"graphic\"><div style=\"width: 532px\" class=\"figure\"><div class=\"ttl\">Prenatal ultrasound image of jejunal atresia</div><div class=\"cntnt\"><img style=\"width:512px; height:337px;\" src=\"images/OBGYN/52533_Jejunal_atresia.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">(A) T2w coronal magnetic resonance image at 33 weeks of gestation shows a single high-signal dilated loop of bowel in the mid abdomen.<br />(B) T1w coronal magnetic resonance image shows the dilated loop is low-signal. The distal bowel was collapsed with normal-appearing meconium in the colon and rectum.</div><div class=\"graphic_reference\">Courtesy of Dorothy I Bulas, MD.</div><div id=\"graphicVersion\">Graphic 52533 Version 5.0</div></div></div>"},"52534":{"type":"graphic_figure","displayName":"Lateral condyle fracture anatomy","title":"Stages of displacement of a lateral condyle fracture","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Stages of displacement of a lateral condyle fracture</div><div class=\"cntnt\"><img style=\"width:376px; height:598px;\" src=\"images/EM/52534_Lateralcondylefxanatomy.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">(A and B): Stage 1 displacement - articular surface intact. <br />(C and D): Stage II displacement - articular surface disrupted. <br />(E and F): Stage III displacement - fragment rotated.</div><div class=\"graphic_reference\">Panels A, C, and E: Reprinted from Jakob R, Fowles JV, Rang M, et al. Observations concerning fractures of the lateral humeral condyle in children. J Bone Joint Surg (BR) 1975;57:430-436; with permission.<br />Panels B, D, and F: Reproduced with permission from: Sawyer JR, Beaty JH. Lateral Condylar and Capitellar Fractures of the Distal Humerus. In: Rockwood and Wilkins' Fractures in Children, 8th ed, Flynn JM, Skaggs DL, Waters PM (Eds), Lippincott Williams &amp; Wilkins 2014. Copyright Â© 2014 Lippincott Williams &amp; Wilkins. <A spellcheck=true href=\"http://www.lww.com/\" target=_blank>www.lww.com</A>.</div><div id=\"graphicVersion\">Graphic 52534 Version 13.0</div></div></div>"},"52535":{"type":"graphic_figure","displayName":"Hormones gonadotroph adenoma","title":"Hormone levels in men with a gonadotroph adenoma","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Hormone levels in men with a gonadotroph adenoma</div><div class=\"cntnt\"><img style=\"width:404px; height:171px;\" src=\"images/ENDO/52535_Hormones_gonadotroph_adenom.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Basal serum concentrations of FSH, LH, free alpha subunit, and LHÎ² subunit in 38 men with clinically nonfunctioning gonadotroph macroadenomas. Each dot represents the value in a single patient; the horizontal lines encompass the ranges of an age-matched control group. Seventeen men had supranormal levels of at least one intact hormone or subunit, and four had multiple basal elevations.</div><div class=\"graphic_footnotes\">FSH: follicle-stimulating hormone; LH: luteinizing hormone.</div><div class=\"graphic_reference\">Data from: Daneshdoost L, Gennarelli TA, Bashey HM, et al. Identification of gonadotroph adenomas in men with clinically nonfunctioning adenomas by the luteinizing hormone beta subunit response to thyrotropin-releasing hormone.&nbsp;J Clin Endocrinol Metab 1993; 77:1352.</div><div id=\"graphicVersion\">Graphic 52535 Version 3.0</div></div></div>"},"52536":{"type":"graphic_diagnosticimage","displayName":"Noncontrast CT scan","title":"Hydronephrosis: noncontrast CT scan","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Hydronephrosis: noncontrast CT scan</div><div class=\"cntnt\"><img style=\"width:372px; height:421px;\" src=\"images/NEPH/52536_Noncontrast_CT_scan.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Transverse (A) and coronal reconstruction (B) from a noncontrast scan showing dilated calyces, pelvis, and proximal ureter on the right side.</div><div class=\"graphic_footnotes\">CT: computed tomography.</div><div class=\"graphic_reference\">Courtesy of Deborah A Baumgarten, MD, MPH.</div><div id=\"graphicVersion\">Graphic 52536 Version 3.0</div></div></div>"},"52537":{"type":"graphic_figure","displayName":"Breech7","title":"Delivery of the head","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Delivery of the head</div><div class=\"cntnt\"><img style=\"width:448px; height:322px;\" src=\"images/OBGYN/52537_Breech7.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Often, delivery of the head is easily accomplished with continued expulsive forces from above, suprapubic pressure, and gentle traction. Cephalic flexion is maintained by pressure (heavy arrow) on the fetal maxilla (not mandible!)</div><div class=\"graphic_reference\">Reproduced with permission from: Gabbe, SG, Niebyl, JR, Simpson, JL (Eds). Obstetrics: Normal and Problem Pregnancies, 4th ed, Churchill Livingstone New York 2003. Copyright &#169; 2003 Elsevier.</div><div id=\"graphicVersion\">Graphic 52537 Version 1.0</div></div></div>"},"52538":{"type":"graphic_diagnosticimage","displayName":"Ultrasound partial mole","title":"Partial molar pregnancy","html":"<div class=\"graphic\"><div style=\"width: 506px\" class=\"figure\"><div class=\"ttl\">Partial molar pregnancy</div><div class=\"cntnt\"><img style=\"width:486px; height:200px;\" src=\"images/OBGYN/52538_Ultrasound_partial_mole.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Transabdominal image at 15 weeks gestational age show (A) a heterogeneous placenta with multiple cysts and (B) a live fetus. Findings are compatible with partial molar pregnancy.</div><div class=\"graphic_reference\">Courtesy of Deborah Levine, MD.</div><div id=\"graphicVersion\">Graphic 52538 Version 3.0</div></div></div>"},"52539":{"type":"graphic_table","displayName":"Prognosis occult breast CA","title":"Studies addressing prognosis of occult breast cancer","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Studies addressing prognosis of occult breast cancer</div><div class=\"cntnt\"><table cellspacing=\"0\">\n<tbody>\n\n<tr>\n<td class=\"subtitle1\">Study</td>\n<td class=\"subtitle1\">Place</td>\n<td class=\"subtitle1\">Year</td>\n<td class=\"subtitle1\">Number of patients</td>\n<td class=\"subtitle1\">5 year OS, percent</td>\n</tr>\n\n<tr>\n<td>Ashikari, R; 1976</td>\n<td>Memorial Hospital, NYC</td>\n<td>1946-75</td>\n<td>42</td>\n<td>79</td>\n</tr>\n\t\n<tr>\n<td>Campana, F; 1989</td>\n<td>Institute Curie</td>\n<td>1960-85</td>\n<td>31</td>\n<td>76</td>\n</tr>\n\n<tr>\n<td>Baron, P; 1990</td>\n<td>MSKCC</td>\n<td>1975-88</td>\n<td>35</td>\n<td>75</td>\n</tr>\n\n<tr>\n<td>Ellerbroek, N; 1990</td>\n<td>MD Anderson</td>\n<td>1944-87</td>\n<td>42</td>\n<td>72</td>\n</tr>\n\n<tr>\n<td>Rosen, P; 1990</td>\n<td>MSKCC</td>\n<td>1966-85</td>\n<td>48</td>\n<td>60</td>\n</tr>\n\n<tr>\n<td>Kyokane, T; 1995</td>\n<td>Japan</td>\n<td>NR</td>\n<td>97</td>\n<td>59</td>\n</tr>\n\n<tr>\n<td rowspan=\"2\">Foroudi, F; 2000</td>\n<td rowspan=\"2\">Australia</td>\n<td rowspan=\"2\">1979-96</td>\n<td rowspan=\"2\">20</td>\n<td>93 (mastectomy or XRT)</td>\n</tr>\n\n<tr>\n<td>41 (no local treatment)</td>\n</tr>\n\n<tr>\n<td>Matsuoka, K; 2003</td>\n<td>Japan</td>\n<td>1985-98</td>\n<td>11</td>\n<td>63</td>\n</tr>\n\n<tr>\n<td rowspan=\"2\">Blanchard, D; 2004</td>\n<td rowspan=\"2\">Mayo</td>\n<td rowspan=\"2\">1975-98</td>\n<td rowspan=\"2\">35</td>\n<td>73 (mastectomy)</td>\n</tr>\n\n<tr>\n<td>36 (no mastectomy)</td>\n</tr>\n\n</tbody>\n</table></div><div class=\"graphic_footnotes\">NR: Not reported; OS: Overall survival; MSKCC: Memorial Sloan Kettering Cancer Center; NYC: New York City.</div><div id=\"graphicVersion\">Graphic 52539 Version 1.0</div></div></div>"},"52540":{"type":"graphic_figure","displayName":"Bones of the foot","title":"Bones of the foot","html":"<div class=\"graphic\"><div style=\"width: 548px\" class=\"figure\"><div class=\"ttl\">Bones of the foot</div><div class=\"cntnt\"><img style=\"width:528px; height:582px;\" src=\"images/SM/52540_Bones_of_the_foot.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The foot has 28 bones, including 14 phalanges, seven tarsal bones (talus, calcaneus, cuboid, navicular, and 3 cuneiforms), 5metatarsals, and 2 sesamoids. The hindfoot connects to the midfoot at the midtarsal (Chopart) joint. The midfoot connects to the forefoot at the Lisfranc joint.</div><div id=\"graphicVersion\">Graphic 52540 Version 2.0</div></div></div>"},"52541":{"type":"graphic_figure","displayName":"Hyperpronation technique","title":"Hyperpronation technique","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Hyperpronation technique</div><div class=\"cntnt\"><img style=\"width:291px; height:491px;\" src=\"images/PEDS/52541_Hyperpronation_technique.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">In this method, the examiner supports the child's arm at the elbow and places moderate pressure on the radial head with one finger. The examiner grips the child's distal forearm with the other hand and hyperpronates the forearm. A click may be felt by the finger over the radial head when the subluxation is reduced.</div><div id=\"graphicVersion\">Graphic 52541 Version 1.0</div></div></div>"},"52542":{"type":"graphic_table","displayName":"TIMI risk index mortality MI","title":"TIMI risk index to predict short-term mortality after acute myocardial infarction","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">TIMI risk index to predict short-term mortality after acute myocardial infarction</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1\" rowspan=\"2\">Risk index&nbsp;</td> <td class=\"subtitle1\" rowspan=\"2\">Risk group</td> <td class=\"subtitle1\">Risk of death</td> <td class=\"subtitle1\" colspan=\"2\">Risk of death</td> </tr> <tr> <td class=\"subtitle2\">24 h </td> <td class=\"subtitle2\">In-hospital</td> <td class=\"subtitle2\">30 days</td> </tr> <tr> <td>&#8804;12.5</td> <td>1</td> <td>0.2</td> <td>0.6</td> <td>0.8</td> </tr> <tr> <td>&#62;12.5 to 17.5</td> <td>2</td> <td>0.4</td> <td>1.5</td> <td>1.9</td> </tr> <tr> <td>&#62;17.5 to 22.5</td> <td>3</td> <td>1.0</td> <td>3.1</td> <td>3.3</td> </tr> <tr> <td>&#62;22.5 to 30</td> <td>4</td> <td>2.4</td> <td>6.5</td> <td>7.3</td> </tr> <tr> <td>&#62;30</td> <td>5</td> <td>6.9</td> <td>15.8</td> <td>17.4</td> </tr> </tbody></table></div><div class=\"graphic_lgnd\">TIMI risk index is derived from the following formula: Heart rate in beats/min x ([age/10]squared) / systolic blood pressure.</div><div class=\"graphic_reference\">Reproduced with permission from Morrow DA, Antman EM, Giugliano RP, et al. Lancet 2001; 358:1571. Copyright &#169; 2001 The Lancet, Ltd.</div><div id=\"graphicVersion\">Graphic 52542 Version 2.0</div></div></div>"},"52543":{"type":"graphic_diagnosticimage","displayName":"Lateral x-ray of intertrochanteric hip fracture","title":"Lateral x-ray of intertrochanteric hip fracture","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Lateral x-ray of intertrochanteric hip fracture</div><div class=\"cntnt\"><img style=\"width:324px; height:388px;\" src=\"images/EM/52543_Hip_fx_lat_xr.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">This lateral plain radiograph shows an intertrochanteric fracture of the hip.&nbsp;On this view, there appears to be no displacement&nbsp;and the hip joint appears intact with the&nbsp;femoral head&nbsp;properly seated in the acetabulum.</div><div class=\"graphic_reference\">Reproduced with permission from: Bucholz RW, MD and Heckman JD, MD. Rockwood &amp; Green's Fractures in Adults, 5th ed. Lippincott Williams &amp; Wilkins, 2001. Copyright Â© 2001 Lippincott Williams &amp; Wilkins.</div><div id=\"graphicVersion\">Graphic 52543 Version 2.0</div></div></div>"},"52544":{"type":"graphic_figure","displayName":"Estrogen levels in PCOS","title":"Serum estrogen and gonadotropin concentrations in women with PCOS","html":"<div class=\"graphic\"><div style=\"width: 542px\" class=\"figure\"><div class=\"ttl\">Serum estrogen and gonadotropin concentrations in women with PCOS</div><div class=\"cntnt\"><img style=\"width:522px; height:238px;\" src=\"images/ENDO/52544_Estrogen_levels_in_PCOS.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Mean serum concentrations of LH (mIU/mL), FSH (mIU/mL), estrone (pg/mL), and estradiol (pg/mL) in 10 normal women between days 2 to 4 of their menstrual cycle and 19 women with the PCOS. Women with PCOS had, on average, higher serum LH and estrone concentrations than normal women. However, there was substantial overlap between the two groups, and some women with PCOS had normal serum LH and/or estrone concentrations.</div><div class=\"graphic_footnotes\">FSH: follicle-stimulating hormone; LH: luteinizing hormone; PCOS: polycystic ovary syndrome.</div><div class=\"graphic_reference\">Data from: DeVane GW, Czekala NM, Judd HL, Yen SS. Circulating gonadotropins, estrogens, and androgens in polycystic ovarian disease.&nbsp;Am J Obstet Gynecol 1975; 121:496.</div><div id=\"graphicVersion\">Graphic 52544 Version 3.0</div></div></div>"},"52546":{"type":"graphic_table","displayName":"Pathophysiology of clinical manifestations of the VIPoma syndrome","title":"Pathophysiology of clinical manifestations of the VIPoma syndrome","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Pathophysiology of clinical manifestations of the VIPoma syndrome</div><div class=\"cntnt\"><table  cellspacing=\"0\">\r\n \r\n   <tr>\r\n  \r\n   <td  class=\"subtitle1\">\r\n  \r\n   Biologic action of VIP\r\n  \r\n   </td>\r\n  \r\n   <td  class=\"subtitle1\">\r\n  \r\n   Clinical signs\r\n  \r\n   </td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  colspan=\"1\" rowspan=\"3\">\r\n  \r\n   Stimulates secretion and inhibits absorption of sodium, chloride, and water in the bowel\r\n  \r\n   </td>\r\n  \r\n   <td>Secretory diarrhea</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Dehydration</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Weight loss</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Stimulates potassium secretion in the large bowel</td>\r\n  \r\n   <td>Hypokalemia</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Inhibits gastric acid secretion</td>\r\n  \r\n   <td>Hypochlorhydria</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Induces vasodilation</td>\r\n  \r\n   <td>Flushing</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Stimulates bone resorption</td>\r\n  \r\n   <td>Hypercalcemia</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Enhances glycogenolysis</td>\r\n  \r\n   <td>Hyperglycemia</td>\r\n  \r\n   </tr>\r\n </table></div><div class=\"graphic_footnotes\">VIP: vasoactive intestinal polypeptide.</div><div id=\"graphicVersion\">Graphic 52546 Version 2.0</div></div></div>"},"52547":{"type":"graphic_diagnosticimage","displayName":"RML and RLL atelectasis I","title":"Combined right middle and right lower lobe atelectasis","html":"<div class=\"graphic normal\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Combined right middle and right lower lobe atelectasis</div><div class=\"cntnt\"><img style=\"width:338px; height:350px;\" src=\"images/PULM/52547_RML_and_RLL_atelectasis_I.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Upright chest radiograph showing atelectasis in the right middle and lower lobes after cholecystectomy. The&nbsp;relevant findings include elevation of the right lung base (arrow) with obscuration of the right hilar structures, basal pulmonary vessels, and right heart border. This radiograph was initially interpreted as a subpulmonic effusion.</div><div class=\"graphic_reference\">Courtesy of Paul Stark, MD.</div><div id=\"graphicVersion\">Graphic 52547 Version 3.0</div></div><div style=\"width: 450px\" class=\"figure\"><div class=\"ttl\">Normal chest radiograph</div><div class=\"cntnt\"><img style=\"width:371px; height:324px;\" src=\"images/PULM/65576_Normal_chest_film_PA.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Posteroanterior view of a normal chest radiograph.</div><div class=\"graphic_reference\">Courtesy of Carol M Black, MD.</div><div id=\"graphicVersion\">Graphic 65576 Version 1.0</div></div></div>"},"52548":{"type":"graphic_diagnosticimage","displayName":"Leukocytoclastic vasculitis I","title":"Leukocytoclastic vasculitis histology","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Leukocytoclastic vasculitis histology</div><div class=\"cntnt\"><img style=\"width:360px; height:237px;\" src=\"images/RHEUM/52548_Leukocytoclastic_vasculit1.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Leukocytoclastic vasculitis involving the dermal papillae capillaries and venules (arrow), a finding that probably reflects an Arthus type III immune complex reaction.</div><div class=\"graphic_reference\">Courtesy of Cynthia Magro, MD.</div><div id=\"graphicVersion\">Graphic 52548 Version 3.0</div></div></div>"},"52549":{"type":"graphic_picture","displayName":"Heart biopsy with nest of amastigotes","title":"Heart biopsy with nest of amastigotes","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Heart biopsy with nest of amastigotes</div><div class=\"cntnt\"><img style=\"width:432px; height:324px;\" src=\"images/ID/52549_Heartbiopsyamastigotes.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The patient was a female from Bolivia who had a transplant for end-stage Chagas cardiomyopathy. The photo is of the explanted heart.</div><div class=\"graphic_reference\">Reproduced with permission from: Vimon Seriburi and Umadevi Katta.</div><div id=\"graphicVersion\">Graphic 52549 Version 2.0</div></div></div>"},"52550":{"type":"graphic_diagnosticimage","displayName":"Traumatic liver laceration","title":"Traumatic liver laceration","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Traumatic liver laceration</div><div class=\"cntnt\"><img style=\"width:396px; height:324px;\" src=\"images/EM/52550_Traumatic_liver_laceration.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Computed tomography image showing Grade II lacerations of the liver (arrows).</div><div class=\"graphic_reference\">Courtesy of David Wesson, MD.</div><div id=\"graphicVersion\">Graphic 52550 Version 4.0</div></div></div>"},"52551":{"type":"graphic_picture","displayName":"PCMZL multifocal skin lesions","title":"Primary cutaneous marginal zone lymphoma multifocal skin lesions","html":"<div class=\"graphic\"><div style=\"width: 524px\" class=\"figure\"><div class=\"ttl\">Primary cutaneous marginal zone lymphoma multifocal skin lesions</div><div class=\"cntnt\"><img style=\"width:504px; height:305px;\" src=\"images/HEME/52551_PCMZL_multifoc_skin_les_PR.jpg\" alt=\"Image\"/></div><div id=\"graphicVersion\">Graphic 52551 Version 1.0</div></div></div>"},"52552":{"type":"graphic_picture","displayName":"Subcorneal pustular dermatosis on back","title":"Subcorneal pustular dermatosis (Sneddon-Wilkinson disease)","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Subcorneal pustular dermatosis (Sneddon-Wilkinson disease)</div><div class=\"cntnt\"><img style=\"width:378px; height:504px;\" src=\"images/DERM/52552_Subcorneal_pust_derm_back.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Multiple flaccid pustules and crusted plaques are present.</div><div class=\"graphic_reference\">Reproduced with permission from: <A style=\"FONT-STYLE: italic\" href=\"http://www.visualdx.com/\" target=_blank>www.visualdx.com</A>. Copyright Logical Images, Inc.</div><div id=\"graphicVersion\">Graphic 52552 Version 4.0</div></div></div>"},"52554":{"type":"graphic_movie","displayName":"Mitral stenosis apical long axis color Doppler echocardiogram","title":"Mitral stenosis","html":"<div class=\"graphic normal\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Mitral stenosis</div><div class=\"cntnt\"><div class=\"videoplayer\" h264=\"images/CARD/52554_aplacomsconv.mp4\" style=\"width:320px;height:256px\"></div><img style=\"width:244px; height:231px;\" src=\"images/CARD/52554_aplacoms.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Apical long axis view from a 2-D echocardiogram with color flow Doppler shows a high velocity narrow &quot;jet&quot; across a stenotic mitral valve during diastole. The mitral leaflets are fibrotic and do not open during diastole.</div><div class=\"graphic_reference\">Courtesy of Thomas Binder, MD. University of Vienna.</div><div id=\"graphicVersion\">Graphic 52554 Version 2.0</div></div></div>"},"52555":{"type":"graphic_picture","displayName":"Chronic rejection Light II","title":"Light micrograph showing chronic vascular renal transplant rejection","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Light micrograph showing chronic vascular renal transplant rejection</div><div class=\"cntnt\"><img style=\"width:378px; height:243px;\" src=\"images/NEPH/52555_Chronic_rejection_Light_II.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Light micrograph shows end-stage chronic vascular rejection in an arcuate artery. The vascular lumen is virtually obliterated by the marked subintimal accumulation of connective tissue (arrow), a response that represents the healed phase of previous inflammatory injury.</div><div class=\"graphic_reference\">Courtesy of Helmut Rennke, MD.</div><div id=\"graphicVersion\">Graphic 52555 Version 3.0</div></div></div>"},"52557":{"type":"graphic_table","displayName":"Cond assoc increased CA 19-9","title":"Conditions associated with increased serum levels of the tumor marker CA 19-9","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Conditions associated with increased serum levels of the tumor marker CA 19-9</div><div class=\"cntnt\"><table cellspacing=\"0\">\r\n            <tbody>\r\n                <tr>\r\n                    <td class=\"subtitle1_single\">Malignant</td>\r\n                </tr>\r\n                <tr>\r\n                    <td>Pancreatic exocrine and neuroendocrine cancers</td>\r\n                </tr>\r\n                <tr>\r\n                    <td>Biliary cancer (gallbladder, cholangiocarcinoma, ampullary cancers)</td>\r\n                </tr>\r\n                <tr>\r\n                    <td>Hepatocellular cancer</td>\r\n                </tr>\r\n                <tr>\r\n                    <td>Gastric, ovarian, colorectal cancer (less often)</td>\r\n                </tr>\r\n                <tr>\r\n                    <td>Lung, breast, uterine cancer (rare)</td>\r\n                </tr>\r\n                <tr>\r\n                    <td class=\"subtitle1_single\">Benign</td>\r\n                </tr>\r\n                <tr>\r\n                    <td>Acute cholangitis</td>\r\n                </tr>\r\n                <tr>\r\n                    <td>Cirrhosis and other cholestatic diseases (including gallstones)</td>\r\n                </tr>\r\n            </tbody>\r\n        </table>\r\n        <!--[if gte mso 9]><xml>\r\n<mso:CustomDocumentProperties>\r\n<mso:Specialty msdt:dt=\"string\">11.0000000000000</mso:Specialty>\r\n<mso:Media_Type msdt:dt=\"string\">Table</mso:Media_Type>\r\n<mso:Edit_Table msdt:dt=\"string\">&#60;a href=&quot;/Graphics/Pages/TableEditor.aspx?SPID=45789&#38;amp;Mode=Edit&quot;&#62;&#60;/a&#62;</mso:Edit_Table>\r\n</mso:CustomDocumentProperties>\r\n</xml><![endif]--></div><div class=\"graphic_footnotes\">CA 19-9: carbohydrate antigen 19-9.</div><div id=\"graphicVersion\">Graphic 52557 Version 3.0</div></div></div>"},"52558":{"type":"graphic_diagnosticimage","displayName":"Ileus","title":"Plain abdominal radiograph demonstrating ileus","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Plain abdominal radiograph demonstrating ileus</div><div class=\"cntnt\"><img style=\"width:360px; height:491px;\" src=\"images/PEDS/52558_Ileus.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Plain film of the abdomen in a child with malrotation illustrates a nonspecific ileus pattern.</div><div class=\"graphic_reference\">Reproduced with permission from Carlo Buonomo, MD, Children's Hospital-Boston. Copyright Â© Carlo Buonomo, MD.</div><div id=\"graphicVersion\">Graphic 52558 Version 2.0</div></div></div>"},"52559":{"type":"graphic_figure","displayName":"Percutaneous transtracheal ventilation catheter adapters","title":"Percutaneous transtracheal ventilation catheter adapters","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Percutaneous transtracheal ventilation catheter adapters</div><div class=\"cntnt\"><img style=\"width:209px; height:432px;\" src=\"images/EM/52559_PTVcatheteradapters.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">A 3-mL syringe with the plunger removed may be used as an adapter between the catheter and a 7.5 mm ID endotracheal tube. Alternately, a 3.0 mm ID endotracheal tube connector can be inserted directly into the catheter hub. Both methods can be used to connect the catheter to a standard self-inflating resuscitation bag.</div><div class=\"graphic_reference\">Reproduced with permission from: Mittal MK, Baren JM. Percutaneous Transtracheal Ventilation. In: Textbook of Pediatric Emergency Procedures, 2nd ed, King C, Henretig FM (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2008. Copyright Â© 2008 Lippincott Williams &amp; Wilkins. <A href=\"http://www.lww.com/\" target=_blank>www.lww.com</A>.</div><div id=\"graphicVersion\">Graphic 52559 Version 11.0</div></div></div>"},"52560":{"type":"graphic_picture","displayName":"Total pelvic exenteration","title":"Total pelvic exenteration","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Total pelvic exenteration</div><div class=\"cntnt\"><img style=\"width:389px; height:255px;\" src=\"images/OBGYN/52560_Total_pelvic_exenteration.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Gross fixed specimen from total pelvic exenteration.</div><div id=\"graphicVersion\">Graphic 52560 Version 1.0</div></div></div>"},"52561":{"type":"graphic_table","displayName":"MM urinary monitor","title":"Suggested protocol for monitoring urinary tract disease in a patient with myelomeningocele","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Suggested protocol for monitoring urinary tract disease in a patient with myelomeningocele</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup span=\"4\" width=\"25%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\">&nbsp;</td> <td class=\"subtitle1\">Bladder and renal ultrasound</td> <td class=\"subtitle1\">Voiding cystourethrogram (VCUG)*</td> <td class=\"subtitle1\">Cystometrogram (CMG) and electromyogram (EMG)*</td> </tr> <tr class=\"divider_bottom\"> <td><strong>Purpose</strong></td> <td>Detect hydronephrosis, hydroureter, assess bladder wall thickness</td> <td>Detect vesicoureteral reflux, measure bladder capacity and postresidual volume</td> <td>Assess bladder pressure, bladder capacity, urine flow rate, sphincter activity, and bladder emptying</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"4\">Age</td> </tr> <tr> <td class=\"indent1\">Birth</td> <td class=\"centered\">X</td> <td class=\"centered\">&nbsp;</td> <td class=\"centered\">&nbsp;</td> </tr> <tr> <td class=\"indent1\">4&nbsp;to&nbsp;6 months</td> <td class=\"centered\">X</td> <td class=\"centered\">X</td> <td class=\"centered\">X</td> </tr> <tr> <td class=\"indent1\">6 months</td> <td class=\"centered\">X</td> <td class=\"centered\">&nbsp;</td> <td class=\"centered\">&nbsp;</td> </tr> <tr> <td class=\"indent1\">9 months</td> <td class=\"centered\">X</td> <td class=\"centered\">&nbsp;</td> <td class=\"centered\">&nbsp;</td> </tr> <tr> <td class=\"indent1\">12 months</td> <td class=\"centered\">X</td> <td class=\"centered\">X</td> <td class=\"centered\">X</td> </tr> <tr> <td class=\"indent1\">18 months</td> <td class=\"centered\">X</td> <td class=\"centered\">&nbsp;</td> <td class=\"centered\">&nbsp;</td> </tr> <tr> <td class=\"indent1\">24 months</td> <td class=\"centered\">X</td> <td class=\"centered\">&nbsp;</td> <td class=\"centered\">&nbsp;</td> </tr> <tr> <td class=\"indent1\">3 years</td> <td class=\"centered\">X</td> <td class=\"centered\">X</td> <td class=\"centered\">X</td> </tr> <tr> <td class=\"indent1\">Every year thereafter</td> <td class=\"centered\">X</td> <td class=\"centered\">&nbsp;</td> <td class=\"centered\">&nbsp;</td> </tr> <tr> <td class=\"indent1\">Every two to three years thereafter</td> <td class=\"centered\">&nbsp;</td> <td class=\"centered\">X</td> <td class=\"centered\">X</td> </tr> </tbody></table></div><div class=\"graphic_lgnd\">VCUG, CMG, and EMG* should be performed more frequently if there is a change in urinary continence, changes in ultrasound findings (eg, hydronephrosis), or recurrent urinary tract infections. Changes in lower urinary tract function may be an early sign of spinal cord tethering. This protocol represents the authors' practice; modified from methods used in Tarcan et al, J Urol 2001; 165:564.</div><div class=\"graphic_footnotes\">* Ideally, VCUG, CMG and EMG are performed at the same time, in the form of a video-urodynamic study.</div><div id=\"graphicVersion\">Graphic 52561 Version 4.0</div></div></div>"},"52562":{"type":"graphic_table","displayName":"Trauma scoring children","title":"Trauma triage scoring systems for children","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Trauma triage scoring systems for children</div><div class=\"cntnt\"><table class=\"container\" cellspacing=\"0\">\r\n<tr>\r\n<td class=\"container\">\r\n<table cellspacing=\"0\">\r\n\r\n  <tbody>\r\n\r\n\r\n    <tr>\r\n\r\n      <td rowspan=\"1\" colspan=\"3\" class=\"subtitle1\">Revised trauma score*</td>\r\n\r\n    </tr>\r\n\r\n    <tr>\r\n\r\n      <td class=\"subtitle2\">Clinical Parameter</td>\r\n\r\n      <td class=\"subtitle2\">Parameter Category</td>\r\n\r\n      <td class=\"subtitle2\">Score</td>\r\n\r\n    </tr>\r\n\r\n    <tr>\r\n\r\n      <td rowspan=\"5\">RR</td>\r\n\r\n      <td>10-24</td>\r\n\r\n      <td>4</td>\r\n\r\n    </tr>\r\n\r\n\r\n    <tr>\r\n\r\n      \r\n\r\n      <td>25-35</td>\r\n\r\n      <td>3</td>\r\n\r\n      \r\n\r\n    </tr>\r\n\r\n    <tr>\r\n\r\n      \r\n\r\n      <td>>35</td>\r\n\r\n      <td>2</td>\r\n\r\n      \r\n\r\n    </tr>\r\n\r\n    <tr>\r\n\r\n      \r\n\r\n      <td><10</td>\r\n\r\n      <td>1</td>\r\n\r\n      \r\n\r\n    </tr>\r\n\r\n    <tr>\r\n\r\n      \r\n\r\n      <td>0</td>\r\n\r\n      <td>0</td>\r\n\r\n      \r\n    </tr>\r\n\r\n   \r\n\r\n    <tr>\r\n\r\n      <td rowspan=\"5\">SBP</td>\r\n\r\n      <td>>90</td>\r\n\r\n      <td>4</td>\r\n\r\n    </tr>\r\n\r\n    <tr>\r\n\r\n      \r\n\r\n      <td>70-90</td>\r\n\r\n      <td>3</td>\r\n\r\n    </tr>\r\n\r\n    <tr>\r\n\r\n      \r\n\r\n      <td>50-69</td>\r\n\r\n      <td>2</td>\r\n\r\n    </tr>\r\n\r\n    <tr>\r\n\r\n      \r\n\r\n      <td><50</td>\r\n\r\n      <td>1</td>\r\n\r\n\r\n    </tr>\r\n\r\n    <tr>\r\n\r\n      \r\n\r\n      <td>0</td>\r\n\r\n      <td>0</td>\r\n    </tr>\r\n\r\n  \r\n\r\n\r\n    <tr>\r\n\r\n      <td rowspan=\"5\">GCS</td>\r\n\r\n      <td>14-15</td>\r\n\r\n      <td>5</td>\r\n\r\n    </tr>\r\n\r\n    <tr>\r\n\r\n      \r\n\r\n      <td>11-13</td>\r\n\r\n      <td>4</td>\r\n\r\n    </tr>\r\n\r\n    <tr>\r\n\r\n      \r\n\r\n      <td>8-10</td>\r\n\r\n      <td>3</td>\r\n\r\n\r\n    </tr>\r\n\r\n    <tr>\r\n\r\n      \r\n\r\n      <td>5-7</td>\r\n\r\n      <td>2 </td>\r\n    </tr>\r\n\r\n    <tr>\r\n\r\n      \r\n\r\n      <td>3-4</td>\r\n\r\n      <td>1</td>\r\n\r\n    </tr>\r\n\r\n  </tbody>\r\n</table>&nbsp;</td>\r\n<td class=\"container\">\r\n\r\n<table cellspacing=\"0\">\r\n\r\n  <tbody>\r\n\r\n    <tr>\r\n      <td class=\"subtitle1\" colspan=\"3\" rowspan=\"1\">Pediatric trauma score&#916;&nbsp;</td>\r\n\r\n\r\n\r\n    </tr>\r\n\r\n    <tr>\r\n\r\n\r\n      <td class=\"subtitle2\">Clinical Parameter</td>\r\n\r\n      <td class=\"subtitle2\">Parameter Category</td>\r\n\r\n      <td class=\"subtitle2\">Score</td>\r\n\r\n    </tr>\r\n\r\n    <tr>\r\n\r\n      <td rowspan=\"3\">Weight (kg)</td>\r\n\r\n      <td>&#8805;20</td>\r\n\r\n      <td>2</td>\r\n\r\n    </tr>\r\n\r\n\r\n    <tr>\r\n\r\n\r\n      \r\n\r\n      <td>10-20</td>\r\n\r\n      <td>1</td>\r\n\r\n    </tr>\r\n\r\n    <tr>\r\n\r\n\r\n      \r\n\r\n      <td><10</td>\r\n\r\n      <td>-1</td>\r\n\r\n    </tr>\r\n\r\n\r\n    <tr>\r\n\r\n\r\n      <td rowspan=\"3\">Airway</td>\r\n\r\n      <td>Normal</td>\r\n\r\n      <td>2</td>\r\n\r\n    </tr>\r\n\r\n    <tr>\r\n\r\n\r\n      \r\n\r\n      <td>Maintainable</td>\r\n\r\n      <td>1</td>\r\n\r\n    </tr>\r\n\r\n    <tr>\r\n\r\n      \r\n\r\n      <td>Unmaintainable</td>\r\n\r\n      <td>-1</td>\r\n\r\n    </tr>\r\n\r\n    <tr>\r\n\r\n\r\n      <td rowspan=\"3\">SBP</td>\r\n\r\n      <td>&#8805;90</td>\r\n\r\n      <td>2</td>\r\n\r\n    </tr>\r\n\r\n    <tr>\r\n\r\n\r\n      \r\n\r\n      <td>50-90</td>\r\n\r\n      <td>1</td>\r\n\r\n    </tr>\r\n\r\n    <tr>\r\n\r\n\r\n      \r\n\r\n      <td><50</td>\r\n\r\n      <td>-1</td>\r\n\r\n    </tr>\r\n\r\n    <tr>\r\n\r\n\r\n      <td rowspan=\"3\">Central nervous system</td>\r\n\r\n      <td>Awake</td>\r\n\r\n      <td>2</td>\r\n\r\n    </tr>\r\n\r\n    <tr>\r\n\r\n\r\n      \r\n\r\n      <td>Obtunded/Loss of consciousness</td>\r\n\r\n      <td>1</td>\r\n\r\n    </tr>\r\n\r\n    <tr>\r\n\r\n\r\n      \r\n\r\n      <td>Coma or decerebrate</td>\r\n\r\n      <td>-1</td>\r\n\r\n    </tr>\r\n\r\n    <tr>\r\n\r\n\r\n      <td rowspan=\"3\">Open wound</td>\r\n\r\n      <td>None</td>\r\n\r\n      <td>2</td>\r\n\r\n    </tr>\r\n\r\n    <tr>\r\n\r\n\r\n      \r\n\r\n      <td>Minor</td>\r\n\r\n      <td>1</td>\r\n\r\n    </tr>\r\n\r\n    <tr>\r\n\r\n\r\n      \r\n\r\n      <td>Major/penetrating</td>\r\n\r\n      <td>-1</td>\r\n\r\n    </tr>\r\n\r\n    <tr>\r\n\r\n\r\n      <td rowspan=\"3\">Skeletal</td>\r\n\r\n      <td>None</td>\r\n\r\n      <td>2</td>\r\n\r\n    </tr>\r\n\r\n    <tr>\r\n\r\n\r\n      \r\n\r\n      <td>Closed fracture</td>\r\n\r\n      <td>1</td>\r\n\r\n    </tr>\r\n\r\n    <tr>\r\n\r\n\r\n      \r\n\r\n      <td>Open/multiple fractures</td>\r\n\r\n      <td>-1</td>\r\n\r\n    </tr>\r\n\r\n  </tbody>\r\n</table>&nbsp;</td>\r\n</tr>\r\n</table></div><div class=\"graphic_footnotes\">* The revised trauma score utilizes respiratory rate, systolic blood pressure, and Glasgow coma score. Unlike the trauma score, it does not include subjective variables such as respiratory effort and capillary refill. The revised trauma score is the sum of the values given for each parameter. Triage to a trauma center is recommended for patients with a score of &#8804;11. <br> &#916; The pediatric trauma score is the sum of the values given for each parameter. Triage to a trauma center is recommended for patients with a score of &#8804;8.</div><div class=\"graphic_reference\">Adapted with permission from Furnival, RA, Schunk, JE. Pediatr Emerg Care 1999; 15:215.</div><div id=\"graphicVersion\">Graphic 52562 Version 1.0</div></div></div>"},"52563":{"type":"graphic_diagnosticimage","displayName":"Cystic hygroma CT IV","title":"Cystic hygroma involving right axilla and mediastinum","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Cystic hygroma involving right axilla and mediastinum</div><div class=\"cntnt\"><img style=\"width:360px; height:276px;\" src=\"images/PULM/52563_Cystic_hygroma_CT_IV.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">A CT scan demonstrates a heterogeneous mass in the right axilla and right anterior aspect of the anterior mediastinum, displacing the thymus to the left.</div><div class=\"graphic_footnotes\">CT: computed tomography.</div><div class=\"graphic_reference\">Courtesy of Paul Stark, MD.</div><div id=\"graphicVersion\">Graphic 52563 Version 4.0</div></div></div>"},"52564":{"type":"graphic_picture","displayName":"Acute watery diarrhea","title":"Acute watery diarrhea","html":"<div class=\"graphic\"><div style=\"width: 616px\" class=\"figure\"><div class=\"ttl\">Acute watery diarrhea</div><div class=\"cntnt\"><img style=\"width:596px; height:233px;\" src=\"images/ID/52564_Acute_watery_diarrhea.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Watery stools of &lt;14 days duration, with no visible blood constitutes acute watery diarrhea.<br />(A) Green watery stool. Green colored stool, often seen in rotavirus gastroenteritis.<br />(B) Rice water stool. White colored stool characteristic of severe cholera.</div><div id=\"graphicVersion\">Graphic 52564 Version 2.0</div></div></div>"},"52565":{"type":"graphic_table","displayName":"Causes of central precocious puberty","title":"Central (gonadotropin-dependent) precocious puberty","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Central (gonadotropin-dependent) precocious puberty</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup width=\"25%\"></colgroup><colgroup width=\"30%\"></colgroup><colgroup width=\"15%\"></colgroup><colgroup width=\"30%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\">Etiology</td> <td class=\"subtitle1\">Clinical features</td> <td class=\"subtitle1\">Bone age</td> <td class=\"subtitle1\">Additional evaluation</td> </tr> <tr> <td> <p><strong>Idiopathic</strong></p> (80 to 90% of girls with CPP, and 25 to 60% of boys with CPP)</td> <td>Early progressive pubertal development, but proceeds in normal sequence.</td> <td class=\"centered\">&#8593;&#8593;</td> <td rowspan=\"2\"> <p>Increased ovarian and uterine volumes on ultrasound may help differentiate girls with CPP from&nbsp;those with premature thelarche.</p> <p>Contrast enhanced MRI to rule out CNS abnormality.</p> </td> </tr> <tr> <td> <p><strong>Secondary to CNS lesions</strong></p> (eg, hypothalamic hamartomas, other CNS tumors and lesions, cranial radiation)</td> <td> <p>Early progressive pubertal development, but proceeds in normal sequence.</p> <p>Central precocious puberty secondary to a CNS lesion occurs more commonly in boys and younger children.</p> </td> <td class=\"centered\">&#8593;&#8593;</td> </tr> <tr> <td> <p><strong>Post early exposure to sex steroids</strong></p> <p>(after treatment for peripheral precocity)</p> </td> <td> <p>History of treatment of peripheral precocity.</p> <p>Progressive pubertal development with breast development in girls and testicular enlargement in boys.</p> </td> <td class=\"centered\">&#8593;&#8593;</td> <td>Basal and stimulated LH concentrations are pubertal.</td> </tr> </tbody></table></div><div class=\"graphic_lgnd\">Central precocious puberty is characterized by basal LH concentrations &gt;0.2 to 0.3 mIU/L, and/or stimulated LH concentration post GnRH or GnRHa of &gt;3.3 to 5.0 mIU/L.</div><div class=\"graphic_footnotes\">ââ: significantly advanced for chronological age (eg, â¥ 2 standard deviations); CPP: central precocious puberty; CNS: central nervous system; LH: luteinizing hormone; MRI: magnetic resonance imaging;&nbsp;GnRH: gonadotropin-releasing hormone; GnRHa: gonadotropin-releasing hormone agonist.</div><div class=\"graphic_reference\">Courtesy of Drs. Jennifer Harrington and Mark Palmert.</div><div id=\"graphicVersion\">Graphic 52565 Version 11.0</div></div></div>"},"52566":{"type":"graphic_figure","displayName":"Spectral computation RPA","title":"Spectral computation of repolarization alternans","html":"<div class=\"graphic\"><div style=\"width: 544px\" class=\"figure\"><div class=\"ttl\">Spectral computation of repolarization alternans</div><div class=\"cntnt\"><img style=\"width:524px; height:469px;\" src=\"images/CARD/52566_Spectral_computation_RPA.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Two consecutive QRS beats from a sequence of 64 are aligned, allowing corresponding timepoints within repolarization to be compared between beats (panel A). STU power spectra between beats are computed at successive timesamples and the 0.5 cycles/beat magnitude indicates alternate-beat periodicity (panel B). Summating these spectra across all timesamples reveals repolarization alternans (RPA) as ST, distinct from respiratory modulation (0.1 cycles/beat). T wave alternans ratio (TWAR) relates ST to noise (0.33 to 0.48 cycles/beat) and TWAR &gt;3 predicts ventricular arrhythmia (here TWAR = 67.6). Panel C shows RPA temporal distribution (time domain reconstruction) showing ST for each STU timesample. T is the timepoint of the center-of-area of this reconstruction normalized to STU duration, and may be early (T&lt;0.5), late (T&gt;0.5), or symmetric within repolarization (T = 0.5, as here). V<SUB>alt</SUB>, voltage difference of alternation.</div><div class=\"graphic_footnotes\">ECG: electrocardiogram.</div><div id=\"graphicVersion\">Graphic 52566 Version 3.0</div></div></div>"},"52567":{"type":"graphic_movie","displayName":"Cardiac cath scimitar syndrome","title":"Cardiac catheterization of a newborn infant with scimitar syndrome","html":"<div class=\"graphic normal\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Cardiac catheterization of a newborn infant with scimitar syndrome</div><div class=\"cntnt\"><div class=\"videoplayer\" h264=\"images/CARD/52567_cascisynconv.mp4\" style=\"width:320px;height:256px\"></div><img style=\"width:495px; height:376px;\" src=\"images/CARD/52567_cascisynedt.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Nearly all segments of the right lung connect anomalously to the inferior vena cava.</div><div class=\"graphic_reference\">Courtesy of Dr. Brian Soriano.</div><div id=\"graphicVersion\">Graphic 52567 Version 5.0</div></div></div>"},"52568":{"type":"graphic_table","displayName":"Concentrations from osmolal gap","title":"Estimated osmolal concentration of common organic intoxicants","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Estimated osmolal concentration of common organic intoxicants</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup width=\"30%\"></colgroup><colgroup width=\"70%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\">Solvent</td> <td class=\"subtitle1\">Concentration (mg/dL) per 1 mosmol/kg elevation in osmolal gap</td> </tr> <tr> <td>Ethanol</td> <td>4.0<sup>[1]</sup></td> </tr> <tr> <td>Methanol</td> <td>3.2</td> </tr> <tr> <td>Ethylene glycol</td> <td>6.2</td> </tr> <tr> <td>Acetone</td> <td>5.8</td> </tr> <tr> <td>Isopropanol</td> <td>6.0</td> </tr> </tbody></table></div><div class=\"graphic_reference\">Reference: &#xD;&#xA;<OL>&#xD;&#xA;<LI>Garrard A, Sollee DR, Butterfield RC, et al. Validation of a pre-existing formula to calculate the contribution of ethanol to the osmolar gap. Clin Toxicol (Phila) 2012; 50:562.</LI></OL>Adapted from: Kulig K, Duffy JP, Linden CH, et al. Toxic effects of methanol, ethylene glycol, and isopropyl alcohol. Top Emerg Med 1984; 6:16.</div><div id=\"graphicVersion\">Graphic 52568 Version 3.0</div></div></div>"},"52570":{"type":"graphic_picture","displayName":"HS sinus1","title":"Hidradenitis suppurativa with a sinus tract","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Hidradenitis suppurativa with a sinus tract</div><div class=\"cntnt\"><img style=\"width:386px; height:254px;\" src=\"images/DERM/52570_HS_sinus1.jpg\" alt=\"Image\"/></div><div class=\"graphic_reference\">Reproduced with permission from: F William Danby, MD, FRCPC, FAAD&#160;and Lynne J Margesson, MD.</div><div id=\"graphicVersion\">Graphic 52570 Version 4.0</div></div></div>"},"52572":{"type":"graphic_picture","displayName":"Tendon xanthomata","title":"Tendon xanthomata","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Tendon xanthomata</div><div class=\"cntnt\"><img style=\"width:418px; height:245px;\" src=\"images/PC/52572_Tendon_xanthomata.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Tendon xanthomata on the dorsum of the hand in a patient with heterozygous familial hypercholesterolemia.</div><div class=\"graphic_reference\">Reproduced with permission from: Durrington P. Dyslipidaemia. Lancet 2003; 362:717. Copyright &#169; 2003 Elsevier.</div><div id=\"graphicVersion\">Graphic 52572 Version 2.0</div></div></div>"},"52575":{"type":"graphic_figure","displayName":"Suture ligation round ligament","title":"Suture ligation of the round ligament during hysterectomy","html":"<div class=\"graphic\"><div style=\"width: 488px\" class=\"figure\"><div class=\"ttl\">Suture ligation of the round ligament during hysterectomy</div><div class=\"cntnt\"><img style=\"width:468px; height:522px;\" src=\"images/OBGYN/52575_Suture_ligation_round_ligam.jpg\" alt=\"Image\"/></div><div id=\"graphicVersion\">Graphic 52575 Version 2.0</div></div></div>"},"52576":{"type":"graphic_figure","displayName":"B lymphocyte analysis by flow cytometry","title":"B lymphocyte analysis by flow cytometry","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">B lymphocyte analysis by flow cytometry</div><div class=\"cntnt\"><img style=\"width:425px; height:457px;\" src=\"images/ALLRG/52576_B_cell_anal.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Top: Patterns of normal B cell differentiation in peripheral blood based on IgD and CD27. Bottom: Patterns of B cell differentiation in peripheral blood of a patient with CVID.</div><div class=\"graphic_footnotes\">IgD: immunoglobulin D; CVID: common variable immunodeficiency.</div><div id=\"graphicVersion\">Graphic 52576 Version 3.0</div></div></div>"},"52578":{"type":"graphic_figure","displayName":"Extraction ratios","title":"The relationship between oxygen consumption (VO2), oxygen delivery (DO2), and the extraction ratio","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">The relationship between oxygen consumption (VO2), oxygen delivery (DO2), and the extraction ratio</div><div class=\"cntnt\"><img style=\"width:428px; height:570px;\" src=\"images/PULM/52578_Extraction_ratios.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">(A) An inverse relationship exists between oxygen delivery (DO<sub>2</sub>) and the extraction raio (ER), with no correlation between oxygen consumption (VO<sub>2</sub>) and the ER.<br />(B) An improved ability to extract oxygen during exercise exists at all levels of DO<sub>2</sub>.</div><div id=\"graphicVersion\">Graphic 52578 Version 2.0</div></div></div>"},"52579":{"type":"graphic_figure","displayName":"Heart attack symptoms PI","title":"Heart attack symptoms","html":"<div class=\"graphic\"><div style=\"width: 496px\" class=\"figure\"><div class=\"ttl\">Heart attack symptoms</div><div class=\"cntnt\"><img style=\"width:476px; height:664px;\" src=\"images/PI/52579_Heart_attack_symptoms_PI_edit.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">This picture shows the main symptoms of a heart attack. People who are having a heart attack often have only some of these symptoms. The pain, pressure, and discomfort caused by a heart attack mostly affect the left side of the body (shown in darker red) but can also affect the right. If you think you are having a heart attack, call 9-1-1 for an ambulance. Do not try to get yourself to the hospital.</div><div id=\"graphicVersion\">Graphic 52579 Version 1.0</div></div></div>"},"52581":{"type":"graphic_picture","displayName":"Raney clip","title":"Raney clips","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Raney clips</div><div class=\"cntnt\"><img style=\"width:329px; height:530px;\" src=\"images/EM/52581_Raney_clips_edt.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Scalp lacerations can sometimes bleed profusely. In such cases, scalp clips (like the Raney Clips&#174; pictured above) can tamponade bleeding.</div><div class=\"graphic_reference\">Reproduced with permission from: Aesculap&#174; Raney Clips. Copyright &#169; 2010 B. Braun Aesculap.</div><div id=\"graphicVersion\">Graphic 52581 Version 5.0</div></div></div>"},"52583":{"type":"graphic_table","displayName":"Diagnosis of hepatitis D","title":"Diagnosis of hepatitis D virus infection in different clinical settings","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Diagnosis of hepatitis D virus infection in different clinical settings</div><div class=\"cntnt\"><table cellspacing=\"0\">\r\n            <tbody>\r\n                <tr>\r\n                    <td class=\"subtitle1\">Diagnostic markers </td>\r\n                    <td class=\"subtitle1\">Acute HBV/HDV coinfection </td>\r\n                    <td class=\"subtitle1\">Acute HDV superinfection </td>\r\n                    <td class=\"subtitle1\">Chronic HDV infection </td>\r\n                </tr>\r\n                <tr>\r\n                    <td>HBsAg</td>\r\n                    <td>Positive</td>\r\n                    <td>Positive</td>\r\n                    <td>Positive</td>\r\n                </tr>\r\n                <tr>\r\n                    <td>Anti-HBc, IgM</td>\r\n                    <td>Positive</td>\r\n                    <td>Negative</td>\r\n                    <td>Negative</td>\r\n                </tr>\r\n                <tr>\r\n                    <td>Serum HDAg (by EIA/RIA)</td>\r\n                    <td>Early and short-lived, frequently missed</td>\r\n                    <td>Early and transient, and frequently missed</td>\r\n                    <td>Not detectable</td>\r\n                </tr>\r\n                <tr>\r\n                    <td>Serum HDV RNA (by hybridization)</td>\r\n                    <td>Early, transient but last longer than HDAg</td>\r\n                    <td>Early and persistent</td>\r\n                    <td>Usually positive</td>\r\n                </tr>\r\n                <tr>\r\n                    <td>Anti-HDV, total</td>\r\n                    <td>Late, low titer</td>\r\n                    <td>Rapidly increasing titers</td>\r\n                    <td>High titers</td>\r\n                </tr>\r\n                <tr>\r\n                    <td>Anti-HDV, IgM</td>\r\n                    <td>Transient, may be the only marker</td>\r\n                    <td>Rapidly increasing and persistent titers</td>\r\n                    <td>Variable titers, usually high</td>\r\n                </tr>\r\n                <tr>\r\n                    <td>Liver HDAg</td>\r\n                    <td>Not indicated</td>\r\n                    <td>Positive</td>\r\n                    <td>Usually positive, may be negative in late stages</td>\r\n                </tr>\r\n            </tbody>\r\n        </table></div><div id=\"graphicVersion\">Graphic 52583 Version 2.0</div></div></div>"},"52584":{"type":"graphic_diagnosticimage","displayName":"CW Doppler AS severe","title":"Severe aortic stenosis","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Severe aortic stenosis</div><div class=\"cntnt\"><img style=\"width:278px; height:238px;\" src=\"images/CARD/52584_CW_Doppler_AS_severe.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Continuous wave Doppler shows a peak velocity across the aortic valve of 4.6 m/sec or a gradient of 85 mmHg, which is compatible with severe aortic stenosis. No aortic regurgitation is present.</div><div class=\"graphic_reference\">Provided by Thomas Binder, MD, et al. Interactive Echocardiography. A Clinical Atlas. Futura, 1997.</div><div id=\"graphicVersion\">Graphic 52584 Version 2.0</div></div></div>"},"52585":{"type":"graphic_table","displayName":"CUP treatment schema","title":"Treatments for specific subsets of patients with CUP","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Treatments for specific subsets of patients with CUP</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1\">Histologic type </td> <td class=\"subtitle1\">Clinical feature </td> <td class=\"subtitle1\">Treatment recommendation </td> </tr> <tr> <td rowspan=\"4\">Adenocarcinoma </td> <td>Women with isolated axillary adenopathy</td> <td>Treat as stage II breast cancer</td> </tr> <tr> <td>Women with peritoneal carcinomatosis</td> <td>Treat as stage III ovarian cancer</td> </tr> <tr> <td>Men with elevated PSA or blastic bone metastases</td> <td>Treat as advanced prostate cancer</td> </tr> <tr> <td>Colon cancer profile</td> <td>Treat as advanced colon cancer</td> </tr> <tr> <td>Adenocarcinoma or PDC</td> <td>Single metastatic lesion</td> <td>Definitive local therapy (resection and/or radiation therapy)</td> </tr> <tr> <td rowspan=\"3\">Squamous cell carcinoma </td> <td>Cervical adenopathy</td> <td>Treat as head and neck cancer with involved neck nodes</td> </tr> <tr> <td>Inguinal adenopathy</td> <td>Inguinal node dissection</td> </tr> <tr> <td>&nbsp;</td> <td><span style=\"color: black;\">Consider concurrent radiation therapy/chemotherapy (as in locally advanced cervical or anal cancer)</span></td> </tr> <tr> <td>Poorly-differentiated carcinoma </td> <td>Young men with midline tumor or elevated hCG/AFP</td> <td>Treat as extragonadal germ cell tumor</td> </tr> <tr> <td>Poorly-differentiated neuroendocrine carcinoma </td> <td>Diverse clinical presentations</td> <td>Treat with platinum/etoposide or paclitaxel/platinum/etoposide</td> </tr> </tbody></table></div><div class=\"graphic_lgnd\">Approximately 20 percent of patients with carcinoma of unknown primary (CUP) fit into one of these subsets with specific treatment implications.</div><div class=\"graphic_footnotes\">PSA: prostate-specific antigen; PDC: poorly-differentiated carcinoma; hCG: human chorionic gonadotropin; AFP: alpha-fetoprotein.</div><div id=\"graphicVersion\">Graphic 52585 Version 5.0</div></div></div>"},"52588":{"type":"graphic_picture","displayName":"Scabies infant trunk","title":"Scabies, infant","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Scabies, infant</div><div class=\"cntnt\"><img style=\"width:396px; height:247px;\" src=\"images/PC/52588_Scabies_infant_trunk.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The rash of scabies may be more diffuse in infants, spreading to the trunk and scalp in addition to the extremities.</div><div class=\"graphic_reference\">Reproduced with permission from: Fleisher GR, Ludwig S, Baskin MN. Atlas of Pediatric Emergency Medicine, Lippincott Williams &amp; Wilkins, Philadelphia 2004. Copyright Â©2004 Lippincott Williams &amp; Wilkins.</div><div id=\"graphicVersion\">Graphic 52588 Version 3.0</div></div></div>"},"52590":{"type":"graphic_figure","displayName":"Loading the wire I","title":"Loading the wire technique for precut sphincterotomy","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Loading the wire technique for precut sphincterotomy</div><div class=\"cntnt\"><img style=\"width:389px; height:258px;\" src=\"images/GAST/52590_Loading_the_wire_I.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Cartoon depicting the &quot;loading the wire&quot; technique for creating a biliary sphincterotomy (see text for details).</div><div class=\"graphic_reference\">Courtesy of Douglas A Howell, MD and David J Desilets, MD, PhD.</div><div id=\"graphicVersion\">Graphic 52590 Version 2.0</div></div></div>"},"52591":{"type":"graphic_picture","displayName":"Piebaldism - forelock","title":"Piebaldism","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Piebaldism</div><div class=\"cntnt\"><img style=\"width:432px; height:324px;\" src=\"images/DERM/52591_Piebaldism_forelock_PR.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">A congenital depigmented patch with white hair is present on the scalp and forehead of this man with piebaldism. The patient also had depigmented patches on the trunk and extremities. Multiple family members had similar lesions.</div><div class=\"graphic_reference\">Copyright Â© Bernard Cohen, MD, Dermatlas; http://www.dermatlas.org.</div><div id=\"graphicVersion\">Graphic 52591 Version 6.0</div></div></div>"},"52592":{"type":"graphic_picture","displayName":"Rust ring","title":"Rust ring","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Rust ring</div><div class=\"cntnt\"><img style=\"width:432px; height:309px;\" src=\"images/EM/52592_Rust_ring.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">This photo shows a typical rust ring, likely caused by a metallic foreign body. Removal can be attempted with a small burr drill.</div><div class=\"graphic_reference\">Courtesy of Kevin J Knoop, MD, MS.</div><div id=\"graphicVersion\">Graphic 52592 Version 2.0</div></div></div>"},"52594":{"type":"graphic_figure","displayName":"Pathogenesis of MEN1","title":"Steps involved in tumor formation in patients with MEN1","html":"<div class=\"graphic\"><div style=\"width: 562px\" class=\"figure\"><div class=\"ttl\">Steps involved in tumor formation in patients with MEN1</div><div class=\"cntnt\"><img style=\"width:542px; height:252px;\" src=\"images/ENDO/52594_Pathogenesis_of_MEN_1.gif\" alt=\"Image\"/></div><div class=\"graphic_footnotes\">MEN1: multiple endocrine neoplasia type 1.</div><div id=\"graphicVersion\">Graphic 52594 Version 2.0</div></div></div>"},"52597":{"type":"graphic_figure","displayName":"Surg ulcerative colitis","title":"Surgical options for ulcerative colitis","html":"<div class=\"graphic\"><div style=\"width: 560px\" class=\"figure\"><div class=\"ttl\">Surgical options for ulcerative colitis</div><div class=\"cntnt\"><img style=\"width:540px; height:625px;\" src=\"images/PC/52597_Surg_ulcerative_colitis.jpg\" alt=\"Image\"/></div><div id=\"graphicVersion\">Graphic 52597 Version 1.0</div></div></div>"},"52599":{"type":"graphic_table","displayName":"Evaluation of asthma mimics","title":"Evaluation of conditions that mimic asthma","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Evaluation of conditions that mimic asthma</div><div class=\"cntnt\"><table  cellspacing=\"0\">\r\n \r\n   <tr>\r\n  \r\n   <td  class=\"subtitle1\">\r\n  \r\n   Diagnosis\r\n  \r\n   </td>\r\n  \r\n   <td  class=\"subtitle1\">\r\n  \r\n   Clinical features\r\n  \r\n   </td>\r\n  \r\n   <td  class=\"subtitle1\">\r\n  \r\n   Testing\r\n  \r\n   </td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Alpha-1 antitrypsin deficiency</td>\r\n  \r\n   <td>\t<p>Dyspnea</p>\n\t<p>\t\t\t\t\t\tFamily history emphysema</p>\n</td>\r\n  \r\n   <td>\t<p>Alpha-1 antitrypsin: below 50 to 80 mg/dL (11 micromol/L)</p>\n\t<p>\t\t\t\t\t\tGenetic confirmation by isoelectric focusing or DNA PCR</p>\n</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Bronchiectasis</td>\r\n  \r\n   <td>\t<p>Daily sputum production</p>\n\t<p>\t\t\t\t\t\tCough refractory to bronchodilators</p>\n\t<p>\t\t\t\t\t\tSometimes end-inspiratory squeak</p>\n\t<p>\t\t\t\t\t\tMay have rhinosinusitis</p>\n</td>\r\n  \r\n   <td>HRCT thorax: bronchiectasis</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Bronchiolitis</td>\r\n  \r\n   <td>\t<p>History of respiratory infection, inhalational injury, CTD, or lung transplant</p>\n\t<p>\t\t\t\t\t\tCrackles and inspiratory squeaks on exam</p>\n</td>\r\n  \r\n   <td>\t<p>PFTs: DLCO and oxygen saturation are reduced</p>\n\t<p>\t\t\t\t\t\tHRCT thorax: interstitial opacities in a mosaic pattern, inspiratory and expiratory views may show focal air trapping</p>\n</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Cardiac disease*</td>\r\n  \r\n   <td>Crackles or wheezes</td>\r\n  \r\n   <td>\t<p>B type natriuretic peptide: elevated</p>\n\t<p>\t\t\t\t\t\tChest xray: increased interstitial opacities, &#177;cardiomegaly</p>\n\t<p>\t\t\t\t\t\tEchocardiogram: reduced ejection fraction</p>\n</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Central airway obstruction</td>\r\n  \r\n   <td>\t<p>Dyspnea on exertion</p>\n\t<p>\t\t\t\t\t\tSometimes monophonic wheeze or stridor</p>\n</td>\r\n  \r\n   <td>\t<p>PFTs: flattening of flow volume loop</p>\n\t<p>\t\t\t\t\t\tHRCT with 3-D reconstruction: narrowed airway</p>\n\t<p>\t\t\t\t\t\tDirect visualization: airway obstruction</p>\n</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Chronic eosinophilic pneumonitis</td>\r\n  \r\n   <td>\t<p>Asthma predates or develops in over 50 percent of patients</p>\n\t<p>\t\t\t\t\t\tFever, weight loss and night sweats are common</p>\n</td>\r\n  \r\n   <td>\t<p>Peripheral blood: &#177;eosinophilia</p>\n\t<p>\t\t\t\t\t\tChest xray: bilateral peripheral opacities</p>\n\t<p>\t\t\t\t\t\tBAL: eosinophilia &#62;40 percent</p>\n</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>COPD*</td>\r\n  \r\n   <td>Smoking history</td>\r\n  \r\n   <td>PFTs: irreversible airflow obstruction and sometimes low DLCO</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Hypersensitivity pneumonitis</td>\r\n  \r\n   <td>\t<p>Exposure to an inciting agent</p>\n\t<p>\t\t\t\t\t\tAbrupt onset fever, chills</p>\n\t<p>\t\t\t\t\t\tDyspnea without wheezing</p>\n</td>\r\n  \r\n   <td>\t<p>PFTs: restrictive or mixed obstructive/restrictive pattern</p>\n\t<p>\t\t\t\t\t\tChest xray: fleeting pulmonary infiltrates</p>\n\t<p>\t\t\t\t\t\tHRCT thorax: ground glass opacities and parenchymal micronodules</p>\n\t<p>\t\t\t\t\t\tBAL: lymphocytosis</p>\n\t<p>\t\t\t\t\t\tLung biopsy: poorly formed granulomata</p>\n</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Obstructive sleep apnea*</td>\r\n  \r\n   <td>\t<p>Daytime hypersomnolence</p>\n\t<p>\t\t\t\t\t\tNocturnal choking</p>\n\t<p>\t\t\t\t\t\tSnoring</p>\n</td>\r\n  \r\n   <td>Polysomnogram: elevated respiratory disturbance index</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Sarcoidosis* (endobronchial)</td>\r\n  \r\n   <td>\t<p>Nonproductive cough</p>\n\t<p>\t\t\t\t\t\tDyspnea</p>\n\t<p>\t\t\t\t\t\tCutaneous stigmata of sarcoidosis</p>\n\t<p>\t\t\t\t\t\tMay have nasal or sinus sarcoid</p>\n</td>\r\n  \r\n   <td>\t<p>Chest xray: Hilar adenopathy with or without interstitial opacities</p>\n\t<p>\t\t\t\t\t\tPFTs: restriction and reduced DLCO</p>\n\t<p>\t\t\t\t\t\tEndobronchial biopsy: noncaseating granulomata</p>\n</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Strongyloidiasis, filariasis</td>\r\n  \r\n   <td>Travel to endemic country</td>\r\n  \r\n   <td>\t<p>Peripheral blood: eosinophilia</p>\n\t<p>\t\t\t\t\t\tIgG antibodies to strongyloides or filaria: positive</p>\n</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Vocal cord dysfunction*</td>\r\n  \r\n   <td>\t<p>Hoarseness/stridor (can be inspiratory and/or expiratory)</p>\n\t<p>\t\t\t\t\t\tSymptoms provoked by exercise</p>\n</td>\r\n  \r\n   <td>\t<p>Flow volume loop: slowing on inspiration</p>\n\t<p>\t\t\t\t\t\tDirect laryngoscopy (possibly during exercise or methacholine challenge): abnormal cord motion</p>\n</td>\r\n  \r\n   </tr>\r\n </table></div><div class=\"graphic_footnotes\">ANCA: antineutrophil cytoplasmic antibodies; BAL: bronchoalveolar lavage; CTD: connective tissue disease; DLCO: diffusing capacity; GERD: gastroesophageal reflux disease; HRCT: high resolution computed tomography; PFTs: pulmonary function testing; PPI: proton pump inhibitor.<br>* These conditions can also co-occur with asthma</div><div id=\"graphicVersion\">Graphic 52599 Version 2.0</div></div></div>"},"52601":{"type":"graphic_diagnosticimage","displayName":"Traumatic knee effusion","title":"Posttraumatic knee effusion","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Posttraumatic knee effusion</div><div class=\"cntnt\"><img style=\"width:266px; height:394px;\" src=\"images/RHEUM/52601_Traumatic_knee_effusion.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The lateral view of the knee demonstrates suprapatellar soft tissue density (arrow) consistent with joint effusion in a patient with patellar fracture.</div><div class=\"graphic_reference\">Courtesy of Shahla Modarresi, MD and Cecilia M Jude, MD.</div><div id=\"graphicVersion\">Graphic 52601 Version 2.0</div></div></div>"},"52604":{"type":"graphic_picture","displayName":"Cribriform prost adenocarcinoma","title":"Cribriform prostate adenocarcinoma","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Cribriform prostate adenocarcinoma</div><div class=\"cntnt\"><img style=\"width:369px; height:278px;\" src=\"images/ONC/52604_Cribriform_prost_adenocarci.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">High-power photomicrograph of an hematoxylin- and eosin-stained section of the prostate gland. The majority of this tissue section is taken up by a prostate adenocarcinoma (arrows) with a cribriform pattern, corresponding to a Gleason pattern 4 lesion.</div><div class=\"graphic_reference\">Courtesy of Ximing Yang, MD.</div><div id=\"graphicVersion\">Graphic 52604 Version 2.0</div></div></div>"},"52608":{"type":"graphic_figure","displayName":"Palmar hand anatomy scheme: arteries and nerves","title":"Palmar hand anatomy scheme: arteries and nerves","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Palmar hand anatomy scheme: arteries and nerves</div><div class=\"cntnt\"><img style=\"width:409px; height:440px;\" src=\"images/PC/52608_Palmar_hand_anatomy.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The path of palmar arteries (red) and nerves (green) to the fingers is shown. Each digit is innervated by four digital nerves; the dorsal arteries and nerves are not shown in this figure. In order to achieve a complete anesthetic effect, it is necessary to block all four nerves.</div><div id=\"graphicVersion\">Graphic 52608 Version 2.0</div></div></div>"},"52609":{"type":"graphic_diagnosticimage","displayName":"Pheochromocytoma silent","title":"Pheochromocytoma silent","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Pheochromocytoma silent</div><div class=\"cntnt\"><img style=\"width:399px; height:257px;\" src=\"images/ENDO/52609_Pheochromocytoma_silent.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Abdominal CT showing an 8 cm left adrenal mass (arrow) discovered incidentally. Note the vascular and inhomogenous imaging characteristics of this mass. Biochemical evaluation was consistent with a clinically silent pheochromocytoma, which was confirmed at surgery.</div><div class=\"graphic_footnotes\">CT: computed tomography.</div><div class=\"graphic_reference\">Courtesy of William F Young, Jr, MD.</div><div id=\"graphicVersion\">Graphic 52609 Version 3.0</div></div></div>"},"52610":{"type":"graphic_diagnosticimage","displayName":"Aphthoid ulcers Crohn BE","title":"Aphthoid ulcers in Crohn disease","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Aphthoid ulcers in Crohn disease</div><div class=\"cntnt\"><img style=\"width:284px; height:353px;\" src=\"images/GAST/52610_Aphth_ulcers_Crohns_BE_edt.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Double contrast barium enema demonstrates small aphthoid ulcers in a patient with early Crohn disease of the colon (arrows). Barium has collected in the superficial erosions, which are surrounded by edematous mucosa. These small erosions, less typically seen in ulcerative colitis, are the precursors of larger discrete ulcers, fistulae, and sinus tracts.</div><div class=\"graphic_reference\">Courtesy of Jonathan Kruskal, MD, PhD.</div><div id=\"graphicVersion\">Graphic 52610 Version 5.0</div></div></div>"},"52614":{"type":"graphic_picture","displayName":"Ocular adherent filaments","title":"Adherent filaments with severe dry eye","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Adherent filaments with severe dry eye</div><div class=\"cntnt\"><img style=\"width:397px; height:264px;\" src=\"images/RHEUM/52614_Ocular_adherent_filaments.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Adherent filaments in a patient with severe dry eye. Extreme dryness of the eye can produce corneal surface filaments, resulting in significant irritation and a foreign body sensation.</div><div class=\"graphic_reference\">Courtesy of Reza Dana, MD, MSc, MPH.</div><div id=\"graphicVersion\">Graphic 52614 Version 3.0</div></div></div>"},"52615":{"type":"graphic_picture","displayName":"Ulcerations in livedoid vaculopathy","title":"Ulcerations in livedoid vasculopathy","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Ulcerations in livedoid vasculopathy</div><div class=\"cntnt\"><img style=\"width:288px; height:274px;\" src=\"images/RHEUM/52615_Ulcerations_LV.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Shallow ulcers over the dorsal feet with postinflammatory hyperpigmentation and stellate scarring.</div><div class=\"graphic_reference\">Reproduced with permission from:&nbsp;Hairston BR, Davis MD, Gibson LE, Drage LA.&nbsp;Treatment of livedoid vasculopathy with low-molecular-weight heparin: report of 2 cases. Arch Dermatol 2003; 139:987. Copyright Â© 2003 American Medical Association.</div><div id=\"graphicVersion\">Graphic 52615 Version 6.0</div></div></div>"},"52616":{"type":"graphic_figure","displayName":"CYP17A1 deficiency","title":"17Î±-hydroxylase/17,20 lyase (CYP17A1) deficiency","html":"<div class=\"graphic\"><div style=\"width: 622px\" class=\"figure\"><div class=\"ttl\">17Î±-hydroxylase/17,20 lyase (CYP17A1) deficiency</div><div class=\"cntnt\"><img style=\"width:602px; height:398px;\" src=\"images/ENDO/52616_CYP17A1_deficiency_edt2.gif\" alt=\"Image\"/></div><div id=\"graphicVersion\">Graphic 52616 Version 1.0</div></div></div>"},"52617":{"type":"graphic_diagnosticimage","displayName":"Tarsometatarsal fracture","title":"Open tarsometatarsal (Lisfranc) fracture","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Open tarsometatarsal (Lisfranc) fracture</div><div class=\"cntnt\"><img style=\"width:426px; height:587px;\" src=\"images/EM/52617_Tarsometatarsalfx.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Complex open Lisfranc injury in a 14-year-old sustained in an all-terrain vehicle (ATV) accident.<br />(A-C) Initial radiographs showing total incongruity pattern.</div><div class=\"graphic_reference\">Reproduced with permission from: Jarvis JG, Moroz PJ. Fractures and Dislocations of the Foot. In: Rockwood and Wilkins' Fractures in Children, 6th ed, Beaty JH, Kasser JR (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. Copyright &copy; 2006 Lippincott Williams &amp; Wilkins. <a href=\"http://www.lww.com/\" target=\"_blank\">www.lww.com</a>.</div><div id=\"graphicVersion\">Graphic 52617 Version 13.0</div></div></div>"},"52618":{"type":"graphic_table","displayName":"Risk recurrent variceal bleed","title":"Risk factors for recurrent variceal hemorrhage*","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Risk factors for recurrent variceal hemorrhage*</div><div class=\"cntnt\"><table cellspacing=\"0\">\n\n  <tbody>\n\n\n\n    <tr>\n\n\n      <td class=\"subtitle1\">&nbsp;</td>\n      <td class=\"subtitle1\">Early rebleeding</td>\n\n      <td class=\"subtitle1\">Late rebleeding</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Age &#62;60 years</td>\n\n      <td>yes</td>\n\n      <td>no</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Severity of initial bleed (hypotension, severe anemia)</td>\n\n      <td>yes</td>\n\n      <td>no</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Renal failure</td>\n\n      <td>yes</td>\n\n      <td>no</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Severity of liver failure</td>\n\n      <td>yes</td>\n\n      <td>yes</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Ascites</td>\n\n      <td>yes</td>\n\n      <td>yes</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Hepatoma</td>\n\n      <td>not known</td>\n\n      <td>yes</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Active alcoholism</td>\n\n      <td>no</td>\n\n      <td>yes</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Active bleeding on endoscopy</td>\n\n      <td>yes</td>\n\n      <td>no</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Increasing varix size</td>\n\n      <td>yes</td>\n\n      <td>yes</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Red signs</td>\n\n      <td>yes</td>\n\n      <td>not known</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Platelet clot on varix</td>\n\n      <td>yes</td>\n\n      <td>not known</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Portal pressures</td>\n\n      <td>unclear</td>\n\n      <td>no</td>\n\n    </tr>\n\n  </tbody>\n</table></div><div class=\"graphic_footnotes\">* Early rebleeding is less than six weeks from index bleed; late rebleeding is more than six weeks.</div><div id=\"graphicVersion\">Graphic 52618 Version 1.0</div></div></div>"},"52620":{"type":"graphic_picture","displayName":"LCDD tubules Light","title":"Light chain deposition disease - light microscopy","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Light chain deposition disease - light microscopy</div><div class=\"cntnt\"><img style=\"width:378px; height:248px;\" src=\"images/NEPH/52620_LCDD_tubules_Light.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Light micrograph in light chain deposition disease reveals marked thickening of the tubular basement membranes (most prominent at the arrow) due to the deposition of PAS-positive light chain fragments.</div><div class=\"graphic_reference\">Courtesy of Helmut Rennke, MD.</div><div id=\"graphicVersion\">Graphic 52620 Version 2.0</div></div></div>"},"52621":{"type":"graphic_table","displayName":"Frequency of aneuploidy in congenital heart defects","title":"Data expressed as overall rate of aneuploidy (percent) for individual congenital cardiac defects","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Data expressed as overall rate of aneuploidy (percent) for individual congenital cardiac defects</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1\">Cardiac anomaly</td> <td class=\"subtitle1\">Overall aneuploid rate percent</td> <td class=\"subtitle1\">T 21 percent</td> <td class=\"subtitle1\">T 18 percent</td> <td class=\"subtitle1\">T 13 percent</td> <td class=\"subtitle1\">45X0 percent</td> <td class=\"subtitle1\">Other percent</td> <td class=\"subtitle1\">22q11 deletion</td> </tr> <tr> <td>AVSD</td> <td>46</td> <td>79</td> <td>13</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>8</td> <td>&nbsp;</td> </tr> <tr> <td>VSD</td> <td>46</td> <td>43</td> <td>45</td> <td>2</td> <td>4</td> <td>6</td> <td>10 to 17</td> </tr> <tr> <td>TOF</td> <td>31</td> <td>43</td> <td>29</td> <td>7</td> <td>&nbsp;</td> <td>21</td> <td>6 to 30</td> </tr> <tr> <td>CoA</td> <td>33</td> <td>18</td> <td>24</td> <td>24</td> <td>12</td> <td>22</td> <td>&nbsp;</td> </tr> <tr> <td>CAT</td> <td>19</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>25</td> <td>75</td> <td>10</td> </tr> <tr> <td>IAAb</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>17 to 50</td> </tr> <tr> <td>APVS</td> <td>20</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr> <td>HLHS</td> <td>7</td> <td>&nbsp;</td> <td>56</td> <td>22</td> <td>11</td> <td>11</td> <td>&nbsp;</td> </tr> <tr> <td>DORV</td> <td>21</td> <td>10</td> <td>40</td> <td>20</td> <td>30</td> <td>&nbsp;</td> <td>1</td> </tr> <tr> <td>Mitral atresia</td> <td>18</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr> <td>UVH</td> <td>15</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr> <td>PS/PA + IVS</td> <td>5</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr> <td>Tricuspid atresia</td> <td>7</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr> <td>TVD</td> <td>4</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr> <td>Aortic stenosis</td> <td>5</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr> <td>ASD</td> <td>17</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr> <td>TGA</td> <td>0</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr> <td>cTGA</td> <td>0</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr> <td>Tumours</td> <td>0</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr> <td>Cardiomyopathy</td> <td>0</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr> <td>Cardiosplenic syndromes</td> <td>0</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr> <td>DIV</td> <td>0</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">AVSD: atrioventricular septal defect; VSD: ventricular septal defect; TOF: tetralogy of Fallot; CoA: coarctation of the aorta; CAT: common arterial trunk; APVS: absent pulmonary valve syndrome; HLHS: hypoplastic left heart syndrome; DORV: double outlet right ventricle; UVH: univentricular heart; PS/PA + IVS: pulmonary stenosis/pulmonary atresia with intact ventricular septum; TVD: tricuspid valve dysplasia; ASD: atrial septal defect; TGA: transposition of the great arteries; cTGA: corrected transposition of the great arteries; DIV: double inlet ventricle; IAAb: interrupted aortic arch type B.</div><div class=\"graphic_reference\">Adapted from studies by Allan et al. (Allan et al., 1994), Paladinin et al. (Paladini et al., 2002), Boldt et al. (Boldt et al., 2002) and Tennstedt et al. (Tennstedt et al., 1999). The incidence of individual types of aneuploidy as a percentage of the total number of aneuploid fetuses are adapted from Paladini et al. (Paladini, et al., 2002), Boldt et al. (Boldt et al., 2002) and Tennstedt et al. (Tennstedt et al., 1999). Incidence of 22q11 deletion adapted from Marino et al. (Marino et al., 2001), Yamagishi et al., 2000), McElhinney et al. (McHElhinney et al., 2003), Lewin et al., 1997) and Ryan et al. (Ryan et al., 1997).<br>Reproduced with permission from: Wimalasundera, RC, Gardiner, HM. Congenital heart disease and aneuploidy. Prenat Diagn 2004; 24:1116. Copyright Â© 2004 John Wiley &amp;Sons.</div><div id=\"graphicVersion\">Graphic 52621 Version 3.0</div></div></div>"},"52622":{"type":"graphic_table","displayName":"Mod approach surg CRC mets","title":"Conventional indications versus modern approach to treatment of hepatic colorectal metastases","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Conventional indications versus modern approach to treatment of hepatic colorectal metastases</div><div class=\"cntnt\"><table cellspacing=\"0\">\n\n  <tbody>\n\n    <tr>\n\n      <td class=\"subtitle1\">Conventional indications</td>\n\n      <td class=\"subtitle1\">Modern aggressive approach</td>\n\n    </tr>\n\n    <tr>\n\n      <td>&#60;4 metastases, unilobar disease</td>\n\n      <td>No limits. Multiple/bilobar metastases acceptable,\nusing neoadjuvant chemotherapy, staged resection, and resection/local\nablative therapy.</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Size &#60;5 cm</td>\n\n      <td>No limits</td>\n\n    </tr>\n\n    <tr>\n\n      <td>No extrahepatic disease</td>\n\n      <td>Pulmonary metastases can be resected</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Resection margin &#62;1 cm</td>\n\n      <td>Resection margin &#60;1 cm managed with ablative\ntreatment of narrow margin (cryosurgery or radiofrequency ablation)</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Adequate remnant liver parenchyma</td>\n\n      <td>Preoperative portal vein embolization to increase liver\nremnant volume</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Resection of all macroscopic disease</td>\n\n      <td>NED can be achieved with combination of resection and\nlocal ablative therapy</td>\n\n    </tr>\n\n    <tr>\n\n      <td>No metachronous liver metastases</td>\n\n      <td>Synchronous and metachronous metastases acceptable</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Absence of vena cava and hepatic vein confluence\ninvasion</td>\n\n      <td>No limits. Caval/hepatic vein resection with\nreconstruction can be performed</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Absence of hepatic pedicle lymph node metastases</td>\n\n      <td>In absence of celiac axis metastases, hepatic pedicle\nlymph node metastases may be resected for improved 3-year survival</td>\n\n    </tr>\n\n\n  </tbody>\n</table></div><div class=\"graphic_footnotes\">NED: No evidence of disease.</div><div class=\"graphic_reference\">Reproduced with permission from: Khatri VP, Petrelli NJ, Belghiti J. Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit? J Clin Oncol 2005; 23:8490. Copyright &#169; 2005 American Society of Clinical Oncology.</div><div id=\"graphicVersion\">Graphic 52622 Version 2.0</div></div></div>"},"52623":{"type":"graphic_picture","displayName":"Basal secretion test","title":"Basal secretion test","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Basal secretion test</div><div class=\"cntnt\"><img style=\"width:360px; height:337px;\" src=\"images/PEDS/52623_Basal_secretion_test.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">(A) Topical anesthesia is placed in each eye. Whatman 41 filter strips are placed in the temporal inferior cul-de-sac.<br> (B) The filter strip absorbs the tears as they are produced.</div><div class=\"graphic_reference\">Adapted with permission from: Paysse EA, Coats DK, Cassidy M. Refinements Volume III/Number 2. San Francisco: American Academy of Opthalmology, 1999.</div><div id=\"graphicVersion\">Graphic 52623 Version 4.0</div></div></div>"},"52624":{"type":"graphic_diagnosticimage","displayName":"Pancreatic calcifications","title":"Pancreatic calcifications","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Pancreatic calcifications</div><div class=\"cntnt\"><img style=\"width:310px; height:360px;\" src=\"images/GAST/52624_Pancreatic_calcification.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Plain film of the abdomen shows pancreatic calcifications (arrows) in a patient with chronic pancreatitis.</div><div class=\"graphic_reference\">With permission from: Steer ML, Waxman I, Freedman SD. N Engl J Med 1995; 332:1482.</div><div id=\"graphicVersion\">Graphic 52624 Version 7.0</div></div></div>"},"52625":{"type":"graphic_picture","displayName":"African Burkitt lymphoma","title":"Burkitt lymphoma (African/endemic)","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Burkitt lymphoma (African/endemic)</div><div class=\"cntnt\"><img style=\"width:245px; height:248px;\" src=\"images/HEME/52625_African_Burkitts_lymphoma.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">A large tumor involving the left side of the jaw is apparent.</div><div class=\"graphic_reference\">From: Warnke RA, Weiss LM, Chan JK, et al. Tumors of the lymph nodes and spleen. Atlas of tumor pathology (electronic fascicle), Third series, fascicle 14, 1995, Washington, DC. Armed Forces Institute of Pathology.</div><div id=\"graphicVersion\">Graphic 52625 Version 4.0</div></div></div>"},"52626":{"type":"graphic_picture","displayName":"Normal tympanic membrane","title":"Normal tympanic membrane","html":"<div class=\"graphic\"><div style=\"width: 524px\" class=\"figure\"><div class=\"ttl\">Normal tympanic membrane</div><div class=\"cntnt\"><img style=\"width:504px; height:379px;\" src=\"images/PEDS/52626_Normal_tympanic_membrane.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Normal left tympanic membrane with pearly gray color.</div><div id=\"graphicVersion\">Graphic 52626 Version 1.0</div></div></div>"},"52628":{"type":"graphic_picture","displayName":"Skin ulceration EGPA (Churg-Strauss)","title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss)","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Eosinophilic granulomatosis with polyangiitis (Churg-Strauss)</div><div class=\"cntnt\"><img style=\"width:360px; height:282px;\" src=\"images/PULM/52628_Churg_Strauss_ulceration.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Cutaneous ulceration on the elbow of a patient with eosinophilic granulomatosis with polyangiitis (Churg-Strauss).</div><div class=\"graphic_reference\">Courtesy of Talmadge E King, Jr, MD.</div><div id=\"graphicVersion\">Graphic 52628 Version 3.0</div></div></div>"},"52630":{"type":"graphic_figure","displayName":"Knee arthrocentesis","title":"Knee arthrocentesis","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Knee arthrocentesis</div><div class=\"cntnt\"><img style=\"width:371px; height:393px;\" src=\"images/RHEUM/52630_Knee_arthrocentesis.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The needle is inserted just posterior to the medial portion of the patella and is directed slightly posteriorly and slightly inferiorly.</div><div class=\"graphic_reference\">Reproduced from Owen DS. Aspiration and injection of joints in soft tissue. In: Textbook of Rheumatology, 4th edition, Kelley WN, Harris ED Jr, Ruddy S, et al (Eds), WB Saunders, Philadelphia 1993. p.545.</div><div id=\"graphicVersion\">Graphic 52630 Version 2.0</div></div></div>"},"52633":{"type":"graphic_picture","displayName":"Axillary bubo","title":"Axillary bubo","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Axillary bubo</div><div class=\"cntnt\"><img style=\"width:432px; height:324px;\" src=\"images/ID/52633_Inguinal_bubo_new.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Large axillary bubo in a patient with plague.</div><div class=\"graphic_reference\">Reproduced with permission from: <A style=\"FONT-STYLE: italic\" href=\"http://www.visualdx.com/\" target=_blank>www.visualdx.com</A>. Copyright Logical Images, Inc.</div><div id=\"graphicVersion\">Graphic 52633 Version 6.0</div></div></div>"},"52634":{"type":"graphic_figure","displayName":"Deployment of coronary stent","title":"Deployment of coronary stent","html":"<div class=\"graphic\"><div style=\"width: 480px\" class=\"figure\"><div class=\"ttl\">Deployment of coronary stent</div><div class=\"cntnt\"><img style=\"width:460px; height:299px;\" src=\"images/CARD/52634_Deploy_coronary_sten_edt.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Steps involved in the deployment of a coronary stent. The first step is balloon angioplasty, which creates intimal disruption (top panel). Following placement (middle panel), the stent is expanded (bottom panel).</div><div class=\"graphic_reference\">Adapted from: Cannon A, Roubin GS, Interventional Cardiovascular Medicine, Roubin GS, Califf RM, O'Neill WW, et al (Eds), Churchill Livingstone, New York, 1994, p.866.</div><div id=\"graphicVersion\">Graphic 52634 Version 3.0</div></div></div>"},"52635":{"type":"graphic_figure","displayName":"Bakri balloon","title":"Bakri balloon for management of postpartum hemorrhage","html":"<div class=\"graphic\"><div style=\"width: 547px\" class=\"figure\"><div class=\"ttl\">Bakri balloon for management of postpartum hemorrhage</div><div class=\"cntnt\"><img style=\"width:527px; height:540px;\" src=\"images/OBGYN/52635_Bakri_balloon.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">A) The Bakri balloon catheter is used for temporary control or reduction of postpartum hemorrhage when conservative management of uterine bleeding is warranted. It is easy to place and rapidly achieves tamponade within the uterine cavity, thereby potentially avoiding a hysterectomy. The tip allows drainage of accumulated blood. B) Under ultrasound guidance, the balloon portion of the catheter is inserted into the uterus, making certain that the entire balloon is inserted past the cervical canal and internal ostium. C) The device is intended for one-time use.</div><div class=\"graphic_reference\">Reproduced with permission from: Cook Women's Health.</div><div id=\"graphicVersion\">Graphic 52635 Version 2.0</div></div></div>"},"52636":{"type":"graphic_picture","displayName":"Type 1 breast lobule","title":"Type 1 breast lobule","html":"<div class=\"graphic\"><div style=\"width: 488px\" class=\"figure\"><div class=\"ttl\">Type 1 breast lobule</div><div class=\"cntnt\"><img style=\"width:468px; height:359px;\" src=\"images/SURG/52636_Breast_lobule_type1_light.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Whole mount preparation of breast tissue of an 18-year-old nulliparous woman showing histology of type 1 breast lobules as viewed by light microscopy.<br />(Left panel) Tissue section stained with toluidine blue. 2.5x.<br />(Right panels) Histological section of lobule type 1 stained with hematoxylin and eosin (H&amp;E). Photographs at 10x and 40x respectively.</div><div class=\"graphic_reference\">Reproduced with permission from: Russo J, Hu Y-F, Silva IDCG, and Russo IH. Cancer risk related to mammary gland structure and development. Microscopy Research and Technique 2001; 52:204. Copyright &copy; 2001 American Cancer Society.</div><div id=\"graphicVersion\">Graphic 52636 Version 6.0</div></div></div>"},"52637":{"type":"graphic_diagnosticimage","displayName":"Avascular necrosis hip","title":"Plain radiograph: Avascular necrosis of the hip (Legg-CalvÃ©-Perthes disease)","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Plain radiograph: Avascular necrosis of the hip (Legg-Calv&#233;-Perthes disease)</div><div class=\"cntnt\"><img style=\"width:326px; height:314px;\" src=\"images/PEDS/52637_Avascular_necrosis_hip.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Projection radiograph of the pelvis demonstrates characteristic changes of ischemic necrosis of the left femoral head (arrow). Mixed lucency and sclerosis along with coxa plana is typical of an active process.</div><div class=\"graphic_reference\">Courtesy of the Department of Diagnostic Imaging, Texas Children's Hospital.</div><div id=\"graphicVersion\">Graphic 52637 Version 2.0</div></div></div>"},"52638":{"type":"graphic_picture","displayName":"AML FAB M6","title":"Erythroleukemia (M6)","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Erythroleukemia (M6)</div><div class=\"cntnt\"><img style=\"width:423px; height:288px;\" src=\"images/HEME/52638_AML_FAB_M6.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Bone marrow smear from a patient with erythroleukemia (FAB classification M6). (Wright-Giemsa stain.) A megaloblastoid erythroblast (blue arrow) is shown along with three myeloblasts (black arrows).</div><div class=\"graphic_reference\">From: Brunning RD, McKenna RW. Tumors of the bone marrow. Atlas of tumor pathology (electronic fascicle), Third series, fascicle 9, 1994, Washington, DC. Armed Forces Institute of Pathology.</div><div id=\"graphicVersion\">Graphic 52638 Version 2.0</div></div></div>"},"52639":{"type":"graphic_table","displayName":"Sensitivity and specificity of proposed RV imaging criteria ARVC","title":"Sensitivity and specificity of proposed RV imaging criteria for ARVC*","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Sensitivity and specificity of proposed RV imaging criteria for ARVC*</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1\">&nbsp;</td> <td class=\"subtitle1\">Value </td> <td class=\"subtitle1\">Sensitivity, percent</td> <td class=\"subtitle1\">Specificity, percent</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"4\">Echocardiogram</td> </tr> <tr> <td class=\"subtitle3_left\" colspan=\"4\">Major</td> </tr> <tr> <td class=\"indent2\">PLAX RVOT (diastole)</td> <td>&#8805;32 mm</td> <td>75</td> <td>95</td> </tr> <tr> <td class=\"indent3\">Corrected for body size (PLAX/BSA)</td> <td>&#8805;19 mm/m<sup>2</sup></td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr> <td class=\"indent2\">PSAX RVOT (diastole)</td> <td>&#8805;36 mm</td> <td>62</td> <td>95</td> </tr> <tr> <td class=\"indent3\">Corrected for body size (PSAX/BSA)</td> <td>&#8805;21 mm/m<sup>2</sup></td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr> <td class=\"indent2\">Fractional area change</td> <td>&#8804;33 percent</td> <td>55</td> <td>95</td> </tr> <tr> <td class=\"subtitle3_left\" colspan=\"4\">Minor</td> </tr> <tr> <td class=\"indent2\">PLAX RVOT (diastole)</td> <td>&#8805;29 mm</td> <td>87</td> <td>87</td> </tr> <tr> <td class=\"indent3\">Corrected for body size (PLAX/BSA)</td> <td>&#8805;16 to &#8804;18 mm/m<sup>2</sup></td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr> <td class=\"indent2\">PSAX RVOT (diastole)</td> <td>&#8805;32 mm</td> <td>80</td> <td>80</td> </tr> <tr> <td class=\"indent3\">Corrected for body size (PSAX/BSA)</td> <td>&#8805;18 to &#8804;20 mm/m<sup>2</sup></td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent2\">Fractional area change</td> <td>&#8804;40 percent</td> <td>76</td> <td>76</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"4\">MRI<sup>&#182;</sup></td> </tr> <tr> <td class=\"subtitle3_left\" colspan=\"4\">Major</td> </tr> <tr> <td class=\"indent2\" colspan=\"4\">Ratio of RV end-diastolic volume to BSA</td> </tr> <tr> <td class=\"indent3\">Males</td> <td>&#8805;110 mL/m<sup>2</sup></td> <td>76</td> <td>90</td> </tr> <tr> <td class=\"indent3\">Females</td> <td>&#8805;100 mL/m<sup>2</sup></td> <td>68</td> <td>98</td> </tr> <tr> <td class=\"indent3\"><strong>or</strong> RV ejection fraction</td> <td>&#8804;40 percent</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr> <td class=\"subtitle3_left\" colspan=\"4\">Minor</td> </tr> <tr> <td class=\"indent2\" colspan=\"4\">Ratio of RV end-diastolic volume to BSA</td> </tr> <tr> <td class=\"indent3\">Males</td> <td>&#8805;100 mL/m<sup>2</sup></td> <td>79</td> <td>85</td> </tr> <tr> <td class=\"indent3\">Females</td> <td>&#8805;90 mL/m<sup>2</sup></td> <td>89</td> <td>97</td> </tr> <tr> <td class=\"indent3\"><strong>or</strong> RV ejection fraction</td> <td>&#8804;45 percent</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">PLAX: parasternal long-axis view; RVOT:&nbsp;right ventricular&nbsp;outflow tract; BSA: body surface area; PSAX: parasternal short-axis view.<br />* All the major and minor criteria listed in this table are in addition to the requirement that regional wall motion abnormalities must also be present.<br />Â¶ The sensitivity and specificity for males and females are the same as listed if, in addition to the stated wall motion criteria, there is either abnormal RV size or function or both.</div><div class=\"graphic_reference\">Reproduced with permission from: Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force criteria. Circulation 2010; 121:1533. Copyright &copy; 2010 Lippincott Williams &amp; Wilkins.</div><div id=\"graphicVersion\">Graphic 52639 Version 15.0</div></div></div>"},"52641":{"type":"graphic_diagnosticimage","displayName":"Tetralogy Fallot LV angiogram","title":"Left ventricular angiogram in tetralogy of Fallot","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Left ventricular angiogram in tetralogy of Fallot</div><div class=\"cntnt\"><img style=\"width:299px; height:349px;\" src=\"images/CARD/52641_Tetralogy_Fallot_LV_angiogr.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The angiogram of the left ventricle (LV) in a patient with tetralogy of Fallot was obtained with the camera in a long axial oblique projection. There is a large malaligned ventricular septal defect (*) with the aorta (AO) overriding the intraventricular septum (IVS).</div><div class=\"graphic_reference\">Photo courtesy of Thomas Doyle, MD.</div><div id=\"graphicVersion\">Graphic 52641 Version 2.0</div></div></div>"},"52642":{"type":"graphic_figure","displayName":"Neck zones","title":"Zones of the neck","html":"<div class=\"graphic\"><div style=\"width: 562px\" class=\"figure\"><div class=\"ttl\">Zones of the neck</div><div class=\"cntnt\"><img style=\"width:542px; height:334px;\" src=\"images/EM/52642_Neck_zones.jpg\" alt=\"Image\"/></div><div id=\"graphicVersion\">Graphic 52642 Version 2.0</div></div></div>"},"52643":{"type":"graphic_picture","displayName":"Papilla extruding mucus","title":"Papilla extruding mucus in a patient with IPMN","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Papilla extruding mucus in a patient with IPMN</div><div class=\"cntnt\"><img style=\"width:400px; height:318px;\" src=\"images/GAST/52643_Papilla_extruding_mucus.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">A gaping papilla extruding mucus, pathognomonic of main-duct intraductal papillary mucinous neoplasm.</div><div class=\"graphic_reference\">Courtesy of Kevin McGrath, MD, and Asif Khalid, MD.</div><div id=\"graphicVersion\">Graphic 52643 Version 1.0</div></div></div>"},"52644":{"type":"graphic_figure","displayName":"Resection interstitial pregnancy","title":"Interstitial pregnancy","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Interstitial pregnancy</div><div class=\"cntnt\"><img style=\"width:411px; height:278px;\" src=\"images/OBGYN/52644_Resectioninterstitialpreg.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Cornual resection and removal of interstitial pregnancy.</div><div class=\"graphic_reference\">Courtesy of William J Mann, Jr, MD.</div><div id=\"graphicVersion\">Graphic 52644 Version 2.0</div></div></div>"},"52646":{"type":"graphic_table","displayName":"Normal BP girls","title":"Blood pressure levels for girls by age and height percentile","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Blood pressure levels for girls by age and height percentile</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup width=\"16%\"></colgroup><colgroup span=\"14\" width=\"6%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\" rowspan=\"3\">BP<br /> (percentile)</td> <td class=\"subtitle1\" colspan=\"7\">Systolic BP (mmHg)</td> <td class=\"subtitle1\" colspan=\"7\">Diastolic BP (mmHg)</td> </tr> <tr> <td class=\"subtitle2\" colspan=\"7\">Height percentile or measured height</td> <td class=\"subtitle2\" colspan=\"7\">Height percentile or measured height</td> </tr> <tr> <td class=\"subtitle3\">5%</td> <td class=\"subtitle3\">10%</td> <td class=\"subtitle3\">25%</td> <td class=\"subtitle3\">50%</td> <td class=\"subtitle3\">75%</td> <td class=\"subtitle3\">90%</td> <td class=\"subtitle3\">95%</td> <td class=\"subtitle3\">5%</td> <td class=\"subtitle3\">10%</td> <td class=\"subtitle3\">25%</td> <td class=\"subtitle3\">50%</td> <td class=\"subtitle3\">75%</td> <td class=\"subtitle3\">90%</td> <td class=\"subtitle3\">95%</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"15\">1 year</td> </tr> <tr> <td class=\"indent1\">Height (in)</td> <td class=\"centered\">29.7</td> <td class=\"centered\">30.2</td> <td class=\"centered\">30.9</td> <td class=\"centered\">31.8</td> <td class=\"centered\">32.7</td> <td class=\"centered\">33.4</td> <td class=\"centered\">33.9</td> <td class=\"centered\">29.7</td> <td class=\"centered\">30.2</td> <td class=\"centered\">30.9</td> <td class=\"centered\">31.8</td> <td class=\"centered\">32.7</td> <td class=\"centered\">33.4</td> <td class=\"centered\">33.9</td> </tr> <tr> <td class=\"indent1\">Height (cm)</td> <td class=\"centered\">75.4</td> <td class=\"centered\">76.6</td> <td class=\"centered\">78.6</td> <td class=\"centered\">80.8</td> <td class=\"centered\">83.0</td> <td class=\"centered\">84.9</td> <td class=\"centered\">86.1</td> <td class=\"centered\">75.4</td> <td class=\"centered\">76.6</td> <td class=\"centered\">78.6</td> <td class=\"centered\">80.8</td> <td class=\"centered\">83.0</td> <td class=\"centered\">84.9</td> <td class=\"centered\">86.1</td> </tr> <tr> <td class=\"indent1\">50<sup>th</sup></td> <td class=\"centered\">84</td> <td class=\"centered\">85</td> <td class=\"centered\">86</td> <td class=\"centered\">86</td> <td class=\"centered\">87</td> <td class=\"centered\">88</td> <td class=\"centered\">88</td> <td class=\"centered\">41</td> <td class=\"centered\">42</td> <td class=\"centered\">42</td> <td class=\"centered\">43</td> <td class=\"centered\">44</td> <td class=\"centered\">45</td> <td class=\"centered\">46</td> </tr> <tr> <td class=\"indent1\">90<sup>th</sup></td> <td class=\"centered\">98</td> <td class=\"centered\">99</td> <td class=\"centered\">99</td> <td class=\"centered\">100</td> <td class=\"centered\">101</td> <td class=\"centered\">102</td> <td class=\"centered\">102</td> <td class=\"centered\">54</td> <td class=\"centered\">55</td> <td class=\"centered\">56</td> <td class=\"centered\">56</td> <td class=\"centered\">57</td> <td class=\"centered\">58</td> <td class=\"centered\">58</td> </tr> <tr> <td class=\"indent1\">95<sup>th</sup></td> <td class=\"centered\">101</td> <td class=\"centered\">102</td> <td class=\"centered\">102</td> <td class=\"centered\">103</td> <td class=\"centered\">104</td> <td class=\"centered\">105</td> <td class=\"centered\">105</td> <td class=\"centered\">59</td> <td class=\"centered\">59</td> <td class=\"centered\">60</td> <td class=\"centered\">60</td> <td class=\"centered\">61</td> <td class=\"centered\">62</td> <td class=\"centered\">62</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">95<sup>th</sup> + 12 mmHg</td> <td class=\"centered\">113</td> <td class=\"centered\">114</td> <td class=\"centered\">114</td> <td class=\"centered\">115</td> <td class=\"centered\">116</td> <td class=\"centered\">117</td> <td class=\"centered\">117</td> <td class=\"centered\">71</td> <td class=\"centered\">71</td> <td class=\"centered\">72</td> <td class=\"centered\">72</td> <td class=\"centered\">73</td> <td class=\"centered\">74</td> <td class=\"centered\">74</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"15\">2 years</td> </tr> <tr> <td class=\"indent1\">Height (in)</td> <td class=\"centered\">33.4</td> <td class=\"centered\">34.0</td> <td class=\"centered\">34.9</td> <td class=\"centered\">35.9</td> <td class=\"centered\">36.9</td> <td class=\"centered\">37.8</td> <td class=\"centered\">38.4</td> <td class=\"centered\">33.4</td> <td class=\"centered\">34.0</td> <td class=\"centered\">34.9</td> <td class=\"centered\">35.9</td> <td class=\"centered\">36.9</td> <td class=\"centered\">37.8</td> <td class=\"centered\">38.4</td> </tr> <tr> <td class=\"indent1\">Height (cm)</td> <td class=\"centered\">84.9</td> <td class=\"centered\">86.3</td> <td class=\"centered\">88.6</td> <td class=\"centered\">91.1</td> <td class=\"centered\">93.7</td> <td class=\"centered\">96.0</td> <td class=\"centered\">97.4</td> <td class=\"centered\">84.9</td> <td class=\"centered\">86.3</td> <td class=\"centered\">88.6</td> <td class=\"centered\">91.1</td> <td class=\"centered\">93.7</td> <td class=\"centered\">96.0</td> <td class=\"centered\">97.4</td> </tr> <tr> <td class=\"indent1\">50<sup>th</sup></td> <td class=\"centered\">87</td> <td class=\"centered\">87</td> <td class=\"centered\">88</td> <td class=\"centered\">89</td> <td class=\"centered\">90</td> <td class=\"centered\">91</td> <td class=\"centered\">91</td> <td class=\"centered\">45</td> <td class=\"centered\">46</td> <td class=\"centered\">47</td> <td class=\"centered\">48</td> <td class=\"centered\">49</td> <td class=\"centered\">50</td> <td class=\"centered\">51</td> </tr> <tr> <td class=\"indent1\">90<sup>th</sup></td> <td class=\"centered\">101</td> <td class=\"centered\">101</td> <td class=\"centered\">102</td> <td class=\"centered\">103</td> <td class=\"centered\">104</td> <td class=\"centered\">105</td> <td class=\"centered\">106</td> <td class=\"centered\">58</td> <td class=\"centered\">58</td> <td class=\"centered\">59</td> <td class=\"centered\">60</td> <td class=\"centered\">61</td> <td class=\"centered\">62</td> <td class=\"centered\">62</td> </tr> <tr> <td class=\"indent1\">95<sup>th</sup></td> <td class=\"centered\">104</td> <td class=\"centered\">105</td> <td class=\"centered\">106</td> <td class=\"centered\">106</td> <td class=\"centered\">107</td> <td class=\"centered\">108</td> <td class=\"centered\">109</td> <td class=\"centered\">62</td> <td class=\"centered\">63</td> <td class=\"centered\">63</td> <td class=\"centered\">64</td> <td class=\"centered\">65</td> <td class=\"centered\">66</td> <td class=\"centered\">66</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">95<sup>th</sup> + 12 mmHg</td> <td class=\"centered\">116</td> <td class=\"centered\">117</td> <td class=\"centered\">118</td> <td class=\"centered\">118</td> <td class=\"centered\">119</td> <td class=\"centered\">120</td> <td class=\"centered\">121</td> <td class=\"centered\">74</td> <td class=\"centered\">75</td> <td class=\"centered\">75</td> <td class=\"centered\">76</td> <td class=\"centered\">77</td> <td class=\"centered\">78</td> <td class=\"centered\">78</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"15\">3 years</td> </tr> <tr> <td class=\"indent1\">Height (in)</td> <td class=\"centered\">35.8</td> <td class=\"centered\">36.4</td> <td class=\"centered\">37.3</td> <td class=\"centered\">38.4</td> <td class=\"centered\">39.6</td> <td class=\"centered\">40.6</td> <td class=\"centered\">41.2</td> <td class=\"centered\">35.8</td> <td class=\"centered\">36.4</td> <td class=\"centered\">37.3</td> <td class=\"centered\">38.4</td> <td class=\"centered\">39.6</td> <td class=\"centered\">40.6</td> <td class=\"centered\">41.2</td> </tr> <tr> <td class=\"indent1\">Height (cm)</td> <td class=\"centered\">91.0</td> <td class=\"centered\">92.4</td> <td class=\"centered\">94.9</td> <td class=\"centered\">97.6</td> <td class=\"centered\">100.5</td> <td class=\"centered\">103.1</td> <td class=\"centered\">104.6</td> <td class=\"centered\">91.0</td> <td class=\"centered\">92.4</td> <td class=\"centered\">94.9</td> <td class=\"centered\">97.6</td> <td class=\"centered\">100.5</td> <td class=\"centered\">103.1</td> <td class=\"centered\">104.6</td> </tr> <tr> <td class=\"indent1\">50<sup>th</sup></td> <td class=\"centered\">88</td> <td class=\"centered\">89</td> <td class=\"centered\">89</td> <td class=\"centered\">90</td> <td class=\"centered\">91</td> <td class=\"centered\">92</td> <td class=\"centered\">93</td> <td class=\"centered\">48</td> <td class=\"centered\">48</td> <td class=\"centered\">49</td> <td class=\"centered\">50</td> <td class=\"centered\">51</td> <td class=\"centered\">53</td> <td class=\"centered\">53</td> </tr> <tr> <td class=\"indent1\">90<sup>th</sup></td> <td class=\"centered\">102</td> <td class=\"centered\">103</td> <td class=\"centered\">104</td> <td class=\"centered\">104</td> <td class=\"centered\">105</td> <td class=\"centered\">106</td> <td class=\"centered\">107</td> <td class=\"centered\">60</td> <td class=\"centered\">61</td> <td class=\"centered\">61</td> <td class=\"centered\">62</td> <td class=\"centered\">63</td> <td class=\"centered\">64</td> <td class=\"centered\">65</td> </tr> <tr> <td class=\"indent1\">95<sup>th</sup></td> <td class=\"centered\">106</td> <td class=\"centered\">106</td> <td class=\"centered\">107</td> <td class=\"centered\">108</td> <td class=\"centered\">109</td> <td class=\"centered\">110</td> <td class=\"centered\">110</td> <td class=\"centered\">64</td> <td class=\"centered\">65</td> <td class=\"centered\">65</td> <td class=\"centered\">66</td> <td class=\"centered\">67</td> <td class=\"centered\">68</td> <td class=\"centered\">69</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">95<sup>th</sup> + 12 mmHg</td> <td class=\"centered\">118</td> <td class=\"centered\">118</td> <td class=\"centered\">119</td> <td class=\"centered\">120</td> <td class=\"centered\">121</td> <td class=\"centered\">122</td> <td class=\"centered\">122</td> <td class=\"centered\">76</td> <td class=\"centered\">77</td> <td class=\"centered\">77</td> <td class=\"centered\">78</td> <td class=\"centered\">79</td> <td class=\"centered\">80</td> <td class=\"centered\">81</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"15\">4 years</td> </tr> <tr> <td class=\"indent1\">Height (in)</td> <td class=\"centered\">38.3</td> <td class=\"centered\">38.9</td> <td class=\"centered\">39.9</td> <td class=\"centered\">41.1</td> <td class=\"centered\">42.4</td> <td class=\"centered\">43.5</td> <td class=\"centered\">44.2</td> <td class=\"centered\">38.3</td> <td class=\"centered\">38.9</td> <td class=\"centered\">39.9</td> <td class=\"centered\">41.1</td> <td class=\"centered\">42.4</td> <td class=\"centered\">43.5</td> <td class=\"centered\">44.2</td> </tr> <tr> <td class=\"indent1\">Height (cm)</td> <td class=\"centered\">97.2</td> <td class=\"centered\">98.8</td> <td class=\"centered\">101.4</td> <td class=\"centered\">104.5</td> <td class=\"centered\">107.6</td> <td class=\"centered\">110.5</td> <td class=\"centered\">112.2</td> <td class=\"centered\">97.2</td> <td class=\"centered\">98.8</td> <td class=\"centered\">101.4</td> <td class=\"centered\">104.5</td> <td class=\"centered\">107.6</td> <td class=\"centered\">110.5</td> <td class=\"centered\">112.2</td> </tr> <tr> <td class=\"indent1\">50<sup>th</sup></td> <td class=\"centered\">89</td> <td class=\"centered\">90</td> <td class=\"centered\">91</td> <td class=\"centered\">92</td> <td class=\"centered\">93</td> <td class=\"centered\">94</td> <td class=\"centered\">94</td> <td class=\"centered\">50</td> <td class=\"centered\">51</td> <td class=\"centered\">51</td> <td class=\"centered\">53</td> <td class=\"centered\">54</td> <td class=\"centered\">55</td> <td class=\"centered\">55</td> </tr> <tr> <td class=\"indent1\">90<sup>th</sup></td> <td class=\"centered\">103</td> <td class=\"centered\">104</td> <td class=\"centered\">105</td> <td class=\"centered\">106</td> <td class=\"centered\">107</td> <td class=\"centered\">108</td> <td class=\"centered\">108</td> <td class=\"centered\">62</td> <td class=\"centered\">63</td> <td class=\"centered\">64</td> <td class=\"centered\">65</td> <td class=\"centered\">66</td> <td class=\"centered\">67</td> <td class=\"centered\">67</td> </tr> <tr> <td class=\"indent1\">95<sup>th</sup></td> <td class=\"centered\">107</td> <td class=\"centered\">108</td> <td class=\"centered\">109</td> <td class=\"centered\">109</td> <td class=\"centered\">110</td> <td class=\"centered\">111</td> <td class=\"centered\">112</td> <td class=\"centered\">66</td> <td class=\"centered\">67</td> <td class=\"centered\">68</td> <td class=\"centered\">69</td> <td class=\"centered\">70</td> <td class=\"centered\">70</td> <td class=\"centered\">71</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">95<sup>th</sup> + 12 mmHg</td> <td class=\"centered\">119</td> <td class=\"centered\">120</td> <td class=\"centered\">121</td> <td class=\"centered\">121</td> <td class=\"centered\">122</td> <td class=\"centered\">123</td> <td class=\"centered\">124</td> <td class=\"centered\">78</td> <td class=\"centered\">79</td> <td class=\"centered\">80</td> <td class=\"centered\">81</td> <td class=\"centered\">82</td> <td class=\"centered\">82</td> <td class=\"centered\">83</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"15\">5 years</td> </tr> <tr> <td class=\"indent1\">Height (in)</td> <td class=\"centered\">40.8</td> <td class=\"centered\">41.5</td> <td class=\"centered\">42.6</td> <td class=\"centered\">43.9</td> <td class=\"centered\">45.2</td> <td class=\"centered\">46.5</td> <td class=\"centered\">47.3</td> <td class=\"centered\">40.8</td> <td class=\"centered\">41.5</td> <td class=\"centered\">42.6</td> <td class=\"centered\">43.9</td> <td class=\"centered\">45.2</td> <td class=\"centered\">46.5</td> <td class=\"centered\">47.3</td> </tr> <tr> <td class=\"indent1\">Height (cm)</td> <td class=\"centered\">103.6</td> <td class=\"centered\">105.3</td> <td class=\"centered\">108.2</td> <td class=\"centered\">111.5</td> <td class=\"centered\">114.9</td> <td class=\"centered\">118.1</td> <td class=\"centered\">120.0</td> <td class=\"centered\">103.6</td> <td class=\"centered\">105.3</td> <td class=\"centered\">108.2</td> <td class=\"centered\">111.5</td> <td class=\"centered\">114.9</td> <td class=\"centered\">118.1</td> <td class=\"centered\">120.0</td> </tr> <tr> <td class=\"indent1\">50<sup>th</sup></td> <td class=\"centered\">90</td> <td class=\"centered\">91</td> <td class=\"centered\">92</td> <td class=\"centered\">93</td> <td class=\"centered\">94</td> <td class=\"centered\">95</td> <td class=\"centered\">96</td> <td class=\"centered\">52</td> <td class=\"centered\">52</td> <td class=\"centered\">53</td> <td class=\"centered\">55</td> <td class=\"centered\">56</td> <td class=\"centered\">57</td> <td class=\"centered\">57</td> </tr> <tr> <td class=\"indent1\">90<sup>th</sup></td> <td class=\"centered\">104</td> <td class=\"centered\">105</td> <td class=\"centered\">106</td> <td class=\"centered\">107</td> <td class=\"centered\">108</td> <td class=\"centered\">109</td> <td class=\"centered\">110</td> <td class=\"centered\">64</td> <td class=\"centered\">65</td> <td class=\"centered\">66</td> <td class=\"centered\">67</td> <td class=\"centered\">68</td> <td class=\"centered\">69</td> <td class=\"centered\">70</td> </tr> <tr> <td class=\"indent1\">95<sup>th</sup></td> <td class=\"centered\">108</td> <td class=\"centered\">109</td> <td class=\"centered\">109</td> <td class=\"centered\">110</td> <td class=\"centered\">111</td> <td class=\"centered\">112</td> <td class=\"centered\">113</td> <td class=\"centered\">68</td> <td class=\"centered\">69</td> <td class=\"centered\">70</td> <td class=\"centered\">71</td> <td class=\"centered\">72</td> <td class=\"centered\">73</td> <td class=\"centered\">73</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">95<sup>th</sup> + 12 mmHg</td> <td class=\"centered\">120</td> <td class=\"centered\">121</td> <td class=\"centered\">121</td> <td class=\"centered\">122</td> <td class=\"centered\">123</td> <td class=\"centered\">124</td> <td class=\"centered\">125</td> <td class=\"centered\">80</td> <td class=\"centered\">81</td> <td class=\"centered\">82</td> <td class=\"centered\">83</td> <td class=\"centered\">84</td> <td class=\"centered\">85</td> <td class=\"centered\">85</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"15\">6 years</td> </tr> <tr> <td class=\"indent1\">Height (in)</td> <td class=\"centered\">43.3</td> <td class=\"centered\">44.0</td> <td class=\"centered\">45.2</td> <td class=\"centered\">46.6</td> <td class=\"centered\">48.1</td> <td class=\"centered\">49.4</td> <td class=\"centered\">50.3</td> <td class=\"centered\">43.3</td> <td class=\"centered\">44.0</td> <td class=\"centered\">45.2</td> <td class=\"centered\">46.6</td> <td class=\"centered\">48.1</td> <td class=\"centered\">49.4</td> <td class=\"centered\">50.3</td> </tr> <tr> <td class=\"indent1\">Height (cm)</td> <td class=\"centered\">110.0</td> <td class=\"centered\">111.8</td> <td class=\"centered\">114.9</td> <td class=\"centered\">118.4</td> <td class=\"centered\">122.1</td> <td class=\"centered\">125.6</td> <td class=\"centered\">127.7</td> <td class=\"centered\">110.0</td> <td class=\"centered\">111.8</td> <td class=\"centered\">114.9</td> <td class=\"centered\">118.4</td> <td class=\"centered\">122.1</td> <td class=\"centered\">125.6</td> <td class=\"centered\">127.7</td> </tr> <tr> <td class=\"indent1\">50<sup>th</sup></td> <td class=\"centered\">92</td> <td class=\"centered\">92</td> <td class=\"centered\">93</td> <td class=\"centered\">94</td> <td class=\"centered\">96</td> <td class=\"centered\">97</td> <td class=\"centered\">97</td> <td class=\"centered\">54</td> <td class=\"centered\">54</td> <td class=\"centered\">55</td> <td class=\"centered\">56</td> <td class=\"centered\">57</td> <td class=\"centered\">58</td> <td class=\"centered\">59</td> </tr> <tr> <td class=\"indent1\">90<sup>th</sup></td> <td class=\"centered\">105</td> <td class=\"centered\">106</td> <td class=\"centered\">107</td> <td class=\"centered\">108</td> <td class=\"centered\">109</td> <td class=\"centered\">110</td> <td class=\"centered\">111</td> <td class=\"centered\">67</td> <td class=\"centered\">67</td> <td class=\"centered\">68</td> <td class=\"centered\">69</td> <td class=\"centered\">70</td> <td class=\"centered\">71</td> <td class=\"centered\">71</td> </tr> <tr> <td class=\"indent1\">95<sup>th</sup></td> <td class=\"centered\">109</td> <td class=\"centered\">109</td> <td class=\"centered\">110</td> <td class=\"centered\">111</td> <td class=\"centered\">112</td> <td class=\"centered\">113</td> <td class=\"centered\">114</td> <td class=\"centered\">70</td> <td class=\"centered\">71</td> <td class=\"centered\">72</td> <td class=\"centered\">72</td> <td class=\"centered\">73</td> <td class=\"centered\">74</td> <td class=\"centered\">74</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">95<sup>th</sup> + 12 mmHg</td> <td class=\"centered\">121</td> <td class=\"centered\">121</td> <td class=\"centered\">122</td> <td class=\"centered\">123</td> <td class=\"centered\">124</td> <td class=\"centered\">125</td> <td class=\"centered\">126</td> <td class=\"centered\">82</td> <td class=\"centered\">83</td> <td class=\"centered\">84</td> <td class=\"centered\">84</td> <td class=\"centered\">85</td> <td class=\"centered\">86</td> <td class=\"centered\">86</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"15\">7 years</td> </tr> <tr> <td class=\"indent1\">Height (in)</td> <td class=\"centered\">45.6</td> <td class=\"centered\">46.4</td> <td class=\"centered\">47.7</td> <td class=\"centered\">49.2</td> <td class=\"centered\">50.7</td> <td class=\"centered\">52.1</td> <td class=\"centered\">53.0</td> <td class=\"centered\">45.6</td> <td class=\"centered\">46.4</td> <td class=\"centered\">47.7</td> <td class=\"centered\">49.2</td> <td class=\"centered\">50.7</td> <td class=\"centered\">52.1</td> <td class=\"centered\">53.0</td> </tr> <tr> <td class=\"indent1\">Height (cm)</td> <td class=\"centered\">115.9</td> <td class=\"centered\">117.8</td> <td class=\"centered\">121.1</td> <td class=\"centered\">124.9</td> <td class=\"centered\">128.8</td> <td class=\"centered\">132.5</td> <td class=\"centered\">134.7</td> <td class=\"centered\">115.9</td> <td class=\"centered\">117.8</td> <td class=\"centered\">121.1</td> <td class=\"centered\">124.9</td> <td class=\"centered\">128.8</td> <td class=\"centered\">132.5</td> <td class=\"centered\">134.7</td> </tr> <tr> <td class=\"indent1\">50<sup>th</sup></td> <td class=\"centered\">92</td> <td class=\"centered\">93</td> <td class=\"centered\">94</td> <td class=\"centered\">95</td> <td class=\"centered\">97</td> <td class=\"centered\">98</td> <td class=\"centered\">99</td> <td class=\"centered\">55</td> <td class=\"centered\">55</td> <td class=\"centered\">56</td> <td class=\"centered\">57</td> <td class=\"centered\">58</td> <td class=\"centered\">59</td> <td class=\"centered\">60</td> </tr> <tr> <td class=\"indent1\">90<sup>th</sup></td> <td class=\"centered\">106</td> <td class=\"centered\">106</td> <td class=\"centered\">107</td> <td class=\"centered\">109</td> <td class=\"centered\">110</td> <td class=\"centered\">111</td> <td class=\"centered\">112</td> <td class=\"centered\">68</td> <td class=\"centered\">68</td> <td class=\"centered\">69</td> <td class=\"centered\">70</td> <td class=\"centered\">71</td> <td class=\"centered\">72</td> <td class=\"centered\">72</td> </tr> <tr> <td class=\"indent1\">95<sup>th</sup></td> <td class=\"centered\">109</td> <td class=\"centered\">110</td> <td class=\"centered\">111</td> <td class=\"centered\">112</td> <td class=\"centered\">113</td> <td class=\"centered\">114</td> <td class=\"centered\">115</td> <td class=\"centered\">72</td> <td class=\"centered\">72</td> <td class=\"centered\">73</td> <td class=\"centered\">73</td> <td class=\"centered\">74</td> <td class=\"centered\">74</td> <td class=\"centered\">75</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">95<sup>th</sup> + 12 mmHg</td> <td class=\"centered\">121</td> <td class=\"centered\">122</td> <td class=\"centered\">123</td> <td class=\"centered\">124</td> <td class=\"centered\">125</td> <td class=\"centered\">126</td> <td class=\"centered\">127</td> <td class=\"centered\">84</td> <td class=\"centered\">84</td> <td class=\"centered\">85</td> <td class=\"centered\">85</td> <td class=\"centered\">86</td> <td class=\"centered\">86</td> <td class=\"centered\">87</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"15\">8 years</td> </tr> <tr> <td class=\"indent1\">Height (in)</td> <td class=\"centered\">47.6</td> <td class=\"centered\">48.4</td> <td class=\"centered\">49.8</td> <td class=\"centered\">51.4</td> <td class=\"centered\">53.0</td> <td class=\"centered\">54.5</td> <td class=\"centered\">55.5</td> <td class=\"centered\">47.6</td> <td class=\"centered\">48.4</td> <td class=\"centered\">49.8</td> <td class=\"centered\">51.4</td> <td class=\"centered\">53.0</td> <td class=\"centered\">54.5</td> <td class=\"centered\">55.5</td> </tr> <tr> <td class=\"indent1\">Height (cm)</td> <td class=\"centered\">121.0</td> <td class=\"centered\">123.0</td> <td class=\"centered\">126.5</td> <td class=\"centered\">130.6</td> <td class=\"centered\">134.7</td> <td class=\"centered\">138.5</td> <td class=\"centered\">140.9</td> <td class=\"centered\">121.0</td> <td class=\"centered\">123.0</td> <td class=\"centered\">126.5</td> <td class=\"centered\">130.6</td> <td class=\"centered\">134.7</td> <td class=\"centered\">138.5</td> <td class=\"centered\">140.9</td> </tr> <tr> <td class=\"indent1\">50<sup>th</sup></td> <td class=\"centered\">93</td> <td class=\"centered\">94</td> <td class=\"centered\">95</td> <td class=\"centered\">97</td> <td class=\"centered\">98</td> <td class=\"centered\">99</td> <td class=\"centered\">100</td> <td class=\"centered\">56</td> <td class=\"centered\">56</td> <td class=\"centered\">57</td> <td class=\"centered\">59</td> <td class=\"centered\">60</td> <td class=\"centered\">61</td> <td class=\"centered\">61</td> </tr> <tr> <td class=\"indent1\">90<sup>th</sup></td> <td class=\"centered\">107</td> <td class=\"centered\">107</td> <td class=\"centered\">108</td> <td class=\"centered\">110</td> <td class=\"centered\">111</td> <td class=\"centered\">112</td> <td class=\"centered\">113</td> <td class=\"centered\">69</td> <td class=\"centered\">70</td> <td class=\"centered\">71</td> <td class=\"centered\">72</td> <td class=\"centered\">72</td> <td class=\"centered\">73</td> <td class=\"centered\">73</td> </tr> <tr> <td class=\"indent1\">95<sup>th</sup></td> <td class=\"centered\">110</td> <td class=\"centered\">111</td> <td class=\"centered\">112</td> <td class=\"centered\">113</td> <td class=\"centered\">115</td> <td class=\"centered\">116</td> <td class=\"centered\">117</td> <td class=\"centered\">72</td> <td class=\"centered\">73</td> <td class=\"centered\">74</td> <td class=\"centered\">74</td> <td class=\"centered\">75</td> <td class=\"centered\">75</td> <td class=\"centered\">75</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">95<sup>th</sup> + 12 mmHg</td> <td class=\"centered\">122</td> <td class=\"centered\">123</td> <td class=\"centered\">124</td> <td class=\"centered\">125</td> <td class=\"centered\">127</td> <td class=\"centered\">128</td> <td class=\"centered\">129</td> <td class=\"centered\">84</td> <td class=\"centered\">85</td> <td class=\"centered\">86</td> <td class=\"centered\">86</td> <td class=\"centered\">87</td> <td class=\"centered\">87</td> <td class=\"centered\">87</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"15\">9 years</td> </tr> <tr> <td class=\"indent1\">Height (in)</td> <td class=\"centered\">49.3</td> <td class=\"centered\">50.2</td> <td class=\"centered\">51.7</td> <td class=\"centered\">53.4</td> <td class=\"centered\">55.1</td> <td class=\"centered\">56.7</td> <td class=\"centered\">57.7</td> <td class=\"centered\">49.3</td> <td class=\"centered\">50.2</td> <td class=\"centered\">51.7</td> <td class=\"centered\">53.4</td> <td class=\"centered\">55.1</td> <td class=\"centered\">56.7</td> <td class=\"centered\">57.7</td> </tr> <tr> <td class=\"indent1\">Height (cm)</td> <td class=\"centered\">125.3</td> <td class=\"centered\">127.6</td> <td class=\"centered\">131.3</td> <td class=\"centered\">135.6</td> <td class=\"centered\">140.1</td> <td class=\"centered\">144.1</td> <td class=\"centered\">146.6</td> <td class=\"centered\">125.3</td> <td class=\"centered\">127.6</td> <td class=\"centered\">131.3</td> <td class=\"centered\">135.6</td> <td class=\"centered\">140.1</td> <td class=\"centered\">144.1</td> <td class=\"centered\">146.6</td> </tr> <tr> <td class=\"indent1\">50<sup>th</sup></td> <td class=\"centered\">95</td> <td class=\"centered\">95</td> <td class=\"centered\">97</td> <td class=\"centered\">98</td> <td class=\"centered\">99</td> <td class=\"centered\">100</td> <td class=\"centered\">101</td> <td class=\"centered\">57</td> <td class=\"centered\">58</td> <td class=\"centered\">59</td> <td class=\"centered\">60</td> <td class=\"centered\">60</td> <td class=\"centered\">61</td> <td class=\"centered\">61</td> </tr> <tr> <td class=\"indent1\">90<sup>th</sup></td> <td class=\"centered\">108</td> <td class=\"centered\">108</td> <td class=\"centered\">109</td> <td class=\"centered\">111</td> <td class=\"centered\">112</td> <td class=\"centered\">113</td> <td class=\"centered\">114</td> <td class=\"centered\">71</td> <td class=\"centered\">71</td> <td class=\"centered\">72</td> <td class=\"centered\">73</td> <td class=\"centered\">73</td> <td class=\"centered\">73</td> <td class=\"centered\">73</td> </tr> <tr> <td class=\"indent1\">95<sup>th</sup></td> <td class=\"centered\">112</td> <td class=\"centered\">112</td> <td class=\"centered\">113</td> <td class=\"centered\">114</td> <td class=\"centered\">116</td> <td class=\"centered\">117</td> <td class=\"centered\">118</td> <td class=\"centered\">74</td> <td class=\"centered\">74</td> <td class=\"centered\">75</td> <td class=\"centered\">75</td> <td class=\"centered\">75</td> <td class=\"centered\">75</td> <td class=\"centered\">75</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">95<sup>th</sup> + 12 mmHg</td> <td class=\"centered\">124</td> <td class=\"centered\">124</td> <td class=\"centered\">125</td> <td class=\"centered\">126</td> <td class=\"centered\">128</td> <td class=\"centered\">129</td> <td class=\"centered\">130</td> <td class=\"centered\">86</td> <td class=\"centered\">86</td> <td class=\"centered\">87</td> <td class=\"centered\">87</td> <td class=\"centered\">87</td> <td class=\"centered\">87</td> <td class=\"centered\">87</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"15\">10 years</td> </tr> <tr> <td class=\"indent1\">Height (in)</td> <td class=\"centered\">51.1</td> <td class=\"centered\">52.0</td> <td class=\"centered\">53.7</td> <td class=\"centered\">55.5</td> <td class=\"centered\">57.4</td> <td class=\"centered\">59.1</td> <td class=\"centered\">60.2</td> <td class=\"centered\">51.1</td> <td class=\"centered\">52.0</td> <td class=\"centered\">53.7</td> <td class=\"centered\">55.5</td> <td class=\"centered\">57.4</td> <td class=\"centered\">59.1</td> <td class=\"centered\">60.2</td> </tr> <tr> <td class=\"indent1\">Height (cm)</td> <td class=\"centered\">129.7</td> <td class=\"centered\">132.2</td> <td class=\"centered\">136.3</td> <td class=\"centered\">141.0</td> <td class=\"centered\">145.8</td> <td class=\"centered\">150.2</td> <td class=\"centered\">152.8</td> <td class=\"centered\">129.7</td> <td class=\"centered\">132.2</td> <td class=\"centered\">136.3</td> <td class=\"centered\">141.0</td> <td class=\"centered\">145.8</td> <td class=\"centered\">150.2</td> <td class=\"centered\">152.8</td> </tr> <tr> <td class=\"indent1\">50<sup>th</sup></td> <td class=\"centered\">96</td> <td class=\"centered\">97</td> <td class=\"centered\">98</td> <td class=\"centered\">99</td> <td class=\"centered\">101</td> <td class=\"centered\">102</td> <td class=\"centered\">103</td> <td class=\"centered\">58</td> <td class=\"centered\">59</td> <td class=\"centered\">59</td> <td class=\"centered\">60</td> <td class=\"centered\">61</td> <td class=\"centered\">61</td> <td class=\"centered\">62</td> </tr> <tr> <td class=\"indent1\">90<sup>th</sup></td> <td class=\"centered\">109</td> <td class=\"centered\">110</td> <td class=\"centered\">111</td> <td class=\"centered\">112</td> <td class=\"centered\">113</td> <td class=\"centered\">115</td> <td class=\"centered\">116</td> <td class=\"centered\">72</td> <td class=\"centered\">73</td> <td class=\"centered\">73</td> <td class=\"centered\">73</td> <td class=\"centered\">73</td> <td class=\"centered\">73</td> <td class=\"centered\">73</td> </tr> <tr> <td class=\"indent1\">95<sup>th</sup></td> <td class=\"centered\">113</td> <td class=\"centered\">114</td> <td class=\"centered\">114</td> <td class=\"centered\">116</td> <td class=\"centered\">117</td> <td class=\"centered\">119</td> <td class=\"centered\">120</td> <td class=\"centered\">75</td> <td class=\"centered\">75</td> <td class=\"centered\">76</td> <td class=\"centered\">76</td> <td class=\"centered\">76</td> <td class=\"centered\">76</td> <td class=\"centered\">76</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">95<sup>th</sup> + 12 mmHg</td> <td class=\"centered\">125</td> <td class=\"centered\">126</td> <td class=\"centered\">126</td> <td class=\"centered\">128</td> <td class=\"centered\">129</td> <td class=\"centered\">131</td> <td class=\"centered\">132</td> <td class=\"centered\">87</td> <td class=\"centered\">87</td> <td class=\"centered\">88</td> <td class=\"centered\">88</td> <td class=\"centered\">88</td> <td class=\"centered\">88</td> <td class=\"centered\">88</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"15\">11 years</td> </tr> <tr> <td class=\"indent1\">Height (in)</td> <td class=\"centered\">53.4</td> <td class=\"centered\">54.5</td> <td class=\"centered\">56.2</td> <td class=\"centered\">58.2</td> <td class=\"centered\">60.2</td> <td class=\"centered\">61.9</td> <td class=\"centered\">63.0</td> <td class=\"centered\">53.4</td> <td class=\"centered\">54.5</td> <td class=\"centered\">56.2</td> <td class=\"centered\">58.2</td> <td class=\"centered\">60.2</td> <td class=\"centered\">61.9</td> <td class=\"centered\">63.0</td> </tr> <tr> <td class=\"indent1\">Height (cm)</td> <td class=\"centered\">135.6</td> <td class=\"centered\">138.3</td> <td class=\"centered\">142.8</td> <td class=\"centered\">147.8</td> <td class=\"centered\">152.8</td> <td class=\"centered\">157.3</td> <td class=\"centered\">160.0</td> <td class=\"centered\">135.6</td> <td class=\"centered\">138.3</td> <td class=\"centered\">142.8</td> <td class=\"centered\">147.8</td> <td class=\"centered\">152.8</td> <td class=\"centered\">157.3</td> <td class=\"centered\">160.0</td> </tr> <tr> <td class=\"indent1\">50<sup>th</sup></td> <td class=\"centered\">98</td> <td class=\"centered\">99</td> <td class=\"centered\">101</td> <td class=\"centered\">102</td> <td class=\"centered\">104</td> <td class=\"centered\">105</td> <td class=\"centered\">106</td> <td class=\"centered\">60</td> <td class=\"centered\">60</td> <td class=\"centered\">60</td> <td class=\"centered\">61</td> <td class=\"centered\">62</td> <td class=\"centered\">63</td> <td class=\"centered\">64</td> </tr> <tr> <td class=\"indent1\">90<sup>th</sup></td> <td class=\"centered\">111</td> <td class=\"centered\">112</td> <td class=\"centered\">113</td> <td class=\"centered\">114</td> <td class=\"centered\">116</td> <td class=\"centered\">118</td> <td class=\"centered\">120</td> <td class=\"centered\">74</td> <td class=\"centered\">74</td> <td class=\"centered\">74</td> <td class=\"centered\">74</td> <td class=\"centered\">74</td> <td class=\"centered\">75</td> <td class=\"centered\">75</td> </tr> <tr> <td class=\"indent1\">95<sup>th</sup></td> <td class=\"centered\">115</td> <td class=\"centered\">116</td> <td class=\"centered\">117</td> <td class=\"centered\">118</td> <td class=\"centered\">120</td> <td class=\"centered\">123</td> <td class=\"centered\">124</td> <td class=\"centered\">76</td> <td class=\"centered\">77</td> <td class=\"centered\">77</td> <td class=\"centered\">77</td> <td class=\"centered\">77</td> <td class=\"centered\">77</td> <td class=\"centered\">77</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">95<sup>th</sup> + 12 mmHg</td> <td class=\"centered\">127</td> <td class=\"centered\">128</td> <td class=\"centered\">129</td> <td class=\"centered\">130</td> <td class=\"centered\">132</td> <td class=\"centered\">135</td> <td class=\"centered\">136</td> <td class=\"centered\">88</td> <td class=\"centered\">89</td> <td class=\"centered\">89</td> <td class=\"centered\">89</td> <td class=\"centered\">89</td> <td class=\"centered\">89</td> <td class=\"centered\">89</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"15\">12 years</td> </tr> <tr> <td class=\"indent1\">Height (in)</td> <td class=\"centered\">56.2</td> <td class=\"centered\">57.3</td> <td class=\"centered\">59.0</td> <td class=\"centered\">60.9</td> <td class=\"centered\">62.8</td> <td class=\"centered\">64.5</td> <td class=\"centered\">65.5</td> <td class=\"centered\">56.2</td> <td class=\"centered\">57.3</td> <td class=\"centered\">59.0</td> <td class=\"centered\">60.9</td> <td class=\"centered\">62.8</td> <td class=\"centered\">64.5</td> <td class=\"centered\">65.5</td> </tr> <tr> <td class=\"indent1\">Height (cm)</td> <td class=\"centered\">142.8</td> <td class=\"centered\">145.5</td> <td class=\"centered\">149.9</td> <td class=\"centered\">154.8</td> <td class=\"centered\">159.6</td> <td class=\"centered\">163.8</td> <td class=\"centered\">166.4</td> <td class=\"centered\">142.8</td> <td class=\"centered\">145.5</td> <td class=\"centered\">149.9</td> <td class=\"centered\">154.8</td> <td class=\"centered\">159.6</td> <td class=\"centered\">163.8</td> <td class=\"centered\">166.4</td> </tr> <tr> <td class=\"indent1\">50<sup>th</sup></td> <td class=\"centered\">102</td> <td class=\"centered\">102</td> <td class=\"centered\">104</td> <td class=\"centered\">105</td> <td class=\"centered\">107</td> <td class=\"centered\">108</td> <td class=\"centered\">108</td> <td class=\"centered\">61</td> <td class=\"centered\">61</td> <td class=\"centered\">61</td> <td class=\"centered\">62</td> <td class=\"centered\">64</td> <td class=\"centered\">65</td> <td class=\"centered\">65</td> </tr> <tr> <td class=\"indent1\">90<sup>th</sup></td> <td class=\"centered\">114</td> <td class=\"centered\">115</td> <td class=\"centered\">116</td> <td class=\"centered\">118</td> <td class=\"centered\">120</td> <td class=\"centered\">122</td> <td class=\"centered\">122</td> <td class=\"centered\">75</td> <td class=\"centered\">75</td> <td class=\"centered\">75</td> <td class=\"centered\">75</td> <td class=\"centered\">76</td> <td class=\"centered\">76</td> <td class=\"centered\">76</td> </tr> <tr> <td class=\"indent1\">95<sup>th</sup></td> <td class=\"centered\">118</td> <td class=\"centered\">119</td> <td class=\"centered\">120</td> <td class=\"centered\">122</td> <td class=\"centered\">124</td> <td class=\"centered\">125</td> <td class=\"centered\">126</td> <td class=\"centered\">78</td> <td class=\"centered\">78</td> <td class=\"centered\">78</td> <td class=\"centered\">78</td> <td class=\"centered\">79</td> <td class=\"centered\">79</td> <td class=\"centered\">79</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">95<sup>th</sup> + 12 mmHg</td> <td class=\"centered\">130</td> <td class=\"centered\">131</td> <td class=\"centered\">132</td> <td class=\"centered\">134</td> <td class=\"centered\">136</td> <td class=\"centered\">137</td> <td class=\"centered\">138</td> <td class=\"centered\">90</td> <td class=\"centered\">90</td> <td class=\"centered\">90</td> <td class=\"centered\">90</td> <td class=\"centered\">91</td> <td class=\"centered\">91</td> <td class=\"centered\">91</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"15\">13 years</td> </tr> <tr> <td class=\"indent1\">Height (in)</td> <td class=\"centered\">58.3</td> <td class=\"centered\">59.3</td> <td class=\"centered\">60.9</td> <td class=\"centered\">62.7</td> <td class=\"centered\">64.5</td> <td class=\"centered\">66.1</td> <td class=\"centered\">67.0</td> <td class=\"centered\">58.3</td> <td class=\"centered\">59.3</td> <td class=\"centered\">60.9</td> <td class=\"centered\">62.7</td> <td class=\"centered\">64.5</td> <td class=\"centered\">66.1</td> <td class=\"centered\">67.0</td> </tr> <tr> <td class=\"indent1\">Height (cm)</td> <td class=\"centered\">148.1</td> <td class=\"centered\">150.6</td> <td class=\"centered\">154.7</td> <td class=\"centered\">159.2</td> <td class=\"centered\">163.7</td> <td class=\"centered\">167.8</td> <td class=\"centered\">170.2</td> <td class=\"centered\">148.1</td> <td class=\"centered\">150.6</td> <td class=\"centered\">154.7</td> <td class=\"centered\">159.2</td> <td class=\"centered\">163.7</td> <td class=\"centered\">167.8</td> <td class=\"centered\">170.2</td> </tr> <tr> <td class=\"indent1\">50<sup>th</sup></td> <td class=\"centered\">104</td> <td class=\"centered\">105</td> <td class=\"centered\">106</td> <td class=\"centered\">107</td> <td class=\"centered\">108</td> <td class=\"centered\">108</td> <td class=\"centered\">109</td> <td class=\"centered\">62</td> <td class=\"centered\">62</td> <td class=\"centered\">63</td> <td class=\"centered\">64</td> <td class=\"centered\">65</td> <td class=\"centered\">65</td> <td class=\"centered\">66</td> </tr> <tr> <td class=\"indent1\">90<sup>th</sup></td> <td class=\"centered\">116</td> <td class=\"centered\">117</td> <td class=\"centered\">119</td> <td class=\"centered\">121</td> <td class=\"centered\">122</td> <td class=\"centered\">123</td> <td class=\"centered\">123</td> <td class=\"centered\">75</td> <td class=\"centered\">75</td> <td class=\"centered\">75</td> <td class=\"centered\">76</td> <td class=\"centered\">76</td> <td class=\"centered\">76</td> <td class=\"centered\">76</td> </tr> <tr> <td class=\"indent1\">95<sup>th</sup></td> <td class=\"centered\">121</td> <td class=\"centered\">122</td> <td class=\"centered\">123</td> <td class=\"centered\">124</td> <td class=\"centered\">126</td> <td class=\"centered\">126</td> <td class=\"centered\">127</td> <td class=\"centered\">79</td> <td class=\"centered\">79</td> <td class=\"centered\">79</td> <td class=\"centered\">79</td> <td class=\"centered\">80</td> <td class=\"centered\">80</td> <td class=\"centered\">81</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">95<sup>th</sup> + 12 mmHg</td> <td class=\"centered\">133</td> <td class=\"centered\">134</td> <td class=\"centered\">135</td> <td class=\"centered\">136</td> <td class=\"centered\">138</td> <td class=\"centered\">138</td> <td class=\"centered\">139</td> <td class=\"centered\">91</td> <td class=\"centered\">91</td> <td class=\"centered\">91</td> <td class=\"centered\">91</td> <td class=\"centered\">92</td> <td class=\"centered\">92</td> <td class=\"centered\">93</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"15\">14 years</td> </tr> <tr> <td class=\"indent1\">Height (in)</td> <td class=\"centered\">59.3</td> <td class=\"centered\">60.2</td> <td class=\"centered\">61.8</td> <td class=\"centered\">63.5</td> <td class=\"centered\">65.2</td> <td class=\"centered\">66.8</td> <td class=\"centered\">67.7</td> <td class=\"centered\">59.3</td> <td class=\"centered\">60.2</td> <td class=\"centered\">61.8</td> <td class=\"centered\">63.5</td> <td class=\"centered\">65.2</td> <td class=\"centered\">66.8</td> <td class=\"centered\">67.7</td> </tr> <tr> <td class=\"indent1\">Height (cm)</td> <td class=\"centered\">150.6</td> <td class=\"centered\">153.0</td> <td class=\"centered\">156.9</td> <td class=\"centered\">161.3</td> <td class=\"centered\">165.7</td> <td class=\"centered\">169.7</td> <td class=\"centered\">172.1</td> <td class=\"centered\">150.6</td> <td class=\"centered\">153.0</td> <td class=\"centered\">156.9</td> <td class=\"centered\">161.3</td> <td class=\"centered\">165.7</td> <td class=\"centered\">169.7</td> <td class=\"centered\">172.1</td> </tr> <tr> <td class=\"indent1\">50<sup>th</sup></td> <td class=\"centered\">105</td> <td class=\"centered\">106</td> <td class=\"centered\">107</td> <td class=\"centered\">108</td> <td class=\"centered\">109</td> <td class=\"centered\">109</td> <td class=\"centered\">109</td> <td class=\"centered\">63</td> <td class=\"centered\">63</td> <td class=\"centered\">64</td> <td class=\"centered\">65</td> <td class=\"centered\">66</td> <td class=\"centered\">66</td> <td class=\"centered\">66</td> </tr> <tr> <td class=\"indent1\">90<sup>th</sup></td> <td class=\"centered\">118</td> <td class=\"centered\">118</td> <td class=\"centered\">120</td> <td class=\"centered\">122</td> <td class=\"centered\">123</td> <td class=\"centered\">123</td> <td class=\"centered\">123</td> <td class=\"centered\">76</td> <td class=\"centered\">76</td> <td class=\"centered\">76</td> <td class=\"centered\">76</td> <td class=\"centered\">77</td> <td class=\"centered\">77</td> <td class=\"centered\">77</td> </tr> <tr> <td class=\"indent1\">95<sup>th</sup></td> <td class=\"centered\">123</td> <td class=\"centered\">123</td> <td class=\"centered\">124</td> <td class=\"centered\">125</td> <td class=\"centered\">126</td> <td class=\"centered\">127</td> <td class=\"centered\">127</td> <td class=\"centered\">80</td> <td class=\"centered\">80</td> <td class=\"centered\">80</td> <td class=\"centered\">80</td> <td class=\"centered\">81</td> <td class=\"centered\">81</td> <td class=\"centered\">82</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">95<sup>th</sup> + 12 mmHg</td> <td class=\"centered\">135</td> <td class=\"centered\">135</td> <td class=\"centered\">136</td> <td class=\"centered\">137</td> <td class=\"centered\">138</td> <td class=\"centered\">139</td> <td class=\"centered\">139</td> <td class=\"centered\">92</td> <td class=\"centered\">92</td> <td class=\"centered\">92</td> <td class=\"centered\">92</td> <td class=\"centered\">93</td> <td class=\"centered\">93</td> <td class=\"centered\">94</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"15\">15 years</td> </tr> <tr> <td class=\"indent1\">Height (in)</td> <td class=\"centered\">59.7</td> <td class=\"centered\">60.6</td> <td class=\"centered\">62.2</td> <td class=\"centered\">63.9</td> <td class=\"centered\">65.6</td> <td class=\"centered\">67.2</td> <td class=\"centered\">68.1</td> <td class=\"centered\">59.7</td> <td class=\"centered\">60.6</td> <td class=\"centered\">62.2</td> <td class=\"centered\">63.9</td> <td class=\"centered\">65.6</td> <td class=\"centered\">67.2</td> <td class=\"centered\">68.1</td> </tr> <tr> <td class=\"indent1\">Height (cm)</td> <td class=\"centered\">151.7</td> <td class=\"centered\">154.0</td> <td class=\"centered\">157.9</td> <td class=\"centered\">162.3</td> <td class=\"centered\">166.7</td> <td class=\"centered\">170.6</td> <td class=\"centered\">173.0</td> <td class=\"centered\">151.7</td> <td class=\"centered\">154.0</td> <td class=\"centered\">157.9</td> <td class=\"centered\">162.3</td> <td class=\"centered\">166.7</td> <td class=\"centered\">170.6</td> <td class=\"centered\">173.0</td> </tr> <tr> <td class=\"indent1\">50<sup>th</sup></td> <td class=\"centered\">105</td> <td class=\"centered\">106</td> <td class=\"centered\">107</td> <td class=\"centered\">108</td> <td class=\"centered\">109</td> <td class=\"centered\">109</td> <td class=\"centered\">109</td> <td class=\"centered\">64</td> <td class=\"centered\">64</td> <td class=\"centered\">64</td> <td class=\"centered\">65</td> <td class=\"centered\">66</td> <td class=\"centered\">67</td> <td class=\"centered\">67</td> </tr> <tr> <td class=\"indent1\">90<sup>th</sup></td> <td class=\"centered\">118</td> <td class=\"centered\">119</td> <td class=\"centered\">121</td> <td class=\"centered\">122</td> <td class=\"centered\">123</td> <td class=\"centered\">123</td> <td class=\"centered\">124</td> <td class=\"centered\">76</td> <td class=\"centered\">76</td> <td class=\"centered\">76</td> <td class=\"centered\">77</td> <td class=\"centered\">77</td> <td class=\"centered\">78</td> <td class=\"centered\">78</td> </tr> <tr> <td class=\"indent1\">95<sup>th</sup></td> <td class=\"centered\">124</td> <td class=\"centered\">124</td> <td class=\"centered\">125</td> <td class=\"centered\">126</td> <td class=\"centered\">127</td> <td class=\"centered\">127</td> <td class=\"centered\">128</td> <td class=\"centered\">80</td> <td class=\"centered\">80</td> <td class=\"centered\">80</td> <td class=\"centered\">81</td> <td class=\"centered\">82</td> <td class=\"centered\">82</td> <td class=\"centered\">82</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">95<sup>th</sup> + 12 mmHg</td> <td class=\"centered\">136</td> <td class=\"centered\">136</td> <td class=\"centered\">137</td> <td class=\"centered\">138</td> <td class=\"centered\">139</td> <td class=\"centered\">139</td> <td class=\"centered\">140</td> <td class=\"centered\">92</td> <td class=\"centered\">92</td> <td class=\"centered\">92</td> <td class=\"centered\">93</td> <td class=\"centered\">94</td> <td class=\"centered\">94</td> <td class=\"centered\">94</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"15\">16 years</td> </tr> <tr> <td class=\"indent1\">Height (in)</td> <td class=\"centered\">59.9</td> <td class=\"centered\">60.8</td> <td class=\"centered\">62.4</td> <td class=\"centered\">64.1</td> <td class=\"centered\">65.8</td> <td class=\"centered\">67.3</td> <td class=\"centered\">68.3</td> <td class=\"centered\">59.9</td> <td class=\"centered\">60.8</td> <td class=\"centered\">62.4</td> <td class=\"centered\">64.1</td> <td class=\"centered\">65.8</td> <td class=\"centered\">67.3</td> <td class=\"centered\">68.3</td> </tr> <tr> <td class=\"indent1\">Height (cm)</td> <td class=\"centered\">152.1</td> <td class=\"centered\">154.5</td> <td class=\"centered\">158.4</td> <td class=\"centered\">162.8</td> <td class=\"centered\">167.1</td> <td class=\"centered\">171.1</td> <td class=\"centered\">173.4</td> <td class=\"centered\">152.1</td> <td class=\"centered\">154.5</td> <td class=\"centered\">158.4</td> <td class=\"centered\">162.8</td> <td class=\"centered\">167.1</td> <td class=\"centered\">171.1</td> <td class=\"centered\">173.4</td> </tr> <tr> <td class=\"indent1\">50<sup>th</sup></td> <td class=\"centered\">106</td> <td class=\"centered\">107</td> <td class=\"centered\">108</td> <td class=\"centered\">109</td> <td class=\"centered\">109</td> <td class=\"centered\">110</td> <td class=\"centered\">110</td> <td class=\"centered\">64</td> <td class=\"centered\">64</td> <td class=\"centered\">65</td> <td class=\"centered\">66</td> <td class=\"centered\">66</td> <td class=\"centered\">67</td> <td class=\"centered\">67</td> </tr> <tr> <td class=\"indent1\">90<sup>th</sup></td> <td class=\"centered\">119</td> <td class=\"centered\">120</td> <td class=\"centered\">122</td> <td class=\"centered\">123</td> <td class=\"centered\">124</td> <td class=\"centered\">124</td> <td class=\"centered\">124</td> <td class=\"centered\">76</td> <td class=\"centered\">76</td> <td class=\"centered\">76</td> <td class=\"centered\">77</td> <td class=\"centered\">78</td> <td class=\"centered\">78</td> <td class=\"centered\">78</td> </tr> <tr> <td class=\"indent1\">95<sup>th</sup></td> <td class=\"centered\">124</td> <td class=\"centered\">125</td> <td class=\"centered\">125</td> <td class=\"centered\">127</td> <td class=\"centered\">127</td> <td class=\"centered\">128</td> <td class=\"centered\">128</td> <td class=\"centered\">80</td> <td class=\"centered\">80</td> <td class=\"centered\">80</td> <td class=\"centered\">81</td> <td class=\"centered\">82</td> <td class=\"centered\">82</td> <td class=\"centered\">82</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">95<sup>th</sup> + 12 mmHg</td> <td class=\"centered\">136</td> <td class=\"centered\">137</td> <td class=\"centered\">137</td> <td class=\"centered\">139</td> <td class=\"centered\">139</td> <td class=\"centered\">140</td> <td class=\"centered\">140</td> <td class=\"centered\">92</td> <td class=\"centered\">92</td> <td class=\"centered\">92</td> <td class=\"centered\">93</td> <td class=\"centered\">94</td> <td class=\"centered\">94</td> <td class=\"centered\">94</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"15\">17 years</td> </tr> <tr> <td class=\"indent1\">Height (in)</td> <td class=\"centered\">60.0</td> <td class=\"centered\">60.9</td> <td class=\"centered\">62.5</td> <td class=\"centered\">64.2</td> <td class=\"centered\">65.9</td> <td class=\"centered\">67.4</td> <td class=\"centered\">68.4</td> <td class=\"centered\">60.0</td> <td class=\"centered\">60.9</td> <td class=\"centered\">62.5</td> <td class=\"centered\">64.2</td> <td class=\"centered\">65.9</td> <td class=\"centered\">67.4</td> <td class=\"centered\">68.4</td> </tr> <tr> <td class=\"indent1\">Height (cm)</td> <td class=\"centered\">154.4</td> <td class=\"centered\">154.7</td> <td class=\"centered\">158.7</td> <td class=\"centered\">163.0</td> <td class=\"centered\">167.4</td> <td class=\"centered\">171.3</td> <td class=\"centered\">173.7</td> <td class=\"centered\">154.4</td> <td class=\"centered\">154.7</td> <td class=\"centered\">158.7</td> <td class=\"centered\">163.0</td> <td class=\"centered\">167.4</td> <td class=\"centered\">171.3</td> <td class=\"centered\">173.7</td> </tr> <tr> <td class=\"indent1\">50<sup>th</sup></td> <td class=\"centered\">107</td> <td class=\"centered\">108</td> <td class=\"centered\">109</td> <td class=\"centered\">110</td> <td class=\"centered\">110</td> <td class=\"centered\">110</td> <td class=\"centered\">111</td> <td class=\"centered\">64</td> <td class=\"centered\">64</td> <td class=\"centered\">65</td> <td class=\"centered\">66</td> <td class=\"centered\">66</td> <td class=\"centered\">66</td> <td class=\"centered\">67</td> </tr> <tr> <td class=\"indent1\">90<sup>th</sup></td> <td class=\"centered\">120</td> <td class=\"centered\">121</td> <td class=\"centered\">123</td> <td class=\"centered\">124</td> <td class=\"centered\">124</td> <td class=\"centered\">125</td> <td class=\"centered\">125</td> <td class=\"centered\">76</td> <td class=\"centered\">76</td> <td class=\"centered\">77</td> <td class=\"centered\">77</td> <td class=\"centered\">78</td> <td class=\"centered\">78</td> <td class=\"centered\">78</td> </tr> <tr> <td class=\"indent1\">95<sup>th</sup></td> <td class=\"centered\">125</td> <td class=\"centered\">125</td> <td class=\"centered\">126</td> <td class=\"centered\">127</td> <td class=\"centered\">128</td> <td class=\"centered\">128</td> <td class=\"centered\">128</td> <td class=\"centered\">80</td> <td class=\"centered\">80</td> <td class=\"centered\">80</td> <td class=\"centered\">81</td> <td class=\"centered\">82</td> <td class=\"centered\">82</td> <td class=\"centered\">82</td> </tr> <tr> <td class=\"indent1\">95<sup>th</sup> + 12 mmHg</td> <td class=\"centered\">137</td> <td class=\"centered\">137</td> <td class=\"centered\">138</td> <td class=\"centered\">139</td> <td class=\"centered\">140</td> <td class=\"centered\">140</td> <td class=\"centered\">140</td> <td class=\"centered\">92</td> <td class=\"centered\">92</td> <td class=\"centered\">92</td> <td class=\"centered\">93</td> <td class=\"centered\">94</td> <td class=\"centered\">94</td> <td class=\"centered\">94</td> </tr> </tbody></table></div><div class=\"graphic_lgnd\">The 50<SUP>th</SUP>, 90<SUP>th</SUP>, and 95<SUP>th</SUP> percentiles were derived by using quantile regression on the basis of normal-weight children (BMI &lt;85<SUP>th</SUP> percentile). BP stages are defined as elevated BP â¥90th percentile but &lt;95<SUP innerHtml>th </SUP>percentile; stage 1 HTN: â¥95th percentile or 130/80 to 139/89 mmHg; and stage 2 HTN: â¥95th percentile + 12 mmHg or &gt;140/90.</div><div class=\"graphic_footnotes\">BP: blood pressure; BMI: body mass index; HTN: hypertension.</div><div class=\"graphic_reference\">Reproduced with permission from: Pediatrics, Vol. 140, doi: 10.1542/peds.2017-1904. Copyright Â© 2017 by the AAP.</div><div id=\"graphicVersion\">Graphic 52646 Version 9.0</div></div></div>"},"52647":{"type":"graphic_table","displayName":"Causes of vertical diplopia","title":"Causes of binocular vertical diplopia and hypertropia-hyperphoria","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Causes of binocular vertical diplopia and hypertropia-hyperphoria</div><div class=\"cntnt\"><table class=\"container\" cellspacing=\"0\"><colgroup span=\"2\" width=\"50%\"></colgroup> <tbody> <tr> <td class=\"container\"> <table cellspacing=\"0\"> <tbody> <tr> <td class=\"subtitle1_single\">Supranuclear causes</td> </tr> <tr> <td class=\"indent1\">Supranuclear monocular elevation paresis (congenital or acquired)</td> </tr> <tr> <td class=\"indent1\">Skew deviation</td> </tr> <tr> <td class=\"indent1\">Vertical one-and-a-half syndrome</td> </tr> <tr> <td class=\"indent1\">Wernicke's syndrome</td> </tr> <tr> <td class=\"indent1\">Paroxysmal superior rectus and levator palpebrae spasm with multiple sclerosis</td> </tr> <tr> <td class=\"subtitle1_single\">Ocular motor nerve dysfunction</td> </tr> <tr> <td class=\"indent1\">Third cranial nerve palsy</td> </tr> <tr> <td class=\"indent1\">Fourth cranial nerve palsy</td> </tr> <tr> <td class=\"indent1\">Superior oblique myokymia</td> </tr> <tr> <td class=\"indent1\">Ocular neuromyotonia</td> </tr> <tr> <td class=\"indent1\">Ophthalmoplegic migraine</td> </tr> <tr> <td class=\"indent1\">Wernicke's syndrome</td> </tr> <tr> <td class=\"indent1\">Fisher's syndrome</td> </tr> <tr> <td class=\"indent1\">Guillain-Barr&#233; syndrome</td> </tr> <tr> <td class=\"indent1\">Sixth cranial nerve palsy</td> </tr> <tr> <td class=\"indent1\">Decompensation of a long-standing phoria</td> </tr> <tr> <td class=\"subtitle1_single\">Neuromuscular junction disease</td> </tr> <tr> <td class=\"indent1\">Myasthenia gravis</td> </tr> <tr> <td class=\"indent1\">Botulism</td> </tr> <tr> <td class=\"subtitle1_single\">Diseases of eye muscle</td> </tr> <tr> <td class=\"indent1\">Isolated paresis of a vertical-acting extraocular muscle, superior oblique, inferior oblique, superior rectus, or inferior rectus (for example, due to congenital causes, myasthenia gravis, Graves' disease, botulism, trauma, postoperative sequelae, trochleitis, orbital metastasis, orbital pseudotumor, and muscle ischemia resulting from giant cell arteritis) </td> </tr> <tr> <td class=\"indent1\">Decompensation of a long-standing phoria</td> </tr> <tr> <td class=\"indent1\">Graves' disease</td> </tr> <tr> <td class=\"indent1\">Chronic progressive external ophthalmoplegia syndromes</td> </tr> <tr> <td class=\"indent1\">Postsurgical (eg, cataract operation)</td> </tr> <tr> <td class=\"indent1\">Congenital strabismus syndromes</td> </tr> <tr> <td class=\"indent1\">Dissociated vertical deviation</td> </tr> <tr> <td class=\"indent1\">Congenital \"double elevator\" palsy (monocular elevation deficiency)</td> </tr> <tr> <td class=\"indent1\">Double depressor paralysis (unilateral paralysis of the inferior rectus and superior oblique) (congenital or acquired)</td> </tr> <tr> <td class=\"indent1\">Physiologic hyperdeviation on lateral gaze (asymptomatic)</td> </tr> </tbody> </table> </td> <td class=\"container\"> <table cellspacing=\"0\"> <tbody> <tr> <td class=\"subtitle1_single\">Mechanical processes causing vertical eye misalignment</td> </tr> <tr> <td class=\"indent1\">Graves' disease</td> </tr> <tr> <td class=\"indent1\">Brown's superior oblique tendon sheath syndrome</td> </tr> <tr> <td class=\"sublist2_start\">Congenital</td> </tr> <tr> <td class=\"sublist2\">Acquired (for example, due to superomedial orbital trauma, tenosynovitis or myositis, adhesions, metastasis to the superior oblique muscle, frontal sinus osteoma, pansinusitis, peribulbar anesthesia, blepharoplasty, maxillofacial or sinus surgery, and superior oblique tuck)</td> </tr> <tr> <td class=\"indent1\">Acquired Brown's syndrome associated with underaction of the ipsilateral superior oblique muscle (\"canine tooth syndrome\")</td> </tr> <tr> <td class=\"indent1\">Orbital floor blow-out fracture</td> </tr> <tr> <td class=\"indent1\">Direct trauma to the extraocular muscles (for example, intramuscular hematoma)</td> </tr> <tr> <td class=\"indent1\">Congenital inferior rectus fibrosis</td> </tr> <tr> <td class=\"indent1\">Strabismus fixus (generalized fibrosis of extraocular muscles)</td> </tr> <tr> <td class=\"indent1\">Postoperative sequelae (including retinal detachment surgery, orbital surgery, strabismus surgery, and cataract surgery)</td> </tr> <tr> <td class=\"indent1\">Orbital inflammation (myositis) and pseudotumor</td> </tr> <tr> <td class=\"indent1\">Metastatic infiltration of extraocular muscles</td> </tr> <tr> <td class=\"indent1\">Orbital tumors Fallen eye syndrome (patient with long-standing superior oblique muscle paresis who habitually fixates with the paretic eye may have development of hypodeviation of the uninvolved eye caused by contracture of the contralateral inferior rectus muscle)</td> </tr> <tr> <td class=\"indent1\">Rising eye syndrome (long-standing inferior oblique muscle palsy may result in contracture and fibrosis of the contralateral superior rectus muscle)</td> </tr> <tr> <td class=\"subtitle1_single\">Hemifield slip, retinal disease, and fictitious diplopia</td> </tr> <tr> <td class=\"indent1\">Hemifield slip phenomenon resulting from dense bitemporal hemianopsia or heteronymous altitudinal field defects</td> </tr> <tr> <td class=\"indent1\">Foveal displacement syndrome (eg, due to subretinal or preretinalneovascular membranes)</td> </tr> <tr> <td class=\"indent1\">Fictitious (nonorganic) vertical diplopia</td> </tr> </tbody> </table> </td> </tr> </tbody></table></div><div class=\"graphic_reference\">Reproduced with permission from: Lee AG, Brazis PW. Clinical Pathways in Neuro-Ophthalmology: An Evidence-Based Approach. Thieme, New York 2002. Copyright &copy; 2002 Thieme Medical Publishers.</div><div id=\"graphicVersion\">Graphic 52647 Version 9.0</div></div></div>"},"52648":{"type":"graphic_diagnosticimage","displayName":"Interstitial keratitis Cogans","title":"Early interstitial keratitis in Cogan's syndrome","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Early interstitial keratitis in Cogan's syndrome</div><div class=\"cntnt\"><img style=\"width:260px; height:380px;\" src=\"images/RHEUM/52648_Interstitial_keratitis_Coga.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The subtle stromal infiltrate (arrow) indicative of early interstitial keratitis in a patient with Cogan's syndrome is demonstrated by the narrow band of light in this slit lamp examination of the eye.</div><div class=\"graphic_reference\">Reproduced with permission from: McCallum RM, St.Clair EW, Haynes BF. Cogan's syndrome. In: Inflammatory Diseases of Blood Vessels. Hoffman GS, Weyand CM (Eds). Marcel Dekker, Inc, New York City, 2002. Copyright &copy; 2002 Marcel Dekker, Inc.</div><div id=\"graphicVersion\">Graphic 52648 Version 4.0</div></div></div>"},"52651":{"type":"graphic_movie","displayName":"Parasternal long axis echo aortic valve vegetation","title":"Parasternal long axis echocardiogram showing an aortic valve vegetation in a patient with endocarditis","html":"<div class=\"graphic normal\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Parasternal long axis echocardiogram showing an aortic valve vegetation in a patient with endocarditis</div><div class=\"cntnt\"><div class=\"videoplayer\" h264=\"images/CARD/52651_laxavendconv.mp4\" style=\"width:320px;height:256px\"></div><img style=\"width:257px; height:437px;\" src=\"images/CARD/52651_laxavend.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Parasternal long axis view from a 2-D echocardiogram of aortic valve endocarditis. Large vegetations can be seen on the ventricular surface of both aortic valve leaflets. The left ventricle is dilated, suggesting the presence of significant aortic regurgitation.</div><div class=\"graphic_reference\">Courtesy of Thomas Binder, MD. University of Vienna.</div><div id=\"graphicVersion\">Graphic 52651 Version 3.0</div></div></div>"},"52652":{"type":"graphic_figure","displayName":"Mechanisms of glomerular damage","title":"Mechanisms of glomerular damage","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Mechanisms of glomerular damage</div><div class=\"cntnt\"><img style=\"width:418px; height:351px;\" src=\"images/NEPH/52652_Mechanisms_of_glomerular_da.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Schematic depiction of the major mechanisms by which immune events lead to capillary wall damage and proteinuria.</div><div class=\"graphic_footnotes\">GEC: glomerular epithelial cells; GEN: glomerular endothelial cells; MC: mesangial cells; PMNs: polymorphonuclear cells.</div><div id=\"graphicVersion\">Graphic 52652 Version 3.0</div></div></div>"},"52654":{"type":"graphic_picture","displayName":"NLD obstruction mattering","title":"Left nasolacrimal duct obstruction","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Left nasolacrimal duct obstruction</div><div class=\"cntnt\"><img style=\"width:401px; height:172px;\" src=\"images/PEDS/52654_nld_obstruction_mattering_crop.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The child's parents complained of epiphora of both eyes since the child's birth. The right eye cleared spontaneously, but the left eye continued to tear, with morning crusting and heavy mattering.</div><div class=\"graphic_reference\">Reproduced with permission from: Tasman W, Jaeger E. The Wills Eye Hospital Atlas of Clinical Ophthalmology, 2nd ed. Lippincott Williams &amp; Wilkins, 2001. Copyright &copy; 2001 Lippincott Williams &amp; Wilkins.</div><div id=\"graphicVersion\">Graphic 52654 Version 4.0</div></div></div>"},"52655":{"type":"graphic_picture","displayName":"Abnormal pap smear","title":"Abnormal pap smear","html":"<div class=\"graphic\"><div style=\"width: 524px\" class=\"figure\"><div class=\"ttl\">Abnormal pap smear</div><div class=\"cntnt\"><img style=\"width:504px; height:389px;\" src=\"images/PC/52655_Abnormal_pap_smear.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">(A) Atypical squamous cells of undetermined significance (ASCUS).<br />(B) Low-grade squamous intraepithelial lesion (LSIL).<br />(C) High-grade squamous intraepithelial lesion (HSIL).</div><div class=\"graphic_reference\">Reproduced with permission from Douglas K. Hanks, MD.</div><div id=\"graphicVersion\">Graphic 52655 Version 3.0</div></div></div>"},"52657":{"type":"graphic_picture","displayName":"Molding short arm cast","title":"Molding for a short arm cast","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Molding for a short arm cast</div><div class=\"cntnt\"><img style=\"width:324px; height:432px;\" src=\"images/EM/52657_Molding_short_arm_cast.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Improper molding or any sharp indentations in the cast can cause complications such as pressure sores and skin ulcers. Clinicians with little experience casting should limit molding to gently compressing the cast into an elliptical shape at the area of the fracture. The palms and heels of the hands should be used; avoid using fingers. Practitioners with experience casting may use a three-point molding technique.</div><div class=\"graphic_reference\">Courtesy of Stephen Titus, MD.</div><div id=\"graphicVersion\">Graphic 52657 Version 1.0</div></div></div>"},"52658":{"type":"graphic_figure","displayName":"Kaplan Meier plots ophtha","title":"Development or progression of ophthalmopathy","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Development or progression of ophthalmopathy</div><div class=\"cntnt\"><img style=\"width:383px; height:377px;\" src=\"images/ENDO/52658_Kaplan_Meier_plots_ophtha.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">443 patients with Graves' hyperthyroidism were randomly assigned to receive radioiodine, radioiodine followed by a three-month course of prednisone, or methimazole for 18 months. Development or worsening of ophthalmopathy occurred more often in the radioiodine than in the methimazole group. Worsening of ophthalmopathy was prevented by the administration of prednisone.</div><div class=\"graphic_reference\">Data from: Bartalena L, Marcocci C, Bogazzi F, et al. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med 1998; 338:73.</div><div id=\"graphicVersion\">Graphic 52658 Version 2.0</div></div></div>"},"52659":{"type":"graphic_picture","displayName":"Types of laparoscopes","title":"Types of laparoscopes","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Types of laparoscopes</div><div class=\"cntnt\"><img style=\"width:324px; height:401px;\" src=\"images/OBGYN/52659_Typesoflaparoscopes.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">(Top) Straight diagnostic laparoscope with zero-degree lens. (Bottom) Operating type laparoscope with zero-degree lens.</div><div id=\"graphicVersion\">Graphic 52659 Version 2.0</div></div></div>"},"52661":{"type":"graphic_picture","displayName":"Thin-cap fibroatheroma","title":"Thin-cap fibroatheroma","html":"<div class=\"graphic\"><div style=\"width: 620px\" class=\"figure\"><div class=\"ttl\">Thin-cap fibroatheroma</div><div class=\"cntnt\"><img style=\"width:600px; height:327px;\" src=\"images/CARD/52661_Thin-cap_fibro2.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Representative images of a thin-cap fibroatheroma, stained by hematoxylin and eosin, Movat pentachrome, and antibody against CD68 (recognition of lesional macrophages). Low-power views show prominent necrotic cores and overlying thin fibrous caps; the boxed areas represent the corresponding high-power views below. The thin fibrous cap is infiltrated by macrophages.</div><div class=\"graphic_reference\">Reproduced with permission from: Finn AV, Nakano M, Narula J. Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol 2010; 30:1282. Copyright Â© 2010 Lippincott Williams &amp; Wilkins.</div><div id=\"graphicVersion\">Graphic 52661 Version 8.0</div></div></div>"},"52664":{"type":"graphic_picture","displayName":"Autoeczematization on hand","title":"Autoeczematization (id reaction)","html":"<div class=\"graphic\"><div style=\"width: 524px\" class=\"figure\"><div class=\"ttl\">Autoeczematization (id reaction)</div><div class=\"cntnt\"><img style=\"width:504px; height:379px;\" src=\"images/DERM/52664_Autoeczematization_hand.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Numerous pinpoint vesicles are present on the hand.</div><div class=\"graphic_reference\">Reproduced with permission from: <A style=\"FONT-STYLE: italic\" href=\"http://www.visualdx.com/\" target=_blank>www.visualdx.com</A>. Copyright Logical Images, Inc.</div><div id=\"graphicVersion\">Graphic 52664 Version 4.0</div></div></div>"},"52665":{"type":"graphic_table","displayName":"GHB product names","title":"Products containing GHB and related compounds","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Products containing GHB and related compounds</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1\">&nbsp; </td> <td class=\"subtitle1\">Gamma hydroxybutyrate (GHB) </td> <td class=\"subtitle1\">Gamma butyrolactone (GBL) </td> <td class=\"subtitle1\">1,4 Butanediol (BD) </td> </tr> <tr> <td><strong>Chemical synonyms</strong></td> <td>Gamma hydroxybutyric acid, sodium oxybate</td> <td>2,3(H) furnanone dihydro, dihydro-2(3H) furanone dihydro</td> <td>Tetramethylene glycol, Sucol B, 1,4 butylene glycol</td> </tr> <tr> <td><strong>Street names</strong></td> <td> <p>G, Gina, Liquid Ecstasy, Liquid E, Liquid X, Georgia Home Boy, Grievous Bodily Harm, Fantasy (Australia, New Zealand), Gamma OH, Salty water, Soap, Swirl</p> <p>Names referring to sexual effects and/or use for sexual assault: Great Hormones at Bedtime, Easy Lay, Scoop</p> </td> <td>GBL, Lactone, Furanone</td> <td>BD, One4B, Fantasy (Australia, New Zealand)</td> </tr> <tr> <td><strong>Pharmaceutical preparations</strong></td> <td> <p>Xyrem&#174; (US, sodium oxybate)</p> <p>Alcover&#174;, Somsanit&#174; (Europe)</p> </td> <td>None</td> <td>None</td> </tr> <tr> <td><strong>\"Dietary Supplements\"</strong> (Note: supplements have largely been removed from the market)</td> <td>Oxy-sleep, Gamma OH, Genetika, Alcover</td> <td>Blast, Blue Nitro, Blue Nitro Vitality, Eclipse 4.0, Firewater, Furan, Furanone, Furamax, G3, Gamma G, Gamma Ram, GenX, GH Gold, GH Revitalizer, Insom-X, Invigorate, Jolt, Nu-Life, ReActive, Regenerize, Remforce, Renewsolvent, RenewTrient, Rest-Eze, Revivarant, Thunder, V3, Verve, Verve 5.0, and others</td> <td>Amino Flex, Biocopia PM, BlueRaine&#174;, Cellu-plex, Dormir, Enliven, InnerG, Liquid Gold, N-Force, NRG3, Potion 9, Rejuv&#64;Nite, Rest-Q, Serenity, Soma Solution, SomatoPro, Thunder Nectar, Ultradiol, Zen, and others</td> </tr> <tr> <td><strong>Cleaners and solvents</strong></td> <td>None</td> <td>Beta Tech, Bravo Ink Cleaner, Contact Cement Remover, Miracle Cleaning Cloth, Once Removed nail polish remover, Paton's (non acetone) nail polish remover pads, Tonercleen, Verve 5.0, and others</td> <td>BlueRaine&#174;, European Cosmetics, Miracle Cleaning Cloth, Organic Hurricane, Phantasy, Puritech, Rejoov, Thunder, Weight Belt Cleaner and others; also Flower Power \"plant hormones\"</td> </tr> <tr> <td><strong>Other products</strong></td> <td>GHB recipes available on the Internet for easy home synthesis of GHB using GBL and NaOH or KOH</td> <td>Industrial grade GBL, diverted from chemical supply companies</td> <td>Industrial grade BD, diverted from chemical supply companies</td> </tr> </tbody></table></div><div id=\"graphicVersion\">Graphic 52665 Version 3.0</div></div></div>"},"52668":{"type":"graphic_table","displayName":"Causes newborn thrombocytopenia","title":"Causes of neonatal thrombocytopenia","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Causes of neonatal thrombocytopenia</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1_single\">Increased destruction or consumption of platelets</td> </tr> <tr> <td class=\"sublist2_start\">Immune thrombocytopenia</td> </tr> <tr> <td class=\"sublist2\">Autoimmune</td> </tr> <tr> <td class=\"sublist2\">Alloimmune</td> </tr> <tr> <td class=\"sublist2\">Drug-induced</td> </tr> <tr> <td class=\"sublist2_start\">Peripheral consumption</td> </tr> <tr> <td class=\"sublist2\">Hypersplenism</td> </tr> <tr> <td class=\"sublist2\">Kasabach-Merritt syndrome</td> </tr> <tr> <td class=\"sublist2\">Disseminated intravascular coagulation</td> </tr> <tr> <td class=\"sublist2\">Thrombosis</td> </tr> <tr> <td class=\"sublist2\">Type 2B von Willebrand disease</td> </tr> <tr> <td class=\"subtitle1_single\">Decreased production of platelets</td> </tr> <tr> <td class=\"indent1\">Congenital thrombocytopenias</td> </tr> <tr> <td class=\"indent1\">Infiltrative disorders</td> </tr> <tr> <td class=\"indent1\">Infections: bacterial, viral, or fungal</td> </tr> <tr> <td class=\"indent1\">Preeclampsia</td> </tr> <tr> <td class=\"subtitle1_single\">âMiscellaneous causes</td> </tr> <tr> <td class=\"indent1\">Infection</td> </tr> <tr> <td class=\"indent1\">Asphyxia</td> </tr> <tr> <td class=\"indent1\">Dilution</td> </tr> </tbody></table></div><div id=\"graphicVersion\">Graphic 52668 Version 3.0</div></div></div>"},"52670":{"type":"graphic_figure","displayName":"Dx resp distress on ventilator","title":"Approach to the ventilated patient in respiratory distress","html":"<div class=\"graphic\"><div style=\"width: 622px\" class=\"figure\"><div class=\"ttl\">Approach to the ventilated patient in respiratory distress</div><div class=\"cntnt\"><img style=\"width:602px; height:552px;\" src=\"images/PULM/52670_Dx_resp_distress_on_ventila.gif\" alt=\"Image\"/></div><div id=\"graphicVersion\">Graphic 52670 Version 1.0</div></div></div>"},"52671":{"type":"graphic_figure","displayName":"PEEP ventilation in COPD","title":"Impact of auto-PEEP on trigger sensitivity and inspiratory effort","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Impact of auto-PEEP on trigger sensitivity and inspiratory effort</div><div class=\"cntnt\"><img style=\"width:396px; height:194px;\" src=\"images/PULM/52671_PEEP_ventilation_in_COPD.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">To trigger a breath, alveolar pressure (Palv) must decrease by the amount of auto-PEEP, plus the set trigger sensitivity. The large dip in esophageal pressure (Pes) reflects this effort. The addition of external PEEP reduces the Palv-Pes gradient and decreases the breathing workload, without a significant increase in end-inspiratory Palv.</div><div class=\"graphic_reference\">Modified from Smith, TC, Marini, JJ, J Appl Physiol 1988; 65:1488.</div><div id=\"graphicVersion\">Graphic 52671 Version 1.0</div></div></div>"},"52672":{"type":"graphic_diagnosticimage","displayName":"Tubal preg yolk sac embryo","title":"Tubal pregnancy without cardiac activity","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Tubal pregnancy without cardiac activity</div><div class=\"cntnt\"><img style=\"width:354px; height:327px;\" src=\"images/OBGYN/52672_Tubal_preg_yolk_sac_embryo.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Transvaginal image shows a tubal ring (arrows) with yolk sac and questionable tiny embryo (arrowhead) but no cardiac activity. This patient went on to medical management for ectopic pregnancy.</div><div class=\"graphic_footnotes\">U: uterus; O: ovary.</div><div class=\"graphic_reference\">Courtesy of Tejas S Mehta, MD, MPH.</div><div id=\"graphicVersion\">Graphic 52672 Version 3.0</div></div></div>"},"52673":{"type":"graphic_table","displayName":"Protocol for IV AAT augmentation","title":"Intravenous augmentation therapy with alpha-1-antiprotease for severe AAT deficiency*","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Intravenous augmentation therapy with alpha-1-antiprotease for severe AAT deficiency*</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup width=\"100%\"></colgroup> <tbody> <tr> <td class=\"subtitle1_single\">Pretreatment testing</td> </tr> <tr> <td class=\"indent1\"> <ul> <li>Spirometry with DLCO. </li> </ul> </td> </tr> <tr> <td class=\"indent1\"> <ul> <li>Liver function tests. </li> </ul> </td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\"> <ul> <li>Serum IgA level. </li> </ul> </td> </tr> <tr> <td class=\"subtitle1_single\">Protocol for augmentation therapy<sup>&#182;</sup></td> </tr> <tr> <td class=\"indent1\"> <ul> <li>Product: Pooled plasma-derived alpha-1-antiprotease (Aralast NP, Prolastin-C, Zemaira, and Glassia). </li> </ul> </td> </tr> <tr> <td class=\"indent1\"> <ul> <li>Interval: Weekly.<sup>&#916;</sup> </li> </ul> </td> </tr> <tr> <td class=\"indent1\"> <ul> <li>Patient's weight: ____kg. </li> </ul> </td> </tr> <tr> <td class=\"indent1\"> <ul> <li>Calculate patient's dose: 60 mg &times; weight in kg = _____weekly dose. </li> </ul> </td> </tr> <tr> <td class=\"indent1\"> <ul> <li>Aralast NP, Prolastin-C, and Zemaira are supplied as lyophilized preparations and require reconstitution according to the package insert. After reconstitution, pooled AAT should be used within three hours. </li> </ul> </td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\"> <ul> <li>Infusion rate depends on specific products used and ranges from &#8804;0.2 mL/kg/minute to 0.08 mL/kg/minute. Consult package insert. The rate can be adjusted, if needed for patient comfort. </li> </ul> </td> </tr> <tr> <td class=\"subtitle1_single\">Supportive care</td> </tr> <tr> <td class=\"indent1\"> <ul> <li>Cessation of smoking and avoidance of passive smoke exposure. </li> </ul> </td> </tr> <tr> <td class=\"indent1\"> <ul> <li>Avoidance of respiratory irritants. </li> </ul> </td> </tr> <tr> <td class=\"indent1\"> <ul> <li>Pulmonary rehabilitation if reduced exercise capacity. </li> </ul> </td> </tr> <tr> <td class=\"indent1\"> <ul> <li>Oxygen therapy (as needed). </li> </ul> </td> </tr> <tr> <td class=\"indent1\"> <ul> <li>Nutritional support as appropriate to maintain healthy body weight. </li> </ul> </td> </tr> <tr> <td class=\"indent1\"> <ul> <li>Influenza and pneumococcal vaccinations. </li> </ul> </td> </tr> <tr> <td class=\"indent1\"> <ul> <li>Treatment of respiratory infections (eg, influenza, bacterial bronchitis, flares of bronchiectasis, pneumonia). </li> </ul> </td> </tr> <tr> <td class=\"indent1\"> <ul> <li>Inhaled bronchodilators and glucocorticoids per guidelines for COPD. </li> </ul> </td> </tr> <tr> <td class=\"indent1\"> <ul> <li>Vaccination against hepatitis A and B viruses, if not already immune.<sup>&#9674;</sup> </li> </ul> </td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">AAT: alpha-1 antitrypsin; DLCO: diffusing capacity for carbon monoxide.<br />* An AAT serum level &lt;11 micromol/L or &lt;57 mg/dL is considered severe deficiency and is usually associated with a genetic variant, such as PI*ZZ or PI*Null. For information about selection of patients for AAT augmentation, refer to UpToDate review on treatment of AAT deficiency.<br />Â¶ Infusion of alpha-1-antiprotease can be performed at home after appropriate training or in an infusion center. Epinephrine should be available, if needed.<br />Î The US Food and Drug Administration approved regimen is 60 mg/kg, administered weekly. In special circumstances, 120 mg/kg is administered biweekly, or 250 mg/kg is administered monthly.<br /><FONT class=lozenge>â</FONT> Vaccination against hepatitis A and B can help prevent superimposed insults to the liver, but is not necessary prior to AAT augmentation therapy, due to the low risk of transmission.</div><div id=\"graphicVersion\">Graphic 52673 Version 6.0</div></div></div>"},"52675":{"type":"graphic_waveform","displayName":"ECG strip sinus bradycardia","title":"Single lead electrocardiogram (ECG) showing sinus bradycardia","html":"<div class=\"graphic normal\"><div style=\"width: 560px\" class=\"figure\"><div class=\"ttl\">Single lead electrocardiogram (ECG) showing sinus bradycardia</div><div class=\"cntnt\"><img style=\"width:540px; height:79px;\" src=\"images/CARD/52675_Sinus_bradycardia.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Marked sinus bradycardia at a rate of 25 to 30 beats/min. The normal P waves (upright in lead II) and PR interval are consistent with a sinus mechanism with normal atrioventricular (AV) conduction.</div><div class=\"graphic_reference\">Courtesy of Ary Goldberger, MD.</div><div id=\"graphicVersion\">Graphic 52675 Version 4.0</div></div><div style=\"width: 450px\" class=\"figure\"><div class=\"ttl\">Normal rhythm strip</div><div class=\"cntnt\"><img style=\"width:432px; height:165px;\" src=\"images/CARD/59022_Normal_rhythm_strip.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Normal rhythm strip in lead II. The PR interval is 0.15 sec and the QRS duration is 0.08 sec. Both the P and T waves are upright.</div><div class=\"graphic_reference\">Courtesy of Morton F Arnsdorf, MD.</div><div id=\"graphicVersion\">Graphic 59022 Version 3.0</div></div></div>"},"52676":{"type":"graphic_table","displayName":"Common brand and generic names PI","title":"Examples of common brand and generic names","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Examples of common brand and generic names</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup span=\"4\" width=\"25%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\">Kind of medicine</td> <td class=\"subtitle1\">US brand name(s)</td> <td class=\"subtitle1\">Generic name</td> <td class=\"subtitle1\">Can you get generic copies?</td> </tr> <tr> <td class=\"divider_bottom\" rowspan=\"2\">Asthma or COPD</td> <td>ProAir, Ventolin</td> <td>Albuterol inhaler</td> <td>Not yet</td> </tr> <tr class=\"divider_bottom\"> <td>Advair, AirDuo</td> <td>Fluticasone and salmeterol inhaler</td> <td>Yes</td> </tr> <tr> <td class=\"divider_bottom\" rowspan=\"6\">Blood pressure or heart</td> <td>Effient</td> <td>Prasugrel</td> <td>Yes</td> </tr> <tr> <td>Microzide</td> <td>Hydrochlorothiazide or HCTZ</td> <td>Yes</td> </tr> <tr> <td>Norvasc</td> <td>Amlodipine</td> <td>Yes</td> </tr> <tr> <td>Plavix</td> <td>Clopidogrel</td> <td>Yes</td> </tr> <tr> <td>Toprol XL</td> <td>Metoprolol succinate</td> <td>Yes</td> </tr> <tr class=\"divider_bottom\"> <td>Zestril</td> <td>Lisinopril</td> <td>Yes</td> </tr> <tr> <td class=\"divider_bottom\" rowspan=\"3\">Cholesterol</td> <td>Livalo</td> <td>Pitavastatin</td> <td>Not yet</td> </tr> <tr> <td>Lipitor</td> <td>Atorvastatin</td> <td>Yes</td> </tr> <tr class=\"divider_bottom\"> <td>Crestor</td> <td>Rosuvastatin</td> <td>Yes</td> </tr> <tr> <td class=\"divider_bottom\" rowspan=\"4\">Diabetes</td> <td>Glucotrol</td> <td>Glipizide</td> <td>Yes</td> </tr> <tr> <td>Glucophage</td> <td>Metformin</td> <td>Yes</td> </tr> <tr> <td>Basaglar, Lantus, Toujeo</td> <td>Insulin glargine</td> <td>Not yet</td> </tr> <tr class=\"divider_bottom\"> <td>Januvia</td> <td>Sitagliptan</td> <td>Not yet</td> </tr> <tr class=\"divider_bottom\"> <td>Stomach upset, heartburn</td> <td>Nexium</td> <td>Esomeprazole</td> <td>Yes</td> </tr> <tr> <td>Thyroid</td> <td>Synthroid</td> <td>Levothyroxine</td> <td>Yes</td> </tr> </tbody></table></div><div class=\"graphic_lgnd\">To find out if your medicine comes as a generic copy, ask your pharmacist or use this government website: <a href=\"http://www.accessdata.fda.gov/scripts/cder/ob/default.cfm\" target=\"_blank\">http://www.accessdata.fda.gov/scripts/cder/ob/default.cfm</a>.</div><div id=\"graphicVersion\">Graphic 52676 Version 10.0</div></div></div>"},"52677":{"type":"graphic_diagnosticimage","displayName":"Prenatal ultrasound image of hypoplastic umbilical artery","title":"Prenatal ultrasound image of hypoplastic umbilical artery","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Prenatal ultrasound image of hypoplastic umbilical artery</div><div class=\"cntnt\"><img style=\"width:232px; height:582px;\" src=\"images/OBGYN/52677_US_hypoplastic_umbil_art.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Hypoplastic umbilical artery.<br> (Upper panel) A three-vessel umbilical cord is identified, but one of the arteries is significantly smaller than the other.<br> (Middle panel) Color Doppler ultrasound demonstrated a functional artery.<br> (Lower panel) Longitudinal view of the cord shows two arteries, one of which is much smaller than the other.</div><div class=\"graphic_reference\">Upper and middle panels have been reproduced from: Sepulveda W, Flack NJ, Bower S, Fisk NM. The value of color Doppler ultrasound in the prenatal diagnosis of hypoplastic umbilical artery. Ultrasound Obstet Gynecol 1994; 4:143. Copyright &#169; 1994. Reproduced with permission from: John Wiley &amp; Sons Inc.</div><div id=\"graphicVersion\">Graphic 52677 Version 4.0</div></div></div>"},"52678":{"type":"graphic_diagnosticimage","displayName":"Morisons pouch free fluid","title":"Ultrasound image of free fluid in Morisons pouch","html":"<div class=\"graphic\"><div style=\"width: 524px\" class=\"figure\"><div class=\"ttl\">Ultrasound image of free fluid in Morisons pouch</div><div class=\"cntnt\"><img style=\"width:504px; height:381px;\" src=\"images/EM/52678_Morisons_pouch_free_flu_edt.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">This image, taken from a FAST examination, shows free fluid surrounding the liver (indicated by the arrow).</div><div class=\"graphic_footnotes\">K: kidney; L: liver</div><div class=\"graphic_reference\">Courtesy of Greg Snead, MD.</div><div id=\"graphicVersion\">Graphic 52678 Version 3.0</div></div></div>"},"52679":{"type":"graphic_figure","displayName":"EST v TIPS variceal rebleed","title":"Variceal rebleeding rate with TIPS versus esophageal sclerotherapy","html":"<div class=\"graphic\"><div style=\"width: 505px\" class=\"figure\"><div class=\"ttl\">Variceal rebleeding rate with TIPS versus esophageal sclerotherapy</div><div class=\"cntnt\"><img style=\"width:485px; height:284px;\" src=\"images/GAST/52679_EST_v_TIPS_variceal_rebleed.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Effects of endoscopic sclerotherapy (EST) and transjugular intrahepatic portosystemic shunt (TIPS) on variceal rebleeding rates in published clinical trials of secondary prevention of variceal hemorrhage. All but the last trial showed a significantly lower rate of rebleeding with TIPS.</div><div class=\"graphic_reference\">Data from:&nbsp; &#xD;&#xA;<OL>&#xD;&#xA;<LI>Jalan R, et al. Hepatology 1997; 26:1115. </LI>&#xD;&#xA;<LI>Rossle M, et al. Lancet 1997; 349:1043. </LI>&#xD;&#xA;<LI>Merli M, et al. Hepatology 1998; 27:48. </LI>&#xD;&#xA;<LI>Cello JP, et al. Ann Intern Med 1997; 126:858. </LI>&#xD;&#xA;<LI>Cabrera J, et al. Gastroenterology 1996; 110:832.</LI>&#xD;&#xA;<LI>Sanyal AJ, et al. Ann Intern Med 1997; 126:849.</LI></OL></div><div id=\"graphicVersion\">Graphic 52679 Version 4.0</div></div></div>"},"52680":{"type":"graphic_picture","displayName":"Haemophilus influenzae in CSF","title":"<EM>Haemophilus influenzae</EM> in cerebrospinal fluid","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\"><EM>Haemophilus influenzae</EM> in cerebrospinal fluid</div><div class=\"cntnt\"><img style=\"width:371px; height:240px;\" src=\"images/ID/52680_Haemophilus2.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Gram stain of cerebrospinal fluid (x1000) shows inflammatory cells and small, pleomorphic, gram-negative coccobacilli. <EM>Haemophilus influenzae </EM>grew from this specimen. </div><div class=\"graphic_reference\">Courtesy of Harriet Provine.</div><div id=\"graphicVersion\">Graphic 52680 Version 5.0</div></div></div>"},"52683":{"type":"graphic_table","displayName":"NYHA and other classifications of cardiovascular disability","title":"NYHA and other classifications of cardiovascular disability","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">NYHA and other classifications of cardiovascular disability</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup span=\"4\" width=\"25%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\">Class</td> <td class=\"subtitle1\">New York Heart Association functional classification<sup>[1]</sup></td> <td class=\"subtitle1\">Canadian Cardiovascular Society functional classification<sup>[2]</sup></td> <td class=\"subtitle1\">Specific activity scale<sup>[3]</sup></td> </tr> <tr class=\"divider_bottom\"> <td class=\"centered\">I</td> <td>Patients with cardiac disease but without resulting limitations of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea, or anginal pain.</td> <td>Ordinary physical activity, such as walking and climbing stairs, does not cause angina. Angina with strenuous or rapid prolonged exertion at work or recreation.</td> <td>Patients can perform to completion any activity requiring &#8805;7 metabolic equivalents, eg, can carry 24 lb up eight steps; do outdoor work (shovel snow, spade soil); do recreational activities (skiing, basketball, squash, handball, jog/walk 5 mph).</td> </tr> <tr class=\"divider_bottom\"> <td class=\"centered\">II</td> <td>Patients with cardiac disease resulting in slight limitation of physical activity. They are comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea, or anginal pain.</td> <td>Slight limitation of ordinary activity. Walking or climbing stairs rapidly, walking uphill, walking or stair climbing after meals, in cold, in wind, or when under emotional stress, or only during the few hours after awakening. Walking more than two blocks on the level and climbing more than one flight of ordinary stairs at a normal pace and in normal conditions.</td> <td>Patients can perform to completion any activity requiring &#8805;5 metabolic equivalents, eg, have sexual intercourse without stopping, garden, rake, weed, roller skate, dance fox trot, walk at 4 mph on level ground, but cannot and do not perform to completion activities requiring &#8805;7 metabolic equivalents.</td> </tr> <tr class=\"divider_bottom\"> <td class=\"centered\">III</td> <td>Patients with cardiac disease resulting in marked limitation of physical activity. They are comfortable at rest. Less than ordinary physical activity causes fatigue, palpitation, dyspnea, or anginal pain.</td> <td>Marked limitation of ordinary physical activity. Walking one to two blocks on the level and climbing one flight in normal conditions.</td> <td>Patients can perform to completion any activity requiring &#8805;2 metabolic equivalents, eg, shower without stopping, strip and make bed, clean windows, walk 2.5 mph, bowl, play golf, dress without stopping, but cannot and do not perform to completion any activities requiring &#62;5 metabolic equivalents.</td> </tr> <tr> <td class=\"centered\">IV</td> <td>Patients with cardiac disease resulting in inability to carry on any physical activity without discomfort. Symptoms of cardiac insufficiency or of the anginal syndrome may be present even at rest. If any physical activity is undertaken, discomfort is increased.</td> <td>Inability to carry on any physical activity without discomfort. Anginal syndrome may be present at rest.</td> <td>Patients cannot or do not perform to completion activities requiring &#62;2 metabolic equivalents. Cannot carry out activities listed above (specific activity scale III).</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">NYHA: New York Heart Association.</div><div class=\"graphic_reference\">References:<br /><OL>&#xD;&#xA;<LI>The Criteria Committee of the New York Heart Association. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels, 9th ed, Little, Brown &amp; Co, Boston, 1994. p.253.</LI>&#xD;&#xA;<LI>Campeau L. Grading of angina pectoris. Circulation 1976Í¾ 54:522.</LI>&#xD;&#xA;<LI>Goldman L, Hashimoto B, Cook EF, Loscalzo A. Comparative reproducibility and validity of systems for assessing cardiovascular functional class: Advantages of a new specific activity scale. Circulation 1981; 64:1227.</LI></OL></div><div id=\"graphicVersion\">Graphic 52683 Version 13.0</div></div></div>"},"52688":{"type":"graphic_figure","displayName":"Eval lymphadenopathy child","title":"Evaluation of localized adenopathy in pediatric patients","html":"<div class=\"graphic\"><div style=\"width: 581px\" class=\"figure\"><div class=\"ttl\">Evaluation of localized adenopathy in pediatric patients</div><div class=\"cntnt\"><img style=\"width:561px; height:580px;\" src=\"images/PEDS/52688_Evallymphadenopathychild.gif\" alt=\"Image\"/></div><div class=\"graphic_reference\">Reproduced with permission from: Kilburn LB, Siegel SE, Steuber CP. Clinical Assessment and Differential Diagnosis of the Child with Suspected Cancer. In: Principles and Practice of Pediatric Oncology, 6th ed, Pizzo PA, Poplack DG (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2010.&nbsp;Copyright Â© 2010 Lippincott Williams &amp; Wilkins. <A spellcheck=true href=\"http://www.lww.com/\" target=_blank>www.lww.com</A>.</div><div id=\"graphicVersion\">Graphic 52688 Version 10.0</div></div></div>"},"52689":{"type":"graphic_picture","displayName":"Aggressive periodontitis","title":"Aggressive periodontitis affecting a 16-year old African-American female","html":"<div class=\"graphic\"><div style=\"width: 597px\" class=\"figure\"><div class=\"ttl\">Aggressive periodontitis affecting a 16-year old African-American female</div><div class=\"cntnt\"><img style=\"width:577px; height:283px;\" src=\"images/PC/52689_Aggressive_periodontitis.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Note little or no bacterial biofilm present. There is minimal inflammation of the gingival tissues. Significant alveolar bone loss is seen radiographically around first molars and both maxillary and mandibular incisors.</div><div id=\"graphicVersion\">Graphic 52689 Version 1.0</div></div></div>"},"52690":{"type":"graphic_table","displayName":"Assisting patients with smoking cessation","title":"Assisting patients with smoking cessation","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Assisting patients with smoking cessation</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1\">Action</td> <td class=\"subtitle1\">Strategies for implementation</td> </tr> <tr> <td rowspan=\"4\">Help the patient with a quit plan</td> <td>Set a quit date. Ideally, the quit date should be within&nbsp;two weeks.</td> </tr> <tr> <td>Tell family, friends, and coworkers about quitting and request understanding and support.</td> </tr> <tr> <td>Anticipate challenges to planned quit attempt, particularly during the critical first few weeks. These include nicotine withdrawal symptoms.</td> </tr> <tr> <td>Remove tobacco products from your environment. Prior to quitting, avoid smoking in places where you spend a lot of time (eg, work, home, car).</td> </tr> <tr class=\"divider_top\"> <td rowspan=\"5\">Provide practical counseling (problem solving/training)</td> <td>Abstinence - Total abstinence is essential. \"Not even a single puff after the quit date.\"</td> </tr> <tr> <td>Past quit experience - Review past quit attempts, including identification of what helped during the quit attempt and what factors contributed to relapse.</td> </tr> <tr> <td>Anticipate triggers or challenges in upcoming attempt - Discuss challenges/triggers and how patient will successfully overcome them. Advise patient to remove all tobacco from home, car, and work environment.</td> </tr> <tr> <td>Alcohol - Because alcohol can cause relapse, the patient should consider limiting/abstaining from alcohol while quitting.</td> </tr> <tr> <td>Other smokers in the household - Quitting is more difficult when there is another smoker in the household. Patients should encourage housemates to quit with them or not smoke in their presence.</td> </tr> <tr class=\"divider_top\"> <td>Provide intra-treatment social support</td> <td>Provide a supportive clinical environment while encouraging the patient in his or her quit attempt. \"My office staff and I are available to assist you.\"</td> </tr> <tr class=\"divider_top\"> <td>Help the patient obtain extra-treatment social support</td> <td>Help the patient develop social support for his or her quit attempt in his or her environments outside of treatment. \"Ask your spouse/partner, friends, and coworkers to support you in your quit attempt.\"</td> </tr> <tr class=\"divider_top\"> <td>Recommend the use of approved pharmacotherapy, except in special circumstances</td> <td>Recommend the use of pharmacotherapies found to be effective. Explain how these medications increase smoking cessation success and reduce withdrawal symptoms.</td> </tr> <tr class=\"divider_top\"> <td rowspan=\"3\">Provide supplementary materials</td> <td>Sources - Federal agencies, nonprofit agencies, or local/state health departments. Offer a free telephone quitline (in the United States, 1-800-QUIT-NOW or 1-800-784-8669 can be used).</td> </tr> <tr> <td>Type - Culturally/racially/educationally/age appropriate for the patient.</td> </tr> <tr> <td>Location - Readily available at every clinician's workstation.</td> </tr> </tbody></table></div><div class=\"graphic_reference\">Adapted from: Fiore MC, Jaen C, Baker T, et al. Treating tobacco use and dependence: 2008 update. Clinical Practice Guideline. Rockville, MD: US Department of Health and Human Services. Public Health Service. 2008.</div><div id=\"graphicVersion\">Graphic 52690 Version 6.0</div></div></div>"},"52691":{"type":"graphic_table","displayName":"Breast cancer risk in white women","title":"Average five-year and lifetime risk of developing breast cancer among white women, beginning at various ages","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Average five-year and lifetime risk of developing breast cancer among white women, beginning at various ages</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup span=\"3\" width=\"33%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\">Age</td> <td class=\"subtitle1\">Five-year risk (%)</td> <td class=\"subtitle1\">Lifetime (until age 90) risk (%)</td> </tr> <tr> <td class=\"centered\">35</td> <td class=\"centered\">0.3</td> <td class=\"centered\">12.6</td> </tr> <tr> <td class=\"centered\">40</td> <td class=\"centered\">0.6</td> <td class=\"centered\">12.4</td> </tr> <tr> <td class=\"centered\">50</td> <td class=\"centered\">1.3</td> <td class=\"centered\">11.2</td> </tr> <tr> <td class=\"centered\">60</td> <td class=\"centered\">1.8</td> <td class=\"centered\">9.1</td> </tr> <tr> <td class=\"centered\">70</td> <td class=\"centered\">2.2</td> <td class=\"centered\">6.3</td> </tr> <tr> <td class=\"centered\">80</td> <td class=\"centered\">2.0</td> <td class=\"centered\">3.1</td> </tr> <tr> <td class=\"centered\">85</td> <td class=\"centered\">1.4</td> <td class=\"centered\">1.4</td> </tr> </tbody></table></div><div class=\"graphic_reference\">Data from: Breast Cancer Risk Assessment Tool. National Institutes of Health. Available at: www.cancer.gov/bcrisktool.</div><div id=\"graphicVersion\">Graphic 52691 Version 5.0</div></div></div>"},"52692":{"type":"graphic_table","displayName":"Risk factors for BOS","title":"Risk factors for bronchiolitis obliterans syndrome","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Risk factors for bronchiolitis obliterans syndrome</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1_single\">Probable</td> </tr> <tr> <td class=\"indent1\">Acute rejection</td> </tr> <tr> <td class=\"indent1\">Lymphocytic bronchitis/bronchiolitis</td> </tr> <tr> <td class=\"indent1\">CMV pneumonitis</td> </tr> <tr> <td class=\"indent1\">Medication noncompliance</td> </tr> <tr> <td class=\"indent1\">Primary graft dysfunction</td> </tr> <tr> <td class=\"subtitle1_single\">Potential</td> </tr> <tr> <td class=\"indent1\">CMV infection (without pneumonitis)</td> </tr> <tr> <td class=\"indent1\">Organizing pneumonia</td> </tr> <tr> <td class=\"indent1\">Recurrent infection other than CMV</td> </tr> <tr> <td class=\"indent1\">Older donor age</td> </tr> <tr> <td class=\"indent1\">Prolonged allograft ischemia</td> </tr> <tr> <td class=\"indent1\">Donor antigen-specific reactivity</td> </tr> <tr> <td class=\"indent1\">Gastroesophageal reflux with aspiration</td> </tr> <tr> <td class=\"indent1\">HLA-mismatching</td> </tr> <tr> <td class=\"indent1\">Underlying cause of lung disease</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">HLA: human leukocyte antigen; CMV: cytomegalovirus.</div><div class=\"graphic_reference\">Adapted from: Estenne M, Maurer JR, Bohler A, et al. Bronchiolitis obliterans syndrome 2001: An update of the diagnostic criteria. J Heart Lung Transplant 2002; 21:297.</div><div id=\"graphicVersion\">Graphic 52692 Version 3.0</div></div></div>"},"52693":{"type":"graphic_picture","displayName":"Sclerotic chronic GVHD","title":"Chronic graft-versus-host disease","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Chronic graft-versus-host disease</div><div class=\"cntnt\"><img style=\"width:413px; height:432px;\" src=\"images/DERM/52693_Sclerotic_chronic_GVHD.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Multiple firm, sclerotic plaques are present with areas of shallow ulceration. Dyspigmentation is also present.</div><div id=\"graphicVersion\">Graphic 52693 Version 1.0</div></div></div>"},"52694":{"type":"graphic_table","displayName":"Treatment of hyperkalemia","title":"Treatment of hyperkalemia","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Treatment of hyperkalemia</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1_single\">Antagonism of membrane actions of potassium</td> </tr> <tr> <td>Calcium</td> </tr> <tr> <td class=\"subtitle1_single\">Drive extracellular potassium into the cells</td> </tr> <tr> <td>Insulin and glucose</td> </tr> <tr> <td>Sodium bicarbonate, primarily if metabolic acidosis</td> </tr> <tr> <td>Beta-2-adrenergic agonists</td> </tr> <tr> <td class=\"subtitle1_single\">Removal of potassium from the body</td> </tr> <tr> <td>Loop or thiazide diuretics</td> </tr> <tr> <td>Cation exchange resin</td> </tr> <tr> <td>Dialysis, preferably hemodialysis if severe</td> </tr> </tbody></table></div><div id=\"graphicVersion\">Graphic 52694 Version 2.0</div></div></div>"},"52695":{"type":"graphic_diagnosticimage","displayName":"Sagittal MRI LSS","title":"Sagittal MRI in lumbar spinal stenosis","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Sagittal MRI in lumbar spinal stenosis</div><div class=\"cntnt\"><img style=\"width:265px; height:432px;\" src=\"images/NEURO/52695_Sagittal_MRI_LSS.jpg\" alt=\"Image\"/></div><div class=\"graphic_footnotes\">MRI: magnetic resonance imaging. </div><div id=\"graphicVersion\">Graphic 52695 Version 4.0</div></div></div>"},"52697":{"type":"graphic_picture","displayName":"Histology desmoplastic melanoma","title":"Desmoplastic melanoma","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Desmoplastic melanoma</div><div class=\"cntnt\"><img style=\"width:386px; height:522px;\" src=\"images/ONC/52697_Histology_desmoplastic_mela.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Panel A: Low power light photomicrograph of a desmoplastic melanoma, showing a poorly circumscribed tumor with a marked fibrogenic stromal response. There is lentigo maligna overlying the dermal tumor (black arrows). Panel B: Higher power view light photomicrograph of a desmoplastic melanoma, showing that the malignant cells have hyperchromatic, elongated nuclei, resembling those of fibroblasts. The malignant spindle cells form long fascicles that dissect dermal collagen.</div><div class=\"graphic_reference\">Courtesy of Vincent Liu, MD and April Wang Armstrong, MD.</div><div id=\"graphicVersion\">Graphic 52697 Version 1.0</div></div></div>"},"52698":{"type":"graphic_figure","displayName":"Blocked sinus passage 1 PI","title":"Blocked sinus","html":"<div class=\"graphic\"><div style=\"width: 555px\" class=\"figure\"><div class=\"ttl\">Blocked sinus</div><div class=\"cntnt\"><img style=\"width:535px; height:481px;\" src=\"images/PI/52698_Blocked_sinus_passage_1_PI.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">This figure depicts a woman with chronic rhinosinusitis. The sinus becomes swollen, blocking the passage and leading to mucus build-up.</div><div id=\"graphicVersion\">Graphic 52698 Version 3.0</div></div></div>"},"52699":{"type":"graphic_table","displayName":"Increasing contraceptive adherence in adolescents","title":"Tips for increasing contraceptive adherence among adolescent females*<SUP>Â¶</SUP>","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Tips for increasing contraceptive adherence among adolescent females*<SUP>Â¶</SUP></div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1\">Contraceptive method</td> <td class=\"subtitle1\">Potential barriers to adherence</td> <td class=\"subtitle1\">Strategies to increase adherence</td> </tr> <tr> <td rowspan=\"5\">Oral contraceptive pills</td> <td rowspan=\"4\"> <p>Failure to refill prescription</p> <p>Forgetting to take pill</p> <p>Using pills sporadically</p> <p>Not using a back-up method when necessary</p> </td> <td class=\"sublist1_start\">Tell (and ask the adolescent to repeat back) three things:</td> </tr> <tr> <td class=\"sublist1\">- When to start the pill</td> </tr> <tr> <td class=\"sublist1\">- Take the pill every day at the same time (eg, when brushing teeth)</td> </tr> <tr> <td class=\"sublist1\">- Call the clinic/office if there are any questions</td> </tr> <tr> <td>Desire to avoid monthly periods</td> <td>Extended-cycle or continuous pill use</td> </tr> <tr class=\"divider_top\"> <td>Depot medroxyprogesterone acetate</td> <td>Failure to make/keep appointment for next shot</td> <td>Schedule the appointment for the next shot when the adolescent is in the clinic/office and ask her to set the alarm on her cell phone as a reminder</td> </tr> <tr class=\"divider_top\"> <td>Transdermal patch</td> <td>Requires weekly change</td> <td> <p>Use a wall, computer, or cell phone calendar</p> <p>Use a cell phone alarm</p> <p>Place a sticker designating the change day on the bathroom mirror</p> </td> </tr> <tr class=\"divider_top\"> <td>Vaginal ring</td> <td>Requires change every three weeks</td> <td> <p>Use a wall, computer, or cell phone calendar</p> <p>Use a cell phone alarm</p> <p>Place a sticker designating the change day on the bathroom mirror</p> </td> </tr> <tr class=\"divider_top\"> <td>Condoms</td> <td>Must be available at time of sexual activity</td> <td> <p>Provide condoms to the adolescent before she leaves the clinic/office</p> <p>Suggest that the adolescent carry condoms in her purse</p> </td> </tr> </tbody></table><html xmlns:mso=\"urn:schemas-microsoft-com:office:office\" xmlns:msdt=\"uuid:C2F41010-65B3-11d1-A29F-00AA00C14882\"><head>\r\n<!--[if gte mso 9]><xml>\n<mso:CustomDocumentProperties>\r\n<mso:Specialty msdt:dt=\"string\">13</mso:Specialty>\r\n<mso:Edit_Table msdt:dt=\"string\">&lt;a href=&quot;/Graphics/Pages/TableEditor.aspx?SPID=49771&amp;amp;Mode=Edit&quot;&gt;&lt;/a&gt;</mso:Edit_Table>\r\n</mso:CustomDocumentProperties>\n</xml><![endif]-->\r\n</head></div><div class=\"graphic_footnotes\">*&nbsp;The intrauterine device and contraceptive implant&nbsp;are recommended as first-line methods of contraception in adolescents. They are effective, safe, and reversible and adherence is not an issue. <br />Â¶ Provide the adolescent with a list of the following information: the clinic/office name, a contact person, the clinic/office phone number, and instructions about what to do if they miss a dose.</div><div id=\"graphicVersion\">Graphic 52699 Version 5.0</div></div></div>"},"52700":{"type":"graphic_figure","displayName":"RR of CV lisin vs chlor ALLHAT","title":"Combined cardiovascular disease outcomes with lisinopril vs chlorthalidone in ALLHAT","html":"<div class=\"graphic\"><div style=\"width: 539px\" class=\"figure\"><div class=\"ttl\">Combined cardiovascular disease outcomes with lisinopril vs chlorthalidone in ALLHAT</div><div class=\"cntnt\"><img style=\"width:519px; height:333px;\" src=\"images/NEPH/52700_RR_of_CV_lisin_vs_chlor_ALL.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Increased relative risk of CV outcomes with lisinopril. Graph, with natural logarithmic scale, showing the relative risk of combined cardiovascular disease outcomes in all patients (total) and prespecified subgroups given either lisinopril or chlorthalidone in the ALLHAT study. Compared with chlorthalidone, lisinopril increased the risk of these outcomes in total and in most subgroups.</div><div class=\"graphic_reference\">Data from the ALLHAT investigators, JAMA 2002; 288:2981.</div><div id=\"graphicVersion\">Graphic 52700 Version 1.0</div></div></div>"},"52701":{"type":"graphic_picture","displayName":"Early diphtheritic membrane","title":"Early-stage diphtheritic membrane on right tonsil of 26-year-old female patient","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Early-stage diphtheritic membrane on right tonsil of 26-year-old female patient</div><div class=\"cntnt\"><img style=\"width:333px; height:505px;\" src=\"images/ID/52701_Early_diphtheritic_membrane.jpg\" alt=\"Image\"/></div><div class=\"graphic_reference\">Reproduced with permission from: Kadirova R, Kartoglu HU, Strebel PM. Clinical characteristics and management of 676 hospitalized diphtheria cases, Kyrgyz Republic, 1995. J Infect Dis 2000; 181:S110. Copyright &#169; 2000 University of Chicago Press.</div><div id=\"graphicVersion\">Graphic 52701 Version 3.0</div></div></div>"},"52703":{"type":"graphic_picture","displayName":"Mixed osteodystrophy","title":"Micrograph showing mixed uremic osteodystrophy","html":"<div class=\"graphic normal\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Micrograph showing mixed uremic osteodystrophy</div><div class=\"cntnt\"><img style=\"width:378px; height:263px;\" src=\"images/NEPH/52703_Mixedosteodystrophy.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Bone biopsy in mixed uremic osteodystrophy which is characterized by features of both osteitis fibrosa and osteomalacia.<br />(Left panel) Trichrome stain reveals increased numbers of multinucleate osteoclasts (short arrow) as expected in osteitis fibrosa plus a marked increase in adjacent nonmineralized osteoid in red-brown (long arrow).<br />(Right panel) Tetracycline labeling demonstrates impaired mineralization as evidenced by diffuse tetracycline deposition (yellow stain, short arrow) and the absence of tetracycline at some bone forming surfaces as in the lower left quadrant (long arrow).</div><div class=\"graphic_reference\">Courtesy of L Darryl Quarles, MD.</div><div id=\"graphicVersion\">Graphic 52703 Version 4.0</div></div><div style=\"width: 450px\" class=\"figure\"><div class=\"ttl\">Micrograph showing normal bone histology</div><div class=\"cntnt\"><img style=\"width:382px; height:269px;\" src=\"images/NEPH/66330_Normalboneedit.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Histologic appearance of normal bone.<br />(Left panel) Goldner Masson trichrome stain shows mineralized lamellar bone in blue and adjacent nonmineralized osteoid in red-brown. Osteoid usually comprises less than 25% of bone surfaces. The cellular area between the osseous structures is the marrow space.<br />(Right panel) Villanueva-stained section viewed under polarized light following time-spaced tetracycline labeling. Osteoid appears orange, mineralized bone is green, and tetracycline markers appear as luminescent yellow-green bands within bone and beneath osteoid (arrow). The distinct dual bands represent active mineralized bone formation.</div><div class=\"graphic_reference\">Courtesy of L Darryl Quarles, MD.</div><div id=\"graphicVersion\">Graphic 66330 Version 6.0</div></div></div>"},"52704":{"type":"graphic_waveform","displayName":"Escape atrial beats tutorial","title":"Escape atrial beats","html":"<div class=\"graphic normal\"><div style=\"width: 536px\" class=\"figure\"><div class=\"ttl\">Escape atrial beats</div><div class=\"cntnt\"><img style=\"width:516px; height:101px;\" src=\"images/CARD/52704_Escape_atrial_beats_tutoria.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The 4th and 5th beats are escape atrial beats. The rate of the atrial escape rhythm is slower than that of the sinus node (first 3 beats) and the P wave morphology differs from that of the sinus P wave, depending upon the location of the ectopic atrial focus.</div><div id=\"graphicVersion\">Graphic 52704 Version 2.0</div></div><div style=\"width: 456px\" class=\"figure\"><div class=\"ttl\">Sinus rhythm</div><div class=\"cntnt\"><img style=\"width:456px; height:103px;\" src=\"images/CARD/69872_Sinus_rhythm_tutorial.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The normal P wave in sinus rhythm is slightly notched since activation of the right atrium precedes that of the left atrium. The P wave is upright in a positive direction in leads I and II. A P wave with a uniform morphology precedes each QRS complex. The rate is between 60 and 100 beats per minute and the cycle length is uniform between sequential P waves and QRS complexes. In addition, the P wave morphology and PR intervals are identical from beat to beat.</div><div id=\"graphicVersion\">Graphic 69872 Version 2.0</div></div></div>"},"52705":{"type":"graphic_picture","displayName":"Pancreatoblastoma","title":"Histologic appearance of pancreatoblastoma","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Histologic appearance of pancreatoblastoma</div><div class=\"cntnt\"><img style=\"width:396px; height:291px;\" src=\"images/ONC/52705_Pancreatoblastoma.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">There are multiple squamoid foci (arrows) among the darker primitive polygonal cells. Hematoxylin and Eosin.</div><div class=\"graphic_reference\">Courtesy of Daniel S Longnecker, MD.</div><div id=\"graphicVersion\">Graphic 52705 Version 3.0</div></div></div>"},"52707":{"type":"graphic_table","displayName":"Causes oropharyngeal dysphagia","title":"Representative causes of oropharyngeal dysphagia","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Representative causes of oropharyngeal dysphagia</div><div class=\"cntnt\"><table class=\"container\" cellspacing=\"0\"><colgroup span=\"2\" width=\"50%\"></colgroup> <tbody> <tr> <td class=\"container\"> <table cellspacing=\"0\"> <tbody> <tr> <td class=\"subtitle1_single\">Iatrogenic</td> </tr> <tr> <td class=\"indent1\">Medication side effects (chemotherapy, neuroleptics, etc)</td> </tr> <tr> <td class=\"indent1\">Postsurgical muscular or neurogenic</td> </tr> <tr> <td class=\"indent1\">Radiation</td> </tr> <tr> <td class=\"indent1\">Corrosive (pill injury, intentional)</td> </tr> <tr> <td class=\"subtitle1_single\">Infectious</td> </tr> <tr> <td class=\"indent1\">Mucositis (herpes, cytomegalovirus, Candida, etc)</td> </tr> <tr> <td class=\"indent1\">Diphtheria</td> </tr> <tr> <td class=\"indent1\">Botulism</td> </tr> <tr> <td class=\"indent1\">Lyme disease</td> </tr> <tr> <td class=\"indent1\">Syphilis</td> </tr> <tr> <td class=\"subtitle1_single\">Metabolic</td> </tr> <tr> <td class=\"indent1\">Amyloidosis</td> </tr> <tr> <td class=\"indent1\">Cushing's syndrome</td> </tr> <tr> <td class=\"indent1\">Thyrotoxicosis</td> </tr> <tr> <td class=\"indent1\">Wilson disease</td> </tr> <tr> <td class=\"subtitle1_single\">Myopathic</td> </tr> <tr> <td class=\"indent1\">Connective tissue disease (overlap syndrome)</td> </tr> <tr> <td class=\"indent1\">Dermatomyositis</td> </tr> <tr> <td class=\"indent1\">Myasthenia gravis</td> </tr> <tr> <td class=\"indent1\">Myotonic dystrophy</td> </tr> <tr> <td class=\"indent1\">Oculopharyngeal dystrophy</td> </tr> <tr> <td class=\"indent1\">Polymyositis</td> </tr> <tr> <td class=\"indent1\">Sarcoidosis</td> </tr> <tr> <td class=\"indent1\">Paraneoplastic syndromes</td> </tr> </tbody> </table> </td> <td class=\"container\"> <table cellspacing=\"0\"> <tbody> <tr> <td class=\"subtitle1_single\">Neurological</td> </tr> <tr> <td class=\"indent1\">Brainstem tumors</td> </tr> <tr> <td class=\"indent1\">Head trauma</td> </tr> <tr> <td class=\"indent1\">Stroke</td> </tr> <tr> <td class=\"indent1\">Cerebral palsy</td> </tr> <tr> <td class=\"indent1\">Guillain-Barr&#233; syndrome</td> </tr> <tr> <td class=\"indent1\">Huntington disease</td> </tr> <tr> <td class=\"indent1\">Multiple sclerosis</td> </tr> <tr> <td class=\"indent1\">Polio</td> </tr> <tr> <td class=\"indent1\">Postpolio syndrome</td> </tr> <tr> <td class=\"indent1\">Tardive dyskinesia</td> </tr> <tr> <td class=\"indent1\">Metabolic encephalopathies</td> </tr> <tr> <td class=\"indent1\">Amyotrophic lateral sclerosis</td> </tr> <tr> <td class=\"indent1\">Parkinson disease</td> </tr> <tr> <td class=\"indent1\">Dementia</td> </tr> <tr> <td class=\"subtitle1_single\">Structural</td> </tr> <tr> <td class=\"indent1\">Cricopharyngeal bar</td> </tr> <tr> <td class=\"indent1\">Zenker's diverticulum</td> </tr> <tr> <td class=\"indent1\">Cervical webs</td> </tr> <tr> <td class=\"indent1\">Oropharyngeal tumors</td> </tr> <tr> <td class=\"indent1\">Osteophytes and skeletal abnormalities</td> </tr> <tr> <td class=\"indent1\">Congenital (cleft palate, diverticula, pouches, etc)</td> </tr> </tbody> </table> </td> </tr> </tbody></table></div><div class=\"graphic_reference\">Adapted from: Cook IJ, Kahrilas PJ. AGA: Technical review: Management of oropharyngeal dysphagia. Gastroenterology 1999; 116:455.</div><div id=\"graphicVersion\">Graphic 52707 Version 7.0</div></div></div>"},"52708":{"type":"graphic_figure","displayName":"Neuromuscular disorders impairing gastric motor function","title":"Neuromuscular disorders impairing gastric motor function","html":"<div class=\"graphic\"><div style=\"width: 524px\" class=\"figure\"><div class=\"ttl\">Neuromuscular disorders impairing gastric motor function</div><div class=\"cntnt\"><img style=\"width:504px; height:334px;\" src=\"images/GAST/52708_Neuro_disorders_GI_motility.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Several common neurologic disorders can affect gastrointestinal motility by altering the parasympathetic or sympathetic supply to the gut.</div><div class=\"graphic_footnotes\">X: vagal nuceli; CNS: central nervous system; CVA: cerebrovascular accident; SCG: sympathetic chain ganglia.</div><div class=\"graphic_reference\">Reproduced with permission from: Camilleri M, Prather CM. In: Sleisenger and Fordtran's Gastrointestinal Disease, 6th ed, Feldman M, Scharschmidt BF, Sleisenger MH (Eds),&nbsp;WB Saunders, Philadelphia 1998. p.572.</div><div id=\"graphicVersion\">Graphic 52708 Version 5.0</div></div></div>"},"52710":{"type":"graphic_figure","displayName":"Annular ligament displacement in nursemaids elbow","title":"Annular ligament displacement","html":"<div class=\"graphic\"><div style=\"width: 539px\" class=\"figure\"><div class=\"ttl\">Annular ligament displacement</div><div class=\"cntnt\"><img style=\"width:519px; height:371px;\" src=\"images/PEDS/52710_Annular_ligament_displaceme.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">With sudden traction on the distal radius, the annular ligament partially slips over the head of the radius and slides into the radiohumeral joint, where it becomes trapped.</div><div id=\"graphicVersion\">Graphic 52710 Version 2.0</div></div></div>"},"52714":{"type":"graphic_diagnosticimage","displayName":"Sclerosis in congenital syphilis","title":"Congenital syphilis: Sclerosis","html":"<div class=\"graphic\"><div style=\"width: 524px\" class=\"figure\"><div class=\"ttl\">Congenital syphilis: Sclerosis</div><div class=\"cntnt\"><img style=\"width:504px; height:210px;\" src=\"images/PEDS/52714_Sclerosis_cong_syphilis.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Diffuse sclerosis with transverse bands of lucency (arrows) in the diaphyses of the femurs and tibias.</div><div class=\"graphic_reference\">Reproduced with permission from: Eisenberg RL. An Atlas of Differential Diagnosis, 4th ed. Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright Â© 2003 Lippincott Williams &amp; Wilkins.</div><div id=\"graphicVersion\">Graphic 52714 Version 3.0</div></div></div>"},"52715":{"type":"graphic_table","displayName":"Strategies increase adherence","title":"Psychologic strategies to help patients deal with threats to adherence","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Psychologic strategies to help patients deal with threats to adherence</div><div class=\"cntnt\"><table cellspacing=\"0\">\n\n  <tbody>\n\n    <tr>\n\n      <td> \nCounter-conditioning - Substitute other activities or experiences when\ntempted by cravings or stress (eg, relaxed abdominal breathing when\ndriving in stressful traffic).</td>\n\n    </tr>\n\n    <tr>\n\n      <td> \nStimulus control - Avoid situations that are likely to produce\ntemptations or pressures (eg, avoid lunch with friends who smoke; do\nnot walk by the bakery section in the supermarket).</td>\n\n    </tr>\n\n    <tr>\n\n      <td> \nReinforcement management - Provide yourself with rewards (eg, a movie,\na shopping trip) when you do well at sticking with the desired changes.</td>\n\n    </tr>\n\n\n  </tbody>\n</table></div><div class=\"graphic_reference\">Adapted from Turk, D, Meichenbaum, D. In: Handbook of Clinical Psychology in Medical Settings, Sweet, JJ, Rozensky, RH, Tovian, SM (Eds), Plenum Press, New York, 1991.</div><div id=\"graphicVersion\">Graphic 52715 Version 1.0</div></div></div>"},"52716":{"type":"graphic_figure","displayName":"Infections after allogeneic HCT","title":"Phases of opportunistic infections among allogeneic hematopoietic cell transplant recipients","html":"<div class=\"graphic\"><div style=\"width: 652px\" class=\"figure\"><div class=\"ttl\">Phases of opportunistic infections among allogeneic hematopoietic cell transplant recipients</div><div class=\"cntnt\"><img style=\"width:632px; height:533px;\" src=\"images/ID/52716_Infect_allogeneic_HCT_edt.jpg\" alt=\"Image\"/></div><div class=\"graphic_footnotes\">EBV: Epstein-Barr virus; HHV6: human herpesvirus 6; PTLD: posttransplant lymphoproliferative disease.</div><div class=\"graphic_reference\">Reproduced from: Tomblyn M, Chiller T, Hermann E, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: A global perspective. Biol Blood Marrow Transplant 2009; 15:1143. Illustration used with the permission of Elsevier Inc. All rights reserved.</div><div id=\"graphicVersion\">Graphic 52716 Version 2.0</div></div></div>"},"52718":{"type":"graphic_diagnosticimage","displayName":"Chagas heart disease PA","title":"Chronic Chagas' heart disease","html":"<div class=\"graphic normal\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Chronic Chagas' heart disease</div><div class=\"cntnt\"><img style=\"width:275px; height:282px;\" src=\"images/CARD/52718_Chagas_heart_disease_PA.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Chest&nbsp;radiograph in a patient with chronic Chagas heart disease and New York Heart association class III heart failure shows marked cardiomegaly with virtually no signs of pulmonary congestion.</div><div id=\"graphicVersion\">Graphic 52718 Version 3.0</div></div><div style=\"width: 450px\" class=\"figure\"><div class=\"ttl\">Normal chest radiograph</div><div class=\"cntnt\"><img style=\"width:371px; height:324px;\" src=\"images/PULM/65576_Normal_chest_film_PA.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Posteroanterior view of a normal chest radiograph.</div><div class=\"graphic_reference\">Courtesy of Carol M Black, MD.</div><div id=\"graphicVersion\">Graphic 65576 Version 1.0</div></div></div>"},"52719":{"type":"graphic_table","displayName":"Further evaluation of the patient with selective IgM deficiency","title":"Further evaluation of the patient with selective IgM deficiency","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Further evaluation of the patient with selective IgM deficiency</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1_single\">Other studies of specific antibody production</td> </tr> <tr> <td>Isohemagglutinins (antibody to blood group antigens A and B)</td> </tr> <tr> <td>Response to neoantigens (bacteriophage fX174 or keyhole limpet hemocyanin)*</td> </tr> <tr> <td class=\"subtitle1_single\">Immunoglobulin G subclass levels</td> </tr> <tr> <td>IgG 1, 2, 3, and 4 </td> </tr> <tr> <td class=\"subtitle1_single\">B and T lymphocyte evaluation</td> </tr> <tr> <td class=\"sublist1_start\">Immunophenotyping of B cells*</td> </tr> <tr> <td class=\"sublist1\">CD19+/CD20+/sIgMD+ (immature B cell)</td> </tr> <tr> <td class=\"sublist1\">CD19+/CD20+/sIgMD+/sIgDD+ (mature B cell)</td> </tr> <tr> <td class=\"sublist1\">CD19+/CD20+/sIgMD+/sIgDD+/CD27+ (memory B cell)</td> </tr> <tr> <td class=\"sublist1_start\">In vitro lymphocyte responses*</td> </tr> <tr> <td class=\"sublist1\">B cell proliferation response to SAC</td> </tr> <tr> <td class=\"sublist1\">IgM production by B cells in response to SAC and BCDF</td> </tr> <tr> <td class=\"sublist1\">Suppressor activity of B cells specific for IgM</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">IgM: immunoglobulin M; IgG: immunoglobulin G; sIgMD: selective immunoglobulin M deficiency; sIgDD: selective immunoglobulin D deficiency; SAC: Staphylococcus aureus Cowan strain 1; BCDF: B cell differentiation factor.<br />* May only be available in specialized centers and research laboratories.</div><div id=\"graphicVersion\">Graphic 52719 Version 9.0</div></div></div>"},"52721":{"type":"graphic_diagnosticimage","displayName":"Pleural plaques asbestos PA","title":"Asbestos-related pleural plaques","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Asbestos-related pleural plaques</div><div class=\"cntnt\"><img style=\"width:329px; height:311px;\" src=\"images/PULM/52721_Pleural_plaques_asbestos_PA.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Chest radiograph shows multiple pleural plaques in a shipyard worker exposed to asbestos. These lesions can be mistaken for multiple pulmonary nodules.</div><div class=\"graphic_reference\">Courtesy of Paul Stark, MD</div><div id=\"graphicVersion\">Graphic 52721 Version 3.0</div></div></div>"},"52723":{"type":"graphic_table","displayName":"GI peptide families","title":"Gastrointestinal peptide families","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Gastrointestinal peptide families</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1\">Family</td> <td class=\"subtitle1\">Members</td> </tr> <tr> <td rowspan=\"2\">Gastrin-cholecystokinin family&nbsp;</td> <td>Gastrin</td> </tr> <tr> <td>Cholecystokinin</td> </tr> <tr> <td rowspan=\"7\">Secretin-glucagon family</td> <td>Secretin</td> </tr> <tr> <td>Glucagon</td> </tr> <tr> <td>Vasoactive intestinal polypeptide</td> </tr> <tr> <td>Glucagon-like peptides (GLP-1 and GLP-2)</td> </tr> <tr> <td>Peptide histidine-isoleucine (PHI)</td> </tr> <tr> <td>Glucose-dependent insulinotropic polypeptide (also called gastric inhibitory polypeptide)</td> </tr> <tr> <td>Pituitary adenylate cyclase-activating polypeptide (PACAP)</td> </tr> <tr> <td rowspan=\"3\">Pancreatic polypeptide family</td> <td>Pancreatic polypeptide (PP)</td> </tr> <tr> <td>Neuropeptide Y (NPY)</td> </tr> <tr> <td>Peptide YY (PYY)</td> </tr> <tr> <td rowspan=\"2\">Tachykinin family</td> <td>Substance P</td> </tr> <tr> <td>Substance K</td> </tr> <tr> <td rowspan=\"2\">Bombesin family</td> <td>Neuromedin B</td> </tr> <tr> <td>Gastrin-releasing polypeptide (GRP)</td> </tr> <tr> <td rowspan=\"5\">Opioid family</td> <td>Enkephalin</td> </tr> <tr> <td>Beta-endorphin</td> </tr> <tr> <td>Dynorphin</td> </tr> <tr> <td>Adrenocorticotropic hormone</td> </tr> <tr> <td>Alpha-melanocyte stimulating hormone</td> </tr> <tr> <td rowspan=\"3\">Growth factors</td> <td>Epidermal growth factor</td> </tr> <tr> <td>Transforming growth factor (TGF-alpha, TGF-beta)</td> </tr> <tr> <td>Insulin-like growth factor</td> </tr> <tr> <td rowspan=\"5\">Other peptides</td> <td>Somatostatin</td> </tr> <tr> <td>Motilin</td> </tr> <tr> <td>Neurotensin</td> </tr> <tr> <td>Galanin</td> </tr> <tr> <td>Endothelin</td> </tr> </tbody></table></div><div id=\"graphicVersion\">Graphic 52723 Version 2.0</div></div></div>"},"52724":{"type":"graphic_algorithm","displayName":"Management of low bone mass in patients with liver disease","title":"Management of low bone mass in patients with liver disease","html":"<div class=\"graphic\"><div style=\"width: 778px\" class=\"figure\"><div class=\"ttl\">Management of low bone mass in patients with liver disease</div><div class=\"cntnt\"><img style=\"width:758px; height:293px;\" src=\"images/GAST/52724_Mgmtosteoporosisliverdz.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Refer to UpToDate content on Evaluation and treatment of low bone mass in patients with primary biliary cholangitis (primary biliary cirrhosis)</div><div class=\"graphic_footnotes\">DXA: dual-energy x-ray absorptiometry; BMD: bone mineral density<br />* Risk factors for fracture include advancing age, tobacco use, significant alcohol consumption, low body weight, and early menopause.<br />Â¶ Laboratory screen for other causes of low BMD: complete blood count, serum calcium, alkaline phosphatase, creatinine, 25-OH vitamin D, protein electrophoresis, and testosterone (in men).</div><div class=\"graphic_reference\">Original figure modified for this publication. Leslie WD, Bernstein CN, Leboff MS. AGA technical review on osteoporosis in hepatic disorders. Gastroenterology 2003; 125:941. Illustration used with the permission of Elsevier Inc. All rights reserved.</div><div id=\"graphicVersion\">Graphic 52724 Version 4.0</div></div></div>"},"52727":{"type":"graphic_figure","displayName":"Laparoscopic cholecystectomy","title":"Laparoscopic cholecystectomy","html":"<div class=\"graphic\"><div style=\"width: 514px\" class=\"figure\"><div class=\"ttl\">Laparoscopic cholecystectomy</div><div class=\"cntnt\"><img style=\"width:494px; height:706px;\" src=\"images/SURG/52727_Lap_cholecystectomy.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">(A) Port placement.<br> (B) Initial retraction of gallbladder.<br> (C) Critical view of safety.<br> (D) Clipping and division of cystic artery and duct.<br> (E) Dissection of gallbladder from liver bed.<br> (F) Extraction of gallbladder.</div><div id=\"graphicVersion\">Graphic 52727 Version 3.0</div></div></div>"},"52728":{"type":"graphic_picture","displayName":"Russells sign","title":"Russell's sign","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Russell's sign</div><div class=\"cntnt\"><img style=\"width:432px; height:287px;\" src=\"images/PSYCH/52728_Russells_sign.jpg\" alt=\"Image\"/></div><div class=\"graphic_reference\">Reproduced with permission from: Strumia R. Dermatologic signs in patients with eating disorders. Am J Clin Dermatol 2005; 6:165. Copyright &#169; 2005 Wolters Kluwer Health.</div><div id=\"graphicVersion\">Graphic 52728 Version 2.0</div></div></div>"},"52729":{"type":"graphic_picture","displayName":"Secondary syphilis - tongue","title":"Secondary syphilis","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Secondary syphilis</div><div class=\"cntnt\"><img style=\"width:324px; height:432px;\" src=\"images/DERM/52729_Sec_syphilis_tongue.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Multiple erosions (mucous patches) are present on the tongue in this patient with secondary syphilis.</div><div class=\"graphic_reference\">Reproduced with permission from: <A style=\"FONT-STYLE: italic\" href=\"http://www.visualdx.com/\" target=_blank>www.visualdx.com</A>. Copyright Logical Images, Inc.</div><div id=\"graphicVersion\">Graphic 52729 Version 3.0</div></div></div>"},"52730":{"type":"graphic_figure","displayName":"Carotid endarterectomy PI","title":"Carotid artery surgery (endarterectomy)","html":"<div class=\"graphic\"><div style=\"width: 502px\" class=\"figure\"><div class=\"ttl\">Carotid artery surgery (endarterectomy)</div><div class=\"cntnt\"><img style=\"width:482px; height:594px;\" src=\"images/PI/52730_Carotid_endarterectomy_PI.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">During carotid artery surgery, also called &quot;endarterectomy,&quot; the doctor clamps the carotid artery above and below the area that has plaque. Then the doctor cuts open the artery and removes the plaque. Next, he or she sews the artery back together and unclamps the artery.</div><div class=\"graphic_reference\">Reproduced from: What To Expect During Carotid Endarterectomy. Diseases and Conditions Index. National Heart Lung and Blood Institute. <a href=\"http://www.nhlbi.nih.gov/health/dci/Diseases/carend/carend_during.html\">http://www.nhlbi.nih.gov/health/dci/Diseases/carend/carend_during.html</a> (Accessed December 3, 2010).</div><div id=\"graphicVersion\">Graphic 52730 Version 4.0</div></div></div>"},"52731":{"type":"graphic_picture","displayName":"Amanita bisporigera-Destroying angel","title":"Amanita bisporigera (\"Destroying angel\")","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Amanita bisporigera (\"Destroying angel\")</div><div class=\"cntnt\"><img style=\"width:324px; height:432px;\" src=\"images/EM/52731_Amanita_bisporigera.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">These&nbsp;tall white to light-tan mushrooms contain cyclopeptides that can cause life-threatening delayed liver toxicity when ingested. They are also sometimes called the \"destroying angel\". This common name is also&nbsp;used to describe&nbsp;three other toxic white Amanita species: A. ocreata, A. virosa and A. verna.</div><div class=\"graphic_reference\">Courtesy of William Hollenbaugh.</div><div id=\"graphicVersion\">Graphic 52731 Version 5.0</div></div></div>"},"52732":{"type":"graphic_picture","displayName":"Patulous dysfunction","title":"Patulous dysfunction (chronic patency of the eustachian tube)","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Patulous dysfunction (chronic patency of the eustachian tube)</div><div class=\"cntnt\"><img style=\"width:329px; height:429px;\" src=\"images/PC/52732_Pat_dys_eus_tube_edt.jpg\" alt=\"Image\"/></div><div id=\"graphicVersion\">Graphic 52732 Version 2.0</div></div></div>"},"52733":{"type":"graphic_picture","displayName":"Acute paracoccoci","title":"Manifestations of acute paracoccidioidomycosis","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Manifestations of acute paracoccidioidomycosis</div><div class=\"cntnt\"><img style=\"width:325px; height:432px;\" src=\"images/ID/52733_Acute_paracocci.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Children presenting with acute paracoccidioidomycosis. (A) Abscesses on the forehead and clavicular region resulting in osteoarticular involvement. (B) Girl presenting with abscess formation originating in the lymph nodes. (C) Inguinal lymphadenopathy. (D) Abdominal lymphadenopathy with ascites and hepatosplenomegaly.</div><div class=\"graphic_reference\">Reproduced with permission from: Shikanai-Yasuda MA, Queiroz Telles Filho F, Mendes RP, et al. Consenso em paracoccidioidomicose [Guidelines in paracoccidioidomycosis]. Revista da Sociedade Brasileira de Medicina Tropical 2006; 39:297-310. Copyright Â©2006 Sociedade Brasileira de Medicina Tropical.</div><div id=\"graphicVersion\">Graphic 52733 Version 3.0</div></div></div>"},"52734":{"type":"graphic_figure","displayName":"Japanese encephaliltis map","title":"Geographic distribution of Japanese encephalitis","html":"<div class=\"graphic\"><div style=\"width: 953px\" class=\"figure\"><div class=\"ttl\">Geographic distribution of Japanese encephalitis</div><div class=\"cntnt\"><img style=\"width:933px; height:635px;\" src=\"images/ID/52734_Japanese_encephallts_mp_Ed1.jpg\" alt=\"Image\"/></div><div class=\"graphic_reference\">Reproduced from: The Centers for Disease Control and Prevention and Brunette, GW (Ed). CDC Health Information for International Travel 2018. Oxford University Press, New York, 2017.</div><div id=\"graphicVersion\">Graphic 52734 Version 3.0</div></div></div>"},"52737":{"type":"graphic_table","displayName":"Desirable clinician behaviors","title":"Desirable clinician behaviors","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Desirable clinician behaviors</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1\">&nbsp;</td> <td class=\"subtitle1\">Getting the visit off to a good start</td> <td class=\"subtitle1\">Finding out what the problem is</td> <td class=\"subtitle1\">Talking about problem/what to do about it</td> <td class=\"subtitle1\">Following up on problem and treatment</td> </tr> <tr> <td rowspan=\"2\">Professionalism</td> <td>Appearance</td> <td>Preparation by clinician</td> <td>Clear/complete explanations</td> <td>Providing access and coverage</td> </tr> <tr> <td>Carry-over from previous patients</td> <td>Limit interruptions</td> <td>Clinician knows limitations</td> <td>Following through</td> </tr> <tr> <td rowspan=\"2\">Respect</td> <td>Punctuality</td> <td>Listens and understands</td> <td>Involves patient in treatment</td> <td>Involves patient in management</td> </tr> <tr> <td>Treats like an equal</td> <td>Explains exam</td> <td>Honesty</td> <td>Conscious of financial situations</td> </tr> <tr> <td rowspan=\"2\">Support</td> <td>Courtesy</td> <td>Takes complaints seriously</td> <td>Taking time to talk</td> <td>Checks on patients at home</td> </tr> <tr> <td>Relaxed atmosphere</td> <td>Concerned about daily life</td> <td>Encourages questions</td> <td>Checks on what patient should be doing</td> </tr> </tbody></table></div><div id=\"graphicVersion\">Graphic 52737 Version 2.0</div></div></div>"},"52738":{"type":"graphic_picture","displayName":"Moisture chambers use","title":"Moisture chamber in use","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Moisture chamber in use</div><div class=\"cntnt\"><img style=\"width:400px; height:352px;\" src=\"images/PC/52738_Moisture_chambers_use.jpg\" alt=\"Image\"/></div><div id=\"graphicVersion\">Graphic 52738 Version 1.0</div></div></div>"},"52740":{"type":"graphic_picture","displayName":"Interstitial keratitis in congenital syphilis","title":"Congenital syphilis: Interstitial keratitis","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Congenital syphilis: Interstitial keratitis</div><div class=\"cntnt\"><img style=\"width:432px; height:291px;\" src=\"images/PEDS/52740_Inter_kerat_cong_syphilis.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">This photograph shows a stromal haze in both eyes of this child due to interstitial keratitis, a manifestation of late congenital syphilis. Interstitial keratitis is an inflammation of the connective tissue structure of the cornea. It usually is bilateral.</div><div class=\"graphic_reference\">Reproduced from: the Public Health Image Library, Centers for Disease Control and Prevention. Photo by Susan Lindsley.</div><div id=\"graphicVersion\">Graphic 52740 Version 2.0</div></div></div>"},"52741":{"type":"graphic_movie","displayName":"Anechoic and complex pleural effusions","title":"Anechoic and complex pleural effusions","html":"<div class=\"graphic normal\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Anechoic and complex pleural effusions</div><div class=\"cntnt\"><div class=\"videoplayer\" h264=\"images/PULM/52741_Anechoiccomplexeffconv.mp4\" style=\"width:320px;height:256px\"></div><img style=\"width:442px; height:363px;\" src=\"images/PULM/52741_Anechoiccomplexeff.jpg\" alt=\"Image\"/></div><div id=\"graphicVersion\">Graphic 52741 Version 2.0</div></div></div>"},"52742":{"type":"graphic_picture","displayName":"Opisthorchiasis egg","title":"Opisthorchiasis egg","html":"<div class=\"graphic\"><div style=\"width: 570px\" class=\"figure\"><div class=\"ttl\">Opisthorchiasis egg</div><div class=\"cntnt\"><img style=\"width:550px; height:309px;\" src=\"images/ID/52742_Opisthorchiasis_egg.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">(A, B) Eggs of <em>O. viverrini</em> in an unstained wet mount of concentrated stool. Images taken at 400x magnification.</div><div class=\"graphic_reference\">Reproduced from: Centers for Disease Control and Prevention. DPDx: Opisthorchiasis. Available at: <a href=\"http://www.cdc.gov/dpdx/opisthorchiasis\" target=\"_blank\">http://www.cdc.gov/dpdx/opisthorchiasis</a>.</div><div id=\"graphicVersion\">Graphic 52742 Version 6.0</div></div></div>"},"52743":{"type":"graphic_figure","displayName":"Internal nasal exam","title":"Internal examination of the nose","html":"<div class=\"graphic\"><div style=\"width: 499px\" class=\"figure\"><div class=\"ttl\">Internal examination of the nose</div><div class=\"cntnt\"><img style=\"width:479px; height:293px;\" src=\"images/ALLRG/52743_Internal_nasal_exam.jpg\" alt=\"Image\"/></div><div id=\"graphicVersion\">Graphic 52743 Version 2.0</div></div></div>"},"52744":{"type":"graphic_table","displayName":"Medications for adult procedural sedation","title":"Intravenous procedural sedation medications for adults*","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Intravenous procedural sedation medications for adults*</div><div class=\"cntnt\"><table  cellspacing=\"0\">\r\n \r\n   <tr>\r\n  \r\n   <td  class=\"subtitle1\">\r\n  \r\n   Medication\r\n  \r\n   </td>\r\n  \r\n   <td  class=\"subtitle1\">\r\n  \r\n   Initial dose\r\n  \r\n   </td>\r\n  \r\n   <td  class=\"subtitle1\">\r\n  \r\n   Onset (minutes)\r\n  \r\n   </td>\r\n  \r\n   <td  class=\"subtitle1\">\r\n  \r\n   Duration (minutes)\r\n  \r\n   </td>\r\n  \r\n   <td  class=\"subtitle1\">\r\n  \r\n   Repeat dose (as necessary)\r\n  \r\n   </td>\r\n  \r\n   <td  class=\"subtitle1\">\r\n  \r\n   Comments\r\n  \r\n   </td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Midazolam</td>\r\n  \r\n   <td>0.02 to 0.03 mg/kg over 2 to 3 minutes; maximum 2.5 mg (1.5 mg maximum if elderly)</td>\r\n  \r\n   <td>1 to 2.5</td>\r\n  \r\n   <td>10 to 40</td>\r\n  \r\n   <td>May repeat after 2 to 5 minutes</td>\r\n  \r\n   <td>\t<p>Sedative and anxiolytic. No analgesia. </p>\n\t<p> \t Relatively slow onset; requires more gradual initiation. </p>\n\t<p> \t Prolonged effect or delayed recovery in elderly, obese, or impaired hepatic function.</p>\n\t<p> \t  Use reduced dose in combination with other agents.</p>\n</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Methohexital</td>\r\n  \r\n   <td>0.75 to 1 mg/kg</td>\r\n  \r\n   <td>1</td>\r\n  \r\n   <td>10</td>\r\n  \r\n   <td>0.5 mg/kg every 2 to 5 minutes</td>\r\n  \r\n   <td>\t<p>Sedative and amnestic. No analgesia.</p>\n\t<p> \t  Cardiorespiratory depression, hypotension, tachycardia can occur. </p>\n\t<p> \t Can precipitate or worsen seizures.</p>\n</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Etomidate</td>\r\n  \r\n   <td>0.1 to 0.15 mg/kg</td>\r\n  \r\n   <td>5 to 15 seconds</td>\r\n  \r\n   <td>5 to 15</td>\r\n  \r\n   <td>0.05 mg/kg every 3 to 5 minutes</td>\r\n  \r\n   <td>\t<p>Sedative. No analgesia. </p>\n\t<p> \t Generally maintains cardiorespiratory stability. </p>\n\t<p> \t Elderly or renal/hepatic insufficiency: use lower dose range. </p>\n\t<p> \t Myoclonus, injection site pain, nausea/vomiting may occur.</p>\n</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Fentanyl</td>\r\n  \r\n   <td>0.5 to 1 mcg/kg</td>\r\n  \r\n   <td>2 to 3</td>\r\n  \r\n   <td>30 to 60</td>\r\n  \r\n   <td>0.5 mcg/kg every 2 minutes</td>\r\n  \r\n   <td>\t<p>Analgesic. No amnesia. </p>\n\t<p> \t Minimal hypotension and histamine release. </p>\n\t<p> \t Use reduced dose in combination with other agents.</p>\n</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Ketamine</td>\r\n  \r\n   <td>1 to 2 mg/kg over 1 to 2 minutes</td>\r\n  \r\n   <td>0.5</td>\r\n  \r\n   <td>5 to 20</td>\r\n  \r\n   <td>0.25 to 0.5 mg/kg every 5 to 10 minutes</td>\r\n  \r\n   <td>\t<p>Dissociative sedative, analgesic, and amnestic. </p>\n\t<p> \t Minimal cardiorespiratory depression.</p>\n\t<p> \t  Does not inhibit protective reflexes.</p>\n\t<p> \t  Sympathetic stimulation, tachycardia, hypertension may occur (rare).</p>\n\t<p> \t  Emergence reactions common in adults. Nausea and vomiting may occur. </p>\n\t<p> \t  Prolonged effect in elderly.</p>\n</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td>Propofol</td>\r\n  \r\n   <td>0.5 to 1 mg/kg</td>\r\n  \r\n   <td>0.5</td>\r\n  \r\n   <td>5</td>\r\n  \r\n   <td>0.5 mg/kg every 3 to 5 minutes</td>\r\n  \r\n   <td>\t<p>Sedative and amnestic. No analgesia. </p>\n\t<p> \t Rapid onset and neurological recovery.</p>\n\t<p> \t  Respiratory depression, hypotension, injection site pain may occur. </p>\n\t<p> \t Elderly: reduce dose by 20 percent, slower administration.</p>\n\t<p> \t  Contains egg lecithin, soybean oil (potential allergens)</p>\n</td>\r\n  \r\n   </tr>\r\n </table></div><div class=\"graphic_footnotes\">* Elderly patients are at increased risk of adverse events with these agents and dosing should be adjusted accordingly. See text for details.</div><div class=\"graphic_reference\">Data from: Gan, TJ Pharmacokinetic and pharmacodynamic characteristics of medications used for moderate sedation. Clin Pharmacokinet 2006;45(9):855-869. Falk, J, Zed, P, Etomidate for procedural sedation in the emergency department. Ann Pharmacother 2004;38:1272-7.</div><div id=\"graphicVersion\">Graphic 52744 Version 2.0</div></div></div>"},"52746":{"type":"graphic_picture","displayName":"Pneumococcal adherence EM","title":"Pneumococcal adherence","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Pneumococcal adherence</div><div class=\"cntnt\"><img style=\"width:308px; height:270px;\" src=\"images/ID/52746_Pneumococcal_adherence_EM.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Scanning electron micrograph of a pneumococcus attaching to a human lung cell. Pneumococci rarely make pili or fimbriae in order to adhere to cells. Rather, they decorate their cell wall with proteins that bind to human cell carbohydrates or the receptor for platelet activating factor, creating direct contact between the bacteria and the host cell over a large area.</div><div class=\"graphic_reference\">Courtesy of Elaine Tuomanen, MD.</div><div id=\"graphicVersion\">Graphic 52746 Version 1.0</div></div></div>"},"52747":{"type":"graphic_picture","displayName":"Urea slant Shigella v Proteus","title":"Shigella versus urease positive gram-negative rods on urea slant","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Shigella versus urease positive gram-negative rods on urea slant</div><div class=\"cntnt\"><img style=\"width:258px; height:248px;\" src=\"images/ID/52747_Urea_slant_Shigella_v_Prote.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Urea slant shows the positive (pink) and negative (yellow) reactions that differentiate Proteus (left) from Shigella (right).</div><div class=\"graphic_reference\">Courtesy of Michael S Glickman, MD.</div><div id=\"graphicVersion\">Graphic 52747 Version 2.0</div></div></div>"},"52748":{"type":"graphic_movie","displayName":"Echo parasternal long axis post MI MR","title":"Echocardiogram parasternal long axis post MI mitral regurgitation ","html":"<div class=\"graphic normal\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Echocardiogram parasternal long axis post MI mitral regurgitation </div><div class=\"cntnt\"><div class=\"videoplayer\" h264=\"images/CARD/52748_palaxmrpconv.mp4\" style=\"width:320px;height:256px\"></div><img style=\"width:244px; height:410px;\" src=\"images/CARD/52748_palaxmrp.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The parasternal long axis view shows an immobile posterior mitral valve leaflet, a result of a previous inferior wall myocardial infarction and papillary muscle dysfunction. The left atrium is enlarged, suggesting the presence of mitral regurgitation.</div><div class=\"graphic_reference\">Courtesy of Thomas Binder, MD. University of Vienna.</div><div id=\"graphicVersion\">Graphic 52748 Version 3.0</div></div></div>"},"52751":{"type":"graphic_table","displayName":"Insulin to carb ratio","title":"Insulin-to-carbohydrate ratio calculation","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Insulin-to-carbohydrate ratio calculation</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1\">Weight, lbs</td> <td class=\"subtitle1\">Ratio</td> </tr> <tr> <td>120 to 129</td> <td>1:15</td> </tr> <tr> <td>130 to 139</td> <td>1:14</td> </tr> <tr> <td>140 to 149</td> <td>1:13</td> </tr> <tr> <td>150 to 169</td> <td>1:12</td> </tr> <tr> <td>170 to 179</td> <td>1:11</td> </tr> <tr> <td>180 to 189</td> <td>1:10</td> </tr> <tr> <td>190 to 199</td> <td>1:9</td> </tr> <tr> <td>&#62;200</td> <td>1:8</td> </tr> </tbody></table></div><div id=\"graphicVersion\">Graphic 52751 Version 3.0</div></div></div>"},"52752":{"type":"graphic_figure","displayName":"Left phrenic nerve course","title":"Course of the left phrenic nerve","html":"<div class=\"graphic\"><div style=\"width: 543px\" class=\"figure\"><div class=\"ttl\">Course of the left phrenic nerve</div><div class=\"cntnt\"><img style=\"width:523px; height:604px;\" src=\"images/SURG/52752_Left-phrenic-nerve-course.jpg\" alt=\"Image\"/></div><div id=\"graphicVersion\">Graphic 52752 Version 1.0</div></div></div>"},"52754":{"type":"graphic_diagnosticimage","displayName":"Angiodysplasia colon angio","title":"Angiodysplasia of the colon","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Angiodysplasia of the colon</div><div class=\"cntnt\"><img style=\"width:294px; height:288px;\" src=\"images/GAST/52754_Angiodysplasia_colon_Angio.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">A superior mesenteric arteriogram demonstrates puddling of contrast material in tortuous distended vessels in the cecal wall (arrows).</div><div class=\"graphic_reference\">Courtesy of Jonathan Kruskal, MD.</div><div id=\"graphicVersion\">Graphic 52754 Version 3.0</div></div></div>"},"52756":{"type":"graphic_figure","displayName":"Folate pathway MTX","title":"Folate pathway with sites of action of methotrexate (MTX) and leucovorin","html":"<div class=\"graphic\"><div style=\"width: 558px\" class=\"figure\"><div class=\"ttl\">Folate pathway with sites of action of methotrexate (MTX) and leucovorin</div><div class=\"cntnt\"><img style=\"width:538px; height:572px;\" src=\"images/ONC/52756_Folate_pathway_MTX.jpg\" alt=\"Image\"/></div><div id=\"graphicVersion\">Graphic 52756 Version 2.0</div></div></div>"},"52758":{"type":"graphic_figure","displayName":"Bronchiolitis anatomy PI","title":"Bronchiolitis","html":"<div class=\"graphic\"><div style=\"width: 560px\" class=\"figure\"><div class=\"ttl\">Bronchiolitis</div><div class=\"cntnt\"><img style=\"width:540px; height:484px;\" src=\"images/PI/52758_Bronchiolitis_anatomy_PI.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Bronchiolitis is an infection that affects the small tubes that carry air in and out of the lungs. When infected, these tubes (called bronchioles) get swollen and inflamed. That makes it harder to breathe.</div><div id=\"graphicVersion\">Graphic 52758 Version 4.0</div></div></div>"},"52760":{"type":"graphic_table","displayName":"Healthy sleep practices for children","title":"Healthy sleep practices for children","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Healthy sleep practices for children</div><div class=\"cntnt\"><table  cellspacing=\"0\">\n   <tr>\n   <td>1. Have a set bedtime and bedtime routine for your child.</td>\n   </tr>\n   <tr>\n   <td>2. Bedtime and wake-up time should be about the same time on school nights and non-school nights. There should not be more than about an hour difference from one day to another.</td>\n   </tr>\n   <tr>\n   <td>3. Make the hour before bed shared quiet time. Avoid high-energy activities, such as rough play, and stimulating activities, such as watching television or playing computer games, just before bed.</td>\n   </tr>\n   <tr>\n   <td>4. Don't send your child to bed hungry. A light snack (such as milk and cookies) before bed is a good idea. Heavy meals within an hour or two of bedtime, however, may interfere with sleep.</td>\n   </tr>\n   <tr>\n   <td>5. Avoid products containing caffeine for at least several hours before bedtime. These include caffeinated sodas, coffee, tea, and chocolate.</td>\n   </tr>\n   <tr>\n   <td>6. Make sure your child spends time outside every day whenever possible and is involved in regular exercise.</td>\n   </tr>\n   <tr>\n   <td>7. Keep your child's bedroom quiet and dark. A low-level night light is acceptable for children who find completely dark rooms frightening.</td>\n   </tr>\n   <tr>\n   <td>8. Keep your child's bedroom at a comfortable temperature during the night (about 75&#176;F).</td>\n   </tr>\n   <tr>\n   <td>9. Don't use your child's bedroom for time-out or punishment.</td>\n   </tr>\n   <tr>\n   <td>10. Keep the television set out of your child's bedroom. Children can easily develop the bad habit of \"needing\" the television to fall asleep. It's also much more difficult to control your child's viewing if the set is in the bedroom.</td>\n   </tr>\n </table></div><div class=\"graphic_reference\">Source: Owens J, Mindell J. Sleep Hygiene: Healthy Sleep Habits for Children and Adolescents. In: A Clinical Guide to Pediatric Sleep, 2nd ed, Lippincott, Williams &amp; Wilkins, Philadelphia 2010.</div><div id=\"graphicVersion\">Graphic 52760 Version 3.0</div></div></div>"},"52761":{"type":"graphic_table","displayName":"Congenital pancreatic anomalies","title":"Anatomic categorization of congenital pancreatic anomalies and variants","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Anatomic categorization of congenital pancreatic anomalies and variants</div><div class=\"cntnt\"><table cellspacing=\"0\">\n\n  <tbody>\n\n\n    <tr>\n\n      <td class=\"sublist1_start\">Ventral/dorsal ductal malfusion</td>\n\n    </tr>\n\n    <tr>\n\n      <td class=\"sublist1\">1. Pancreas divisum</td>\n\n    </tr>\n\n    <tr>\n      <td class=\"sublist1\">2. Incomplete pancreas divisum </td>\n    </tr>\n    <tr>\n      <td class=\"sublist1\">3. Isolated dorsal segment</td>\n    </tr>\n    <tr>\n\n      <td class=\"sublist1_start\">Rotation or migration problems</td>\n\n    </tr>\n\n    <tr>\n\n      <td class=\"sublist1\">1. Annular pancreas</td>\n\n    </tr>\n\n    <tr>\n      <td class=\"sublist1\">2. Ectopic pancreas</td>\n    </tr>\n    <tr>\n      <td class=\"sublist1\">3. Ectopic papillae</td>\n    </tr>\n    <tr>\n\n      <td>Agenesis or hypoplasia</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Ductal duplication</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Atypical ductal configuration</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Anomalous pancreatobiliary ductal junction</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Cystic malformations</td>\n\n    </tr>\n\n  </tbody>\n</table></div><div id=\"graphicVersion\">Graphic 52761 Version 1.0</div></div></div>"},"52763":{"type":"graphic_waveform","displayName":"Basic case 8 with answer","title":"Atrial flutter","html":"<div class=\"graphic\"><div style=\"width: 540px\" class=\"figure\"><div class=\"ttl\">Atrial flutter</div><div class=\"cntnt\"><img style=\"width:520px; height:112px;\" src=\"images/CARD/52763_Basic_case_8_with_answer.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Atrial flutter (at an atrial rate of approximately 240 beats/min) with a variable degree of atrioventricular block. The typical flutter (F) waves have a uniform, sawtooth appearance and occur at regular intervals which distinguish them from irregular fibrillatory waves in atrial fibrillation.</div><div class=\"graphic_reference\">Courtesy of Ary Goldberger, MD.</div><div id=\"graphicVersion\">Graphic 52763 Version 2.0</div></div></div>"},"52765":{"type":"graphic_table","displayName":"Causes of lumbosacral plexopathy","title":"Causes of lumbosacral plexopathy","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Causes of lumbosacral plexopathy</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td>Diabetic amyotrophy (diabetic lumbosacral radiculoplexus neuropathy)</td> </tr> <tr> <td>Idiopathic lumbosacral radiculoplexus neuropathy</td> </tr> <tr> <td>Primary neoplastic invasion/compression</td> </tr> <tr> <td>Metastatic cancer</td> </tr> <tr> <td>Benign neoplasms</td> </tr> <tr> <td>Radiation plexopathy</td> </tr> <tr> <td>Ischemic plexopathy</td> </tr> <tr> <td>Postoperative plexopathy</td> </tr> <tr> <td>Retroperitoneal hematoma</td> </tr> <tr> <td>Arterial (pseudo) aneurysm</td> </tr> <tr> <td>Trauma</td> </tr> <tr> <td>Obstetric (antepartum, intrapartum, postpartum)</td> </tr> <tr> <td>Vasculitides</td> </tr> <tr> <td>Connective tissue disorders</td> </tr> <tr> <td>Sarcoidosis</td> </tr> <tr> <td>Amyloidosis</td> </tr> <tr> <td>Infection (eg, human immunodeficiency virus, Epstein-Barr virus, cytomegalovirus, varicella zoster virus, Lyme disease, syphilis)</td> </tr> <tr> <td>Abscess (eg, tuberculosis, salmonella)</td> </tr> <tr> <td>Heroin injection</td> </tr> </tbody></table></div><div id=\"graphicVersion\">Graphic 52765 Version 3.0</div></div></div>"},"52767":{"type":"graphic_diagnosticimage","displayName":"Ultrasound of appendicitis child","title":"Ultrasound of appendicitis in a child","html":"<div class=\"graphic\"><div style=\"width: 534px\" class=\"figure\"><div class=\"ttl\">Ultrasound of appendicitis in a child</div><div class=\"cntnt\"><img style=\"width:514px; height:526px;\" src=\"images/EM/52767_US_of_appendicitis.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Saggital (A) and transverse (B) ultrasound images of the right lower quadrant in a four-year-old boy with fever, leucocytosis and acute right lower quadrant pain show an enlarged (8 mm), fluid filled, blind ending tubular structure surrounded by brightly echogenic, edematous mesenteric fat (arrows).</div><div class=\"graphic_reference\">Courtesy of George A Taylor, MD.</div><div id=\"graphicVersion\">Graphic 52767 Version 7.0</div></div></div>"},"52768":{"type":"graphic_diagnosticimage","displayName":"Pseudofractures in osteomalacia","title":"Pseudofractures in osteomalacia","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Pseudofractures in osteomalacia</div><div class=\"cntnt\"><img style=\"width:436px; height:598px;\" src=\"images/ENDO/52768_Pseudofractures_in_osteomal.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">(A and B) Plain film images of Looser-Milkman pseudofractures of the pelvis and the left femoral neck (arrows) in a patient with osteomalacia.<br />(C) CT of the pubic symphysis from a patient with osteomalacia. There is a pseudofracture (white arrow) in the superior pubic ramus on the right.</div><div class=\"graphic_footnotes\">CT: computed tomography.</div><div class=\"graphic_reference\">A and B courtesy of CJ Menkes, MD.</div><div id=\"graphicVersion\">Graphic 52768 Version 5.0</div></div></div>"},"52769":{"type":"graphic_table","displayName":"IDUS versus ERCP","title":"Performance characteristics of intraductal ultrasound (IDUS) versus endoscopic retrograde cholangiopancreatography (ERCP) with and without tissue sampling","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Performance characteristics of intraductal ultrasound (IDUS) versus endoscopic retrograde cholangiopancreatography (ERCP) with and without tissue sampling</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup span=\"4\" width=\"25%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\">&nbsp;</td> <td class=\"subtitle1\">Sensitivity (percent)</td> <td class=\"subtitle1\">Specificity (percent)</td> <td class=\"subtitle1\">Accuracy (percent)</td> </tr> <tr> <td><strong>ERCP</strong></td> <td>83</td> <td>42</td> <td>67*</td> </tr> <tr> <td><strong>Tissue sampling</strong></td> <td>50</td> <td>100</td> <td>68<sup>&#182;</sup></td> </tr> <tr> <td><strong>ERCP &#38; tissue sampling</strong></td> <td>83</td> <td>42</td> <td>67<sup>&#916;</sup></td> </tr> <tr> <td><strong>IDUS</strong></td> <td>89</td> <td>92</td> <td>90</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">* p&lt;0.02 vs IDUS.<br />&para; p&lt;0.03 vs IDUS.<br />&Delta; p&lt;0.02 vs IDUS.</div><div class=\"graphic_reference\">Data from: Vazquez-Sequeiros E, Baron TH, Clain JE, et al. Evaluation of indeterminate bile duct strictures by intraductal US. Gastrointest Endosc 2002; 56:372.</div><div id=\"graphicVersion\">Graphic 52769 Version 5.0</div></div></div>"},"52770":{"type":"graphic_diagnosticimage","displayName":"Intradecidual sign","title":"Intradecidual sign","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Intradecidual sign</div><div class=\"cntnt\"><img style=\"width:354px; height:463px;\" src=\"images/OBGYN/52770_Intradecidual_sign.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">A) Sagittal and B) transverse views of the endometrial cavity. There is an eccentrically located fluid collection abutting the endometrium with echogenic rim (arrowhead) representing the intradecidual sign.</div><div class=\"graphic_reference\">Courtesy of Tejas S Mehta, MD, MPH.</div><div id=\"graphicVersion\">Graphic 52770 Version 2.0</div></div></div>"},"52771":{"type":"graphic_picture","displayName":"Heart in chronic Chagas disease","title":"Heart in chronic Chagas disease","html":"<div class=\"graphic\"><div style=\"width: 571px\" class=\"figure\"><div class=\"ttl\">Heart in chronic Chagas disease</div><div class=\"cntnt\"><img style=\"width:551px; height:261px;\" src=\"images/CARD/52771_Heart_in_chronic_Chagas_dis.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Longitudinal coronal section of the heart at autopsy (left panel) reveals a typical apical aneurysm; moderate dilation of both ventricles without significant thinning of the left ventricular wall is also found. In the right panel, a closeup of the apical aneurysm shows virtual apposition of endocardium to epicardium.</div><div class=\"graphic_reference\">Courtesy of Jo&#227;o Samuel Meira Oliveira, MD.</div><div id=\"graphicVersion\">Graphic 52771 Version 1.0</div></div></div>"},"52772":{"type":"graphic_table","displayName":"Gene defects renal malformation","title":"Human gene mutations associated with defects in renal morphogenesis","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Human gene mutations associated with defects in renal morphogenesis</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup span=\"3\" width=\"33%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\">Primary disease</td> <td class=\"subtitle1\">Gene</td> <td class=\"subtitle1\">Kidney phenotype</td> </tr> <tr> <td>Alagille syndrome</td> <td><em>JAGGED1</em><em>, </em><em>NOTCH2</em></td> <td>Cystic dysplasia</td> </tr> <tr> <td>Apert syndrome</td> <td><em>FGFR2</em></td> <td>Hydronephrosis</td> </tr> <tr> <td>Bardet-Biedl syndrome</td> <td><em>BBS1</em></td> <td>Cystic dysplasia</td> </tr> <tr> <td>Beckwith-Wiedemann syndrome</td> <td>Dysregulation of imprinting in chromosome 11p15.5</td> <td>Medullary dysplasia</td> </tr> <tr> <td>Branchio-Oto-Renal syndrome (BOR)</td> <td><em>EYA1, SIX1, SIX5</em></td> <td>Unilateral/bilateral agenesis/dysplasia, hypoplasia, collecting system anomalies</td> </tr> <tr> <td>Campomelic dysplasia</td> <td><em>SOX9</em></td> <td>Dysplasia, hydronephrosis</td> </tr> <tr> <td>Cenani-Lenz syndrome</td> <td><em>LRP4</em></td> <td>Agenesis, UPJO</td> </tr> <tr> <td>DiGeorge syndrome</td> <td>22q11.2 deletions </td> <td>Agenesis, dysplasia</td> </tr> <tr> <td>Fraser syndrome</td> <td><em>FRAS1</em><em>, FREM2, GRIP1</em></td> <td>Agenesis, dysplasia</td> </tr> <tr> <td>Hypoparathyroidism, sensorineural deafness, and renal anomalies (HDR)</td> <td><em>GATA3</em></td> <td>Dysplasia</td> </tr> <tr> <td>Kallmann syndrome</td> <td><em>KAL1, SEMA3A</em></td> <td>Agenesis</td> </tr> <tr> <td>Mammary-Ulnar syndrome</td> <td><em>TBX3</em></td> <td>Dysplasia</td> </tr> <tr> <td>Meckel Gruber syndrome</td> <td><em>MKS1</em>, <em>MKS3</em>, <em>NPHP6</em>, <em>NPHP8</em></td> <td>Cystic dysplasia</td> </tr> <tr> <td>Nephronophthisis</td> <td><em>CEP290, GLIS2, RPGRIP1L, NEK8, SDCCAG8, TMEM 67, TTC21B</em></td> <td>Cystic dysplasia</td> </tr> <tr> <td>Okihiro syndrome</td> <td><em>SALL4</em></td> <td>Unilateral agenesis, VUR, malrotation, cross-fused ectopia</td> </tr> <tr> <td>Pallister-Hall syndrome</td> <td><em>GLI3</em></td> <td>Agenesis, dysplasia, hydronephrosis</td> </tr> <tr> <td>Renal coloboma syndrome</td> <td><em>PAX2</em></td> <td>Hypoplasia, VUR</td> </tr> <tr> <td>Renal dysplasia, isolated (cystic or non-cystic)</td> <td><em>DACH1, BICC1, CDC5L, NRIP1</em></td> <td>Dysplasia</td> </tr> <tr> <td>Renal hypoplasia, isolated</td> <td><em>BMP4, RET, DSTYK</em></td> <td>Hypoplasia, VUR; DSTYK mutations also associated with UPJO</td> </tr> <tr> <td>Renal tubular dysgenesis</td> <td>Renin, angiotensinogen, ACE, AT1 receptor</td> <td>Tubular dysgenesis</td> </tr> <tr> <td>Rubinstein-Taybi syndrome</td> <td><em>CREBBP</em></td> <td>Agenesis, hypoplasia</td> </tr> <tr> <td>Simpson-Golabi Behmel syndrome</td> <td><em>GPC3</em></td> <td>Medullary dysplasia</td> </tr> <tr> <td>Townes-Brock syndrome</td> <td><em>SALL1</em></td> <td>Hypoplasia, dysplasia, VUR</td> </tr> <tr> <td>Zellweger syndrome</td> <td><em>PEX1</em></td> <td>Cystic dysplasia</td> </tr> <tr> <td>Smith-Lemli-Opitz syndrome</td> <td><em>DHCR7</em></td> <td>Renal hypoplasia, cysts, and aplasia</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">ACE: angiotensin converting enzyme; AT1: angiotensin II receptor type 1; VUR: vesicoureteral reflux; UPJO: ureteropelvic junction obstruction.</div><div id=\"graphicVersion\">Graphic 52772 Version 10.0</div></div></div>"},"52774":{"type":"graphic_picture","displayName":"Pulmonary histiocytosis X Low","title":"Pulmonary Langerhans cell histiocytosis","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Pulmonary Langerhans cell histiocytosis</div><div class=\"cntnt\"><img style=\"width:411px; height:273px;\" src=\"images/PULM/52774_Pulmonary_histiocytosis_X_L.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Low power photomicrograph shows both nodular (long arrow) and stellate (short arrow) lesions.</div><div class=\"graphic_reference\">From Colby TV, Koss MN, Travis WD. Tumors of the Lower Respiratory Tract. Armed Forces Institute of Pathology, Washington, DC.</div><div id=\"graphicVersion\">Graphic 52774 Version 2.0</div></div></div>"},"52776":{"type":"graphic_picture","displayName":"Pemphigoid gestationis extremity","title":"Pemphigoid gestationis","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Pemphigoid gestationis</div><div class=\"cntnt\"><img style=\"width:432px; height:324px;\" src=\"images/DERM/52776_Pemph_gestationis_ext_edt.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Widespread erythematous plaques, bullae, and erosions are present on this patient with extensive disease.</div><div class=\"graphic_reference\">Reproduced with permission from: <A style=\"FONT-STYLE: italic\" href=\"http://www.visualdx.com/\" target=_blank>www.visualdx.com</A>. Copyright Logical Images, Inc.</div><div id=\"graphicVersion\">Graphic 52776 Version 6.0</div></div></div>"},"52777":{"type":"graphic_picture","displayName":"Cryptococcal papular skin lesions","title":"Cryptococcal papular skin lesions","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Cryptococcal papular skin lesions</div><div class=\"cntnt\"><img style=\"width:360px; height:353px;\" src=\"images/ID/52777_Cryptococcus_skin.jpg\" alt=\"Image\"/></div><div class=\"graphic_reference\">Courtesy of www.doctorfungus.org. Copyright &#169;2006.</div><div id=\"graphicVersion\">Graphic 52777 Version 3.0</div></div></div>"},"52778":{"type":"graphic_figure","displayName":"Innervation of upper airways","title":"The innervation of the upper airways depicted in a highly schematic diagram","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">The innervation of the upper airways depicted in a highly schematic diagram</div><div class=\"cntnt\"><img style=\"width:425px; height:470px;\" src=\"images/PULM/52778_Innervation_of_upper_airway.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Sympathetic and parasympathetic nerves innervate the airways. Sympathetic nerves innervate blood vessels in the airways and mediate vasoconstriction. Parasympathetic nerves innervate the vasculature as well as the mucus glands of the airways. When activated, parasympathetic nerves initiate mucus secretion and dilatation of airway blood vessels. Parasympathetic nerves also innervate airway smooth muscle. The opposing actions of the sympathetic and parasympathetic nerves on nasal blood flow likely serves to optimize the air conditioning function of the nasal passages. Afferent nerves innervating the nose regulate such homeostatic reflexes as well as defensive reflexes like mucus secretion and sneezing. Upper airway afferent nerves, which arise from the trigeminal ganglion may also initiate reflex effects in the lower airways and may regulate respiration. These interactions between the upper and lower airways are facilitated by the proximity of CNS structures regulating upper and lower airway function.</div><div class=\"graphic_reference\">Modified with permission from: Canning, BJ. Neurology of allergic inflammation and rhinitis. Curr Allergy Asthma Rep 2002; 2:210. Copyright &#169; 2002 Springer Science and Business Media.</div><div id=\"graphicVersion\">Graphic 52778 Version 2.0</div></div></div>"},"52779":{"type":"graphic_diagnosticimage","displayName":"RUL atelectasis III","title":"Peripheral atelectasis of the right upper lobe","html":"<div class=\"graphic normal\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Peripheral atelectasis of the right upper lobe</div><div class=\"cntnt\"><img style=\"width:401px; height:376px;\" src=\"images/PULM/52779_RUL_atelectasis_III.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">An apicolateral opacity with convex medial borders is visible (arrows). It has the appearance of a loculated pleural effusion but the overall lung volume in the right hemithorax is reduced and the trachea is shifted towards the opacity. The superior segment of the hyperexpanded right lower lobe is interposed between the peripheral RUL atelectasis and the mediastinum.</div><div class=\"graphic_footnotes\">RUL: right upper lobe.</div><div class=\"graphic_reference\">Courtesy of Paul Stark, MD.</div><div id=\"graphicVersion\">Graphic 52779 Version 3.0</div></div><div style=\"width: 450px\" class=\"figure\"><div class=\"ttl\">Normal chest radiograph</div><div class=\"cntnt\"><img style=\"width:371px; height:324px;\" src=\"images/PULM/65576_Normal_chest_film_PA.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Posteroanterior view of a normal chest radiograph.</div><div class=\"graphic_reference\">Courtesy of Carol M Black, MD.</div><div id=\"graphicVersion\">Graphic 65576 Version 1.0</div></div></div>"},"52781":{"type":"graphic_diagnosticimage","displayName":"Lunate fracture T2 MRI","title":"Lunate fracture and osteonecrosis","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Lunate fracture and osteonecrosis</div><div class=\"cntnt\"><img style=\"width:324px; height:239px;\" src=\"images/PC/52781_Lunate_fracture_T2_MRI.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">This T2-weighted, axial magnetic resonance image of the wrist shows a curvilinear region of increased signal traversing the lunate, indicative of fracture. Moderately increased signal from the marrow of the lunate is consistent with post traumatic osteonecrosis (Kienbock's disease).</div><div class=\"graphic_reference\">Courtesy of Kevin E Burroughs, MD.</div><div id=\"graphicVersion\">Graphic 52781 Version 3.0</div></div></div>"},"52783":{"type":"graphic_picture","displayName":"T cell NHL hemophagocytosis","title":"Large T cell lymphoma with reactive hemophagocytosis","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Large T cell lymphoma with reactive hemophagocytosis</div><div class=\"cntnt\"><img style=\"width:299px; height:287px;\" src=\"images/HEME/52783_T_cell_NHL_hemophagocytosis.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The red pulp of the spleen is diffusely permeated by large lymphoma cells (T lineage, blue arrows) and histiocytes showing erythrophagocytosis (black arrow). The histiocytes have smaller, bland-looking nuclei with delicate chromatin.</div><div class=\"graphic_reference\">From: Warnke RA, Weiss LM, Chan JK, et al. Tumors of the lymph nodes and spleen. Atlas of tumor pathology (electronic fascicle), Third series, fascicle 14, 1995, Washington, DC. Armed Forces Institute of Pathology.</div><div id=\"graphicVersion\">Graphic 52783 Version 2.0</div></div></div>"},"52784":{"type":"graphic_picture","displayName":"Alopecia areata ophiasis","title":"Alopecia areata - ophiasis","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Alopecia areata - ophiasis</div><div class=\"cntnt\"><img style=\"width:432px; height:319px;\" src=\"images/DERM/52784_Alopecia_areata_ophiasis.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">A band-like distribution of hair loss extends along the occipital scalp.</div><div class=\"graphic_reference\">Reproduced with permission from: <A style=\"FONT-STYLE: italic\" href=\"http://www.visualdx.com/\" target=_blank>www.visualdx.com</A>. Copyright Logical Images, Inc.</div><div id=\"graphicVersion\">Graphic 52784 Version 4.0</div></div></div>"},"52785":{"type":"graphic_table","displayName":"Organic psychosis","title":"Medical conditions associated with acute psychosis in children","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Medical conditions associated with acute psychosis in children</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1_single\">Condition</td> </tr> <tr> <td class=\"subtitle2_single\">Substrate deficiency</td> </tr> <tr> <td class=\"indent1\">Hypoglycemia*</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">Cerebral hypoxia*<sup>&#182;</sup></td> </tr> <tr> <td class=\"subtitle2_single\">CNS abnormality</td> </tr> <tr> <td class=\"indent1\">Brain tumor*</td> </tr> <tr> <td class=\"indent1\">Brain abscess*</td> </tr> <tr> <td class=\"indent1\">Intracranial injury (head trauma)*</td> </tr> <tr> <td class=\"indent1\">CNS infection (meningitis, encephalitis)*</td> </tr> <tr> <td class=\"indent1\">Stroke*</td> </tr> <tr> <td class=\"indent1\">Interictal psychosis</td> </tr> <tr> <td class=\"indent1\">Temporal lobe epilepsy</td> </tr> <tr> <td class=\"indent1\">Landau Kleffner syndrome</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">SSPE*</td> </tr> <tr> <td class=\"subtitle2_single\">Systemic lupus erythematosus</td> </tr> <tr class=\"divider_bottom\"> <td class=\"subtitle2_single\">Metabolic disease</td> </tr> <tr> <td class=\"indent1\">Urea cycle defect*</td> </tr> <tr> <td class=\"indent1\">Acute intermittent porphyria*</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">Wilson disease*</td> </tr> <tr> <td class=\"subtitle2_single\">Other</td> </tr> <tr> <td class=\"indent1\">Electrolyte disturbance*<sup>&#916;</sup></td> </tr> <tr> <td class=\"indent1\">Hepatic failure*</td> </tr> <tr> <td class=\"indent1\">Uremia*</td> </tr> <tr> <td class=\"indent1\">Postpartum psychosis*</td> </tr> <tr> <td class=\"indent1\">Hashimoto thyroiditis (Hashimoto encephalopathy)</td> </tr> <tr> <td class=\"indent1\">Thyroid storm*</td> </tr> <tr> <td class=\"indent1\">Antiphospholipid syndrome</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">CNS: central nervous syndrome; SSPE: subacute sclerosing panencephalitis; SLE: systemic lupus erythematosus.<br />* Life-threatening.<br />Â¶ Causes of cerebral hypoxia include cardiac insufficiency, pulmonary insufficiency, and severe anemia.<br />Î Acute psychosis may be seen with hypocalcemia and hypomagnesemia. Hypo- or hypernatremia may cause encephalopathy with delirium.</div><div id=\"graphicVersion\">Graphic 52785 Version 4.0</div></div></div>"},"52786":{"type":"graphic_figure","displayName":"Position of the RF catheter","title":"The \"Stretta\" procedure","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">The &quot;Stretta&quot; procedure</div><div class=\"cntnt\"><img style=\"width:364px; height:282px;\" src=\"images/GAST/52786_Position_of_the_RF_catheter.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Radiofrequency energy catheter positioned within esophageal lumen at gastroesophageal junction.</div><div class=\"graphic_reference\">Courtesy of George Triadafilopoulos, MD.</div><div id=\"graphicVersion\">Graphic 52786 Version 2.0</div></div></div>"},"52788":{"type":"graphic_figure","displayName":"Sturmdorf sutures","title":"Sturmdorf sutures for cervical (uterine cervix) conization","html":"<div class=\"graphic\"><div style=\"width: 475px\" class=\"figure\"><div class=\"ttl\">Sturmdorf sutures for cervical (uterine cervix) conization</div><div class=\"cntnt\"><img style=\"width:455px; height:494px;\" src=\"images/OBGYN/52788_Sturmdorf_sutures.jpg\" alt=\"Image\"/></div><div id=\"graphicVersion\">Graphic 52788 Version 2.0</div></div></div>"},"52790":{"type":"graphic_diagnosticimage","displayName":"Ultrasound of early breast cancer","title":"Ultrasound of early breast cancer","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Ultrasound of early breast cancer</div><div class=\"cntnt\"><img style=\"width:432px; height:374px;\" src=\"images/SURG/52790_US_small_breast_cancer.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Left breast ultrasound demonstrates a hypoechoic nodule with posterior acoustic shadowing that corresponds to the mammographic abnormality.</div><div class=\"graphic_reference\">Courtesy of Pierre J Sasson, MD.</div><div id=\"graphicVersion\">Graphic 52790 Version 4.0</div></div></div>"},"52791":{"type":"graphic_picture","displayName":"Bunny lines","title":"\"Bunny lines\"","html":"<div class=\"graphic\"><div style=\"width: 523px\" class=\"figure\"><div class=\"ttl\">&quot;Bunny lines&quot;</div><div class=\"cntnt\"><img style=\"width:503px; height:327px;\" src=\"images/DERM/52791_Bunny_lines_edt.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Wrinkles on the dorsal and lateral nose can occur during contraction of the upper nasalis muscle.</div><div id=\"graphicVersion\">Graphic 52791 Version 2.0</div></div></div>"},"52792":{"type":"graphic_diagnosticimage","displayName":"MRI subependymal nodules","title":"Brain MRI of multiple subependymal nodules","html":"<div class=\"graphic\"><div style=\"width: 599px\" class=\"figure\"><div class=\"ttl\">Brain MRI of multiple subependymal nodules</div><div class=\"cntnt\"><img style=\"width:579px; height:386px;\" src=\"images/NEURO/52792_MRI_subependymal_nodules_PR.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">(A) T1-weighted MRI of multiple subependymal nodules within the lateral ventricles (arrows). Nodules are relatively isointense to surrounding brain tissue.<br />(B) Note that two nodules enhance (arrowheads) after gadolinium administration, suggesting that these are subependymal giant cell astrocytomas.</div><div class=\"graphic_footnotes\">MRI: magnetic resonance imaging.</div><div class=\"graphic_reference\">Reproduced with permission from: Crino PB, Henske EP. New developments in the neurobiology of the tuberous sclerosis complex. Neurology 1999; 53:1384. Copyright &copy; 1999 Lippincott Williams &amp; Wilkins.</div><div id=\"graphicVersion\">Graphic 52792 Version 5.0</div></div></div>"},"52793":{"type":"graphic_figure","displayName":"Types of craniosynostosis","title":"Types of craniosynostosis","html":"<div class=\"graphic\"><div style=\"width: 500px\" class=\"figure\"><div class=\"ttl\">Types of craniosynostosis</div><div class=\"cntnt\"><img style=\"width:480px; height:662px;\" src=\"images/ALLRG/52793_Synostosis_variations.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Note that deformational plagiocephaly is caused by positional deformation and is often correctable without surgical intervention.</div><div class=\"graphic_reference\">Reproduced with permission from Texas Children's Hospital. Copyright Â© 2017. All rights reserved.</div><div id=\"graphicVersion\">Graphic 52793 Version 3.0</div></div></div>"},"52794":{"type":"graphic_picture","displayName":"Bullous reaction to arthropod bite","title":"Bullous arthropod bite","html":"<div class=\"graphic\"><div style=\"width: 524px\" class=\"figure\"><div class=\"ttl\">Bullous arthropod bite</div><div class=\"cntnt\"><img style=\"width:504px; height:308px;\" src=\"images/DERM/52794_Bullous_react_arthropod.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Multiple erythematous papules consistent with arthropod bites are present on the foot. An intact, fluid-filled bulla is present at the site of one lesion.</div><div id=\"graphicVersion\">Graphic 52794 Version 1.0</div></div></div>"},"52795":{"type":"graphic_picture","displayName":"Endogenous Candida endophthalmitis with vitritis","title":"Endogenous <EM>Candida</EM> endophthalmitis with marked vitritis","html":"<div class=\"graphic\"><div style=\"width: 524px\" class=\"figure\"><div class=\"ttl\">Endogenous <EM>Candida</EM> endophthalmitis with marked vitritis</div><div class=\"cntnt\"><img style=\"width:504px; height:410px;\" src=\"images/ID/52795_Endog_Cand_endopht_vitritis.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Endogenous <EM>Candida</EM> endophthalmitis with marked vitritis; initially mistaken for uveitis.</div><div class=\"graphic_reference\">Courtesy of Marlene Durand, MD.</div><div id=\"graphicVersion\">Graphic 52795 Version 3.0</div></div></div>"},"52800":{"type":"graphic_picture","displayName":"Hand-foot-and-mouth disease - lip and hand","title":"Hand-foot-and-mouth disease - lip and hand","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Hand-foot-and-mouth disease - lip and hand</div><div class=\"cntnt\"><img style=\"width:316px; height:440px;\" src=\"images/PEDS/52800_Hand_foot_mouth_disease.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">(A) Oral lesion: Note the oval shape and rim of erythema.<br />(B) Oval intact vesicles are noted on the palm.</div><div class=\"graphic_reference\">Reproduced with permission from: Goodheart HP. Goodheart's Photoguide of Common Skin Disorders, 2<SUP>nd </SUP>ed, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright Â© 2003 Lippincott Williams &amp; Wilkins.</div><div id=\"graphicVersion\">Graphic 52800 Version 7.0</div></div></div>"},"52802":{"type":"graphic_figure","displayName":"PVOD venous obliteration","title":"Cross-section of a small pulmonary vein","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Cross-section of a small pulmonary vein</div><div class=\"cntnt\"><img style=\"width:385px; height:265px;\" src=\"images/PULM/52802_PVOD_venous_obliteration.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Showing complete luminal obliteration by pink collagen (between arrows). Hematoxylin-eosin; original magnification: x20.</div><div class=\"graphic_reference\">Reproduced with permission from: Mandel, J, Mark, E, Hales, C. Pulmonary veno-occlusive disease. Am J Respir Crit Care Med 2000; 162:1964. Official Journal of the American Thoracic Society &#169; American Lung Association.</div><div id=\"graphicVersion\">Graphic 52802 Version 1.0</div></div></div>"},"52803":{"type":"graphic_picture","displayName":"Infantile seborrheic dermatitis multiple sites","title":"Seborrheic dermatitis involving multiple skin folds","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Seborrheic dermatitis involving multiple skin folds</div><div class=\"cntnt\"><img style=\"width:432px; height:324px;\" src=\"images/DERM/52803_Infan_sebor_derm_mult_sites.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Moist erythematous plaques involving the flexural area in a child with infantile seborrheic dermatitis.</div><div class=\"graphic_reference\">Reproduced with permission from: <A style=\"FONT-STYLE: italic\" href=\"http://www.visualdx.com/\" target=_blank>www.visualdx.com</A>. Copyright Logical Images, Inc.</div><div id=\"graphicVersion\">Graphic 52803 Version 5.0</div></div></div>"},"52804":{"type":"graphic_figure","displayName":"Mobilization of the breast off the chest wall for mastectomy","title":"Mobilization of the breast off the chest wall for mastectomy","html":"<div class=\"graphic\"><div style=\"width: 546px\" class=\"figure\"><div class=\"ttl\">Mobilization of the breast off the chest wall for mastectomy</div><div class=\"cntnt\"><img style=\"width:526px; height:339px;\" src=\"images/SURG/52804_Mobilbroffchestwallmast.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Mobilization of the breast off the chest wall can be aided by place of Allis clamps along the superior border of the breast, including the investing &quot;fascia&quot; of the muscle (perimysium). The tissue is pulled up or inferiorly with gentle traction. The dissection is performed utilizing electrocautery or sharp dissection, traveling in parallel to the chest wall muscle ï¬bers. Since the pectoralis major muscle ï¬bers splay, the angle of dissection shifts as one progresses within the dissection.</div><div class=\"graphic_reference\">Reproduced with permission from: Shaughnessy EA. Simple mastectomy. In: Master Techniques in General Surgery: Breast Surgery, Bland KI, Klimberg SV (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2011. Copyright Â© 2011 Lippincott Williams &amp; Wilkins. <A href=\"http://www.lww.com/\" target=_blank>www.lww.com</A>.</div><div id=\"graphicVersion\">Graphic 52804 Version 7.0</div></div></div>"},"52805":{"type":"graphic_picture","displayName":"Linear IgA bullous dermatosis of childhood close view","title":"Linear IgA bullous dermatosis of childhood","html":"<div class=\"graphic\"><div style=\"width: 524px\" class=\"figure\"><div class=\"ttl\">Linear IgA bullous dermatosis of childhood</div><div class=\"cntnt\"><img style=\"width:504px; height:378px;\" src=\"images/DERM/52805_Line_IgA_bull_derm_ch_close.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Multiple inflammatory plaques with peripheral vesiculation are present.</div><div class=\"graphic_reference\">Reproduced with permission from: <A style=\"FONT-STYLE: italic\" href=\"http://www.visualdx.com/\" target=_blank>www.visualdx.com</A>. Copyright Logical Images, Inc.</div><div id=\"graphicVersion\">Graphic 52805 Version 3.0</div></div></div>"},"52806":{"type":"graphic_picture","displayName":"Olympus QuickClip2 endosc","title":"Treatment of a bleeding gastric ulcer with endoclips","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Treatment of a bleeding gastric ulcer with endoclips</div><div class=\"cntnt\"><img style=\"width:324px; height:322px;\" src=\"images/GAST/52806_Olympus_QuickClip2_endosc.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Bleeding gastric ulcer following placment of Olympus QuickClip2 endoclips.</div><div class=\"graphic_reference\">Courtesy of Dennis M. Jensen, MD.</div><div id=\"graphicVersion\">Graphic 52806 Version 3.0</div></div></div>"},"52808":{"type":"graphic_table","displayName":"Risk factors pathogens CAP","title":"Epidemiologic conditions and/or risk factors related to specific pathogens in community-acquired pneumonia","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Epidemiologic conditions and/or risk factors related to specific pathogens in community-acquired pneumonia</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1\">Condition </td> <td class=\"subtitle1\">Commonly encountered pathogen(s) </td> </tr> <tr> <td>Alcoholism</td> <td><em>Streptococcus pneumoniae</em>, oral anaerobes, <em>Klebsiella pneumoniae, Acinetobacter</em> species, <em>Mycobacterium tuberculosis</em></td> </tr> <tr> <td>COPD and/or smoking</td> <td><em>Haemophilus influenzae, Pseudomonas aeruginosa, Legionella</em> species, <em>S. pneumoniae, Moraxella catarrhalis, Chlamydia pneumoniae</em></td> </tr> <tr> <td>Aspiration</td> <td>Gram-negative enteric pathogens, oral anaerobes</td> </tr> <tr> <td>Lung abscess</td> <td>CA-MRSA, oral anaerobes, endemic fungal pneumonia,<em> M. tuberculosis</em>, atypical mycobacteria</td> </tr> <tr> <td>Exposure to bat or bird droppings</td> <td><em>Histoplasma capsulatum</em></td> </tr> <tr> <td>Exposure to birds</td> <td><em>Chlamydia psittaci</em> (if poultry: avian influenza)</td> </tr> <tr> <td>Exposure to rabbits</td> <td><em>Francisella tularensis</em></td> </tr> <tr> <td>Exposure to farm animals or parturient cats</td> <td><em>Coxiella burnetti</em> (Q fever)</td> </tr> <tr> <td>HIV infection (early)</td> <td><em>S. pneumoniae, H. influenzae, M. tuberculosis </em></td> </tr> <tr> <td>HIV infection (late)</td> <td>The pathogens listed for early infection plus <em>Pneumocystis jirovecii, Cryptococcus, Histoplasma, Aspergillus</em>, atypical mycobacteria (especially <em>Mycobacterium kansasii</em>), <em>P. aeruginosa, H. influenzae</em></td> </tr> <tr> <td>Hotel or cruise ship stay in previous&nbsp;two weeks</td> <td><em>Legionella</em> species</td> </tr> <tr> <td>Travel to or residence in southwestern United States</td> <td><em>Coccidioides</em> species, hantavirus</td> </tr> <tr> <td>Travel to or residence in Southeast and East Asia</td> <td><em>Burkholderia pseudomallei</em>, avian (H5N1, H7N9)&nbsp;influenza, SARS coronavirus</td> </tr> <tr> <td>Travel to or residence in the Arabian peninsula</td> <td>Middle East respiratory syndrome coronavirus</td> </tr> <tr> <td>Influenza active in community</td> <td>Influenza, <em>S. pneumoniae, Staphylococcus aureus, H. influenzae</em></td> </tr> <tr> <td>Cough &#62;2 weeks with whoop or posttussive vomiting</td> <td><em>Bordetella pertussis </em></td> </tr> <tr> <td>Structural lung disease (eg, bronchiectasis)</td> <td><em>Pseudomonas aeruginosa, Burkholderia cepacia, S. aureus</em></td> </tr> <tr> <td>Injection drug use</td> <td><em>S. aureus, </em>anaerobes<em>, M. tuberculosis, S. pneumoniae</em></td> </tr> <tr> <td>Endobronchial obstruction</td> <td>Anaerobes,<em> S. pneumoniae, H. influenzae, S. aureus</em></td> </tr> <tr> <td>In context of bioterrorism</td> <td><em>Bacillus anthracis</em> (anthrax), <em>Yersinia pestis</em> (plague), <em>Francisella tularensis</em> (tularemia)</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">COPD: chronic obstructive pulmonary disease; CA-MRSA: community-acquired methicillin-resistant <EM>Staphylococcus aureus</EM>; HIV: human&nbsp;immunodeficiency virus; SARS: severe acute respiratory syndrome.</div><div class=\"graphic_reference\">Adapted with permission from: Mandell, LA, Wunderink, RG, Anzueto, A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44:S27. Copyright Â© 2007 University of Chicago Press.</div><div id=\"graphicVersion\">Graphic 52808 Version 3.0</div></div></div>"},"52809":{"type":"graphic_picture","displayName":"Yeasts incubate agar","title":"Colonies of <em>Penicillium marneffei</em> yeasts after incubating at 37Â°C on brain heart infusion agar","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Colonies of <em>Penicillium marneffei</em> yeasts after incubating at 37&#176;C on brain heart infusion agar</div><div class=\"cntnt\"><img style=\"width:396px; height:286px;\" src=\"images/ID/52809_Yeasts_incubate_agar.jpg\" alt=\"Image\"/></div><div class=\"graphic_reference\">Courtesy of Drs. Khuanchai Supparatpinyo and Thira Sirisanthana.</div><div id=\"graphicVersion\">Graphic 52809 Version 1.0</div></div></div>"},"52812":{"type":"graphic_figure","displayName":"Cardinal movements labor","title":"Principal movements in the mechanism of labor and delivery, left occiput anterior position","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Principal movements in the mechanism of labor and delivery, left occiput anterior position</div><div class=\"cntnt\"><img style=\"width:362px; height:527px;\" src=\"images/OBGYN/52812_Cardinal_movements_labor.jpg\" alt=\"Image\"/></div><div class=\"graphic_reference\">Reproduced with permission from: Pritchard JA, MacDonald PC. Williams Obstetrics, 16<SUP>th</SUP> ed, Appleton-Century-Crofts, New York 1980. p. 397. Copyright Â© 1980 McGraw Hill. </div><div id=\"graphicVersion\">Graphic 52812 Version 2.0</div></div></div>"},"52814":{"type":"graphic_figure","displayName":"Androgens in the development of the pilosebaceous unit","title":"Androgens in the development of the pilosebaceous unit","html":"<div class=\"graphic\"><div style=\"width: 510px\" class=\"figure\"><div class=\"ttl\">Androgens in the development of the pilosebaceous unit</div><div class=\"cntnt\"><img style=\"width:490px; height:386px;\" src=\"images/ENDO/52814_androgen_pilosebaceous.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Solid lines indicate effects of androgens; dotted lines indicate effects of antiandrogens. Hairs are depicted only in the anagen (growing) phase of the growth cycle. In balding scalp (bracketed area), terminal hairs not previously dependent on androgen regress to vellus hairs under the influence of androgen.</div><div class=\"graphic_reference\">Reproduced with permission from: Rosenfield RL, Deplewski D. The role of androgens in the development of biology of the pilosebaceous unit. Am J Med 1995; 98:80S. Copyright &#169; 1995 Excerpta Media, Inc.</div><div id=\"graphicVersion\">Graphic 52814 Version 3.0</div></div></div>"},"52815":{"type":"graphic_table","displayName":"Effector cell populations","title":"Properties of effector cell populations","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Properties of effector cell populations</div><div class=\"cntnt\"><table cellspacing=\"0\">\n\n  <tbody>\n\n\n    <tr>\n\n      <td class=\"subtitle1\">Property</td>\n\n      <td class=\"subtitle1\">NK</td>\n\n      <td class=\"subtitle1\">CTL</td>\n\n      <td class=\"subtitle1\">NK-like T cells</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Phenotype</td>\n\n      <td>CD3-CD56+CD16+</td>\n\n      <td>CD3+CD56-CD8+</td>\n\n      <td>CD3+CD56+CD16-</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Precursor cell</td>\n\n      <td>NK</td>\n\n      <td>T</td>\n\n      <td>T</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Antigen specific</td>\n\n      <td>No</td>\n\n      <td>Yes</td>\n\n      <td>No</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Expandable</td>\n\n      <td>Limited</td>\n\n      <td>Yes</td>\n\n      <td>Yes</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Require IL-2 in vivo</td>\n\n      <td>Yes</td>\n\n      <td>No</td>\n\n      <td>No</td>\n\n    </tr>\n\n\n\n  </tbody>\n</table></div><div class=\"graphic_footnotes\">NK: natural killer cells; CTL: cytotoxic T lymphocytes.</div><div class=\"graphic_reference\">Adapted from Lu, LPH, Negrin, RS. Biol Blood Marrow Transplant 1997; 3:113.</div><div id=\"graphicVersion\">Graphic 52815 Version 1.0</div></div></div>"},"52816":{"type":"graphic_diagnosticimage","displayName":"Disk battery","title":"Disk battery lodged in the esophagus","html":"<div class=\"graphic\"><div style=\"width: 524px\" class=\"figure\"><div class=\"ttl\">Disk battery lodged in the esophagus</div><div class=\"cntnt\"><img style=\"width:504px; height:259px;\" src=\"images/PEDS/52816_Disk_battery.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">An AP radiograph of an eight-month-old child with an opaque circular object in the esophagus. A) The &quot;halo&quot; lucency along the edge of the circular object suggests that the item has a bi-level contour consistent with a battery. The radiolucent trachea and bronchi are to the side and the orientation of the object suggests esophageal location. B) The lateral view also shows the bi-level contour of the object consistent with a battery.</div><div id=\"graphicVersion\">Graphic 52816 Version 3.0</div></div></div>"},"52817":{"type":"graphic_picture","displayName":"Histopath bronchogenic cyst","title":"Histopathology of a bronchogenic cyst","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Histopathology of a bronchogenic cyst</div><div class=\"cntnt\"><img style=\"width:432px; height:288px;\" src=\"images/PEDS/52817_Histopath_bronchogenic_cyst.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The wall of the cyst has features of respiratory epithelium and contains cartilage and smooth muscle typical of a bronchus. The finding of cartilage plates is essential for the diagnosis.</div><div class=\"graphic_reference\">Courtesy of Christopher Oermann, MD and Claire Langston, MD</div><div id=\"graphicVersion\">Graphic 52817 Version 2.0</div></div></div>"},"52818":{"type":"graphic_picture","displayName":"Neonatal HSV adrenals","title":"Adrenal pathology in disseminated neonatal herpes simplex virus (HSV) infection","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Adrenal pathology in disseminated neonatal herpes simplex virus (HSV) infection</div><div class=\"cntnt\"><img style=\"width:313px; height:475px;\" src=\"images/PEDS/52818_Neonatal_HSV_adrenals.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Panel A) Histopathologic slide (magnification 10X) of adrenal gland of a neonate who died of disseminated HSV. Adrenal gland shows area of necrosis. Immunoperoxidase stain specific for HSV antigens shows area of HSV-associated adrenal necrosis in reddish brown. Panel B) Histopathologic slide (magnification 10X) of adrenal gland of a neonate who died of disseminated HSV. Adrenal gland shows area of necrosis.</div><div class=\"graphic_reference\">Courtesy of Edwina Popek, DO, Department of Pathology, Texas Children's Hospital.</div><div id=\"graphicVersion\">Graphic 52818 Version 1.0</div></div></div>"},"52819":{"type":"graphic_picture","displayName":"Retracted tympanic membrane","title":"Retracted tympanic membrane","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Retracted tympanic membrane</div><div class=\"cntnt\"><img style=\"width:432px; height:369px;\" src=\"images/PEDS/52819_Retracted_tympanic_membrane.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">When there is a negative pressure in the middle ear cavity, the position of the tympanic membrane will be retracted.</div><div id=\"graphicVersion\">Graphic 52819 Version 1.0</div></div></div>"},"52820":{"type":"graphic_figure","displayName":"Auto PEEP effect","title":"Quantification of the auto-PEEP effect","html":"<div class=\"graphic\"><div style=\"width: 558px\" class=\"figure\"><div class=\"ttl\">Quantification of the auto-PEEP effect</div><div class=\"cntnt\"><img style=\"width:538px; height:323px;\" src=\"images/PULM/52820_Auto_PEEP_effect.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">During mechanical ventilation of the patient with airflow obstruction, expiratory flow is too slow to allow complete deflation of the lung to its normal relaxed state before the ventilator delivers another breath. Slow flow continues until interrupted by the next inflation. Upper panel: Alveolar pressure remains positive at end exhalation (15 cmH2O) but is not measured by the ventilator manometer (0 cmH2O) located downstream from the site of increased airway resistance. Lower panel: Alveolar pressure at end-exhalation can be quantified by stopping flow transiently at the end of a set exhalation period, thereby allowing equilibration of pressures.</div><div class=\"graphic_reference\">Adapted from O'Quinn, R, Marini, JJ, Am Rev Respir Dis 1983; 128:319.</div><div id=\"graphicVersion\">Graphic 52820 Version 1.0</div></div></div>"},"52821":{"type":"graphic_picture","displayName":"Subungual melanoma - advanced on thumb","title":"Subungual acral lentiginous melanoma","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Subungual acral lentiginous melanoma</div><div class=\"cntnt\"><img style=\"width:432px; height:325px;\" src=\"images/DERM/52821_Sub_melanoma_adv_thumb.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Destruction of the nail bed by the tumor is present in this patient with subungual melanoma involving the toe. Note the presence of pigment involving the periungual skin (Hutchinson's sign).</div><div class=\"graphic_reference\">Reproduced with permission from: <A style=\"FONT-STYLE: italic\" href=\"http://www.visualdx.com/\" target=_blank>www.visualdx.com</A>. Copyright Logical Images, Inc.</div><div id=\"graphicVersion\">Graphic 52821 Version 3.0</div></div></div>"},"52823":{"type":"graphic_figure","displayName":"Posterior vaginal wall prolapse 6","title":"Repair of posterior vaginal wall prolapse","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Repair of posterior vaginal wall prolapse</div><div class=\"cntnt\"><img style=\"width:372px; height:349px;\" src=\"images/OBGYN/52823_Tx_post_vaginal_wall_def_6.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Locations of site-specific defects in the posterior vaginal wall. Defects in the fibromuscularis can be found in the lateral sidewalls (L), midline (M), or in a transverse orientation (T) at the apex or distally near the perineal body.</div><div class=\"graphic_reference\">Reproduced with permission from: Walters, MD, Karram, MM. Urogynecology and reconstructive pelvic surgery, 3rd ed, Mosby-Elsevier, 2007. Copyright &#169;2007 Elsevier.</div><div id=\"graphicVersion\">Graphic 52823 Version 2.0</div></div></div>"},"52824":{"type":"graphic_picture","displayName":"Occlusion objection test","title":"Occlusion objection test","html":"<div class=\"graphic\"><div style=\"width: 553px\" class=\"figure\"><div class=\"ttl\">Occlusion objection test</div><div class=\"cntnt\"><img style=\"width:533px; height:339px;\" src=\"images/PEDS/52824_Occlusion_objection_test.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Child is not bothered when amblyopic left eye is covered, but becomes fussy when normal right eye is covered.</div><div class=\"graphic_reference\">Modified from: Coats DK, Jenkins RH. Refinements: Vision assessment of the patient 1:1. San Francisco, American Academy of Ophthalmology, 1997.</div><div id=\"graphicVersion\">Graphic 52824 Version 3.0</div></div></div>"},"52825":{"type":"graphic_table","displayName":"High-calorie food fortifiers","title":"Increasing caloric density of beverages and foods for toddlers","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Increasing caloric density of beverages and foods for toddlers</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup span=\"3\" width=\"33%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\">Fortifier</td> <td class=\"subtitle1\">Calories</td> <td class=\"subtitle1\">Add to:</td> </tr> <tr> <td>Nonfat dry milk</td> <td>25 kcal/tablespoon</td> <td>Potatoes, ground meats, cereals, pudding, yogurt</td> </tr> <tr> <td>Cheese</td> <td>100 kcal/ounce</td> <td>Vegetables, casseroles, fish</td> </tr> <tr> <td>Sour cream</td> <td>30 kcal/tablespoon</td> <td>Beans, squash, potatoes, gravies, casseroles, salad dressing</td> </tr> <tr> <td>Whipping cream (also called heavy cream)</td> <td>60 kcal/tablespoon</td> <td>Gravies, casseroles, salad dressings, hot chocolate, cereal, potatoes, eggs</td> </tr> <tr> <td>Butter, margarine, oil</td> <td>40 kcal/teaspoon</td> <td>Gravies, mashed potatoes, cereal, rice, pasta, bread, muffins, tomato sauce</td> </tr> <tr> <td>Instant breakfast preparation</td> <td>130 kcal/packet</td> <td>&nbsp;</td> </tr> <tr> <td class=\"subtitle1_single\" colspan=\"3\">Recipes</td> </tr> <tr> <td class=\"indent1\" colspan=\"3\">One jar (4 ounces) strained fruit plus one scoop formula powder*</td> </tr> <tr> <td class=\"indent1\" colspan=\"3\">8 ounces whole milk + 2 tablespoons nonfat dry milk powder = 24 kcal per ounce*</td> </tr> <tr> <td class=\"indent1\" colspan=\"3\">8 ounces whole milk + 3 tablespoons nonfat dry milk powder = 28 kcal per ounce*</td> </tr> <tr> <td class=\"indent1\" colspan=\"3\">4 cups whole milk + 1 cup nonfat dry milk powder = 28 kcal per ounce*<sup>&#182;</sup></td> </tr> <tr> <td class=\"indent1\" colspan=\"3\">Mix 1 cup whole milk, 1 package instant breakfast, and 1 cup ice cream in blender (430 kcal)*</td> </tr> <tr> <td class=\"indent1\" colspan=\"3\">Mix one-half cup whole milk and one-half cup \"half-and-half\" to increase calories<sup>&#182;</sup></td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">1 kcal = 1 calorie.<br />* If making any of these changes causes your child to have diarrhea, stop and call your child's health care provider.<br />Â¶ Can be used in cooking (eg, mashed potatoes), baking (eg, muffins, waffles), desserts (eg, pudding, custard), etc.</div><div class=\"graphic_reference\">Data from: &#xD;&#xA;<OL>&#xD;&#xA;<LI>Bithoney WG, Dubowitz H, Egan H. Failure to thrive/growth deficiency. Pediatr Rev 1992; 13:453. </LI>&#xD;&#xA;<LI>Frank DA. Failure to thrive. In: The Zuckerman Parker Handbook of Developmental and Behavioral Pediatrics for Primary Care, 3rd ed, Augustyn M, Zuckerman B, Caronna EB (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2011. p.204.</LI>&#xD;&#xA;<LI>Texas Children's Hospital. High-calorie, high-protein diet.</LI></OL></div><div id=\"graphicVersion\">Graphic 52825 Version 7.0</div></div></div>"},"52826":{"type":"graphic_diagnosticimage","displayName":"Nasal septal deformity","title":"AxialÂ CT of congenital nasal septal deformity","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Axial&nbsp;CT of congenital nasal septal deformity</div><div class=\"cntnt\"><img style=\"width:288px; height:258px;\" src=\"images/PEDS/52826_Nasal_septal_deformity.jpg\" alt=\"Image\"/></div><div class=\"graphic_footnotes\">CT: computed tomography.</div><div class=\"graphic_reference\">Courtesy of Glenn Isaacson, MD, FAAP, FACS.</div><div id=\"graphicVersion\">Graphic 52826 Version 3.0</div></div></div>"},"52829":{"type":"graphic_picture","displayName":"Vaginoscope","title":"Vaginoscope","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Vaginoscope</div><div class=\"cntnt\"><img style=\"width:392px; height:261px;\" src=\"images/OBGYN/52829_Vaginoscope.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Relative size of the Cameron-Myers vaginoscope (A, B, D), as compared to a 3 mm hysteroscope (C) or a pediatric speculum (E).</div><div id=\"graphicVersion\">Graphic 52829 Version 1.0</div></div></div>"},"52831":{"type":"graphic_diagnosticimage","displayName":"Tree-in-bud CT","title":"Tree-in-bud","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Tree-in-bud</div><div class=\"cntnt\"><img style=\"width:432px; height:280px;\" src=\"images/PULM/52831_Tree-in-bud_CT.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Chest CT with arrow A pointing to extensive tree-in-bud and arrow B of dilated and thickened airways.</div><div class=\"graphic_footnotes\">CT: computed tomography.</div><div id=\"graphicVersion\">Graphic 52831 Version 3.0</div></div></div>"},"52832":{"type":"graphic_table","displayName":"Effects of mast cell mediators in mastocytosis","title":"Effects of mast cell mediators in mastocytosis","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Effects of mast cell mediators in mastocytosis</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1_single\">Histamine</td> </tr> <tr> <td class=\"indent1\">Pruritus, urticaria, gastric hypersecretion, bronchoconstriction</td> </tr> <tr> <td class=\"indent1\">Increased vasopermeability and systemic hypotension</td> </tr> <tr> <td class=\"subtitle1_single\">Heparin</td> </tr> <tr> <td class=\"indent1\">Local anticoagulation, osteopenia, and osteoporosis</td> </tr> <tr> <td class=\"subtitle1_single\">Proteases (tryptases, chymase)</td> </tr> <tr> <td class=\"indent1\">Fibrinogen degradation, stimulation of fibroblast proliferation, activation of procollagenase and tissue remodeling (degrade fibronectin)</td> </tr> <tr> <td class=\"subtitle1_single\">Cysteinyl leukotrienes (LTC<sub>4</sub>, LTD<sub>4</sub>, LTE<sub>4</sub>)</td> </tr> <tr> <td class=\"indent1\">Increased vasopermeability, vasodilation, bronchoconstriction</td> </tr> <tr> <td class=\"subtitle1_single\">Prostaglandins (PGD<sub>2</sub>)</td> </tr> <tr> <td class=\"indent1\">Vasodilation, bronchoconstriction, flushing</td> </tr> <tr> <td class=\"subtitle1_single\">Platelet-activating factor</td> </tr> <tr> <td class=\"indent1\">Increased vasopermeability, vasodilation</td> </tr> <tr> <td class=\"subtitle1_single\">Cytokines (TNF-alpha, TGF-beta, nerve growth factor) and growth factors (IL-3, IL-5, IL-6)</td> </tr> <tr> <td class=\"indent1\">Activation of vascular endothelial cells, cachexia, and fibrosis</td> </tr> <tr> <td class=\"indent1\">Mast cell and eosinophil proliferation</td> </tr> <tr> <td class=\"indent1\">B cell proliferation with polyclonal increase in immunoglobulins and paraproteins</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">LTC<SUB>4</SUB>: leukotriene C<SUB>4</SUB>; LTD<SUB>4</SUB>: leukotriene D<SUB>4</SUB>; LTE<SUB>4</SUB>: leukotriene E<SUB>4</SUB>; PGD<SUB>2</SUB>: prostaglandin D<SUB>2</SUB>; TNF-alpha: tumor necrosis factor-alpha; TGF-beta: transforming growth factor-beta; IL-3: interleukin-3; IL-5: interleukin-5;&nbsp;IL-6: interleukin-6.</div><div id=\"graphicVersion\">Graphic 52832 Version 8.0</div></div></div>"},"52833":{"type":"graphic_figure","displayName":"Upper abdominal cross-sectional anatomy","title":"Upper abdominal cross-sectional anatomy","html":"<div class=\"graphic\"><div style=\"width: 560px\" class=\"figure\"><div class=\"ttl\">Upper abdominal cross-sectional anatomy</div><div class=\"cntnt\"><img style=\"width:540px; height:361px;\" src=\"images/SURG/52833_Cross_section_upper_abdomen.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">During splenectomy, the ligamentous attachments to surrounding structures are divided first. These include the gastrosplenic ligament which contains the short gastric vessels, and splenorenal ligament.</div><div id=\"graphicVersion\">Graphic 52833 Version 5.0</div></div></div>"},"52834":{"type":"graphic_figure","displayName":"Incision for axillary dissection","title":"Incision for axillary dissection","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Incision for axillary dissection</div><div class=\"cntnt\"><img style=\"width:418px; height:319px;\" src=\"images/SURG/52834_Incis_ax_dissect.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Axillary incision is sketched onto the skin using land-marks mentioned in the text.</div><div class=\"graphic_reference\">Reproduced with permission from: Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the Breast, Third Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 2004. Copyright &#169; 2004 Lippincott Williams &amp; Wilkins.</div><div id=\"graphicVersion\">Graphic 52834 Version 2.0</div></div></div>"},"52835":{"type":"graphic_picture","displayName":"Bivalving of torsed ovary","title":"Enlarged left ovary following bivalve procedure with electrosurgery","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Enlarged left ovary following bivalve procedure with electrosurgery</div><div class=\"cntnt\"><img style=\"width:432px; height:283px;\" src=\"images/OBGYN/52835_Bivalvingoftorsedovary.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Continued arterial perfusion is suggested by the red blood extruding into the cortex along with patches of improved duskiness following this release of the capsular pressure.</div><div class=\"graphic_reference\">Reproduced with permission from: Pediatric&nbsp;and Adolescent Gynecology, 6th ed, Emans SJ, Laufer MR, Goldstein DP (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2012. Copyright Â© 2012 Lippincott Williams &amp; Wilkins. <A href=\"http://www.lww.com/\" target=_blank>www.lww.com</A>.</div><div id=\"graphicVersion\">Graphic 52835 Version 13.0</div></div></div>"},"52836":{"type":"graphic_waveform","displayName":"Left bundle branch block 1","title":"Complete left bundle branch block","html":"<div class=\"graphic\"><div style=\"width: 531px\" class=\"figure\"><div class=\"ttl\">Complete left bundle branch block</div><div class=\"cntnt\"><img style=\"width:511px; height:139px;\" src=\"images/CARD/52836_Complete_LBBB_tutorial.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Delayed and abnormal activation of the left ventricular myocardium, and a diffuse slowing of conduction throughout the left ventricle leads to the following changes on the ECG: there is a tall monophasic and broadened R wave in leads I, aVL, and V6 instead of a septal Q wave; there is a QS complex which is abnormal and widened in V1 instead of a small initial R wave due to septal activation; the QRS interval is prolonged &gt;0.12 seconds; myocardial repolarization changes including T wave inversion and ST segment depression are evident.</div><div id=\"graphicVersion\">Graphic 52836 Version 3.0</div></div></div>"},"52837":{"type":"graphic_table","displayName":"BPD Axis I disorder","title":"Number of patients with borderline personality disorder who met criteria for other Axis I disorders","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Number of patients with borderline personality disorder who met criteria for other Axis I disorders</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1\" rowspan=\"2\">Axis I disorder</td> <td class=\"subtitle1\" colspan=\"2\"> <p>Subjects with borderline personality disorder</p> <p>N=379</p> </td> </tr> <tr> <td class=\"subtitle2\">n</td> <td class=\"subtitle2\">Percent</td> </tr> <tr> <td class=\"subtitle2_left\">Mood disorders</td> <td class=\"subtitle2_left\">365</td> <td class=\"subtitle2_left\">96</td> </tr> <tr> <td class=\"indent1\">Major depression</td> <td>314</td> <td>83</td> </tr> <tr> <td class=\"indent1\">Dysthymia</td> <td>146</td> <td>39</td> </tr> <tr> <td class=\"indent1\">Bipolar II disorder</td> <td>36</td> <td>9</td> </tr> <tr class=\"divider_top\"> <td class=\"subtitle2_left\">Anxiety disorders</td> <td class=\"subtitle2_left\">335</td> <td class=\"subtitle2_left\">88</td> </tr> <tr> <td class=\"indent1\">Posttraumatic stress disorder</td> <td>212</td> <td>56</td> </tr> <tr> <td class=\"indent1\">Panic disorder</td> <td>181</td> <td>48</td> </tr> <tr> <td class=\"indent1\">Social phobia</td> <td>174</td> <td>46</td> </tr> <tr> <td class=\"indent1\">Simple phobia</td> <td>120</td> <td>32</td> </tr> <tr> <td class=\"indent1\">Obsessive-compulsive disorder</td> <td>59</td> <td>16</td> </tr> <tr> <td class=\"indent1\">Generalized anxiety disorder</td> <td>51</td> <td>13</td> </tr> <tr> <td class=\"indent1\">Agoraphobia</td> <td>46</td> <td>12</td> </tr> <tr class=\"divider_top\"> <td class=\"subtitle2_left\">Substance use disorders</td> <td class=\"subtitle2_left\">243</td> <td class=\"subtitle2_left\">64</td> </tr> <tr> <td class=\"indent1\">Alcohol abuse/dependence</td> <td>198</td> <td>52</td> </tr> <tr> <td class=\"indent1\">Drug abuse/dependence</td> <td>175</td> <td>46</td> </tr> <tr class=\"divider_top\"> <td class=\"subtitle2_left\">Eating disorders</td> <td class=\"subtitle2_left\">201</td> <td class=\"subtitle2_left\">53</td> </tr> <tr> <td class=\"indent1\">Bulimia nervosa</td> <td>97</td> <td>26</td> </tr> <tr> <td class=\"indent1\">Anorexia nervosa</td> <td>79</td> <td>21</td> </tr> <tr> <td class=\"indent1\">Eating disorder not otherwise specified</td> <td>99</td> <td>26</td> </tr> <tr class=\"divider_top\"> <td class=\"subtitle2_left\">Somatoform disorders</td> <td class=\"subtitle2_left\">39</td> <td class=\"subtitle2_left\">10</td> </tr> <tr> <td class=\"indent1\">Hypochondriasis</td> <td>18</td> <td>5</td> </tr> <tr> <td class=\"indent1\">Somatization disorder</td> <td>16</td> <td>4</td> </tr> <tr> <td class=\"indent1\">Somatoform pain disorder</td> <td>16</td> <td>4</td> </tr> </tbody></table><html xmlns:mso=\"urn:schemas-microsoft-com:office:office\" xmlns:msdt=\"uuid:C2F41010-65B3-11d1-A29F-00AA00C14882\"><head>\r\n<!--[if gte mso 9]><xml>\n<mso:CustomDocumentProperties>\r\n<mso:Specialty msdt:dt=\"string\">22</mso:Specialty>\r\n<mso:Edit_Table msdt:dt=\"string\">&lt;a href=&quot;/Graphics/Pages/TableEditor.aspx?SPID=62104&amp;amp;Mode=Edit&quot;&gt;&lt;/a&gt;</mso:Edit_Table>\r\n<mso:Media_Notes msdt:dt=\"string\"></mso:Media_Notes>\r\n</mso:CustomDocumentProperties>\n</xml><![endif]-->\r\n</head></div><div class=\"graphic_reference\">Adapted from: Zanarini, MC, Frankenburg, FR, Dubo, ED, et al. Axis I comorbidity of borderline personality disorder. Am J Psychiatry 1998; 155:1733.</div><div id=\"graphicVersion\">Graphic 52837 Version 2.0</div></div></div>"},"52839":{"type":"graphic_figure","displayName":"Clubbing of the fingers","title":"Clubbing of the fingers","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Clubbing of the fingers</div><div class=\"cntnt\"><img style=\"width:425px; height:527px;\" src=\"images/PULM/52839_Clubbing_of_the_fingers.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">In a normal finger, the length of the perpendicular dropped from point A to point B should be greater than a similar line from C to D. In clubbing, the relationships are reversed&nbsp;â that is, the distance C-D is greater than the distance A-B. The other important change is the angle described by A-C-E. In the normal finger this is usually &lt;180 degrees, whereas in clubbing it is &gt;180 degrees.</div><div class=\"graphic_reference\">Panels A and C redrawn from: DeRemee RA. Facets of the algorithmic synthesis. In: DeRemee RA, (Ed), Clinical profiles of diffuse interstitial pulmonary disease, Mount Kisco, NY, Futura Publishing Company, Inc, 1990, pp. 9-44.<br />Panel B redrawn from: Bates B. A Guide to Physical Examination and History Taking, 5th Ed. Philadelphia: J.B. Lippincott Company, 1991.</div><div id=\"graphicVersion\">Graphic 52839 Version 4.0</div></div></div>"},"52840":{"type":"graphic_figure","displayName":"Types of stenosis","title":"Different types of tracheal stenosis","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Different types of tracheal stenosis</div><div class=\"cntnt\"><img style=\"width:434px; height:334px;\" src=\"images/PULM/52840_Types_of_stenosis.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">a) segmental stenosis, b) funnel stenosis, c) generalized stenosis.</div><div id=\"graphicVersion\">Graphic 52840 Version 1.0</div></div></div>"},"52841":{"type":"graphic_diagnosticimage","displayName":"Multiple metatarsal neck fractures","title":"Multiple metatarsal neck fractures","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Multiple metatarsal neck fractures</div><div class=\"cntnt\"><img style=\"width:230px; height:463px;\" src=\"images/RHEUM/52841_Angulated_mt_neck_fractures.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Fractures of the third and fourth distal metatarsal shaft (neck) are indicated by the arrows; the metatarsal heads are angulated.</div><div class=\"graphic_reference\">Courtesy of Robert L Hatch, MD, MPH and James R Clugston, MD, MS.</div><div id=\"graphicVersion\">Graphic 52841 Version 2.0</div></div></div>"},"52842":{"type":"graphic_figure","displayName":"Rel risk disease increase wt","title":"Adult weight change and the risk of disease","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Adult weight change and the risk of disease</div><div class=\"cntnt\"><img style=\"width:371px; height:512px;\" src=\"images/ENDO/52842_Rel_risk_disease_increase_w.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Even a modest increase in weight as an adult is associated with an increased risk of type 2 diabetes, hypertension, coronary heart disease, and cholelithiasis. Panel A shows data for women in the Nurses' Health Study, initially 30 to 55 years of age, who were followed for up to 18 years. Panel B shows data for men in the Health Professionals Follow-up Study, initially 40 to 65 years of age, who were followed for up to 10 years.</div><div class=\"graphic_reference\">Data from: Willett WC, Dietz WH, Colditz GA. Guidelines for healthy weight. N Engl J Med 1999; 341:427.</div><div id=\"graphicVersion\">Graphic 52842 Version 2.0</div></div></div>"},"52843":{"type":"graphic_diagnosticimage","displayName":"AIP ERCP","title":"Autoimmune pancreatitis","html":"<div class=\"graphic\"><div style=\"width: 492px\" class=\"figure\"><div class=\"ttl\">Autoimmune pancreatitis</div><div class=\"cntnt\"><img style=\"width:472px; height:346px;\" src=\"images/GAST/52843_AIP_ERCP.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Endoscopic retrograde cholangiopancreatography in a patient with autoimmune pancreatitis. The left panel shows a stricture in the common bile duct due to the surrounding enlarged pancreas (long arrow). The right panel shows a stent that has been inserted across the narrowed segment (short arrow).</div><div class=\"graphic_reference\">Courtesy of Peter Banks, MD.</div><div id=\"graphicVersion\">Graphic 52843 Version 3.0</div></div></div>"},"52845":{"type":"graphic_picture","displayName":"Vulvar debridement","title":"Vulvar debridement","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Vulvar debridement</div><div class=\"cntnt\"><img style=\"width:412px; height:325px;\" src=\"images/OBGYN/52845_Vulvar_debridement.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Extent of surgical excision in a diabetic with necrotizing fasciitis of the left vulva. Photograph taken on approximately hospital day 28, when closure was performed.</div><div class=\"graphic_reference\">Reproduced with permission from: Sweet RL, Gibbs RS. Atlas of Infectious Diseases of the Female Genital Tract. Philadelphia: Lippincott Williams &amp; Wilkins, 2005. Copyright &#169;2005 Lippincott Williams &amp; Wilkins.</div><div id=\"graphicVersion\">Graphic 52845 Version 1.0</div></div></div>"},"52846":{"type":"graphic_picture","displayName":"Stensens duct infxn SS","title":"Ascending salivary gland infection affecting Stensen's duct in SjÃ¶gren's syndrome","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Ascending salivary gland infection affecting Stensen's duct in Sj&#246;gren's syndrome</div><div class=\"cntnt\"><img style=\"width:396px; height:304px;\" src=\"images/RHEUM/52846_Stensens_duct_infxn_SS.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Xerostomia in Sj&#246;gren's syndrome predisposes patient to salivary gland infections and, as shown here, of Stensen's duct. The picture demonstrates pus from the opening of the duct.</div><div class=\"graphic_reference\">Courtesy of Robert Fox, MD, PhD.</div><div id=\"graphicVersion\">Graphic 52846 Version 3.0</div></div></div>"},"52847":{"type":"graphic_table","displayName":"Risk classific exercise class D","title":"Risk classification for exercise training: class D: unstable disease with activity restriction*","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Risk classification for exercise training: class D: unstable disease with activity restriction*</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1_single\">This classification includes individuals with any of the following:</td> </tr> <tr> <td class=\"indent1\">1. Unstable ischemia.</td> </tr> <tr> <td class=\"indent1\">2. Severe and symptomatic valvular stenosis or regurgitation.</td> </tr> <tr> <td class=\"indent1\">3. Congenital heart disease; criteria for risk that would prohibit exercise conditioning in patients with congenital heart disease should be guided by the 27<sup>th</sup> Bethesda Conference recommendations.</td> </tr> <tr> <td class=\"indent1\">4. Heart failure that is not compensated.</td> </tr> <tr> <td class=\"indent1\">5. Uncontrolled arrhythmias.</td> </tr> <tr> <td class=\"indent1\">6. Other medical conditions that could be aggravated by exercise.</td> </tr> <tr> <td class=\"subtitle1_single\">Activity guidelines:</td> </tr> <tr> <td class=\"indent1\">1. No activity is recommended for conditioning purposes.</td> </tr> <tr> <td class=\"indent1\">2. Attention should be directed to treating the patient and restoring the patient to Class C or better.</td> </tr> <tr> <td class=\"indent1\">3. Daily activities must be prescribed on the basis of individual assessment by the patient's personal clinician.</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">* Exercise for conditioning purposes is not recommended.</div><div class=\"graphic_reference\">Reproduced with permission from: Fletcher GF, Balady GJ, Amsterdam EA, et al. Circulation 2001; 104:1694. Copyright &copy; 2001 Lippincott Williams and Wilkins.</div><div id=\"graphicVersion\">Graphic 52847 Version 6.0</div></div></div>"},"52848":{"type":"graphic_picture","displayName":"Lichen planopilaris","title":"Lichen planopilaris","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Lichen planopilaris</div><div class=\"cntnt\"><img style=\"width:432px; height:325px;\" src=\"images/DERM/52848_Lichen_planopilaris.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Erythematous, keratotic papules at the base of hair follicles and scarring alopecia are present on the scalp in this patient with lichen planopilaris.</div><div class=\"graphic_reference\">Reproduced with permission from: <A style=\"FONT-STYLE: italic\" href=\"http://www.visualdx.com/\" target=_blank>www.visualdx.com</A>. Copyright Logical Images, Inc.</div><div id=\"graphicVersion\">Graphic 52848 Version 3.0</div></div></div>"},"52849":{"type":"graphic_figure","displayName":"Technique of below-knee amputation with skew flap","title":"Technique of below-knee amputation with skew flap","html":"<div class=\"graphic\"><div style=\"width: 528px\" class=\"figure\"><div class=\"ttl\">Technique of below-knee amputation with skew flap</div><div class=\"cntnt\"><img style=\"width:508px; height:679px;\" src=\"images/SURG/52849_BKA-skew-flap.jpg\" alt=\"Image\"/></div><div id=\"graphicVersion\">Graphic 52849 Version 2.0</div></div></div>"},"52850":{"type":"graphic_figure","displayName":"Anatomic distributions of the trigeminal nerve","title":"Anatomic distributions of the trigeminal nerve","html":"<div class=\"graphic\"><div style=\"width: 604px\" class=\"figure\"><div class=\"ttl\">Anatomic distributions of the trigeminal nerve</div><div class=\"cntnt\"><img style=\"width:584px; height:578px;\" src=\"images/EM/52850_Anatdistribtrigenerve.jpg\" alt=\"Image\"/></div><div class=\"graphic_reference\">Reproduced with permission from: Kassutto Z. Orofacial anesthesia techniques. In: Textbook of Pediatric Procedures, 2nd Edition, King C, Henretig FM (Eds), Lippincott Williams &amp; Wilkins, Philadelphia, 2008. Copyright Â© 2008 Lippincott Williams &amp; Wilkins. <A href=\"http://www.lww.com/\" target=_blank>www.lww.com</A>.</div><div id=\"graphicVersion\">Graphic 52850 Version 6.0</div></div></div>"},"52851":{"type":"graphic_table","displayName":"Causes palpitations child","title":"Causes of palpitations in children","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Causes of palpitations in children</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1_single\">Life threatening cardiac conditions</td> </tr> <tr> <td class=\"indent1\">Arrhythmia (eg, Wolff-Parkinson-White syndrome, prolonged QT syndrome, cardiac structural abnormalities [congenital heart disease, intracardiac tumors])</td> </tr> <tr> <td class=\"indent1\">Hypertrophic cardiomyopathy (HCM)</td> </tr> <tr> <td class=\"indent1\">Myocarditis</td> </tr> <tr> <td class=\"indent1\">Sick sinus syndrome</td> </tr> <tr> <td class=\"indent1\">Pacemaker malfunction</td> </tr> <tr> <td class=\"subtitle1_single\">Life threatening non-cardiac conditions</td> </tr> <tr> <td class=\"indent1\">Hypoglycemia</td> </tr> <tr> <td class=\"indent1\">Toxic exposure</td> </tr> <tr> <td class=\"indent1\">Pheochromocytoma</td> </tr> <tr> <td class=\"subtitle1_single\">Common conditions</td> </tr> <tr> <td class=\"indent1\">Premature atrial contractions</td> </tr> <tr> <td class=\"indent1\">Premature ventricular contractions</td> </tr> <tr> <td class=\"indent1\">Fever</td> </tr> <tr> <td class=\"indent1\">Anemia</td> </tr> <tr> <td class=\"indent1\">Exercise</td> </tr> <tr> <td class=\"indent1\">Emotional arousal</td> </tr> <tr> <td class=\"indent1\">Anxiety, panic attack</td> </tr> <tr> <td class=\"indent1\">Hyperventilation syndrome</td> </tr> <tr> <td class=\"indent1\">Drug-induced (caffeine, herbal medications, dietary supplements, albuterol, isotretinoin)</td> </tr> <tr> <td class=\"indent1\">Postural orthostatic tachycardia syndrome (POTS)</td> </tr> <tr> <td class=\"subtitle1_single\">Other conditions</td> </tr> <tr> <td class=\"indent1\">Acute rheumatic fever with valvular disease</td> </tr> <tr> <td class=\"indent1\">Hyperthyroidism</td> </tr> <tr> <td class=\"indent1\">Mitral valve prolapse</td> </tr> </tbody></table></div><div id=\"graphicVersion\">Graphic 52851 Version 4.0</div></div></div>"},"52852":{"type":"graphic_figure","displayName":"Dose response curves in HTN","title":"Dose relation between therapeutic effect and toxicity with antihypertensive drugs","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Dose relation between therapeutic effect and toxicity with antihypertensive drugs</div><div class=\"cntnt\"><img style=\"width:364px; height:250px;\" src=\"images/NEPH/52852_Dose_response_curves_in_HTN.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The theoretical therapeutic and toxic effect curves of antihypertensive agents vary based upon the administered dose. The theoretical effects of a single drug given at two different doses (10 and 20 units) are shown. At a dose of 10 units, the antihypertensive agent has a minimal toxic effect (A') and a moderate therapeutic effect (A). Doubling the dose, however, is associated with substantial toxic effects (B') but little increase in therapeutic efficacy (B).</div><div class=\"graphic_reference\">Redrawn from Epstein, M, Bakris, G, Arch Intern Med 1996; 156:1969.</div><div id=\"graphicVersion\">Graphic 52852 Version 1.0</div></div></div>"},"52853":{"type":"graphic_movie","displayName":"Apical 4-chamber echo HCM","title":"Apical 4-chamber echocardiogram in a patient with hypertrophic cardiomyopathy (HCM)","html":"<div class=\"graphic normal\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Apical 4-chamber echocardiogram in a patient with hypertrophic cardiomyopathy (HCM)</div><div class=\"cntnt\"><div class=\"videoplayer\" h264=\"images/CARD/52853_4chaphcmconv.mp4\" style=\"width:360px;height:272px\"></div><img style=\"width:289px; height:410px;\" src=\"images/CARD/52853_4chaphcm.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Apical four-chamber view from a two-dimensional echocardiogram shows apical and midventricular hypertrophy. During systole, the left ventricular cavity is nearly obliterated.</div><div class=\"graphic_reference\">Courtesy of Thomas Binder, MD. University of Vienna.</div><div id=\"graphicVersion\">Graphic 52853 Version 4.0</div></div></div>"},"52855":{"type":"graphic_waveform","displayName":"Continuous wave Doppler MS","title":"Continuous wave Doppler in mitral stenosis (MS)","html":"<div class=\"graphic\"><div style=\"width: 684px\" class=\"figure\"><div class=\"ttl\">Continuous wave Doppler in mitral stenosis (MS)</div><div class=\"cntnt\"><img style=\"width:664px; height:648px;\" src=\"images/CARD/52855_Continuous_wave_Doppler_MS.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Continuous wave Doppler obtained across the mitral orifice records a peak velocity of 1.7 m/s in this patient with rheumatic mitral stenosis (MS). Using the simplified Bernoulli formula, the initial diastolic gradient across the mitral valve is 12 mmHg.</div><div id=\"graphicVersion\">Graphic 52855 Version 3.0</div></div></div>"},"52857":{"type":"graphic_table","displayName":"Tumor size lymph node status","title":"Tumor size and lymph node status for women undergoing biopsy after screening mammography: breast cancer surveillance consortium, 1996-2001","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Tumor size and lymph node status for women undergoing biopsy after screening mammography: breast cancer surveillance consortium, 1996-2001</div><div class=\"cntnt\"><table cellspacing=\"0\">\r\n<tbody>\r\n\r\n<tr>\r\n<td class=\"subtitle1\" rowspan=\"4\">Variable</td>\r\n<td class=\"subtitle1\" colspan=\"11\">Lymph node status</td>\r\n</tr>\r\n<tr>\r\n<td class=\"subtitle2\" colspan=\"2\" rowspan=\"2\">Lymph nodes not examined</td>\r\n<td class=\"subtitle2\" colspan=\"2\" rowspan=\"2\">Negative</td>\r\n<td class=\"subtitle2\" colspan=\"6\">No. of positive LN's</td>\r\n<td class=\"subtitle2\" rowspan=\"3\">Total no.</td>\r\n</tr>\r\n<tr>\r\n<td class=\"subtitle2_left\" colspan=\"2\">1 to 3</td>\r\n<td class=\"subtitle2_left\" colspan=\"2\">4 to 9</td>\r\n<td class=\"subtitle2_left\" colspan=\"2\">&#8805;10</td>\r\n</tr>\r\n<tr>\r\n<td class=\"subtitle3\">No.</td>\r\n<td class=\"subtitle3\">Row percent</td>\r\n<td class=\"subtitle3\">No.</td>\r\n<td class=\"subtitle3\">Row percent</td>\r\n<td class=\"subtitle3\">No.</td>\r\n<td class=\"subtitle3\">Row percent</td>\r\n<td class=\"subtitle3\">No.</td>\r\n<td class=\"subtitle3\">Row percent</td>\r\n<td class=\"subtitle3\">No.</td>\r\n<td class=\"subtitle3\">Row percent</td>\r\n</tr>\r\n<tr>\r\n<td class=\"subtitle2_left\">Total</td>\r\n<td>639</td>\r\n<td>9.4</td>\r\n<td>4828</td>\r\n<td>71.0</td>\r\n<td>937</td>\r\n<td>13.8</td>\r\n<td>267</td>\r\n<td>3.9</td>\r\n<td>133</td>\r\n<td>2.0</td>\r\n<td>6804</td>\r\n</tr>\r\n<tr>\r\n\t<td class=\"subtitle2_left\" colspan=\"12\">Tumor size</td>\r\n</tr>\r\n<tr>\r\n<td class=\"indent1\">0-10 mm</td>\r\n<td>315</td>\r\n<td>13.3</td>\r\n<td>1882</td>\r\n<td>79.6</td>\r\n<td>133</td>\r\n<td>5.6</td>\r\n<td>22</td>\r\n<td>0.9</td>\r\n<td>13</td>\r\n<td>0.5</td>\r\n<td>2365 (100 percent)</td>\r\n</tr>\r\n<tr>\r\n<td class=\"indent1\">11-20 mm</td>\r\n<td>169</td>\r\n<td>7.0</td>\r\n<td>1760</td>\r\n<td>72.8</td>\r\n<td>394</td>\r\n<td>16.3</td>\r\n<td>72</td>\r\n<td>3.0</td>\r\n<td>24</td>\r\n<td>1.0</td>\r\n<td>2419 (100 percent)</td>\r\n</tr>\r\n<tr>\r\n<td class=\"indent1\">21-50 mm</td>\r\n<td>51</td>\r\n<td>4.2</td>\r\n<td>675</td>\r\n<td>55.6</td>\r\n<td>305</td>\r\n<td>25.1</td>\r\n<td>123</td>\r\n<td>10.1</td>\r\n<td>61</td>\r\n<td>5.0</td>\r\n<td>1215 (percent)</td>\r\n</tr>\r\n<tr>\r\n<td class=\"indent1\">&#62;50</td>\r\n<td>13</td>\r\n<td>6.3</td>\r\n<td>79</td>\r\n<td>38.2</td>\r\n<td>48</td>\r\n<td>23.2</td>\r\n<td>36</td>\r\n<td>17.4</td>\r\n<td>31</td>\r\n<td>15.0</td>\r\n<td>207</td>\r\n</tr>\r\n<tr>\r\n<td class=\"indent1\">Unknown*</td>\r\n<td>91</td>\r\n<td>15.2</td>\r\n<td>432</td>\r\n<td>72.2</td>\r\n<td>57</td>\r\n<td>9.5</td>\r\n<td>14</td>\r\n<td>2.3</td>\r\n<td>4</td>\r\n<td>0.7</td>\r\n<td>598</td>\r\n</tr>\r\n\r\n</tbody>\r\n</table></div><div class=\"graphic_footnotes\">LN: Lymph nodes.<br>* Unknown tumor size includes mammography diagnoses only, Paget disease, and pathologically invasive carcinoma, all with size not stated. Excluded from the table were 339 women who had lymph node examinations, including 10 women with an unknown number of positive lymph nodes and 329 women with unknown status of the lymph nodes examined.</div><div class=\"graphic_reference\">Reproduced from: Weaver, D, Rosenberg, R, Barlow, W, et al. Pathologic findings from the breast cancer surveillance consortium. CANCER 2006; 106:732. Copyright &#169;2006 the American Cancer Society. The material is reproduced with the permission of Wiley-Liss, Inc., a subsidiary of John Wiley &amp; Sons, Inc.</div><div id=\"graphicVersion\">Graphic 52857 Version 1.0</div></div></div>"},"52858":{"type":"graphic_waveform","displayName":"Rhythms with DDD pacemaker","title":"Rhythms seen with a normal DDD pacemaker","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Rhythms seen with a normal DDD pacemaker</div><div class=\"cntnt\"><img style=\"width:263px; height:267px;\" src=\"images/CARD/52858_RhythmswithDDDpacemaker.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The rhythms that occur in a patient with a DDD pacemaker depend upon the underlying heart rate and atrioventricular (AV) nodal conduction. The pacemaker spike is represented in blue. First panel: The pacemaker may be completely inhibited when the sinus rate is greater than the lower rate limit of the pacemaker. Second panel: P-wave synchronous pacing occurs when there is intrinsic AV nodal delay which is greater than the AV delay in the pacemaker. Third panel: Atrial pacing occurs when the sinus rate falls below the lower limit of the pacemaker and AV nodal conduction is intact. Fourth panel: If there is sinus bradycardia and AV nodal conduction delay, the pacemaker paces both atrium and ventricle, known as AV sequential pacing.</div><div id=\"graphicVersion\">Graphic 52858 Version 3.0</div></div></div>"},"52859":{"type":"graphic_figure","displayName":"Birth wt and insulin resistance","title":"Birth weight and insulin resistance","html":"<div class=\"graphic\"><div style=\"width: 490px\" class=\"figure\"><div class=\"ttl\">Birth weight and insulin resistance</div><div class=\"cntnt\"><img style=\"width:470px; height:310px;\" src=\"images/ENDO/52859_Birth_wt_and_insulin_resist.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Contrasting relationship between ponderal index at birth (kg/m<SUP>3</SUP>) and body mass index (kg/m<SUP>2</SUP>) in adulthood on mean insulin resistance. Insulin resistance varies directly with adult BMI and inversely with ponderal index at birth. Thus, the degree of insulin resistance is greatest with lower ponderal index at birth and higher BMI in adulthood (first panel, orange column). Insulin resistance is measured as the half-life (t<SUB>1/2</SUB>) of the fall in blood glucose during an intravenous insulin tolerance test.</div><div class=\"graphic_footnotes\">BMI: body mass index.</div><div class=\"graphic_reference\">Data from: Phillips DI, Barker DJ, Hales CN, et al. Thinness at birth and insulin resistance in adult life. Diabetologia 1994; 37:150.</div><div id=\"graphicVersion\">Graphic 52859 Version 4.0</div></div></div>"},"52860":{"type":"graphic_table","displayName":"Acute Rx severe UGI bleeding","title":"Acute management of severe upper gastrointestinal bleeding","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Acute management of severe upper gastrointestinal bleeding</div><div class=\"cntnt\"><table cellspacing=\"0\">\r\n            <tbody>\r\n                <tr>\r\n                    <td>1. Resuscitation and stabilization, initiation of medical therapy with an intravenous proton pump inhibitor</td>\r\n                </tr>\r\n                <tr>\r\n                    <td>2. Assessment of onset and severity of bleeding</td>\r\n                </tr>\r\n                <tr>\r\n                    <td>3. Risk stratification using validated prognostic scale</td>\r\n                </tr>\r\n                <tr>\r\n                    <td class=\"sublist1_start\">4. Diagnostic endoscopy</td>\r\n                </tr>\r\n                <tr>\r\n                    <td class=\"sublist2\">Preparation for emergent upper endoscopy</td>\r\n                </tr>\r\n                <tr>\r\n                    <td class=\"sublist2\">Localization and identification of the bleeding site</td>\r\n                </tr>\r\n                <tr>\r\n                    <td class=\"sublist2\">Idenification of stigmata of recent hemorrhage</td>\r\n                </tr>\r\n                <tr>\r\n                    <td class=\"sublist2\">Stratification of the risk for rebleeding</td>\r\n                </tr>\r\n                <tr>\r\n                    <td class=\"sublist1_start\">4. Therapeutic endoscopy</td>\r\n                </tr>\r\n                <tr>\r\n                    <td class=\"sublist2\">Control of active bleeding or high-risk lesions</td>\r\n                </tr>\r\n                <tr>\r\n                    <td class=\"sublist2\">Minimization of treatment-related complications</td>\r\n                </tr>\r\n                <tr>\r\n                    <td class=\"sublist2\">Treatment of persistent or recurrent bleeding</td>\r\n                </tr>\r\n            </tbody>\r\n        </table></div><div id=\"graphicVersion\">Graphic 52860 Version 4.0</div></div></div>"},"52861":{"type":"graphic_table","displayName":"EUS gallbladder polyps","title":"Endoscopic ultrasonography for the differential diagnosis of polypoid gallbladder lesions","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Endoscopic ultrasonography for the differential diagnosis of polypoid gallbladder lesions</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1\" rowspan=\"2\">&nbsp;</td> <td class=\"subtitle1\" rowspan=\"2\">Number of patients</td> <td class=\"subtitle1\" colspan=\"3\">Histologic diagnosis</td> </tr> <tr> <td class=\"subtitle2\">Cholesterol polyp</td> <td class=\"subtitle2\">Adenomyomatosis</td> <td class=\"subtitle2\">Neoplastic</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"5\">Preoperative diagnosis with endoscopic US</td> </tr> <tr> <td class=\"indent1\">Cholesterol polyp</td> <td>34</td> <td>34</td> <td>0</td> <td>0</td> </tr> <tr> <td class=\"indent1\">Adenomyomatosis</td> <td>7</td> <td>0</td> <td>7</td> <td>0</td> </tr> <tr> <td class=\"indent1\">Neoplastic</td> <td>17</td> <td>2</td> <td>0</td> <td>15</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"5\">Preoperative diagnosis with transabdominal US</td> </tr> <tr> <td class=\"indent1\">Cholesterol polyp</td> <td>24</td> <td>24</td> <td>0</td> <td>0</td> </tr> <tr> <td class=\"indent1\">Adenomymatosis</td> <td>5</td> <td>0</td> <td>5</td> <td>0</td> </tr> <tr> <td class=\"indent1\">Neoplastic</td> <td>29</td> <td>12</td> <td>2</td> <td>15</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">US: ultrasound.</div><div class=\"graphic_reference\">Data from: Sugiyama, M, Xie, XY, Atomi, Y, Saito, M, Ann Surg 1999; 229:498.</div><div id=\"graphicVersion\">Graphic 52861 Version 2.0</div></div></div>"},"52862":{"type":"graphic_picture","displayName":"LPL path","title":"Bone marrow histology of lymphoplasmacytic lymphoma","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Bone marrow histology of lymphoplasmacytic lymphoma</div><div class=\"cntnt\"><img style=\"width:432px; height:289px;\" src=\"images/HEME/52862_LPLpath.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Bone marrow aspirate from a patient with WaldenstrÃ¶m macroglobulinemia demonstrating excess mature lymphocytes (thin arrow), lymphoplasmacytic cells, and plasma cells (thick arrow) consistent with lymphoplasmacytic lymphoma.</div><div class=\"graphic_reference\">Reproduced with permission from: Armitage JO, Mauch PM, Harris NL, et al. Non-Hodgkin Lymphomas, 2nd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2010. Copyright Â© 2010 Lippincott Williams &amp; Wilkins. <A href=\"http://www.lww.com/\" target=_blank>www.lww.com</A>.</div><div id=\"graphicVersion\">Graphic 52862 Version 8.0</div></div></div>"},"52863":{"type":"graphic_picture","displayName":"Fingertip bruises","title":"Fingertip bruises","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Fingertip bruises</div><div class=\"cntnt\"><img style=\"width:216px; height:141px;\" src=\"images/EM/52863_Fingertipbruises.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Note the oval shaped bruises on the child's trunk.</div><div class=\"graphic_reference\">Courtesy of Joan E Shook, MD.</div><div id=\"graphicVersion\">Graphic 52863 Version 2.0</div></div></div>"},"52864":{"type":"graphic_table","displayName":"Comparison of PFC properties","title":"Physical properties of air, water, saline, and three perfluorochemical fluids","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Physical properties of air, water, saline, and three perfluorochemical fluids</div><div class=\"cntnt\"><table cellspacing=\"0\">\n\n  <tbody>\n\n\n    <tr>\n\n      <td class=\"subtitle1\">Physical property</td>\n\n      <td class=\"subtitle1\">Air</td>\n\n      <td class=\"subtitle1\">Water</td>\n\n      <td class=\"subtitle1\">Saline</td>\n\n      <td class=\"subtitle1\">Perfluoro- octylbromide (LiquiVent)</td>\n\n      <td class=\"subtitle1\">Perfluoro- alkylfuran (RIMAR)</td>\n\n      <td class=\"subtitle1\">Perfluoro- decalin (APF-140)</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Density (gm/mL at 25&#176;C)</td>\n\n      <td>0.0013</td>\n\n      <td>1.00</td>\n\n      <td>1.00</td>\n\n      <td>1.93</td>\n\n      <td>1.78</td>\n\n      <td>1.95</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Viscosity (centipoise at 25&#176;C)</td>\n\n      <td>0.02</td>\n\n      <td>0.67</td>\n\n      <td>1.0</td>\n\n      <td>2.12</td>\n\n      <td>1.46</td>\n\n      <td>5.65</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Surface tension (dynes/cm at 25&#176;C)</td>\n\n      <td>-</td>\n\n      <td>60.0</td>\n\n      <td>72.0</td>\n\n      <td>18.0</td>\n\n      <td>15.0</td>\n\n      <td>15.0</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Vapor pressure (torr at 37&#176;C)</td>\n\n      <td>-</td>\n\n      <td>50.0</td>\n\n      <td>47.0</td>\n\n      <td>11.0</td>\n\n      <td>63.0</td>\n\n      <td>14.0</td>\n\n    </tr>\n\n    <tr>\n\n      <td>O2 solubility at 25&#176;C (mL gas/100 mL liquid)</td>\n\n      <td>21.0</td>\n\n      <td>3.0</td>\n\n      <td>3.0</td>\n\n      <td>53.0</td>\n\n      <td>52.0</td>\n\n      <td>49.0</td>\n\n    </tr>\n\n    <tr>\n\n      <td>CO2 solubility at 37&#176;C (mL gas/100 mL liquid)</td>\n\n      <td>-</td>\n\n      <td>55.0</td>\n\n      <td>57.0</td>\n\n      <td>210.0</td>\n\n      <td>160.0</td>\n\n      <td>140.0</td>\n\n    </tr>\n\n  </tbody>\n</table></div><div id=\"graphicVersion\">Graphic 52864 Version 1.0</div></div></div>"},"52865":{"type":"graphic_table","displayName":"Myocardial states LV dysfunct","title":"Spectrum of irreversible and viable myocardial findings in patients with areas of LV dysfunction at rest","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Spectrum of irreversible and viable myocardial findings in patients with areas of LV dysfunction at rest</div><div class=\"cntnt\"><table cellspacing=\"0\">\n\n  <tbody>\n\n    <tr>\n\n      <td class=\"subtitle1\">State of myocardium</td>\n\n      <td class=\"subtitle1\" colspan=\"6\" rowspan=\"1\">LV\ndysfunction at rest</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Irreversibly damaged</td>\n\n      <td>+</td>\n\n      <td>+</td>\n\n      <td>+</td>\n\n      <td>+</td>\n\n      <td>-</td>\n\n      <td>-</td>\n\n    </tr>\n\n    <tr>\n\n      <td class=\"sublist1_start\" colspan=\"7\">Viable and at risk</td>\n    </tr>\n\n    <tr>\n\n      <td class=\"sublist1\">Hibernating</td>\n\n      <td class=\"sublist_other\">-</td>\n\n      <td class=\"sublist_other\">+</td>\n\n      <td class=\"sublist_other\">-</td>\n\n      <td class=\"sublist_other\">+</td>\n\n      <td class=\"sublist_other\">+</td>\n\n      <td class=\"sublist_other\">+</td>\n\n    </tr>\n\n    <tr>\n\n      <td class=\"sublist1\">Ischemic on \"stress\"</td>\n\n      <td class=\"sublist_other\">-</td>\n\n      <td class=\"sublist_other\">-</td>\n\n      <td class=\"sublist_other\">+</td>\n\n      <td class=\"sublist_other\">+</td>\n\n      <td class=\"sublist_other\">-</td>\n\n      <td class=\"sublist_other\">+</td>\n\n    </tr>\n\n\n  </tbody>\n</table></div><div class=\"graphic_footnotes\">LV: left ventricular; +: yes; -: no.</div><div id=\"graphicVersion\">Graphic 52865 Version 1.0</div></div></div>"},"52867":{"type":"graphic_figure","displayName":"Survival RPC and renal dis","title":"Survival in relapsing polychondritis with and without renal involvement","html":"<div class=\"graphic\"><div style=\"width: 490px\" class=\"figure\"><div class=\"ttl\">Survival in relapsing polychondritis with and without renal involvement</div><div class=\"cntnt\"><img style=\"width:470px; height:261px;\" src=\"images/RHEUM/52867_Survival_RPC_and_renal_dis.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The relative survival of patients with relapsing polychondritis and renal disease is significantly less than those with polychondritis and without renal involvement.</div><div class=\"graphic_reference\">Data from Chang-Miller, A, Okamura, M, Torres, VE, et al. Medicine 1987; 66:202.</div><div id=\"graphicVersion\">Graphic 52867 Version 1.0</div></div></div>"},"52868":{"type":"graphic_picture","displayName":"A lumbricoides adult worm","title":"<em>Ascaris lumbricoides</em> adult female worm","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\"><em>Ascaris lumbricoides</em> adult female worm</div><div class=\"cntnt\"><img style=\"width:371px; height:300px;\" src=\"images/ID/52868_A_lumbricoides_adult_worm.jpg\" alt=\"Image\"/></div><div class=\"graphic_reference\">Centers for Disease Control and Prevention.&nbsp;DPDx: Ascariasis.&nbsp;<A href=\"http://www.cdc.gov/dpdx/ascariasis/index.html\">http://www.cdc.gov/dpdx/ascariasis/index.html</A>.</div><div id=\"graphicVersion\">Graphic 52868 Version 4.0</div></div></div>"},"52869":{"type":"graphic_table","displayName":"Accuracy transferrin saturation","title":"Sensitivity and specificity of transferrin saturation and serum ferritin concentration for detection of C282Y/C282Y homozygosity in hereditary hemochromatosis*","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Sensitivity and specificity of transferrin saturation and serum ferritin concentration for detection of C282Y/C282Y homozygosity in hereditary hemochromatosis*</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1\" rowspan=\"2\">Substance</td> <td class=\"subtitle1\" colspan=\"3\">Sensitivity</td> <td class=\"subtitle1\" colspan=\"3\">Specificity</td> </tr> <tr> <td class=\"subtitle2\">Men</td> <td class=\"subtitle2\">Women</td> <td class=\"subtitle2\">Both</td> <td class=\"subtitle2\">Men</td> <td class=\"subtitle2\">Women</td> <td class=\"subtitle2\">Both</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"7\">Transferrin saturation, percent</td> </tr> <tr> <td class=\"indent1\">&#8805;45 </td> <td>0.81&nbsp;</td> <td>0.48</td> <td>0.64 (0.56-0.72)</td> <td>0.94</td> <td>0.97</td> <td>0.96 (0.96-0.96)</td> </tr> <tr> <td class=\"indent1\">&#8805;50 </td> <td>0.76</td> <td>0.40</td> <td>0.57 (0.49-0.65)</td> <td>0.97</td> <td>0.99</td> <td>0.98 (0.98-0.98)</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"7\">Serum ferritin concentration</td> </tr> <tr> <td class=\"indent1\">&#8805;200 mcg/L</td> <td>0.78</td> <td>0.54 </td> <td>0.66 (0.58-0.73)</td> <td>0.76</td> <td>0.95</td> <td>0.85 (0.85-0.86)</td> </tr> <tr> <td class=\"indent1\">&#8805;250 mcg/L</td> <td>0.77</td> <td>0.46</td> <td>0.60 (0.52-0.68)</td> <td>0.85</td> <td>0.97</td> <td>0.91 (0.91-0.91)</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">* Values in parentheses are 95 percent confidence intervals.</div><div class=\"graphic_reference\">Data from: Beutler E, Felitti V, Gelbart T, Ho N. Ann Intern Med 2000; 133:329. Updated from Koziol JA, et al. Ann Intern Med 2002; 137:700.</div><div id=\"graphicVersion\">Graphic 52869 Version 4.0</div></div></div>"},"52874":{"type":"graphic_diagnosticimage","displayName":"TTTS3","title":"TTTS3","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">TTTS3</div><div class=\"cntnt\"><img style=\"width:360px; height:360px;\" src=\"images/OBGYN/52874_TTTS3.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Distended fetal bladder in the recipient fetus is noted at approximately 21.5 weeks of gestation.</div><div class=\"graphic_reference\">Courtesy of Kenneth J Moise, Jr, MD &amp; Anthony Johnson, DO.</div><div id=\"graphicVersion\">Graphic 52874 Version 3.0</div></div></div>"},"52877":{"type":"graphic_figure","displayName":"Synthesis of gastrin","title":"Synthesis of gastrin","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Synthesis of gastrin</div><div class=\"cntnt\"><img style=\"width:439px; height:547px;\" src=\"images/GAST/52877_Synthesis_of_gastrin.gif\" alt=\"Image\"/></div><div id=\"graphicVersion\">Graphic 52877 Version 1.0</div></div></div>"},"52880":{"type":"graphic_table","displayName":"FTT tips for parents PI","title":"Tips for parents of children who need to gain weight","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Tips for parents of children who need to gain weight</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1_single\">Food advice</td> </tr> <tr> <td class=\"indent1\">Children who drink a lot may not eat as much food. At mealtimes, give your child food first. (Drinks are filling and have fewer calories.)</td> </tr> <tr> <td class=\"indent1\">Fruit juices should not be offered to children before 1 year of age. After 1 year, give only 100% fruit juice and limit to 4 ounces (120 milliliters) per day. Limit all sweetened or carbonated beverages. Breast milk, formula, or milk (for children older than 1 year) is best. </td> </tr> <tr> <td class=\"indent1\">Don't worry if your child wants to eat the same food every day. It is more important that he or she gets enough calories and protein.</td> </tr> <tr> <td class=\"indent1\">Junk foods have little protein and fewer calories than some other food choices. Junk foods will not help growth.</td> </tr> <tr> <td class=\"indent1\">Offer foods that are easy for your child to handle (such as cereal, slices of banana, or green beans).</td> </tr> <tr> <td class=\"indent1\">Add margarine, mayonnaise, gravies, and grated cheese. For snacks, use cheese, pudding, bananas, or dried fruit.</td> </tr> <tr> <td class=\"subtitle1_single\">Feeding times</td> </tr> <tr> <td class=\"indent1\">Children need to eat often, but not all the time. Offer something every 2 to 3 hours, to allow 3 meals and 2 to 3 snacks a day. Avoid snacks right after an unfinished meal.</td> </tr> <tr> <td class=\"indent1\">Children work well with schedules. Try to keep mealtimes and snack times about the same each day.</td> </tr> <tr> <td class=\"indent1\">Allow 1 hour without food or drink (except water) before a meal so your child gets hungry.</td> </tr> <tr> <td class=\"indent1\">Do not make mealtime too long for your child. (Fifteen minutes is probably long enough for a toddler.)</td> </tr> <tr> <td class=\"subtitle1_single\">Feeding behavior</td> </tr> <tr> <td class=\"indent1\">Try to relax. Mealtimes should be nice for everyone.</td> </tr> <tr> <td class=\"indent1\">Learn how your child acts when he or she is hungry or full. Learn what foods he or she likes.</td> </tr> <tr> <td class=\"indent1\">You can choose what food to feed your child, but your child chooses how much to eat.</td> </tr> <tr> <td class=\"indent1\">Avoid battles over eating. Do not force, bribe, threaten, or punish your child. Instead, praise your child for eating well.</td> </tr> <tr> <td class=\"indent1\">Do not punish your child by not feeding him or her.</td> </tr> <tr> <td class=\"indent1\">Allow your child to feed himself or herself. Try very small amounts at first. Offer seconds later. Expect a mess and be ready for easy clean-up (use bibs, newspaper under high chair, etc).</td> </tr> <tr> <td class=\"indent1\">If your baby wants to hold the spoon, use 2 spoons. Let your baby hold one, and you use the other to feed your baby.</td> </tr> <tr> <td class=\"subtitle1_single\">Feeding area</td> </tr> <tr> <td class=\"indent1\">Try to eat together as a family so that brothers, sisters, and parents can show a young child what good eating behavior is.</td> </tr> <tr> <td class=\"indent1\">Limit things that take your child's attention away from eating, such as television.</td> </tr> <tr> <td class=\"indent1\">Make sure your child can reach the food. (Use a high chair, booster seat, or small table.)</td> </tr> </tbody></table></div><div class=\"graphic_reference\">Data from:<br /><OL>&#xD;&#xA;<LI>Bithoney WG, Dubowitz H, Egan H. Failure to thrive/growth deficiency. Pediatr Rev 1992; 13:453. </LI>&#xD;&#xA;<LI>Frank DA, Zeisel SH. Failure to thrive. Pediatr Clin North Am 1988; 35:1187. </LI>&#xD;&#xA;<LI>Frank D, Silva M, Needlman R. Failure to thrive: Mystery, myth and method. Contemp Pediatr 1993; 10:114. </LI></OL></div><div id=\"graphicVersion\">Graphic 52880 Version 11.0</div></div></div>"},"52882":{"type":"graphic_figure","displayName":"Normal assortment","title":"Normal assortment","html":"<div class=\"graphic\"><div style=\"width: 628px\" class=\"figure\"><div class=\"ttl\">Normal assortment</div><div class=\"cntnt\"><img style=\"width:608px; height:334px;\" src=\"images/PC/52882_Normal_assortment.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Normal chromosomal crossover and assortment during meiosis. Maternal (M) and Paternal (P) chromosomes exchange homologous segments during metaphase, resulting in new haplotypes (in red). Following disjunction (separation of two chromosomal copies), one copy of each chromosome assorts into individual gametes.</div><div id=\"graphicVersion\">Graphic 52882 Version 1.0</div></div></div>"},"52883":{"type":"graphic_figure","displayName":"Stocking donner","title":"Using a stocking donner to put on compression stockings","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Using a stocking donner to put on compression stockings</div><div class=\"cntnt\"><img style=\"width:345px; height:498px;\" src=\"images/PC/52883_Stocking_donner.jpg\" alt=\"Image\"/></div><div id=\"graphicVersion\">Graphic 52883 Version 1.0</div></div></div>"},"52885":{"type":"graphic_figure","displayName":"External eye structure","title":"External eye structures","html":"<div class=\"graphic\"><div style=\"width: 571px\" class=\"figure\"><div class=\"ttl\">External eye structures</div><div class=\"cntnt\"><img style=\"width:551px; height:468px;\" src=\"images/ID/52885_External_eye_structure.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Diagram of the external eye structures with surrounding muscles and the optic nerve.</div><div id=\"graphicVersion\">Graphic 52885 Version 3.0</div></div></div>"},"52887":{"type":"graphic_table","displayName":"Drugs removed with HP","title":"Drugs and chemicals removed with hemoperfusion","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Drugs and chemicals removed with hemoperfusion</div><div class=\"cntnt\"><table class=\"container\" cellspacing=\"0\"><tbody> <tr> <td class=\"container\"> <table cellspacing=\"0\"> <tbody> <tr> <td class=\"subtitle1_single\">Barbiturates</td> </tr> <tr> <td class=\"indent1\">Amobarbital</td> </tr> <tr> <td class=\"indent1\">Butabarbital</td> </tr> <tr> <td class=\"indent1\">Hexabarbital</td> </tr> <tr> <td class=\"indent1\">Pentobarbital</td> </tr> <tr> <td class=\"indent1\">Phenobarbital</td> </tr> <tr> <td class=\"indent1\">Quinalbital</td> </tr> <tr> <td class=\"indent1\">Secobarbital</td> </tr> <tr> <td class=\"indent1\">Thiopental</td> </tr> <tr> <td class=\"indent1\">Vinalbital</td> </tr> <tr> <td class=\"subtitle1_single\">Antidepressants</td> </tr> <tr> <td class=\"indent1\">(Amitryptiline)</td> </tr> <tr> <td class=\"indent1\">(Imipramine)</td> </tr> <tr> <td class=\"indent1\">(Tricyclics)</td> </tr> <tr> <td class=\"subtitle1_single\">Metals</td> </tr> <tr> <td class=\"indent1\">Aluminum*</td> </tr> <tr> <td class=\"indent1\">Cisplatin*</td> </tr> <tr> <td class=\"indent1\">Iron*</td> </tr> <tr> <td class=\"indent1\">Thallium</td> </tr> <tr> <td class=\"subtitle1_single\">Miscellaneous</td> </tr> <tr> <td class=\"indent1\">Aminophylline</td> </tr> <tr> <td class=\"indent1\">Cimetidine</td> </tr> <tr> <td class=\"indent1\">(Fluoroacetamide)</td> </tr> <tr> <td class=\"indent1\">(Phencyclidine)</td> </tr> <tr> <td class=\"indent1\">Phenols</td> </tr> <tr> <td class=\"indent1\">(Podophyllin)</td> </tr> <tr> <td class=\"indent1\">Theophylline</td> </tr> <tr> <td class=\"subtitle1_single\">Solvents, gases</td> </tr> <tr> <td class=\"indent1\">Carbon tetrachloride</td> </tr> <tr> <td class=\"indent1\">Ethylene oxide</td> </tr> <tr> <td class=\"indent1\">Trichloroethane</td> </tr> </tbody> </table> </td> <td class=\"container\"> <table cellspacing=\"0\"> <tbody> <tr> <td class=\"subtitle1_single\">Antimicrobials/anticancer</td> </tr> <tr> <td class=\"indent1\">(Adriamycin)</td> </tr> <tr> <td class=\"indent1\">Ampicillin</td> </tr> <tr> <td class=\"indent1\">Carmustine</td> </tr> <tr> <td class=\"indent1\">Chloramphenicol</td> </tr> <tr> <td class=\"indent1\">Chloroquine</td> </tr> <tr> <td class=\"indent1\">Clindamycin</td> </tr> <tr> <td class=\"indent1\">Dapsone</td> </tr> <tr> <td class=\"indent1\">Doxorubicin</td> </tr> <tr> <td class=\"indent1\">Gentamicin</td> </tr> <tr> <td class=\"indent1\">Isoniazid</td> </tr> <tr> <td class=\"indent1\">(Methotrexate)</td> </tr> <tr> <td class=\"indent1\">Thiabendazole</td> </tr> <tr> <td class=\"indent1\">Vancomycin</td> </tr> <tr> <td class=\"indent1\">Pentamidine</td> </tr> <tr> <td class=\"subtitle1_single\">Analgesics, antirheumatic</td> </tr> <tr> <td class=\"indent1\">Acetaminophen</td> </tr> <tr> <td class=\"indent1\">Acetylsalicylic acid</td> </tr> <tr> <td class=\"indent1\">Colchicine</td> </tr> <tr> <td class=\"indent1\">D-propoxyphyene</td> </tr> <tr> <td class=\"indent1\">Methylsalicylate</td> </tr> <tr> <td class=\"indent1\">Phenylbutazone</td> </tr> <tr> <td class=\"indent1\">Salicylic acid</td> </tr> <tr> <td class=\"indent1\">Tramadol</td> </tr> <tr> <td class=\"subtitle1_single\">Cardiovascular</td> </tr> <tr> <td class=\"indent1\">Digoxin</td> </tr> <tr> <td class=\"indent1\">Diltazem</td> </tr> <tr> <td class=\"indent1\">(Disopyramide)</td> </tr> <tr> <td class=\"indent1\">Metoprolol</td> </tr> <tr> <td class=\"indent1\">N-acetylprocainamide</td> </tr> <tr> <td class=\"indent1\">Procainamide</td> </tr> <tr> <td class=\"indent1\">Quinidine</td> </tr> <tr> <td class=\"indent1\">Cibenzoline</td> </tr> </tbody> </table> </td> <td class=\"container\"> <table cellspacing=\"0\"> <tbody> <tr> <td class=\"subtitle1_single\">Plant and animal toxins, herbicides, insecticides</td> </tr> <tr> <td class=\"indent1\">Amanitin</td> </tr> <tr> <td class=\"indent1\">Chlordane</td> </tr> <tr> <td class=\"indent1\">Demeton sulfoxide</td> </tr> <tr> <td class=\"indent1\">Dimethoate</td> </tr> <tr> <td class=\"indent1\">Diquat</td> </tr> <tr> <td class=\"indent1\">Methylparathion</td> </tr> <tr> <td class=\"indent1\">Nitrostigmine</td> </tr> <tr> <td class=\"indent1\">Organophosphates<sup>&#182;</sup></td> </tr> <tr> <td class=\"indent1\">Phalloidin</td> </tr> <tr> <td class=\"indent1\">Polychlorinated biphenyls</td> </tr> <tr> <td class=\"indent1\">Paraquat</td> </tr> <tr> <td class=\"indent1\">Parathion</td> </tr> <tr> <td class=\"indent1\">Star fruit</td> </tr> <tr> <td class=\"indent1\">Tetramine</td> </tr> <tr> <td class=\"subtitle1_single\">Nonbarbiturate hypnotics, sedatives and tranquilizers</td> </tr> <tr> <td class=\"indent1\">Carbromal</td> </tr> <tr> <td class=\"indent1\">Chloral hydrate</td> </tr> <tr> <td class=\"indent1\">Chlorpromazine</td> </tr> <tr> <td class=\"indent1\">(Diazepam)</td> </tr> <tr> <td class=\"indent1\">Diphenhydramine</td> </tr> <tr> <td class=\"indent1\">Ethchlorvynol</td> </tr> <tr> <td class=\"indent1\">Glutethimide</td> </tr> <tr> <td class=\"indent1\">Meprobamate</td> </tr> <tr> <td class=\"indent1\">Methaqualone</td> </tr> <tr> <td class=\"indent1\">Methsuximide</td> </tr> <tr> <td class=\"indent1\">Methyprylon</td> </tr> <tr> <td class=\"indent1\">Promazine</td> </tr> <tr> <td class=\"indent1\">Promethazine</td> </tr> <tr> <td class=\"indent1\">Valproic acid</td> </tr> </tbody> </table> </td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">( ): not well removed.<br />* Removed with chelating agent.<br />&para; With lipid emulsion.</div><div id=\"graphicVersion\">Graphic 52887 Version 2.0</div></div></div>"},"52889":{"type":"graphic_picture","displayName":"Toxoplasmosis of placenta","title":"Toxoplasmosis of the placenta","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Toxoplasmosis of the placenta</div><div class=\"cntnt\"><img style=\"width:396px; height:503px;\" src=\"images/OBGYN/52889_Toxoplasmosis_of_placenta.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">(A) Granulomatous villitis (B) Trophozoites.</div><div class=\"graphic_reference\">Courtesy of Drucilla J Roberts, MD.</div><div id=\"graphicVersion\">Graphic 52889 Version 2.0</div></div></div>"},"52891":{"type":"graphic_figure","displayName":"Delivery rates by diagnosis","title":"Cumulative delivery rates after oocyte donation","html":"<div class=\"graphic\"><div style=\"width: 532px\" class=\"figure\"><div class=\"ttl\">Cumulative delivery rates after oocyte donation</div><div class=\"cntnt\"><img style=\"width:512px; height:373px;\" src=\"images/ENDO/52891_Delivery_rates_by_diagnosis.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Life-table analysis of women undergoing oocyte donation denoting success rates for live births per embryo transfer over five cycles according to the primary diagnosis. The thick white line represents the mean rate of success.</div><div class=\"graphic_footnotes\">POF: premature ovarian failure; IVF: in vitro fertilization.</div><div class=\"graphic_reference\">Adapted from: Paulson RJ, et al. Cumulative conception and live birth rates after oocyte donation: implications regarding endometrial receptivity. Hum Reprod 1997; 12:835.</div><div id=\"graphicVersion\">Graphic 52891 Version 2.0</div></div></div>"},"52892":{"type":"graphic_table","displayName":"Drugs that cause hypoglycemia","title":"Drugs other than antihyperglycemic agents and alcohol reported to cause hypoglycemia","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Drugs other than antihyperglycemic agents and alcohol reported to cause hypoglycemia</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1_single\">Moderate quality of evidence </td> </tr> <tr> <td>Cibenzoline</td> </tr> <tr> <td>Gatifloxacin</td> </tr> <tr> <td>Pentamidine</td> </tr> <tr> <td>Quinine</td> </tr> <tr> <td>Indomethacin</td> </tr> <tr> <td>Glucagon (during endoscopy)</td> </tr> <tr> <td class=\"subtitle1_single\">Low quality of evidence </td> </tr> <tr> <td>Chloroquineoxaline sulfonamide</td> </tr> <tr> <td>Artesunate/artemisin/artemether</td> </tr> <tr> <td>IGF-1</td> </tr> <tr> <td>Lithium</td> </tr> <tr> <td>Propoxyphene/dextropropoxyphene</td> </tr> <tr> <td class=\"subtitle1_single\">Very low quality of evidence </td> </tr> <tr> <td class=\"subtitle2_single\">Drugs with &#62;25 cases of hypoglycemia identified </td> </tr> <tr> <td class=\"indent1\">Angiotensin-converting enzyme inhibitors </td> </tr> <tr> <td class=\"indent1\">Angiotensin receptor antagonists </td> </tr> <tr> <td class=\"indent1\">Beta-adrenergic receptor antagonists </td> </tr> <tr> <td class=\"indent1\">Levofloxacin </td> </tr> <tr> <td class=\"indent1\">Mifepristone </td> </tr> <tr> <td class=\"indent1\">Disopyramide </td> </tr> <tr> <td class=\"indent1\">Trimethoprim-sulfamethoxazole </td> </tr> <tr> <td class=\"indent1\">Heparin </td> </tr> <tr> <td class=\"indent1\">6-mercaptopurine </td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">IGF-1: insulin-like growth factor 1.</div><div class=\"graphic_reference\">Reproduced with permission from: Cryer PE, Axelrod L, Grossman AB, et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2009; 94:709. Copyright Â© 2009 The Endocrine Society.</div><div id=\"graphicVersion\">Graphic 52892 Version 9.0</div></div></div>"},"52895":{"type":"graphic_algorithm","displayName":"Nonresolving pneumonia approach","title":"Approach to nonresolving pneumonia","html":"<div class=\"graphic\"><div style=\"width: 596px\" class=\"figure\"><div class=\"ttl\">Approach to nonresolving pneumonia</div><div class=\"cntnt\"><img style=\"width:576px; height:640px;\" src=\"images/PULM/52895_Nonresolving_pneu_appr_edt2.gif\" alt=\"Image\"/></div><div class=\"graphic_footnotes\">CT: computed tomography; EBUS: endobronchial ultrasound; FNA: fine needle aspiration.</div><div id=\"graphicVersion\">Graphic 52895 Version 4.0</div></div></div>"},"52896":{"type":"graphic_figure","displayName":"Isoelectric focusing of hemoglobins","title":"Isoelectric focusing for separation of hemoglobins","html":"<div class=\"graphic\"><div style=\"width: 606px\" class=\"figure\"><div class=\"ttl\">Isoelectric focusing for separation of hemoglobins</div><div class=\"cntnt\"><img style=\"width:586px; height:310px;\" src=\"images/HEME/52896_Isoelectric_focus_Hgb_edt.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Isoelectric focusing gel showing separation pattern of various hemoglobins. C is a control mix of Hbs A, F, S, and C. Note the differences in mobility of Hb C and E (lanes 5 and 6), and Hb S and D (lanes 1 and 2) using this separation method.</div><div id=\"graphicVersion\">Graphic 52896 Version 5.0</div></div></div>"},"52897":{"type":"graphic_figure","displayName":"Venovenous bypass to control liver bleeding","title":"Venovenous bypass to control liver bleeding","html":"<div class=\"graphic\"><div style=\"width: 552px\" class=\"figure\"><div class=\"ttl\">Venovenous bypass to control liver bleeding</div><div class=\"cntnt\"><img style=\"width:532px; height:655px;\" src=\"images/SURG/52897_Venovenous-bypass.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Venovenous bypass diverts venous blood below the level of a clamp on the inferior vena cava through an extracorporeal circuit and into the superior vena cava.</div><div id=\"graphicVersion\">Graphic 52897 Version 3.0</div></div></div>"},"52899":{"type":"graphic_picture","displayName":"Scedosporium and Lomentospora cultures","title":"<EM>Scedosporium apiospermum</EM> and <EM>Lomentospora prolificans </EM>cultures","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\"><EM>Scedosporium apiospermum</EM> and <EM>Lomentospora prolificans </EM>cultures</div><div class=\"cntnt\"><img style=\"width:432px; height:234px;\" src=\"images/ID/52899_Apiospermumandprolificans.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Macroscopic appearance of<EM> S. apiospermum </EM>(left) and <EM>L. prolificans </EM>(right).</div><div class=\"graphic_reference\">Courtesy of Barbara D. Alexander, MD, MHS and Sylvia F. Costa, MD.</div><div id=\"graphicVersion\">Graphic 52899 Version 6.0</div></div></div>"},"52901":{"type":"graphic_figure","displayName":"Calcium scores CHD men women","title":"Diagnostic yield of calcium screening in symptomatic men and women","html":"<div class=\"graphic\"><div style=\"width: 545px\" class=\"figure\"><div class=\"ttl\">Diagnostic yield of calcium screening in symptomatic men and women</div><div class=\"cntnt\"><img style=\"width:525px; height:351px;\" src=\"images/CARD/52901_Cal_scores_CHD_men_wom_edt.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">In a study of 1764 symptomatic patients with suspected coronary heart disease who underwent electron beam computed tomography (EBCT) and coronary angiography, the calcium score on EBCT correlates with the presence or absence of a significant stenosis on angiography. The higher scores (A for men and C for women) define the calcium score thresholds (CSTs) for the 90 percent of patients with significant stenoses, while the lower scores (B for men and D for women) define the CSTs for the 95 percent of patients without significant stenoses. For example, a man at the age of 50 years is probably free of coronary stenosis if his score is &lt;56. At score values &gt;217, he has a high risk of coronary stenosis.</div><div class=\"graphic_reference\">Data from: Haberl R, Becker A, Leber A, et al. J Am Coll Cardiol 2001; 37:451.</div><div id=\"graphicVersion\">Graphic 52901 Version 4.0</div></div></div>"},"52903":{"type":"graphic_picture","displayName":"Contact derm face","title":"Contact dermatitis involving the facial and periorbital skin","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Contact dermatitis involving the facial and periorbital skin</div><div class=\"cntnt\"><img style=\"width:432px; height:324px;\" src=\"images/ALLRG/52903_Contact_derm_face.jpg\" alt=\"Image\"/></div><div class=\"graphic_reference\">Reproduced with permission from: <A style=\"FONT-STYLE: italic\" href=\"http://www.visualdx.com/\" target=_blank>www.visualdx.com</A>. Copyright Logical Images, Inc.</div><div id=\"graphicVersion\">Graphic 52903 Version 4.0</div></div></div>"},"52904":{"type":"graphic_figure","displayName":"Flutter circuit right atrium","title":"Reentrant circuit of typical atrial flutter within the right atrium","html":"<div class=\"graphic\"><div style=\"width: 547px\" class=\"figure\"><div class=\"ttl\">Reentrant circuit of typical atrial flutter within the right atrium</div><div class=\"cntnt\"><img style=\"width:527px; height:550px;\" src=\"images/CARD/52904_Flutter_circuit_r_atrium.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Schematic representation of reentrant circuit (red arrow) of typical (type 1) atrial flutter. The reentrant impulse rotates in a counterclockwise direction around the tricuspid annulus. The crista terminalis (CT) and eustacian ridge (ER) serve as lines of block, preventing the impulse from short-circuiting the annulus. Ablation is performed in the isthmus between the IVC and TA, which is an obligatory part of the circuit.</div><div class=\"graphic_footnotes\">SVC: superior vena cava; CS: coronary sinus; IVC: inferior vena cava; FO: foramen ovale</div><div id=\"graphicVersion\">Graphic 52904 Version 5.0</div></div></div>"},"52905":{"type":"graphic_figure","displayName":"Bone markers risk hip fracture","title":"Interaction of low bone mineral density and increased bone turnover in predicting fracture risk","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Interaction of low bone mineral density and increased bone turnover in predicting fracture risk</div><div class=\"cntnt\"><img style=\"width:340px; height:282px;\" src=\"images/ENDO/52905_Bone_markers_risk_hip_fract.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">In women over age 75 years followed prospectively, the odds ratio for hip fracture was increased 2.7-fold in those with a 1 standard deviation reduction in hip BMD but normal markers for bone turnover (first column), approximately twofold in those with normal BMD but a value for urinary&nbsp;CTX excretion or free&nbsp;D-Pyr excretion above the premenopausal range (second and third columns), and 4.5-fold when both risk factors were present (last two columns).</div><div class=\"graphic_footnotes\">BMD: bone mineral density; CTX: C-terminal telopeptide of type 1 collagen; D-Pyr: deoxypyridinoline.</div><div class=\"graphic_reference\">Data from: Garnero P, Hausherr E, Chapuy MC, et al. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study. J Bone Miner Res 1996; 11:1531.</div><div id=\"graphicVersion\">Graphic 52905 Version 5.0</div></div></div>"},"52907":{"type":"graphic_table","displayName":"Comparison between WHO criteria and the irRC ","title":"Comparison between WHO criteria and the Immune-related response criteria","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Comparison between WHO criteria and the Immune-related response criteria</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup width=\"20%\"></colgroup><colgroup span=\"2\" width=\"40%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\">&nbsp;</td> <td class=\"subtitle1\">WHO</td> <td class=\"subtitle1\">irRC</td> </tr> <tr> <td><strong>New, measurable lesions<br /> (ie, &#8805;5 x 5 mm)</strong></td> <td>Always represent PD</td> <td>Incorporated into tumor burden</td> </tr> <tr> <td><strong>New, nonmeasurable lesions<br /> (ie, &#60;5 x 5 mm)</strong></td> <td>Always represent PD</td> <td>Do not define progression (but preclude irCR)</td> </tr> <tr> <td><strong>Non-index lesions</strong></td> <td>Changes contribute to defining best objective response of CR, PR, SD, and PD</td> <td>Contribute to defining irCR (complete disappearance required)</td> </tr> <tr> <td><strong>CR</strong></td> <td>Disappearance of all lesions in two consecutive observations not less than 4 weeks apart</td> <td>Disappearance of all lesions in two consecutive observations not less than 4 weeks apart</td> </tr> <tr> <td><strong>PR</strong></td> <td>&#8805;50% decrease in SPD of all index lesions compared with baseline in two observations at least 4 weeks apart, in absence of new lesions or unequivocal progression of non-index lesions</td> <td>&#8805;50% decrease in tumor burden compared with baseline in two observations at least 4 weeks apart</td> </tr> <tr> <td><strong>SD</strong></td> <td>50% decrease in SPD compared with baseline cannot be established nor 25% increase compared with nadir, in absence of new lesions or unequivocal progression of non-index lesions</td> <td>50% decrease in tumor burden compared with baseline cannot be established nor 25% increase compared with nadir</td> </tr> <tr> <td><strong>PD</strong></td> <td>At least 25% increase in SPD compared with nadir and/or unequivocal progression of non-index lesions and/or appearance of new lesions (at any single time point)</td> <td>At least 25% increase in tumor burden compared with nadir (at any single time point) in two consecutive observations at least 4 weeks apart</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">irRC: immune-related response criteria; PD: progressive disease; CR: complete response; PR: partial response; SD: stable disease; SPD: sum of the product of the two largest perpendicular diameters; irCR: immune-related complete response.</div><div class=\"graphic_reference\">Reprinted by permission from: the American Association for Cancer Research: Wolchok JD, Hoos A, O'Day S, et al. Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria. Clin Cancer Res 2009 Dec 1; 15(23):7412-20. DOI: 10.1158/1078-0432.CCR-09-1624.</div><div id=\"graphicVersion\">Graphic 52907 Version 7.0</div></div></div>"},"52908":{"type":"graphic_picture","displayName":"Cervical AIS histology","title":"Histology of adenocarcinoma in situ of the uterine cervix","html":"<div class=\"graphic\"><div style=\"width: 520px\" class=\"figure\"><div class=\"ttl\">Histology of adenocarcinoma in situ of the uterine cervix</div><div class=\"cntnt\"><img style=\"width:500px; height:348px;\" src=\"images/OBGYN/52908_Cervical_AIS_histology.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Cervical adenocarcinoma in situ showing tall columnar cells with nuclear stratification, hyperchromatism, and irregularity.</div><div class=\"graphic_reference\">Reproduced with permission from: Scott JR, Gibbs RS. Danforth's Obstetrics and Gynecology, Ninth Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 2003. Copyright &#169; 2003 Lippincott Williams &amp; Wilkins.</div><div id=\"graphicVersion\">Graphic 52908 Version 1.0</div></div></div>"},"52909":{"type":"graphic_diagnosticimage","displayName":"Membranous VSD with double chambered RV still frame","title":"Membranous VSD with double chambered RV still frame","html":"<div class=\"graphic\"><div style=\"width: 565px\" class=\"figure\"><div class=\"ttl\">Membranous VSD with double chambered RV still frame</div><div class=\"cntnt\"><img style=\"width:545px; height:368px;\" src=\"images/CARD/52909_Membr_VSD_double_chambered.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Paired subcostal parasagittal images with and without superimposed color flow mapping, demonstrating narrowing of the right ventricular outflow tract (RVOT) by muscle bundles (thick arrows), positioned cephalad to the ventricular septal defect (VSD) (thin arrow), dividing the right ventricle into a caudal high pressure chamber and a more cephalad low pressure chamber.</div><div class=\"graphic_footnotes\">PA: pulmonary artery; LVOT: left ventricular outflow tract; LA: left atrium; RV: right ventricle; IVS: intraventricular septum; thin arrow: VSD.</div><div id=\"graphicVersion\">Graphic 52909 Version 3.0</div></div></div>"},"52912":{"type":"graphic_diagnosticimage","displayName":"Distal radius measurements lateral view","title":"Distal radius measurements: Lateral view","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Distal radius measurements: Lateral view</div><div class=\"cntnt\"><img style=\"width:352px; height:440px;\" src=\"images/EM/52912_Distal_radius_measure_later.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">In a true lateral projection, the radius and ulna should be superimposed, and the pisiform projected over the distal pole of the scaphoid (white arrow). Normally, the lunate is seated within the fossa of the distal radius, and the curvature of their articular surfaces should correspond. Palmar migration is a sign of radiocarpal instability. Palmar tilt is the angle formed by the intersection of one line perpendicular to the longitudinal axis of the radial shaft and a second line drawn through the apices of the palmar and the dorsal rims of the radius. AP distance can also be measured.</div><div class=\"graphic_reference\">Courtesy of Erik L Schroeder, MD.</div><div id=\"graphicVersion\">Graphic 52912 Version 3.0</div></div></div>"},"52913":{"type":"graphic_diagnosticimage","displayName":"Congenital diaphragmatic hernia","title":"This intubated newborn infant with the prenatal diagnosis of a left chest mass shows classic findings of a congenital diaphragmatic hernia","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">This intubated newborn infant with the prenatal diagnosis of a left chest mass shows classic findings of a congenital diaphragmatic hernia</div><div class=\"cntnt\"><img style=\"width:317px; height:504px;\" src=\"images/PEDS/52913_Congenital_diaphragmatic_he.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">There are air-filled bowel loops in the left chest causing mass effect and mediastinal shift towards the right. The nasogastric tube terminates in the left thoracic stomach. The umbilical venous catheter takes an atypical course because the liver is partially herniated into the left chest.</div><div class=\"graphic_reference\">Courtesy of Jeanne Chow, MD, and Children's Hospital Boston.</div><div id=\"graphicVersion\">Graphic 52913 Version 2.0</div></div></div>"},"52914":{"type":"graphic_figure","displayName":"Types of TEF","title":"Types of tracheoesophageal fistulas","html":"<div class=\"graphic\"><div style=\"width: 562px\" class=\"figure\"><div class=\"ttl\">Types of tracheoesophageal fistulas</div><div class=\"cntnt\"><img style=\"width:542px; height:668px;\" src=\"images/PEDS/52914_Types_of_TEF.jpg\" alt=\"Image\"/></div><div class=\"graphic_reference\">Data from: Clark, DC. Esophageal atresia and tracheoesophageal fistula. Am Fam Physician 1999;59:910. TEF types classified according to the scheme developed by EC Vogt in 1929, as modified by Gross.</div><div id=\"graphicVersion\">Graphic 52914 Version 3.0</div></div></div>"},"52916":{"type":"graphic_diagnosticimage","displayName":"Flock workers lung CT - Nodular consolidation","title":"Flock worker's lung CT - Nodular consolidation","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Flock worker's lung CT - Nodular consolidation</div><div class=\"cntnt\"><img style=\"width:285px; height:301px;\" src=\"images/PULM/52916_Flock_workers_lung_CT_III.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Nodular consolidation around the bronchovascular bundle.</div><div class=\"graphic_footnotes\">CT: computed tomography.</div><div class=\"graphic_reference\">Courtesy of David Kern, MD and Robert Crausman, MD.</div><div id=\"graphicVersion\">Graphic 52916 Version 6.0</div></div></div>"},"52917":{"type":"graphic_figure","displayName":"Anorectal fistulas Parks' classification","title":"Parks' classification of anorectal fistulas, anterior view","html":"<div class=\"graphic\"><div style=\"width: 535px\" class=\"figure\"><div class=\"ttl\">Parks' classification of anorectal fistulas, anterior view</div><div class=\"cntnt\"><img style=\"width:515px; height:491px;\" src=\"images/SURG/52917_ARFParksclassifcoloredt.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Parks described four types of anorectal fistulas that originate from cryptoglandular infections. Fistulas can have a complicated anatomy with one or more extensions and accessory tracts. The original Parks' classification did not include a superficial fistula tract.<br />Type 1 is an intersphincteric fistula that travels along the intersphincteric plane.<br />Type 2 is a transsphincteric fistula that encompasses a portion of the internal and external sphincter.<br />Type 3 is a suprasphincteric fistula that encompasses the entire sphincter apparatus.<br />Type 4 is an extrasphincteric fistula that extends from a primary opening in the rectum, encompasses the entire sphincter apparatus, and opens onto the skin overlying the buttock.</div><div id=\"graphicVersion\">Graphic 52917 Version 6.0</div></div></div>"},"52918":{"type":"graphic_table","displayName":"Congenital toxoplasmosis initial evaluation","title":"Initial clinical evaluation of the newborn/infant with suspected congenital toxoplasmosis","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Initial clinical evaluation of the newborn/infant with suspected congenital toxoplasmosis</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup width=\"40%\"></colgroup><colgroup width=\"60%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\">Test</td> <td class=\"subtitle1\">Comment</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"2\">Clinical evaluations</td> </tr> <tr> <td class=\"indent1\">Complete physical examination</td> <td>Fever, jaundice, hepatosplenomegaly, and lymphadenopathy are common findings in symptomatic infants (but the examination is normal in most cases)</td> </tr> <tr> <td class=\"indent1\">Detailed neurologic examination</td> <td>Evaluate for abnormal motor tone and/or delayed milestones</td> </tr> <tr> <td class=\"indent1\">Eye examination by ophthalmologist experienced in retinal examinations in newborn and young infants</td> <td>Chorioretinitis may be the only manifestation</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">Auditory brainstem response</td> <td>Routine newborn hearing screening is performed in many regions (including the United States); however, diagnostic ABR testing may be preferred, especially for infants with symptomatic disease, since this test is more sensitive than the automated tests used in screening protocols.</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"2\">Lumbar puncture</td> </tr> <tr> <td class=\"indent1\">CSF glucose, protein, cell count</td> <td>CSF abnormalities may be the only manifestation; CSF protein may be &#62;1 g/dL in severely affected infants but is typically lower in mild or subclinical disease</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">Toxoplasma-specific PCR<sup></sup>*<sup>&#182;</sup></td> <td>Performed when there is a strong suspicion for congenital toxoplasma infection; can establish the diagnosis</td> </tr> <tr class=\"divider_bottom\"> <td class=\"subtitle2_left\">Neuroimaging<sup>&#916;</sup></td> <td>Intracranial&nbsp;calcifications or hydrocephalus may be the only formation</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"2\">Serology<sup>&#182;</sup>(performed in conjunction with maternal serology)</td> </tr> <tr> <td class=\"indent1\">Toxoplasma-specific IgG </td> <td>Does not differentiate maternal from infant infection in the newborn period</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">Toxoplasma-specific IgM (ELISA or ISAGA)<sup>&#182;</sup> </td> <td> <p>Indicative of congenital infection if not contaminated with maternal blood; if there is concern for false-positive due to contamination of infant's blood with maternal blood during labor, the&nbsp;test should be repeated at least 5 days after birth</p> <p>False-positive test results can be caused by blood product transfusion; test should be repeated at least 7 days after last transfusion</p> <p>Negative IgM does not exclude congenital toxoplasmosis<sup>&#9674;</sup></p> </td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">Toxoplasma-specific IgA (ELISA or ISAGA)<sup>&#182;</sup></td> <td> <p>Especially useful&nbsp;if IgG and IgM assays are indeterminate</p> <p>Indicative of congenital infection if not contaminated with maternal blood; if there is concern for&nbsp;false-positive due to contamination of infant's blood with maternal blood during labor, the&nbsp;test should be repeated at least 10 days after birth</p> <p>False-positive test results can be causes by blood product transfusion; test should be repeated at least 7 days after last transfusion</p> </td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"2\">Blood tests (primarily performed before initiating treatment in confirmed or suspected cases)</td> </tr> <tr> <td class=\"indent1\">CBC with differential and platelet count</td> <td>Anemia and thrombocytopenia are common in symptomatic infants; also necessary to establish baseline before treatment, which may cause bone marrow suppression</td> </tr> <tr> <td class=\"indent1\">Evaluation for G6PD deficiency (before initiation of treatment)</td> <td>Treatment with sulfadiazine may cause hemolysis in G6PD-deficient children</td> </tr> <tr> <td class=\"indent1\">Liver function tests (aspartate aminotransferase, alanine aminotransferase, total and direct bilirubin)</td> <td>Primarily for baseline studies before initiating treatment; both direct and cholestatic jaundice may occur in infected infants</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent1\">Serum creatinine and urinalysis (before initiation of treatment)</td> <td>Sulfadiazine (or sulfamerazine or sulfamethazine) dosing requires adjustment in patients with renal insufficiency</td> </tr> <tr> <td class=\"subtitle2_left\" colspan=\"2\">Testing for other infections</td> </tr> <tr> <td class=\"indent1\">Urine for&nbsp;CMV and other congenital infections as appropriate based on maternal exposure (eg, Zika)<sup>&#167;</sup></td> <td>To exclude other congenital infections&nbsp;which may have similar clinical manifestations; coinfection with cytomegalovirus and toxoplasmosis may occur</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\"><FONT color=black>ABR: auditory brainstem response; </FONT><FONT color=black>CT: computed tomography; CMV: cytomegalovirus; CSF: cerebrospinal fluid; PCR: polymerase chain reaction; IgG: immunoglobulin G; ELISA: enzyme-linked immunosorbent assay; IgM: immunoglobulin M; IgA: immunoglobulin A; ISAGA: immunosorbent agglutination assay; CBC: complete blood count; G6PD: glucose-6-phosphate-dehydrogenase; MRI: magnetic resonance imaging.<br /><br />* Blood and urine <EM innerHtml>Toxoplasma</EM> PCR may also be useful. <br />Â¶&nbsp;Testing should be performed or confirmed in a reference laboratory (eg, the Toxoplasmosis Serology Laboratory at the Palo Alto Medical Foundation Research </FONT>Institute -- <A href=\"http://www.pamf.org/serology\" target=_blank>www.pamf.org/serology</A>; the WHO/FAO International Centre for Research and Reference on Toxoplasmosis, Staten Serum Institute, Copenhagen, Denmark; the Toxoplasma Reference Laboratory, Public <FONT color=black>Health Laboratory, Singleton Hospital, Swansea, United Kingdom).<br />Î&nbsp;CT is generally the preferred modality for neuroimaging because it has a high sensitivity for detection of calcifications and it readily detects other structural abnormalities (eg, ventriculomegaly and hydrocephalus). Head ultrasonography can detect ventriculomegaly and hydrocephalus but does not detect calcification well. Ultrasonography has been used in regions where the rate of symptomatic congenital toxoplasmosis is very low compared with the United States (ie, mainly in Europe). MRI is a reasonable option for initial evaluation because it obviates the risk of radiation associated with CT.&nbsp;<br />â If maternal serologic titers were suggestive of an acute primary infection acquired late in gestation, initially negative Toxoplasma IgM and IgA results at birth may be attributable to delayed antibody production; repeat testing 2 to 4 weeks after birth and every 4 weeks thereafter until 3 months of age may be warranted in such cases.&nbsp;<br />Â§ For the approach testing for congenital CMV, Zika virus, and other congenital infections, refer to separate UpToDate content.</FONT></div><div class=\"graphic_reference\">Adapted from: &#xD;&#xA;<OL>&#xD;&#xA;<LI>Maldonado YA, Read JS, COMMITTEE ON INFECTIOUS DISEASES. Diagnosis, Treatment, and Prevention of Congenital Toxoplasmosis in the United States. Pediatrics 2017; 139.</LI>&#xD;&#xA;<LI>Remington JS, McLeod R, Wilson CB, Desmonts G. Toxoplasmosis. In: Infectious Diseases of the Fetus and Newborn Infant, 7th ed, Remington JS, Klein JO, Wilson CB, et al (Eds), Elsevier Saunders, Philadelphia 2011. p.918. </LI></OL></div><div id=\"graphicVersion\">Graphic 52918 Version 11.0</div></div></div>"},"52921":{"type":"graphic_figure","displayName":"Clinical manifestations of fatal and near-fatal reactions","title":"Clinical manifestations of fatal and near-fatal reactions","html":"<div class=\"graphic\"><div style=\"width: 594px\" class=\"figure\"><div class=\"ttl\">Clinical manifestations of fatal and near-fatal reactions</div><div class=\"cntnt\"><img style=\"width:574px; height:388px;\" src=\"images/ALLRG/52921_Clin_manif_FRs_NFRs.gif\" alt=\"Image\"/></div><div class=\"graphic_reference\">Data from: Amin HS, Liss GM, Bernstein DI. Evaluation of near-fatal reactions to allergen immunotherapy injections. J Allergy Clin Immunol 2006; 117:169.</div><div id=\"graphicVersion\">Graphic 52921 Version 3.0</div></div></div>"},"52922":{"type":"graphic_table","displayName":"Spine injury classification","title":"Classification of spinal injuries","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Classification of spinal injuries</div><div class=\"cntnt\"><table  cellspacing=\"0\">\r\n \r\n   <tr>\r\n  \r\n   <td  class=\"subtitle1\">\r\n  \r\n   Mechanisms of spinal injury\r\n  \r\n   </td>\r\n  \r\n   <td  class=\"subtitle1\">\r\n  \r\n   Stability\r\n  \r\n   </td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"subtitle2_left\" colspan=\"2\">\r\n  \r\n   Flexion\r\n  \r\n   </td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"indent1\">\r\n  \r\n   Anterior wedge fracture\r\n  \r\n   </td>\r\n  \r\n   <td>Stable</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"indent1\">\r\n  \r\n   Flexion teardrop fracture\r\n  \r\n   </td>\r\n  \r\n   <td>Extremely unstable</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"indent1\">\r\n  \r\n   Clay shoveler's fracture\r\n  \r\n   </td>\r\n  \r\n   <td>Stable</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"indent1\">\r\n  \r\n   Subluxation\r\n  \r\n   </td>\r\n  \r\n   <td>Potentially unstable</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"indent1\">\r\n  \r\n   Bilateral facet dislocation\r\n  \r\n   </td>\r\n  \r\n   <td>Always unstable</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"indent1\">\r\n  \r\n   Atlanto-occipital dislocation\r\n  \r\n   </td>\r\n  \r\n   <td>Unstable</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"indent1\">\r\n  \r\n   Anterior atlantoaxial dislocation with or without fracture\r\n  \r\n   </td>\r\n  \r\n   <td>Unstable</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"indent1\">\r\n  \r\n   Odontoid fracture with lateral displacement\r\n  \r\n   </td>\r\n  \r\n   <td>Unstable</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"indent1\">\r\n  \r\n   Fracture of transverse process\r\n  \r\n   </td>\r\n  \r\n   <td>Stable</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"subtitle2_left\" colspan=\"2\">\r\n  \r\n   Flexion-rotation\r\n  \r\n   </td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"indent1\">\r\n  \r\n   Unilateral facet dislocation\r\n  \r\n   </td>\r\n  \r\n   <td>Stable</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"indent1\">\r\n  \r\n   Rotary atlantoaxial dislocation\r\n  \r\n   </td>\r\n  \r\n   <td>Unstable</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"subtitle2_left\" colspan=\"2\">\r\n  \r\n   Extension\r\n  \r\n   </td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"indent1\">\r\n  \r\n   Posterior neural arch fracture (C1)\r\n  \r\n   </td>\r\n  \r\n   <td>Unstable</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"indent1\">\r\n  \r\n   Hangman's fracture (C2)\r\n  \r\n   </td>\r\n  \r\n   <td>Unstable</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"indent1\">\r\n  \r\n   Extension teardrop fracture\r\n  \r\n   </td>\r\n  \r\n   <td>Usually stable in flexion; unstable in extension</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"indent1\">\r\n  \r\n   Posterior atlantoaxial dislocation with or without fracture\r\n  \r\n   </td>\r\n  \r\n   <td>Unstable</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"subtitle2_left\" colspan=\"2\">\r\n  \r\n   Vertical compression\r\n  \r\n   </td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"indent1\">\r\n  \r\n   Burst fracture of vertebral body\r\n  \r\n   </td>\r\n  \r\n   <td>Stable</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"indent1\">\r\n  \r\n   Jefferson fracture (C1)\r\n  \r\n   </td>\r\n  \r\n   <td>Extremely unstable</td>\r\n  \r\n   </tr>\r\n  \r\n   <tr>\r\n  \r\n   <td  class=\"indent1\">\r\n  \r\n   Isolated fractures of articular pillar and vertebral body\r\n  \r\n   </td>\r\n  \r\n   <td>Stable</td>\r\n  \r\n   </tr>\r\n </table></div><div class=\"graphic_reference\">Reproduced with permission from: Marx, JA, Hockberber, RS, Walls, RM. Rosen's emergency medicine: concepts and clinical practice, 6th ed, Mosby, Inc., St. Louis 2006. Copyright &#169;2006 Elsevier.</div><div id=\"graphicVersion\">Graphic 52922 Version 1.0</div></div></div>"},"52924":{"type":"graphic_picture","displayName":"Corneal clouding","title":"Corneal clouding in a patient with mucopolysaccharidosis type I (MPS I, Hurler-Scheie syndrome)","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Corneal clouding in a patient with mucopolysaccharidosis type I (MPS I, Hurler-Scheie syndrome)</div><div class=\"cntnt\"><img style=\"width:371px; height:275px;\" src=\"images/PEDS/52924_Corneal_clouding.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The eye in a 17-year-old male with Hurler-Scheie syndrome. Severe grainy corneal clouding is apparent.</div><div class=\"graphic_reference\">Courtesy of Emil Kakkis, MD, PhD.</div><div id=\"graphicVersion\">Graphic 52924 Version 2.0</div></div></div>"},"52925":{"type":"graphic_picture","displayName":"BL starry-sky pattern","title":"Burkitt lymphoma âstarry-skyâ pattern","html":"<div class=\"graphic\"><div style=\"width: 524px\" class=\"figure\"><div class=\"ttl\">Burkitt lymphoma âstarry-skyâ pattern</div><div class=\"cntnt\"><img style=\"width:504px; height:379px;\" src=\"images/HEME/52925_BLstarryskypattern.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Low-power magnification showing sheets of uniform neoplastic cells with evenly interspersed reactive tingible-body macrophages resulting in characteristic \"starry-sky\" pattern. Hematoxylin-eosin stain.</div><div class=\"graphic_reference\">Reproduced with permission from: Ioachim HL, Medeiros LJ. Burkitt lymphoma. In: Ioachim's Lymph Node Pathology, 4th ed, Lippincott Williams &amp; Wilkins, Philadelphia 2009. Copyright Â© 2009 Lippincott Williams &amp; Wilkins. <A href=\"http://www.lww.com/\" target=_blank>www.lww.com</A>.</div><div id=\"graphicVersion\">Graphic 52925 Version 6.0</div></div></div>"},"52926":{"type":"graphic_table","displayName":"Differential diagnosis of acute dysnpea","title":"Differential diagnosis of acute dyspnea","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Differential diagnosis of acute dyspnea</div><div class=\"cntnt\"><table class=\"container\" cellspacing=\"0\"><tbody> <tr> <td class=\"container\"> <table cellspacing=\"0\"> <tbody> <tr> <td class=\"subtitle1_single\">HEENT </td> </tr> <tr> <td>Angiodema</td> </tr> <tr> <td>Anaphylaxis</td> </tr> <tr> <td>Pharyngeal infections</td> </tr> <tr> <td>Deep neck infections</td> </tr> <tr> <td>Foreign body</td> </tr> <tr> <td>Neck trauma</td> </tr> <tr> <td class=\"subtitle1_single\">Chest wall </td> </tr> <tr> <td>Rib fractures</td> </tr> <tr> <td>Flail chest</td> </tr> <tr> <td class=\"subtitle1_single\">Pulmonary </td> </tr> <tr> <td>COPD exacerbation</td> </tr> <tr> <td>Asthma exacerbation</td> </tr> <tr> <td>Pulmonary embolism</td> </tr> <tr> <td>Pneumothorax</td> </tr> <tr> <td>Pulmonary infection</td> </tr> <tr> <td>ARDS</td> </tr> <tr> <td>Pulmonary contusion or other lung injury</td> </tr> <tr> <td>Hemorrhage</td> </tr> <tr> <td class=\"subtitle1_single\">Cardiac </td> </tr> <tr> <td>ACS</td> </tr> <tr> <td>ADHF</td> </tr> <tr> <td>Flash pulmonary edema</td> </tr> <tr> <td>High output failure</td> </tr> <tr> <td>Cardiomyopathy</td> </tr> <tr> <td>Arrhythmia</td> </tr> <tr> <td>Valvular dysfunction</td> </tr> <tr> <td>Cardiac tamponade</td> </tr> </tbody> </table> </td> <td class=\"container\"> <table cellspacing=\"0\"> <tbody> <tr> <td class=\"subtitle1_single\">Neurologic</td> </tr> <tr> <td>Stroke</td> </tr> <tr> <td>Neuromuscular disease</td> </tr> <tr> <td class=\"subtitle1_single\">Toxic/metabolic </td> </tr> <tr> <td>Organophosphate poisoning</td> </tr> <tr> <td>Salicylate poisioning</td> </tr> <tr> <td>CO poisoning</td> </tr> <tr> <td>Toxic ingestion</td> </tr> <tr> <td>Diabetic ketoacidosis</td> </tr> <tr> <td>Sepsis</td> </tr> <tr> <td>Anemia</td> </tr> <tr> <td>Acute chest syndrome</td> </tr> <tr> <td class=\"subtitle1_single\">Miscellaneous </td> </tr> <tr> <td>Hyperventilation</td> </tr> <tr> <td>Anxiety</td> </tr> <tr> <td>Pneumomediastinum</td> </tr> <tr> <td>Lung tumor</td> </tr> <tr> <td>Pleural effusion</td> </tr> <tr> <td>Intra-abdominal process</td> </tr> <tr> <td>Ascites</td> </tr> <tr> <td>Pregnancy*</td> </tr> <tr> <td>Massive obesity*</td> </tr> </tbody> </table> </td> </tr> </tbody></table></div><div class=\"graphic_lgnd\">HEENT: head, eyes, ears, nose, and throat; ACS: acute coronary syndrome; ADHF: acute decompensated heart failure; ARDS: acute respiratory distress syndrome; CO: carbon monoxide; COPD: chronic obstructive pulmonary disease.</div><div class=\"graphic_footnotes\">*While these conditions do not cause acute dyspnea directly, they can exacerbate symptoms or contribute to other underlying causes.</div><div id=\"graphicVersion\">Graphic 52926 Version 4.0</div></div></div>"},"52927":{"type":"graphic_table","displayName":"Cancers in acromegaly","title":"Increased cancer risk in acromegaly","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Increased cancer risk in acromegaly</div><div class=\"cntnt\"><table cellspacing=\"0\">\n\n  <tbody>\n\n    <tr>\n\n      <td class=\"subtitle1\" colspan=\"1\" rowspan=\"1\">&nbsp;</td>\n\n      <td class=\"subtitle1\">Cancers</td>\n\n      <td class=\"subtitle1\">Expected</td>\n\n      <td class=\"subtitle1\">O/E</td>\n\n    </tr>\n\n    <tr>\n\n      \n\n      <td>All</td>\n<td>116</td>\n\n      <td>72</td>\n\n      <td>1.6</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Colon</td>\n\n      <td>13</td>\n\n      <td>4.2</td>\n\n      <td>3.1</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Esophagus</td>\n\n      <td>7 </td>\n\n      <td>2.3</td>\n\n      <td>3.1</td>\n\n    </tr>\n\n    <tr>\n\n      <td>Stomach</td>\n\n      <td>4 </td>\n\n      <td>1.6</td>\n\n      <td>2.5 </td>\n\n    </tr>\n\n    <tr>\n\n      <td>Melanoma</td>\n\n      <td>3</td>\n\n      <td>0.9</td>\n\n      <td>3.3</td>\n\n    </tr>\n\n  </tbody>\n</table>\n\n\r\n\r\n<html xmlns:mso=\"urn:schemas-microsoft-com:office:office\" xmlns:msdt=\"uuid:C2F41010-65B3-11d1-A29F-00AA00C14882\"><head>\n<!--[if gte mso 9]><xml>\n<mso:CustomDocumentProperties>\n<mso:Specialty msdt:dt=\"string\">4.00000000000000</mso:Specialty>\n<mso:Media_Type msdt:dt=\"string\">Table</mso:Media_Type>\n<mso:Edit_Table msdt:dt=\"string\">&lt;a href=&quot;/Graphics/Pages/TableEditor.aspx?SPID=14164&amp;amp;Mode=Edit&quot;&gt;&lt;/a&gt;</mso:Edit_Table>\n</mso:CustomDocumentProperties>\n</xml><![endif]-->\n<title>Cancers_in_acromegaly.htm</title></head></div><div class=\"graphic_footnotes\">Common cancers occurring in 1041 men with acromegaly with no evidence for cancer at diagnosis. Excluded from this analysis were men who had gastrointestinal cancer at the time of diagnosis. There was an overall ratio of observed to expected (O/E) cancers of 1.6.</div><div class=\"graphic_reference\">Data from: Ron E, Gridley G, Hrubec Z, et al. Acromegaly and gastrointestinal cancer. Cancer 1991; 68:1673.</div><div id=\"graphicVersion\">Graphic 52927 Version 2.0</div></div></div>"},"52929":{"type":"graphic_diagnosticimage","displayName":"Thumbprinting C difficile","title":"Thumbprinting in pseudomembranous colitis","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Thumbprinting in pseudomembranous colitis</div><div class=\"cntnt\"><img style=\"width:208px; height:360px;\" src=\"images/GAST/52929_Thumbprinting_C_difficile.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Plain film of the abdomen demonstrates marked thickening of the wall of the ascending colon (arrows), producing a thumbprinting pattern. This appearance is seen in all forms of colitis.</div><div class=\"graphic_reference\">Courtesy of Jonathan Kruskal, MD, PhD.</div><div id=\"graphicVersion\">Graphic 52929 Version 2.0</div></div></div>"},"52930":{"type":"graphic_table","displayName":"Recommendations to cardiopulmonary patients who fly","title":"General recommendations to cardiopulmonary patients traveling by air","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">General recommendations to cardiopulmonary patients traveling by air</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td>1. Allow extra time at airports and use porter services to avoid anxiety and stress of hurried departures, transfers, and long walks with baggage.</td> </tr> <tr> <td>2. Preboard if extra time or assistance is needed.</td> </tr> <tr> <td>3. Carry on sufficient supply of medications for entire trip. Bring a fresh supply of sublingual nitroglycerin&nbsp;if applicable. Carry medications in carry-on baggage.</td> </tr> <tr> <td>4. Bring a list of medications and prescriptions, kept separately from the medications themselves.</td> </tr> <tr> <td>5. Take medications on schedule or adjust drug regimen when travel requires crossing multiple time zones.</td> </tr> <tr> <td>6. Carry a copy of most recent electrocardiogram (ECG), with and without pacemaker activation, and a pacemaker or defibrillator card, if applicable.</td> </tr> <tr> <td>7. Request special meals (low salt, low cholesterol).</td> </tr> <tr> <td>8. Avoid placing baggage in the space under the seat in front if that reduces the ability to move the legs. Flying first class or better designed aircrafts seats are considerations.</td> </tr> <tr> <td>9. Exercise legs at regular intervals while seated to improve venous flow, eg, strong alternating stretching and flexing of the feet.</td> </tr> <tr> <td>10. Change position frequently and do not sleep in cramped position.</td> </tr> <tr> <td>11. Walk in cabin aisle every hour.</td> </tr> <tr> <td>12. Avoid hypnotic drugs, because veins can be damaged by unrecognized compression. Sleep also promotes muscular relaxation, which can lead to stasis.</td> </tr> <tr> <td>13. Drink adequate fluids before and during the flight. Alcohol should be avoided on long trips due to diuretic and vasodilating effects.</td> </tr> <tr> <td>14. Consider elastic support stocking in patients with mild deep vein thromboembolism (DVT) risk.</td> </tr> <tr> <td>15. Consider pharmacologic&nbsp;prophylaxis&nbsp;before boarding in patients with moderate DVT risk.</td> </tr> <tr> <td>16. Consider full oral anticoagulation or low molecular weight heparin in patients with high DVT risk.</td> </tr> <tr> <td>17. Consider purchasing medical evacuation insurance if health insurance does not cover medical evacuation.</td> </tr> <tr> <td>18. Carry a letter from caregiver(s) explaining condition, medications, allergies, and devices (such as pacemaker or implantable cardioverter defibrillator).</td> </tr> </tbody></table></div><div class=\"graphic_reference\">Adapted from: Gong H. Cardiologica 1995; 40:477.</div><div id=\"graphicVersion\">Graphic 52930 Version 7.0</div></div></div>"},"52931":{"type":"graphic_algorithm","displayName":"Unconjugated bilirubin w anemia child","title":"Approach to the child with unconjugated hyperbilirubinemia who has anemia and/or hemolysis","html":"<div class=\"graphic\"><div style=\"width: 551px\" class=\"figure\"><div class=\"ttl\">Approach to the child with unconjugated hyperbilirubinemia who has anemia and/or hemolysis</div><div class=\"cntnt\"><img style=\"width:531px; height:694px;\" src=\"images/PEDS/52931_Unconj_bili_w_anemia.gif\" alt=\"Image\"/></div><div class=\"graphic_footnotes\">G6PD: glucose-6-phosphate dehydrogenase deficiency; HUS: hemolytic-uremic syndrome; RBC: red blood cell.<br> * Symptomatic G6PD is most common in males of African or Mediterranean descent.</div><div class=\"graphic_reference\">Modified from: Mandl KD. Jaundice-Unconjugated Hyperbilirubinemia. In: Textbook of Pediatric Emergency Medicine, Fleisher GR, Ludwig S, Henretig FM (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006.</div><div id=\"graphicVersion\">Graphic 52931 Version 10.0</div></div></div>"},"52932":{"type":"graphic_figure","displayName":"Anatomy of sacrum and coccyx","title":"Anatomy of the sacrum and coccyx","html":"<div class=\"graphic\"><div style=\"width: 552px\" class=\"figure\"><div class=\"ttl\">Anatomy of the sacrum and coccyx</div><div class=\"cntnt\"><img style=\"width:532px; height:377px;\" src=\"images/PC/52932_Lateral_view_coccyx.jpg\" alt=\"Image\"/></div><div id=\"graphicVersion\">Graphic 52932 Version 3.0</div></div></div>"},"52935":{"type":"graphic_diagnosticimage","displayName":"CT neuroendocrine tumor liver metastases","title":"CT of neuroendocrine tumor liver metastases","html":"<div class=\"graphic\"><div style=\"width: 531px\" class=\"figure\"><div class=\"ttl\">CT of neuroendocrine tumor liver metastases</div><div class=\"cntnt\"><img style=\"width:511px; height:409px;\" src=\"images/ONC/52935_CT_hypervasc_liver_metast.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">In patient A (top two images), the hypervascular liver metastases are more clearly observed on the arterial phase (left) compared to the portal venous phase (right); whereas in patient B (lower two images), the liver metastases are not as hypervascular and more clearly delineated on the portal venous phase (right) compared to the arterial phase (left).</div><div class=\"graphic_footnotes\">CT: computed tomography.</div><div id=\"graphicVersion\">Graphic 52935 Version 3.0</div></div></div>"},"52939":{"type":"graphic_figure","displayName":"Age and stroke etiology","title":"Relative proportions of etiologic subgroups (TOAST) in age-groups","html":"<div class=\"graphic\"><div style=\"width: 518px\" class=\"figure\"><div class=\"ttl\">Relative proportions of etiologic subgroups (TOAST) in age-groups</div><div class=\"cntnt\"><img style=\"width:498px; height:430px;\" src=\"images/NEURO/52939_Age_and_stroke_etiology.gif\" alt=\"Image\"/></div><div class=\"graphic_reference\">Reproduced with permission from: Putaala J, Metso AJ, Metso TM, et al.Â Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: the Helsinki Young Stroke Registry. Stroke 2009; 40:1195. Copyright Â© 2009 Lippincott Williams &amp; Wilkins.</div><div id=\"graphicVersion\">Graphic 52939 Version 8.0</div></div></div>"},"52940":{"type":"graphic_table","displayName":"Pathologic findings in mastectectomy in occult breast cancer","title":"Pathologic findings at mastectomy in patients with occult primary breast cancer","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Pathologic findings at mastectomy in patients with occult primary breast cancer</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup width=\"25%\"></colgroup><colgroup span=\"5\" width=\"15%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\">Author,<br /> year</td> <td class=\"subtitle1\">Years</td> <td class=\"subtitle1\">Mastectomy,<br /> n</td> <td class=\"subtitle1\">In situ,<br /> n</td> <td class=\"subtitle1\">Invasive,<br /> n</td> <td class=\"subtitle1\">Cancer,<br /> percent</td> </tr> <tr> <td>Owens H; 1954</td> <td>1907-50</td> <td class=\"centered\">27</td> <td class=\"centered\">0</td> <td class=\"centered\">25</td> <td class=\"centered\">92</td> </tr> <tr> <td>Feuerman L; 1962</td> <td>1949-61</td> <td class=\"centered\">2</td> <td class=\"centered\">0</td> <td class=\"centered\">1</td> <td class=\"centered\">50</td> </tr> <tr> <td>Fitts W; 1963</td> <td>1948-63</td> <td class=\"centered\">11</td> <td class=\"centered\">0</td> <td class=\"centered\">7</td> <td class=\"centered\">70</td> </tr> <tr> <td>Haagensen C; 1974</td> <td>1916-66</td> <td class=\"centered\">13</td> <td class=\"centered\">0</td> <td class=\"centered\">12</td> <td class=\"centered\">92</td> </tr> <tr> <td>Ashikari R; 1976</td> <td>1946-75</td> <td class=\"centered\">34</td> <td class=\"centered\">3</td> <td class=\"centered\">20</td> <td class=\"centered\">67</td> </tr> <tr> <td>Patel J; 1981</td> <td>1952-79</td> <td class=\"centered\">29</td> <td class=\"centered\">0</td> <td class=\"centered\">16</td> <td class=\"centered\">60</td> </tr> <tr> <td>Kemeny M; 1986</td> <td>1973-85</td> <td class=\"centered\">11</td> <td class=\"centered\">2</td> <td class=\"centered\">3</td> <td class=\"centered\">45</td> </tr> <tr> <td>Bhatia S; 1987</td> <td>1977-85</td> <td class=\"centered\">11</td> <td class=\"centered\">2</td> <td class=\"centered\">9</td> <td class=\"centered\">100</td> </tr> <tr> <td>Baron P; 1990</td> <td>1975-78</td> <td class=\"centered\">28</td> <td class=\"centered\">4</td> <td class=\"centered\">16</td> <td class=\"centered\">71</td> </tr> <tr> <td>Ellerbroek N; 1990</td> <td>1944-87</td> <td class=\"centered\">13</td> <td class=\"centered\">0</td> <td class=\"centered\">1</td> <td class=\"centered\">8</td> </tr> <tr> <td>Merson M; 1992</td> <td>1945-87</td> <td class=\"centered\">33</td> <td class=\"centered\">0</td> <td class=\"centered\">27</td> <td class=\"centered\">82</td> </tr> <tr> <td>Feigenberg S; 2003</td> <td>1971-74</td> <td class=\"centered\">4</td> <td class=\"centered\">0</td> <td class=\"centered\">3</td> <td class=\"centered\">80</td> </tr> <tr> <td>Blanchard D; 2004</td> <td>1975-98</td> <td class=\"centered\">18</td> <td class=\"centered\">1</td> <td class=\"centered\">5</td> <td class=\"centered\">33</td> </tr> <tr class=\"divider_bottom\"> <td>He M; 2012</td> <td>1998-2010</td> <td class=\"centered\">64</td> <td class=\"centered\">16</td> <td class=\"centered\">4</td> <td class=\"centered\">31</td> </tr> <tr> <td><strong>Total</strong></td> <td>&ndash;</td> <td class=\"centered\">298</td> <td class=\"centered\">28</td> <td class=\"centered\">149</td> <td class=\"centered\">59</td> </tr> </tbody></table></div><div id=\"graphicVersion\">Graphic 52940 Version 3.0</div></div></div>"},"52941":{"type":"graphic_picture","displayName":"Well different E cadherin","title":"Well differentiated (intestinal type) adenocarcinoma","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Well differentiated (intestinal type) adenocarcinoma</div><div class=\"cntnt\"><img style=\"width:432px; height:277px;\" src=\"images/ONC/52941_Well_different_E_cadherin.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">E-cadherin strains prominent in the intercellular membranes.</div><div id=\"graphicVersion\">Graphic 52941 Version 1.0</div></div></div>"},"52942":{"type":"graphic_algorithm","displayName":"Algorithm for evaluation and management of possible ACS","title":"Algorithm for evaluation and management of patients suspected of having ACS","html":"<div class=\"graphic\"><div style=\"width: 708px\" class=\"figure\"><div class=\"ttl\">Algorithm for evaluation and management of patients suspected of having ACS</div><div class=\"cntnt\"><img style=\"width:688px; height:589px;\" src=\"images/CARD/52942_Algor_ev_mgt_suspected_ACS.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">To facilitate interpretation of this algorithm and a more detailed discussion in the text, each box is assigned a letter code that reflects its level in the algorithm and a number that is allocated from left to right across the diagram on a given level.</div><div class=\"graphic_footnotes\">ACC/AHA: American College of Cardiology/American Heart Associations; ACS: acute coronary syndrome; ECG: electrocardiogram; LV: left ventricular.</div><div class=\"graphic_reference\">Reproduced with permission from: Anderson J, Adams C, Antman E, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 2002 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, American College or Physicians, Society for Academic Emergency Medicine, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2007; 50:e1.</div><div id=\"graphicVersion\">Graphic 52942 Version 4.0</div></div></div>"},"52944":{"type":"graphic_figure","displayName":"Croup_PI","title":"Croup","html":"<div class=\"graphic\"><div style=\"width: 565px\" class=\"figure\"><div class=\"ttl\">Croup</div><div class=\"cntnt\"><img style=\"width:545px; height:513px;\" src=\"images/PI/52944_Croup.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">This figure shows the appearance of the vocal cords (larynx) and wind pipe (trachea) in a child with croup. The viruses that cause croup initially infect the nose and pharynx, and then spread along the upper respiratory tract to the larynx and trachea. As the infection progresses, the trachea and larynx become swollen, which narrows the available space for air to enter the lungs. The characteristic &quot;barking cough&quot; of croup is caused by the narrow airway.</div><div id=\"graphicVersion\">Graphic 52944 Version 3.0</div></div></div>"},"52945":{"type":"graphic_picture","displayName":"Duck waddle","title":"Duck waddle","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Duck waddle</div><div class=\"cntnt\"><img style=\"width:371px; height:275px;\" src=\"images/EM/52945_Duck_waddle.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">This maneuver assesses the stability of the knee and the ability to perform complex tasks. The patient is asked to squat and then move forward, transferring the weight back and forth from the right to the left side, while remaining in a squatting position.</div><div class=\"graphic_reference\">Courtesy of Bruce C Anderson, MD.</div><div id=\"graphicVersion\">Graphic 52945 Version 3.0</div></div></div>"},"52948":{"type":"graphic_picture","displayName":"Acanthosis nigricans on neck close view","title":"Acanthosis nigricans","html":"<div class=\"graphic\"><div style=\"width: 524px\" class=\"figure\"><div class=\"ttl\">Acanthosis nigricans</div><div class=\"cntnt\"><img style=\"width:504px; height:351px;\" src=\"images/DERM/52948_Acanthosis_Nigricans_Close.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">A mildly hyperpigmented,&#160;velvety plaque with small papillary projections&#160;is present on the neck.</div><div id=\"graphicVersion\">Graphic 52948 Version 1.0</div></div></div>"},"52949":{"type":"graphic_picture","displayName":"FNH trichrome","title":"Focal nodular hyperplasia of the liver","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Focal nodular hyperplasia of the liver</div><div class=\"cntnt\"><img style=\"width:411px; height:248px;\" src=\"images/GAST/52949_FNH_trichrome.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Biopsy specimen showing the fibrous septae and a large, thick-walled artery at the edge of the stellate scare (arrow). (Klatskin trichrome stain X 10).</div><div class=\"graphic_reference\">Courtesy of Frank A Mitros, MD.</div><div id=\"graphicVersion\">Graphic 52949 Version 2.0</div></div></div>"},"52952":{"type":"graphic_figure","displayName":"Child upper GI anatomy PI","title":"Upper digestive system in a child","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Upper digestive system in a child</div><div class=\"cntnt\"><img style=\"width:432px; height:486px;\" src=\"images/PI/52952_Child_upper_GI_anatomy_PI.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">This drawing shows where the esophagus, stomach, and small intestine are located in a child.</div><div id=\"graphicVersion\">Graphic 52952 Version 3.0</div></div></div>"},"52953":{"type":"graphic_table","displayName":"Signs dehydration PI","title":"Signs and symptoms of dehydration in infants and children","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Signs and symptoms of dehydration in infants and children</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup span=\"4\" width=\"25%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\">Finding</td> <td class=\"subtitle1\">Mild<br /> (3 to 5 percent)</td> <td class=\"subtitle1\">Moderate<br /> (6 to 9 percent)</td> <td class=\"subtitle1\">Severe<br /> (&#8805;10 percent)</td> </tr> <tr> <td>Pulse</td> <td>Full, normal rate</td> <td>Rapid</td> <td>Rapid and weak</td> </tr> <tr> <td>Systolic pressure</td> <td>Normal</td> <td>Normal to low</td> <td>Very low</td> </tr> <tr> <td>Respirations</td> <td>Normal</td> <td>Deep, rate may be increased</td> <td>Deep, rapid rate</td> </tr> <tr> <td>Oral tissues</td> <td>Tacky or slightly dry</td> <td>Dry</td> <td>Parched</td> </tr> <tr> <td>Infant fontanelle (soft spot in skull)</td> <td>Normal</td> <td>Sunken</td> <td>Markedly sunken</td> </tr> <tr> <td>Eyes</td> <td>Normal</td> <td>Sunken</td> <td>Markedly sunken</td> </tr> <tr> <td>Skin</td> <td>Normal</td> <td>Cool</td> <td>Cool, mottled, blue-tinged hands/feet</td> </tr> <tr> <td>Urine output</td> <td>Mildly reduced</td> <td>Markedly reduced</td> <td>Absent</td> </tr> <tr> <td>Systemic signs</td> <td>Increased thirst</td> <td>Listlessness, irritability</td> <td>Grunting, lethargy, coma</td> </tr> </tbody></table></div><div id=\"graphicVersion\">Graphic 52953 Version 4.0</div></div></div>"},"52955":{"type":"graphic_figure","displayName":"Hallux valgus anatomy","title":"Anatomy relevant to hallux valgus deformity","html":"<div class=\"graphic\"><div style=\"width: 564px\" class=\"figure\"><div class=\"ttl\">Anatomy relevant to hallux valgus deformity</div><div class=\"cntnt\"><img style=\"width:544px; height:485px;\" src=\"images/EM/52955_Hallux_valgus_anatomy.jpg\" alt=\"Image\"/></div><div id=\"graphicVersion\">Graphic 52955 Version 2.0</div></div></div>"},"52959":{"type":"graphic_figure","displayName":"Right phrenic nerve course","title":"Course of the right phrenic nerve","html":"<div class=\"graphic\"><div style=\"width: 543px\" class=\"figure\"><div class=\"ttl\">Course of the right phrenic nerve</div><div class=\"cntnt\"><img style=\"width:523px; height:603px;\" src=\"images/SURG/52959_Right-phrenic-nerve-course.jpg\" alt=\"Image\"/></div><div id=\"graphicVersion\">Graphic 52959 Version 3.0</div></div></div>"},"52960":{"type":"graphic_table","displayName":"Initial assessment of primary neurologic involvement in GD","title":"Minimum clinical protocol for initial assessment of primary neurologic involvement in Gaucher disease","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Minimum clinical protocol for initial assessment of primary neurologic involvement in Gaucher disease</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1_single\">1. Clinical examination</td> </tr> <tr> <td class=\"indent1\">Neurologic examination, preferably by a neurologist with experience in neuronopathic GD.</td> </tr> <tr> <td class=\"indent1\">Eye movement examination, preferably by a neuroophthalmologist or a neurologist. At the minimum, elicitation of repeated maximal amplitude horizontal saccades should be performed at the bedside and compared with a healthy subject. It is desirable to add an objective measurement (eg, DC-coupled electrooculography) as clinical examination alone often misses slowed saccades or gaze palsy.<sup>[1]</sup></td> </tr> <tr> <td class=\"indent1\">Additional neuroophthalmological investigation, including direct ophthalmoscopy.</td> </tr> <tr> <td class=\"indent1\">Measurement of peripheral hearing (electroacoustical emission in small children, pure tone audiometry in older patients).</td> </tr> <tr> <td class=\"subtitle1_single\">2. Brain imaging</td> </tr> <tr> <td class=\"indent1\">Preferably by MRI or, if MRI is unavailable, by CT. In very sick children, the risks of anesthesia should be considered and the scan deferred until the child is clinically stable.</td> </tr> <tr> <td class=\"subtitle1_single\">3. Neurophysiology</td> </tr> <tr> <td class=\"indent1\">EEG.</td> </tr> <tr> <td class=\"subtitle1_single\">4. Neuropsychometry</td> </tr> <tr> <td class=\"indent1\">Age-appropriate testing should be assessed by an appropriately qualified psychologist. It may be advisable to defer testing, especially in young children, until the patient's overall health is sufficiently improved to permit meaningful measurement. Widely available protocols, such as the Wechsler Intelligence Scale for Children - Fourth UK Edition (WISC-IVUK), should be used unless not valid for language or cultural reasons. Specific testing (eg, of speech and language, memory, visuospatial skills, etc) may be required. Such testing should be tailored to the needs of the individual child.</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">GD: Gaucher disease; DC: direct current; MRI: magnetic resonance imaging; CT: computed tomography; EEG: electroencephalography.</div><div class=\"graphic_reference\">Reference:<br /><ol>&#xD;&#xA;    <li>Harris CM, Taylor DS, Vellodi A. Ocular motor abnormalities in Gaucher disease. Neuropediatrics 1999; 30:289. </li>&#xD;&#xA;</ol>&#xD;&#xA;Reproduced from: Vellodi A, Tylki-Szymanska A, Davies EH, et al. Management of neuronopathic Gaucher disease: revised recommendations. J Inherit Metab Dis 2009; 32:660, with kind permission from Springer Science + Business Media B.V. Copyright &copy; 2009.</div><div id=\"graphicVersion\">Graphic 52960 Version 11.0</div></div></div>"},"52962":{"type":"graphic_table","displayName":"Empiric antibiotic therapy for mesh graft infections","title":"Empiric antibiotic therapy for mesh graft infections in adults and adolescents","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Empiric antibiotic therapy for mesh graft infections in adults and adolescents</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup span=\"2\" width=\"50%\"></colgroup> <tbody> <tr> <td class=\"subtitle1_single\" colspan=\"2\">Options for empiric parenteral therapy:</td> </tr> <tr> <td class=\"subtitle2_left\">Drug</td> <td class=\"subtitle2_left\">Dose*</td> </tr> <tr> <td class=\"indent1\" colspan=\"2\">Monotherapy with a beta-lactam/beta-lactamase inhibitor or carbapenem such as <strong>ONE</strong> of the following:</td> </tr> <tr> <td class=\"indent2\">Ampicillin-sulbactam<sup>&#182;</sup></td> <td>3 g every 6 hours</td> </tr> <tr> <td class=\"indent2\">Piperacillin-tazobactam<sup>&#916;</sup></td> <td>3.375 g every 6 hours or 4.5 g every 8 hours</td> </tr> <tr> <td class=\"indent2\">Ticarcillin-clavulanate<sup>&#916;</sup></td> <td>3.1 g every 4 to 6 hours</td> </tr> <tr> <td class=\"indent2\">Imipenem<sup>&#916;</sup></td> <td>500 mg every 6 hours</td> </tr> <tr> <td class=\"indent2\">Meropenem<sup>&#916;</sup></td> <td>1 g every 8 hours</td> </tr> <tr> <td class=\"indent2\">Ertapenem</td> <td>1 g every 24 hours</td> </tr> <tr> <td class=\"indent1\" colspan=\"2\">Combination therapy with a third generation cephalosporin or fluoroquinolone <strong>plus</strong> anti-anaerobic coverage, such as <strong>ONE</strong> of the following:</td> </tr> <tr> <td class=\"indent2\">Ceftriaxone</td> <td>1 g every 24 hours</td> </tr> <tr> <td class=\"indent2\">Ciprofloxacin</td> <td>400 mg every 12 hours</td> </tr> <tr> <td class=\"indent2\">Levofloxacin</td> <td>500 mg every 24 hours</td> </tr> <tr> <td class=\"indent3\" colspan=\"2\"><strong>PLUS</strong></td> </tr> <tr> <td class=\"indent2\">Metronidazole</td> <td>500 mg every 8 hours</td> </tr> <tr> <td class=\"indent1\" colspan=\"2\"><strong>If MRSA risk present,</strong> add vancomycin to any of the above regimens</td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent2\">Vancomycin</td> <td>15 to 20 mg/kg every 8 to 12 hours, not to exceed 2 grams per dose<sup>&#9674;</sup></td> </tr> <tr> <td class=\"subtitle1_single\" colspan=\"2\">Options for empiric oral therapy:</td> </tr> <tr> <td class=\"indent1\" colspan=\"2\">Monotherapy with combination beta-lactam/beta-lactamase inhibitor such as:</td> </tr> <tr> <td class=\"indent2\">Amoxicillin-clavulanate</td> <td>875/125 mg twice daily</td> </tr> <tr> <td class=\"indent1\" colspan=\"2\">Combination therapy with fluoroquinolone <strong>plus</strong> anti-anaerobic coverage such as:</td> </tr> <tr> <td class=\"indent2\">Ciprofloxacin</td> <td>500 to 750 mg twice per day</td> </tr> <tr> <td class=\"indent2\">Levofloxacin</td> <td>500 to 750 mg once per day</td> </tr> <tr> <td class=\"indent3\" colspan=\"2\"><strong>PLUS</strong></td> </tr> <tr> <td class=\"indent2\">Metronidazole</td> <td>500 mg three times per day</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">* The doses recommended above are intended for patients with normal renal function; the doses of some of these agents must be adjusted in patients with renal insufficiency.<br />&para; Increasing gram-negative (Enterobacteriaceae) resistance to ampicillin-sulbactam; consult local susceptibilities prior to use as monotherapy; may be combined with an aminoglycoside.<br />&Delta; Provides anti-P. aeruginosa coverage.<br /><span class=\"lozenge\">&loz;</span> Adjust dose and frequency to maintain a target serum trough level of 15 to 20 mcg/mL.</div><div class=\"graphic_reference\">Source: Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis 2014; 59:e10.</div><div id=\"graphicVersion\">Graphic 52962 Version 4.0</div></div></div>"},"52965":{"type":"graphic_figure","displayName":"Rectal prolapse reduction","title":"Rectal prolapse reduction","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Rectal prolapse reduction</div><div class=\"cntnt\"><img style=\"width:433px; height:459px;\" src=\"images/PEDS/52965_Rectal_prolapse_reduction.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">(A) The child is placed prone in the knee-chest position on the examination table or the parent's lap. <br />(B) Hold the prolapsed edges with a gauze pad. Using lubricated gloves, apply gentle but firm pressure to reduce the prolapsed mucosa. <br />(C) Digital rectal examination is performed after reduction to ensure that reduction is complete.</div><div id=\"graphicVersion\">Graphic 52965 Version 2.0</div></div></div>"},"52967":{"type":"graphic_table","displayName":"MIP and MEP reference range","title":"Maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) reference ranges derived from population-based studies with good reference equations","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) reference ranges derived from population-based studies with good reference equations</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup span=\"3\" width=\"33%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\">&nbsp;</td> <td class=\"subtitle1\">MIP*</td> <td class=\"subtitle1\">MEP*</td> </tr> <tr> <td class=\"divider_bottom\" rowspan=\"2\">Children (ages 7 to 13)<sup>[1]</sup></td> <td>Male: 77 to 114</td> <td>99 to 161</td> </tr> <tr class=\"divider_bottom\"> <td>Female: 71 to 108</td> <td>74 to 126</td> </tr> <tr> <td class=\"divider_bottom\" rowspan=\"2\">Adolescents (ages 13 to 35)<sup>[2]</sup></td> <td>Male: 114 to 121</td> <td>131 to 161</td> </tr> <tr class=\"divider_bottom\"> <td>Female: 65 to 85</td> <td>92 to 95</td> </tr> <tr> <td class=\"divider_bottom\" rowspan=\"2\">Adults (ages 18 to 65)<sup>[3]</sup></td> <td>Male: 92 to 121</td> <td>140<sup>&#182;</sup></td> </tr> <tr class=\"divider_bottom\"> <td>Female: 68 to 79</td> <td>95<sup>&#182;</sup></td> </tr> <tr> <td rowspan=\"2\">Older adults (ages 65 to 85)<sup>[4]</sup></td> <td>Male: 65 to 90</td> <td>140 to 190</td> </tr> <tr> <td>Female: 45 to 60</td> <td>90 to 130</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">* Mean values in cm H<sub>2</sub>O.<br />&para; These mean MEP values from another study<sup>[5]</sup>. They are under-estimates because the mouthpiece was used between the teeth instead of against the lips and teeth.</div><div class=\"graphic_reference\">Data from: &#xD;&#xA;<OL>&#xD;&#xA;<LI>Gaultier C, Zinman R. Maximal static pressures in healthy children. Respir Physiol 1983; 51:45.</LI>&#xD;&#xA;<LI>Leech JA, Ghezzo H, Stevens D, Becklake MR. Respiratory pressures and function in young adults. Am Rev Respir Dis 1983; 128:17.</LI>&#xD;&#xA;<LI>Harik-Khan RI, Wise RA, Fozard JL. Determinants of maximal inspiratory pressure: the Baltimore Longitudinal Study of Aging. Am J Respir Crit Care Med 1998; 158:1459.</LI>&#xD;&#xA;<LI>Enright PL, Kronmal RA, Manolino TA, et al. Respiratory muscle strength in the elderly. Correlates and reference values. Am J Respir Crit Care Med 1994; 149:430.</LI>&#xD;&#xA;<LI>Bruschi C, Cerveri I, Zoia MC, et al. Reference values of maximal respiratory mouth pressures: a population-based study. Am Rev Respir Dis 1992; 146:790.</LI></OL></div><div id=\"graphicVersion\">Graphic 52967 Version 3.0</div></div></div>"},"52969":{"type":"graphic_diagnosticimage","displayName":"Fistula to hip area BE","title":"Fistulous tract to right lower quadrant on barium enema","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Fistulous tract to right lower quadrant on barium enema</div><div class=\"cntnt\"><img style=\"width:316px; height:305px;\" src=\"images/GAST/52969_Fistula_to_hip_area_BE.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">A barium enema in a 64-year-old man with three weeks of right hip pain reveals extravasation of barium from a perforated sigmoid diverticulum with collection of contrast material in an abscess cavity (arrow) adjacent to the diverticulum. There is a fistulous communication extending from the abscess cavity toward the right lower quadrant to the region of the right hip (arrowhead).</div><div id=\"graphicVersion\">Graphic 52969 Version 3.0</div></div></div>"},"52970":{"type":"graphic_picture","displayName":"Transpancreatic precut","title":"Transpancreatic precut sphincterotomy","html":"<div class=\"graphic\"><div style=\"width: 471px\" class=\"figure\"><div class=\"ttl\">Transpancreatic precut sphincterotomy</div><div class=\"cntnt\"><img style=\"width:451px; height:515px;\" src=\"images/GAST/52970_Transpancreatic_precut.jpg\" alt=\"Image\"/></div><div class=\"graphic_reference\">Courtesy of Martin L Freeman, MD.</div><div id=\"graphicVersion\">Graphic 52970 Version 4.0</div></div></div>"},"52971":{"type":"graphic_diagnosticimage","displayName":"Zenkers diverticulum UGI","title":"Zenker's diverticulum","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Zenker's diverticulum</div><div class=\"cntnt\"><img style=\"width:251px; height:304px;\" src=\"images/GAST/52971_Zenkers_diverticulum_UGI.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Barium study of the upper esophagus of an 82-year-old woman with dysphagia demonstrates a large diverticulum arising from the posterior wall of the upper esophagus (large arrow) producing extrinsic narrowing of the more anterior esophageal lumen (arrow head).</div><div class=\"graphic_reference\">Courtesy of Jonathan Kruskal, MD, PhD.</div><div id=\"graphicVersion\">Graphic 52971 Version 2.0</div></div></div>"},"52972":{"type":"graphic_picture","displayName":"Seborrheic dermatitis diaper area PI","title":"Infantile seborrheic dermatitis involving the diaper area","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Infantile seborrheic dermatitis involving the diaper area</div><div class=\"cntnt\"><img style=\"width:432px; height:324px;\" src=\"images/PI/52972_Seborr_derm_diaper_area_PI.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Moist, glistening, non-scaly and confluent erythematous plaques&nbsp;involving the lower abdomen, groin area, and buttocks are characteristic of seborrheic dermatitis of the diaper area.</div><div class=\"graphic_reference\">Reproduced with permission from: <A style=\"FONT-STYLE: italic\" href=\"http://www.visualdx.com/\" target=_blank>www.visualdx.com</A>. Copyright Logical Images, Inc.</div><div id=\"graphicVersion\">Graphic 52972 Version 5.0</div></div></div>"},"52973":{"type":"graphic_figure","displayName":"Solid-phase enzyme-linked immunosorbent assay (ELISA)","title":"Solid-phase enzyme-linked immunosorbent assay (ELISA)","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Solid-phase enzyme-linked immunosorbent assay (ELISA)</div><div class=\"cntnt\"><img style=\"width:323px; height:562px;\" src=\"images/ALLRG/52973_Immunoassay_technique.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Many variations of the solid-phase immunoassay are possible. Depicted in the figure is a common antigen-binding immunoassay using a primary antibody (IgE in test serum) and secondary antibody (anti-IgE). The secondary antibody is labeled, either with a radioactive or fluorescent tag or with an enzyme that can act on a substrate to generate a detectable product.</div><div class=\"graphic_footnotes\">IgE: immunoglobulin E; IgG: immunoglobulin G; E: enzyme; S: substrate.</div><div id=\"graphicVersion\">Graphic 52973 Version 3.0</div></div></div>"},"52974":{"type":"graphic_picture","displayName":"Interstitial granulomatous dermatitis","title":"Interstitial granulomatous dermatitis","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Interstitial granulomatous dermatitis</div><div class=\"cntnt\"><img style=\"width:288px; height:284px;\" src=\"images/DERM/52974_Interstitialgranulomatous.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Erythematous, annular plaques are present on the trunk.</div><div id=\"graphicVersion\">Graphic 52974 Version 3.0</div></div></div>"},"52976":{"type":"graphic_figure","displayName":"Pivot shift test A","title":"Pivot shift test","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Pivot shift test</div><div class=\"cntnt\"><img style=\"width:426px; height:422px;\" src=\"images/EM/52976_Pivot_shift_test_A.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The pivot shift test is sensitive only in a fully relaxed patient. The test is performed with the knee starting in extension. The clinician holds the lower leg with one hand and internally rotates the tibia, while placing a valgus stress on the knee using the other hand. While maintaining the forces described, the clinician flexes the knee. In the ACL-deficient knee this causes a reduction of the subluxed tibia, which the clinician senses as a 'clunk,' and which constitutes a positive test.</div><div class=\"graphic_reference\">Courtesy of Ryan P Friedberg, MD.</div><div id=\"graphicVersion\">Graphic 52976 Version 1.0</div></div></div>"},"52977":{"type":"graphic_picture","displayName":"Widow bite","title":"Redback spider bite","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Redback spider bite</div><div class=\"cntnt\"><img style=\"width:432px; height:375px;\" src=\"images/EM/52977_Widow_bite.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The blanched circular patch with a surrounding red perimeter and central punctum is typical for widow spider bites. This lesion was caused by an Australian redback spider (<EM>Latrodectus hasselti</EM>).</div><div class=\"graphic_reference\">Reproduced with permission from Julian White, MD.</div><div id=\"graphicVersion\">Graphic 52977 Version 2.0</div></div></div>"},"52982":{"type":"graphic_table","displayName":"Evaluation of patients prior to initiation of PrEP against HIV","title":"Evaluation of patients prior to initiation of pre-exposure prophylaxis (PrEP) against HIV","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Evaluation of patients prior to initiation of pre-exposure prophylaxis (PrEP) against HIV</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1_single\">Before initiating PrEP</td> </tr> <tr> <td class=\"indent1\"><strong>Determine eligibility</strong>*</td> </tr> <tr> <td class=\"indent2\">Document negative HIV test(s) immediately before starting PrEP medication</td> </tr> <tr> <td class=\"indent2\">Test for acute HIV infection with HIV RNA if patient has symptoms consistent with acute HIV infection or has had a high-risk exposure in the last four weeks</td> </tr> <tr> <td class=\"indent2\">Confirm that patient is at substantial, ongoing, high risk for acquiring HIV infection based upon detailed sexual and drug use history and results of STI testing</td> </tr> <tr> <td class=\"indent2\">Confirm that calculated estimated glomerular filtration rate is &#8805;60 mL/min/1.73 m<sup>2</sup></td> </tr> <tr> <td class=\"indent1\"><strong>Other recommended tests to determine risks of PrEP</strong></td> </tr> <tr> <td class=\"indent2\">Screen for HBV<sup>&#182;</sup></td> </tr> <tr> <td class=\"indent2\">Obtain urinalysis in patients with risk factors for renal disease<sup>&#916;</sup></td> </tr> <tr> <td class=\"indent2\">Perform DXA scan in patients with, or at high risk for, osteoporosis<sup>&#9674;</sup></td> </tr> <tr class=\"divider_bottom\"> <td class=\"indent2\">Perform pregnancy testing for patients who could become pregnant</td> </tr> <tr> <td class=\"subtitle1_single\">Beginning PrEP medication regimen</td> </tr> <tr> <td class=\"indent1\">Prescribe 1 tablet of TDF-FTC daily</td> </tr> <tr> <td class=\"indent1\">In general, prescribe no more than a 90-day supply, renewable only after HIV testing confirms that patient remains HIV uninfected</td> </tr> <tr> <td class=\"indent1\">Provide counseling on condoms,<sup>&#167;</sup> risk reduction, and PrEP medication adherence</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">DXA: dual-energy x-ray absorptiometry; FTC: emtricitabine; HBV: hepatitis B virus; HIV: human immunodeficiency virus; PrEP: pre-exposure prophylaxis; STI: sexually transmitted infection; TDF: tenofovir disoproxil fumarate.<br />* Refer to the topic on pre-exposure prophylaxis for discussions of HIV testing and how to assess high-risk HIV behaviors.<br />Â¶ Vaccinate against hepatitis B if susceptible. If&nbsp;chronic HBV is diagnosed, TDF-FTC can be used for both treatment of chronic HBV and HIV prevention; however patients should also be referred to a specialist with an expertise in the management of HBV.<br />Î Risk factors for renal disease include hypertension, diabetes, proteinuria, and prior history of renal insufficiency.<br /><FONT class=lozenge>â</FONT> Refer to the topic within UpToDate that discusses risk factors for osteoporosis.<br />Â§ In addition to preventing sexually transmitted infections, condoms should be encouraged until adequate levels of tenofovir are achieved in the rectal and cervicovaginal tissues (7 days in patients engaging exclusively in receptive anal sex and 21 days for women engaging in receptive vaginal sex).</div><div class=\"graphic_reference\">References:&#xD;&#xA;<ol>&#xD;&#xA;    <li>Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. MMWR 2011; 60:65.</li>&#xD;&#xA;    <li>Interim Guidance for Clinicians Considering the Use of Preexposure Prophylaxis for the Prevention of HIV Infection in Heterosexually Active Adults. MMWR 2012; 61:586.</li>&#xD;&#xA;    <li>US Public Health Service. United States Public Health Service Clinical Practice Guideline. Available at: <a href=\"http://www.cdc.gov/hiv/pdf/prepguidelines2014.pdf\" target=\"_blank\">http://www.cdc.gov/hiv/pdf/prepguidelines2014.pdf</a> (Accessed on July 10, 2014).</li>&#xD;&#xA;    <li>Cohen S, Vittinghoff E, Philip SS. Quarterly STI screening optimizes STI detection among PrEP users in the Demo Project. Presented at the Conference on Retroviruses and Opportunistic Infections, Boston MA, February 22-25, 2016. Abstract #877.</li>&#xD;&#xA;</ol></div><div id=\"graphicVersion\">Graphic 52982 Version 10.0</div></div></div>"},"52983":{"type":"graphic_table","displayName":"ACP Best Practice Advice - Lower back pain","title":"American College of Physicians best practice advice: Diagnostic imaging for low back pain","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">American College of Physicians best practice advice: Diagnostic imaging for low back pain</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td rowspan=\"3\">Diagnostic imaging techniques</td> <td>Radiography</td> </tr> <tr> <td>Computed tomography (CT)</td> </tr> <tr> <td>Magnetic resonance imaging (MRI)</td> </tr> <tr class=\"divider_top\"> <td rowspan=\"4\">Indications for diagnostic imaging</td> <td> <p>Radiography is recommended in patients with acute low back pain who have major risk factors for cancer (new onset of low back pain with history of cancer, multiple risk factors for cancer, or strong clinical suspicion for cancer).</p> <p>MRI is recommended in patients with acute low back pain who have risk factors for spinal infection (new onset of low back pain with fever and history of intravenous drug use or recent infection), risk factors for or signs of the cauda equina syndrome (new urinary retention, fecal incontinence, or saddle anesthesia), or severe or progressive neurologic deficits.</p> </td> </tr> <tr> <td> <p>Radiography is recommended after a trial of therapy in patients with minor risk factors for cancer (unexplained weight loss or age &#62;50 years), risk factors for ankylosing spondylitis (morning stiffness that improves with exercise, alternating buttock pain, awakening because of back pain during the second part of the night), risk factors for vertebral compression fracture (history of osteoporosis, glucocorticoid use, significant trauma, or older age [&#62;65 years for men or &#62;75 years for women]).</p> <p>MRI is recommended after a trial of therapy in patients with signs/symptoms of radiculopathy (back pain with leg pain in an L4, L5, or S1 nerve root distribution or positive result on straight leg raise or crossed straight leg raise test) who are candidates for surgery or epidural steroid injection. MRI is also recommended in patients with risk factors for or symptoms of symptomatic spinal stenosis (radiating leg pain, older age, or pseudoclaudication) in patients who are candidates for surgery.</p> </td> </tr> <tr> <td>MRI is generally preferred over CT scan for most cases of low back pain. CT scan may help visualize bony abnormalities and is used when patients have a magnetic implant that is not suitable for MRI.</td> </tr> <tr> <td>Repeated imaging is only recommended in patients with new or changed low back symptoms.</td> </tr> <tr class=\"divider_top\"> <td rowspan=\"2\">Evidence that expanding imaging to patients without these indications does not improve outcomes</td> <td>Randomized trials of routine imaging versus usual care without routine imaging in patients without indications for diagnostic imaging suggest no clinically meaningful benefits on outcomes related to pain, function, quality of life, or mental health.</td> </tr> <tr> <td>Other supporting evidence includes the weak correlation between most imaging findings and symptoms, the favorable natural history of acute low back pain with or without imaging, the low prevalence of serious or specific underlying conditions, and unclear effects of imaging on treatment decisions.</td> </tr> <tr class=\"divider_top\"> <td rowspan=\"4\">Harms of unnecessary imaging</td> <td>Radiation exposure (for lumbar radiography and CT)</td> </tr> <tr> <td>Labeling</td> </tr> <tr> <td>Hypersensitivity reactions and contrast nephropathy (for iodinated contrast with CT)</td> </tr> <tr> <td>Potential association with subsequent unnecessary, invasive, and expensive procedures</td> </tr> <tr class=\"divider_top\"> <td rowspan=\"4\">Approaches to overcome barriers to evidence-based practice</td> <td>Patient expectations or preferences for routine imaging: Use talking points based on evidence-based guidelines to aid in patient education</td> </tr> <tr> <td>Time constraints: Use evidence-based online or print education material to supplement face-to-face education</td> </tr> <tr> <td>Clinician uncertainty: Recognize the low likelihood of serious conditions in the absence of clinical risk factors and the evidence that shows no benefit associated with routine imaging</td> </tr> <tr> <td>Clinician incentives based on patient satisfaction: Advocate for incentives that are based on providing appropriate care</td> </tr> <tr class=\"divider_top\"> <td rowspan=\"7\">Talking points for clinicians when discussing low back pain imaging with patients</td> <td>Risk factor assessment can almost always identify patients who require imaging</td> </tr> <tr> <td>The prevalence of serious underlying conditions is low in patients without risk factors</td> </tr> <tr> <td>The natural history of acute low back pain is quite favorable, but patients require reevaluation if they are not better after about&nbsp;one month</td> </tr> <tr> <td>Routine imaging does not improve clinical outcomes but increases costs and may lead to potentially unnecessary invasive treatments, such as surgery</td> </tr> <tr> <td>Imaging abnormalities are extremely common, especially in older adults, but most are poorly correlated with symptoms</td> </tr> <tr> <td>In most cases, treatment plans do not change after imaging studies</td> </tr> <tr> <td>Back imaging is associated with radiation exposure, which can increase the risk for cancer in the case of lumbar radiography and CT</td> </tr> </tbody></table></div><div class=\"graphic_reference\">Modified and reproduced with permission from: Chou R, Qaseem A, Owens DK, et al. Diagnostic imaging for low back pain: Advice for high-value health care from the American College of Physicians. Ann Intern Med 2011; 154:181. Copyright Â© 2011 American College of Physicians.</div><div id=\"graphicVersion\">Graphic 52983 Version 12.0</div></div></div>"},"52984":{"type":"graphic_picture","displayName":"CMV esophagitis Light","title":"CMV esophagitis","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">CMV esophagitis</div><div class=\"cntnt\"><img style=\"width:317px; height:288px;\" src=\"images/ID/52984_CMV_esophagitis_Light.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Light micrograph from a patient with esophagitis due to cytomegalovirus (CMV) shows mucosal inflammation and large cells containing eosinophilic intranuclear and basophilic intracytoplasmic inclusions (arrow).</div><div class=\"graphic_reference\">Courtesy of Robert Odze, MD.</div><div id=\"graphicVersion\">Graphic 52984 Version 1.0</div></div></div>"},"52988":{"type":"graphic_picture","displayName":"Merkel cell carcinoma - forearm","title":"Merkel cell carcinoma","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Merkel cell carcinoma</div><div class=\"cntnt\"><img style=\"width:396px; height:254px;\" src=\"images/ONC/52988_Merkel_cell_cancer.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Large, eroded Merkel cell carcinoma nodule arising on the forearm.</div><div class=\"graphic_reference\">Reproduced with permission from: Fitzpatrick TB, Johnson RA, Wolff K, Suurmond D. Color Atlas &amp; Synopsis of Clinical Dermatology. Common &amp; Serious Diseases. (4th Ed). McGraw-Hill, New York 2001. pgs. 268 &amp; 289. Copyright Â© 2001 McGraw-Hill.</div><div id=\"graphicVersion\">Graphic 52988 Version 5.0</div></div></div>"},"52989":{"type":"graphic_table","displayName":"Activity energy child","title":"Age-adjusted metabolic equivalents of adolescent boys and girls as multiples of resting metabolic rate","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Age-adjusted metabolic equivalents of adolescent boys and girls as multiples of resting metabolic rate</div><div class=\"cntnt\"><table cellspacing=\"0\">\r\n            <tbody>\r\n                <tr>\r\n                    <td class=\"subtitle1\" rowspan=\"2\">Activity</td>\r\n                    <td class=\"subtitle1\" colspan=\"2\">Age-adjusted metabolic equivalents (MET)*</td>\r\n                </tr>\r\n                <tr>\r\n                    <td class=\"subtitle2\">Ages: 13-15 years for boys and 12-14 years for girls</td>\r\n                    <td class=\"subtitle2\">Ages: 16-18 years for boys and 15-18 years for girls</td>\r\n                </tr>\r\n                <tr>\r\n                    <td>Homework/reading</td>\r\n                    <td>1.17</td>\r\n                    <td>1.13</td>\r\n                </tr>\r\n                <tr>\r\n                    <td>TV watching</td>\r\n                    <td>1.06</td>\r\n                    <td>1.02</td>\r\n                </tr>\r\n                <tr>\r\n                    <td>Video game sitting</td>\r\n                    <td>1.28</td>\r\n                    <td>1.26</td>\r\n                </tr>\r\n                <tr>\r\n                    <td>Video game standing</td>\r\n                    <td>1.47</td>\r\n                    <td>1.47</td>\r\n                </tr>\r\n                <tr>\r\n                    <td>Sweeping</td>\r\n                    <td>3.12</td>\r\n                    <td>2.83</td>\r\n                </tr>\r\n                <tr>\r\n                    <td>Walking 2.5 mph</td>\r\n                    <td>3.49</td>\r\n                    <td>3.32</td>\r\n                </tr>\r\n                <tr>\r\n                    <td>Vacuuming</td>\r\n                    <td>3.81</td>\r\n                    <td>3.37</td>\r\n                </tr>\r\n                <tr>\r\n                    <td>Walking 3.5 mph</td>\r\n                    <td>4.66</td>\r\n                    <td>4.52</td>\r\n                </tr>\r\n                <tr>\r\n                    <td>Stair climbing</td>\r\n                    <td>6.51</td>\r\n                    <td>6.51</td>\r\n                </tr>\r\n                <tr>\r\n                    <td>Rope skipping</td>\r\n                    <td>8.04</td>\r\n                    <td>7.52</td>\r\n                </tr>\r\n                <tr>\r\n                    <td>Running 5 mph</td>\r\n                    <td>8.25</td>\r\n                    <td>8.13</td>\r\n                </tr>\r\n            </tbody>\r\n        </table></div><div class=\"graphic_footnotes\">* Age-adjusted metabolic equivalent (MET) = VO<SUB>2</SUB> of activity/VO<SUB>2</SUB> at rest.</div><div class=\"graphic_reference\">Data from: Harrell, JS, McMurray, RG, Baggett, CD, et al. Energy costs of physical activities in children and adolescents. Med Sci Sports Exerc 2005; 37:329.</div><div id=\"graphicVersion\">Graphic 52989 Version 2.0</div></div></div>"},"52991":{"type":"graphic_figure","displayName":"Examining the peripheral smear","title":"How to examine the peripheral blood smear","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">How to examine the peripheral blood smear</div><div class=\"cntnt\"><img style=\"width:419px; height:210px;\" src=\"images/HEME/52991_Examining_the_peripheral_sm.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">This schematic depicts a well-made peripheral blood smear. A drop of blood has been placed on the left-hand side of a clean glass slide at point A, and has been pulled towards the right-hand side using another glass slide, stopping at point B. The area near point A is too thick and too darkly stained for interpretation, whereas the area at the very end of the smear, near point B (the &quot;feather edge&quot;) is too thin, distorting the morphology of all cells in that area. The optimal area for viewing is just behind point B (shown by the asterisk), in an area where the red blood cells are just touching and demonstrate central pallor.</div><div id=\"graphicVersion\">Graphic 52991 Version 2.0</div></div></div>"},"52992":{"type":"graphic_diagnosticimage","displayName":"Midshaft clavicle fracture with superior displacement","title":"Midshaft clavicle fracture with superior displacement","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Midshaft clavicle fracture with superior displacement</div><div class=\"cntnt\"><img style=\"width:396px; height:375px;\" src=\"images/EM/52992_Clav_mid3_fx_sup_disp.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">A fracture of the middle third of the clavicle with complete displacement is shown. Note the typical upward displacement of the proximal fragment caused by the pull of the sternocleidomastoid muscle. Displacement is approximately two and one half times the width of the clavicle, greater than is typically seen.</div><div class=\"graphic_reference\">Courtesy of Robert L Hatch, MD, MPH.</div><div id=\"graphicVersion\">Graphic 52992 Version 2.0</div></div></div>"},"52997":{"type":"graphic_figure","displayName":"Estrogen therapy and treatment of Alzheimer","title":"EstrogenÂ therapy is not effective for treatment of Alzheimer disease","html":"<div class=\"graphic\"><div style=\"width: 485px\" class=\"figure\"><div class=\"ttl\">Estrogen&nbsp;therapy is not effective for treatment of Alzheimer disease</div><div class=\"cntnt\"><img style=\"width:465px; height:309px;\" src=\"images/ENDO/52997_ERT_and_treatment_of_Alzhei.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Data from a randomized clinical trial shows no difference between estrogen replacement therapy and placebo on the course of Alzheimer disease using a Clinical Global Impression of Change score (mean, 95% CI).</div><div class=\"graphic_reference\">Data from: Mulnard RA, Cotman CW, Kawas C, et al. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Society. JAMA 2000; 283:1007.</div><div id=\"graphicVersion\">Graphic 52997 Version 6.0</div></div></div>"}};